"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value";"Value"
"CHEMBL3947422";"";"None";"439.56";"0";"3.48";"BDBM198510";"CC(C)(C)OC(=O)N[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353488";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL237347";"GW559768X";"None";"328.39";"0";"3.40";"GW559768X";"Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12";"Inhibition";"'='";"9.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"9.66"
"CHEMBL4788122";"";"None";"422.46";"0";"2.39";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cccnn2)c1OC";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"21.11";"0.39";"6.46";"6.76";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.4"
"CHEMBL4784838";"";"None";"498.53";"0";"2.76";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"0.51";"nM";"9.29";"";"";"UO_0000065";"18.75";"0.35";"6.53";"6.14";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.51"
"CHEMBL4796821";"";"None";"479.56";"0";"3.23";"26";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"19.56";"0.36";"6.09";"6.74";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.48"
"CHEMBL4759666";"";"None";"411.94";"0";"4.04";"30b";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2cccc(Cl)c2)CC1";"GI50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";"";"10.0"
"CHEMBL459850";"";"None";"456.43";"0";"4.21";"8";"Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O";"EC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL966747";"Inhibition of Tyk2 by cellular assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149823";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";"";"2000.0"
"CHEMBL4789693";"";"None";"411.94";"0";"4.04";"31b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)[C@@H](C)C1";"IC50";"'='";"61.7";"nM";"7.21";"";"";"UO_0000065";"17.50";"0.34";"3.17";"9.87";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"61.7"
"CHEMBL3359907";"";"None";"260.34";"0";"2.28";"3a";"C[C@@H](Nc1c(C(N)=O)cnn2cccc12)C(C)(C)C";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"29.94";"0.56";"5.52";"10.76";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"16.0"
"CHEMBL3359912";"";"None";"288.35";"0";"1.39";"4a";"CC1(C)[C@@H](O)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"24.63";"0.46";"5.71";"7.67";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"79.0"
"CHEMBL3359913";"";"None";"288.35";"0";"1.39";"4b";"CC1(C)[C@H](O)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"26.56";"0.50";"6.27";"8.27";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"22.0"
"CHEMBL259850";"";"None";"308.32";"0";"2.38";"SID103904634";"COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3354191";"";"None";"382.47";"0";"2.74";"10";"COC1CCN(c2nccc(Nc3cc4c(cn3)c(N)nn4C(C)C)n2)CC1";"Inhibition";"'<'";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3375811";"Inhibition of Tyk2 (unknown origin) at 1000 nM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"20.0"
"CHEMBL2035184";"";"None";"478.62";"1";"5.03";"14k, 95:5 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2csc(c2)COC/1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"15.31";"0.29";"2.30";"10.66";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.047"
"CHEMBL3976846";"";"None";"378.48";"0";"2.62";"BDBM255004";"N#CCNC[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"443994";"UO_0000065";"18.39";"0.34";"4.34";"7.90";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"110.0"
"CHEMBL3892672";"";"None";"395.43";"0";"3.12";"BDBM255007";"CN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"62.0";"nM";"7.21";"";"443997";"UO_0000065";"18.23";"0.35";"4.09";"11.22";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"62.0"
"CHEMBL3898972";"";"None";"431.56";"0";"2.40";"BDBM255027";"CN(C[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O";"IC50";"'='";"260.0";"nM";"6.58";"";"444017";"UO_0000065";"15.26";"0.30";"4.19";"7.35";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"260.0"
"CHEMBL3984749";"";"None";"417.54";"0";"2.01";"BDBM254982";"CN1CN([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"94.0";"nM";"7.03";"";"444023";"UO_0000065";"16.83";"0.33";"5.02";"7.84";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"94.0"
"CHEMBL573339";"PI-103";"None";"348.36";"0";"2.98";"PI-103";"Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL1721885";"SU-014813";"2.0";"442.49";"0";"1.69";"SU-14813";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1";"Kd";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"11.96";"0.23";"3.60";"4.96";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"5100.0"
"CHEMBL463931";"GSK-2163632A";"None";"548.67";"1";"4.19";"GSK2163632A";"COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C";"Inhibition";"'='";"-4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.11"
"CHEMBL3105873";"";"None";"345.36";"0";"1.94";"1e";"NC(=O)c1cc(-c2cccc3[nH]ncc23)cc2c(C#CCCO)n[nH]c12";"Inhibition";"'='";"9.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"9.3"
"CHEMBL3105869";"";"None";"277.29";"0";"2.21";"1a";"NC(=O)c1cc(-c2cccc3[nH]ncc23)cc2cn[nH]c12";"Inhibition";"'='";"7.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"7.8"
"CHEMBL261454";"";"None";"272.31";"0";"3.69";"14";"c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL1288001";"";"None";"358.35";"0";"2.64";"19";"CN(C)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1292869";"Inhibition of TYK2-mediated INFgamma production in IL-12-stimulated human PBMC at 10 uM treated for 15 mins before IL12 challenge measured after 48 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL210928";"";"None";"443.91";"0";"2.32";"35";"CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL862052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148638";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1900.0"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.205";"nM";"9.69";"";"";"UO_0000065";"20.77";"0.38";"5.34";"13.95";"0";"CHEMBL4328665";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"2.05"
"CHEMBL3655082";"";"None";"337.45";"0";"1.50";"BDBM159749";"CC(C)CS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"479.0";"nM";"6.32";"";"302643";"UO_0000065";"18.73";"0.38";"4.82";"6.95";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"479.0"
"CHEMBL3648431";"";"None";"309.39";"0";"3.60";"BDBM107140";"CSCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226450";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL3648438";"";"None";"335.36";"0";"3.19";"BDBM107147";"CCOC(=O)CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226457";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL2012574";"";"None";"337.35";"0";"3.96";"42, LDN-211898";"COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1";"Inhibition";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2014517";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010722";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"15.0"
"CHEMBL479038";"GW806776X";"None";"334.42";"0";"3.39";"GW806776X";"O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1";"Inhibition";"'='";"-2.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.99"
"CHEMBL176857";"GW442130X";"None";"502.16";"2";"5.48";"GW442130X";"COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O";"Inhibition";"'='";"-1.22";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.22"
"CHEMBL477989";"SB590885";"None";"453.55";"0";"4.87";"EUB0000655a";"CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1";"% of control";"'='";"52.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5473113";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000655a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 13.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20023/results";"";"";"52.0"
"CHEMBL14762";"SELICICLIB";"2.0";"354.46";"0";"3.20";"EUB0000650a";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5472603";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000650a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 12.0 None | Selectivity number of targets = 456.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH1domain-catalytic) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20124/";"";"";"100.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"Ki";"'='";"4.39";"nM";"8.36";"";"";"UO_0000065";"26.75";"0.50";"6.82";"9.40";"0";"CHEMBL5473628";"Selectivity interaction (Peptide mobility shift assay) EUB0000286bCit TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Remarks: In-vitro potency | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"4.39"
"CHEMBL3906872";"";"None";"376.42";"0";"3.12";"BDBM198206";"O=C(OCc1ccccc1)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1";"IC50";"'='";"2200.0";"nM";"5.66";"";"353188";"UO_0000065";"15.03";"0.28";"2.54";"6.40";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2200.0"
"CHEMBL3986686";"";"None";"339.43";"0";"2.44";"BDBM198211";"c1cc2c(ncn3nnc(C4CCCN(Cc5cncs5)C4)c23)[nH]1";"IC50";"'='";"1000.0";"nM";"6.00";"";"353193";"UO_0000065";"17.68";"0.34";"3.56";"8.00";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3933612";"";"None";"376.42";"0";"3.12";"BDBM198218";"O=C(OCc1ccccc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353200";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3931293";"";"None";"352.32";"0";"2.26";"BDBM198221";"O=C(CC(F)(F)F)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353203";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3969865";"";"None";"369.41";"0";"1.87";"BDBM198222";"O=C(Nc1nncs1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"353204";"UO_0000065";"18.13";"0.35";"4.83";"5.73";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL3890660";"";"None";"414.44";"0";"4.05";"BDBM198234";"FC(F)(F)c1ccc(CCN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353216";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3983078";"";"None";"339.43";"0";"2.44";"BDBM198236";"c1cc2c(ncn3nnc(C4CCN(Cc5cncs5)CC4)c23)[nH]1";"IC50";"'='";"120.0";"nM";"6.92";"";"353218";"UO_0000065";"20.39";"0.39";"4.48";"9.23";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"120.0"
"CHEMBL3917774";"";"None";"255.32";"0";"3.04";"BDBM198259";"c1cc2c(ncn3nnc(C4CCCCCC4)c23)[nH]1";"IC50";"'='";"27.0";"nM";"7.57";"";"353241";"UO_0000065";"29.64";"0.54";"4.53";"12.86";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"27.0"
"CHEMBL3900224";"";"None";"309.30";"0";"3.44";"BDBM198262";"FC(F)(F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"353243";"UO_0000065";"23.88";"0.46";"3.95";"12.55";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"41.0"
"CHEMBL3922488";"";"None";"363.47";"0";"3.11";"BDBM198282";"N#CC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"610.0";"nM";"6.21";"";"353260";"UO_0000065";"17.10";"0.31";"3.10";"7.23";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"610.0"
"CHEMBL3900746";"";"None";"428.46";"0";"4.69";"BDBM198291";"FC(F)(F)c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"2.6";"nM";"8.59";"";"353269";"UO_0000065";"20.04";"0.38";"3.90";"12.11";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.6"
"CHEMBL3926748";"";"None";"326.40";"0";"1.96";"BDBM198317";"c1cc2c(ncn3nnc(C4CCC(N5CCOCC5)CC4)c23)[nH]1";"IC50";"'='";"550.0";"nM";"6.26";"";"353295";"UO_0000065";"19.18";"0.36";"4.30";"8.77";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"550.0"
"CHEMBL3912553";"";"None";"373.87";"0";"3.10";"BDBM198349";"Clc1ncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'='";"91.0";"nM";"7.04";"";"353327";"UO_0000065";"18.83";"0.38";"3.94";"9.39";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"91.0"
"CHEMBL3908624";"";"None";"410.50";"0";"2.39";"BDBM198355";"CS(=O)(=O)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"650.0";"nM";"6.19";"";"353333";"UO_0000065";"15.07";"0.29";"3.80";"6.43";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"650.0"
"CHEMBL3917860";"";"None";"458.49";"0";"3.92";"BDBM198371";"OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F";"IC50";"'='";"630.0";"nM";"6.20";"";"353349";"UO_0000065";"13.52";"0.26";"2.28";"6.80";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"630.0"
"CHEMBL3965520";"";"None";"390.47";"0";"4.08";"BDBM198378";"Fc1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353356";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3954819";"";"None";"376.46";"0";"2.96";"BDBM198405";"OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'='";"260.0";"nM";"6.58";"";"353383";"UO_0000065";"17.49";"0.32";"3.63";"7.23";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"260.0"
"CHEMBL3936927";"";"None";"256.31";"0";"1.41";"BDBM198419";"CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353397";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3961357";"";"None";"375.41";"0";"3.00";"BDBM198425";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F";"IC50";"'='";"770.0";"nM";"6.11";"";"353403";"UO_0000065";"16.28";"0.30";"3.11";"7.12";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"770.0"
"CHEMBL3894366";"";"None";"412.40";"0";"3.31";"BDBM198432";"FC1(F)Oc2cccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)c2O1";"IC50";"'>'";"1000.0";"nM";"";"";"353410";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3936877";"";"None";"402.29";"0";"3.69";"BDBM198434";"Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)n1";"IC50";"'='";"610.0";"nM";"6.21";"";"353412";"UO_0000065";"15.45";"0.31";"2.52";"8.29";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"610.0"
"CHEMBL3917783";"";"None";"403.88";"0";"4.00";"BDBM198438";"N#C/C(=C\N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(Cl)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353416";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL268885";"GSK-711701A";"None";"416.89";"0";"3.43";"GSK711701A";"COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"-0.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.68"
"CHEMBL247228";"GW770249X";"None";"431.35";"1";"5.27";"GW770249X";"Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12";"Inhibition";"'='";"0.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.28"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445888";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-21, JAK1/3, pSTAT3 in rat CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"187.0"
"CHEMBL1796254";"";"None";"553.13";"1";"3.20";"11";"COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1";"Inhibition";"'<'";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1798380";"Inhibition of TYK2 domain 2 at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1795227";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";"";"65.0"
"CHEMBL1909381";"GW575808A";"None";"371.83";"0";"3.08";"GW575808A";"Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl";"Inhibition";"'='";"16.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"16.87"
"CHEMBL188426";"GW807982X";"None";"430.39";"0";"4.36";"GW807982X";"CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1";"Inhibition";"'='";"1.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.53"
"CHEMBL5207953";"";"None";"564.65";"1";"3.43";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3C([2H])([2H])CCC3([2H])[2H])cc2)c1OC";"Tm";"'='";"59.5";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"59.5"
"CHEMBL5203217";"";"None";"597.65";"1";"3.32";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3[C@H](C#N)C[C@@H]4C[C@@H]43)cc2)c1OC";"Tm";"'='";"63.7";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"63.7"
"CHEMBL5204955";"";"None";"596.68";"1";"2.97";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"58.25";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"58.25"
"CHEMBL5189220";"";"None";"534.59";"1";"2.94";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NCC)cc2)c1OC";"IC50";"'='";"9.6";"nM";"8.02";"";"";"UO_0000065";"15.08";"0.28";"5.08";"4.91";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"9.6"
"CHEMBL3658858";"";"None";"374.47";"0";"1.35";"BDBM159777";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CC[C@@H](C#N)C2)C1";"IC50";"'='";"444.0";"nM";"6.35";"";"302671";"UO_0000065";"16.96";"0.33";"5.00";"5.99";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"444.0"
"CHEMBL1987034";"";"None";"475.33";"0";"3.28";"SID103904592";"N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1";"Ki";"'='";"6.31";"nM";"8.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"8.2"
"CHEMBL1972840";"";"None";"400.51";"0";"4.79";"SID103904751";"NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974457";"";"None";"273.29";"0";"3.80";"SID103905049";"O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975900";"";"None";"348.19";"0";"3.34";"SID103905263";"O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL378627";"";"None";"448.50";"0";"1.92";"SID103905196";"COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990496";"";"None";"461.57";"0";"4.64";"SID103905562";"Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997623";"";"None";"411.39";"1";"5.47";"SID103904367";"Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL451401";"";"None";"161.16";"0";"0.66";"SID103904656";"NC(=O)c1cccc2cn[nH]c12";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL1982122";"";"None";"361.47";"0";"4.89";"SID103904560";"OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006237";"";"None";"393.50";"0";"1.77";"SID103904687";"CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965631";"";"None";"375.44";"0";"2.37";"SID103904529";"CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL231209";"";"None";"378.43";"1";"5.33";"SID103904347";"Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000104";"";"None";"346.43";"0";"2.86";"SID103905051";"CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL402846";"";"None";"390.42";"0";"4.31";"SID103904342";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1682359";"";"None";"227.27";"0";"3.17";"SID103904543";"CCCc1cc(-c2ccc3[nH]ncc3c2)on1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL207995";"";"None";"331.72";"0";"2.47";"SID103904885";"COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001923";"";"None";"675.71";"2";"7.94";"SID103905427";"O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL387971";"";"None";"476.60";"0";"3.11";"SID103904812";"COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1967560";"";"None";"522.65";"1";"3.61";"SID103904643";"CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL272453";"";"None";"408.85";"1";"5.38";"SID103904857";"COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979252";"";"None";"347.30";"0";"3.05";"SID103905144";"O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1986499";"";"None";"384.42";"0";"4.26";"SID103904466";"Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001288";"";"None";"393.14";"0";"-1.38";"SID103905653";"Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL260092";"";"None";"441.42";"0";"4.66";"SID103904742";"Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972489";"";"None";"271.71";"0";"3.47";"SID103904665";"O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999112";"";"None";"409.42";"0";"1.09";"SID103905318";"CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996066";"";"None";"317.38";"0";"3.60";"SID103904819";"N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969755";"";"None";"350.39";"0";"3.22";"SID103904580";"O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL233002";"";"None";"350.42";"1";"5.04";"SB-814597";"N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2";"Inhibition";"'='";"-3.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.01"
"CHEMBL1975418";"";"None";"315.38";"0";"3.75";"SID103904512";"c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1986530";"";"None";"448.50";"0";"2.13";"SID103905570";"O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1983006";"";"None";"347.72";"0";"2.35";"SID103904900";"COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996111";"";"None";"346.39";"0";"2.57";"SID103904518";"CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL468280";"";"None";"282.66";"0";"2.25";"SID103905547";"CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006276";"";"None";"332.36";"0";"4.14";"SID103904673";"COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006785";"";"None";"361.25";"1";"5.64";"SID103904745";"Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991063";"";"None";"427.34";"1";"5.19";"SID103904480";"Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979093";"";"None";"406.42";"1";"5.18";"SID103904351";"COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5207105";"";"None";"423.42";"0";"3.09";"17";"CCNC(=O)Cc1ccc(Nc2cc(-c3c(F)cccc3F)nc3c2C(=O)NC3)nc1";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"20.99";"0.39";"5.80";"9.26";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"1.3"
"CHEMBL5072425";"";"None";"324.39";"0";"2.24";"8";"Cn1cc(Nc2ncc3cccc(OC4CCNCC4)c3n2)cn1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"20.35";"0.38";"4.36";"8.58";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.6"
"CHEMBL5073925";"";"None";"255.28";"0";"2.12";"11";"COc1cccc2cnc(Nc3cnn(C)c3)nc12";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"24.29";"0.45";"4.08";"9.56";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.2"
"CHEMBL5084129";"";"None";"337.43";"0";"2.64";"5";"Cc1cnc(Nc2ccccc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"21.30";"0.39";"4.55";"10.25";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"65.0"
"CHEMBL5086893";"";"None";"436.56";"0";"2.86";"53";"Cc1cnc(Nc2ccc(N3CCOC(C)C3)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"17.20";"0.32";"4.65";"9.09";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"31.0"
"CHEMBL1290746";"";"None";"420.40";"0";"3.39";"2j";"Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292175";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"5.0"
"CHEMBL4554938";"";"None";"416.49";"0";"2.29";"EUB0000178b";"CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21";"% of control";"'='";"2.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5213018";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000178b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity Comments: XMU-MP-1 treatment inhibited hydrogen peroxide (H2O2)-Âstimulated MOB1 phosphorylation and MST1/2 autophosphorylation in a variety of cell lines, including mouse macrophage-like cells (RAW264.7), human osteosarcoma (U2OS), human colorectal adenocarcinoma (SW480), immortalized human retinal pigment epithelial cells (RPE1), human pleomorphic hepatocellular carcinoma (SNU-423): EC50 <3 ÂµM, PMID: 27535619; | Selectivity number of off-targets = 20.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 ÂµM (in vitro, S(10) = 0.05), TYK2 (JH1 catalytic domain) | Selectivity Source Knowledge: https://doi.org/10.1126/scitranslmed.aaf2304";"";"";"2.7"
"CHEMBL3675694";"";"None";"445.34";"0";"4.86";"BDBM120137";"CCc1cc(Nc2nccc3nc(-c4c(Cl)cc(C(N)=O)cc4Cl)sc23)ncn1";"Ki";"'='";"1.6";"nM";"8.80";"";"247343";"UO_0000065";"19.75";"0.41";"3.94";"8.25";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1.6"
"CHEMBL5409666";"";"None";"335.37";"0";"3.07";"1a";"COc1ccccc1Nc1cc(Nc2ccccn2)ncc1C(N)=O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"24.52";"0.45";"5.15";"8.05";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"6.0"
"CHEMBL5278999";"";"None";"529.58";"1";"3.37";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3cccn3)cc2)c1OC";"Tm";"'='";"56.24";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"56.24"
"CHEMBL5284638";"";"None";"556.60";"1";"3.34";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccccc3=O)cc2)c1OC";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"15.35";"0.28";"5.15";"5.43";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"3.2"
"CHEMBL604483";"";"None";"559.67";"2";"5.86";"23";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1";"Residual activity";"'='";"102.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1073157";"Residual activity of TYK2 at 0.1 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"102.0"
"CHEMBL2035041";"";"None";"379.51";"0";"3.45";"13a, 95:5 trans/Cis mixture";"CN1C/C=C/COCC2CCCN(C2)c2ccnc(n2)Nc2cccc(c2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"10.0"
"CHEMBL1164180";"";"None";"502.97";"1";"5.00";"5e";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168301";"Inhibition of TYK2 JH2 pseudokinase domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL2035050";"";"None";"495.63";"1";"5.71";"14b, 95:5 trans/Cis mixture";"Cc1cnc2nc1-c1ccc3ccn(c3c1)C/C=C/COCc1cc(ccc1OCCN1CCCC1)N2";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"12.83";"0.23";"0.65";"9.86";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.44"
"CHEMBL1077739";"";"None";"444.88";"0";"3.71";"32";"O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O";"Inhibition";"'='";"-3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1111282";"Inhibition of TYK2 at 5 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154316";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";"";"-3.0"
"CHEMBL3892634";"";"None";"309.37";"0";"2.64";"BDBM255000";"N#CCN1CN(C2CCCCC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"48.0";"nM";"7.32";"";"443990";"UO_0000065";"23.66";"0.43";"4.68";"9.63";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"48.0"
"CHEMBL3944182";"";"None";"366.47";"0";"2.47";"BDBM255005";"CCN1CN([C@H]2CC[C@H](CNCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"443995";"UO_0000065";"18.62";"0.35";"4.35";"7.75";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"150.0"
"CHEMBL3968326";"";"None";"420.44";"0";"3.02";"BDBM255006";"N#CCNC[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"443996";"UO_0000065";"16.16";"0.31";"3.78";"7.72";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"160.0"
"CHEMBL3910814";"";"None";"419.55";"0";"2.25";"BDBM255028";"CCN1CN([C@H]2CC[C@H](CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"370.0";"nM";"6.43";"";"444018";"UO_0000065";"15.33";"0.30";"4.18";"7.18";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"370.0"
"CHEMBL3961430";"";"None";"439.48";"0";"3.44";"BDBM254985";"COCN1CN([C@H]2CC[C@H](CN(C)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"72.0";"nM";"7.14";"";"444026";"UO_0000065";"16.25";"0.31";"3.70";"11.04";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"72.0"
"CHEMBL3896236";"";"None";"380.50";"0";"2.82";"BDBM255041";"CCN1CN([C@H]2CC[C@H](CN(C)CC#N)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"700.0";"nM";"6.16";"";"444047";"UO_0000065";"16.18";"0.30";"3.33";"7.77";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"700.0"
"CHEMBL4082278";"";"None";"484.59";"1";"5.62";"EUB0000171b";"C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1";"% of control";"'='";"46.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5470005";"Selectivity interaction (ProQinase) EUB0000171b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Cysteine for covalent attachment conserved among all isoforms; Metabolically stable: 31% degradation after 190 min; | Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 410.0 None | Selectivity Remarks: Screened at 5 uM (in vitro) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/27977190/";"";"";"46.0"
"CHEMBL189231";"";"None";"284.32";"0";"2.57";"SB-734117";"Nc1nonc1-c1nc2cnccc2n1C1CCCCC1";"Inhibition";"'='";"4.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.5"
"CHEMBL514261";"GSK-1819799A";"None";"519.58";"1";"4.82";"GSK1819799A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1";"Inhibition";"'='";"-3.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.16"
"CHEMBL607535";"MEISOINDIGO";"None";"276.30";"0";"2.53";"2";"CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21";"Inhibition";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1066108";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152632";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"8.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"20, CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"23.32";"0.43";"5.74";"8.19";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.052"
"CHEMBL595143";"";"None";"541.68";"2";"5.72";"24";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1";"Residual activity";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1073157";"Residual activity of TYK2 at 0.1 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"90.0"
"CHEMBL210618";"";"None";"356.38";"0";"2.13";"6o";"CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL862052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148638";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1900.0"
"CHEMBL1794055";"GW589933X";"None";"372.43";"0";"2.35";"GW589933X";"NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1";"Inhibition";"'='";"63.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"63.58"
"CHEMBL1909385";"GW458787A";"None";"565.10";"2";"5.35";"GW458787A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl";"Inhibition";"'='";"-2.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.79"
"CHEMBL365072";"";"None";"258.29";"0";"1.65";"SB-751148";"CCc1nccc2c1nc(-c1nonc1N)n2CC";"Inhibition";"'='";"-2.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.82"
"CHEMBL188048";"";"None";"216.20";"0";"0.60";"SB-736290";"Cn1c(-c2nonc2N)nc2cnccc21";"Inhibition";"'='";"-2.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.09"
"CHEMBL397570";"";"None";"300.36";"0";"3.89";"SB-347804";"N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2";"Inhibition";"'='";"-1.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.49"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"AC220";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL180022";"NERATINIB";"4.0";"557.05";"2";"5.93";"HKI-272";"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3215582";"";"None";"588.33";"1";"6.41";"1";"Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl";"Activity";"'='";"28.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1059392";"Inhibition of TYK2 kinase domain 2 assessed as enzyme activity at 1 uM relative to untreated control";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155237";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"28.0"
"CHEMBL186213";"GW827105X";"None";"462.44";"1";"5.62";"GW827105X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1";"Inhibition";"'='";"0.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.38"
"CHEMBL458415";"GSK-2186269A";"None";"483.58";"0";"3.86";"GSK2186269A";"COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2";"Inhibition";"'='";"-1.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.57"
"CHEMBL1967116";"";"None";"454.56";"1";"5.90";"SID103904313";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1";"Ki";"'='";"398.11";"nM";"6.40";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.4"
"CHEMBL2002702";"";"None";"238.29";"0";"3.12";"SID103905112";"Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL220244";"GW427984X";"None";"296.37";"0";"3.28";"GW427984X";"Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1";"Inhibition";"'='";"-2.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.56"
"CHEMBL188784";"GW828529X";"None";"468.39";"1";"5.89";"GW828529X";"Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F";"Inhibition";"'='";"-3.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.25"
"CHEMBL426800";"GW785404X";"None";"247.23";"0";"1.83";"GW785404X";"CCn1c(-c2nonc2N)nc2ccc(F)cc21";"Inhibition";"'='";"-4.18";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.18"
"CHEMBL1909390";"GW576609A";"None";"691.10";"2";"6.57";"GW576609A";"O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1";"Inhibition";"'='";"-1.86";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.86"
"CHEMBL231623";"GSK-620503A";"None";"307.33";"0";"3.24";"GSK620503A";"NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N";"Inhibition";"'='";"-2.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.58"
"CHEMBL2387110";"";"None";"407.26";"0";"3.95";"5";"CC(=O)Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"EC50";"'='";"393.0";"nM";"6.41";"";"";"UO_0000065";"15.73";"0.32";"2.46";"6.39";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"393.0"
"CHEMBL2387217";"";"None";"393.23";"0";"2.70";"31";"NC(=O)[C@@H]1C[C@@H]1C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"11.1";"nM";"7.96";"";"";"UO_0000065";"20.23";"0.42";"5.25";"6.97";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"11.1"
"CHEMBL2385101";"";"None";"417.26";"0";"3.77";"22";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(-c2nnc[nH]2)cc1Cl";"Ki";"'='";"10.9";"nM";"7.96";"";"";"UO_0000065";"19.08";"0.39";"4.19";"7.07";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"10.9"
"CHEMBL234838";"GW572738X";"None";"300.36";"0";"3.89";"GW572738X";"N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2";"Inhibition";"'='";"0.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.85"
"CHEMBL2387125";"";"None";"374.23";"0";"3.97";"20";"C#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"21.44";"0.44";"4.05";"11.28";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"9.5"
"CHEMBL2387117";"";"None";"404.25";"0";"3.33";"12";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(C#CCO)cc1Cl";"Ki";"'='";"10.3";"nM";"7.99";"";"";"UO_0000065";"19.76";"0.40";"4.66";"8.75";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"10.3"
"CHEMBL2387224";"";"None";"350.20";"0";"3.99";"3";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"23.75";"0.49";"4.33";"11.70";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"4.8"
"CHEMBL1909356";"GW569530A";"None";"650.15";"2";"6.23";"GW569530A";"CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl";"Inhibition";"'='";"-3.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.62"
"CHEMBL1909350";"GSK-949675A";"None";"421.89";"0";"0.80";"GSK949675A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl";"Inhibition";"'='";"-2.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.59"
"CHEMBL191105";"";"None";"287.33";"0";"1.02";"SB-751399";"CN(C)CCCn1c(-c2nonc2N)nc2cnccc21";"Inhibition";"'='";"-2.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.99"
"CHEMBL1909387";"GW567808A";"None";"633.09";"2";"6.37";"GW567808A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl";"Inhibition";"'='";"-2.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.56"
"CHEMBL1909401";"";"None";"465.41";"0";"4.56";"SB-285234-W";"O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]";"Inhibition";"'='";"-2.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.36"
"CHEMBL232601";"GW846105X";"None";"401.49";"0";"4.71";"GW846105X";"N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1";"Inhibition";"'='";"-7.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.84"
"CHEMBL481510";"GW853606X";"None";"496.31";"1";"5.55";"GW853606X";"NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br";"Inhibition";"'='";"-3.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.62"
"CHEMBL1794065";"GSK-554170A";"None";"539.52";"0";"1.58";"GSK554170A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"-1.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.24"
"CHEMBL588025";"GW770249A";"None";"467.81";"1";"5.27";"GW770249A";"Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12";"Inhibition";"'='";"-1.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.29"
"CHEMBL215993";"GW284372X";"None";"393.45";"1";"6.21";"GW284372X";"c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1";"Inhibition";"'='";"-2.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.46"
"CHEMBL188268";"";"None";"307.32";"0";"1.51";"SB-750140";"NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1";"Inhibition";"'='";"-2.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.73"
"CHEMBL513330";"GW781673X";"None";"336.79";"0";"3.45";"GW781673X";"Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1";"Inhibition";"'='";"1.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.83"
"CHEMBL1909364";"GW589961A";"None";"488.33";"1";"5.83";"GW589961A";"COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl";"Inhibition";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.0"
"CHEMBL365248";"GW810372X";"None";"402.34";"0";"3.84";"GW810372X";"COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1";"Inhibition";"'='";"-2.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.09"
"CHEMBL1909341";"GW641155A";"None";"364.83";"1";"5.88";"GW641155A";"Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1";"Inhibition";"'='";"-0.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.13"
"CHEMBL419903";"";"None";"295.32";"0";"3.72";"SB-735467";"O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1";"Inhibition";"'='";"-5.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.76"
"CHEMBL346551";"";"None";"264.28";"0";"2.17";"SKF-62604";"O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1";"Inhibition";"'='";"-3.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.23"
"CHEMBL261129";"";"None";"430.31";"0";"3.37";"SB-732881";"CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1";"Inhibition";"'='";"-0.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.92"
"CHEMBL269985";"GW701032X";"None";"413.48";"0";"4.96";"GW701032X";"COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1";"Inhibition";"'='";"0.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.15"
"CHEMBL408732";"";"None";"308.34";"0";"2.98";"SB-711237";"COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1";"Inhibition";"'='";"0.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.27"
"CHEMBL1909366";"GW659386A";"None";"539.87";"2";"6.34";"GW659386A";"COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl";"Inhibition";"'='";"1.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.53"
"CHEMBL480382";"GSK-312948A";"None";"415.50";"0";"3.84";"GSK312948A";"COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"0.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.53"
"CHEMBL1909344";"";"None";"372.86";"0";"2.30";"SB-678557-A";"CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl";"Inhibition";"'='";"-3.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.53"
"CHEMBL1794069";"GSK-571989A";"None";"525.07";"2";"5.70";"GSK571989A";"C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl";"Inhibition";"'='";"-2.69";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.69"
"CHEMBL1080159";"";"None";"506.55";"2";"5.36";"14";"Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)ccc1C(=O)N(C)C";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.22";"0.25";"1.34";"9.46";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.2"
"CHEMBL1938653";"";"None";"350.45";"0";"3.71";"18";"CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C#N)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938654";"";"None";"418.54";"0";"2.98";"19";"CNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938655";"";"None";"448.57";"0";"2.34";"21";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCO)c3s2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938659";"";"None";"517.68";"1";"2.68";"25";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1";"Inhibition";"'='";"27.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1941376";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate at 1 uM after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"27.0"
"CHEMBL1938652";"";"None";"367.35";"0";"3.80";"17";"CNC(=O)c1cnc(N)c2cc(-c3ccc(OC(F)(F)F)cc3)sc12";"IC50";"'='";"208.0";"nM";"6.68";"";"";"UO_0000065";"18.19";"0.37";"2.88";"8.65";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.208"
"CHEMBL1938657";"";"None";"475.64";"0";"2.91";"23";"CN(C)CCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"11.33";"0.23";"2.48";"4.59";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"4.1"
"CHEMBL1909410";"GSK-259178A";"None";"728.70";"2";"5.27";"GSK259178A";"O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"-1.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.85"
"CHEMBL517171";"GSK-1713088A";"None";"568.05";"2";"5.60";"GSK1713088A";"CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1";"Inhibition";"'='";"0.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.33"
"CHEMBL373073";"GW642138X";"None";"241.25";"0";"2.48";"GW642138X";"COc1ccc(-c2cc3c(N)ncnc3o2)cc1";"Inhibition";"'='";"3.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.74"
"CHEMBL1909377";"";"None";"341.80";"0";"3.29";"SB-400868-A";"Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1";"Inhibition";"'='";"-1.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.06"
"CHEMBL251549";"GW782612X";"None";"345.37";"0";"2.94";"GW782612X";"NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1";"Inhibition";"'='";"39.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"39.12"
"CHEMBL450071";"GSK-1392956A";"None";"592.68";"2";"3.21";"GSK1392956A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1";"Inhibition";"'='";"-2.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.95"
"CHEMBL218859";"GW445012X";"None";"266.34";"0";"3.23";"GW445012X";"CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1";"Inhibition";"'='";"-0.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.15"
"CHEMBL243907";"GW673715X";"None";"445.48";"1";"5.74";"GW673715X";"CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1";"Inhibition";"'='";"-2.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.46"
"CHEMBL237570";"";"None";"467.59";"1";"6.02";"SB-630812";"COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1";"Inhibition";"'='";"0.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.94"
"CHEMBL268885";"GSK-711701A";"None";"416.89";"0";"3.43";"GSK711701A";"COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"-6.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.53"
"CHEMBL1909364";"GW589961A";"None";"488.33";"1";"5.83";"GW589961A";"COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl";"Inhibition";"'='";"-0.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.96"
"CHEMBL1909408";"GSK-200398A";"None";"616.15";"1";"4.38";"GSK200398A";"Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"1.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.01"
"CHEMBL428877";"";"None";"443.53";"1";"5.43";"SB-242719";"CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-1.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.9"
"CHEMBL95502";"";"None";"394.50";"0";"4.21";"SB-221466";"CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1";"Inhibition";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.0"
"CHEMBL1909351";"GW824645A";"None";"368.82";"0";"2.61";"GW824645A";"Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1";"Inhibition";"'='";"-3.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.9"
"CHEMBL525191";"";"None";"334.38";"0";"2.73";"GDC-0879";"OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"21.13";"0.39";"5.06";"7.43";"0";"CHEMBL1017052";"Binding affinity to TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151738";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"250.0"
"CHEMBL2035049";"";"None";"481.60";"1";"5.40";"14a, 95:5 trans/Cis mixture";"C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)COC/1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";""
"CHEMBL2133806";"JNJ-38877605";"1.0";"377.36";"0";"3.21";"JNJ-38877605";"Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL482767";"SNS-314";"1.0";"430.95";"1";"5.10";"SNS-314";"O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1970340";"";"None";"226.24";"0";"2.78";"SID103905579";"Nc1noc2cccc(-c3cccc(O)c3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1993424";"";"None";"379.45";"0";"2.87";"SID103905251";"NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1";"Ki";"'='";"158.49";"nM";"6.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.8"
"CHEMBL2005828";"";"None";"359.39";"0";"4.42";"SID103904329";"Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002479";"";"None";"448.91";"0";"4.86";"SID103904647";"NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL562488";"";"None";"225.04";"0";"1.69";"SID103905307";"O=c1[nH]cnc2ccc(Br)cc12";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL495727";"AT-9283";"2.0";"381.44";"0";"2.07";"16, AT9283";"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.59";"0.44";"6.93";"8.11";"0";"CHEMBL1009905";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139387";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"1.0"
"CHEMBL1785003";"";"None";"486.55";"0";"4.28";"SB-264866";"NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"1.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.93"
"CHEMBL4062680";"";"None";"411.26";"0";"4.38";"32";"CNc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1";"EC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"17.37";"0.35";"2.76";"6.20";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.072"
"CHEMBL1289494";"TIVOZANIB";"4.0";"454.87";"1";"5.64";"Tivozanib";"COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4062946";"";"None";"271.32";"0";"1.55";"4";"C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL1201182";"TEMSIROLIMUS";"4.0";"1030.30";"None";"None";"Torisel";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL14762";"SELICICLIB";"2.0";"354.46";"0";"3.20";"(R)-roscovitine, seliciclib";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3218576";"COPANLISIB";"4.0";"480.53";"1";"0.66";"Copanlisib";"COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1084546";"PF-00562271";"1.0";"507.50";"1";"3.14";"SID103905684";"CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL587723";"AEE-788";"2.0";"440.60";"0";"4.94";"AEE-788";"CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2035187";"PACRITINIB";"4.0";"472.59";"0";"4.47";"Pacritinib";"C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2";"Kd";"'='";"38.0";"nM";"7.42";"";"Active";"UO_0000065";"15.70";"0.29";"2.95";"10.96";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.83 None";"";"";"38.0"
"CHEMBL215152";"AZD-1152-HQPA";"-1.0";"507.57";"1";"3.50";"Barasertib_HQPA";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3544960";"AT-13148";"1.0";"313.79";"0";"2.92";"AT-13148";"NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3334567";"SAVOLITINIB";"3.0";"345.37";"0";"1.88";"Volitinib";"C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2035048";"";"None";"349.39";"0";"4.08";"13h, 95:5 trans/Cis mixture";"C1=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)COC/1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"17.67";"0.32";"2.09";"8.89";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.67"
"CHEMBL3814099";"";"None";"316.41";"0";"1.50";"3e";"NCCCn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1";"IC50";"'='";"30700.0";"nM";"4.51";"";"";"UO_0000065";"14.26";"0.27";"3.01";"4.21";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"30.7"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3615460";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of IFNalpha5-induced STAT3 phosphorylation at 1 uM pre-incubated for 30 mins before IFNalpha5 stimulation for 30 mins mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL4777648";"";"None";"422.46";"0";"2.39";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccncn2)c1OC";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"21.19";"0.39";"6.50";"6.78";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.3"
"CHEMBL4799559";"";"None";"480.54";"0";"2.62";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.45";"0.31";"5.23";"5.19";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"14.0"
"CHEMBL4792694";"";"None";"493.54";"0";"2.10";"29";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(=O)N(C)C)nn2)c1OC";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.22";"0.30";"5.86";"5.26";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"11.0"
"CHEMBL4788122";"";"None";"422.46";"0";"2.39";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cccnn2)c1OC";"IC50";"'='";"183.0";"nM";"6.74";"";"";"UO_0000065";"16.06";"0.30";"4.35";"5.14";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"183.0"
"CHEMBL4792231";"";"None";"480.54";"0";"2.62";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"15.47";"0.29";"4.77";"4.88";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"41.0"
"CHEMBL1989708";"";"None";"498.61";"1";"5.74";"SID103904326";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Kd";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"15.10";"0.29";"1.02";"8.82";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"2000.0"
"CHEMBL4483513";"";"None";"421.45";"0";"2.94";"28";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCC(=O)OC)c2cn[nH]c2c1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"15.19";"0.30";"3.46";"5.27";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.4"
"CHEMBL450786";"PHA-665752";"None";"641.62";"2";"6.11";"PHA-665752";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4853377";"";"None";"370.42";"0";"4.58";"6b";"Cc1ccc(-c2cc3cnc4[nH]ccc4c3n2-c2cnn(CCCC#N)c2)o1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";""
"CHEMBL386661";"";"None";"549.60";"2";"6.39";"32";"CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1";"IC50";"'='";"2730.0";"nM";"5.56";"";"";"UO_0000065";"10.12";"0.19";"-0.83";"7.01";"0";"CHEMBL871539";"Inhibition of Tyk2 by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149344";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"2.73"
"CHEMBL3544966";"GSK-1059615";"1.0";"333.37";"0";"3.62";"GSK-1059615";"O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3799512";"TP-004";"None";"363.34";"0";"2.92";"EUB0000303";"Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12";"% Control";"'='";"58.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507303";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"58.0"
"CHEMBL3622826";"";"None";"287.37";"0";"0.56";"5c";"NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21";"Activity";"'>'";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3626373";"Inhibition of Tyk2 (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"65.0"
"CHEMBL3137308";"PEFICITINIB";"4.0";"326.40";"0";"2.01";"peficitinib";"NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.49";"0.47";"6.31";"8.00";"0";"CHEMBL3625892";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"4.8"
"CHEMBL3655096";"";"None";"376.49";"0";"0.69";"BDBM159763";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CN(C3CC3)C2)C1";"IC50";"'='";"4910.0";"nM";"5.31";"";"302657";"UO_0000065";"14.10";"0.28";"4.62";"5.63";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"4910.0"
"CHEMBL5423566";"";"None";"345.82";"0";"3.42";"6";"Cc1cc(Nc2ncc(Cl)c(-c3cnn(CCC#N)c3)n2)sn1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"25.52";"0.52";"5.40";"9.56";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"1.5"
"CHEMBL4759953";"";"None";"520.64";"2";"5.61";"13aa";"Cc1ccc(C(=O)/C=C/C(=O)N2CCc3cc(Nc4ncc(C)c(-c5cnn(C(C)C)c5)n4)ccc3C2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.44";"0.25";"1.39";"7.53";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"100.0"
"CHEMBL4754856";"";"None";"446.56";"0";"4.06";"13x";"COC(=O)/C=C/CN1CCc2cc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)ccc2C1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"15.80";"0.29";"3.00";"8.28";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"88.0"
"CHEMBL1288002";"";"None";"358.35";"0";"2.64";"20";"CN(C)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"19.97";"0.38";"4.51";"8.03";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"70.0"
"CHEMBL4532948";"";"None";"434.44";"0";"1.90";"6b";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"0.086";"nM";"10.07";"";"";"UO_0000065";"23.17";"0.43";"8.17";"8.51";"1";"CHEMBL5327931";"Inhibition of TYK2 JH2 domain (unknown origin) in presence of 10 uM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.086"
"CHEMBL5438635";"";"None";"495.58";"0";"2.71";"43";"CNc1cc(Nc2cccn([C@H]3CC[C@@H](OC)CC3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.004";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL5403825";"";"None";"512.59";"1";"2.19";"44";"CNc1cc(Nc2cccn(C3CCN(CCF)CC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.003";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL5399515";"";"None";"434.44";"0";"2.09";"10";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NC3CC3)cnn12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.67";"0.33";"5.59";"6.49";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"21.0"
"CHEMBL5430037";"";"None";"266.30";"0";"2.29";"Fig 2, Cpd 3";"Cc1ccc(-n2ncc3c(=O)[nH]c(C4CC4)nc32)cc1";"Kd";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"24.24";"0.44";"4.17";"10.16";"0";"CHEMBL5328003";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as dissociation constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"350.0"
"CHEMBL4297477";"BREPOCITINIB";"3.0";"389.41";"0";"1.79";"1; PF-06700841";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.61";"0.37";"5.85";"9.65";"0";"CHEMBL5327921";"Inhibition of TYK2 JH1 domain (unknown origin) in presence of 1 mM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"23.0"
"CHEMBL5398548";"";"None";"464.46";"0";"1.72";"13";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3C[C@@H]3OC)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5402351";"";"None";"484.44";"0";"2.73";"15";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CCC3(F)F)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5433700";"";"None";"464.46";"0";"1.45";"22";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@H]3O)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5437915";"";"None";"464.46";"0";"1.45";"23";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@H]3O)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5419398";"";"None";"490.50";"0";"2.11";"25";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NC3CC4(COC4)C3)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5432382";"";"None";"478.49";"0";"2.11";"18";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"20.27";"0.38";"7.59";"7.61";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.2"
"CHEMBL5396767";"";"None";"492.52";"0";"2.50";"24";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@]3(C)OC)cnn12";"Kd";"'='";"0.086";"nM";"10.07";"";"";"UO_0000065";"20.44";"0.38";"7.57";"7.90";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.086"
"CHEMBL5398529";"";"None";"478.49";"0";"2.11";"35";"CNc1cc(Nc2cccn(-c3cncc(F)c3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.006";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.006"
"CHEMBL5415951";"";"None";"353.39";"0";"1.81";"8";"CNc1cc(Nc2cccnc2OC)nc2c(C(=O)NC3CC3)cnn12";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"21.46";"0.40";"5.78";"7.19";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"26.0"
"CHEMBL5405569";"";"None";"452.43";"0";"2.04";"11";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3C[C@@H]3F)cnn12";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"16.93";"0.32";"5.62";"6.48";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"22.0"
"CHEMBL379218";"";"None";"358.45";"0";"3.88";"A-674563";"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"23.91";"0.44";"5.93";"8.40";"1";"CHEMBL3299215";"Inhibition of recombinant GST-fused TYK2 kinase domain (870 to 1187) (unknown origin) harboring C1187S modification using 5-FAM-KKSRGDYMTMQIG as substrate assessed as inhibition of substrate phosphorylation by peptide mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297690";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"34.0"
"CHEMBL1909412";"";"None";"413.31";"0";"4.62";"SB-476429-A";"Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1";"Inhibition";"'='";"-1.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.84"
"CHEMBL1794060";"GW575533A";"None";"332.79";"0";"4.10";"GW575533A";"COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl";"Inhibition";"'='";"0.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.66"
"CHEMBL5418961";"";"None";"452.51";"0";"3.04";"21; ABBV-712";"COCc1cc(-c2cn(C3COC3)c3cnc(NC(C)=O)cc23)nc([C@]2(OC)CCOC2)c1";"EC50";"'='";"195.0";"nM";"6.71";"";"";"UO_0000065";"14.83";"0.28";"3.67";"6.94";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.195"
"CHEMBL3688339";"";"None";"487.43";"1";"6.04";"OTS-167";"CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2420848";"";"None";"267.12";"0";"3.64";"11";"O=C(Nc1ccncc1)c1cccc(Cl)c1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL1650951";"";"None";"526.52";"1";"3.17";"2; NIBR3049";"CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1";"IC50";"'='";"2110.0";"nM";"5.68";"";"";"UO_0000065";"10.78";"0.20";"2.51";"5.37";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2110.0"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"2";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"EC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"15.72";"0.31";"2.63";"6.24";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"1200.0"
"CHEMBL4062758";"";"None";"371.23";"0";"4.77";"16";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"EC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"18.24";"0.37";"2.00";"8.53";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.17"
"CHEMBL377300";"BRIVANIB";"3.0";"370.38";"0";"3.52";"BMS-540215";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL2420817";"";"None";"290.15";"0";"4.45";"27";"Clc1cccc(Cl)c1-c1ncc(-c2ccncc2)[nH]1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL2420816";"";"None";"290.15";"0";"4.45";"26";"Clc1cccc(Cl)c1-c1cnc(-c2ccncc2)[nH]1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL1938659";"";"None";"517.68";"1";"2.68";"25";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1";"IC50";"'='";"757.0";"nM";"6.12";"";"";"UO_0000065";"11.82";"0.24";"3.44";"4.83";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.757"
"CHEMBL1938644";"";"None";"382.49";"0";"3.13";"9";"CCNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"15.61";"0.30";"2.84";"7.42";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"1.07"
"CHEMBL558752";"RAF-265";"2.0";"518.42";"2";"6.93";"RAF-265";"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1909403";"GW569293E";"None";"547.47";"0";"4.41";"GW569293E";"O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1";"Inhibition";"'='";"-6.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.14"
"CHEMBL410072";"GW301784X";"None";"445.50";"0";"0.85";"GW301784X";"CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"4.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.08"
"CHEMBL603469";"LESTAURTINIB";"3.0";"439.47";"0";"3.47";"CEP-701";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"13.75";"0.25";"2.57";"6.81";"0";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"910.0"
"CHEMBL608533";"MIDOSTAURIN";"4.0";"570.65";"2";"5.91";"PKC-412";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"11.57";"0.21";"0.69";"8.49";"1";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"250.0"
"CHEMBL1614701";"SELUMETINIB";"4.0";"457.69";"0";"3.53";"Selumetinib";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3114773";"";"None";"457.47";"0";"3.67";"8c";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccccc1OCCNc1ccnc(F)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL3964636";"";"None";"310.33";"0";"2.87";"16";"Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12";"Inhibition";"'='";"45.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"45.0"
"CHEMBL4104105";"";"None";"349.46";"0";"1.60";"43";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCCC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL381604";"GW799251X";"None";"446.87";"0";"4.36";"GW799251X";"Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1";"Inhibition";"'='";"-1.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.09"
"CHEMBL271595";"GW297361X";"None";"372.43";"0";"2.35";"GW297361X";"NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1";"Inhibition";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.37"
"CHEMBL269450";"";"None";"433.46";"1";"5.00";"SB-242717";"Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-5.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.03"
"CHEMBL237347";"GW559768X";"None";"328.39";"0";"3.40";"GW559768X";"Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12";"Inhibition";"'='";"-1.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.89"
"CHEMBL407113";"";"None";"356.41";"0";"2.23";"SB-741905";"NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1";"Inhibition";"'='";"0.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.42"
"CHEMBL267228";"";"None";"371.40";"0";"4.03";"SB-431533";"OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1";"Inhibition";"'='";"-3.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.23"
"CHEMBL1789962";"GW643971X";"None";"374.40";"0";"3.03";"GW643971X";"COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O";"Inhibition";"'='";"3.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.47"
"CHEMBL1909392";"GW580496A";"None";"643.99";"2";"6.11";"GW580496A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl";"Inhibition";"'='";"-4.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.08"
"CHEMBL2386633";"";"None";"309.37";"0";"3.22";"31";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](C#N)CC1";"EC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"16.98";"0.31";"2.03";"5.80";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5600.0"
"CHEMBL271843";"GW275944X";"None";"330.37";"0";"1.41";"GW275944X";"Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"1.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.2"
"CHEMBL1516890";"GW441756X";"None";"275.31";"0";"3.07";"GW441756X";"Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21";"Inhibition";"'='";"0.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.73"
"CHEMBL215993";"GW284372X";"None";"393.45";"1";"6.21";"GW284372X";"c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1";"Inhibition";"'='";"-4.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.95"
"CHEMBL513897";"GSK-994854A";"None";"481.60";"1";"5.35";"GSK994854A";"CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1";"Inhibition";"'='";"-5.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.21"
"CHEMBL516248";"GW804482X";"None";"379.44";"0";"3.77";"GW804482X";"COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1";"Inhibition";"'='";"-0.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.53"
"CHEMBL261129";"";"None";"430.31";"0";"3.37";"SB-732881";"CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1";"Inhibition";"'='";"-2.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.31"
"CHEMBL1909366";"GW659386A";"None";"539.87";"2";"6.34";"GW659386A";"COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl";"Inhibition";"'='";"1.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.94"
"CHEMBL4455582";"BAY-693";"None";"529.57";"1";"3.59";"EUB0000708";"Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL31965";"CANERTINIB";"3.0";"485.95";"0";"4.39";"Canertinib";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2376648";"";"None";"547.42";"1";"4.28";"X-396";"C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1801204";"AZD-8055";"1.0";"465.55";"0";"2.64";"AZD-8055";"COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL575448";"BMS-754807";"2.0";"461.51";"0";"3.61";"BMS-754807";"C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3699142";"";"None";"464.57";"0";"4.17";"BI-847325";"CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1236682";"REFAMETINIB";"2.0";"572.34";"1";"3.48";"Refametinib";"COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL571546";"TIRBANIBULIN";"4.0";"431.54";"0";"3.32";"KX2-391";"O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL495771";"GW708336X";"None";"337.39";"0";"1.60";"GW708336X";"c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1";"Inhibition";"'='";"-4.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.59"
"CHEMBL361237";"GW785804X";"None";"322.37";"0";"4.14";"GW785804X";"Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1";"Inhibition";"'='";"-2.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.9"
"CHEMBL4128266";"";"None";"357.42";"1";"5.21";"11";"N#C/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"20.58";"0.37";"2.15";"8.82";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"44.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"24.39";"0.45";"6.08";"8.57";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"24.0"
"CHEMBL514582";"";"None";"410.46";"0";"1.45";"4";"NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1";"Activity";"'='";"19.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"19.2"
"CHEMBL17370";"";"None";"361.45";"1";"5.67";"SID103905410";"CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL243088";"";"None";"322.32";"0";"3.37";"SID103904594";"O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1";"Ki";"'='";"50.12";"nM";"7.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.3"
"CHEMBL1990884";"";"None";"390.42";"0";"4.68";"SID103905315";"Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL41783";"";"None";"360.37";"0";"2.58";"SID103905385";"CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972142";"";"None";"327.39";"0";"4.16";"SID103904567";"O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1624529";"";"None";"416.36";"0";"1.89";"SID103905367";"NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL939";"GEFITINIB";"4.0";"446.91";"0";"4.28";"SID103905344";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL590109";"";"None";"425.52";"0";"4.40";"SID103904961";"NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21";"Ki";"'='";"1995.26";"nM";"5.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969523";"";"None";"379.46";"0";"3.71";"SID103904937";"Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970217";"";"None";"346.43";"0";"4.56";"SID103904557";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969843";"";"None";"283.34";"0";"2.25";"SID103904517";"c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969588";"";"None";"334.81";"0";"4.89";"SID103904192";"Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL1999811";"";"None";"329.34";"0";"2.26";"SID103905509";"O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL4789015";"";"None";"421.48";"0";"3.00";"30";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncccn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4780233";"";"None";"435.50";"0";"3.31";"31";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C)cn2)c1OC";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"22.13";"0.41";"6.26";"8.10";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.27"
"CHEMBL4792694";"";"None";"493.54";"0";"2.10";"29";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(=O)N(C)C)nn2)c1OC";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.00";"0.28";"5.26";"4.86";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"44.0"
"CHEMBL233000";"";"None";"282.37";"0";"3.75";"5";"N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL3545360";"ASP-3026";"1.0";"580.76";"2";"3.77";"ASP-3026";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2387224";"";"None";"350.20";"0";"3.99";"3";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl";"EC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"18.33";"0.38";"2.43";"9.03";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"380.0"
"CHEMBL3697701";"A-079";"None";"207.25";"0";"3.47";"EUB0000308";"CCC(=N\O)/C(C)=C/c1ccc(F)cc1";"% Control";"'='";"73.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507256";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"73.0"
"CHEMBL1970074";"";"None";"410.40";"1";"6.20";"SID103904358";"Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1986970";"";"None";"390.45";"0";"2.59";"SID103904516";"COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2003456";"";"None";"211.22";"0";"1.92";"SID103904364";"O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1682558";"";"None";"391.45";"0";"3.56";"SID103904550";"Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL507936";"";"None";"369.43";"0";"4.83";"SID103904369";"Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL412142";"LADUVIGLUSIB";"1.0";"465.35";"0";"4.94";"SID103905640";"Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987756";"";"None";"446.37";"0";"3.58";"SID103905082";"O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL210928";"";"None";"443.91";"0";"2.32";"SID103905197";"CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994361";"";"None";"480.54";"1";"5.13";"SID103904476";"Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992306";"";"None";"430.39";"0";"4.90";"SID103904741";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1";"Ki";"'='";"1584.89";"nM";"5.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL1984367";"";"None";"376.49";"0";"4.29";"SID103905001";"CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2007151";"";"None";"481.64";"1";"6.15";"SID103904994";"Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006581";"";"None";"384.85";"0";"1.29";"SID103905388";"CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975121";"";"None";"332.40";"0";"4.25";"SID103904565";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988537";"";"None";"368.85";"1";"5.19";"SID103905590";"COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974310";"";"None";"272.30";"0";"3.20";"SID103904987";"NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994693";"";"None";"387.47";"0";"4.68";"SID103904349";"Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1985092";"";"None";"377.83";"1";"5.55";"SID103905577";"Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL223367";"";"None";"431.88";"0";"3.51";"SID103905150";"N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL595546";"";"None";"778.87";"1";"2.38";"1a";"CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Activity";"'='";"19.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1043383";"Binding affinity to human TYK2 kinase domain 2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152541";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"19.0"
"CHEMBL1981079";"";"None";"331.74";"0";"2.61";"SID103904988";"NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1980896";"";"None";"473.78";"1";"5.54";"SID103904856";"Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991429";"";"None";"585.69";"2";"6.57";"SID103904411";"O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL398951";"";"None";"415.50";"0";"3.41";"SID103904813";"N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996831";"";"None";"279.34";"0";"4.21";"SID103904809";"O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL422897";"";"None";"401.85";"0";"3.30";"SID103905277";"CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL117697";"";"None";"251.29";"0";"3.38";"SID103904646";"COc1cccc(Nc2ncnc3ccccc23)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971021";"";"None";"439.44";"1";"5.88";"SID103904332";"Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982711";"";"None";"271.71";"0";"2.98";"SID103904191";"NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL513909";"BI-2536";"2.0";"521.67";"1";"3.56";"BI-2536";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1964444";"";"None";"346.31";"0";"4.60";"SID103904873";"Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1980540";"";"None";"366.73";"0";"4.95";"SID103904899";"O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1986186";"";"None";"273.34";"0";"2.27";"SID103904939";"CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974288";"";"None";"318.38";"0";"3.21";"SID103904552";"O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000568";"";"None";"236.27";"0";"3.43";"SID103904786";"CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005548";"";"None";"487.34";"1";"5.08";"SID103905266";"CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997534";"";"None";"405.52";"1";"5.41";"SID103904738";"COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1977346";"";"None";"338.11";"0";"2.39";"SID103905414";"O=C1Nc2ccccc2Nc2nnc(I)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL511337";"";"None";"296.31";"0";"3.06";"16";"NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL3917405";"";"None";"518.61";"2";"5.32";"51";"O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO";"Inhibition";"'='";"56.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3877349";"Inhibition of TYK2 (unknown origin) at 0.1 uM preincubated for 20 mins followed by [33P]ATP addition measured after 120 mins by Hotspot assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3877241";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"56.0"
"CHEMBL1982506";"";"None";"258.23";"0";"1.14";"SID103905550";"COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997597";"";"None";"316.39";"0";"2.57";"SID103904489";"CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL1982957";"";"None";"313.36";"0";"4.00";"SID103904195";"NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973860";"";"None";"270.36";"0";"3.37";"SID103905449";"OCCNc1cc2cc(-c3ccsc3)ccc2cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4241272";"";"None";"366.43";"0";"1.23";"9a";"C=CC(=O)N1CCCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"3964.8";"nM";"5.40";"";"";"UO_0000065";"14.74";"0.27";"4.17";"5.01";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"3964.8"
"CHEMBL4242842";"";"None";"381.44";"0";"1.11";"9h";"COCCn1cc(-c2nn(CC3CCCN(C#N)C3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4104623";"";"None";"329.34";"0";"1.97";"15";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(F)cc2)n1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"26.55";"0.50";"6.77";"8.25";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"1.8"
"CHEMBL4102140";"";"None";"377.35";"0";"2.43";"17";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(OC(F)F)cc2)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"24.26";"0.46";"6.72";"7.95";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.7"
"CHEMBL3589166";"";"None";"429.48";"0";"3.57";"3";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.45";"0.32";"3.92";"7.68";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"32.0"
"CHEMBL553";"ERLOTINIB";"4.0";"393.44";"0";"3.41";"Erlotinib";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL558752";"RAF-265";"2.0";"518.42";"2";"6.93";"CHIR-265/RAF-265";"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21";"Kd";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"12.32";"0.24";"-0.54";"7.92";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"410.0"
"CHEMBL5075673";"";"None";"407.49";"0";"3.98";"51g";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H]2C[C@H]3CC[C@@H](C2)N3)c2nc(N)ncc2c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"17.18";"0.32";"3.02";"7.28";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL5170148";"";"None";"528.51";"1";"3.36";"11";"O=C1NCc2nc(-c3c(F)cccc3F)nc(Nc3ccc(CC(=O)N4CCN(CC(F)F)CC4)cc3)c21";"Ki";"'='";"0.97";"nM";"9.01";"";"";"UO_0000065";"17.05";"0.32";"5.65";"9.96";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.97"
"CHEMBL1908397";"KW-2449";"1.0";"332.41";"0";"2.78";"KW-2449";"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1";"Kd";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"20.44";"0.37";"4.02";"11.14";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"160.0"
"CHEMBL3658860";"";"None";"336.46";"0";"2.39";"BDBM159779";"CCCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"553.0";"nM";"6.26";"";"302673";"UO_0000065";"18.60";"0.37";"3.87";"7.93";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"553.0"
"CHEMBL5270672";"";"None";"381.41";"0";"3.09";"O-10";"CC[C@H]1Nc2ccc3ncc(n3n2)C(=O)NC2(CC2)COc2ccc(F)cc21";"Inhibition";"'='";"43.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5259935";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257114";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"43.27"
"CHEMBL300138";"ENZASTAURIN";"3.0";"515.62";"1";"4.93";"LY-317615";"Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5270823";"";"None";"578.62";"1";"3.85";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2F)c1OC";"Tm";"'='";"56.18";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"56.18"
"CHEMBL5284638";"";"None";"556.60";"1";"3.34";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccccc3=O)cc2)c1OC";"Tm";"'='";"56.0";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"56.0"
"CHEMBL5281991";"";"None";"574.66";"1";"4.10";"7";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCCC3=O)cc2)c1OC";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"15.05";"0.28";"4.50";"5.56";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"2.5"
"CHEMBL5278999";"";"None";"529.58";"1";"3.37";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3cccn3)cc2)c1OC";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"15.56";"0.29";"4.82";"5.39";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"6.4"
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL5225288";"Induction of TYK2 degradation in human Jurkat cells at 1 uM incubated for 6 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM | TIME = 6.0 hr";"DEGRADER";"";""
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"DC50";"'='";"230.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5225292";"Induction of TYK2 degradation in human Jurkat cells incubated for 24 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 24.0 hr";"DEGRADER";"";"230.0"
"CHEMBL1796257";"";"None";"567.16";"1";"3.54";"23";"COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1";"Inhibition";"'<'";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1798380";"Inhibition of TYK2 domain 2 at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1795227";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";"";"65.0"
"CHEMBL1721885";"SU-014813";"2.0";"442.49";"0";"1.69";"SU-14813";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1";"Kd";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"11.96";"0.23";"3.60";"4.96";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"5100.0"
"CHEMBL3613594";"";"None";"320.19";"0";"3.24";"1";"CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1";"Inhibition";"'='";"83.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615451";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"83.0"
"CHEMBL3622193";"";"None";"592.68";"1";"4.93";"34";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1";"IC50";"'='";"14300.0";"nM";"4.84";"";"";"UO_0000065";"8.17";"0.15";"-0.09";"4.22";"0";"CHEMBL3627433";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"14300.0"
"CHEMBL4060984";"";"None";"367.46";"0";"2.14";"25";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cc[nH]n4)cc23)CC[C@]1(C)N";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"21.37";"0.40";"5.71";"6.18";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"14.0"
"CHEMBL4091096";"";"None";"422.53";"0";"3.21";"36";"CCOc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.56";"0.33";"4.21";"6.15";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"38.0"
"CHEMBL473629";"GSK-204925A";"None";"423.49";"0";"3.82";"GSK204925A";"COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-2.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.99"
"CHEMBL468963";"GW779439X";"None";"454.46";"0";"3.70";"GW779439X";"CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"0.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.5"
"CHEMBL1938647";"";"None";"410.54";"0";"3.91";"12";"CC(C)(C)NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'='";"6980.0";"nM";"5.16";"";"";"UO_0000065";"12.56";"0.24";"1.25";"6.41";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"6.98"
"CHEMBL5184187";"";"None";"529.00";"1";"1.80";"12g";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1C[C@H]2C[C@@H]1CN2C";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"12.72";"0.25";"4.93";"5.55";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"187.0"
"CHEMBL3645538";"";"None";"325.80";"0";"4.25";"BDBM107121";"O=C(CCCCl)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226430";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL4764176";"";"None";"388.44";"0";"2.41";"17, cis isomer";"CO[C@H]1C[C@@](CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"20.07";"0.37";"5.39";"7.89";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"16.0"
"CHEMBL3648429";"";"None";"289.34";"0";"3.81";"BDBM107138";"C=CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226448";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL3645543";"";"None";"367.46";"0";"4.16";"BDBM107128";"O=S(=O)(Nc1cccc(-c2cnc3ccccc3n2)c1)c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"226438";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL3781427";"";"None";"310.36";"0";"2.51";"2";"O=c1[nH]ccc(NC2CCOCC2)c1-c1nc2ccccc2[nH]1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"25.92";"0.48";"5.54";"9.72";"0";"CHEMBL3784141";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779778";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"9.0"
"CHEMBL3782012";"";"None";"364.43";"0";"1.48";"1";"CS(=O)(=O)c1ccc(Nc2nn(C3CCOCC3)cc2C(N)=O)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"19.82";"0.39";"5.74";"6.21";"0";"CHEMBL3784141";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779778";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"60.0"
"CHEMBL4792719";"";"None";"419.53";"0";"3.54";"17j";"COc1cccc(CN2CCC(Nc3c(C(=O)NC4CC4)cnc4[nH]ccc34)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";"";"10000.0"
"CHEMBL4755612";"";"None";"407.52";"0";"3.40";"31h";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)[C@H](C)C1";"IC50";"'='";"79.5";"nM";"7.10";"";"";"UO_0000065";"17.42";"0.32";"3.70";"8.63";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"79.5"
"CHEMBL595373";"";"None";"512.64";"2";"6.57";"25";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1";"Residual activity";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1043836";"Residual activity of TYK2 at 1 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"90.0"
"CHEMBL4763801";"";"None";"393.49";"0";"3.01";"17e";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(OC)c2)CC1";"IC50";"'='";"1212.0";"nM";"5.92";"";"";"UO_0000065";"15.04";"0.28";"2.91";"7.19";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"1212.0"
"CHEMBL604483";"";"None";"559.67";"2";"5.86";"23";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1";"Residual activity";"'='";"92.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1043836";"Residual activity of TYK2 at 1 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"92.0"
"CHEMBL188257";"GW827106X";"None";"452.47";"0";"4.38";"GW827106X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1";"Inhibition";"'='";"-1.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.85"
"CHEMBL4640647";"";"None";"443.19";"None";"None";"14m";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(B(O)O)cc3)ncc2C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL4860979";"";"None";"466.54";"0";"3.21";"I-28";"CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804690";"Inhibition of TYK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 10.0 microM";"";"";"0.0"
"CHEMBL4777528";"";"None";"493.54";"0";"2.10";"25";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C(=O)N(C)C)cn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4797596";"";"None";"480.54";"0";"2.62";"28";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(C)(C)O)nn2)c1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.33";"0.30";"5.18";"5.15";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"16.0"
"CHEMBL4784391";"";"None";"440.45";"0";"2.53";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"163.0";"nM";"6.79";"";"";"UO_0000065";"15.52";"0.29";"4.26";"5.18";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"163.0"
"CHEMBL4579439";"";"None";"434.44";"0";"2.09";"6h";"CNc1cc(Nc2cccn(-c3cccc(F)n3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"16.47";"0.31";"5.06";"6.05";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"70.0"
"CHEMBL4571920";"";"None";"452.43";"0";"2.04";"6r";"CNc1cc(Nc2cccn(-c3cccc(F)n3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.51";"0.33";"5.88";"6.70";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"12.0"
"CHEMBL4438107";"";"None";"418.46";"0";"2.20";"6n";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC(C)C)cnc12";"Ki";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"14.64";"0.27";"3.92";"5.18";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"750.0"
"CHEMBL3675693";"";"None";"367.87";"1";"5.16";"BDBM120136";"Cc1cc(Nc2nccc3nc(-c4ccccc4Cl)sc23)nc(C)n1";"Ki";"'='";"8.6";"nM";"8.07";"";"247342";"UO_0000065";"21.92";"0.44";"2.91";"12.68";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"8.6"
"CHEMBL3402762";"TEPOTINIB";"4.0";"492.58";"0";"4.01";"Tepotinib";"CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2325741";"CAPIVASERTIB";"4.0";"428.92";"0";"2.10";"AZD-5363";"NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL384304";"RG-547";"2.0";"441.46";"0";"1.41";"R-547";"COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3039525";"GOLVATINIB";"2.0";"633.70";"1";"4.75";"Golvatinib";"CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3545157";"TIDEGLUSIB";"2.0";"334.40";"0";"3.26";"Tideglusib";"O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL574738";"AST-487";"1.0";"529.57";"2";"5.11";"AST-487";"CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3945378";"";"None";"399.46";"0";"3.07";"BDBM198553";"N#Cc1ccc(CNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"540.0";"nM";"6.27";"";"353531";"UO_0000065";"15.69";"0.29";"3.20";"5.61";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"540.0"
"CHEMBL4560222";"";"None";"444.54";"0";"4.18";"12d";"C/C=C/C(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL3658865";"";"None";"373.48";"0";"2.28";"BDBM159784";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)[C@@H]2CC[C@@H](C#N)C2)C1";"IC50";"'='";"3280.0";"nM";"5.48";"";"302678";"UO_0000065";"14.68";"0.29";"3.20";"5.34";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"3280.0"
"CHEMBL4543715";"";"None";"379.41";"0";"2.37";"26";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCO)c2cn[nH]c2c1";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"16.34";"0.33";"3.83";"5.38";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.2"
"CHEMBL3764637";"";"None";"300.37";"0";"1.92";"9";"CC(C)C(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"27.30";"0.51";"6.28";"8.68";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"6.3"
"CHEMBL4522773";"BAY-827";"None";"385.86";"0";"4.94";"EUB0002889";"CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507263";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4867844";"";"None";"494.05";"0";"3.38";"C7";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1";"Activity";"'>'";"75.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4808037";"Inhibition of TYK2 (unknown origin) assessed as residual activity measured at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 1.0 microM";"";"";"75.0"
"CHEMBL3675687";"";"None";"354.22";"0";"3.60";"BDBM120130";"O=C(CO)Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12";"Ki";"'='";"23.0";"nM";"7.64";"";"247336";"UO_0000065";"21.56";"0.47";"4.04";"10.17";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"23.0"
"CHEMBL3675695";"";"None";"428.35";"1";"6.38";"BDBM120138";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C5CC5)cc4Cl)sc23)ncn1";"Ki";"'='";"4.1";"nM";"8.39";"";"247344";"UO_0000065";"19.58";"0.41";"2.01";"13.19";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"4.1"
"CHEMBL3968041";"";"None";"387.39";"0";"2.81";"BDBM198571";"O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F";"IC50";"'='";"30.0";"nM";"7.52";"";"353549";"UO_0000065";"19.42";"0.40";"4.71";"8.09";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"30.0"
"CHEMBL4111044";"";"None";"296.34";"0";"3.19";"BDBM198572";"[N-]=[N+]=NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"9.2";"nM";"8.04";"";"353550";"UO_0000065";"27.12";"0.50";"4.85";"7.47";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"9.2"
"CHEMBL3953229";"";"None";"362.44";"0";"2.76";"BDBM198583";"N#CCCN(CCC#N)C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"353561";"UO_0000065";"20.84";"0.38";"4.79";"6.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"28.0"
"CHEMBL3906460";"";"None";"408.43";"0";"3.14";"BDBM198628";"FC(F)(F)COC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353606";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3815093";"";"None";"417.49";"0";"2.36";"2";"CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1";"Inhibition";"'='";"6.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3816872";"Inhibition of human TYK2 at 1 uM using [KKSRGDYMTMQIG] as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813650";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"6.0"
"CHEMBL1092926";"";"None";"490.56";"0";"4.20";"39; NVP-BSK805";"Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1";"IC50";"'='";"10.76";"nM";"7.97";"";"";"UO_0000065";"16.24";"0.30";"3.77";"11.70";"0";"CHEMBL5245561";"Competitive inhibition of TYK2 (unknown origin) in the presence of ATP by JAK radiometric filter binding kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"10.76"
"CHEMBL5422886";"";"None";"451.48";"0";"2.80";"13";"COCCOC(=O)Cc1ccc(Nc2cc(Nc3ccccc3OC)c(C(N)=O)cn2)nc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.27";"0.36";"5.90";"6.32";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"2.0"
"CHEMBL1081291";"";"None";"410.86";"1";"5.92";"4";"COc1cc(Nc2nc3cccc(-c4cccc(Cl)c4)c3o2)cc(OC)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10.0"
"CHEMBL1076700";"";"None";"563.65";"2";"5.34";"17";"Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)ccc1C(=O)NCCCN(C)C";"IC50";"'='";"97.0";"nM";"7.01";"";"";"UO_0000065";"12.44";"0.23";"1.67";"8.46";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.097"
"CHEMBL5403897";"";"None";"425.88";"0";"3.82";"6";"CCOC(=O)Cc1ccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)nc1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.24";"0.35";"3.95";"6.52";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"17.0"
"CHEMBL5395839";"";"None";"441.88";"0";"3.66";"8";"CCOC(=O)COc1ccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)nc1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"16.45";"0.32";"3.61";"5.66";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"54.0"
"CHEMBL379218";"";"None";"358.45";"0";"3.88";"A-674563";"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5417230";"";"None";"440.50";"0";"2.88";"20";"COCCOc1cc(-c2cn(C)c3cnc(NC(C)=O)cc23)nc([C@]2(OC)CCOC2)c1";"EC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"17.08";"0.32";"4.64";"7.78";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.03"
"CHEMBL5432571";"";"None";"453.45";"0";"3.77";"15";"CO[C@@]1(c2cc(C#N)cc(-c3cn([C@@H]4CC4(F)F)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"15.21";"0.29";"3.13";"6.76";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.127"
"CHEMBL5083330";"";"None";"437.48";"0";"3.62";"15c";"O=C(CCCCCn1cc(Nc2ncc3ccn(Cc4ccccc4F)c3n2)cn1)NO";"IC50";"'='";"13.3";"nM";"7.88";"";"";"UO_0000065";"18.00";"0.34";"4.26";"7.17";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"13.3"
"CHEMBL3658863";"";"None";"384.45";"0";"2.63";"BDBM159782";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)CC2CC(F)(F)C2)C1";"IC50";"'='";"582.0";"nM";"6.24";"";"302676";"UO_0000065";"16.22";"0.33";"3.61";"7.90";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"582.0"
"CHEMBL4872996";"";"None";"290.33";"0";"3.01";"6k";"N#CCCCn1cc(-n2ccc3cnc4[nH]ccc4c32)cn1";"IC50";"'>'";"300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";"300.0"
"CHEMBL535";"SUNITINIB";"4.0";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3545076";"LY-2584702";"1.0";"445.42";"0";"4.30";"LY-2584702";"Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3589170";"";"None";"495.41";"1";"5.17";"7";"CN(C)[C@H]1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)c(Cl)c5)cc4c3c2)C1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"14.83";"0.30";"2.18";"8.91";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"45.0"
"CHEMBL3589171";"";"None";"442.52";"0";"3.48";"8";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c3c2)c1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"16.74";"0.31";"3.93";"8.08";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"39.0"
"CHEMBL3589174";"";"None";"399.45";"0";"3.56";"11";"NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1cc(C(=O)N3CCOCC3)ccc12";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"17.91";"0.33";"3.59";"8.09";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"70.0"
"CHEMBL3589327";"";"None";"518.06";"1";"4.32";"19";"CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc(CN5CCOCC5)c(Cl)c4)cc23)CC1";"IC50";"'='";"197.0";"nM";"6.71";"";"";"UO_0000065";"12.94";"0.25";"2.39";"8.62";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"197.0"
"CHEMBL3991931";"";"None";"456.51";"0";"3.31";"ONO-4059-analogue";"C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4781706";"";"None";"411.94";"0";"4.04";"30c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccc(Cl)cc2)CC1";"IC50";"'='";"49.4";"nM";"7.31";"";"";"UO_0000065";"17.74";"0.34";"3.27";"10.00";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"49.4"
"CHEMBL3655089";"";"None";"383.44";"0";"1.17";"BDBM159756";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2cc(C#N)ccn2)C1";"IC50";"'='";"260.0";"nM";"6.58";"";"302650";"UO_0000065";"17.17";"0.33";"5.42";"5.16";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"260.0"
"CHEMBL3969370";"";"None";"533.59";"2";"5.26";"1; FMF-01-086-2";"C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1";"Activity";"'='";"73.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4186096";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"73.0"
"CHEMBL3105870";"";"None";"292.30";"0";"1.79";"1b";"NC(=O)c1cc(-c2cc(N)cc3[nH]ncc23)cc2cn[nH]c12";"Inhibition";"'='";"12.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"12.1"
"CHEMBL3667527";"";"None";"336.36";"0";"1.44";"BDBM153675";"N#CC1CCN(c2n[nH]cc2NC(=O)c2cnn3cccnc23)CC1";"Ki";"'='";"230.0";"nM";"6.64";"";"295036";"UO_0000065";"19.74";"0.36";"5.20";"5.77";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"230.0"
"CHEMBL3670392";"";"None";"402.34";"0";"4.04";"BDBM116314";"Cc1cc(NC(=O)c2cnn3ccc(Nc4cccc(C(F)(F)F)c4)nc23)on1";"Ki";"'='";"62.4";"nM";"7.21";"";"241647";"UO_0000065";"17.91";"0.34";"3.16";"7.40";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"62.4"
"CHEMBL535";"SUNITINIB";"4.0";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"16.17";"0.30";"3.11";"8.34";"0";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"360.0"
"CHEMBL516312";"";"None";"339.36";"0";"3.75";"2";"N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL4753549";"";"None";"459.60";"0";"3.98";"13ac";"Cc1cnc(Nc2ccc3c(c2)CCN(C(=O)/C=C/CN(C)C)C3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"15.50";"0.29";"3.14";"9.00";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"75.0"
"CHEMBL3658862";"";"None";"348.47";"0";"2.39";"BDBM159781";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)CCC2CC2)C1";"IC50";"'='";"1460.0";"nM";"5.84";"";"302675";"UO_0000065";"16.75";"0.33";"3.45";"7.39";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1460.0"
"CHEMBL3763213";"";"None";"385.47";"0";"1.76";"17";"CC(C)[C@H](C)n1cc(-c2cc(N3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"17.38";"0.33";"4.94";"6.26";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"200.0"
"CHEMBL378627";"";"None";"448.50";"0";"1.92";"18b";"COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL862052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148638";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1900.0"
"CHEMBL4782449";"";"None";"422.46";"0";"2.39";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnccn2)c1OC";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"22.17";"0.41";"6.91";"7.10";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.5"
"CHEMBL4777175";"";"None";"534.51";"1";"3.16";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(C)(O)C(F)(F)F)cn2)c1OC";"IC50";"'='";"0.44";"nM";"9.36";"";"";"UO_0000065";"17.60";"0.34";"6.20";"6.19";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.44"
"CHEMBL4780315";"";"None";"451.50";"0";"3.01";"32";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(OC)cn2)c1OC";"IC50";"'='";"0.54";"nM";"9.27";"";"";"UO_0000065";"20.66";"0.38";"6.26";"7.28";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.54"
"CHEMBL4799830";"";"None";"421.48";"0";"3.00";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccccn2)c1OC";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"17.65";"0.33";"4.39";"6.25";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"41.0"
"CHEMBL4846916";"";"None";"439.40";"0";"4.56";"49";"Cc1ccc(NC(=O)c2ccc(C(F)(F)F)nc2)cc1NC(=O)c1cnc2ccccn12";"Inhibition";"'='";"16.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4816270";"Inhibition of human TYK2 at 0.1 uM using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4813977";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"Dose = 0.1 microM";"";"";"16.0"
"CHEMBL4075230";"";"None";"285.35";"0";"1.40";"8";"CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL4064189";"";"None";"347.21";"0";"4.28";"6";"O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)[nH]c12)C1CC1";"Ki";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"25.26";"0.52";"4.49";"12.41";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0017"
"CHEMBL4093092";"";"None";"414.30";"0";"4.84";"29";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)nc(N(C)C)n1";"Ki";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"19.32";"0.39";"3.16";"9.69";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0099"
"CHEMBL3675700";"";"None";"408.87";"0";"4.90";"BDBM120143";"[C-]#[N+]c1cccc(Cl)c1-c1nc2ccnc(Nc3cc(CO)nc(C)n3)c2s1";"Ki";"'='";"0.5";"nM";"9.30";"";"247349";"UO_0000065";"22.75";"0.45";"4.40";"10.55";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.5"
"CHEMBL2105728";"CRENOLANIB";"3.0";"443.55";"0";"3.92";"Crenolanib";"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2087361";"ICOTINIB";"3.0";"391.43";"0";"3.16";"Icotinib";"C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL217092";"SARACATINIB";"3.0";"542.04";"1";"3.94";"Saracatinib";"CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2386889";"SCH-900776";"2.0";"376.26";"0";"1.94";"SCH-900776";"Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5196877";"";"None";"423.42";"0";"3.09";"12";"CCNC(=O)Cc1ccc(Nc2nc(-c3c(F)cccc3F)nc3c2C(=O)NC3)cc1";"Ki";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"19.15";"0.36";"5.02";"8.44";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"7.8"
"CHEMBL5191597";"";"None";"425.85";"0";"3.67";"25";"CCNC(=O)c1ccc(Nc2cc(-c3c(F)cccc3Cl)nc3c2C(=O)NC3)nc1";"Ki";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"21.04";"0.41";"5.29";"9.33";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"1.1"
"CHEMBL111612";"ABT-546";"None";"532.72";"2";"5.54";"EUB0000348";"CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC";"% Control";"'='";"85.9";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507258";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"85.9"
"CHEMBL5273136";"";"None";"546.65";"1";"4.18";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3)cc2)c1OC";"Tm";"'='";"63.36";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"63.36"
"CHEMBL5291007";"";"None";"540.60";"1";"4.25";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3cccnc3)cc2)c1OC";"Tm";"'='";"55.52";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"55.52"
"CHEMBL5278635";"";"None";"556.60";"1";"3.34";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2cccc(-n3ccccc3=O)c2)c1OC";"Tm";"'='";"52.86";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"52.86"
"CHEMBL1163510";"";"None";"447.84";"1";"5.55";"5j";"O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL4063870";"";"None";"378.48";"0";"2.81";"23";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4)cc23)CC[C@]1(C)N";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"19.44";"0.36";"4.55";"6.61";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"44.0"
"CHEMBL4855542";"";"None";"372.45";"0";"3.89";"I-13";"Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O";"% inhibition";"'='";"0.6";"uM";"";"";"Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ";"UO_0000064";"";"";"";"";"0";"CHEMBL4804508";"Inhibition of TYK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"0.6"
"CHEMBL4473365";"";"None";"602.16";"1";"4.93";"7c";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C";"Activity";"'='";"17.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4382805";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382192";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"17.0"
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL1081976";"";"None";"469.52";"0";"4.64";"7";"COc1cc(Nc2nc3cccc(-c4cccc(NS(C)(=O)=O)c4)c3o2)cc(OC)c1OC";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"11.59";"0.23";"0.80";"4.86";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"3.6"
"CHEMBL1081484";"";"None";"507.52";"1";"4.88";"10";"COc1cc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)c(F)c4)c3o2)cc(OC)c1OC";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"14.19";"0.27";"2.32";"7.56";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.063"
"CHEMBL1081663";"";"None";"470.53";"0";"4.41";"12";"CN(C)C(=O)c1ccc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3o2)cc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"13.04";"0.24";"1.73";"6.98";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.73"
"CHEMBL3622822";"";"None";"261.33";"0";"-0.01";"4a";"NCCCn1c(CCN)nc2cc(C(N)=O)ccc21";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"19.87";"0.37";"5.20";"4.60";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"6.4"
"CHEMBL3622823";"";"None";"294.36";"0";"2.15";"4b";"NCCCn1c(-c2ccccc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"18.92";"0.35";"3.42";"6.41";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"2.7"
"CHEMBL1170139";"";"None";"545.61";"2";"5.68";"12";"CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1175112";"Inhibition of TYK2 JH2 pseudokinase domain at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177794";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"96.0"
"CHEMBL4096219";"";"None";"281.31";"0";"2.60";"13";"CCc1cc(O)ccc1-c1ccc2c(C(N)=O)n[nH]c2c1";"IC50";"'='";"54.5";"nM";"7.26";"";"";"UO_0000065";"25.82";"0.47";"4.66";"7.90";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"54.5"
"CHEMBL5396135";"";"None";"398.54";"0";"2.01";"31";"Cc1cc(Nc2ncc(C)c(N3CC(CC#N)(N4CCN(C)CC4)C3)n2)sn1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"21.42";"0.42";"6.53";"10.14";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"2.9"
"CHEMBL3981587";"";"None";"338.42";"0";"1.74";"BDBM254989";"N#CCNC[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"444030";"UO_0000065";"22.82";"0.42";"5.98";"7.97";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"19.0"
"CHEMBL4874046";"";"None";"417.39";"0";"4.35";"12f";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(Nc3ccccc3OC)n2)cc1";"IC50";"'='";"21.94";"nM";"7.66";"";"";"UO_0000065";"18.35";"0.35";"3.31";"8.69";"0";"CHEMBL4824349";"Inhibition of TYK2 (unknown origin) measured after 40 mins by HTRF";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4823267";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"21.94"
"CHEMBL3933397";"";"None";"417.47";"0";"3.32";"BDBM198477";"O=C1COc2ccc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)cc2N1";"IC50";"'='";"200.0";"nM";"6.70";"";"353455";"UO_0000065";"16.05";"0.30";"3.38";"6.13";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL4112919";"";"None";"390.49";"0";"3.20";"BDBM198480";"O[C@H](CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'='";"50.0";"nM";"7.30";"";"353458";"UO_0000065";"18.70";"0.34";"4.10";"8.01";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"50.0"
"CHEMBL3919050";"";"None";"390.49";"0";"3.68";"BDBM198473";"COc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"4.8";"nM";"8.32";"";"353451";"UO_0000065";"21.30";"0.39";"4.64";"10.38";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"4.8"
"CHEMBL3978189";"";"None";"354.46";"0";"2.65";"BDBM198496";"COCC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"353474";"UO_0000065";"18.36";"0.34";"3.86";"8.12";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL5420083";"";"None";"421.46";"0";"3.18";"12";"CCOC(=O)Cc1ccc(Nc2cc(Nc3ccccc3OC)c(C(N)=O)cn2)nc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"18.22";"0.34";"4.50";"5.98";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"21.0"
"CHEMBL5426374";"";"None";"429.37";"0";"2.98";"6; WD-118313";"CS(=O)(=O)N1CC[C@H](C#CC(=O)N2CCC[C@@H](c3ccc(Cl)c(Cl)c3)C2)C1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"17.09";"0.37";"4.36";"12.72";"0";"CHEMBL5364797";"Inhibition of TYK2 signalling pathway in human PBMC cells assessed as IFN alpha induced p-STAT3 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL4295367";"";"INHIBITOR";"";"46.0"
"CHEMBL3670393";"";"None";"388.22";"0";"3.26";"BDBM116315";"Nc1ccn2ncc(C(=O)Nc3c[nH]nc3-c3cc(Cl)ccc3Cl)c2n1";"Ki";"'='";"4.1";"nM";"8.39";"";"241648";"UO_0000065";"21.60";"0.44";"5.13";"7.36";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"4.1"
"CHEMBL5403272";"";"None";"358.42";"0";"2.39";"10";"CCS(=O)(=O)c1cccc(-c2cn(C)c3cnc(NC(C)=O)cc23)n1";"EC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"19.62";"0.38";"4.64";"7.48";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.093"
"CHEMBL5396134";"";"None";"358.42";"0";"2.44";"6";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)c3)c[nH]c2cn1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"14.57";"0.29";"2.78";"5.49";"0";"CHEMBL5373716";"Inhibition of TYK2 JH1 domain (unknown origin) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"6.0"
"CHEMBL3426891";"";"None";"402.93";"0";"3.22";"(R)-9b";"CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1";"Inhibition";"'='";"98.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3428994";"Inhibition of human TYK2 using KKSRGDYMTMQIG peptide substrate at 1 uM by 33P Hotspot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425491";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"98.9"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"EUB0000050b";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5475820";"Selectivity interaction (Ambit KINOMEscan) EUB0000050b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 9.0 None | Selectivity number of targets = 402.0 None | Selectivity Remarks: Screened at 10 uM (in-vitro potency, TYK2(JH1domain-catalytic)) | Source Knowledge: https://ashpublications.org/blood/article/114/14/2984/107842/AC220-is-a-uniquely-potent-and-selective-inhibitor";"";"";"10000.0"
"CHEMBL1171523";"";"None";"506.57";"2";"5.20";"3";"CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"4.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1175111";"Inhibition of TYK2 JH1 catalytic domain at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177794";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"4.2"
"CHEMBL5087239";"";"None";"451.51";"0";"4.01";"15h";"O=C(CCCCCCn1cc(Nc2ncc3ccn(Cc4cccc(F)c4)c3n2)cn1)NO";"IC50";"'='";"21.7";"nM";"7.66";"";"";"UO_0000065";"16.97";"0.32";"3.65";"6.97";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"21.7"
"CHEMBL2386636";"";"None";"337.43";"0";"4.00";"34";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CCC#N)CC1";"Ki";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"25.99";"0.48";"4.77";"9.69";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.7"
"CHEMBL4078165";"";"None";"295.34";"0";"2.86";"14";"CCc1cc(O)ccc1-c1ccc2c(C(=O)NC)n[nH]c2c1";"IC50";"'='";"796.2";"nM";"6.10";"";"";"UO_0000065";"20.65";"0.38";"3.24";"7.82";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"796.2"
"CHEMBL4758891";"";"None";"401.47";"0";"3.85";"8";"C=CC(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1";"IC50";"'='";"2439.0";"nM";"5.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"2439.0"
"CHEMBL4756089";"";"None";"364.41";"0";"2.85";"9";"C=CC(=O)Nc1ccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4793519";"";"None";"364.41";"0";"2.85";"2";"C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL3667512";"";"None";"338.76";"0";"2.82";"BDBM153660";"O=C(Nc1ccnn1-c1ccccc1Cl)c1cnn2cccnc12";"Ki";"'='";"98.0";"nM";"7.01";"";"295033";"UO_0000065";"20.69";"0.40";"4.19";"9.09";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"98.0"
"CHEMBL3655088";"";"None";"388.50";"0";"1.93";"BDBM159755";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@](C)(CC#N)C2)C1";"IC50";"'='";"2440.0";"nM";"5.61";"";"302649";"UO_0000065";"14.45";"0.28";"3.68";"4.89";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2440.0"
"CHEMBL4799031";"";"None";"422.46";"0";"2.39";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncccn2)c1OC";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.52";"0.34";"5.38";"5.93";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"17.0"
"CHEMBL4785512";"";"None";"492.55";"0";"2.70";"27";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.04";"0.30";"5.15";"5.67";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"14.0"
"CHEMBL4799830";"";"None";"421.48";"0";"3.00";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccccn2)c1OC";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"15.21";"0.28";"3.37";"5.39";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"430.0"
"CHEMBL4800399";"";"None";"521.60";"1";"2.88";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(=O)N(CC)CC)cn2)c1OC";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"14.22";"0.27";"4.50";"4.87";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"42.0"
"CHEMBL4295151";"";"None";"377.44";"0";"4.55";"17a";"COc1cc2c(=O)n(C3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"1.93";"nM";"8.71";"";"";"UO_0000065";"23.09";"0.43";"4.16";"12.60";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1.93"
"CHEMBL4286762";"";"None";"409.44";"0";"3.56";"13c";"CCOC(=O)C(CC)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"17.4";"nM";"7.76";"";"";"UO_0000065";"18.95";"0.35";"4.20";"8.13";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"17.4"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.351";"nM";"9.46";"";"";"UO_0000065";"20.27";"0.37";"5.10";"13.61";"0";"CHEMBL4050199";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of [gamma-32P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4049399";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";"";"3.51"
"CHEMBL4077886";"";"None";"351.41";"0";"2.70";"16";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(C3CC3)cc2)n1";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"23.93";"0.44";"5.71";"7.94";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"3.9"
"CHEMBL4064171";"";"None";"361.37";"0";"1.57";"26";"N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1C#N";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"22.02";"0.40";"6.39";"5.18";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"11.0"
"CHEMBL4085737";"";"None";"370.80";"0";"2.35";"27";"N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1Cl";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"22.65";"0.44";"6.05";"6.47";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"4.0"
"CHEMBL4517542";"";"None";"353.39";"0";"1.11";"6a";"CNc1cc(Nc2cccn(C)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"25.84";"0.48";"8.02";"8.67";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.74"
"CHEMBL4561123";"";"None";"434.44";"0";"2.09";"6i";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"22.61";"0.42";"7.73";"8.31";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.15"
"CHEMBL4438107";"";"None";"418.46";"0";"2.20";"6n";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC(C)C)cnc12";"Ki";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"23.62";"0.44";"7.69";"8.36";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.13"
"CHEMBL4438296";"";"None";"430.47";"0";"2.34";"6o";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CCC3)cnc12";"Ki";"'='";"384.0";"nM";"6.42";"";"";"UO_0000065";"14.90";"0.27";"4.08";"5.43";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"384.0"
"CHEMBL208637";"";"None";"220.23";"0";"0.89";"SID103905194";"CCOc1nc(NC(C)=O)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL226471";"";"None";"307.33";"0";"3.17";"SID103904965";"O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1995740";"";"None";"377.36";"0";"4.29";"SID103904713";"COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL234085";"";"None";"312.38";"0";"1.54";"SID103905419";"CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"50.12";"nM";"7.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.3"
"CHEMBL1969042";"";"None";"359.39";"0";"4.60";"SID103905578";"Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3675692";"";"None";"446.32";"0";"3.77";"BDBM120135";"OC1CN(c2cc(Nc3ncnc4nc(-c5c(Cl)cccc5Cl)sc34)ncn2)C1";"Ki";"'='";"87.0";"nM";"7.06";"";"247341";"UO_0000065";"15.82";"0.33";"3.29";"7.06";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"87.0"
"CHEMBL3675699";"";"None";"408.45";"1";"5.48";"BDBM120142";"[C-]#[N+]c1cc(C#N)cc([N+]#[C-])c1-c1nc2ccnc(Nc3cc(C)nc(C)n3)c2s1";"Ki";"'='";"0.8";"nM";"9.10";"";"247348";"UO_0000065";"22.27";"0.41";"3.62";"9.47";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.8"
"CHEMBL4590082";"";"None";"458.52";"0";"3.42";"7j";"Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.59";"0.34";"5.10";"7.93";"0";"CHEMBL4341347";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340527";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"3.0"
"CHEMBL2180604";"TAK-593";"1.0";"445.48";"0";"3.47";"TAK-593";"Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3408248";"AZD-8186";"1.0";"457.48";"0";"3.78";"AZD-8186";"C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1908391";"MASITINIB";"4.0";"498.66";"1";"5.26";"Masitinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL571948";"Y-39983";"1.0";"280.33";"0";"2.83";"Y-39983";"C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3120215";"OSI-027";"2.0";"406.45";"0";"3.22";"OSI-027";"COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"INH";"'='";"0.036";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"0.036"
"CHEMBL3618145";"";"None";"309.33";"0";"1.23";"13";"N#CCC(=O)N1CCC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1";"INH";"'='";"0.29";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"0.29"
"CHEMBL4239990";"";"None";"441.54";"0";"0.72";"9f";"COCCn1cc(-c2nn(CC3CCCN(C(=O)CN(C)C)C3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4248202";"";"None";"365.40";"0";"0.89";"12c";"Cn1cc(-c2nn(C3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1";"IC50";"'='";"2427.4";"nM";"5.62";"";"";"UO_0000065";"15.37";"0.28";"4.72";"4.27";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"2427.4"
"CHEMBL4245604";"";"None";"383.46";"0";"0.53";"13e";"CN(C)CC(=O)N1CCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4238436";"";"None";"323.36";"0";"0.93";"13g";"Cn1cc(-c2nn(C3CCN(C#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL1091565";"";"None";"485.54";"0";"4.46";"13";"COc1cc(-c2cnc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"11.41";"0.21";"1.08";"6.67";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"2900.0"
"CHEMBL1092926";"";"None";"490.56";"0";"4.20";"26";"Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1";"IC50";"'='";"384.0";"nM";"6.42";"";"";"UO_0000065";"13.08";"0.24";"2.22";"9.42";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"384.0"
"CHEMBL1091190";"";"None";"561.66";"1";"4.10";"11";"COc1cc(-c2cnc3cc(C)cc(-c4ccc(CC(=O)N5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL1093119";"";"None";"544.60";"1";"4.86";"23";"Cc1cc(-c2cnc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3n2)ccc1C(=O)N1CCOCC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.71";"0.24";"2.06";"10.21";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"120.0"
"CHEMBL1092925";"";"None";"564.66";"1";"3.62";"25";"CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCS(=O)(=O)CC6)c(F)c5)c4n3)cn2)CC1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"12.51";"0.24";"3.45";"8.56";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"86.0"
"CHEMBL4516549";"";"None";"401.47";"0";"3.56";"15d";"N#CNc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL2325895";"";"None";"380.45";"0";"1.96";"3q";"CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1";"Kd";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"20.49";"0.38";"5.84";"6.79";"0";"CHEMBL2329036";"Binding affinity to TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321829";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"16.0"
"CHEMBL609010";"";"None";"1952.21";"None";"None";"7";"CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1045150";"Binding affinity to human TYK2 kinase domain 2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152541";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"100.0"
"CHEMBL4868141";"";"None";"532.67";"1";"4.90";"I-65";"Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O";"% inhibition";"'='";"-3.5";"uM";"";"";"Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ";"UO_0000064";"";"";"";"";"0";"CHEMBL4804508";"Inhibition of TYK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"-3.5"
"CHEMBL3601862";"";"None";"771.34";"3";"3.70";"85";"C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@@H]54)c3)ncc2Cl)c1";"IC50";"'='";"3120.0";"nM";"5.51";"";"";"UO_0000065";"7.14";"0.14";"1.81";"2.83";"0";"CHEMBL3603320";"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600288";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3120.0"
"CHEMBL4861517";"";"None";"506.53";"2";"6.19";"11m";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)c2cccc(C(F)(F)F)c2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"14.56";"nM";"7.84";"";"";"UO_0000065";"15.47";"0.29";"1.65";"10.32";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"14.56"
"CHEMBL4862108";"";"None";"509.64";"1";"2.59";"11o";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)CN2CCS(=O)(=O)CC2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"1.99";"nM";"8.70";"";"";"UO_0000065";"17.07";"0.33";"6.11";"7.68";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1.99"
"CHEMBL4873919";"";"None";"553.57";"2";"5.08";"13j";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.71";"0.30";"3.62";"7.45";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2.0"
"CHEMBL4851075";"";"None";"349.37";"0";"3.10";"14a";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4)ncc2F)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.90";"0.46";"5.60";"9.51";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2.0"
"CHEMBL4871133";"";"None";"363.36";"0";"2.38";"14b";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CNC4=O)ncc2F)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"22.44";"0.41";"5.77";"7.51";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"7.0"
"CHEMBL4856634";"";"None";"442.46";"0";"3.33";"14j";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4C(=O)C3(C#N)CC3)ncc2F)cn1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"18.58";"0.34";"4.89";"6.66";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"6.0"
"CHEMBL4864387";"";"None";"479.42";"0";"3.79";"14l";"N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4S(=O)(=O)C(F)(F)F)c3)ncc2F)cn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.78";"0.33";"4.26";"6.79";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"9.0"
"CHEMBL595373";"";"None";"512.64";"2";"6.57";"25";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1";"Residual activity";"'='";"72.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1073365";"Residual activity of TYK2 at 10 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"72.0"
"CHEMBL1287970";"";"None";"387.35";"0";"2.75";"16";"CCOC(=O)c1cccc(Nc2nc(N)nn2C(=O)c2c(F)cccc2F)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL1288062";"";"None";"369.36";"0";"2.61";"23";"CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccccc3F)n2)c1";"IC50";"'='";"6040.0";"nM";"5.22";"";"";"UO_0000065";"14.13";"0.26";"2.61";"4.65";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"6040.0"
"CHEMBL3954540";"";"None";"284.36";"0";"2.75";"BDBM254998";"CN1CN(C2CCCCC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"46.0";"nM";"7.34";"";"443988";"UO_0000065";"25.80";"0.48";"4.59";"14.05";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"46.0"
"CHEMBL4091991";"";"None";"524.60";"2";"5.01";"EUB0000045b";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5469116";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000045b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 12.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20332/";"";"";"100.0"
"CHEMBL4462395";"";"None";"392.38";"1";"5.05";"EUB0000229b";"COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC";"% binding";"'='";"99.0";"%";"";"";"% Binding";"UO_0000187";"";"";"";"";"0";"CHEMBL5478657";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000229b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01213#";"";"";"99.0"
"CHEMBL3928338";"";"None";"438.51";"0";"2.43";"BDBM198567";"O=C(NCS(=O)(=O)c1ccccc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"353545";"UO_0000065";"15.23";"0.29";"4.25";"5.47";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"210.0"
"CHEMBL3975088";"";"None";"413.48";"0";"3.49";"BDBM198568";"O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)cc1";"IC50";"'='";"340.0";"nM";"6.47";"";"353546";"UO_0000065";"15.64";"0.30";"2.98";"6.95";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"340.0"
"CHEMBL3949248";"";"None";"504.51";"1";"3.69";"BDBM198597";"COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1OC";"IC50";"'='";"360.0";"nM";"6.44";"";"353575";"UO_0000065";"12.77";"0.24";"2.75";"5.88";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"360.0"
"CHEMBL3958508";"";"None";"385.48";"0";"3.34";"BDBM198598";"N#Cc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"580.0";"nM";"6.24";"";"353576";"UO_0000065";"16.18";"0.29";"2.90";"6.59";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"580.0"
"CHEMBL4114359";"";"None";"340.43";"0";"1.95";"BDBM198612";"O[C@@H]1CCN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"770.0";"nM";"6.11";"";"353590";"UO_0000065";"17.96";"0.33";"4.16";"7.42";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"770.0"
"CHEMBL3938593";"";"None";"327.39";"0";"2.83";"BDBM198646";"CCOC(=O)CC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"580.0";"nM";"6.24";"";"353624";"UO_0000065";"19.05";"0.35";"3.41";"7.32";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"580.0"
"CHEMBL3974289";"";"None";"380.37";"0";"2.95";"BDBM198651";"O=C(C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F";"IC50";"'='";"790.0";"nM";"6.10";"";"353629";"UO_0000065";"16.04";"0.31";"3.15";"6.94";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"790.0"
"CHEMBL3950137";"";"None";"380.37";"0";"2.95";"BDBM198652";"O=C(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F";"IC50";"'='";"880.0";"nM";"6.06";"";"353630";"UO_0000065";"15.92";"0.31";"3.11";"6.88";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"880.0"
"CHEMBL3955124";"";"None";"349.40";"0";"1.86";"BDBM198566";"N#CC1CN(C(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353544";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL483321";"CP-724714";"2.0";"469.55";"0";"4.95";"EUB0000595a";"COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5466049";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000595a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 17.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH1domain-catalytic) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20029/";"";"";"100.0"
"CHEMBL4855730";"";"None";"452.51";"0";"3.33";"I-51";"Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O";"% inhibition";"'='";"-23.9";"uM";"";"";"Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ";"UO_0000064";"";"";"";"";"0";"CHEMBL4804508";"Inhibition of TYK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"-23.9"
"CHEMBL5196877";"";"None";"423.42";"0";"3.09";"12";"CCNC(=O)Cc1ccc(Nc2nc(-c3c(F)cccc3F)nc3c2C(=O)NC3)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"13.75";"0.26";"2.73";"6.07";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"1.5"
"CHEMBL3658856";"";"None";"399.47";"0";"2.23";"BDBM159775";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCC(F)(F)CC2)C1";"IC50";"'='";"713.0";"nM";"6.15";"";"302669";"UO_0000065";"15.39";"0.31";"3.92";"7.48";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"713.0"
"CHEMBL4074855";"";"None";"309.37";"0";"3.20";"15";"CCc1cc(O)ccc1-c1ccc2c(C(=O)N(C)C)n[nH]c2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL5431291";"";"None";"312.38";"0";"2.15";"9";"Cc1cnc(NC2CCOCC2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"13.77";"0.26";"2.15";"4.85";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"50000.0"
"CHEMBL5421134";"";"None";"237.26";"0";"2.33";"43";"NC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5348900";"Inhibition of TYK2 (unknown origin) at 1 uM preincubated for 10 mins followed by substrate addition measured for 60 to 120 mins by HTRF assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346907";"1";"Scientific Literature";"Eur J Med Chem";"2023";"None";"DOSE = 1.0 microM | TIME_Lower = 70.0 min | TIME_Upper = 130.0 min";"";"";"0.0"
"CHEMBL4060444";"";"None";"392.51";"0";"3.12";"32";"Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"19.20";"0.35";"4.42";"6.77";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"29.0"
"CHEMBL4098840";"";"None";"396.47";"0";"2.95";"34";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)nc4)cc23)CC[C@]1(C)N";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"19.09";"0.36";"4.62";"6.80";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"27.0"
"CHEMBL4089568";"";"None";"361.23";"0";"4.29";"8";"Cn1c(-c2c(Cl)cccc2Cl)nc2ccnc(NC(=O)C3CC3)c21";"Ki";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"21.37";"0.44";"3.43";"12.91";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.019"
"CHEMBL3765131";"";"None";"340.77";"0";"2.35";"5";"Cn1ccc(-c2cn(-c3ccccc3Cl)c(=O)c3c(N)n[nH]c23)n1";"IC50";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"23.49";"0.46";"5.65";"8.47";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"9.9"
"CHEMBL4780984";"";"None";"364.41";"0";"2.85";"11";"C=CC(=O)Nc1ccc(-c2ccnc(Nc3cnn(CCOC)c3)n2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL3667524";"";"None";"457.49";"0";"3.03";"BDBM153672";"COc1ccc(C#N)cc1-c1nn(CC2(O)CCCC2)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"46.0";"nM";"7.34";"";"295023";"UO_0000065";"16.04";"0.29";"4.31";"5.63";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"46.0"
"CHEMBL4795901";"";"None";"419.53";"0";"3.54";"20d";"CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1cccc(OC)c1";"IC50";"'='";"88.2";"nM";"7.05";"";"";"UO_0000065";"16.82";"0.31";"3.51";"8.57";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"88.2"
"CHEMBL4746760";"";"None";"447.46";"0";"0.80";"29";"CNC(=O)Cn1cc(Nc2cc(-c3cccc(NC(=O)CNC(=O)CC#N)c3)ncn2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4755671";"";"None";"377.41";"0";"2.58";"33";"COCCn1cc(Nc2cc(-c3ccc(NC(=O)CC#N)cc3)ncn2)cn1";"IC50";"'='";"1872.0";"nM";"5.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"1872.0"
"CHEMBL24828";"VANDETANIB";"4.0";"475.36";"0";"4.43";"ZD-6474";"COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL4750605";"";"None";"383.88";"0";"3.26";"19b";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(Cl)c2)C1";"IC50";"'='";"597.0";"nM";"6.22";"";"";"UO_0000065";"16.21";"0.31";"2.96";"8.52";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"597.0"
"CHEMBL3667513";"";"None";"338.76";"0";"2.82";"BDBM153661";"O=C(Nc1ccnn1-c1ccc(Cl)cc1)c1cnn2cccnc12";"Ki";"'='";"850.0";"nM";"6.07";"";"295034";"UO_0000065";"17.92";"0.35";"3.25";"7.87";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"850.0"
"CHEMBL4559936";"";"None";"613.73";"2";"6.20";"(+/-)-6";"O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O";"Activity";"'='";"39.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4391627";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4390652";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"39.0"
"CHEMBL3911320";"";"None";"340.81";"0";"3.78";"13";"Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12";"IC50";"'='";"279.0";"nM";"6.55";"";"";"UO_0000065";"19.23";"0.37";"2.77";"8.74";"0";"CHEMBL3854814";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"279.0"
"CHEMBL3645537";"";"None";"457.97";"0";"4.71";"BDBM107120";"O=C(CN1CCN(c2ccc(Cl)cc2)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226429";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL3622150";"";"None";"418.51";"0";"3.49";"14";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)[nH]n3)nc21";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"20.84";"0.38";"5.23";"9.02";"0";"CHEMBL3625648";"Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621135";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"1.9"
"CHEMBL3763358";"";"None";"393.41";"0";"1.89";"27g";"COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC";"Kd";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"18.78";"0.35";"5.50";"6.00";"0";"CHEMBL3768616";"Binding affinity to human TYK2 JH2 domain pseudokinase";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763144";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"41.0"
"CHEMBL3622827";"";"None";"286.38";"0";"2.14";"5d";"NCCn1c(C2CCCCC2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"19.14";"0.36";"3.34";"6.31";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.3"
"CHEMBL2425644";"";"None";"309.37";"0";"2.74";"13";"O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1";"Inhibition";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2427783";"Competitive binding affinity to TYK2 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424622";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"86.0"
"CHEMBL3938113";"";"None";"407.44";"0";"3.31";"BDBM255010";"O=C1NCN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c1cnc1[nH]ccc21";"IC50";"'='";"19.0";"nM";"7.72";"";"444000";"UO_0000065";"18.95";"0.36";"4.41";"10.57";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"19.0"
"CHEMBL3976204";"";"None";"352.44";"0";"2.08";"BDBM255013";"CN1CN([C@H]2CC[C@H](CNCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"42.0";"nM";"7.38";"";"444003";"UO_0000065";"20.93";"0.39";"5.30";"8.38";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"42.0"
"CHEMBL3981038";"";"None";"439.48";"0";"3.14";"BDBM255015";"COCCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"60.0";"nM";"7.22";"";"444005";"UO_0000065";"16.43";"0.32";"4.08";"9.83";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"60.0"
"CHEMBL3913622";"";"None";"431.56";"0";"2.44";"BDBM254991";"CCN1CN([C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"370.0";"nM";"6.43";"";"444032";"UO_0000065";"14.90";"0.29";"3.99";"6.54";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"370.0"
"CHEMBL3985528";"";"None";"341.39";"0";"2.83";"BDBM254992";"N#CCN1CN([C@H]2CC[C@H](CF)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"49.0";"nM";"7.31";"";"444033";"UO_0000065";"21.41";"0.40";"4.48";"9.62";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"49.0"
"CHEMBL3933776";"";"None";"403.48";"0";"3.36";"BDBM255035";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)F)CC2)CN1C1CC1";"IC50";"'='";"290.0";"nM";"6.54";"";"444041";"UO_0000065";"16.20";"0.31";"3.18";"10.17";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"290.0"
"CHEMBL3981121";"";"None";"388.34";"0";"3.42";"BDBM198588";"FC(F)(F)C(F)(F)CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353566";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3949242";"";"None";"382.39";"0";"2.39";"BDBM198546";"OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F";"IC50";"'='";"440.0";"nM";"6.36";"";"353524";"UO_0000065";"16.62";"0.32";"3.97";"6.98";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"440.0"
"CHEMBL3892159";"";"None";"324.43";"0";"2.88";"BDBM198494";"CC1CC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353472";"UO_0000065";"21.13";"0.39";"3.97";"9.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3942120";"";"None";"328.42";"0";"1.80";"BDBM198500";"CN(CCO)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"320.0";"nM";"6.50";"";"353478";"UO_0000065";"19.78";"0.37";"4.69";"7.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"320.0"
"CHEMBL3906776";"";"None";"382.51";"0";"3.02";"BDBM198515";"O[C@H]1CCCC[C@H]1CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"370.0";"nM";"6.43";"";"353493";"UO_0000065";"16.81";"0.31";"3.41";"7.06";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"370.0"
"CHEMBL3889588";"";"None";"404.49";"0";"4.30";"BDBM198526";"Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)CC2)cc1";"IC50";"'='";"780.0";"nM";"6.11";"";"353504";"UO_0000065";"15.10";"0.28";"1.81";"8.61";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"780.0"
"CHEMBL5424439";"";"None";"439.90";"0";"4.21";"10";"CC(C)OC(=O)Cc1ccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)nc1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"17.13";"0.33";"3.33";"6.32";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"29.0"
"CHEMBL5431257";"";"None";"397.82";"0";"3.34";"11";"NC(=O)c1cnc(Nc2ccc(CC(=O)O)cn2)cc1Nc1ccccc1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"20.11";"0.39";"4.66";"6.14";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"10.0"
"CHEMBL3786167";"";"None";"508.60";"1";"3.25";"28";"CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3790310";"Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL4092337";"";"None";"335.37";"0";"2.17";"13a";"C=CC(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"2000.0"
"CHEMBL3352835";"";"None";"473.36";"0";"4.79";"3";"COC1CCN(c2nccc(Nc3cc(NC(=O)c4c(Cl)cccc4Cl)ccn3)n2)CC1";"Inhibition";"'>'";"80.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3375819";"Inhibition of Tyk2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"80.0"
"CHEMBL3818247";"DALMELITINIB";"2.0";"461.48";"0";"3.32";"4d";"CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3820677";"Inhibition of TYK2 (unknown origin) incubated for 1 hr by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817824";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";"";"30000.0"
"CHEMBL3309990";"";"None";"337.31";"0";"2.32";"7o";"Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375006";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352169";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"10.0"
"CHEMBL507329";"GW869810X";"None";"608.10";"2";"5.36";"GW869810X";"O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"-6.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.96"
"CHEMBL234838";"GW572738X";"None";"300.36";"0";"3.89";"GW572738X";"N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2";"Inhibition";"'='";"2.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.79"
"CHEMBL520037";"GW837331X";"None";"459.43";"0";"4.89";"GW837331X";"COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC";"Inhibition";"'='";"-1.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.24"
"CHEMBL3975326";"";"None";"324.36";"0";"3.26";"15";"Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12";"Inhibition";"'='";"62.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"62.0"
"CHEMBL1909349";"GSK-1007102B";"None";"561.52";"0";"2.28";"GSK1007102B";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F";"Inhibition";"'='";"2.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.96"
"CHEMBL588025";"GW770249A";"None";"467.81";"1";"5.27";"GW770249A";"Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12";"Inhibition";"'='";"-7.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.38"
"CHEMBL3309995";"";"None";"334.34";"0";"1.76";"10b";"Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375006";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352169";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"10.0"
"CHEMBL3814406";"";"None";"317.39";"0";"1.53";"3c";"C[C@@H](O)Cn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1";"IC50";"'='";"25700.0";"nM";"4.59";"";"";"UO_0000065";"14.46";"0.27";"3.06";"4.53";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"25.7"
"CHEMBL3648441";"";"None";"347.42";"0";"2.14";"BDBM107150";"O=C(CN1CCNCC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226460";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL4793760";"";"None";"439.47";"0";"3.14";"33";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncccn2)c1OC";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"22.00";"0.41";"6.46";"8.13";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4792231";"";"None";"480.54";"0";"2.62";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.85";"0.31";"5.43";"5.32";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"9.0"
"CHEMBL4795231";"";"None";"493.54";"0";"2.10";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"16.55";"0.31";"6.02";"5.37";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"7.6"
"CHEMBL4785957";"";"None";"436.49";"0";"2.70";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C)cn2)c1OC";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"15.89";"0.29";"4.19";"5.26";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"130.0"
"CHEMBL4096145";"";"None";"377.49";"0";"3.42";"2";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N";"Activity";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4054938";"Inhibition of TYK2 (unknown origin) assessed as residual activity at 50 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"50.0"
"CHEMBL3765517";"";"None";"433.54";"0";"1.16";"19";"CC(C)[C@H](C)n1cc(-c2cc(N3CCS(=O)(=O)CC3)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.58";"0.41";"7.76";"6.76";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"1.2"
"CHEMBL498859";"";"None";"243.70";"0";"3.47";"2";"Nc1n[nH]c2ccc(-c3ccccc3Cl)cc12";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"26.89";"0.53";"3.08";"11.98";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"280.0"
"CHEMBL3763184";"";"None";"314.39";"0";"2.31";"12";"CCC(C(C)C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"16.42";"0.31";"2.85";"5.46";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"6900.0"
"CHEMBL4076191";"";"None";"395.48";"0";"3.56";"13";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4F)cc23)CC[C@]1(C)N";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"19.78";"0.37";"4.26";"7.95";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"15.0"
"CHEMBL4104127";"";"None";"396.47";"0";"2.95";"29";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccnc(F)c4)cc23)CC[C@]1(C)N";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"18.23";"0.34";"4.28";"6.49";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"59.0"
"CHEMBL4096795";"";"None";"403.49";"0";"2.68";"38";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)nc4)cc23)CC[C@]1(C)N";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"18.16";"0.33";"4.65";"5.42";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"47.0"
"CHEMBL4060536";"";"None";"391.52";"0";"3.73";"9";"Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"20.60";"0.38";"4.34";"8.19";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"8.6"
"CHEMBL4071255";"";"None";"407.52";"0";"3.43";"10";"COc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"18.84";"0.35";"4.25";"7.13";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"21.0"
"CHEMBL3359923";"";"None";"274.32";"0";"1.15";"5b";"C[C@@]1(O)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"24.50";"0.46";"5.57";"7.25";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"190.0"
"CHEMBL4076823";"";"None";"411.94";"0";"4.07";"17";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(Cl)c4)cc23)CC[C@]1(C)N";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"18.69";"0.36";"3.63";"7.82";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"20.0"
"CHEMBL3884319";"";"None";"386.45";"0";"4.24";"33";"CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"12.94";"0.24";"0.76";"6.38";"0";"CHEMBL3876133";"Inhibition of human recombinant N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875183";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"10000.0"
"CHEMBL558752";"RAF-265";"2.0";"518.42";"2";"6.93";"CHIR-265/RAF-265";"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL3655103";"";"None";"430.54";"0";"1.36";"BDBM159770";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CCC(c3cc[nH]n3)CC2)C1";"IC50";"'='";"365.0";"nM";"6.44";"";"302664";"UO_0000065";"14.95";"0.29";"5.08";"5.24";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"365.0"
"CHEMBL3613597";"";"None";"495.43";"0";"3.96";"12";"CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1";"Inhibition";"'='";"99.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615451";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"99.0"
"CHEMBL3763991";"";"None";"382.47";"0";"2.42";"14";"CC(C)[C@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"19.14";"0.36";"4.90";"7.17";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"48.0"
"CHEMBL3763184";"";"None";"314.39";"0";"2.31";"12";"CCC(C(C)C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"22.40";"0.42";"4.73";"7.45";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"91.0"
"CHEMBL3763833";"";"None";"316.36";"0";"3.27";"7";"Cc1ccccc1-n1cc(-c2ccccc2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"19.32";"0.35";"2.84";"7.97";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"770.0"
"CHEMBL4078773";"";"None";"407.52";"0";"3.43";"12";"COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1";"IC50";"'='";"9.2";"nM";"8.04";"";"";"UO_0000065";"19.72";"0.37";"4.61";"7.46";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"9.2"
"CHEMBL4096145";"";"None";"377.49";"0";"3.42";"2";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"21.52";"0.40";"4.70";"8.25";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"7.5"
"CHEMBL4561123";"";"None";"434.44";"0";"2.09";"6i";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"16.12";"0.30";"4.91";"5.92";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"99.0"
"CHEMBL4579439";"";"None";"434.44";"0";"2.09";"6h";"CNc1cc(Nc2cccn(-c3cccc(F)n3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"371.0";"nM";"6.43";"";"";"UO_0000065";"14.80";"0.27";"4.34";"5.44";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"371.0"
"CHEMBL573339";"PI-103";"None";"348.36";"0";"2.98";"PI-103";"Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4050199";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of [gamma-32P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4049399";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";"";""
"CHEMBL4126514";"";"None";"405.50";"0";"4.70";"17";"CN(C)C(=O)CCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"16.91";"0.31";"2.16";"8.58";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"139.0"
"CHEMBL3655082";"";"None";"337.45";"0";"1.50";"7";"CC(C)CS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4100048";"";"None";"308.41";"0";"1.61";"16";"CCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4089286";"";"None";"323.42";"0";"1.11";"21";"CCNS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4103435";"";"None";"377.39";"0";"1.80";"31";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CCC(F)(F)F)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4079179";"";"None";"391.42";"0";"2.19";"32";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CCCC(F)(F)F)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4452772";"";"None";"426.92";"0";"4.67";"12t";"CC(Oc1cc(-c2cccc(N3CCNCC3)c2)cnc1N)c1cc(F)ccc1Cl";"IC50";"'='";"2530.0";"nM";"5.60";"";"";"UO_0000065";"13.11";"0.25";"0.93";"8.83";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"2.53"
"CHEMBL4092508";"";"None";"658.56";"2";"5.74";"2t";"COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl";"Activity";"'='";"95.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4044239";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043093";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";"";"";"";"95.0"
"CHEMBL3622147";"";"None";"433.52";"0";"2.89";"10";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)n(C)n3)nc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3625648";"Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621135";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";""
"CHEMBL4175555";"";"None";"627.73";"1";"4.63";"20a";"CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCC(C(=O)Nc5ccc(/C=C/C(=O)NO)cc5)CC4)cc3)n2)cc1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"11.69";"0.22";"2.71";"4.43";"0";"CHEMBL4150583";"Inhibition of TYK2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145634";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"46.0"
"CHEMBL3967880";"";"None";"354.41";"0";"1.90";"BDBM198481";"O=C(O)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"400.0";"nM";"6.40";"";"353459";"UO_0000065";"18.05";"0.34";"4.50";"6.44";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"400.0"
"CHEMBL3949461";"";"None";"324.43";"0";"3.02";"BDBM198486";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CCC5)CC4)c23)[nH]1";"IC50";"'='";"230.0";"nM";"6.64";"";"353464";"UO_0000065";"20.46";"0.38";"3.62";"9.36";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"230.0"
"CHEMBL3930431";"";"None";"310.41";"0";"2.59";"BDBM198489";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCC5)CC4)c23)[nH]1";"IC50";"'='";"230.0";"nM";"6.64";"";"353467";"UO_0000065";"21.39";"0.39";"4.05";"10.69";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"230.0"
"CHEMBL3899587";"";"None";"420.56";"0";"3.41";"BDBM198506";"OC12CC3CC(C1)C(NC[C@H]1CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC1)C(C3)C2";"IC50";"'>'";"1000.0";"nM";"";"";"353484";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3916457";"";"None";"420.36";"0";"3.96";"BDBM198520";"FC(F)(F)C(NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F";"IC50";"'='";"620.0";"nM";"6.21";"";"353498";"UO_0000065";"14.77";"0.29";"2.25";"8.76";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"620.0"
"CHEMBL3916717";"SELONSERTIB";"3.0";"445.50";"0";"4.68";"EUB0000695a";"Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1";"% of control";"'='";"81.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5474048";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000695a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 321.0 None | Selectivity Remarks: Screened at 100 nM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01458";"";"";"81.0"
"CHEMBL3667523";"";"None";"491.94";"0";"3.30";"BDBM153671";"COc1ccc(Cl)cc1-c1nn(CC(=O)N2CC=CCC2)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"10.0";"nM";"8.00";"";"295025";"UO_0000065";"16.26";"0.31";"4.70";"7.50";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"10.0"
"CHEMBL3655084";"";"None";"374.47";"0";"1.54";"BDBM159751";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@@H](CC#N)C2)C1";"IC50";"'='";"2710.0";"nM";"5.57";"";"302645";"UO_0000065";"14.87";"0.29";"4.03";"4.85";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2710.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"% of inhibition";"'='";"101.0";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5479494";"Selectivity interaction (Kinase panel (Carna Biosciences)) EUB0001542aTs TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 4.0 None | Selectivity number of targets = 306.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, conc. ATP = Km) | Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"101.0"
"CHEMBL3655102";"";"None";"361.43";"0";"0.21";"BDBM159769";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC(C#N)C2)C1";"IC50";"'='";"332.0";"nM";"6.48";"";"302663";"UO_0000065";"17.93";"0.35";"6.27";"5.49";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"332.0"
"CHEMBL2420815";"";"None";"281.14";"0";"3.32";"25";"O=C(NCc1ccncc1)c1c(Cl)cccc1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL4534832";"";"None";"424.44";"0";"2.83";"21";"CNC(=O)c1ccc(Nc2cc(Nc3ccc(F)cn3)ncc2C(=O)NC)c(OC)c1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"14.81";"0.28";"3.45";"5.36";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"520.0"
"CHEMBL4566158";"";"None";"461.50";"0";"4.18";"32";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2ccn(C)n2)c1OC";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"15.39";"0.29";"2.92";"6.70";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"79.0"
"CHEMBL4641006";"";"None";"446.51";"0";"2.18";"23";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCCCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"15.11";"0.28";"4.56";"5.61";"0";"CHEMBL4627624";"Inhibition of TYK2 in human Jurkat cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307526";"";"";"";"180.0"
"CHEMBL4547009";"";"None";"379.42";"0";"1.90";"6b";"CNc1cc(Nc2cccn(C3CC3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.33";"nM";"9.48";"";"";"UO_0000065";"24.99";"0.46";"7.58";"9.00";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.33"
"CHEMBL4577523";"GOLIDOCITINIB";"2.0";"489.58";"0";"2.69";"21; AZD4205";"COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"11.34";"0.21";"2.86";"4.78";"0";"CHEMBL4406252";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402602";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"2.8"
"CHEMBL1986139";"";"None";"261.74";"0";"4.09";"SID103905168";"Clc1csc2ncnc(Nc3ccccc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3787614";"";"None";"433.56";"0";"3.90";"1";"Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3790310";"Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL2443026";"";"None";"578.67";"1";"4.49";"38";"CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2443724";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439976";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL215152";"AZD-1152-HQPA";"-1.0";"507.57";"1";"3.50";"AZD-1152 HQPA";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL2035046";"";"None";"360.42";"0";"3.89";"13f, 95:5 trans/Cis mixture";"C1=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)COC/1";"IC50";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"16.71";"0.30";"2.13";"8.71";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.95"
"CHEMBL1650951";"";"None";"526.52";"1";"3.17";"1";"CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1";"IC50";"'='";"8055.0";"nM";"5.09";"";"";"UO_0000065";"9.67";"0.18";"1.92";"4.82";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"8055.0"
"CHEMBL4241889";"";"None";"427.51";"0";"0.64";"12f";"COCCn1cc(-c2nn(C3CCCN(C(=O)CN(C)C)C3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4293510";"";"None";"488.42";"0";"4.92";"34";"NC(=O)c1cnc2c(N[C@H]3C[C@H]3F)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251858";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha-induced IP10 production";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"10.0"
"CHEMBL4248451";"";"None";"367.42";"0";"1.04";"13h";"COCCn1cc(-c2nn(C3CCN(C#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL2035186";"";"None";"462.55";"0";"4.56";"14m, 95:5 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2coc(c2)COC/1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"14.96";"0.28";"2.36";"8.45";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.12"
"CHEMBL5416410";"";"None";"506.03";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O";"Kd";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.77";"0.24";"2.43";"5.39";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"1800.0"
"CHEMBL5416410";"";"None";"506.03";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O";"Kd";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"14.26";"0.29";"3.65";"6.53";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"110.0"
"CHEMBL1230020";"PLX-4720";"None";"413.83";"0";"3.88";"PLX-4720";"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1173655";"AFATINIB";"4.0";"485.95";"0";"4.39";"BIBW-2992";"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5188967";"";"None";"574.66";"1";"3.86";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NC3CCCC3)cc2)c1OC";"Tm";"'='";"60.23";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"60.23"
"CHEMBL5190418";"";"None";"578.62";"1";"3.56";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)c(F)c2)c1OC";"IC50";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"15.76";"0.29";"5.51";"5.87";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"0.85"
"CHEMBL5175777";"";"None";"566.68";"1";"2.85";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)NC2CCC(C(=O)N3CCCC3)CC2)c1OC";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"13.37";"0.25";"4.69";"4.87";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"29.0"
"CHEMBL1986781";"";"None";"420.45";"0";"3.61";"SID103904423";"CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972659";"";"None";"358.44";"0";"4.25";"SID103905060";"Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL1972937";"";"None";"310.38";"0";"3.59";"SID103904703";"COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970203";"";"None";"432.51";"0";"4.79";"SID103904353";"Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974702";"";"None";"330.59";"0";"4.13";"SID103905310";"Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988437";"";"None";"386.48";"0";"4.64";"SID103905539";"CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL1968245";"";"None";"404.90";"0";"4.73";"SID103904753";"NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979554";"";"None";"387.23";"0";"3.82";"SID103904662";"O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990885";"";"None";"398.48";"0";"3.33";"SID103905670";"CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C";"Ki";"'>'";"1258.93";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL1980142";"";"None";"400.28";"1";"5.31";"SID103904901";"O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1082440";"";"None";"319.43";"0";"1.92";"SID103905676";"Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL443563";"GW627512B";"None";"326.35";"0";"4.11";"GW627512B";"COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC";"Inhibition";"'='";"-2.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.24"
"CHEMBL1909347";"";"None";"546.38";"0";"3.37";"SB-732881-H";"CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O";"Inhibition";"'='";"0.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.31"
"CHEMBL275798";"";"None";"415.47";"0";"4.86";"SB-239272";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1";"Inhibition";"'='";"-1.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.8"
"CHEMBL189353";"GW809897X";"None";"571.49";"2";"6.48";"GW809897X";"CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1";"Inhibition";"'='";"1.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.51"
"CHEMBL1093191";"";"None";"499.57";"0";"4.39";"8";"COc1cc(-c2cnc3cccc(-c4ccc(CC(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"12.40";"0.23";"1.80";"7.46";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"640.0"
"CHEMBL189148";"GW829055X";"None";"398.86";"1";"5.25";"GW829055X";"Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1";"Inhibition";"'='";"0.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.28"
"CHEMBL373751";"GSK-319347A";"None";"469.54";"0";"3.96";"GSK319347A";"COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC";"Inhibition";"'='";"1.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.09"
"CHEMBL1909403";"GW569293E";"None";"547.47";"0";"4.41";"GW569293E";"O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1";"Inhibition";"'='";"-1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.77"
"CHEMBL1909351";"GW824645A";"None";"368.82";"0";"2.61";"GW824645A";"Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1";"Inhibition";"'='";"-1.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.33"
"CHEMBL1909397";"GW279320X";"None";"364.81";"0";"2.06";"GW279320X";"Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"0.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.66"
"CHEMBL471789";"GSK-1030059A";"None";"476.48";"1";"5.90";"GSK1030059A";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC";"Inhibition";"'='";"-0.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.07"
"CHEMBL1909374";"GW709042A";"None";"585.95";"2";"7.41";"GW709042A";"Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F";"Inhibition";"'='";"-0.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.97"
"CHEMBL222419";"GSK-237701A";"None";"457.94";"0";"5.00";"GSK237701A";"COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-0.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.55"
"CHEMBL405021";"";"None";"277.33";"0";"3.58";"SB-732941";"O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1";"Inhibition";"'='";"-4.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.71"
"CHEMBL275200";"";"None";"471.58";"1";"6.16";"SB-278538";"CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-0.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.01"
"CHEMBL2152299";"";"None";"345.45";"0";"4.00";"6";"C[C@@H]1CCN(Cc2ccccc2)C[C@@H]1n1cnc2cnc3[nH]ccc3c21";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"19.67";"0.36";"2.80";"13.66";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"160.0"
"CHEMBL2152305";"";"None";"331.42";"0";"3.75";"12";"c1ccc(CN2CCC(n3cnc4cnc5[nH]ccc5c43)CC2)cc1";"Ki";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"21.33";"0.39";"3.32";"14.22";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"85.0"
"CHEMBL31965";"CANERTINIB";"3.0";"485.95";"0";"4.39";"CI-1033";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"30.36";"0.55";"5.83";"11.18";"1";"CHEMBL2389430";"Inhibition of human TYK2 (873-1187) expressed in baculovirus-infected Sf9 cells using EQEDEPEGDYFEWLE as substrate after 1 hr by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";"";"";"";"0.5"
"CHEMBL2387112";"";"None";"366.20";"0";"3.69";"7";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(O)cc1Cl";"EC50";"'='";"436.0";"nM";"6.36";"";"";"UO_0000065";"17.37";"0.36";"2.67";"6.97";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"436.0"
"CHEMBL2387127";"";"None";"368.19";"0";"3.94";"23";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2F)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"23.36";"0.49";"4.66";"12.10";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"2.5"
"CHEMBL2152301";"";"None";"331.42";"0";"3.75";"8";"c1ccc(CN2CCC[C@@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1";"Ki";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"19.92";"0.36";"2.85";"13.27";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"250.0"
"CHEMBL3771285";"";"None";"371.85";"0";"4.22";"12";"Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3";"Activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3772131";"Inhibition of human recombinant TYK2 (JH1 domain-catalytic) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769377";"1";"Scientific Literature";"Medchemcomm";"2015";"None";"";"";"";"94.0"
"CHEMBL3601223";"";"None";"508.03";"1";"4.37";"9";"C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3603320";"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600288";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"10000.0"
"CHEMBL3589172";"";"None";"413.48";"0";"3.48";"9";"NC(=O)c1cc(Cc2ccccc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"179.0";"nM";"6.75";"";"";"UO_0000065";"16.32";"0.30";"3.27";"7.63";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"179.0"
"CHEMBL4224807";"";"None";"284.32";"0";"0.91";"6";"CN(c1ncnc2[nH]ccc12)[C@@H]1CCN(C(=O)CC#N)C1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"24.47";"0.45";"6.05";"7.83";"0";"CHEMBL4220898";"Inhibition of recombinant human TYK2 (875-end residues) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219073";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"1.1"
"CHEMBL4637587";"";"None";"418.46";"0";"1.75";"21";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"14.07";"0.26";"4.14";"4.90";"0";"CHEMBL4627624";"Inhibition of TYK2 in human Jurkat cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307526";"";"";"";"1300.0"
"CHEMBL1797211";"";"None";"413.75";"0";"4.12";"2";"O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1799030";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1795280";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";"";"50.0"
"CHEMBL2420860";"";"None";"253.13";"0";"4.00";"23";"Clc1cccc(Cl)c1CNc1ccncc1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL5408994";"";"None";"390.49";"0";"4.00";"A7";"Cc1cnc(Nc2ccc(CNC(=O)C3CC3)cc2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"18.46";"0.34";"3.21";"8.51";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"62.0"
"CHEMBL5175777";"";"None";"566.68";"1";"2.85";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)NC2CCC(C(=O)N3CCCC3)CC2)c1OC";"Tm";"'='";"58.26";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"58.26"
"CHEMBL5173760";"";"None";"518.55";"1";"2.68";"27";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CC(=O)N3)c1OC";"Tm";"'='";"59.46";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"59.46"
"CHEMBL4585243";"BAY-7598";"None";"505.57";"1";"3.60";"EUB0000728a";"O=C(O)[C@H]1[C@H](Cn2nnc3ccccc3c2=O)CC[C@@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1";"% of control";"'='";"41.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5213674";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000728a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 ÂµM (in vitro) | Selectivity Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-7598";"";"";"41.0"
"CHEMBL4549451";"";"None";"381.44";"0";"2.08";"17";"COc1ccc(-c2cc3c(N[C@H](CO)CC4CC4)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"18.14";"0.34";"4.84";"6.03";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"120.0"
"CHEMBL2181325";"";"None";"485.59";"0";"4.16";"17f, 85:15 trans/cis mixture";"CC(=O)N1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"14.33";"0.26";"2.80";"8.72";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.11"
"CHEMBL4435047";"";"None";"434.44";"0";"2.09";"6j";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"16.61";"0.31";"5.12";"6.10";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"61.0"
"CHEMBL4474801";"";"None";"434.44";"0";"2.09";"6f";"CNc1cc(Nc2cccn(-c3ccc(F)nc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"22.68";"0.42";"7.76";"8.33";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.14"
"CHEMBL4438296";"";"None";"430.47";"0";"2.34";"6o";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CCC3)cnc12";"Ki";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"16.78";"0.31";"4.88";"6.11";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"60.0"
"CHEMBL4561123";"";"None";"434.44";"0";"2.09";"6i";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"236.0";"nM";"6.63";"";"";"UO_0000065";"15.25";"0.28";"4.54";"5.60";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"236.0"
"CHEMBL405042";"GW335962X";"None";"329.38";"0";"2.13";"GW335962X";"C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21";"Inhibition";"'='";"6.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"6.88"
"CHEMBL506153";"GW876790X";"None";"330.35";"0";"0.03";"GW876790X";"CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21";"Inhibition";"'='";"-3.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.39"
"CHEMBL2062290";"";"None";"598.48";"0";"4.51";"SB-739245-AC";"CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O";"Inhibition";"'='";"-2.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.72"
"CHEMBL1789962";"GW643971X";"None";"374.40";"0";"3.03";"GW643971X";"COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O";"Inhibition";"'='";"-1.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.56"
"CHEMBL1909389";"GW574782A";"None";"633.09";"2";"6.37";"GW574782A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl";"Inhibition";"'='";"-7.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.44"
"CHEMBL187081";"PYRAZOLOPYRIDAZINE 1";"None";"318.34";"0";"2.94";"GW810576X";"COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1";"Inhibition";"'='";"-4.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.06"
"CHEMBL3785500";"";"None";"459.59";"0";"4.43";"3";"Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3790310";"Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL188794";"GW829115X";"None";"496.88";"1";"6.28";"GW829115X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1";"Inhibition";"'='";"-2.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.93"
"CHEMBL475599";"GSK-300014A";"None";"603.17";"2";"6.67";"GSK300014A";"CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1";"Inhibition";"'='";"-4.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.26"
"CHEMBL1909379";"";"None";"387.87";"0";"4.84";"GR-269666A";"Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1";"Inhibition";"'='";"-9.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-9.76"
"CHEMBL4228766";"";"None";"448.52";"0";"4.42";"8; SB1578";"C1=C/COc2ccc(o2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)COC/1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"14.80";"0.27";"2.22";"8.11";"0";"CHEMBL4220351";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219057";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"230.0"
"CHEMBL3763864";"";"None";"320.36";"0";"2.00";"8";"Cc1ccccc1-n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"23.48";"0.43";"5.52";"7.96";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"30.0"
"CHEMBL4288201";"";"None";"291.31";"0";"2.52";"16";"N#CNC1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"2517.0";"nM";"5.60";"";"";"UO_0000065";"19.22";"0.35";"3.08";"6.46";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2517.0"
"CHEMBL4294868";"";"None";"291.31";"0";"2.17";"25";"N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4280180";"";"None";"364.41";"0";"2.73";"8";"C=CC(=O)N1CCOc2ccc(-c3ncnc4[nH]cc(CCOC)c34)cc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL230597";"GSK-586581A";"None";"381.46";"0";"3.07";"GSK586581A";"CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1";"Inhibition";"'='";"-1.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.8"
"CHEMBL3618148";"";"None";"332.39";"0";"0.89";"16";"O=S(=O)(C1CC1)N1CC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1";"INH";"'='";"8.1";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"8.1"
"CHEMBL249697";"BMS-345541";"None";"255.32";"0";"1.87";"BMS-345541";"Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL2181318";"";"None";"375.43";"0";"4.36";"16d, 85:15 trans/cis mixture";"COc1ccc2cc1COCC=CCOc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"18.43";"0.34";"2.56";"10.57";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.12"
"CHEMBL2181317";"";"None";"389.46";"0";"4.75";"16c, 85:15 trans/cis mixture";"COc1ccc2cc1COCC=CCCOc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"17.52";"0.32";"2.07";"10.42";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.15"
"CHEMBL1983932";"";"None";"373.21";"0";"4.04";"SID103904891";"COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975128";"";"None";"416.23";"0";"3.06";"SID103904465";"Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12";"Ki";"'='";"100.0";"nM";"7.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.0"
"CHEMBL2005186";"BELUMOSUDIL";"4.0";"452.52";"0";"4.82";"SID103905007";"CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2003286";"";"None";"251.26";"0";"1.72";"SID103905210";"COc1cc(C=C2SC(=O)NC2=O)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3099720";"";"None";"437.50";"1";"5.26";"3";"CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3101876";"Inhibition of TYK2 (unknown origin) at 1 uM after 1 hr";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3098003";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";"";""
"CHEMBL3675689";"";"None";"403.29";"1";"5.30";"BDBM120132";"OCc1ccnc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)sc23)c1";"Ki";"'='";"0.3";"nM";"9.52";"";"247338";"UO_0000065";"23.61";"0.50";"4.22";"13.43";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.3"
"CHEMBL2159210";"";"None";"270.34";"0";"2.70";"20";"Cc1nc2cnc3[nH]ccc3c2n1[C@@H]1CCC[C@@H](O)C1";"Ki";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"30.36";"0.56";"5.51";"12.30";"0";"CHEMBL2160363";"Inhibition of TYK2 kinase domain using N-terminal 5-carboxyfluorescein-tagged Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157937";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"6.2"
"CHEMBL3799512";"TP-004";"None";"363.34";"0";"2.92";"EUB0000303";"Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12";"% Control";"'='";"70.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507303";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"70.0"
"CHEMBL482326";"GSK-1030062A";"None";"505.52";"2";"5.40";"GSK1030062A";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC";"Inhibition";"'='";"-4.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.64"
"CHEMBL4799830";"";"None";"421.48";"0";"3.00";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccccn2)c1OC";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"21.02";"0.39";"5.80";"7.45";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.6"
"CHEMBL4777175";"";"None";"534.51";"1";"3.16";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(C)(O)C(F)(F)F)cn2)c1OC";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"13.69";"0.26";"4.12";"4.81";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"53.0"
"CHEMBL4789015";"";"None";"421.48";"0";"3.00";"30";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncccn2)c1OC";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"17.65";"0.33";"4.39";"6.25";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"41.0"
"CHEMBL4780315";"";"None";"451.50";"0";"3.01";"32";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(OC)cn2)c1OC";"IC50";"'='";"341.0";"nM";"6.47";"";"";"UO_0000065";"14.42";"0.27";"3.46";"5.08";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"341.0"
"CHEMBL1650955";"";"None";"468.44";"0";"3.03";"9";"O=CN1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1";"IC50";"'='";"5040.0";"nM";"5.30";"";"";"UO_0000065";"11.31";"0.21";"2.27";"6.20";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"5040.0"
"CHEMBL2035051";"";"None";"473.58";"0";"4.36";"14c, 95:5 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cncc(c2)COC/1";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"13.09";"0.24";"1.84";"7.60";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.63"
"CHEMBL514409";"HESPERADIN";"None";"516.67";"2";"5.37";"7";"CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL524195";"";"None";"444.26";"0";"4.01";"8";"CCOC(=O)c1cn(-c2c(F)c(F)c(C#N)c(F)c2F)c2c(F)c(F)c(F)cc2c1=O";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL1019241";"Inhibition of IFN-alpha-induced Tyk2 Y1054/1055 phosphorylation in serum starved human U266 cells by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-266";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155075";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308535";"";"";"";""
"CHEMBL3326802";"";"None";"425.50";"0";"4.17";"44";"CC(C)(O)Cn1cc(-c2ccc(-c3cc4c(Nc5ccncc5)ncnn4c3)cc2)cn1";"Inhibition";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3376340";"Inhibition of TYK2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351500";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"96.0"
"CHEMBL4869982";"";"None";"386.48";"1";"5.04";"6d";"Cc1ccc(-c2cc3cnc4[nH]ccc4c3n2-c2cnn(CCCC#N)c2)s1";"IC50";"'>'";"300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";"300.0"
"CHEMBL1093468";"";"None";"547.63";"1";"3.79";"9";"COc1cc(-c2cnc3cccc(-c4ccc(CC(=O)N5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"11.81";"0.23";"2.68";"5.99";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"340.0"
"CHEMBL3655097";"";"None";"350.45";"0";"0.76";"14";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCC2CC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL1375418";"";"None";"315.38";"0";"3.71";"SID103904924";"Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970806";"";"None";"323.38";"0";"2.57";"SID103904982";"O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972362";"";"None";"332.41";"0";"2.47";"SID103905047";"CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989423";"";"None";"156.19";"0";"1.98";"SID103905447";"c1ccc2c(c1)Cc1c[nH]nc1-2";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL1164181";"";"None";"469.42";"0";"4.63";"5g";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL385478";"";"None";"293.37";"0";"3.76";"SID103904205";"c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL1998193";"";"None";"356.43";"0";"2.98";"SID103904795";"O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991800";"";"None";"446.53";"0";"4.38";"SID103904760";"CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994830";"";"None";"344.78";"0";"4.37";"SID103905372";"Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1236126";"";"None";"440.46";"0";"3.53";"SID103905081";"CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992937";"";"None";"269.26";"0";"2.92";"SID103905536";"Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971017";"";"None";"272.30";"0";"3.20";"SID103905042";"NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982135";"";"None";"401.50";"0";"4.99";"SID103904356";"Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989474";"";"None";"254.27";"0";"2.68";"SID103905180";"Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000685";"";"None";"708.80";"2";"1.02";"SID103904743";"CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004892";"";"None";"302.36";"0";"2.18";"SID103904487";"CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL1970314";"";"None";"263.30";"0";"2.58";"SID103905443";"NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1981720";"";"None";"265.28";"0";"2.67";"SID103904889";"O=C(Nc1cnccn1)Nc1ccnc2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3694587";"";"None";"352.83";"0";"4.94";"BDBM125908";"C[C@@H]1Nc2nc(ncc2Cl)Nc2cccc(c2)COc2cccc1c2";"IC50";"'>'";"1000.0";"nM";"";"";"255719";"UO_0000065";"";"";"";"";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3359914";"";"None";"302.38";"0";"1.78";"4c";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@]1(C)O";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"22.08";"0.41";"4.90";"7.21";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"210.0"
"CHEMBL3359921";"";"None";"301.39";"0";"1.75";"4j";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@]1(C)N";"IC50";"'='";"97.0";"nM";"7.01";"";"";"UO_0000065";"23.27";"0.44";"5.26";"7.12";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"97.0"
"CHEMBL3359928";"";"None";"276.32";"0";"2.13";"5h";"C[C@@]1(F)CCC[C@@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"23.15";"0.44";"4.27";"8.83";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"400.0"
"CHEMBL1794071";"";"None";"409.92";"0";"3.73";"SB-614067-R";"Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21";"Inhibition";"'='";"-0.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.2"
"CHEMBL521806";"GSK-237700A";"None";"457.94";"0";"5.00";"GSK237700A";"COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-2.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.87"
"CHEMBL1794064";"GSK-561866B";"None";"470.41";"0";"0.12";"GSK561866B";"CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"5.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.99"
"CHEMBL365297";"GW827099X";"None";"440.44";"0";"4.51";"GW827099X";"Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1";"Inhibition";"'='";"-3.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.36"
"CHEMBL466412";"GSK-238063A";"None";"566.06";"2";"5.59";"GSK238063A";"CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1";"Inhibition";"'='";"0.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.28"
"CHEMBL231013";"GSK-605714A";"None";"228.25";"0";"1.86";"GSK605714A";"COc1ccc(-c2ccncc2)cc1C(N)=O";"Inhibition";"'='";"-3.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.25"
"CHEMBL1938642";"";"None";"354.44";"0";"2.48";"3";"NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"20.26";"0.39";"4.70";"7.60";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.066"
"CHEMBL3814951";"";"None";"317.39";"0";"1.54";"3b";"NC(=O)c1ccc2c(c1)nc([C@H]1CC[C@H](O)CC1)n2CCCO";"IC50";"'='";"42200.0";"nM";"4.38";"";"";"UO_0000065";"13.78";"0.26";"2.83";"4.32";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"42.2"
"CHEMBL4645110";"";"None";"431.50";"0";"3.21";"27";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COC/C=C/COCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.36";"0.34";"4.71";"7.89";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"12.0"
"CHEMBL2420841";"";"None";"198.22";"0";"2.33";"2";"O=C(Nc1ccncc1)c1ccccc1";"Ki";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"27.79";"0.50";"3.18";"13.12";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.1"
"CHEMBL2420820";"";"None";"296.16";"0";"3.68";"30";"CNc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"19.66";"0.42";"2.14";"10.78";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.5"
"CHEMBL2420825";"";"None";"360.20";"0";"4.17";"35";"O=C(Nc1ccnc(Nc2ncccn2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"16.44";"0.34";"1.75";"7.42";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.2"
"CHEMBL3622134";"";"None";"421.53";"0";"3.91";"15";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nccs3)nc21";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"17.92";"0.34";"3.64";"9.34";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"28.0"
"CHEMBL5412967";"";"None";"465.51";"0";"3.19";"(S)-3";"COC[C@H](C)OC(=O)Cc1ccc(Nc2cc(Nc3ccccc3OC)c(C(N)=O)cn2)nc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.33";"0.36";"5.81";"6.54";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"1.0"
"CHEMBL5407329";"";"None";"393.40";"0";"2.70";"4";"COc1ccccc1Nc1cc(Nc2ccc(CC(=O)O)cn2)ncc1C(N)=O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.73";"0.38";"5.45";"5.85";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"7.0"
"CHEMBL5407260";"";"None";"463.49";"0";"2.95";"(R)-14";"COc1ccccc1Nc1cc(Nc2ccc(CC(=O)O[C@@H]3CCOC3)cn2)ncc1C(N)=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.77";"0.35";"5.75";"6.32";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"2.0"
"CHEMBL3764383";"";"None";"382.47";"0";"2.42";"15";"CC(C)[C@@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"9.7";"nM";"8.01";"";"";"UO_0000065";"20.95";"0.39";"5.59";"7.85";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"9.7"
"CHEMBL5408759";"";"None";"384.46";"0";"2.83";"7";"CN(C)S(=O)(=O)c1cccc(-c2c[nH]c3cnc(NC(=O)C4CC4)cc23)c1";"EC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"16.30";"0.32";"3.44";"6.59";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.54"
"CHEMBL5401070";"";"None";"367.41";"0";"2.39";"14";"CO[C@@]1(c2cccc(-c3cn(C)c4cnc(NC(N)=O)cc34)n2)CCOC1";"EC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"19.66";"0.37";"4.83";"6.92";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.06"
"CHEMBL3645544";"";"None";"289.34";"0";"3.65";"BDBM107129";"O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)C1CC1";"IC50";"'>'";"50000.0";"nM";"";"";"226439";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL5185440";"";"None";"565.50";"1";"2.65";"12c";"CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(O[C@@H]5CO[C@H]6[C@@H]5OC[C@H]6O)n4)cc3Cl)CC2)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"12.07";"0.25";"4.17";"7.15";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"150.0"
"CHEMBL1909357";"GW410563A";"None";"347.80";"0";"3.40";"GW410563A";"COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl";"Inhibition";"'='";"-5.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.98"
"CHEMBL409892";"GW305178X";"None";"367.39";"0";"1.65";"GW305178X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1";"Inhibition";"'='";"7.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"7.29"
"CHEMBL3099716";"";"None";"443.55";"1";"5.12";"4";"CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3101876";"Inhibition of TYK2 (unknown origin) at 1 uM after 1 hr";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3098003";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";"";""
"CHEMBL269827";"GW276655X";"None";"383.39";"0";"1.76";"GW276655X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1";"Inhibition";"'='";"-0.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.2"
"CHEMBL1909367";"GW680908A";"None";"587.94";"2";"5.38";"GW680908A";"COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl";"Inhibition";"'='";"0.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.09"
"CHEMBL2420847";"";"None";"300.67";"0";"4.01";"10";"O=C(Nc1ccncc1)c1c(Cl)cccc1C(F)(F)F";"Ki";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"19.03";"0.39";"1.71";"13.63";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.9"
"CHEMBL4533018";"";"None";"404.94";"0";"2.21";"IM-93";"CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl";"Activity";"'='";"82.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4308093";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304811";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"82.0"
"CHEMBL4533018";"";"None";"404.94";"0";"2.21";"IM-93";"CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl";"Activity";"'='";"88.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4308094";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304811";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"88.0"
"CHEMBL2420822";"";"None";"360.22";"0";"3.01";"32";"CS(=O)(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL4440261";"";"None";"308.39";"0";"3.17";"12";"CC(C)CNc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"23.35";"0.43";"4.03";"9.94";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"63.0"
"CHEMBL5094318";"";"None";"393.54";"0";"3.93";"38";"Cc1cnc(Nc2ccc(C(C)(C)C)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"102.0";"nM";"6.99";"";"";"UO_0000065";"17.77";"0.33";"3.06";"9.97";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"102.0"
"CHEMBL5079149";"";"None";"546.45";"1";"3.87";"13";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2Br)cc1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"13.39";"0.29";"3.45";"5.14";"0";"CHEMBL5046599";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"48.0"
"CHEMBL3667525";"";"None";"466.47";"0";"2.53";"BDBM153673";"COc1ccc(F)cc1-c1nn(CC2(O)CCOCC2)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"47.0";"nM";"7.33";"";"295021";"UO_0000065";"15.71";"0.29";"4.80";"6.33";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"47.0"
"CHEMBL1797224";"";"None";"449.25";"0";"3.86";"3";"Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1799030";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1795280";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";"";"50.0"
"CHEMBL2152297";"";"None";"322.37";"0";"2.24";"4";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1n1cnc2cnc3[nH]ccc3c21";"Ki";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"25.98";"0.48";"6.14";"9.25";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"4.2"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"15.54";"0.28";"2.90";"10.44";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"56.0"
"CHEMBL1989856";"";"None";"251.25";"0";"2.19";"SID103905300";"Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999590";"";"None";"344.38";"0";"3.68";"SID103905140";"Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975233";"";"None";"317.74";"0";"2.96";"SID103904892";"COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL508928";"";"None";"438.50";"0";"4.33";"SID103904288";"Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3290628";"";"None";"418.50";"0";"4.73";"13k";"CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O";"Activity";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3294391";"Inhibition of human TYK2 assessed as residual activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286226";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"86.0"
"CHEMBL4060295";"";"None";"396.45";"0";"4.55";"9d";"CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3995068";"Inhibition of human TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3994581";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"100.0"
"CHEMBL3658861";"";"None";"322.43";"0";"2.00";"BDBM159780";"CCCS(=O)(=O)C[C@H]1C[C@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"3610.0";"nM";"5.44";"";"302674";"UO_0000065";"16.88";"0.34";"3.44";"6.89";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"3610.0"
"CHEMBL4796206";"";"None";"458.52";"0";"2.96";"26";"C=CC(=O)NCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4777465";"";"None";"378.44";"0";"3.24";"32";"C/C=C/C(=O)Nc1ccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL3675998";"";"None";"394.45";"0";"3.13";"BDBM127751";"C[C@H](NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12)C1CC1";"IC50";"'>'";"1000.0";"nM";"";"";"258567";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4564280";"";"None";"428.50";"0";"4.67";"EUB0000006b";"CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"459.0";"nM";"6.34";"";"";"UO_0000065";"14.79";"0.27";"1.67";"6.11";"0";"CHEMBL5213575";"Selectivity interaction (Enzyme kinetic assay (ProQinase)) EUB0000006b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity Comments: Positive control NIBR3049 available with IC50(JAK3) = 8 nM (enzymatic assay), https://www.thesgc.org/chemical-probes/FM-381; | Selectivity Remarks: In-vitro potency | Selectivity Source Knowledge: https://www.thesgc.org/chemical-probes/FM-381";"";"";"459.0"
"CHEMBL2181316";"";"None";"345.40";"0";"4.60";"16b, 85:15 trans/cis mixture";"C1=CCOc2cccc(c2)Nc2nccc(n2)-c2cccc(c2)OCC1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"20.71";"0.38";"2.55";"12.72";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.07"
"CHEMBL5284095";"";"None";"1056.31";"None";"None";"37";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Emax";"'='";"78.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5225303";"Induction of TYK2 degradation in human Jurkat cells at 100 nM incubated for 24 hrs relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 100.0 nM | TIME = 24.0 hr";"DEGRADER";"";"78.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"32.3";"nM";"7.49";"";"";"UO_0000065";"23.98";"0.44";"5.95";"8.43";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"32.3"
"CHEMBL4587735";"";"None";"345.41";"0";"3.96";"7";"C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL5078528";"";"None";"427.51";"0";"2.66";"36";"COc1cc(Nc2ncc(C)c(N3CCC4(CCNC4=O)CC3)n2)cc(OC)c1OC";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.94";"0.36";"5.44";"8.28";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"8.0"
"CHEMBL4459585";"ROPSACITINIB";"2.0";"383.42";"0";"2.54";"2; PF-06846647";"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.26";"0.37";"5.23";"6.85";"1";"CHEMBL5327921";"Inhibition of TYK2 JH1 domain (unknown origin) in presence of 1 mM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"17.0"
"CHEMBL4784391";"";"None";"440.45";"0";"2.53";"5; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"22.22";"0.41";"7.19";"7.42";"0";"CHEMBL5327930";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF based binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.19"
"CHEMBL5404091";"";"None";"433.45";"0";"2.70";"9";"CNc1cc(Nc2cccn(-c3ccc(F)cc3)c2=O)nc2c(C(=O)NC3CC3)cnn12";"Kd";"'='";"0.063";"nM";"10.20";"";"";"UO_0000065";"23.53";"0.44";"7.50";"9.68";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.063"
"CHEMBL5402351";"";"None";"484.44";"0";"2.73";"15";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CCC3(F)F)cnn12";"Kd";"'='";"0.008";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.008"
"CHEMBL5397381";"";"None";"425.49";"0";"2.16";"29";"CNc1cc(Nc2cccn(C(C)C)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"20.10";"0.38";"6.39";"7.46";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"2.8"
"CHEMBL5438892";"";"None";"308.35";"0";"2.04";"4";"Cc1cnc(Nc2cnn(C)c2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"27.46";"0.50";"6.43";"8.71";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"3.4"
"CHEMBL5428288";"";"None";"450.46";"1";"1.56";"36";"CNc1cc(Nc2cccn(-c3ncco3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.005";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.005"
"CHEMBL230911";"GSK-625137A";"None";"289.34";"0";"3.10";"GSK625137A";"NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N";"Inhibition";"'='";"-2.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.55"
"CHEMBL3601120";"";"None";"413.87";"0";"2.80";"50";"C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"16.56";"0.32";"4.05";"5.86";"0";"CHEMBL3603320";"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600288";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"140.0"
"CHEMBL5408743";"";"None";"922.02";"2";"3.22";"PTD10";"C[C@H]1CN(C(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL5342669";"Degradation of TYK2 in human TMD8 cells by measuring protein level at 111 nM for 6 hrs using label free proteomic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338787";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 111.0 nM | TIME = 6.0 hr";"";"";""
"CHEMBL5403157";"";"None";"435.54";"0";"4.12";"21";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)C([2H])([2H])c1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL2323775";"MK-8033";"1.0";"471.54";"0";"3.16";"MK-8033";"Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL574737";"UCN-01";"2.0";"482.54";"0";"3.84";"UCN-01";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL466412";"GSK-238063A";"None";"566.06";"2";"5.59";"GSK238063A";"CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1";"Inhibition";"'='";"1.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.84"
"CHEMBL2392500";"";"None";"309.33";"0";"1.38";"3";"N#CCC(=O)N1CCC[C@@H](n2nnc3cnc4[nH]ccc4c32)C1";"Ki";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"24.89";"0.46";"6.32";"7.44";"0";"CHEMBL2394362";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390952";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"20.0"
"CHEMBL2103882";"TIVANTINIB";"3.0";"369.42";"0";"3.59";"Tivantinib";"O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL553";"ERLOTINIB";"4.0";"393.44";"0";"3.41";"Erlotinib";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1983111";"";"None";"474.49";"0";"4.06";"PF-03814735";"CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12";"Kd";"'='";"1866.0";"nM";"5.73";"";"Active";"UO_0000065";"12.07";"0.23";"1.67";"5.77";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.96 None";"";"";"1866.0"
"CHEMBL1999774";"";"None";"336.78";"0";"1.37";"SID103905288";"Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001539";"";"None";"176.24";"0";"2.24";"SID103905580";"c1cc2c(s1)CCc1cn[nH]c1-2";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL1994526";"";"None";"247.34";"0";"2.17";"SID103904954";"CC(N)C1CCC(C(=O)Nc2ccncc2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2420813";"";"None";"340.17";"0";"3.82";"55";"COC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"19.90";"0.42";"2.95";"8.43";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.17"
"CHEMBL269883";"GW416981X";"None";"415.47";"0";"2.55";"GW416981X";"CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"4.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.42"
"CHEMBL196022";"GW642125X";"None";"241.25";"0";"2.48";"GW642125X";"COc1ccc(-c2coc3ncnc(N)c23)cc1";"Inhibition";"'='";"-3.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.97"
"CHEMBL1230122";"R-1487";"1.0";"388.37";"0";"2.99";"SID103905625";"Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992796";"";"None";"399.88";"1";"5.29";"SID103905482";"O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL223257";"";"None";"463.88";"0";"2.32";"SID103905153";"N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001751";"";"None";"476.54";"1";"5.26";"SID103904754";"NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1985074";"";"None";"278.76";"0";"2.90";"SID103905287";"CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991725";"";"None";"479.58";"0";"4.45";"SID103904474";"CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972119";"";"None";"417.39";"0";"4.13";"SID103904895";"O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982361";"";"None";"297.29";"0";"2.17";"SID103904729";"O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973711";"";"None";"287.66";"0";"1.98";"SID103905594";"N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979516";"";"None";"449.51";"1";"5.08";"SID103904336";"CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL392642";"";"None";"416.55";"0";"3.90";"SID103905471";"CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972849";"";"None";"410.38";"0";"3.25";"SID103905069";"CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5193702";"";"None";"533.03";"1";"2.56";"12n";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4OC)n2)ccc1N(C)CCN(C)C";"IC50";"'='";"365.0";"nM";"6.44";"";"";"UO_0000065";"12.08";"0.24";"3.88";"5.84";"0";"CHEMBL5141304";"Inhibition of human TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"365.0"
"CHEMBL5076599";"";"None";"338.42";"0";"2.03";"42";"Cc1cnc(Nc2ccncc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"20.25";"0.37";"4.82";"8.25";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"140.0"
"CHEMBL5088830";"";"None";"355.45";"0";"1.68";"47";"Cc1cnc(Nc2cn(C)nc2C)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"85.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"85.0"
"CHEMBL1982924";"";"None";"343.39";"0";"4.49";"SID103904210";"COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL523823";"";"None";"280.67";"0";"1.81";"SID103905546";"CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1983449";"";"None";"307.35";"0";"2.65";"SID103904951";"Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997129";"";"None";"315.38";"0";"3.53";"SID103905259";"O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21";"Ki";"'>'";"1258.93";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL519697";"";"None";"415.50";"0";"4.24";"SID103905077";"CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5185016";"";"None";"545.04";"1";"2.43";"12j";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1CCC(N(C)C)CC1";"IC50";"'='";"241.0";"nM";"6.62";"";"";"UO_0000065";"12.14";"0.24";"4.19";"5.46";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"241.0"
"CHEMBL1999918";"";"None";"369.19";"0";"4.10";"SID103905043";"NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5206970";"";"None";"378.48";"0";"2.95";"42";"N#CCCN1CC2(CCC(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)C1";"IC50";"'='";"371.0";"nM";"6.43";"";"";"UO_0000065";"16.99";"0.31";"3.48";"7.45";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"371.0"
"CHEMBL3645546";"";"None";"361.45";"0";"2.48";"BDBM107132";"CN1CCN(CC(=O)Nc2cccc(-c3cnc4ccccc4n3)c2)CC1";"IC50";"'>'";"50000.0";"nM";"";"";"226442";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL5418687";"";"None";"386.43";"0";"1.77";"11";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)C4COC4)n3)cn(C)c2cn1";"EC50";"'='";"194.0";"nM";"6.71";"";"";"UO_0000065";"17.37";"0.34";"4.94";"6.51";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.194"
"CHEMBL1909374";"GW709042A";"None";"585.95";"2";"7.41";"GW709042A";"Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F";"Inhibition";"'='";"-4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.63"
"CHEMBL232601";"GW846105X";"None";"401.49";"0";"4.71";"GW846105X";"N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1";"Inhibition";"'='";"-5.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.1"
"CHEMBL4741075";"";"None";"506.61";"2";"5.30";"13aj";"Cc1cnc(Nc2ccc3c(c2)CN(C(=O)/C=C/C(=O)c2ccccc2)CC3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"14.38";"0.26";"1.98";"7.83";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"52.0"
"CHEMBL4799683";"";"None";"441.42";"0";"2.48";"10";"Cn1cc(-c2cc(-c3cnn(C4(CC#N)CN(CC(F)(F)F)C4)c3)n3cnnc3c2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"10000.0"
"CHEMBL4741903";"";"None";"398.43";"0";"1.44";"16";"Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CC#N)C4)c3)n2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.47";"0.37";"6.71";"6.99";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"7.0"
"CHEMBL4740298";"";"None";"383.42";"0";"2.54";"21, cis isomer";"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@H](C#N)C4)c3)n2)cn1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"21.44";"0.39";"5.68";"7.25";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"6.0"
"CHEMBL442363";"GW809885X";"None";"373.42";"0";"3.36";"GW809885X";"COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1";"Inhibition";"'='";"-0.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.79"
"CHEMBL4461011";"";"None";"322.41";"0";"3.56";"14";"CC(C)(C)CNc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"22.19";"0.41";"3.59";"9.88";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"70.0"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"6a";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327925";"Inhibition of TYK2 JH1 domain (unknown origin) in presence of 10 uM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5415951";"";"None";"353.39";"0";"1.81";"8";"CNc1cc(Nc2cccnc2OC)nc2c(C(=O)NC3CC3)cnn12";"Kd";"'='";"0.039";"nM";"10.41";"";"";"UO_0000065";"29.45";"0.55";"8.60";"9.87";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.039"
"CHEMBL274064";"SB-220025";"None";"338.39";"0";"2.65";"SID103905253";"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1967564";"";"None";"254.29";"0";"2.85";"SID103905382";"CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979176";"";"None";"362.31";"0";"4.30";"SID103904896";"COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL248757";"";"None";"471.93";"0";"4.27";"SID103905151";"N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL213505";"";"None";"414.35";"0";"4.53";"SID103904357";"Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979718";"";"None";"345.41";"0";"3.68";"SID103905662";"Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989834";"";"None";"210.24";"0";"2.52";"SID103905442";"O=c1[nH][nH]c2cccc(-c3ccccc3)c12";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL2006263";"";"None";"328.40";"0";"2.63";"SID103904950";"Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5199899";"";"None";"416.23";"0";"3.18";"23a";"Cc1c(-c2ncnc3[nH]ccc23)nnn1Cc1ccc(I)cc1";"Inhibition";"'='";"41.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5133089";"Inhibition of TYK2 (unknown origin) at 1 uM by biochemical assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"41.3"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"25.20";"0.46";"4.25";"9.28";"1";"CHEMBL5342280";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338778";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"19.0"
"CHEMBL1938652";"";"None";"367.35";"0";"3.80";"17";"CNC(=O)c1cnc(N)c2cc(-c3ccc(OC(F)(F)F)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938653";"";"None";"350.45";"0";"3.71";"18";"CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C#N)cc3)sc12";"IC50";"'='";"146.0";"nM";"6.84";"";"";"UO_0000065";"19.51";"0.37";"3.13";"7.45";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.146"
"CHEMBL4777342";"";"None";"418.79";"0";"3.64";"21";"Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1";"Inhibition";"'='";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4666944";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (833 to 1187 residues) expressed in baculovirus expression system using Tyr 03 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"Dose = 0.1 microM | TIME = 1.0 hr";"INHIBITOR";"";"98.0"
"CHEMBL4084173";"";"None";"505.40";"1";"3.76";"13f";"NC(=O)c1cnn2cccc2c1NCc1cccc(NC(=O)COc2c(F)c(F)c(F)c(F)c2F)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"2000.0"
"CHEMBL4098094";"";"None";"338.44";"0";"0.76";"12";"CCCNS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4085011";"";"None";"371.47";"0";"2.04";"10";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)Cc2ccccc2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3658853";"";"None";"387.47";"0";"0.60";"BDBM159772";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@H]3C[C@@]3(C#N)C2)C1";"IC50";"'='";"565.0";"nM";"6.25";"";"302666";"UO_0000065";"16.12";"0.32";"5.65";"5.29";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"565.0"
"CHEMBL1938649";"";"None";"283.36";"0";"2.91";"14";"CNC(=O)c1cnc(N)c2cc(-c3ccccc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938650";"";"None";"297.38";"0";"3.21";"15";"CNC(=O)c1cnc(N)c2cc(-c3ccc(C)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938657";"";"None";"475.64";"0";"2.91";"23";"CN(C)CCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Inhibition";"";"";"%";"";"";"Dose-dependent effect";"UO_0000187";"";"";"";"";"0";"CHEMBL3615459";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of IFNalpha5-induced STAT3 phosphorylation pre-incubated for 30 mins before IFNalpha5 stimulation for 30 mins mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL3622838";"";"None";"282.31";"0";"0.55";"5o";"NCCn1c(-c2cncnc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"19.67";"0.36";"5.00";"4.93";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"2.8"
"CHEMBL3667509";"";"None";"357.38";"0";"2.66";"BDBM153657";"Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(C#N)ccc2C)n1";"Ki";"'='";"131.0";"nM";"6.88";"";"295031";"UO_0000065";"19.26";"0.35";"4.22";"6.82";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"131.0"
"CHEMBL3645545";"";"None";"423.52";"0";"4.06";"BDBM107131";"O=C(CN1CCN(c2ccccc2)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226441";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL1970104";"";"None";"290.37";"0";"4.40";"SID103904906";"CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1";"Ki";"'='";"251.19";"nM";"6.60";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.6"
"CHEMBL5189603";"";"None";"418.84";"0";"1.90";"12e";"C=CC(=O)Nc1cccc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)c1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"16.78";"0.33";"5.13";"6.12";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"94.0"
"CHEMBL5174210";"";"None";"519.00";"1";"1.90";"12m";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N(C)CCN(C)C";"IC50";"'='";"424.0";"nM";"6.37";"";"";"UO_0000065";"12.28";"0.24";"4.47";"5.25";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"424.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"BDBM103727";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"72.7";"nM";"7.14";"";"221730";"UO_0000065";"16.78";"0.32";"5.16";"7.38";"0";"CHEMBL3707911";"Inhibition Assay: In vitro inhibition assay using various enzyme.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638964";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"72.7"
"CHEMBL206544";"GW682841X";"None";"340.43";"1";"5.32";"GW682841X";"CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1";"Inhibition";"'='";"0.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.66"
"CHEMBL441702";"GSK-270822A";"None";"396.45";"0";"4.23";"GSK270822A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1";"Inhibition";"'='";"0.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.09"
"CHEMBL241517";"GW856804X";"None";"433.92";"0";"4.65";"GW856804X";"Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12";"Inhibition";"'='";"-1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.25"
"CHEMBL275473";"GW572401X";"None";"401.49";"0";"4.12";"GW572401X";"CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1";"Inhibition";"'='";"0.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.12"
"CHEMBL483747";"GSK-980961A";"None";"390.46";"0";"4.13";"GSK980961A";"NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1";"Inhibition";"'='";"-2.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.99"
"CHEMBL1909414";"";"None";"508.02";"0";"4.87";"SB-590885-AAD";"CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O";"Inhibition";"'='";"-5.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.49"
"CHEMBL204934";"GW813360X";"None";"345.37";"0";"2.67";"GW813360X";"COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1";"Inhibition";"'='";"3.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.46"
"CHEMBL1909353";"GW458344A";"None";"379.85";"0";"4.31";"GW458344A";"Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl";"Inhibition";"'='";"0.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.06"
"CHEMBL330422";"";"None";"396.47";"0";"2.82";"SB-226879";"CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1";"Inhibition";"'='";"-3.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.21"
"CHEMBL4574669";"";"None";"395.46";"0";"1.93";"(R,R)-36n";"CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4352105";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350961";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL4563315";"";"None";"325.85";"0";"3.97";"29";"CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4333676";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"100.0"
"CHEMBL5076728";"";"None";"451.51";"0";"4.01";"15d";"O=C(CCCCCCn1cc(Nc2ncc3ccn(Cc4ccccc4F)c3n2)cn1)NO";"Inhibition";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5038986";"Inhibition of human recombinant TYK2 assessed as reduction in substrate phosphorylation at 50 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 50.0 nM | TIME = 1.0 hr";"INHIBITOR";"";"50.0"
"CHEMBL5207953";"";"None";"564.65";"1";"3.43";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3C([2H])([2H])CCC3([2H])[2H])cc2)c1OC";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"15.77";"0.29";"5.37";"5.69";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.6"
"CHEMBL5193226";"";"None";"587.63";"1";"4.35";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.32";"0.28";"4.61";"5.95";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.1"
"CHEMBL5087006";"";"None";"467.56";"0";"3.11";"16";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(NC(=O)N4CCCC4)c3)n2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046627";"Inhibition of NanoLuc-fused TYK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"";"";"10000.0"
"CHEMBL5202260";"";"None";"478.50";"0";"2.73";"9";"CN1CCN(C(=O)Cc2ccc(Nc3nc(-c4c(F)cccc4F)nc4c3C(=O)NC4)cc2)CC1";"Ki";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"18.28";"0.34";"6.01";"9.67";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"1.8"
"CHEMBL166031";"";"None";"352.39";"0";"4.80";"3";"CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1";"Inhibition";"'='";"9.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631616";"Inhibition of TYK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627608";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";"";"9.99"
"CHEMBL3261228";"";"None";"250.28";"0";"2.09";"1";"CCOC(=O)c1sc(-c2ccncc2)nc1O";"Inhibition";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3266945";"Inhibition of JH1 catalytic domain of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259739";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";"";"100.0"
"CHEMBL3648430";"";"None";"342.20";"0";"3.63";"BDBM107139";"O=C(CBr)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226449";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL1446198";"";"None";"277.33";"0";"3.65";"BDBM107122";"CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226431";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL411907";"SONOLISIB";"2.0";"525.60";"1";"3.13";"Sonolisib";"C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2105717";"CABOZANTINIB";"4.0";"501.51";"2";"5.54";"Cabozantinib";"COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4062471";"";"None";"472.53";"0";"3.06";"13g";"NC(=O)c1cnn2cccc2c1NCc1cccc(NC(=O)Cn2sc3ccccc3c2=O)c1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"14.01";"0.27";"3.56";"5.36";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"240.0"
"CHEMBL4070262";"";"None";"456.34";"0";"4.43";"24";"OC1CCN(c2cc(Nc3nccc4nc(-c5c(Cl)cccc5Cl)[nH]c34)ncn2)CC1";"EC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"14.12";"0.28";"2.01";"6.27";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.36"
"CHEMBL257167";"";"None";"279.30";"0";"2.14";"3";"NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O";"Activity";"'='";"1.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"1.7"
"CHEMBL4780644";"";"None";"471.52";"0";"2.69";"28";"N#CCC(=O)NCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4740169";"";"None";"414.47";"0";"3.58";"35";"N#CCC(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL3658857";"";"None";"447.48";"0";"1.89";"BDBM159776";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCC(O)(C(F)(F)F)CC2)C1";"IC50";"'='";"358.0";"nM";"6.45";"";"302670";"UO_0000065";"14.41";"0.29";"4.56";"6.29";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"358.0"
"CHEMBL1164181";"";"None";"469.42";"0";"4.63";"5g";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168301";"Inhibition of TYK2 JH2 pseudokinase domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL271594";"GW300653X";"None";"358.42";"0";"2.23";"GW300653X";"CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"1.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.48"
"CHEMBL188257";"GW827106X";"None";"452.47";"0";"4.38";"GW827106X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1";"Inhibition";"'='";"-1.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.16"
"CHEMBL467581";"GSK-2219385A";"None";"520.57";"1";"3.52";"GSK2219385A";"COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1";"Inhibition";"'='";"0.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.02"
"CHEMBL456252";"GSK-2110236A";"None";"520.62";"1";"3.45";"GSK2110236A";"COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2";"Inhibition";"'='";"-8.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.98"
"CHEMBL418348";"";"None";"493.56";"0";"4.27";"SB-254169";"CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-1.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.72"
"CHEMBL266707";"";"None";"297.36";"0";"3.86";"SKF-86055";"Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1";"Inhibition";"'='";"0.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.83"
"CHEMBL1794053";"GW407323A";"None";"529.64";"1";"5.12";"GW407323A";"Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1";"Inhibition";"'='";"2.43";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.43"
"CHEMBL1794069";"GSK-571989A";"None";"525.07";"2";"5.70";"GSK571989A";"C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl";"Inhibition";"'='";"-4.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.49"
"CHEMBL185238";"GW786460X";"None";"287.33";"0";"3.39";"GW786460X";"Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1";"Inhibition";"'='";"-0.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.15"
"CHEMBL275724";"";"None";"458.50";"0";"3.96";"SB-242718";"NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-1.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.79"
"CHEMBL1794056";"GW301789X";"None";"303.32";"0";"2.67";"GW301789X";"O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1";"Inhibition";"'='";"-4.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.51"
"CHEMBL179311";"GW580509X";"None";"388.45";"0";"3.90";"GW580509X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1";"Inhibition";"'='";"-4.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.34"
"CHEMBL1909342";"";"None";"395.44";"0";"1.77";"SB-657836-AAA";"N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O";"Inhibition";"'='";"-1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.25"
"CHEMBL477583";"GW743024X";"None";"374.44";"0";"4.65";"GW743024X";"Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-3.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.59"
"CHEMBL14112";"SB-210313";"None";"366.44";"0";"3.47";"SB-210313";"Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1";"Inhibition";"'='";"1.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.6"
"CHEMBL525191";"";"None";"334.38";"0";"2.73";"GDC-0879";"OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL318728";"GW549390X";"None";"236.27";"0";"4.09";"GW549390X";"c1ccc(Nc2ncc(-c3ccccc3)o2)cc1";"Inhibition";"'='";"-4.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.84"
"CHEMBL103080";"";"None";"370.43";"0";"2.95";"SB-742864";"CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1";"Inhibition";"'='";"-0.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.54"
"CHEMBL1938642";"";"None";"354.44";"0";"2.48";"3";"NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938646";"";"None";"444.56";"0";"4.31";"11";"Nc1ncc(C(=O)NCc2ccccc2)c2sc(-c3ccc(N4CCOCC4)cc3)cc12";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"12.56";"0.24";"1.28";"6.94";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"2.6"
"CHEMBL2062290";"";"None";"598.48";"0";"4.51";"SB-739245-AC";"CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O";"Inhibition";"'='";"2.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.37"
"CHEMBL1785002";"";"None";"472.52";"0";"3.89";"SB-264865";"NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"-2.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.45"
"CHEMBL1096290";"GSK-1000163A";"None";"395.47";"0";"1.80";"GSK1000163A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21";"Inhibition";"'='";"3.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.47"
"CHEMBL365072";"";"None";"258.29";"0";"1.65";"SB-751148";"CCc1nccc2c1nc(-c1nonc1N)n2CC";"Inhibition";"'='";"1.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.46"
"CHEMBL3667518";"";"None";"360.34";"0";"1.65";"BDBM153666";"COc1ncc(C#N)cc1-c1n[nH]cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"6.6";"nM";"8.18";"";"295019";"UO_0000065";"22.70";"0.41";"6.53";"6.11";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"6.6"
"CHEMBL3655087";"";"None";"388.50";"0";"1.93";"BDBM159754";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@@](C)(CC#N)C2)C1";"IC50";"'='";"5240.0";"nM";"5.28";"";"302648";"UO_0000065";"13.59";"0.27";"3.35";"4.60";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"5240.0"
"CHEMBL3667514";"";"None";"333.33";"0";"3.18";"BDBM153662";"O=C(Nc1ccncc1-c1cccc(F)c1)c1cnn2cccnc12";"Ki";"'='";"140.0";"nM";"6.85";"";"295013";"UO_0000065";"20.56";"0.37";"3.67";"9.50";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3667529";"";"None";"454.88";"0";"1.99";"BDBM153678";"COc1ncc(Cl)cc1-c1nn(CC(=O)N(C)C)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"14.0";"nM";"7.85";"";"295027";"UO_0000065";"17.27";"0.34";"5.86";"6.57";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"14.0"
"CHEMBL3618147";"";"None";"295.31";"0";"0.84";"15";"N#CCC(=O)N1CC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1";"INH";"'='";"3.95";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"3.95"
"CHEMBL4784391";"";"None";"440.45";"0";"2.53";"5; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327979";"Inhibition of TYK2 JH1 domain (unknown origin) by HTRF based binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5399515";"";"None";"434.44";"0";"2.09";"10";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NC3CC3)cnn12";"Kd";"'='";"0.099";"nM";"10.00";"";"";"UO_0000065";"23.03";"0.43";"7.91";"8.46";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.099"
"CHEMBL275473";"GW572401X";"None";"401.49";"0";"4.12";"GW572401X";"CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1";"Inhibition";"'='";"-1.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.59"
"CHEMBL95207";"";"None";"352.42";"0";"3.00";"SB-220455";"CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1";"Inhibition";"'='";"-0.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.01"
"CHEMBL1909371";"GW694590A";"None";"453.89";"1";"5.18";"GW694590A";"COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl";"Inhibition";"'='";"-1.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.49"
"CHEMBL3670390";"";"None";"381.83";"0";"3.02";"BDBM116312";"Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2cc(Cl)ccc2C)n1";"Ki";"'='";"32.8";"nM";"7.48";"";"241645";"UO_0000065";"19.60";"0.38";"4.46";"7.26";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"32.8"
"CHEMBL3645540";"";"None";"288.31";"0";"3.15";"BDBM107124";"N#CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226433";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL1938654";"";"None";"418.54";"0";"2.98";"19";"CNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12";"IC50";"'='";"266.0";"nM";"6.58";"";"";"UO_0000065";"15.71";"0.32";"3.60";"5.76";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.266"
"CHEMBL4082575";"";"None";"357.24";"1";"5.56";"3";"O=C(Nc1cc2cc(-c3c(Cl)cccc3Cl)ccc2cn1)C1CC1";"Ki";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"20.65";"0.42";"1.82";"17.57";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.042"
"CHEMBL4080904";"";"None";"485.38";"0";"3.58";"26";"OCCN1CCN(c2cc(Nc3nccc4nc(-c5c(Cl)cccc5Cl)[nH]c34)ncn2)CC1";"Ki";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.38";"0.37";"5.34";"8.41";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0012"
"CHEMBL4105148";"";"None";"371.23";"0";"4.77";"27";"Cc1nccc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)n1";"Ki";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"22.34";"0.45";"3.52";"10.45";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0051"
"CHEMBL441702";"GSK-270822A";"None";"396.45";"0";"4.23";"GSK270822A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1";"Inhibition";"'='";"4.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.98"
"CHEMBL3335685";"";"None";"380.47";"0";"1.53";"12";"CC(C)CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL3377098";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";""
"CHEMBL2348350";"";"None";"438.56";"0";"2.40";"15u";"CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1";"Activity";"'='";"59.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806815";"Inhibition of human TYK2 JH2 pseudokinase domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804286";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 2000.0 nM";"";"";"59.0"
"CHEMBL3667516";"";"None";"475.43";"0";"3.04";"BDBM153664";"COc1cnc(C(F)(F)F)cc1-c1nn(CC(C)(C)O)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"350.0";"nM";"6.46";"";"295029";"UO_0000065";"13.58";"0.26";"3.42";"5.40";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"350.0"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"19.77";"0.36";"4.87";"13.28";"0";"CHEMBL3820677";"Inhibition of TYK2 (unknown origin) incubated for 1 hr by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817824";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";"";"0.6"
"CHEMBL1996931";"";"None";"366.85";"0";"3.74";"SID103904574";"O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994040";"";"None";"450.49";"0";"4.27";"SID103904773";"CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004771";"";"None";"341.37";"0";"4.48";"SID103904651";"O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL116070";"";"None";"349.21";"0";"3.95";"SID103905046";"NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL262433";"";"None";"394.44";"0";"4.43";"SID103904346";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000354";"";"None";"326.38";"0";"3.29";"SID103905208";"COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006567";"";"None";"258.31";"0";"2.22";"SID103905192";"CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1998435";"";"None";"265.32";"0";"2.70";"SID103905450";"OCCNc1cc2cc(-c3ccncc3)ccc2cn1";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL1965423";"";"None";"405.50";"1";"5.46";"SID103905062";"CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973348";"";"None";"497.00";"1";"5.65";"SID103904501";"Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL483747";"GSK-980961A";"None";"390.46";"0";"4.13";"GSK980961A";"NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1";"Inhibition";"'='";"-5.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.35"
"CHEMBL365663";"GW780159X";"None";"338.82";"0";"4.66";"GW780159X";"Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1";"Inhibition";"'='";"-3.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.11"
"CHEMBL1909358";"GW654652C";"None";"489.00";"0";"3.98";"GW654652C";"CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl";"Inhibition";"'='";"-2.86";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.86"
"CHEMBL1909376";"";"None";"378.82";"0";"0.13";"SB-759335-B";"CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl";"Inhibition";"'='";"-1.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.93"
"CHEMBL269883";"GW416981X";"None";"415.47";"0";"2.55";"GW416981X";"CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"3.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.35"
"CHEMBL1909380";"GW282449A";"None";"447.93";"0";"4.79";"GW282449A";"COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl";"Inhibition";"'='";"-1.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.09"
"CHEMBL187985";"";"None";"299.34";"0";"1.68";"SB-744941";"CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21";"Inhibition";"'='";"4.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.26"
"CHEMBL1988075";"";"None";"469.55";"1";"6.70";"SID103904287";"Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965845";"";"None";"376.46";"0";"4.13";"SID103905119";"COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969506";"";"None";"497.53";"0";"2.42";"SID103905267";"CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974870";"";"None";"392.89";"0";"4.54";"SID103904479";"Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1981045";"";"None";"611.69";"1";"4.86";"SID103904725";"COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001239";"";"None";"438.80";"0";"3.40";"SID103905496";"Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1968590";"";"None";"380.50";"0";"4.22";"SID103905091";"CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL336961";"AZAKENPAULLONE";"None";"328.17";"0";"3.49";"SID103905441";"O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000801";"";"None";"431.41";"1";"6.77";"SID103904379";"O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1909395";"GW633459A";"None";"679.60";"2";"7.57";"GW633459A";"Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1";"Inhibition";"'='";"-1.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.8"
"CHEMBL275724";"";"None";"458.50";"0";"3.96";"SB-242718";"NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-4.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.56"
"CHEMBL1909399";"GW352430A";"None";"457.94";"0";"2.28";"GW352430A";"Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1";"Inhibition";"'='";"-1.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.59"
"CHEMBL208437";"GW711782X";"None";"408.47";"0";"4.48";"GW711782X";"c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1";"Inhibition";"'='";"1.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.04"
"CHEMBL230592";"GSK-635416A";"None";"453.54";"0";"3.89";"GSK635416A";"CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N";"Inhibition";"'='";"-3.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.89"
"CHEMBL272026";"GW290597X";"None";"467.51";"0";"1.12";"GW290597X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1";"Inhibition";"'='";"-2.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.26"
"CHEMBL1909401";"";"None";"465.41";"0";"4.56";"SB-285234-W";"O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]";"Inhibition";"'='";"-3.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.71"
"CHEMBL273564";"GW795493X";"None";"413.36";"1";"5.13";"GW795493X";"Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12";"Inhibition";"'='";"-3.69";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.69"
"CHEMBL4292612";"";"None";"335.37";"0";"2.49";"9";"COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CCO4)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4288935";"";"None";"412.48";"0";"1.75";"29";"COCCS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL272165";"GW300657X";"None";"450.48";"0";"1.43";"GW300657X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1";"Inhibition";"'='";"-8.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.31"
"CHEMBL4283724";"";"None";"314.39";"0";"2.15";"13";"NC(=O)c1cnc2c(NC3CC3)cc(NC3CCCCC3)nn12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251839";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"2.0"
"CHEMBL4289426";"";"None";"396.50";"0";"2.88";"24";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"17.55";"0.33";"4.08";"6.72";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.11"
"CHEMBL1909413";"";"None";"349.82";"0";"4.51";"SB-610251-B";"Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1";"Inhibition";"'='";"-1.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.97"
"CHEMBL4289426";"";"None";"396.50";"0";"2.88";"24";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"16.45";"0.31";"3.64";"6.30";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.3"
"CHEMBL4240238";"";"None";"366.43";"0";"1.23";"10a";"C=CC(=O)N1CCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4290130";"";"None";"518.47";"1";"3.55";"35";"C[C@](O)(CO)CNc1cc(Nc2cccc(-c3ccc(C(F)(F)F)cc3F)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"10.37";"0.20";"1.83";"3.90";"0";"CHEMBL4251858";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha-induced IP10 production";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"4.2"
"CHEMBL231623";"GSK-620503A";"None";"307.33";"0";"3.24";"GSK620503A";"NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N";"Inhibition";"'='";"-2.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.58"
"CHEMBL272028";"GW300660X";"None";"453.48";"0";"0.80";"GW300660X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1";"Inhibition";"'='";"0.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.3"
"CHEMBL516248";"GW804482X";"None";"379.44";"0";"3.77";"GW804482X";"COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1";"Inhibition";"'='";"-1.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.93"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1794058";"GW278681X";"None";"329.38";"0";"2.46";"GW278681X";"CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1";"Inhibition";"'='";"9.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"9.24"
"CHEMBL3745954";"";"None";"389.86";"0";"3.84";"28";"COc1ccc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)c1";"IC50";"'='";"11400.0";"nM";"4.94";"";"";"UO_0000065";"12.68";"0.25";"1.10";"6.60";"0";"CHEMBL3751021";"Inhibition of N-terminal 6His-tagged human recombinant Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745697";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"11.4"
"CHEMBL4537678";"";"None";"380.38";"0";"2.56";"5";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"16.50";"0.31";"3.72";"5.14";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.53"
"CHEMBL4448796";"";"None";"439.50";"0";"2.09";"19";"CCNC(=O)c1ccc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)nc1";"IC50";"'='";"7202.0";"nM";"5.14";"";"";"UO_0000065";"11.70";"0.22";"3.05";"4.98";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"7202.0"
"CHEMBL4519857";"";"None";"405.46";"0";"1.67";"8";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H]3CN4C(=O)CC#N)n2)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"18.84";"0.35";"5.97";"6.69";"0";"CHEMBL4411530";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using ATP at its Km level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"23.0"
"CHEMBL2153266";"";"None";"261.29";"0";"2.76";"9";"Nc1nc2c(-c3cnc4ccccc4c3)nccc2[nH]1";"Kd";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"25.02";"0.45";"3.78";"8.12";"0";"CHEMBL2154989";"Binding affinity to JH domain of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150858";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"290.0"
"CHEMBL3764030";"";"None";"300.37";"0";"1.92";"16";"CC(C)[C@H](C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"22.72";"0.42";"4.90";"7.22";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"150.0"
"CHEMBL2348865";"";"None";"391.44";"0";"2.39";"9a, CC214-1";"O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2350843";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346597";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"100.0"
"CHEMBL1651522";"";"None";"348.40";"0";"2.55";"2";"COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1656381";"Inhibition of TYK2 by TR-FRET based LanthaScreen assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649097";"1";"Scientific Literature";"ACS Med Chem Lett";"2011";"None";"";"";"";"10000.0"
"CHEMBL5187271";"";"None";"325.38";"0";"4.55";"29";"Cc1cc(-c2n[nH]c3ccc(Nc4ccccc4C#N)cc23)ccn1";"Inhibition";"'='";"39.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5157156";"Inhibition of TYK2 (unknown origin) at 0.1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154686";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"Dose = 0.1 microM";"";"";"39.0"
"CHEMBL2181082";"";"None";"486.57";"0";"4.14";"21f, 85:15 trans/cis mixture";"O=C1CCN(CCOc2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)C1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.09";"0.26";"2.71";"7.99";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.14"
"CHEMBL2420818";"";"None";"291.14";"0";"3.84";"28";"Clc1cccc(Cl)c1-c1nnc(-c2ccncc2)[nH]1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL5197758";"";"None";"403.43";"0";"2.88";"22";"O=C(Nc1nc2cccc([C@H]3CC[C@@H](NC(=O)[C@@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"18.89";"0.36";"4.74";"8.62";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"24.0"
"CHEMBL5179073";"";"None";"406.49";"0";"2.87";"30";"N#CCC(=O)N1CCC2(CCC(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)C1";"IC50";"'='";"278.0";"nM";"6.56";"";"";"UO_0000065";"16.13";"0.30";"3.69";"6.34";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"278.0"
"CHEMBL5192867";"";"None";"420.52";"0";"3.11";"40";"CC(C)(C#N)C(=O)N1CC2(CCC(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)C1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"16.59";"0.31";"3.86";"6.75";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"106.0"
"CHEMBL1882194";"GW780056X";"None";"373.46";"0";"3.77";"GW780056X";"CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1";"Inhibition";"'='";"11.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"11.6"
"CHEMBL1909386";"GW566221A";"None";"565.10";"2";"5.35";"GW566221A";"CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl";"Inhibition";"'='";"0.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.61"
"CHEMBL272026";"GW290597X";"None";"467.51";"0";"1.12";"GW290597X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1";"Inhibition";"'='";"-1.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.72"
"CHEMBL434729";"GW829906X";"None";"446.44";"1";"5.92";"GW829906X";"Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1";"Inhibition";"'='";"-1.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.51"
"CHEMBL2062289";"";"None";"550.52";"0";"3.36";"SB-698596-AC";"CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O";"Inhibition";"'='";"2.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.26"
"CHEMBL13972";"";"None";"440.48";"0";"4.73";"SB-242721";"N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-0.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.38"
"CHEMBL1909413";"";"None";"349.82";"0";"4.51";"SB-610251-B";"Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1";"Inhibition";"'='";"-1.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.42"
"CHEMBL181361";"GW693481X";"None";"305.37";"0";"3.40";"GW693481X";"Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1";"Inhibition";"'='";"-3.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.74"
"CHEMBL63728";"GW644007X";"None";"326.36";"0";"2.57";"GW644007X";"COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O";"Inhibition";"'='";"4.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.77"
"CHEMBL189459";"GW833373X";"None";"396.43";"1";"5.04";"GW833373X";"Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1";"Inhibition";"'='";"-1.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.64"
"CHEMBL188240";"";"None";"274.28";"0";"1.48";"SB-737198";"CCOc1nccc2c1nc(-c1nonc1N)n2CC";"Inhibition";"'='";"-0.93";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.93"
"CHEMBL475599";"GSK-300014A";"None";"603.17";"2";"6.67";"GSK300014A";"CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1";"Inhibition";"'='";"-4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.0"
"CHEMBL486124";"GW874091X";"None";"352.44";"0";"2.23";"GW874091X";"Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12";"Inhibition";"'='";"-3.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.48"
"CHEMBL189415";"GW819077X";"None";"432.41";"1";"5.62";"GW819077X";"FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1";"Inhibition";"'='";"-5.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.81"
"CHEMBL188247";"GW832467X";"None";"504.47";"2";"5.70";"GW832467X";"Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1";"Inhibition";"'='";"-0.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.28"
"CHEMBL384073";"GSK-180736A";"None";"365.37";"0";"2.97";"GSK180736A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1";"Inhibition";"'='";"1.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.26"
"CHEMBL1794068";"GSK-326090A";"None";"558.63";"2";"6.07";"GSK326090A";"C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Inhibition";"'='";"2.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.67"
"CHEMBL446024";"GW683003X";"None";"294.24";"0";"2.16";"GW683003X";"FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1";"Inhibition";"'='";"-2.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.6"
"CHEMBL410072";"GW301784X";"None";"445.50";"0";"0.85";"GW301784X";"CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"-1.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.38"
"CHEMBL359999";"GW801372X";"None";"348.37";"0";"2.95";"GW801372X";"COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1";"Inhibition";"'='";"4.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.29"
"CHEMBL220465";"GSK-248233A";"None";"484.52";"0";"4.19";"GSK248233A";"CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21";"Inhibition";"'='";"-0.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.04"
"CHEMBL101253";"VATALANIB";"3.0";"346.82";"1";"5.01";"PTK-787";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL261849";"GW632580X";"None";"366.42";"0";"2.83";"GW-2580";"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1289926";"AXITINIB";"4.0";"386.48";"0";"4.64";"AG-013736";"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL2322143";"";"None";"239.32";"0";"3.86";"50";"c1cc2c(ncc3ccc(C4CCCCC4)n32)[nH]1";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"22.22";"0.40";"1.46";"16.07";"0";"CHEMBL2327342";"Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321825";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"4.8"
"CHEMBL3676049";"";"None";"380.43";"0";"2.81";"BDBM127808";"Cc1ncc(F)cc1[C@H]1CCCN1c1ccn2ncc(C(=O)NC3CC3)c2n1";"IC50";"'>'";"1000.0";"nM";"";"";"258564";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4280294";"";"None";"289.34";"0";"3.03";"15";"CN(C#N)C1CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"9487.0";"nM";"5.02";"";"";"UO_0000065";"17.36";"0.31";"1.99";"7.32";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"9487.0"
"CHEMBL3645536";"";"None";"332.41";"0";"3.33";"BDBM107119";"O=C(CN1CCCC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226428";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL1945559";"";"None";"363.25";"0";"2.96";"20";"Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1947869";"Inhibition of TYK2 using ATP as substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944596";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"10.0"
"CHEMBL189231";"";"None";"284.32";"0";"2.57";"SB-734117";"Nc1nonc1-c1nc2cnccc2n1C1CCCCC1";"Inhibition";"'='";"6.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"6.77"
"CHEMBL4469812";"";"None";"383.45";"0";"4.18";"25";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1SC";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"22.81";"0.44";"4.56";"11.08";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0018"
"CHEMBL3639663";"";"None";"548.83";"1";"4.36";"BDBM153677";"COc1ccc(Cl)cc1-c1nn(CC(O)(C(F)(F)F)C(F)(F)F)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"31.0";"nM";"7.51";"";"295024";"UO_0000065";"13.68";"0.28";"3.15";"7.05";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"31.0"
"CHEMBL3667521";"";"None";"440.85";"0";"1.57";"BDBM153669";"COc1ccc(Cl)cc1-c1c(NC(=O)c2c(N)nn3cccnc23)cnn1CC(N)=O";"Ki";"'='";"2.3";"nM";"8.64";"";"295017";"UO_0000065";"19.59";"0.38";"7.07";"5.56";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.3"
"CHEMBL3655097";"";"None";"350.45";"0";"0.76";"BDBM159764";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCC2CC2)C1";"IC50";"'='";"1780.0";"nM";"5.75";"";"302658";"UO_0000065";"16.41";"0.33";"4.99";"5.58";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1780.0"
"CHEMBL1909360";"GW830263A";"None";"665.22";"1";"4.56";"GW830263A";"CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl";"Inhibition";"'='";"-4.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.74"
"CHEMBL3628628";"";"None";"453.93";"0";"3.77";"5";"COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC";"Inhibition";"'='";"13.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631616";"Inhibition of TYK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627608";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";"";"13.21"
"CHEMBL3622828";"";"None";"280.33";"0";"1.76";"5e";"NCCn1c(-c2ccccc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"19.18";"0.35";"3.62";"6.19";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"4.2"
"CHEMBL2181310";"";"None";"490.58";"1";"5.10";"22c, 85:15 trans/cis mixture";"Fc1cnc2nc1-c1cccc(c1)COCC=CCOCc1cc(ccc1OCCN1CCCC1)N2";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"13.97";"0.26";"1.75";"9.97";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.14"
"CHEMBL2181086";"";"None";"501.63";"2";"5.16";"21l, 85:15 trans/cis mixture";"CCN(CC)CCC(=O)Nc1cc2cc(c1)Nc1nccc(n1)-c1cccc(c1)COCC=CCOC2";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.44";"0.29";"2.58";"8.74";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.018"
"CHEMBL3670391";"";"None";"364.43";"0";"3.30";"BDBM116313";"Cc1nc(-c2ccccc2C)c(NC(=O)c2cnn3ccc(N)nc23)s1";"Ki";"'='";"43.8";"nM";"7.36";"";"241646";"UO_0000065";"20.19";"0.39";"4.06";"7.49";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"43.8"
"CHEMBL3658869";"";"None";"378.48";"0";"1.67";"BDBM159788";"Cc1ncc(S(=O)(=O)N[C@H]2C[C@@H](N(C)c3ncnc4[nH]ccc34)C2)s1";"IC50";"'='";"546.0";"nM";"6.26";"";"302682";"UO_0000065";"16.55";"0.34";"4.59";"6.03";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"546.0"
"CHEMBL3904533";"";"None";"387.47";"0";"0.60";"BDBM159773";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@@H]3C[C@]3(C#N)C2)C1";"IC50";"'='";"1970.0";"nM";"5.71";"";"302667";"UO_0000065";"14.73";"0.29";"5.11";"4.83";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1970.0"
"CHEMBL1794073";"GW770220A";"None";"459.96";"0";"2.83";"GW770220A";"Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl";"Inhibition";"'='";"-1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.02"
"CHEMBL192417";"GW632046X";"None";"250.30";"0";"4.39";"GW632046X";"Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1";"Inhibition";"'='";"1.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.38"
"CHEMBL5414602";"";"None";"478.49";"0";"2.11";"31";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL5411775";"";"None";"467.53";"0";"1.93";"41";"CNc1cc(Nc2cccn([C@H]3CCCOC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"16.38";"0.31";"5.73";"6.18";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"22.0"
"CHEMBL4213175";"";"None";"312.33";"0";"2.09";"15";"COc1ccncc1NC(=O)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252893";"Inhibition of TYK2 (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL5436454";"";"None";"337.38";"0";"2.59";"Example 93";"CC(=O)Nc1cc2c(cn1)c(C)nn2-c1cccc(C2CCOC2)n1";"IC50";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5346250";"Inhibition of human TYK2 JH2 domain (575 to 876 residues) incubated for 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5344452";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME = 1.0 hr";"INHIBITOR";"";"10.0"
"CHEMBL3360318";"";"None";"308.34";"0";"2.75";"3";"COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1";"IC50";"'='";"519.0";"nM";"6.29";"";"";"UO_0000065";"20.38";"0.37";"3.53";"9.17";"0";"CHEMBL3388146";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351789";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"519.0"
"CHEMBL4555459";"";"None";"481.60";"1";"5.59";"43";"O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1";"Inhibition";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4389525";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"50.0"
"CHEMBL4591082";"SR-302";"None";"622.79";"1";"3.26";"EUB0000712";"CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1";"% Control";"'='";"84.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507324";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"84.0"
"CHEMBL3354186";"";"None";"390.45";"0";"3.10";"5";"COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)n2)CC1";"Ki";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"19.06";"0.35";"4.34";"6.92";"0";"CHEMBL3375810";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"36.0"
"CHEMBL3667519";"";"None";"399.86";"0";"4.08";"BDBM153667";"COc1ccc(Cl)cc1-c1nc(C)sc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"2.1";"nM";"8.68";"";"295026";"UO_0000065";"21.70";"0.44";"4.60";"10.66";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.1"
"CHEMBL156524";"";"None";"324.77";"0";"2.77";"SB-333612";"O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1";"Inhibition";"'='";"-4.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.27"
"CHEMBL3359918";"";"None";"287.37";"0";"1.36";"4g";"CC1(C)[C@H](N)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"24.21";"0.45";"5.60";"7.07";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"110.0"
"CHEMBL3359919";"";"None";"287.37";"0";"1.36";"4h";"CC1(C)[C@@H](N)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"24.21";"0.45";"5.60";"7.07";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"110.0"
"CHEMBL4744172";"";"None";"404.76";"0";"3.63";"20";"O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12";"Inhibition";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4666944";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (833 to 1187 residues) expressed in baculovirus expression system using Tyr 03 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"Dose = 0.1 microM | TIME = 1.0 hr";"INHIBITOR";"";"100.0"
"CHEMBL4564973";"";"None";"544.64";"1";"4.20";"50";"O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4390001";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"0.0"
"CHEMBL3667528";"";"None";"480.96";"0";"4.37";"BDBM153676";"CCOc1ccc(Cl)cc1-c1nn([C@H]2CCCC[C@@H]2O)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"76.0";"nM";"7.12";"";"295028";"UO_0000065";"14.80";"0.29";"2.75";"6.68";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"76.0"
"CHEMBL3648437";"";"None";"331.38";"0";"3.93";"BDBM107146";"C/C(Nc1cccc(-c2cnc3ccccc3n2)c1)=C1/CCOC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"226456";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL3667510";"";"None";"387.23";"0";"3.78";"BDBM153658";"Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(Cl)ccc2Cl)n1";"Ki";"'='";"104.0";"nM";"6.98";"";"295030";"UO_0000065";"18.03";"0.37";"3.20";"9.06";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"104.0"
"CHEMBL2385096";"";"None";"367.38";"0";"3.21";"29";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@@H](NCC(F)(F)F)C1";"EC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"15.40";"0.30";"2.45";"7.18";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"2200.0"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL473420";"GSK-1030058A";"None";"492.48";"1";"5.49";"GSK1030058A";"COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F";"Inhibition";"'='";"-3.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.12"
"CHEMBL249697";"BMS-345541";"None";"255.32";"0";"1.87";"BMS-345541";"Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1";"Kd";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"22.32";"0.41";"3.83";"8.35";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"2000.0"
"CHEMBL1938656";"";"None";"462.60";"0";"3.00";"22";"COCCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL1938660";"";"None";"531.70";"1";"3.07";"26";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCCN4CCOCC4)c3s2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL4740831";"";"None";"369.39";"0";"2.53";"24, trans isomer";"N#CC[C@]1(n2cc(-c3nc(-c4cn[nH]c4)cn4nccc34)cn2)C[C@H](C#N)C1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"19.92";"0.36";"4.83";"5.92";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"44.0"
"CHEMBL4460368";"";"None";"451.47";"0";"1.55";"6s";"CNc1cc(Nc2cccn(-c3cc(C)n(C)n3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"15.61";"0.29";"5.50";"5.72";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"90.0"
"CHEMBL3105872";"";"None";"346.35";"0";"1.13";"1d";"NC(=O)c1cc(-c2cc(N)cc3[nH]ncc23)cc2c(C#CCO)n[nH]c12";"Inhibition";"'='";"0.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"0.6"
"CHEMBL3105871";"";"None";"331.34";"0";"1.55";"1c";"NC(=O)c1cc(-c2cccc3[nH]ncc23)cc2c(C#CCO)n[nH]c12";"Inhibition";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"2.5"
"CHEMBL5404091";"";"None";"433.45";"0";"2.70";"9";"CNc1cc(Nc2cccn(-c3ccc(F)cc3)c2=O)nc2c(C(=O)NC3CC3)cnn12";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"16.95";"0.31";"4.65";"6.97";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"45.0"
"CHEMBL5288565";"";"None";"376.39";"0";"3.88";"29";"O=C(Nc1cnccc1-c1ccc(F)cc1)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252893";"Inhibition of TYK2 (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"14.73";"0.27";"3.06";"5.18";"0";"CHEMBL5209683";"Cellular target engagement assay with: TYK2kinase 1";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-293T";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4632348";"55";"EUbOPEN Chemogenomic Library";"";"";"CHEMBL3706569";"NanoBRET Tracer: Tracer K10 | NanoBRET Tracer Concentration = -6.6 nM | NanoBRET Tracer kD = -6.68 nM";"";"";"25000.0"
"CHEMBL103104";"GW831090X";"None";"330.37";"0";"2.17";"GW831090X";"NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1";"Inhibition";"'='";"-9.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-9.08"
"CHEMBL1938658";"";"None";"515.71";"1";"3.84";"24";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCCCC4)c3s2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL3613597";"";"None";"495.43";"0";"3.96";"12";"CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3615457";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of IFNalpha5-induced STAT3 phosphorylation at 10 uM pre-incubated for 30 mins before IFNalpha5 stimulation for 30 mins mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL3613597";"";"None";"495.43";"0";"3.96";"12";"CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3615460";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of IFNalpha5-induced STAT3 phosphorylation at 1 uM pre-incubated for 30 mins before IFNalpha5 stimulation for 30 mins mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3216659";"";"None";"541.28";"0";"2.86";"61; MLS-2384";"Cl.Cl.O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.59";"0.33";"4.44";"9.36";"0";"CHEMBL5347077";"Inhibition of recombinant GST-tagged TYK2 catalytic domain (unknown origin) using pEY (4:1) as substrate incubated for 120 mins in presence of 33P-labeled ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";"";"50.0"
"CHEMBL1081678";"";"None";"438.23";"0";"3.05";"12r";"Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1101783";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";"";"50.0"
"CHEMBL4867931";"";"None";"464.55";"0";"3.20";"I-50";"COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804690";"Inhibition of TYK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 10.0 microM";"";"";"0.0"
"CHEMBL4868141";"";"None";"532.67";"1";"4.90";"I-65";"Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804690";"Inhibition of TYK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 10.0 microM";"";"";"0.0"
"CHEMBL4093872";"";"None";"442.31";"0";"4.30";"23";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3cc(N4CCOCC4)ncn3)c2[nH]1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.85";"0.42";"4.92";"10.04";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0006"
"CHEMBL1909415";"GW693881A";"None";"487.39";"1";"6.80";"GW693881A";"Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1";"Inhibition";"'='";"-1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.0"
"CHEMBL3335686";"";"None";"394.50";"0";"1.92";"13";"CC(C)(C)CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL3377098";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";""
"CHEMBL3335685";"";"None";"380.47";"0";"1.53";"12";"CC(C)CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL3377099";"Binding affinity to TYK2 JH2 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";""
"CHEMBL1822054";"";"None";"460.88";"0";"3.34";"10";"CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1";"Activity";"'='";"64.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1826202";"Activity of TYK2(JH2domain-pseudokinase) kinase at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821651";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"64.0"
"CHEMBL272165";"GW300657X";"None";"450.48";"0";"1.43";"GW300657X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1";"Inhibition";"'='";"0.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.98"
"CHEMBL1909388";"GW568377A";"None";"565.10";"2";"5.35";"GW568377A";"CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl";"Inhibition";"'='";"0.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.15"
"CHEMBL3658868";"";"None";"382.45";"0";"1.91";"BDBM159787";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2cc(C#N)ccn2)C1";"IC50";"'='";"418.0";"nM";"6.38";"";"302681";"UO_0000065";"16.68";"0.32";"4.47";"5.52";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"418.0"
"CHEMBL384304";"RG-547";"2.0";"441.46";"0";"1.41";"R547";"COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1908394";"GSK-461364";"1.0";"543.62";"2";"5.09";"GSK-461364A";"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3114783";"";"None";"497.53";"0";"4.23";"11a";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCN(c3ccnc(F)c3)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL505187";"GSK-718429A";"None";"528.62";"2";"7.34";"GSK718429A";"CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1";"Inhibition";"'='";"0.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.94"
"CHEMBL509032";"TAE-684";"None";"614.22";"2";"5.02";"TAE-684";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"Kd";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"11.58";"0.23";"2.09";"6.91";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"77.0"
"CHEMBL66004";"GW578748X";"None";"284.28";"0";"1.51";"GW578748X";"COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O";"Inhibition";"'='";"4.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.1"
"CHEMBL3667520";"";"None";"355.75";"0";"1.51";"BDBM153668";"O=C(Nc1c[nH]nc1-n1cc(Cl)ccc1=O)c1cnn2cccnc12";"Ki";"'='";"980.0";"nM";"6.01";"";"295015";"UO_0000065";"16.89";"0.33";"4.50";"5.46";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"980.0"
"CHEMBL3785951";"";"None";"508.60";"1";"3.25";"33";"CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3790310";"Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL1971141";"";"None";"345.40";"0";"4.40";"SID103904383";"Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001485";"";"None";"539.67";"2";"6.01";"SID103904283";"Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1977041";"";"None";"416.44";"0";"3.72";"SID103904316";"COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969049";"";"None";"346.43";"0";"4.56";"SID103904559";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006778";"";"None";"380.45";"0";"4.23";"SID103905094";"CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL1968406";"";"None";"415.52";"1";"5.25";"SID103904361";"CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4645258";"";"None";"432.48";"0";"1.79";"22";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"15.44";"0.29";"4.89";"5.55";"0";"CHEMBL4627624";"Inhibition of TYK2 in human Jurkat cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307526";"";"";"";"210.0"
"CHEMBL4636795";"";"None";"390.45";"0";"2.58";"33";"CN(C)C(=O)c1ccc(Nc2cc(N3CC[C@@](C#N)(C4CC4)C3=O)ccn2)nc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"22.94";"0.42";"6.38";"8.76";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"1.1"
"CHEMBL1984363";"";"None";"374.42";"0";"4.44";"SID103905034";"Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1993584";"";"None";"371.44";"0";"4.11";"SID103904750";"OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988163";"";"None";"365.42";"0";"2.81";"SID103905250";"NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1";"Ki";"'='";"15.85";"nM";"7.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.8"
"CHEMBL4076767";"";"None";"422.53";"0";"4.29";"13";"COc1cc(N2CCOCC2)ccc1Nc1nc(NC2CCCCC2)c2cc[nH]c2n1";"IC50";"'='";"132000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4050199";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of [gamma-32P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4049399";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";"";"1.32"
"CHEMBL3780467";"";"None";"385.47";"0";"1.72";"21";"COC(=O)C1CCc2[nH]c(-c3c(N[C@H]4CC[C@@H](N)CC4)cc[nH]c3=O)nc2C1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"21.16";"0.40";"6.43";"6.48";"0";"CHEMBL3784141";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779778";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"7.0"
"CHEMBL347580";"";"None";"320.35";"0";"2.13";"SB-361058";"COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1";"Inhibition";"'='";"-5.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.5"
"CHEMBL1909372";"GW700494A";"None";"622.07";"2";"6.21";"GW700494A";"CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl";"Inhibition";"'='";"-2.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.82"
"CHEMBL1909392";"GW580496A";"None";"643.99";"2";"6.11";"GW580496A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl";"Inhibition";"'='";"-5.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.11"
"CHEMBL3655091";"";"None";"335.43";"0";"1.25";"BDBM159758";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@H](NS(=O)(=O)CC2CC2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"302652";"UO_0000065";"";"";"";"";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"10000.0"
"CHEMBL3667515";"";"None";"412.84";"0";"2.50";"BDBM153663";"COc1ccc(Cl)cc1-c1c(NC(=O)c2cnn3cccnc23)cnn1CCO";"Ki";"'='";"5.6";"nM";"8.25";"";"295035";"UO_0000065";"19.99";"0.39";"5.75";"7.74";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"5.6"
"CHEMBL261386";"";"None";"363.78";"1";"5.02";"1";"O=c1[nH]ccc2c3[nH]c(-c4ccccc4Cl)nc3c3ccc(F)cc3c12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"22.42";"0.43";"3.13";"13.25";"0";"CHEMBL1840114";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833803";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"7.0"
"CHEMBL65884";"GW817396X";"None";"362.37";"0";"3.41";"GW817396X";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1";"Inhibition";"'='";"-4.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.95"
"CHEMBL2387219";"";"None";"418.24";"0";"2.90";"33";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2c2nn[nH]n2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"21.25";"0.43";"5.99";"7.08";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.3"
"CHEMBL2387218";"";"None";"394.21";"0";"3.30";"32";"O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@@H]2C(=O)O)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"21.55";"0.45";"5.19";"7.84";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"3.2"
"CHEMBL2387118";"";"None";"379.25";"0";"3.45";"13";"NCc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"EC50";"'='";"452.0";"nM";"6.34";"";"";"UO_0000065";"16.73";"0.35";"2.89";"6.53";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"452.0"
"CHEMBL2387222";"";"None";"351.74";"0";"3.42";"36";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2F)c1)c1c(F)cccc1Cl";"Ki";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"25.01";"0.50";"5.38";"12.37";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.6"
"CHEMBL608533";"MIDOSTAURIN";"4.0";"570.65";"2";"5.91";"PKC-412";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"11.57";"0.21";"0.69";"8.49";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"250.0"
"CHEMBL1908395";"";"None";"497.04";"0";"3.76";"JNJ-28312141";"CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl";"Kd";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"17.88";"0.33";"4.48";"7.84";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"5.8"
"CHEMBL4588496";"";"None";"457.58";"0";"4.10";"12e'";"C/C=C/C(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL5198005";"";"None";"409.40";"0";"3.16";"18";"CCNC(=O)c1ccc(Nc2cc(-c3c(F)cccc3F)nc3c2C(=O)NC3)nc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"17.90";"0.33";"4.17";"7.63";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.047"
"CHEMBL4563315";"";"None";"325.85";"0";"3.97";"29";"CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4333675";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"100.0"
"CHEMBL157258";"";"None";"383.62";"0";"3.83";"SB-390523";"O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1";"Inhibition";"'='";"-5.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.94"
"CHEMBL396107";"GW795486X";"None";"481.36";"1";"6.15";"GW795486X";"Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12";"Inhibition";"'='";"-8.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.39"
"CHEMBL5184093";"";"None";"586.67";"1";"3.96";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3C4CCC3CC4)cc2)c1OC";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.35";"0.28";"5.00";"5.79";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.1"
"CHEMBL5200056";"";"None";"578.64";"1";"3.02";"29";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@@H]3COCCO3)cc2)c1OC";"Tm";"'='";"57.34";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"57.34"
"CHEMBL5197513";"";"None";"435.43";"0";"3.64";"20";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCCC4)cn3)c21";"Ki";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"22.33";"0.41";"6.08";"11.15";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.19"
"CHEMBL5182688";"";"None";"450.45";"0";"3.49";"29";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCOCC4)cc3)c21";"Ki";"'='";"0.35";"nM";"9.46";"";"";"UO_0000065";"20.99";"0.39";"5.97";"11.32";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.35"
"CHEMBL5182922";"";"None";"450.45";"0";"3.22";"31";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CC[C@H](O)C4)cc3)c21";"Ki";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"20.94";"0.39";"6.21";"9.97";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.37"
"CHEMBL5188608";"";"None";"423.42";"0";"3.25";"21";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCOCC4)cn3)c21";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"16.55";"0.31";"3.76";"8.83";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.098"
"CHEMBL3694582";"";"None";"352.83";"0";"4.94";"BDBM125903";"C[C@H]1Nc2nc(ncc2Cl)Nc2cccc(c2)COc2cccc1c2";"IC50";"'>'";"1000.0";"nM";"";"";"255714";"UO_0000065";"";"";"";"";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3694583";"";"None";"368.82";"0";"4.26";"BDBM125904";"Clc1cnc2nc1NCc1cccc(c1)OCCOc1cccc(c1)N2";"IC50";"'='";"43.0";"nM";"7.37";"";"255715";"UO_0000065";"19.97";"0.39";"3.11";"10.79";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"43.0"
"CHEMBL1794065";"GSK-554170A";"None";"539.52";"0";"1.58";"GSK554170A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"1.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.52"
"CHEMBL1909356";"GW569530A";"None";"650.15";"2";"6.23";"GW569530A";"CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl";"Inhibition";"'='";"-0.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.77"
"CHEMBL1909398";"GW282536X";"None";"330.37";"0";"1.41";"GW282536X";"Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"-0.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.5"
"CHEMBL1909347";"";"None";"546.38";"0";"3.37";"SB-732881-H";"CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O";"Inhibition";"'='";"-0.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.98"
"CHEMBL183993";"GW811761X";"None";"400.36";"0";"4.35";"GW811761X";"CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1";"Inhibition";"'='";"-0.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.74"
"CHEMBL1081485";"";"None";"475.55";"1";"5.10";"11";"COc1cc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc(OC)c1OC";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"13.69";"0.25";"1.41";"8.32";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.31"
"CHEMBL1089773";"";"None";"515.61";"1";"4.83";"24";"CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cc2)CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"13.63";"0.25";"2.20";"15.71";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"94.0"
"CHEMBL3589168";"";"None";"457.53";"0";"4.35";"5";"CCCOc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"15.06";"0.28";"2.54";"7.06";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"129.0"
"CHEMBL1081977";"";"None";"469.52";"0";"4.64";"8";"COc1cc(Nc2nc3cccc(-c4ccc(NS(C)(=O)=O)cc4)c3o2)cc(OC)c1OC";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.53";"0.28";"2.18";"6.10";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.15"
"CHEMBL4845758";"";"None";"440.57";"0";"4.08";"11b";"CCCS(=O)(=O)N1CCc2cc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)ccc21";"IC50";"'='";"3.84";"nM";"8.42";"";"";"UO_0000065";"19.10";"0.37";"4.34";"9.05";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"3.84"
"CHEMBL4871878";"";"None";"555.52";"2";"5.35";"14m";"N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4S(=O)(=O)c4ccc(C(F)(F)F)cc4)c3)ncc2F)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"";"";""
"CHEMBL1081443";"";"None";"377.40";"0";"4.66";"2";"COc1cc(Nc2nc3cccc(-c4ccccn4)c3o2)cc(OC)c1OC";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"16.41";"0.30";"1.53";"7.88";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.64"
"CHEMBL5437915";"";"None";"464.46";"0";"1.45";"23";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@H]3O)cnn12";"Kd";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"20.06";"0.37";"7.87";"6.73";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.48"
"CHEMBL5407138";"";"None";"478.49";"0";"1.70";"28";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NCC3(CO)CC3)cnn12";"Kd";"'='";"0.033";"nM";"10.48";"";"";"UO_0000065";"21.91";"0.41";"8.78";"7.57";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.033"
"CHEMBL5440397";"";"None";"464.49";"1";"1.87";"38";"CNc1cc(Nc2cccn(-c3cnc(C)o3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.001";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.001"
"CHEMBL5419281";"";"None";"464.49";"1";"1.87";"39";"CNc1cc(Nc2cccn(-c3ocnc3C)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL5436767";"";"None";"467.53";"0";"1.93";"45";"CNc1cc(Nc2cccn([C@H]3C[C@H](OC)C3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL5425400";"";"None";"467.53";"0";"1.93";"46";"CNc1cc(Nc2cccn([C@H]3C[C@@H](OC)C3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL595143";"";"None";"541.68";"2";"5.72";"24";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1";"Residual activity";"'='";"93.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1043836";"Residual activity of TYK2 at 1 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"93.0"
"CHEMBL1089814";"";"None";"489.55";"0";"4.96";"19";"COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4F)c3n2)cc(OC)c1OC";"IC50";"'='";"9300.0";"nM";"5.03";"";"";"UO_0000065";"10.28";"0.19";"0.07";"7.63";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"9300.0"
"CHEMBL1092588";"";"None";"471.56";"0";"4.82";"14";"COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL4239312";"";"None";"418.46";"0";"2.09";"8";"C=CC(=O)Nc1cccc(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL1979057";"";"None";"340.39";"0";"4.22";"SID103905248";"O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2007296";"";"None";"360.46";"1";"5.03";"SID103904566";"CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991577";"";"None";"299.37";"0";"2.80";"SID103904956";"CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992634";"";"None";"273.13";"0";"3.99";"SID103904215";"Brc1cnc2[nH]cc(-c3ccccc3)c2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996390";"";"None";"255.30";"0";"3.66";"SID103905050";"O=C(O)c1cc2c(-c3ccccc3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4583185";"";"None";"419.46";"0";"2.26";"49";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.09";"0.32";"4.44";"5.32";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.2"
"CHEMBL282342";"";"None";"335.46";"0";"3.51";"12";"CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1";"Activity";"'='";"24.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"24.9"
"CHEMBL5288565";"";"None";"376.39";"0";"3.88";"29";"O=C(Nc1cnccc1-c1ccc(F)cc1)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252872";"Inhibition of TYK2 (0 to 887 residues) (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"EUB0001543a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5444447";"Affinity Phenotypic Cellular interaction: (STAT-dependent luciferase reporter assay in PBMCs (IL-23 stimulation, measuring STAT3 phosphorylation in CD161+ CD3+ T-cells, TYK2 dependent signaling)) EUB0001543a TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"Mode of action: Allosteric inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295367";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00444";"";"";"9.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"298.0";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445111";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IFNxcexb3 induced pSTAT1 (CD14+ cells), JAK1/JAK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"298.0"
"CHEMBL5279787";"";"None";"427.85";"0";"4.25";"1";"CCOC(=O)Oc1cccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)n1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"16.90";"0.33";"2.98";"5.63";"1";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"59.0"
"CHEMBL5440964";"";"None";"398.90";"0";"3.83";"A4";"Cc1cnc(Nc2ccc(CNC(=O)CCl)cc2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"18.76";"0.36";"3.65";"8.83";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"33.0"
"CHEMBL4643899";"";"None";"431.50";"0";"3.21";"28";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COC/C=C\COCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"15.26";"0.28";"3.38";"6.56";"0";"CHEMBL4627624";"Inhibition of TYK2 in human Jurkat cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307526";"";"";"";"260.0"
"CHEMBL237570";"";"None";"467.59";"1";"6.02";"SB-630812";"COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1";"Inhibition";"'='";"-1.86";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.86"
"CHEMBL257113";"GW734508X";"None";"333.39";"0";"3.85";"GW734508X";"Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1";"Inhibition";"'='";"-5.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.67"
"CHEMBL205765";"GW794726X";"None";"487.92";"1";"5.34";"GW794726X";"CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1";"Inhibition";"'='";"2.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.39"
"CHEMBL2035044";"";"None";"373.46";"0";"4.05";"13d, 95:5 trans/Cis mixture";"CN1C/C=C/CCOc2cc(ccn2)-c2ccnc(n2)Nc2cccc(c2)C1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"19.24";"0.35";"3.14";"11.38";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.065"
"CHEMBL2035056";"";"None";"436.51";"0";"4.02";"14h, 95:5 trans/Cis mixture";"COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(o1)-c1ccnc(n1)N2";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"14.27";"0.27";"2.21";"7.61";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.59"
"CHEMBL2035181";"";"None";"462.55";"0";"4.56";"14n, 95:5 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cc(co2)COC/1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"14.07";"0.26";"1.95";"7.95";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.31"
"CHEMBL220243";"GW406731X";"None";"283.33";"0";"3.36";"GW406731X";"COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1";"Inhibition";"'='";"-3.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.53"
"CHEMBL572881";"MOTESANIB";"3.0";"373.46";"0";"4.04";"AMG-706";"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL4748354";"";"None";"506.61";"2";"5.30";"13z";"Cc1cnc(Nc2ccc3c(c2)CCN(C(=O)/C=C/C(=O)c2ccccc2)C3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"14.02";"0.26";"1.80";"7.64";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"79.0"
"CHEMBL3814934";"";"None";"301.39";"0";"0.82";"3f";"CNCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"17.87";"0.33";"4.57";"6.34";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"4.1"
"CHEMBL1938659";"";"None";"517.68";"1";"2.68";"25";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL604483";"";"None";"559.67";"2";"5.86";"23";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1";"Residual activity";"'='";"55.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1073365";"Residual activity of TYK2 at 10 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"55.0"
"CHEMBL1794070";"GSK-579289A";"None";"511.05";"2";"5.45";"GSK579289A";"C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl";"Inhibition";"'='";"-7.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.54"
"CHEMBL517123";"GSK-182497A";"None";"566.06";"2";"5.59";"GSK182497A";"CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1";"Inhibition";"'='";"-7.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.95"
"CHEMBL103080";"";"None";"370.43";"0";"2.95";"SB-742864";"CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1";"Inhibition";"'='";"0.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.85"
"CHEMBL485745";"GW434756X";"None";"289.31";"0";"4.20";"GW434756X";"Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1";"Inhibition";"'='";"-0.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.08"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"2, CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"21.62";"0.40";"5.21";"7.60";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"176.0"
"CHEMBL384407";"GW616030X";"None";"620.11";"2";"6.38";"GW616030X";"CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Inhibition";"'='";"-3.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.9"
"CHEMBL187985";"";"None";"299.34";"0";"1.68";"SB-744941";"CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21";"Inhibition";"'='";"2.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.25"
"CHEMBL1794060";"GW575533A";"None";"332.79";"0";"4.10";"GW575533A";"COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl";"Inhibition";"'='";"5.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.03"
"CHEMBL477978";"GW782907X";"None";"390.53";"0";"4.86";"GW782907X";"Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-2.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.34"
"CHEMBL1909410";"GSK-259178A";"None";"728.70";"2";"5.27";"GSK259178A";"O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"-1.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.34"
"CHEMBL101804";"";"None";"268.28";"0";"2.57";"SB-743899";"O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1";"Inhibition";"'='";"-1.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.09"
"CHEMBL179465";"GW621970X";"None";"376.41";"0";"4.03";"GW621970X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1";"Inhibition";"'='";"-0.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.94"
"CHEMBL273611";"";"None";"459.48";"0";"4.59";"SB-250715";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1";"Inhibition";"'='";"-2.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.53"
"CHEMBL215943";"";"None";"535.57";"2";"5.62";"47";"Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1";"IC50";"'='";"1830.0";"nM";"5.74";"";"";"UO_0000065";"10.71";"0.20";"0.12";"7.23";"0";"CHEMBL871539";"Inhibition of Tyk2 by HTRF kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149344";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1.83"
"CHEMBL197603";"";"None";"621.75";"1";"4.48";"20, A-770041";"COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL863896";"Inhibitory activity against TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148543";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";"";"25.0"
"CHEMBL1909369";"GW693917A";"None";"556.93";"2";"7.07";"GW693917A";"COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl";"Inhibition";"'='";"-0.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.09"
"CHEMBL237571";"";"None";"483.59";"1";"5.69";"SB-633825";"COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1";"Inhibition";"'='";"-1.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.13"
"CHEMBL4453441";"";"None";"440.47";"0";"2.43";"6c";"CNc1cc(Nc2cccn(-c3ccc(C#N)cc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.02";"0.40";"7.27";"7.51";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.2"
"CHEMBL4437714";"";"None";"435.42";"0";"1.49";"6k";"CNc1cc(Nc2cccn(-c3ncc(F)cn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"21.63";"0.40";"7.93";"7.18";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.38"
"CHEMBL4454109";"";"None";"433.48";"0";"1.60";"6m";"CNc1cc(Nc2cccn(-c3cc(C)n(C)n3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"21.50";"0.40";"7.72";"7.57";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.48"
"CHEMBL4438296";"";"None";"430.47";"0";"2.34";"6o";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CCC3)cnc12";"Ki";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"22.27";"0.41";"7.25";"8.11";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.26"
"CHEMBL4437714";"";"None";"435.42";"0";"1.49";"6k";"CNc1cc(Nc2cccn(-c3ncc(F)cn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"235.0";"nM";"6.63";"";"";"UO_0000065";"15.22";"0.28";"5.14";"5.06";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"235.0"
"CHEMBL4517542";"";"None";"353.39";"0";"1.11";"6a";"CNc1cc(Nc2cccn(C)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"";"";"";"";"";"Nd(Insoluble)";"";"";"";"";"";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";""
"CHEMBL4466139";"";"None";"416.45";"0";"1.95";"6e";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"382.0";"nM";"6.42";"";"";"UO_0000065";"15.41";"0.28";"4.47";"5.43";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"382.0"
"CHEMBL5414946";"";"None";"467.53";"0";"1.93";"40";"CNc1cc(Nc2cccn(C3CCOCC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"15.85";"0.30";"5.48";"5.98";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"39.0"
"CHEMBL4532948";"";"None";"434.44";"0";"1.90";"6b";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327925";"Inhibition of TYK2 JH1 domain (unknown origin) in presence of 10 uM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5405569";"";"None";"452.43";"0";"2.04";"11";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3C[C@@H]3F)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL1235315";"";"None";"455.40";"0";"2.71";"12";"O=C1CCN(c2ncc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1";"IC50";"'='";"4333.0";"nM";"5.36";"";"";"UO_0000065";"11.78";"0.22";"2.65";"4.96";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"4333.0"
"CHEMBL4303389";"NS-018";"2.0";"389.44";"0";"4.33";"38";"C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"19.66";"0.36";"3.33";"9.51";"0";"CHEMBL5245552";"Inhibition of human TYK2 kinase domain incubated for 1 hrs in the presence of ATP by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr";"INHIBITOR";"";"22.0"
"CHEMBL1163565";"";"None";"530.98";"1";"4.92";"5o";"CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1";"Inhibition";"'='";"72.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"72.0"
"CHEMBL1163518";"";"None";"514.98";"2";"6.48";"5k";"O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL3675929";"";"None";"366.40";"0";"2.50";"BDBM127679";"O=C(NC1CC1)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12";"IC50";"'>'";"1000.0";"nM";"";"";"258559";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3675988";"";"None";"340.36";"0";"1.96";"BDBM127741";"CNC(=O)c1cnn2ccc(N3CCCC3c3cncc(F)c3)nc12";"IC50";"'>'";"1000.0";"nM";"";"";"258563";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL5171417";"";"None";"558.61";"1";"3.31";"26";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CN(C2CC2)C3=O)c1OC";"Tm";"'='";"55.06";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"55.06"
"CHEMBL5440017";"";"None";"403.49";"0";"2.65";"20b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(C#N)n2)[C@H](C)C1";"IC50";"'='";"44.9";"nM";"7.35";"";"";"UO_0000065";"18.21";"0.33";"4.70";"6.70";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"44.9"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"15.54";"0.28";"2.90";"10.44";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"56.0"
"CHEMBL607707";"PELITINIB";"2.0";"467.93";"1";"5.10";"EKB-569";"CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL5418485";"";"None";"465.49";"1";"1.93";"2n";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(OC)ccn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"21.96";"0.41";"8.22";"6.60";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.07"
"CHEMBL5403477";"";"None";"441.44";"0";"1.93";"3b";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.12";"0.41";"7.77";"6.74";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.2"
"CHEMBL5411146";"";"None";"422.46";"0";"2.39";"3a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ccccn2)c1OC";"IC50";"'='";"312.0";"nM";"6.51";"";"";"UO_0000065";"15.51";"0.29";"4.12";"4.97";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"312.0"
"CHEMBL5394367";"";"None";"373.44";"0";"1.84";"9";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)n3)cn(C)c2cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"22.49";"0.44";"6.56";"8.64";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.004"
"CHEMBL5440340";"";"None";"432.43";"0";"3.46";"19";"CO[C@@]1(c2cc(OC(F)F)cc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"16.29";"0.31";"3.59";"8.05";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.09"
"CHEMBL5403113";"";"None";"454.53";"0";"3.01";"23";"CO[C@@]1(c2cc(O[C@@H](C)CCO)cc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"134.0";"nM";"6.87";"";"";"UO_0000065";"15.12";"0.28";"3.86";"6.38";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.134"
"CHEMBL4283970";"";"None";"294.31";"0";"0.51";"Yfq77";"O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1";"Inhibition";"'='";"2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4267277";"Inhibition of human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265907";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"2.5"
"CHEMBL1089833";"";"None";"519.62";"1";"4.22";"10";"COc1cc(-c2cnc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"12.09";"0.23";"2.06";"6.92";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"520.0"
"CHEMBL1171523";"";"None";"506.57";"2";"5.20";"3";"CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"99.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1175112";"Inhibition of TYK2 JH2 pseudokinase domain at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177794";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"99.0"
"CHEMBL1938660";"";"None";"531.70";"1";"3.07";"26";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCCN4CCOCC4)c3s2)cc1";"IC50";"'='";"1550.0";"nM";"5.81";"";"";"UO_0000065";"10.93";"0.22";"2.74";"4.59";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"1.55"
"CHEMBL1985580";"";"None";"394.48";"0";"4.31";"SID103904969";"NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4543066";"";"None";"462.51";"0";"1.81";"6p";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NCC(C)(C)CO)cnc12";"Ki";"'='";"0.29";"nM";"9.54";"";"";"UO_0000065";"20.62";"0.38";"7.73";"6.89";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.29"
"CHEMBL4454109";"";"None";"433.48";"0";"1.60";"6m";"CNc1cc(Nc2cccn(-c3cc(C)n(C)n3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"14.92";"0.28";"4.87";"5.25";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"340.0"
"CHEMBL5284638";"";"None";"556.60";"1";"3.34";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccccc3=O)cc2)c1OC";"Tm";"'='";"62.25";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"62.25"
"CHEMBL5266772";"";"None";"574.59";"1";"3.68";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ccc(F)c(=O)[nH]3)cc2)c1OC";"Tm";"'='";"55.89";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"55.89"
"CHEMBL4068319";"";"None";"349.46";"0";"1.64";"30";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CCC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL179311";"GW580509X";"None";"388.45";"0";"3.90";"GW580509X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1";"Inhibition";"'='";"-5.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.06"
"CHEMBL261440";"";"None";"313.31";"0";"3.86";"SB-735465";"O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1";"Inhibition";"'='";"-1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.0"
"CHEMBL2443138";"";"None";"452.51";"0";"3.44";"30";"CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2443724";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439976";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL1909357";"GW410563A";"None";"347.80";"0";"3.40";"GW410563A";"COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl";"Inhibition";"'='";"-3.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.35"
"CHEMBL361894";"GW806290X";"None";"346.35";"0";"2.70";"GW806290X";"c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1";"Inhibition";"'='";"-1.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.73"
"CHEMBL3114763";"";"None";"467.50";"0";"4.18";"11g";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(C2CCN(c3ccnc(F)c3)C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL4284396";"";"None";"371.35";"0";"3.09";"10";"COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4281693";"";"None";"291.31";"0";"1.65";"27";"N#CN[C@@H]1c2cc(-c3ncnc4[nH]ccc34)ccc2C[C@H]1O";"IC50";"'='";"4285.0";"nM";"5.37";"";"";"UO_0000065";"18.43";"0.33";"3.72";"5.50";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"4285.0"
"CHEMBL5207953";"";"None";"564.65";"1";"3.43";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3C([2H])([2H])CCC3([2H])[2H])cc2)c1OC";"Tm";"'='";"66.1";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"66.1"
"CHEMBL5179468";"";"None";"587.66";"2";"3.81";"31";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Tm";"'='";"62.03";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"62.03"
"CHEMBL2062289";"";"None";"550.52";"0";"3.36";"SB-698596-AC";"CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O";"Inhibition";"'='";"0.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.26"
"CHEMBL2181324";"";"None";"487.60";"0";"3.60";"17e, 85:15 trans/cis mixture";"OCCN1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"13.94";"0.26";"3.20";"8.19";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.16"
"CHEMBL437747";"";"None";"513.52";"2";"6.94";"SID103905437";"CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971943";"BAY-549";"None";"402.79";"0";"4.71";"SID103905649";"Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982476";"";"None";"451.94";"1";"5.20";"SID103904309";"CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12";"Ki";"'='";"501.19";"nM";"6.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.3"
"CHEMBL1995813";"";"None";"308.39";"0";"2.70";"SID103904202";"NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1909391";"GW576924A";"None";"579.10";"2";"5.92";"GW576924A";"Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1";"Inhibition";"'='";"-3.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.99"
"CHEMBL1990912";"";"None";"265.32";"0";"2.70";"SID103904736";"OCCNc1cc2cc(-c3cccnc3)ccc2cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000508";"";"None";"295.34";"0";"4.26";"SID103905065";"Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL476351";"GW775608X";"None";"470.57";"0";"4.29";"GW775608X";"Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"3.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.42"
"CHEMBL4867261";"";"None";"358.43";"0";"4.35";"5h";"N#CCCn1cc(-n2c(-c3cccs3)cc3cnc4[nH]ccc4c32)cn1";"IC50";"'>'";"300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";"300.0"
"CHEMBL4854943";"";"None";"344.42";"0";"4.27";"9c";"N#CCCCn1cc(-n2c(C3CCC3)cc3cnc4[nH]ccc4c32)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";""
"CHEMBL272414";"GW416469X";"None";"358.42";"0";"1.81";"GW416469X";"CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"17.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"17.16"
"CHEMBL418348";"";"None";"493.56";"0";"4.27";"SB-254169";"CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-0.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.68"
"CHEMBL3747305";"";"None";"401.90";"0";"3.71";"25";"COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC";"IC50";"'='";"1280.0";"nM";"5.89";"";"";"UO_0000065";"14.66";"0.29";"2.18";"7.01";"0";"CHEMBL3751021";"Inhibition of N-terminal 6His-tagged human recombinant Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745697";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"1.28"
"CHEMBL1909352";"GW441806A";"None";"329.79";"0";"2.75";"GW441806A";"Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl";"Inhibition";"'='";"-2.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.7"
"CHEMBL188240";"";"None";"274.28";"0";"1.48";"SB-737198";"CCOc1nccc2c1nc(-c1nonc1N)n2CC";"Inhibition";"'='";"1.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.21"
"CHEMBL495696";"GW778894X";"None";"313.32";"0";"2.80";"GW778894X";"N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1";"Inhibition";"'='";"-4.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.17"
"CHEMBL1909395";"GW633459A";"None";"679.60";"2";"7.57";"GW633459A";"Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1";"Inhibition";"'='";"-2.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.79"
"CHEMBL4097778";"TP-030n";"None";"458.54";"0";"1.13";"EUB0003063";"CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.09";"0.26";"4.87";"5.89";"0";"CHEMBL4885463";"Tyk2(TYK2LGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"6.0"
"CHEMBL4249784";"";"None";"379.43";"0";"0.96";"10c";"Cn1cc(-c2nn(CC3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL419903";"";"None";"295.32";"0";"3.72";"SB-735467";"O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1";"Inhibition";"'='";"-3.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.58"
"CHEMBL244378";"";"None";"346.35";"0";"3.54";"SID103904604";"O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1";"Ki";"'='";"31.62";"nM";"7.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.5"
"CHEMBL2000114";"";"None";"238.32";"0";"1.47";"SID103904504";"CSc1c[nH]c2ncnc(NCCCO)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL184847";"";"None";"371.44";"0";"4.86";"SID103904377";"Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975534";"";"None";"363.16";"0";"-0.70";"SID103905378";"NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1966722";"";"None";"411.91";"0";"3.59";"SID103904450";"O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1978200";"";"None";"424.46";"0";"4.01";"SID103904764";"Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL219722";"";"None";"343.39";"0";"4.46";"SID103904370";"Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12";"Ki";"'='";"398.11";"nM";"6.40";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.4"
"CHEMBL1966808";"";"None";"323.38";"0";"2.57";"SID103904979";"O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965910";"";"None";"467.62";"1";"5.84";"SID103904995";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971430";"";"None";"425.54";"0";"3.80";"SID103905563";"Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4559521";"";"None";"394.41";"0";"2.95";"6";"CCNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"19.99";"0.37";"4.94";"6.46";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.013"
"CHEMBL4097446";"";"None";"497.39";"0";"3.99";"25";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3cc(N4CCN(C5COC5)CC4)ncn3)c2[nH]1";"EC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"14.53";"0.29";"3.24";"7.60";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.059"
"CHEMBL4078655";"";"None";"336.42";"0";"0.51";"13";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NC2CC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3655080";"";"None";"363.37";"0";"1.41";"8";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC(F)(F)F)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4099048";"";"None";"348.43";"0";"1.15";"35";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CCCC#N)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL218088";"GW435821X";"None";"268.32";"0";"2.67";"GW435821X";"Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1";"Inhibition";"'='";"-0.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.58"
"CHEMBL237571";"";"None";"483.59";"1";"5.69";"SB-633825";"COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1";"Inhibition";"'='";"-5.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.17"
"CHEMBL4537259";"";"None";"424.44";"0";"2.88";"22";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(N)=O)c1OC";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"16.98";"0.32";"4.33";"5.49";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"62.0"
"CHEMBL4559585";"";"None";"498.47";"0";"4.15";"40";"CNC(=O)c1cnc(Nc2ccc(C(F)(F)F)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"14.37";"0.27";"3.01";"6.02";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"69.0"
"CHEMBL2005792";"";"None";"422.46";"0";"3.43";"SID103904776";"COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL210963";"";"None";"434.47";"0";"1.54";"SID103905193";"CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000832";"";"None";"483.50";"1";"5.45";"SID103904711";"COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL209534";"";"None";"297.32";"0";"1.26";"SID103904794";"CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002346";"";"None";"301.35";"0";"3.63";"SID103904201";"c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1";"Ki";"'='";"100.0";"nM";"7.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.0"
"CHEMBL477182";"GW769076X";"None";"454.57";"1";"5.05";"GW769076X";"Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-3.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.05"
"CHEMBL1093454";"";"None";"485.58";"1";"5.13";"15";"COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(C)c4)c3n2)cc(OC)c1OC";"IC50";"'='";"7130.0";"nM";"5.15";"";"";"UO_0000065";"10.60";"0.20";"0.02";"7.81";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"7130.0"
"CHEMBL1997822";"";"None";"433.56";"1";"5.41";"SID103904321";"Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988387";"";"None";"506.54";"2";"6.19";"SID103904292";"Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1966816";"";"None";"350.28";"0";"4.43";"SID103904882";"O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL191705";"GW621431X";"None";"400.46";"0";"4.09";"GW621431X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1";"Inhibition";"'='";"-1.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.19"
"CHEMBL4103341";"";"None";"347.20";"1";"5.15";"11";"O=C(Nc1nccc2cc(-c3c(Cl)cccc3Cl)oc12)C1CC1";"Ki";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"21.63";"0.45";"2.36";"13.62";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.031"
"CHEMBL3694588";"";"None";"380.88";"0";"4.85";"BDBM125909";"Clc1cnc2nc1NCCc1cccc(c1)OCCCc1cccc(c1)N2";"IC50";"'='";"400.0";"nM";"6.40";"";"255720";"UO_0000065";"16.80";"0.32";"1.55";"10.83";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"400.0"
"CHEMBL4868858";"";"None";"521.48";"2";"5.36";"14g";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4C(=O)c3ccc(C(F)(F)F)cc3)ncc2F)cn1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.92";"0.30";"2.94";"8.32";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"5.0"
"CHEMBL4516471";"BI 1675";"None";"554.64";"1";"2.95";"EUB0000319";"O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1";"% Control";"'='";"99.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507284";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"99.0"
"CHEMBL4566600";"PPTN-NC";"None";"489.54";"1";"7.67";"EUB0000337";"Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507292";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1794050";"GW429374A";"None";"508.60";"1";"5.47";"GW429374A";"Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1";"Inhibition";"'='";"0.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.81"
"CHEMBL275200";"";"None";"471.58";"1";"6.16";"SB-278538";"CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-2.22";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.22"
"CHEMBL218969";"GW445015X";"None";"252.32";"0";"2.92";"GW445015X";"CNC(=O)c1cncc(/C=C/c2ccccc2C)c1";"Inhibition";"'='";"-3.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.23"
"CHEMBL188426";"GW807982X";"None";"430.39";"0";"4.36";"GW807982X";"CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1";"Inhibition";"'='";"-2.65";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.65"
"CHEMBL5195823";"";"None";"449.48";"0";"3.91";"31";"O=C(Nc1nc2cccc(C3CCC4(CC3)CCN(C(=O)CC(F)(F)F)C4)n2n1)C1CC1";"IC50";"'='";"1526.0";"nM";"5.82";"";"";"UO_0000065";"12.94";"0.25";"1.91";"7.31";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1526.0"
"CHEMBL5180245";"";"None";"435.45";"0";"3.52";"33";"O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)CC(F)(F)F)C4)n2n1)C1CC1";"IC50";"'='";"311.0";"nM";"6.51";"";"";"UO_0000065";"14.94";"0.29";"2.99";"8.17";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"311.0"
"CHEMBL362155";"GW827102X";"None";"490.45";"1";"5.39";"GW827102X";"FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1";"Inhibition";"'='";"-3.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.08"
"CHEMBL4060201";"";"None";"328.38";"0";"2.28";"24";"O=C(CCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO";"Activity";"'='";"3.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4031313";"Inhibition of wild type human TYK2 (V877 to C1187 residues) expressed in mammalian cells assessed as residual activity at 1 uM by KINOMEscan assay relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028864";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"3.3"
"CHEMBL5268459";"";"None";"355.79";"0";"3.42";"4";"NC(=O)c1cnc(Nc2ccc(O)cn2)cc1Nc1ccccc1Cl";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"21.84";"0.42";"4.35";"6.87";"0";"CHEMBL5252498";"Inhibition of GST-fused Tyk2 (888 to 1187 residues) (unknown origin) using FITC-AhxKKSRGDYMTMQIG-NH2 peptide as substrate incubated for 60 mins in presence of ATP by Janus kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247683";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"17.0"
"CHEMBL511765";"GSK-2213727A";"None";"506.54";"1";"3.50";"GSK2213727A";"COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1";"Inhibition";"'='";"1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.0"
"CHEMBL2387116";"";"None";"408.29";"0";"4.22";"11";"CC(C)(O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"21.8";"nM";"7.66";"";"";"UO_0000065";"18.76";"0.39";"3.44";"8.39";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"21.8"
"CHEMBL5440397";"";"None";"464.49";"1";"1.87";"38";"CNc1cc(Nc2cccn(-c3cnc(C)o3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"17.24";"0.32";"6.14";"5.70";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"9.8"
"CHEMBL5414851";"";"None";"464.46";"0";"1.45";"20";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3O)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL4083798";"";"None";"402.50";"0";"3.29";"19";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4C#N)cc23)CC[C@]1(C)N";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"18.56";"0.34";"4.18";"6.11";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"34.0"
"CHEMBL4068856";"";"None";"391.52";"0";"3.73";"7";"Cc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"18.63";"0.34";"3.56";"7.41";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"51.0"
"CHEMBL4101374";"";"None";"357.44";"0";"1.90";"4";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2ccccc2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3966536";"";"None";"542.09";"1";"4.64";"16d";"CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl";"Activity";"'='";"67.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3856693";"Inhibition of human TYK2 assessed as remaining activity at 10 uM in presence of [gamma-32P]ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856191";"1";"Scientific Literature";"Eur J Med Chem";"2016";"None";"";"";"";"67.0"
"CHEMBL5186817";"";"None";"437.45";"0";"3.37";"23";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCC(O)CC4)cn3)c21";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"16.20";"0.30";"3.72";"7.84";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.08199999999999999"
"CHEMBL5395308";"";"None";"376.47";"0";"3.77";"13";"Cc1cnc(Nc2cnn(C)c2)nc1-c1cnn([C@H](CC#N)C2CCCC2)c1";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"23.93";"0.44";"5.24";"9.26";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"0.98"
"CHEMBL205798";"GW703087X";"None";"486.93";"1";"5.95";"GW703087X";"CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1";"Inhibition";"'='";"1.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.05"
"CHEMBL179453";"GW622055X";"None";"392.86";"0";"4.54";"GW622055X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1";"Inhibition";"'='";"-3.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.24"
"CHEMBL475761";"GW784684X";"None";"564.09";"2";"6.81";"GW784684X";"CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1";"Inhibition";"'='";"-2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.41"
"CHEMBL1909355";"GW461104A";"None";"528.46";"0";"4.42";"GW461104A";"CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl";"Inhibition";"'='";"-3.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.38"
"CHEMBL572881";"MOTESANIB";"3.0";"373.46";"0";"4.04";"AMG-706";"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4860979";"";"None";"466.54";"0";"3.21";"I-28";"CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1";"% inhibition";"'='";"3.8";"uM";"";"";"Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ";"UO_0000064";"";"";"";"";"0";"CHEMBL4804508";"Inhibition of TYK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"3.8"
"CHEMBL4869338";"";"None";"491.60";"0";"3.71";"1c";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-n3c(-c4cccs4)cc4cnc5[nH]ccc5c43)cn2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";""
"CHEMBL2003524";"";"None";"286.29";"0";"1.70";"SID103905551";"CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994321";"";"None";"505.63";"1";"4.40";"SID103904304";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5413489";"";"None";"426.38";"0";"2.02";"56-2";"NC(=O)c1nnc(-c2c(F)cccc2F)cc1Nc1ccc(N2CCOCC2=O)cn1";"IC50";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"23.68";"0.44";"8.08";"8.19";"0";"CHEMBL5383631";"Inhibition of human recombinant TYK2 preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"0.08"
"CHEMBL5424441";"";"None";"473.50";"0";"1.02";"71-3";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@@H]3CCN(C)C3=O)cnn12";"IC50";"'<'";"254.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383633";"Inhibition of TYK2 JH2 (unknown origin) by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.254"
"CHEMBL5418744";"";"None";"478.49";"0";"2.11";"17";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"17.07";"0.32";"6.06";"6.41";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"6.8"
"CHEMBL5435131";"";"None";"341.42";"0";"1.31";"10";"Cc1cnc(NCCN2CCOCC2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"16836.0";"nM";"4.77";"";"";"UO_0000065";"13.98";"0.26";"3.46";"5.20";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"16836.0"
"CHEMBL5286565";"";"None";"560.63";"1";"3.18";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C3CCCNC3=O)cc2)c1OC";"Tm";"'='";"70.2";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"70.2"
"CHEMBL5267449";"";"None";"596.68";"1";"3.12";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCS3(=O)=O)cc2)c1OC";"Tm";"'='";"58.74";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"58.74"
"CHEMBL516908";"GW796920X";"None";"362.47";"0";"4.54";"GW796920X";"Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-2.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.78"
"CHEMBL1885746";"GW561436X";"None";"370.39";"0";"4.04";"GW561436X";"N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1";"Inhibition";"'='";"0.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.53"
"CHEMBL2420843";"";"None";"266.22";"0";"3.35";"5";"O=C(Nc1ccncc1)c1ccccc1C(F)(F)F";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL275666";"";"None";"483.47";"1";"5.88";"SB-253226";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1";"Inhibition";"'='";"-2.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.19"
"CHEMBL2386629";"";"None";"381.40";"0";"3.60";"26";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](NCC(F)(F)F)CC1";"EC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"17.07";"0.33";"2.91";"8.26";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"310.0"
"CHEMBL517666";"GW796921X";"None";"336.44";"0";"4.15";"GW796921X";"CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1";"Inhibition";"'='";"-0.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.87"
"CHEMBL559626";"";"None";"438.66";"1";"6.51";"G6, NSC-33994";"CC/C(=C(/CC)c1ccc(O)c(CN(CC)CC)c1)c1ccc(O)c(CN(CC)CC)c1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1031280";"Inhibition of TYK2 transfected in mouse embryonic fibroblasts at 25 uM by Western blotting";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158435";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";"";""
"CHEMBL559626";"";"None";"438.66";"1";"6.51";"G6, NSC-33994";"CC/C(=C(/CC)c1ccc(O)c(CN(CC)CC)c1)c1ccc(O)c(CN(CC)CC)c1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1031281";"Inhibition of TYK2 autophosphorylation transfected in mouse embryonic fibroblasts at 25 uM by Western blotting";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158435";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";"";""
"CHEMBL595545";"";"None";"2030.37";"None";"None";"4";"CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Activity";"'='";"62.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1050479";"Binding affinity to human TYK2 kinase domain 2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152541";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"62.0"
"CHEMBL4797596";"";"None";"480.54";"0";"2.62";"28";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(C)(C)O)nn2)c1OC";"IC50";"'='";"0.71";"nM";"9.15";"";"";"UO_0000065";"19.16";"0.36";"6.53";"6.05";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.71"
"CHEMBL4789639";"BMS-986202";"1.0";"439.47";"0";"3.14";"7; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"22.27";"0.41";"6.58";"8.23";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.19"
"CHEMBL4799019";"";"None";"452.49";"0";"2.40";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(OC)cn2)c1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.55";"0.33";"5.49";"5.62";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL4784838";"";"None";"498.53";"0";"2.76";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"73.0";"nM";"7.14";"";"";"UO_0000065";"14.40";"0.27";"4.38";"4.72";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"73.0"
"CHEMBL2386802";"";"None";"587.68";"1";"4.65";"10f";"CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1";"Inhibition";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2389808";"Inhibition of TYK2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384934";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"86.0"
"CHEMBL4637587";"";"None";"418.46";"0";"1.75";"21";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"16.46";"0.30";"5.14";"5.73";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"130.0"
"CHEMBL3114772";"";"None";"457.47";"0";"3.67";"8b";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCNc2ccnc(F)c2)cc1";"IC50";"'='";"9844.0";"nM";"5.01";"";"";"UO_0000065";"10.94";"0.20";"1.34";"4.63";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"9844.0"
"CHEMBL3764277";"";"None";"384.48";"0";"2.82";"18";"CC(C)[C@H](C)n1cc(-c2cc(C3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"23.43";"0.44";"6.19";"8.68";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"0.98"
"CHEMBL3763252";"";"None";"382.47";"0";"2.42";"13";"CC(C)C(C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"23.07";"0.43";"6.40";"8.65";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"1.5"
"CHEMBL3763310";"";"None";"385.84";"0";"4.11";"1";"O=C(O)Cc1cnc(Nc2n[nH]c3ccc(-c4ncccc4Cl)cc23)s1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"16.04";"0.32";"2.08";"5.96";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"650.0"
"CHEMBL4101534";"";"None";"372.43";"0";"4.45";"16";"CCc1cc(O)ccc1-c1ccc2c(C(=O)Nc3ccc(C)nc3)n[nH]c2c1";"IC50";"'='";"815.9";"nM";"6.09";"";"";"UO_0000065";"16.35";"0.30";"1.64";"6.70";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"815.9"
"CHEMBL3904952";"";"None";"454.51";"0";"2.65";"BDBM127767";"COc1ncc(F)cc1[C@H]1CCCN1c1ccn2ncc(C(=O)NC3CCC(O)CC3)c2n1";"IC50";"'>'";"1000.0";"nM";"";"";"258560";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL1909352";"GW441806A";"None";"329.79";"0";"2.75";"GW441806A";"Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl";"Inhibition";"'='";"-2.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.89"
"CHEMBL1895450";"GSK-2220400A";"None";"529.61";"1";"3.05";"GSK2220400A";"CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12";"Inhibition";"'='";"-1.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.39"
"CHEMBL1909362";"GW830900A";"None";"534.09";"0";"3.22";"GW830900A";"CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl";"Inhibition";"'='";"-3.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.31"
"CHEMBL477583";"GW743024X";"None";"374.44";"0";"4.65";"GW743024X";"Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-0.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.16"
"CHEMBL1909344";"";"None";"372.86";"0";"2.30";"SB-678557-A";"CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl";"Inhibition";"'='";"-0.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.97"
"CHEMBL442363";"GW809885X";"None";"373.42";"0";"3.36";"GW809885X";"COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1";"Inhibition";"'='";"0.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.67"
"CHEMBL1909363";"GSK-269962B";"None";"607.07";"2";"3.84";"GSK269962B";"CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl";"Inhibition";"'='";"-1.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.13"
"CHEMBL1909396";"GW768505A";"None";"573.93";"2";"6.95";"GW768505A";"COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl";"Inhibition";"'='";"0.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.14"
"CHEMBL3765822";"";"None";"358.45";"0";"2.15";"20";"CC(C)[C@@H](C)n1cc(-c2cc(C(C)(C)O)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"24.21";"0.46";"6.53";"7.56";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.1"
"CHEMBL3763213";"";"None";"385.47";"0";"1.76";"17";"CC(C)[C@H](C)n1cc(-c2cc(N3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"24.02";"0.45";"7.50";"8.65";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"0.55"
"CHEMBL3764277";"";"None";"384.48";"0";"2.82";"18";"CC(C)[C@H](C)n1cc(-c2cc(C3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"18.10";"0.34";"4.14";"6.71";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"110.0"
"CHEMBL3764167";"";"None";"286.34";"0";"1.68";"10";"CCC(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"21.61";"0.40";"4.51";"6.55";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"650.0"
"CHEMBL13868";"";"None";"507.57";"2";"6.66";"SB-245392";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1";"Inhibition";"'='";"-1.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.07"
"CHEMBL480382";"GSK-312948A";"None";"415.50";"0";"3.84";"GSK312948A";"COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-2.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.34"
"CHEMBL480371";"GW853609X";"None";"496.31";"1";"5.55";"GW853609X";"NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br";"Inhibition";"'='";"0.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.53"
"CHEMBL4075575";"";"None";"320.42";"0";"1.75";"17";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)C2CC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4103586";"";"None";"356.45";"0";"2.65";"20";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2ccccc2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4092191";"";"None";"381.23";"0";"4.94";"19";"N#Cc1ccnc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)c1";"Ki";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"24.01";"0.48";"4.21";"10.14";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0007"
"CHEMBL4092116";"";"None";"397.23";"0";"3.92";"31";"N#Cc1cc(Cl)c(-c2nc3ccnc(Nc4cc(N)ncn4)c3[nH]2)c(Cl)c1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"23.22";"0.47";"5.30";"7.14";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0006"
"CHEMBL4784576";"";"None";"447.58";"0";"4.32";"17l";"COc1cccc(CN2CCC(Nc3c(C(=O)NC4CCCC4)cnc4[nH]ccc34)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"";"";"10000.0"
"CHEMBL1289926";"AXITINIB";"4.0";"386.48";"0";"4.64";"AG-013736";"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1";"Kd";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"14.09";"0.27";"0.80";"7.70";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"3600.0"
"CHEMBL4127590";"";"None";"359.43";"1";"5.13";"20";"N#CCCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"21.15";"0.38";"2.47";"9.11";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"25.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"INCB18424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Kd";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"19.11";"0.35";"2.38";"7.04";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"1400.0"
"CHEMBL1973142";"";"None";"303.17";"0";"3.27";"SID103905605";"CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1966628";"";"None";"308.39";"0";"2.70";"SID103904203";"NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1";"Ki";"'='";"794.33";"nM";"6.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.1"
"CHEMBL1472492";"";"None";"397.67";"1";"7.61";"SID103905627";"CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C";"Ki";"'='";"1584.89";"nM";"5.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL1990583";"";"None";"405.39";"0";"3.35";"SID103904451";"Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970142";"";"None";"525.64";"2";"5.67";"SID103904293";"CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL531804";"GW301888X";"None";"395.47";"0";"4.30";"GW301888X";"CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1";"Inhibition";"'='";"-7.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.84"
"CHEMBL1909396";"GW768505A";"None";"573.93";"2";"6.95";"GW768505A";"COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl";"Inhibition";"'='";"-5.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.26"
"CHEMBL1794052";"GW405841X";"None";"453.09";"0";"4.20";"GW405841X";"COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2";"Inhibition";"'='";"5.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.83"
"CHEMBL218720";"GSK-466314A";"None";"428.41";"0";"4.41";"GSK466314A";"CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1";"Inhibition";"'='";"0.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.25"
"CHEMBL1091191";"";"None";"517.56";"1";"4.53";"12";"COc1cc(-c2cnc3cc(F)cc(-c4ccc(CC(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL4859660";"";"None";"378.36";"0";"3.33";"I-9";"Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804690";"Inhibition of TYK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 10.0 microM";"";"";"0.0"
"CHEMBL1081978";"";"None";"489.53";"0";"4.74";"9";"COc1cc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3o2)cc(OC)c1OC";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"14.21";"0.26";"2.22";"7.30";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.11"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL595373";"";"None";"512.64";"2";"6.57";"25";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1";"Residual activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1073157";"Residual activity of TYK2 at 0.1 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"94.0"
"CHEMBL230806";"AGELADINE A";"None";"357.01";"0";"3.06";"1";"Nc1nc2ccnc(-c3cc(Br)c(Br)[nH]3)c2[nH]1";"Activity";"'<='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2154877";"Binding affinity to JH domain of TYK2 assessed as ATP binding remaining at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150858";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"5.0"
"CHEMBL4798378";"";"None";"387.49";"0";"3.85";"13t";"Cc1cnc(Nc2ccc3c(c2)CCN(CC#N)C3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"18.71";"0.34";"3.40";"8.77";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"56.0"
"CHEMBL1170139";"";"None";"545.61";"2";"5.68";"12";"CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"6.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1175111";"Inhibition of TYK2 JH1 catalytic domain at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177794";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"6.8"
"CHEMBL585927";"";"None";"523.55";"1";"4.88";"1";"CNc1ccn(-c2ccccc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1038364";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155349";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";"";"1.0"
"CHEMBL3655092";"";"None";"337.45";"0";"1.64";"BDBM159759";"CCCS(=O)(=O)N[C@H]1CC[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"2040.0";"nM";"5.69";"";"302653";"UO_0000065";"16.86";"0.34";"4.05";"6.25";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2040.0"
"CHEMBL3114785";"";"None";"469.48";"0";"3.45";"11c";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CN(c3ccnc(F)c3)C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL3655100";"";"None";"402.48";"0";"0.51";"BDBM159767";"Cn1cc2c(n1)CN(S(=O)(=O)N[C@H]1C[C@@H](N(C)c3ncnc4[nH]ccc34)C1)C2";"IC50";"'='";"7380.0";"nM";"5.13";"";"302661";"UO_0000065";"12.75";"0.25";"4.62";"4.58";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"7380.0"
"CHEMBL2181326";"";"None";"535.67";"1";"3.96";"17g, 85:15 trans/cis mixture";"CCS(=O)(=O)N1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"12.79";"0.25";"2.89";"7.07";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.14"
"CHEMBL2181323";"";"None";"457.58";"0";"4.24";"17d, 85:15 trans/cis mixture";"CN1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.69";"0.27";"2.48";"10.71";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.19"
"CHEMBL1794053";"GW407323A";"None";"529.64";"1";"5.12";"GW407323A";"Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1";"Inhibition";"'='";"1.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.72"
"CHEMBL4576489";"";"None";"915.85";"None";"None";"8b";"CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"7.98";"None";"None";"None";"0";"CHEMBL4322752";"Binding affinity to recombinant N-terminal His-FLAG-GST-tagged TYK2 (unknown origin) (871 to 1187 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321812";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308860";"";"";"";"49.0"
"CHEMBL1909411";"";"None";"393.87";"0";"4.96";"GI261520A";"COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl";"Inhibition";"'='";"-1.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.0"
"CHEMBL181361";"GW693481X";"None";"305.37";"0";"3.40";"GW693481X";"Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1";"Inhibition";"'='";"-1.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.33"
"CHEMBL1909383";"GW784307A";"None";"494.99";"0";"2.56";"GW784307A";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl";"Inhibition";"'='";"-5.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.03"
"CHEMBL374453";"GSK-299115A";"None";"415.28";"0";"4.39";"GSK299115A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1";"Inhibition";"'='";"0.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.3"
"CHEMBL1909368";"GW683134A";"None";"575.91";"2";"7.00";"GW683134A";"Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F";"Inhibition";"'='";"-3.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.76"
"CHEMBL1794068";"GSK-326090A";"None";"558.63";"2";"6.07";"GSK326090A";"C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Inhibition";"'='";"3.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.05"
"CHEMBL1163559";"";"None";"584.09";"2";"6.55";"5m";"O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL5402829";"";"None";"403.39";"0";"4.81";"40";"O=C(Nc1cnccc1-c1ccc(F)cc1)c1ccnc(Nc2ccc(F)cc2)n1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"11.82";"0.22";"-0.04";"5.98";"0";"CHEMBL5343418";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338804";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"17.0"
"CHEMBL2107823";"GANDOTINIB";"2.0";"469.95";"0";"4.03";"34";"Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.65";"0.30";"3.33";"8.82";"0";"CHEMBL5245517";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"44.0"
"CHEMBL1909393";"GW583373A";"None";"595.55";"2";"6.43";"GW583373A";"Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1";"Inhibition";"'='";"-1.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.17"
"CHEMBL1076310";"";"None";"626.79";"None";"None";"1";"CCOC(=O)C[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)O[C@@H]1CNC(=O)NC";"Inhibition";"'='";"31.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1937143";"Inhibition of TYK2 at 10 uM after 1 hr by competitive binding assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1933013";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";"";"";"31.0"
"CHEMBL372474";"GW678313X";"None";"452.51";"1";"5.69";"GW678313X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1";"Inhibition";"'='";"1.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.31"
"CHEMBL186213";"GW827105X";"None";"462.44";"1";"5.62";"GW827105X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1";"Inhibition";"'='";"-0.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.27"
"CHEMBL218932";"GW432441X";"None";"339.40";"0";"2.95";"GW432441X";"CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1";"Inhibition";"'='";"-4.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.14"
"CHEMBL1938658";"";"None";"515.71";"1";"3.84";"24";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCCCC4)c3s2)cc1";"IC50";"'='";"2670.0";"nM";"5.57";"";"";"UO_0000065";"10.81";"0.22";"1.73";"4.75";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"2.67"
"CHEMBL255863";"NILOTINIB";"4.0";"529.53";"2";"6.36";"Nilotinib";"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1966703";"";"None";"325.39";"0";"4.06";"SID103905100";"Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4290750";"";"None";"372.38";"0";"2.59";"Yfq73";"CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1";"Inhibition";"'='";"-1.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4267277";"Inhibition of human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265907";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"-1.4"
"CHEMBL5423944";"";"None";"412.93";"0";"3.44";"37b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(Cl)cn2)[C@@H](C)C1";"IC50";"'='";"9.32";"nM";"8.03";"";"";"UO_0000065";"19.45";"0.38";"4.59";"9.34";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"9.32"
"CHEMBL539474";"";"None";"281.31";"0";"1.90";"SID103904913";"O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002992";"";"None";"286.38";"0";"2.66";"SID103905614";"CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969156";"";"None";"210.24";"0";"1.98";"SID103905329";"Nc1nccc2cnc(-c3ccccc3)n12";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL363648";"TAK-715";"2.0";"399.52";"1";"6.00";"SID103905024";"CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973098";"";"None";"267.33";"0";"1.89";"SID103905205";"COc1cc(C=C2SC(=S)NC2=O)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5419098";"";"None";"574.69";"1";"4.57";"54";"CCN(CC)c1nc2ccc(-c3nc(Nc4ccc(C(=O)N5CCN(C(=O)C6CC6)CC5)cn4)ncc3F)cc2s1";"Inhibition";"'='";"-5.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5378225";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375975";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 1.0 microM";"";"";"-5.49"
"CHEMBL5405178";"";"None";"400.42";"0";"0.74";"2a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(C)=O)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"24.41";"0.46";"8.96";"6.52";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.2"
"CHEMBL5437122";"";"None";"449.49";"1";"2.23";"2k";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(C)ccn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.05";"nM";"10.30";"";"";"UO_0000065";"23.07";"0.43";"8.07";"7.12";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.05"
"CHEMBL4632980";"";"None";"256.31";"0";"2.48";"19";"Cc1[nH]nc2[nH]c(=O)c(C#N)c(C3CCCCC3)c12";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"19.35";"0.36";"2.48";"5.81";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"11.0"
"CHEMBL5416999";"";"None";"389.46";"0";"4.50";"2";"COc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"17.15";"0.31";"2.18";"10.20";"0";"CHEMBL5380357";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5376015";"1";"Scientific Literature";"RSC Med Chem";"2024";"None";"";"INHIBITOR";"";"0.21"
"CHEMBL3648440";"";"None";"362.43";"0";"2.69";"BDBM107149";"O=C(CN1CCC(O)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226459";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL2178257";"";"None";"354.76";"0";"2.87";"BDBM50399031";"Nc1ccn2ncc(C(=O)Nc3conc3-c3cccc(Cl)c3)c2n1";"Ki";"'='";"36.1";"nM";"7.44";"";"241649";"UO_0000065";"20.98";"0.41";"4.57";"6.68";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"36.1"
"CHEMBL5419978";"";"None";"426.55";"0";"3.55";"A12";"Cc1cnc(Nc2ccc(CNS(=O)(=O)C3CC3)cc2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"204.0";"nM";"6.69";"";"";"UO_0000065";"15.68";"0.30";"3.14";"6.57";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"204.0"
"CHEMBL4740889";"";"None";"334.38";"0";"3.14";"13";"C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(C)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4763424";"";"None";"378.44";"0";"3.24";"15";"C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4762354";"";"None";"390.41";"0";"1.59";"23";"Cn1cc(Nc2cc(-c3cccc(NC(=O)CNC(=O)CC#N)c3)ncn2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4750184";"";"None";"415.50";"0";"4.24";"38";"C/C=C/C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4647223";"";"None";"401.45";"0";"0.90";"12";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(CCO)c4)ncc3F)C[C@]12NC(=O)C1CC1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"18.04";"0.34";"6.34";"6.70";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"57.0"
"CHEMBL4439617";"";"None";"468.49";"0";"2.50";"27";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NCCO)c1OC";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"14.02";"0.26";"4.07";"4.78";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"270.0"
"CHEMBL5439751";"";"None";"464.57";"0";"3.29";"91-4";"CO[C@@]1(c2cc(C)cc(-n3cc(C4CCN(C)CC4)c4cnc(NC(N)=O)cc43)n2)CCOC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383685";"Inhibition of TYK2 JH1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL5440463";"";"None";"434.50";"0";"2.67";"70-4";"CNc1cc(-c2cn(C(C)C)c3nnccc23)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL5396254";"";"None";"460.53";"0";"4.23";"87-3";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383668";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IL-2 induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"100.0"
"CHEMBL5419994";"";"None";"463.54";"0";"3.71";"Example 34";"COC1CC(Oc2cc(C3CCOC3)nc(-n3nc(C4CC4)c4cnc(NC(C)=O)cc43)c2)C1";"IC50";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5346250";"Inhibition of human TYK2 JH2 domain (575 to 876 residues) incubated for 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5344452";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME = 1.0 hr";"INHIBITOR";"";"10.0"
"CHEMBL5419281";"";"None";"464.49";"1";"1.87";"39";"CNc1cc(Nc2cccn(-c3ocnc3C)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"18.83";"0.35";"6.87";"6.22";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.8"
"CHEMBL5270922";"";"None";"595.07";"1";"4.36";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)c(Cl)c2)c1OC";"Tm";"'='";"65.55";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"65.55"
"CHEMBL5278999";"";"None";"529.58";"1";"3.37";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3cccn3)cc2)c1OC";"Tm";"'='";"61.08";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"61.08"
"CHEMBL5282377";"";"None";"558.62";"1";"3.47";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(CC)n3)cc2)c1OC";"Tm";"'='";"58.19";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"58.19"
"CHEMBL5273814";"";"None";"569.64";"1";"4.50";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"IC50";"'='";"0.81";"nM";"9.09";"";"";"UO_0000065";"16.05";"0.30";"4.59";"6.04";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"0.81"
"CHEMBL5282623";"";"None";"587.63";"1";"4.64";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.39";"0.29";"4.36";"5.98";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL1516890";"GW441756X";"None";"275.31";"0";"3.07";"GW441756X";"Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21";"Inhibition";"'='";"-0.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.05"
"CHEMBL4434711";"";"None";"473.54";"0";"2.79";"6d";"CNc1cc(Nc2cccn(-c3ccc(C(C)(C)O)cc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"21.44";"0.40";"7.36";"8.09";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.07"
"CHEMBL4442827";"";"None";"449.45";"0";"1.60";"6t";"CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"16.02";"0.30";"5.60";"5.49";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"63.0"
"CHEMBL3639444";"";"None";"275.31";"0";"3.42";"BDBM107137";"C=CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226447";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL3114774";"";"None";"457.47";"0";"3.67";"8d";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCNc2ccnc(F)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL3114769";"";"None";"427.46";"0";"3.31";"7d";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCCn2ccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL3114766";"";"None";"427.46";"0";"3.31";"7a";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCCn2ccnc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL4077123";"";"None";"647.78";"2";"6.25";"9; CHMFL-BTK-01";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"Activity";"'='";"86.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4025428";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"86.0"
"CHEMBL1909362";"GW830900A";"None";"534.09";"0";"3.22";"GW830900A";"CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl";"Inhibition";"'='";"-2.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.14"
"CHEMBL1909390";"GW576609A";"None";"691.10";"2";"6.57";"GW576609A";"O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1";"Inhibition";"'='";"-4.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.3"
"CHEMBL1909393";"GW583373A";"None";"595.55";"2";"6.43";"GW583373A";"Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1";"Inhibition";"'='";"-0.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.57"
"CHEMBL1909399";"GW352430A";"None";"457.94";"0";"2.28";"GW352430A";"Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1";"Inhibition";"'='";"-0.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.26"
"CHEMBL1794055";"GW589933X";"None";"372.43";"0";"2.35";"GW589933X";"NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1";"Inhibition";"'='";"11.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"11.03"
"CHEMBL352222";"";"None";"394.17";"0";"3.09";"SB-358518";"O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1";"Inhibition";"'='";"2.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.74"
"CHEMBL95502";"";"None";"394.50";"0";"4.21";"SB-221466";"CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1";"Inhibition";"'='";"0.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.03"
"CHEMBL188268";"";"None";"307.32";"0";"1.51";"SB-750140";"NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1";"Inhibition";"'='";"-7.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.21"
"CHEMBL2387126";"";"None";"416.27";"0";"4.38";"21";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(-c2cn[nH]c2)cc1Cl";"EC50";"'='";"198.0";"nM";"6.70";"";"";"UO_0000065";"16.10";"0.33";"2.32";"6.72";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"198.0"
"CHEMBL2387111";"";"None";"443.31";"0";"3.36";"6";"CS(=O)(=O)Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"13.5";"nM";"7.87";"";"";"UO_0000065";"17.75";"0.38";"4.51";"6.71";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"13.5"
"CHEMBL231013";"GSK-605714A";"None";"228.25";"0";"1.86";"GSK605714A";"COc1ccc(-c2ccncc2)cc1C(N)=O";"Inhibition";"'='";"-2.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.48"
"CHEMBL212250";"GW615311X";"None";"644.12";"2";"8.00";"GW615311X";"O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1";"Inhibition";"'='";"-0.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.44"
"CHEMBL574738";"AST-487";"1.0";"529.57";"2";"5.11";"AST-487";"CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1";"Kd";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"10.72";"0.20";"0.57";"6.00";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"2100.0"
"CHEMBL2387114";"";"None";"380.23";"0";"3.48";"9";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(CO)cc1Cl";"Ki";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"21.74";"0.45";"4.79";"9.05";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5.4"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"19.87";"0.37";"4.67";"6.98";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"620.0"
"CHEMBL603469";"LESTAURTINIB";"3.0";"439.47";"0";"3.47";"CEP-701";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.80";"0.32";"4.35";"8.83";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"15.0"
"CHEMBL1987910";"";"None";"428.44";"1";"6.21";"SID103904327";"Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5192374";"";"None";"457.43";"0";"4.64";"24";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCC(F)(F)CC4)cn3)c21";"Ki";"'='";"0.081";"nM";"10.09";"";"";"UO_0000065";"22.06";"0.42";"5.45";"14.39";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.081"
"CHEMBL289959";"";"None";"221.26";"0";"3.37";"SID103905123";"c1ccc(Nc2ncnc3ccccc23)cc1";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL1977681";"";"None";"275.31";"0";"2.79";"SID103904940";"CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989518";"";"None";"241.29";"0";"1.98";"SID103904971";"NCCOc1cncc(C=Cc2ccncc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL504950";"";"None";"230.30";"0";"2.44";"SID103905425";"Cc1cc(C)c2c(n1)sc1c(N)ncnc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988608";"";"None";"375.39";"0";"2.47";"SID103904658";"CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971186";"";"None";"378.41";"0";"3.35";"SID103904414";"Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997340";"";"None";"312.33";"0";"1.81";"SID103904524";"O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL210887";"";"None";"340.34";"0";"2.58";"SID103905079";"O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1888586";"";"None";"353.40";"0";"3.20";"SB-223133";"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1";"Inhibition";"'='";"0.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.09"
"CHEMBL365663";"GW780159X";"None";"338.82";"0";"4.66";"GW780159X";"Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1";"Inhibition";"'='";"-0.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.72"
"CHEMBL479079";"GW612286X";"None";"406.45";"0";"4.17";"GW612286X";"COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC";"Inhibition";"'='";"-1.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.55"
"CHEMBL319556";"";"None";"488.37";"1";"6.77";"14b";"O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL819923";"Inhibition of Tyrosine kinase 2 kinase, tyk-2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136271";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";"";"10.0"
"CHEMBL2004871";"";"None";"297.33";"0";"3.13";"SID103905252";"OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004872";"";"None";"333.39";"0";"3.64";"SID103905121";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3670395";"";"None";"377.45";"0";"2.22";"BDBM116317";"O=C(NC1CCOCC1)c1cnn2ccc(NC3Cc4ccccc4C3)nc12";"Ki";"'='";"152.0";"nM";"6.82";"";"241651";"UO_0000065";"18.06";"0.33";"4.60";"8.46";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"152.0"
"CHEMBL1785002";"";"None";"472.52";"0";"3.89";"SB-264865";"NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"-1.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.14"
"CHEMBL4564337";"";"None";"358.20";"0";"4.59";"3";"COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br";"Kd";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"16.04";"0.36";"1.15";"8.59";"0";"CHEMBL4338246";"Binding affinity to wild-type human partial length TYK2 JH2 domain-pseudokinase expressed in mammalian expression system by active-site directed competition binding assay based Kinomescan method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334516";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"1.8"
"CHEMBL1909368";"GW683134A";"None";"575.91";"2";"7.00";"GW683134A";"Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F";"Inhibition";"'='";"1.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.41"
"CHEMBL4065419";"";"None";"414.30";"0";"4.84";"28";"Cc1nc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)cc(N(C)C)n1";"EC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";""
"CHEMBL4289875";"";"None";"340.36";"0";"2.59";"12";"Cc1cc(F)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"22.39";"0.42";"5.03";"7.83";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.024"
"CHEMBL4278757";"";"None";"412.49";"0";"1.85";"25";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(CO)CO)cnc12";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"18.97";"0.36";"5.97";"6.32";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.015"
"CHEMBL3114768";"";"None";"413.44";"0";"2.92";"7c";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCn2ccnc2)cc1";"IC50";"'='";"7368.0";"nM";"5.13";"";"";"UO_0000065";"12.41";"0.23";"2.21";"5.08";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"7368.0"
"CHEMBL5076717";"";"None";"327.39";"0";"1.06";"11";"Cn1cc(Nc2nccc(N3CCC4(CCNC4=O)CC3)n2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"";"";"1000.0"
"CHEMBL5088678";"";"None";"355.42";"0";"2.77";"37";"Cc1cnc(Nc2ccc(F)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"19.77";"0.37";"4.26";"10.02";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"94.0"
"CHEMBL5094671";"";"None";"405.42";"0";"3.65";"39";"Cc1cnc(Nc2ccc(C(F)(F)F)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"17.52";"0.33";"3.45";"10.12";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"79.0"
"CHEMBL5078526";"";"None";"422.53";"0";"2.47";"50";"Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.66";"0.35";"5.42";"9.54";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL4294002";"";"None";"476.46";"0";"3.92";"19b";"COc1cc2c(=O)n([C@@H](C(=O)NCC(F)(F)F)C(C)C)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"1163.5";"nM";"5.93";"";"";"UO_0000065";"12.45";"0.24";"2.01";"6.04";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1163.5"
"CHEMBL271843";"GW275944X";"None";"330.37";"0";"1.41";"GW275944X";"Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"1.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.67"
"CHEMBL5086265";"";"None";"478.60";"0";"2.98";"56";"Cc1cnc(Nc2ccc(N3CCC4(CC3)OCCO4)cc2)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"2.0"
"CHEMBL450071";"GSK-1392956A";"None";"592.68";"2";"3.21";"GSK1392956A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1";"Inhibition";"'='";"-4.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.74"
"CHEMBL5087006";"";"None";"467.56";"0";"3.11";"16";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(NC(=O)N4CCCC4)c3)n2)cc1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"16.00";"0.31";"4.37";"5.26";"0";"CHEMBL5046599";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"33.0"
"CHEMBL373073";"GW642138X";"None";"241.25";"0";"2.48";"GW642138X";"COc1ccc(-c2cc3c(N)ncnc3o2)cc1";"Inhibition";"'='";"-0.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.95"
"CHEMBL269450";"";"None";"433.46";"1";"5.00";"SB-242717";"Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-3.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.11"
"CHEMBL269827";"GW276655X";"None";"383.39";"0";"1.76";"GW276655X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1";"Inhibition";"'='";"9.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"9.13"
"CHEMBL3589167";"";"None";"468.34";"0";"4.87";"4";"NC(=O)c1cc(-c2ccc(Cl)cc2Cl)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.80";"0.32";"2.53";"8.37";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"40.0"
"CHEMBL3589178";"";"None";"443.50";"0";"4.46";"15";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(NC(=O)C5CCOCC5)ccc4c3c2)c1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"15.92";"0.29";"2.60";"6.63";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"87.0"
"CHEMBL3589325";"";"None";"384.48";"0";"3.84";"17";"CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccccc4)cc23)CC1";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"18.59";"0.34";"3.31";"10.94";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"71.0"
"CHEMBL5190418";"";"None";"578.62";"1";"3.56";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)c(F)c2)c1OC";"Tm";"'='";"60.91";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"60.91"
"CHEMBL5191508";"";"None";"578.64";"1";"3.02";"30";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Kd";"'<'";"0.017";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5131243";"Binding affinity to T7-tagged TYK2 JH2 (unknown origin) expressed in Escherichia coli BL21 cells incubated for 1 hr by qPCR analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.017"
"CHEMBL4066236";"";"None";"373.46";"0";"3.88";"18";"CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(C)CC4)n[nH]c2c1";"IC50";"'='";"20.1";"nM";"7.70";"";"";"UO_0000065";"20.61";"0.38";"3.82";"9.52";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"20.1"
"CHEMBL522892";"DOVITINIB";"3.0";"392.44";"0";"2.54";"CHIR-258/TKI-258";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Kd";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"14.42";"0.27";"3.12";"6.02";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"2200.0"
"CHEMBL939";"GEFITINIB";"4.0";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3628627";"";"None";"684.77";"3";"5.33";"4";"CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1";"Inhibition";"'='";"54.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631616";"Inhibition of TYK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627608";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";"";"54.82"
"CHEMBL385426";"GW450241X";"None";"294.40";"0";"3.74";"GW450241X";"CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1";"Inhibition";"'='";"-7.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.46"
"CHEMBL4577224";"";"None";"452.49";"0";"3.48";"25";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)N(C)C)c1OC";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"13.54";"0.25";"2.64";"5.65";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"750.0"
"CHEMBL4527672";"";"None";"478.53";"0";"3.92";"26";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NCC2CC2)c1OC";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"12.66";"0.24";"2.14";"5.17";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"870.0"
"CHEMBL4580625";"";"None";"459.51";"0";"3.14";"41";"CNC(=O)c1cnc(Nc2cc(C)nc(C)n2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"16.80";"0.31";"4.58";"5.86";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"19.0"
"CHEMBL1909365";"GW607049C";"None";"617.56";"2";"6.69";"GW607049C";"COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O";"Inhibition";"'='";"-0.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.72"
"CHEMBL5179489";"";"None";"512.57";"1";"2.35";"7";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2csc(C(N)=O)c2)c1OC";"Tm";"'='";"53.74";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"53.74"
"CHEMBL379093";"GW651576X";"None";"429.88";"1";"5.99";"GW651576X";"Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1";"Inhibition";"'='";"-4.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.7"
"CHEMBL479079";"GW612286X";"None";"406.45";"0";"4.17";"GW612286X";"COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC";"Inhibition";"'='";"33.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"33.27"
"CHEMBL1909345";"";"None";"422.87";"0";"2.97";"SB-686709-A";"CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl";"Inhibition";"'='";"-3.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.82"
"CHEMBL1909382";"GW759710A";"None";"359.79";"0";"3.20";"GW759710A";"Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1";"Inhibition";"'='";"32.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"32.36"
"CHEMBL196022";"GW642125X";"None";"241.25";"0";"2.48";"GW642125X";"COc1ccc(-c2coc3ncnc(N)c23)cc1";"Inhibition";"'='";"-3.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.01"
"CHEMBL66004";"GW578748X";"None";"284.28";"0";"1.51";"GW578748X";"COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O";"Inhibition";"'='";"-2.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.44"
"CHEMBL518953";"GSK-1023156A";"None";"428.31";"0";"4.53";"GSK1023156A";"NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br";"Inhibition";"'='";"-1.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.33"
"CHEMBL480371";"GW853609X";"None";"496.31";"1";"5.55";"GW853609X";"NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br";"Inhibition";"'='";"-3.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.05"
"CHEMBL4643061";"";"None";"282.35";"0";"2.60";"40";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4C[C@@H]3C[C@@H]4CC#N)c12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"27.27";"0.50";"5.10";"9.02";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.02"
"CHEMBL381948";"GW680975X";"None";"316.34";"0";"4.34";"GW680975X";"Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1";"Inhibition";"'='";"-4.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.52"
"CHEMBL207410";"GW772405X";"None";"486.93";"1";"5.35";"GW772405X";"CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1";"Inhibition";"'='";"0.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.07"
"CHEMBL218088";"GW435821X";"None";"268.32";"0";"2.67";"GW435821X";"Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1";"Inhibition";"'='";"-2.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.57"
"CHEMBL1516890";"GW441756X";"None";"275.31";"0";"3.07";"SID103905238";"Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2003817";"";"None";"333.27";"0";"3.69";"SID103904890";"O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005631";"";"None";"449.51";"0";"5.00";"SID103904310";"CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4079206";"";"None";"462.33";"0";"4.46";"11d";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(/C=C/c4c(Cl)cccc4Cl)oc23)[C@H](O)C1";"Inhibition";"'>'";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4048342";"Inhibition of partial length wild type human Tyk2 expressed in mammalian expression system at 0.5 uM by KINOMEscan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043283";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"98.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"EC50";"'<'";"5.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5132031";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131378";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"5.0"
"CHEMBL1966514";"";"None";"444.49";"1";"6.59";"SID103904285";"Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996208";"";"None";"316.37";"0";"0.62";"SID103905498";"NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1";"Ki";"'='";"1584.89";"nM";"5.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL1995592";"";"None";"367.80";"0";"2.77";"SID103905641";"Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL451964";"";"None";"319.29";"0";"3.38";"SID103905360";"FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004934";"";"None";"350.39";"0";"4.39";"SID103904558";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2003482";"";"None";"275.74";"0";"2.73";"SID103905510";"O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1964644";"";"None";"278.29";"0";"2.37";"SID103905106";"O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969301";"";"None";"457.58";"1";"5.50";"SID103905076";"CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996979";"";"None";"349.34";"0";"4.76";"SID103904196";"O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969561";"";"None";"374.45";"0";"3.35";"SID103904515";"CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1795071";"RUXOLITINIB PHOSPHATE";"4.0";"404.37";"0";"3.47";"GLPG0634";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"22.64";"0.41";"3.47";"8.34";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"116.0"
"CHEMBL1240703";"CGP-52421";"None";"586.65";"2";"5.40";"CGP-52421";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL5077126";"";"None";"395.48";"0";"3.79";"51b";"CCc1cc(O)c(F)cc1-c1cc(NC2CCN(C)CC2)c2nc(N)ncc2c1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"17.19";"0.32";"3.01";"7.79";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.8"
"CHEMBL379093";"GW651576X";"None";"429.88";"1";"5.99";"GW651576X";"Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1";"Inhibition";"'='";"-1.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.45"
"CHEMBL1964937";"";"None";"362.43";"0";"3.10";"SID103904206";"O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005528";"";"None";"258.28";"0";"1.63";"SID103905407";"CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991678";"";"None";"424.46";"0";"3.87";"SID103904779";"Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL394790";"";"None";"394.89";"1";"5.84";"SID103904359";"Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3261517";"";"None";"361.81";"0";"2.61";"77";"COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1";"Inhibition";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3266945";"Inhibition of JH1 catalytic domain of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259739";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";"";"94.0"
"CHEMBL1980489";"";"None";"313.74";"0";"2.69";"SID103904952";"O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970903";"";"None";"397.48";"0";"4.36";"SID103904484";"Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL526901";"";"None";"277.33";"0";"3.65";"15";"CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL1994538";"";"None";"333.27";"0";"3.69";"SID103904888";"O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974328";"";"None";"340.43";"0";"2.31";"SID103904806";"Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL474432";"";"None";"478.45";"1";"5.40";"SID103905428";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC";"Ki";"'>'";"1258.93";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL1980802";"";"None";"391.77";"0";"1.14";"SID103905156";"N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002726";"";"None";"358.45";"0";"3.88";"SID103904468";"Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL535";"SUNITINIB";"4.0";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"14.54";"0.27";"2.47";"7.50";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"1600.0"
"CHEMBL2002407";"";"None";"281.28";"0";"1.64";"SID103905206";"COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O";"Ki";"'='";"794.33";"nM";"6.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.1"
"CHEMBL1991395";"";"None";"392.44";"0";"3.42";"SID103904759";"CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2003638";"";"None";"412.43";"0";"4.26";"SID103904514";"O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL259922";"";"None";"411.43";"0";"4.11";"SID103905455";"Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965570";"";"None";"444.49";"1";"6.59";"SID103904286";"Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2007592";"";"None";"322.39";"0";"3.18";"SID103904978";"O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1984633";"";"None";"339.42";"0";"3.70";"SID103904908";"COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990482";"";"None";"238.25";"0";"1.72";"SID103904688";"NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990904";"";"None";"360.40";"0";"3.81";"SID103904763";"Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL183844";"";"None";"371.44";"0";"4.86";"SID103904360";"Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL220057";"";"None";"357.42";"0";"4.76";"SID103904333";"Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Ki";"'>'";"1258.93";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL211378";"";"None";"360.38";"0";"3.82";"SID103904365";"Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2007002";"";"None";"359.39";"0";"4.20";"SID103904737";"COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1084546";"PF-00562271";"1.0";"507.50";"1";"3.14";"SID103905684";"CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL1992740";"";"None";"429.48";"0";"2.65";"SID103905384";"CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1985095";"";"None";"439.50";"0";"3.92";"SID103904962";"NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1998829";"";"None";"347.81";"1";"5.14";"SID103904213";"O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4075131";"";"None";"361.23";"0";"4.29";"7";"Cn1c(-c2c(Cl)cccc2Cl)nc2c(NC(=O)C3CC3)nccc21";"Ki";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.83";"0.45";"3.60";"13.19";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.013"
"CHEMBL5075360";"";"None";"437.55";"0";"3.57";"17";"O=C(NCCCNc1ccnc(Nc2cccc(NC(=O)N3CCCC3)c2)n1)C1CCC1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"14.04";"0.26";"2.57";"5.52";"0";"CHEMBL5046599";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"720.0"
"CHEMBL5082741";"";"None";"399.46";"0";"1.24";"16";"CCOC(=O)c1cnc(Nc2cnn(C)c2)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"84.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"84.0"
"CHEMBL5182426";"";"None";"506.54";"1";"2.29";"5";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(N)=O)cc2)c1OC";"Tm";"'='";"56.98";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"56.98"
"CHEMBL5194842";"";"None";"578.67";"1";"3.34";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCSC3)cc2)c1OC";"Tm";"'='";"65.12";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"65.12"
"CHEMBL5204171";"";"None";"518.55";"1";"2.43";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CNC3=O)c1OC";"Tm";"'='";"57.95";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"57.95"
"CHEMBL5196735";"";"None";"560.63";"1";"3.43";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"60.22";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"60.22"
"CHEMBL5188967";"";"None";"574.66";"1";"3.86";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NC3CCCC3)cc2)c1OC";"Tm";"'='";"56.04";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"56.04"
"CHEMBL5191508";"";"None";"578.64";"1";"3.02";"30";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Tm";"'='";"58.38";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"58.38"
"CHEMBL5184123";"";"None";"518.55";"1";"2.43";"25";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2cccc3c2C(=O)NC3)c1OC";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"13.92";"0.26";"4.74";"4.39";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"67.0"
"CHEMBL4787731";"";"None";"393.49";"0";"3.14";"31l";"COc1cccc(CN2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)C[C@H]2C)c1";"IC50";"'='";"157.0";"nM";"6.80";"";"";"UO_0000065";"17.29";"0.32";"3.66";"7.07";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"157.0"
"CHEMBL4761365";"";"None";"411.94";"0";"4.04";"31g";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1";"GI50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"";"";"10.0"
"CHEMBL4748740";"";"None";"481.58";"1";"3.87";"1; IACS-9439";"COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4729087";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system at 1 uM by Kinomescan method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725356";"1";"Scientific Literature";"J Med Chem";"2020";"None";"Dose = 1.0 microM";"";"";""
"CHEMBL4633028";"";"None";"314.39";"0";"2.11";"24";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)C4CC4)CC3)c12";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"17.66";"0.33";"3.44";"6.13";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"2.8"
"CHEMBL1682552";"";"None";"332.41";"0";"4.02";"SID103904509";"c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999749";"";"None";"544.66";"2";"6.51";"SID103905566";"COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006715";"";"None";"607.65";"2";"6.92";"SID103904419";"O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1682545";"";"None";"292.37";"0";"4.43";"SID103904520";"c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987143";"";"None";"210.24";"0";"1.98";"SID103905374";"Nc1nnc2ccc(-c3ccccc3)cn12";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL2005375";"";"None";"506.65";"1";"4.80";"SID103904641";"CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2007064";"";"None";"310.35";"0";"3.14";"SID103905113";"Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1968151";"";"None";"269.29";"0";"1.69";"SID103904980";"O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994938";"";"None";"482.41";"0";"4.72";"SID103904796";"Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1090356";"";"None";"587.71";"2";"6.28";"SID103904417";"O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1986328";"";"None";"348.36";"0";"4.24";"SID103905269";"CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1375640";"";"None";"332.82";"0";"3.72";"SID103905409";"Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969264";"";"None";"318.38";"0";"3.79";"SID103905515";"CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991138";"";"None";"453.59";"1";"5.15";"SID103905464";"Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989029";"";"None";"269.30";"0";"2.42";"SID103905114";"CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1980144";"";"None";"418.48";"0";"4.48";"SID103904705";"Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1976220";"";"None";"439.34";"1";"5.95";"SID103904362";"Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1986597";"";"None";"505.56";"1";"2.60";"SID103904690";"NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975500";"";"None";"460.49";"0";"3.24";"SID103904712";"COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1090360";"";"None";"587.71";"2";"6.28";"SID103904420";"O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL2003271";"";"None";"399.69";"1";"5.21";"SID103904677";"NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988300";"";"None";"383.48";"1";"5.17";"SID103905092";"Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000271";"";"None";"372.47";"0";"4.13";"SID103904470";"Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969502";"";"None";"344.37";"0";"2.99";"SID103905055";"O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL1682553";"";"None";"292.35";"0";"3.09";"SID103904510";"CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991434";"";"None";"388.22";"0";"3.81";"SID103905415";"COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4521305";"";"None";"445.57";"0";"3.93";"13e'";"CCC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL1999321";"";"None";"385.42";"0";"3.87";"SID103905268";"O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988153";"";"None";"377.35";"1";"5.47";"SID103905370";"Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999556";"";"None";"254.31";"0";"3.06";"SID103905041";"NC(=O)c1cc2c(-c3ccccc3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004438";"";"None";"423.40";"1";"5.54";"SID103904371";"Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL249282";"";"None";"387.44";"0";"2.63";"SID103904817";"N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1976134";"";"None";"234.26";"0";"3.11";"SID103905212";"c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1998611";"";"None";"305.58";"0";"3.00";"SID103905308";"NC(=O)c1sc2c(Br)ccc(Cl)c2c1N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1998545";"";"None";"332.40";"0";"3.08";"SID103904581";"O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970879";"";"None";"621.75";"1";"4.48";"SID103905316";"COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"11.81";"0.21";"1.16";"7.93";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"3100.0"
"CHEMBL4783938";"";"None";"411.94";"0";"4.04";"38a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(Cl)cc2)[C@@H](C)C1";"IC50";"'='";"8.17";"nM";"8.09";"";"";"UO_0000065";"19.63";"0.38";"4.05";"11.07";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"8.17"
"CHEMBL4750196";"";"None";"598.99";"2";"5.57";"6g";"O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F";"Activity";"'='";"99.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4720856";"Inhibition of human TYK2 assessed as residual activity using KKSRGDYMTMQIG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"Dose = 1.0 microM";"";"";"99.99"
"CHEMBL4742766";"";"None";"411.48";"0";"2.96";"32b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@H]1F";"IC50";"'='";"696.0";"nM";"6.16";"";"";"UO_0000065";"14.96";"0.28";"3.20";"7.48";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"696.0"
"CHEMBL4747742";"";"None";"411.48";"0";"2.96";"32c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@@H]1F";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.86";"0.32";"3.98";"8.43";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"116.0"
"CHEMBL4761611";"";"None";"413.49";"0";"2.33";"13";"Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CC5CC5)C4)c3)n2)cn1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"17.89";"0.33";"5.07";"7.97";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"40.0"
"CHEMBL4782355";"";"None";"403.45";"0";"0.91";"15";"Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CCO)C4)c3)n2)cn1";"IC50";"'='";"189.0";"nM";"6.72";"";"";"UO_0000065";"16.67";"0.31";"5.81";"5.95";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"189.0"
"CHEMBL4781973";"";"None";"397.45";"0";"2.93";"20, trans isomer";"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](CC#N)C4)c3)n2)cn1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"19.17";"0.35";"4.69";"6.72";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"24.0"
"CHEMBL4795231";"";"None";"493.54";"0";"2.10";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(=O)N(C)C)cn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL2420846";"";"None";"247.69";"0";"2.57";"9";"Nc1cccc(Cl)c1C(=O)Nc1ccncc1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL4283724";"";"None";"314.39";"0";"2.15";"13";"NC(=O)c1cnc2c(NC3CC3)cc(NC3CCCCC3)nn12";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"17.39";"0.32";"3.32";"5.62";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"3.4"
"CHEMBL4285841";"";"None";"380.41";"0";"2.18";"26";"CNc1cc(Nc2cccc3c2OCCO3)nn2c(C(=O)NC3CC3)cnc12";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.03";"0.39";"5.82";"7.86";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.01"
"CHEMBL4279883";"";"None";"436.42";"0";"1.27";"29";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.57";"0.30";"5.53";"5.11";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.16"
"CHEMBL2386635";"";"None";"323.40";"0";"3.61";"33";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1";"Ki";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"29.06";"0.53";"5.79";"10.38";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"0.4"
"CHEMBL1822054";"";"None";"460.88";"0";"3.34";"10";"CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1";"Activity";"'='";"87.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1827253";"Activity of TYK2(JH1domain-catalytic) kinase at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821651";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"87.0"
"CHEMBL4125719";"";"None";"382.43";"1";"5.11";"27";"N#CC(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"20.54";"0.37";"2.74";"7.33";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"14.0"
"CHEMBL3667526";"";"None";"397.48";"0";"2.33";"BDBM153674";"CC1CCCCN1c1nn(CC(C)(C)O)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"410.0";"nM";"6.39";"";"295018";"UO_0000065";"16.07";"0.30";"4.06";"6.35";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"410.0"
"CHEMBL4084436";"";"None";"372.22";"0";"4.05";"17";"Nc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"EC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"17.69";"0.36";"2.54";"6.25";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.26"
"CHEMBL1909378";"";"None";"420.86";"0";"3.63";"SB-431542-A";"Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1";"Inhibition";"'='";"-0.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.31"
"CHEMBL4446338";"";"None";"531.62";"2";"5.68";"THZ-P1-2";"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3cc(-c4c[nH]c5ccccc45)ncn3)c2)cc1";"Activity";"'='";"0.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4345231";"Inhibition of human TYK2 expressed in mammalian expression system assessed as enzyme activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342488";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";"";"0.9"
"CHEMBL1794061";"GW627834A";"None";"297.74";"0";"3.96";"GW627834A";"Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1";"Inhibition";"'='";"-1.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.92"
"CHEMBL1721885";"SU-014813";"2.0";"442.49";"0";"1.69";"SU-14813";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1";"Kd";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"13.83";"0.26";"4.43";"5.74";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"760.0"
"CHEMBL1794072";"";"None";"490.00";"1";"5.74";"SB-682330-A";"CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl";"Inhibition";"'='";"0.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.1"
"CHEMBL477979";"GW785974X";"None";"350.46";"0";"3.94";"GW785974X";"Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"1.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.94"
"CHEMBL4648104";"";"None";"469.23";"None";"None";"14i";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OCC4)ncc2C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL3298400";"";"None";"345.47";"0";"3.05";"1";"CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3300852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297733";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL4749364";"";"None";"401.47";"0";"3.85";"10";"C=CC(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4746272";"";"None";"401.47";"0";"3.85";"12";"C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"IC50";"'='";"2783.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"2783.0"
"CHEMBL4741588";"";"None";"377.41";"0";"2.58";"16";"COCCn1cc(Nc2cc(-c3cccc(NC(=O)CC#N)c3)ncn2)cn1";"IC50";"'='";"2264.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"2264.0"
"CHEMBL4754061";"";"None";"391.44";"0";"2.34";"20";"C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CC(=O)NC)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4739907";"";"None";"363.38";"0";"1.93";"22";"N#CCC(=O)Nc1cccc(-c2cc(Nc3cnn(CCO)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4758931";"";"None";"435.49";"0";"2.36";"25";"C/C=C/C(=O)NCC(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4796925";"";"None";"378.40";"0";"2.19";"14l; YD57";"C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1";"IC50";"'='";"1689.0";"nM";"5.77";"";"";"UO_0000065";"15.25";"0.28";"3.58";"4.72";"0";"CHEMBL4686942";"Inhibition of human recombinant TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680251";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1689.0"
"CHEMBL1909345";"";"None";"422.87";"0";"2.97";"SB-686709-A";"CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl";"Inhibition";"'='";"3.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.04"
"CHEMBL482326";"GSK-1030062A";"None";"505.52";"2";"5.40";"GSK1030062A";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC";"Inhibition";"'='";"1.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.47"
"CHEMBL1794057";"GW284408X";"None";"292.30";"0";"2.26";"GW284408X";"O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1";"Inhibition";"'='";"18.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"18.73"
"CHEMBL1794067";"GSK-978744A";"None";"487.97";"0";"3.71";"GSK978744A";"C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl";"Inhibition";"'='";"3.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.13"
"CHEMBL156987";"";"None";"377.18";"0";"3.17";"SB-409513";"O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1";"Inhibition";"'='";"-0.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.74"
"CHEMBL103115";"GW831091X";"None";"348.36";"0";"2.31";"GW831091X";"NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1";"Inhibition";"'='";"5.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.71"
"CHEMBL156263";"";"None";"294.31";"0";"2.17";"SB-376719";"COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O";"Inhibition";"'='";"-2.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.23"
"CHEMBL3645550";"";"None";"311.77";"0";"3.86";"BDBM107136";"CC(Cl)C(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226446";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL485556";"";"None";"472.55";"0";"3.58";"SID103905075";"CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971245";"";"None";"428.50";"0";"2.39";"SID103904422";"CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987648";"";"None";"406.47";"0";"3.73";"SID103904778";"Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1998585";"";"None";"447.42";"1";"5.74";"SID103904277";"Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972125";"";"None";"462.55";"0";"4.99";"SID103904473";"Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973145";"";"None";"390.47";"0";"4.48";"SID103904363";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001224";"";"None";"371.83";"0";"4.28";"SID103905155";"Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2003420";"";"None";"384.48";"0";"2.34";"SID103904793";"O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL1973395";"";"None";"294.36";"0";"2.59";"SID103904214";"OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL206010";"GW814408X";"None";"344.38";"0";"3.47";"GW814408X";"COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1";"Inhibition";"'='";"10.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"10.47"
"CHEMBL1997023";"";"None";"265.29";"0";"1.39";"SID103905667";"CN(C)c1cc2sncc2cc1NC(=O)C(=O)O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1964687";"";"None";"415.52";"1";"5.30";"SID103904330";"Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1984711";"";"None";"425.49";"1";"5.03";"SID103905215";"COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4789639";"BMS-986202";"1.0";"439.47";"0";"3.14";"7; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"Ki";"'='";"0.02";"nM";"10.70";"";"";"UO_0000065";"24.51";"0.46";"7.56";"9.06";"0";"CHEMBL4775562";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay based Morrison titration analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.02"
"CHEMBL394619";"";"None";"374.47";"1";"5.50";"SID103904295";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975138";"";"None";"395.46";"0";"3.08";"SID103904449";"O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL103667";"DORAMAPIMOD";"2.0";"527.67";"2";"5.99";"SID103904828";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982610";"";"None";"371.57";"0";"2.95";"SID103905053";"O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1976732";"";"None";"410.38";"0";"3.29";"SID103905067";"CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL253969";"OSI-632";"2.0";"532.41";"1";"3.86";"SID103905622";"NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000481";"";"None";"463.52";"0";"2.08";"SID103905096";"NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL396523";"";"None";"346.35";"0";"3.54";"SID103904593";"O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1";"Ki";"'='";"31.62";"nM";"7.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.5"
"CHEMBL4787133";"";"None";"407.52";"0";"3.40";"30d";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2cccc(OC)c2)CC1";"IC50";"'='";"42.7";"nM";"7.37";"";"";"UO_0000065";"18.08";"0.34";"3.97";"8.96";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"42.7"
"CHEMBL4785998";"";"None";"397.91";"0";"3.78";"31k";"C[C@@H]1C[C@H](Nc2c(C(N)=O)cnc3[nH]ccc23)CCN1Cc1cccc(Cl)c1";"IC50";"'='";"48.4";"nM";"7.32";"";"";"UO_0000065";"18.38";"0.36";"3.54";"8.40";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"48.4"
"CHEMBL4761365";"";"None";"411.94";"0";"4.04";"31g";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1";"GI50";"'='";"655.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"0.655"
"CHEMBL4783938";"";"None";"411.94";"0";"4.04";"38a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(Cl)cc2)[C@@H](C)C1";"GI50";"'='";"475.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"0.475"
"CHEMBL3589326";"";"None";"418.93";"0";"4.49";"18";"CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4cccc(Cl)c4)cc23)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"16.22";"0.31";"2.31";"10.40";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"160.0"
"CHEMBL1909391";"GW576924A";"None";"579.10";"2";"5.92";"GW576924A";"Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1";"Inhibition";"'='";"-3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.81"
"CHEMBL458438";"GSK-1511931A";"None";"508.63";"2";"5.53";"GSK1511931A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1";"Inhibition";"'='";"2.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.42"
"CHEMBL2004419";"";"None";"423.49";"1";"5.60";"SID103905063";"CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991188";"";"None";"380.42";"0";"4.40";"SID103905120";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979577";"";"None";"455.59";"1";"5.59";"SID103904303";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1909402";"GW568326X";"None";"373.31";"0";"4.20";"GW568326X";"Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1";"Inhibition";"'='";"-2.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.71"
"CHEMBL2181321";"";"None";"444.54";"0";"4.33";"17a, 85:15 trans/cis mixture";"C1=CCOCc2cc(ccc2N2CCOCC2)Nc2nccc(n2)-c2cccc(c2)COC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.29";"0.28";"2.47";"9.89";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.16"
"CHEMBL4792780";"";"None";"511.53";"1";"2.23";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"18.26";"0.34";"7.05";"6.13";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.52"
"CHEMBL4788122";"";"None";"422.46";"0";"2.39";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cccnn2)c1OC";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"17.07";"0.32";"4.77";"5.47";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"69.0"
"CHEMBL4792780";"";"None";"511.53";"1";"2.23";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.73";"0.30";"5.77";"5.29";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL4777528";"";"None";"493.54";"0";"2.10";"25";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"16.73";"0.31";"6.11";"5.42";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"6.2"
"CHEMBL4776752";"";"None";"452.49";"0";"2.40";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(OC)n2)c1OC";"IC50";"'='";"461.0";"nM";"6.34";"";"";"UO_0000065";"14.10";"0.26";"3.94";"4.52";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"461.0"
"CHEMBL4795231";"";"None";"493.54";"0";"2.10";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"14.82";"0.28";"5.17";"4.80";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"54.0"
"CHEMBL4792780";"";"None";"511.53";"1";"2.23";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"14.41";"0.27";"5.10";"4.84";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"47.0"
"CHEMBL4796821";"";"None";"479.56";"0";"3.23";"26";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"107.0";"nM";"6.97";"";"";"UO_0000065";"14.63";"0.27";"3.74";"5.04";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"107.0"
"CHEMBL4867814";"";"None";"426.55";"0";"3.69";"11a";"CCS(=O)(=O)N1CCc2cc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)ccc21";"IC50";"'='";"1.61";"nM";"8.79";"";"";"UO_0000065";"20.61";"0.40";"5.10";"9.45";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1.61"
"CHEMBL4873733";"";"None";"524.63";"1";"4.16";"11r";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)[C@H]2CCCN2C(=O)C2(C#N)CC2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"2.05";"nM";"8.69";"";"";"UO_0000065";"16.56";"0.30";"4.53";"7.24";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2.05"
"CHEMBL502835";"NINTEDANIB";"4.0";"539.64";"1";"3.62";"Nintedanib";"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL372764";"PERIFOSINE";"3.0";"461.67";"1";"6.99";"Perifosine";"CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1288094";"";"None";"341.33";"0";"2.06";"26";"CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccco3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL1288769";"";"None";"247.26";"0";"1.31";"17";"CCOC(=O)c1cccc(Nc2n[nH]c(N)n2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1292869";"Inhibition of TYK2-mediated INFgamma production in IL-12-stimulated human PBMC at 10 uM treated for 15 mins before IL12 challenge measured after 48 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL4870304";"";"None";"499.53";"0";"3.51";"IV";"COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F";"Activity";"'='";"37.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4805797";"Inhibition of human TYK2 JH1 catalytic domain assessed as percent of control at 1000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804283";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 1000.0 nM";"INHIBITOR";"";"37.0"
"CHEMBL196363";"";"None";"375.46";"0";"4.89";"SID103904276";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1";"Ki";"'='";"630.96";"nM";"6.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.2"
"CHEMBL1092063";"";"None";"569.73";"1";"3.89";"20";"Cc1cc(-c2cnc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)c3n2)ccc1C(=O)N1CCN(C)CC1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"11.38";"0.22";"2.59";"7.47";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"330.0"
"CHEMBL1092840";"";"None";"526.61";"1";"4.72";"22";"Cc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(F)c4)c3n2)ccc1C(=O)N1CCOCC1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"11.93";"0.22";"1.56";"9.27";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"520.0"
"CHEMBL2386796";"";"None";"570.70";"2";"5.31";"9p";"Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1";"Inhibition";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2389808";"Inhibition of TYK2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384934";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"3.0"
"CHEMBL1966524";"";"None";"400.51";"0";"4.79";"SID103904752";"NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1968380";"";"None";"521.67";"1";"3.56";"SID103904638";"CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3215582";"";"None";"588.33";"1";"6.41";"1";"Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl";"Activity";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1059391";"Inhibition of TYK2 kinase domain 1 assessed as enzyme activity at 1 uM relative to untreated control";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155237";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"96.0"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"Imatinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Kd";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"10.25";"0.19";"0.47";"5.87";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"8700.0"
"CHEMBL1987009";"";"None";"363.44";"0";"4.23";"SID103904702";"COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987054";"";"None";"548.05";"2";"6.07";"SID103904785";"COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL1983923";"";"None";"375.48";"0";"3.17";"SID103905558";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL1971947";"";"None";"475.58";"1";"6.29";"SID103904297";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996587";"";"None";"410.43";"0";"3.15";"SID103905444";"CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4543066";"";"None";"462.51";"0";"1.81";"6p";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NCC(C)(C)CO)cnc12";"Ki";"'='";"285.0";"nM";"6.54";"";"";"UO_0000065";"14.15";"0.26";"4.74";"4.73";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"285.0"
"CHEMBL4466139";"";"None";"416.45";"0";"1.95";"6e";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"22.74";"0.42";"7.52";"8.01";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.34"
"CHEMBL4435047";"";"None";"434.44";"0";"2.09";"6j";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"22.84";"0.42";"7.83";"8.39";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.12"
"CHEMBL4517542";"";"None";"353.39";"0";"1.11";"6a";"CNc1cc(Nc2cccn(C)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"614.0";"nM";"6.21";"";"";"UO_0000065";"17.58";"0.33";"5.10";"5.90";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"614.0"
"CHEMBL4585272";"";"None";"416.45";"0";"1.95";"6g";"CNc1cc(Nc2cccn(-c3ccncc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"16.40";"0.30";"4.88";"5.78";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"148.0"
"CHEMBL4750448";"";"None";"369.39";"0";"2.53";"26, trans";"N#CC[C@]1(n2cc(-c3nc(-c4cc[nH]n4)cn4nccc34)cn2)C[C@H](C#N)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"20.53";"0.37";"5.06";"6.10";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"26.0"
"CHEMBL4781984";"";"None";"369.39";"0";"2.53";"23, cis isomer";"N#CC[C@]1(n2cc(-c3nc(-c4cn[nH]c4)cn4nccc34)cn2)C[C@@H](C#N)C1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.92";"0.39";"5.57";"6.52";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"8.0"
"CHEMBL4637596";"";"None";"256.31";"0";"2.36";"23";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](C#N)CC3)c12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL188048";"";"None";"216.20";"0";"0.60";"SB-736290";"Cn1c(-c2nonc2N)nc2cnccc21";"Inhibition";"'='";"-2.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.34"
"CHEMBL1909412";"";"None";"413.31";"0";"4.62";"SB-476429-A";"Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1";"Inhibition";"'='";"1.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.75"
"CHEMBL3236403";"";"None";"205.07";"0";"3.00";"1";"Clc1nc(Cl)c2sccc2n1";"Inhibition";"'<'";"40.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3241099";"Inhibition of TYK2 (unknown origin) at 5 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232736";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"40.0"
"CHEMBL270544";"GW396574X";"None";"370.43";"0";"2.53";"GW396574X";"CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"3.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.75"
"CHEMBL4277193";"";"None";"460.52";"0";"3.17";"33";"COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4292341";"";"None";"381.44";"0";"3.84";"35";"N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4531793";"";"None";"390.47";"0";"2.18";"42";"CNC(=O)c1cnc(NC(=O)C(C)C)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"13.53";"0.27";"3.10";"4.51";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"5.2"
"CHEMBL4283724";"";"None";"314.39";"0";"2.15";"13";"NC(=O)c1cnc2c(NC3CC3)cc(NC3CCCCC3)nn12";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"21.18";"0.40";"4.51";"6.84";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.22"
"CHEMBL4279883";"";"None";"436.42";"0";"1.27";"29";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.24";"0.37";"7.13";"6.31";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.004"
"CHEMBL4278757";"";"None";"412.49";"0";"1.85";"25";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(CO)CO)cnc12";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"15.32";"0.29";"4.47";"5.10";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.48"
"CHEMBL4291611";"";"None";"358.41";"0";"3.28";"32";"CNc1cc(Nc2cccc(-c3ccccc3)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"18.08";"0.33";"3.20";"6.66";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.33"
"CHEMBL4515441";"";"None";"597.12";"2";"6.05";"15a";"C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4358174";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354843";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"100.0"
"CHEMBL4541291";"";"None";"415.90";"0";"4.38";"12k";"CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1cc(F)ccc1Cl";"IC50";"'='";"1298.0";"nM";"5.89";"";"";"UO_0000065";"14.15";"0.28";"1.51";"7.55";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"1.298"
"CHEMBL4636371";"";"None";"231.30";"0";"2.61";"7";"Cc1[nH]nc2[nH]c(=O)cc(C3CCCCC3)c12";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"26.69";"0.50";"3.56";"10.03";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.67"
"CHEMBL4648612";"";"None";"257.34";"0";"2.85";"13";"Cc1[nH]nc2[nH]c(=O)cc(C3CC4CCC3CC4)c12";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"25.87";"0.48";"3.81";"10.82";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.22"
"CHEMBL4465076";"";"None";"411.48";"0";"3.74";"12l";"COc1ccc(F)cc1C(C)Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N";"IC50";"'='";"794.0";"nM";"6.10";"";"";"UO_0000065";"14.82";"0.28";"2.36";"6.99";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"0.794"
"CHEMBL1984038";"";"None";"545.62";"2";"5.73";"SID103904721";"COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1682540";"";"None";"235.25";"0";"2.27";"SID103904528";"c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL497151";"";"None";"437.22";"0";"4.04";"SID103905371";"O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999718";"";"None";"357.30";"0";"4.16";"SID103904897";"N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987679";"";"None";"400.44";"0";"3.61";"SID103904478";"NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL560813";"";"None";"333.31";"0";"2.84";"SID103904886";"N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975647";"";"None";"283.27";"0";"2.81";"SID103904887";"O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006493";"";"None";"282.22";"0";"3.33";"SID103905619";"O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992323";"";"None";"220.62";"0";"2.32";"SID103904797";"O=c1[nH]cnc2c1oc1ccc(Cl)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3114786";"";"None";"483.50";"0";"3.84";"11d";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCN(c3ccnc(F)c3)C2)c1";"IC50";"'='";"11927.0";"nM";"4.92";"";"";"UO_0000065";"10.18";"0.19";"1.08";"4.96";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"11927.0"
"CHEMBL271381";"";"None";"453.30";"1";"5.49";"SID103904335";"COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4776752";"";"None";"452.49";"0";"2.40";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(OC)n2)c1OC";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"19.70";"0.37";"6.45";"6.31";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.4"
"CHEMBL4776752";"";"None";"452.49";"0";"2.40";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(OC)n2)c1OC";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"16.24";"0.30";"4.90";"5.21";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"50.0"
"CHEMBL4777175";"";"None";"534.51";"1";"3.16";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(C)(O)C(F)(F)F)cn2)c1OC";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"15.17";"0.29";"4.91";"5.33";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"8.6"
"CHEMBL4800399";"";"None";"521.60";"1";"2.88";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(=O)N(CC)CC)cn2)c1OC";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"15.56";"0.29";"5.19";"5.33";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"8.5"
"CHEMBL4780233";"";"None";"435.50";"0";"3.31";"31";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C)cn2)c1OC";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"17.43";"0.32";"4.23";"6.38";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"29.0"
"CHEMBL4780315";"";"None";"451.50";"0";"3.01";"32";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(OC)cn2)c1OC";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"16.77";"0.31";"4.51";"5.91";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"30.0"
"CHEMBL4789639";"BMS-986202";"1.0";"439.47";"0";"3.14";"7; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.33";"0.34";"4.86";"6.77";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL4780233";"";"None";"435.50";"0";"3.31";"31";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C)cn2)c1OC";"IC50";"'='";"233.0";"nM";"6.63";"";"";"UO_0000065";"15.34";"0.28";"3.32";"5.61";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"233.0"
"CHEMBL4789639";"BMS-986202";"1.0";"439.47";"0";"3.14";"7; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"16.58";"0.31";"4.10";"6.13";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"58.0"
"CHEMBL2208034";"";"None";"444.54";"0";"3.41";"10d, XL019";"O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1";"IC50";"'='";"348.3";"nM";"6.46";"";"";"UO_0000065";"14.53";"0.27";"3.05";"7.06";"0";"CHEMBL2212847";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203210";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"348.3"
"CHEMBL4877552";"";"None";"383.45";"1";"5.42";"20";"O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1";"Activity";"'<'";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4827591";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825714";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 microM";"INHIBITOR";"";"10.0"
"CHEMBL3359910";"";"None";"272.35";"0";"2.42";"3d";"CC1(C)CCC[C@@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"25.28";"0.47";"4.47";"9.51";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"130.0"
"CHEMBL3359911";"";"None";"244.30";"0";"1.79";"3e";"NC(=O)c1cnn2cccc2c1NC1CCCC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"27.93";"0.52";"5.03";"9.42";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"150.0"
"CHEMBL3359915";"";"None";"302.38";"0";"1.78";"4d";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@@]1(C)O";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"26.97";"0.51";"6.37";"8.80";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"7.0"
"CHEMBL4640314";"";"None";"401.45";"0";"1.14";"8";"O=C(C1CC1)N1C2CCC1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"18.08";"0.34";"6.12";"7.30";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"55.0"
"CHEMBL4649054";"";"None";"314.39";"0";"2.11";"25";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](C(=O)NC4CC4)CC3)c12";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"15.44";"0.29";"2.74";"5.36";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"14.0"
"CHEMBL4639973";"";"None";"350.37";"0";"2.36";"27";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)[C@@H]4CC4(F)F)CC3)c12";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"19.00";"0.36";"4.30";"7.35";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.22"
"CHEMBL4639048";"";"None";"378.50";"0";"2.31";"31";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NS(=O)(=O)CC4CCC4)CC3)c12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL4634289";"";"None";"282.35";"0";"2.60";"41";"Cc1[nH]nc2[nH]c(=O)cc([C@@H]3C[C@@H]4C[C@H]3C[C@@H]4CC#N)c12";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"23.58";"0.43";"4.06";"7.80";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.22"
"CHEMBL4638953";"";"None";"350.37";"0";"2.36";"28";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)[C@H]4CC4(F)F)CC3)c12";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"15.89";"0.30";"3.21";"6.14";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"2.7"
"CHEMBL3694593";"";"None";"352.83";"0";"3.56";"BDBM125914";"Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2";"IC50";"'='";"386.0";"nM";"6.41";"";"255725";"UO_0000065";"18.18";"0.35";"2.85";"7.23";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"386.0"
"CHEMBL3991935";"";"None";"438.31";"0";"3.30";"P-276-00";"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL283120";"AXL-1717";"2.0";"414.41";"0";"2.41";"AXL-1717";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL551064";"AEW-541";"1.0";"425.54";"0";"4.67";"AEW-541";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3109738";"JNJ-26483327";"1.0";"457.37";"1";"5.14";"JNJ-26483327";"COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL608533";"MIDOSTAURIN";"4.0";"570.65";"2";"5.91";"Midostaurin";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4530719";"";"None";"401.42";"0";"2.61";"29";"CS(=O)(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"18.38";"0.36";"4.77";"5.81";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.042"
"CHEMBL4544320";"";"None";"397.46";"0";"2.73";"38";"CNC(=O)c1cnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"16.61";"0.32";"3.87";"5.84";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.25"
"CHEMBL4436287";"";"None";"393.45";"0";"1.53";"10";"CCNC(=O)c1ccc(Nc2nccc(N3CCN(C(=O)CC#N)CC3)n2)cc1";"IC50";"'='";"368.0";"nM";"6.43";"";"";"UO_0000065";"16.35";"0.30";"4.90";"5.63";"0";"CHEMBL4411530";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using ATP at its Km level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"368.0"
"CHEMBL4295039";"";"None";"398.47";"0";"2.27";"27";"CNc1cc(Nc2ccccc2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"20.83";"0.39";"6.03";"7.36";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.005"
"CHEMBL4285530";"";"None";"364.45";"0";"3.54";"21";"Cc1cc(C)cc(Nc2cc(NC3CCCC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"14.09";"0.26";"1.60";"5.28";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"7.3"
"CHEMBL4286006";"";"None";"372.43";"0";"3.93";"22";"Cc1cc(C)cc(Nc2cc(Nc3ccccc3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"14.26";"0.26";"1.38";"5.45";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"4.9"
"CHEMBL4525866";"";"None";"363.38";"0";"1.82";"19";"CNC(=O)c1cnc(Nc2ncccn2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"19.87";"0.37";"5.40";"5.35";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.06"
"CHEMBL4471908";"";"None";"395.44";"0";"1.72";"des-methoxy 11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10.0"
"CHEMBL2376144";"";"None";"462.90";"0";"2.27";"6a";"C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1";"Kd";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"13.95";"0.27";"4.19";"4.87";"0";"CHEMBL2378154";"Binding affinity to TYK2 (unknown origin) by ligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2375236";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"350.0"
"CHEMBL4645110";"";"None";"431.50";"0";"3.21";"27";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COC/C=C/COCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"14.73";"0.27";"3.15";"6.33";"0";"CHEMBL4627624";"Inhibition of TYK2 in human Jurkat cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307526";"";"";"";"440.0"
"CHEMBL2387219";"";"None";"418.24";"0";"2.90";"33";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2c2nn[nH]n2)c1)c1c(Cl)cccc1Cl";"EC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5.0"
"CHEMBL2420850";"";"None";"262.70";"0";"3.00";"13";"COc1cccc(C(=O)Nc2ccncc2)c1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL1287941";"";"None";"359.29";"0";"2.27";"15";"Nc1nc(Nc2ccc(C(=O)O)cc2)nn1C(=O)c1c(F)cccc1F";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"20.53";"0.39";"5.11";"5.99";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"42.0"
"CHEMBL1288001";"";"None";"358.35";"0";"2.64";"19";"CN(C)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"19.97";"0.38";"4.51";"8.03";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"70.0"
"CHEMBL4778980";"";"None";"415.50";"0";"4.24";"17";"C/C=C/C(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4750671";"";"None";"391.48";"0";"3.16";"19";"C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CCN(C)C)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4795109";"";"None";"472.55";"0";"3.35";"27";"C/C=C/C(=O)NCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4862231";"";"None";"542.59";"2";"5.74";"11e";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"14.37";"0.28";"2.06";"8.38";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"16.0"
"CHEMBL4872684";"";"None";"572.61";"2";"5.72";"13k";"CCOC(C)n1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)c3ccc(C(F)(F)F)cc3)ncc2C)cn1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"12.96";"0.25";"1.70";"7.26";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"38.0"
"CHEMBL1969879";"";"None";"303.37";"0";"0.62";"SID103905420";"CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"1995.26";"nM";"5.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965988";"";"None";"427.53";"0";"4.81";"SID103904300";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL316264";"";"None";"333.34";"1";"5.08";"SID103905184";"Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1980163";"";"None";"327.39";"0";"4.95";"SID103904652";"c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004355";"";"None";"375.41";"0";"0.51";"SID103905187";"CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000345";"";"None";"384.23";"0";"4.41";"SID103905618";"COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL1999931";"";"None";"394.44";"0";"4.12";"SID103904511";"O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1";"Ki";"'='";"501.19";"nM";"6.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.3"
"CHEMBL1976240";"";"None";"347.42";"0";"3.19";"SID103904556";"COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3991929";"Cerdulatinib Hydrochloride";"None";"482.01";"0";"1.37";"Cerdulatinib Hydrochloride";"CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl";"Kd";"'='";"32.0";"nM";"7.50";"";"Active";"UO_0000065";"16.82";"0.33";"6.12";"5.61";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.79 None";"";"";"32.0"
"CHEMBL3645548";"";"None";"311.77";"0";"3.86";"BDBM107134";"O=C(CCCl)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226444";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL3655101";"";"None";"378.46";"0";"0.23";"BDBM159768";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@H]3C[C@@H](C2)O3)C1";"IC50";"'='";"2030.0";"nM";"5.69";"";"302662";"UO_0000065";"15.04";"0.30";"5.46";"5.50";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2030.0"
"CHEMBL3911874";"";"None";"249.28";"0";"2.58";"BDBM198197";"Cc1ccccc1-c1nnn2cnc3[nH]ccc3c12";"IC50";"'='";"130.0";"nM";"6.89";"";"351829";"UO_0000065";"27.62";"0.49";"4.31";"11.70";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL1973483";"";"None";"400.28";"1";"5.31";"SID103904898";"O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1980704";"";"None";"345.43";"0";"4.13";"SID103905204";"Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL207410";"GW772405X";"None";"486.93";"1";"5.35";"GW772405X";"CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1";"Inhibition";"'='";"-0.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.77"
"CHEMBL206010";"GW814408X";"None";"344.38";"0";"3.47";"GW814408X";"COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1";"Inhibition";"'='";"1.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.21"
"CHEMBL1909373";"GW701427A";"None";"497.90";"0";"4.88";"GW701427A";"COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl";"Inhibition";"'='";"1.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.17"
"CHEMBL179453";"GW622055X";"None";"392.86";"0";"4.54";"GW622055X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1";"Inhibition";"'='";"-1.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.06"
"CHEMBL4092116";"";"None";"397.23";"0";"3.92";"31";"N#Cc1cc(Cl)c(-c2nc3ccnc(Nc4cc(N)ncn4)c3[nH]2)c(Cl)c1";"EC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"15.98";"0.32";"2.43";"4.91";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.45"
"CHEMBL1992242";"";"None";"373.48";"1";"6.22";"SID103904384";"Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3764463";"";"None";"337.77";"0";"3.01";"6";"Nc1n[nH]c2c(-c3ccccn3)cn(-c3ccccc3Cl)c(=O)c12";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"24.20";"0.47";"5.16";"9.12";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"6.7"
"CHEMBL4293619";"";"None";"308.35";"0";"2.15";"10";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3ccccc3)nn12";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"18.89";"0.35";"3.67";"5.98";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.5"
"CHEMBL1992536";"";"None";"348.36";"0";"2.52";"SID103904655";"COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002373";"";"None";"279.34";"0";"2.99";"SID103905254";"OCCCn1cnc(-c2ccccc2)c1-c1ccncc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2006188";"";"None";"404.51";"0";"4.01";"SID103904561";"COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1976420";"";"None";"281.36";"0";"3.41";"SID103905182";"CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL4286963";"";"None";"291.31";"0";"2.17";"26";"N#CN[C@H]1C[C@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"3372.0";"nM";"5.47";"";"";"UO_0000065";"18.78";"0.34";"3.30";"5.61";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"3372.0"
"CHEMBL1909350";"GSK-949675A";"None";"421.89";"0";"0.80";"GSK949675A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl";"Inhibition";"'='";"-0.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.47"
"CHEMBL4521312";"";"None";"403.48";"0";"4.32";"24";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C2CCCC2)c2cn[nH]c2c1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"15.86";"0.31";"2.08";"6.73";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.4"
"CHEMBL4528217";"";"None";"432.53";"0";"4.02";"13d";"CCC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL397570";"";"None";"300.36";"0";"3.89";"SB-347804";"N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2";"Inhibition";"'='";"-3.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.45"
"CHEMBL4093813";"";"None";"401.47";"0";"3.79";"19";"CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(C(C)=O)CC4)n[nH]c2c1";"IC50";"'='";"22.7";"nM";"7.64";"";"";"UO_0000065";"19.04";"0.35";"3.85";"7.81";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"22.7"
"CHEMBL4448847";"";"None";"291.32";"0";"3.17";"11b";"c1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1";"Inhibition";"'='";"34.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4431287";"Inhibition of TYK2 (unknown origin) at 20 nM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428138";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"34.6"
"CHEMBL3658867";"";"None";"408.89";"0";"3.44";"BDBM159786";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2ccc(F)c(Cl)c2)C1";"IC50";"'='";"242.0";"nM";"6.62";"";"302680";"UO_0000065";"16.18";"0.33";"3.18";"8.38";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"242.0"
"CHEMBL3622824";"";"None";"247.30";"0";"-0.40";"5a";"NCCc1nc2cc(C(N)=O)ccc2n1CCN";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"22.28";"0.42";"5.91";"4.88";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.1"
"CHEMBL4247704";"";"None";"410.48";"0";"4.63";"7g";"CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12";"Kd";"'>='";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4233048";"Binding affinity to human TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229410";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"5.0"
"CHEMBL3670394";"";"None";"388.22";"0";"3.06";"BDBM116316";"Nc1ccn2ncc(C(=O)Nc3ccnn3-c3cc(Cl)ccc3Cl)c2n1";"Ki";"'='";"43.5";"nM";"7.36";"";"241650";"UO_0000065";"18.96";"0.39";"4.30";"7.14";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"43.5"
"CHEMBL4077614";"";"None";"364.48";"0";"1.25";"39";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CCCCC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4550702";"";"None";"406.39";"0";"3.15";"9";"Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"17.31";"0.34";"3.89";"9.12";"0";"CHEMBL4479787";"Inhibition of recombinant human N-terminal GST-tagged cytoplasmic TYK2 (833 to 1187 residues) catalytic domain expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"92.0"
"CHEMBL188247";"GW832467X";"None";"504.47";"2";"5.70";"GW832467X";"Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1";"Inhibition";"'='";"0.31";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.31"
"CHEMBL4097446";"";"None";"497.39";"0";"3.99";"25";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3cc(N4CCN(C5COC5)CC4)ncn3)c2[nH]1";"Ki";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.94";"0.36";"4.93";"9.38";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0012"
"CHEMBL272028";"GW300660X";"None";"453.48";"0";"0.80";"GW300660X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1";"Inhibition";"'='";"-1.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.79"
"CHEMBL4279883";"";"None";"436.42";"0";"1.27";"29";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"15.17";"0.29";"5.35";"4.98";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.24"
"CHEMBL4287761";"";"None";"434.45";"0";"2.55";"28";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"17.32";"0.33";"4.97";"6.67";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.03"
"CHEMBL4283351";"";"None";"338.42";"0";"2.91";"31";"CNc1cc(Nc2cccc(C(C)(C)C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"18.87";"0.35";"3.48";"6.56";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.41"
"CHEMBL4290130";"";"None";"518.47";"1";"3.55";"35";"C[C@](O)(CO)CNc1cc(Nc2cccc(-c3ccc(C(F)(F)F)cc3F)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"11.81";"0.23";"2.57";"4.44";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.75"
"CHEMBL3655090";"";"None";"415.52";"0";"2.13";"BDBM159757";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C(C)(C)O)c2)C1";"IC50";"'='";"6670.0";"nM";"5.18";"";"302651";"UO_0000065";"12.46";"0.24";"3.05";"4.65";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"6670.0"
"CHEMBL4244856";"";"None";"367.42";"0";"1.04";"12h";"COCCn1cc(-c2nn(C3CCCN(C#N)C3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4276860";"";"None";"275.31";"0";"2.68";"13";"N#CN[C@@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"3144.0";"nM";"5.50";"";"";"UO_0000065";"19.99";"0.36";"2.82";"7.11";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"3144.0"
"CHEMBL4278647";"";"None";"289.34";"0";"2.93";"20";"C[C@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N";"IC50";"'='";"2010.0";"nM";"5.70";"";"";"UO_0000065";"19.69";"0.35";"2.77";"7.36";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2010.0"
"CHEMBL4293510";"";"None";"488.42";"0";"4.92";"34";"NC(=O)c1cnc2c(N[C@H]3C[C@H]3F)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"13.30";"0.25";"1.57";"6.67";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.32"
"CHEMBL4643899";"";"None";"431.50";"0";"3.21";"28";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COC/C=C\COCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"19.20";"0.35";"5.07";"8.25";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"5.2"
"CHEMBL4645258";"";"None";"432.48";"0";"1.79";"22";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"17.66";"0.33";"5.85";"6.35";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"23.0"
"CHEMBL1909382";"GW759710A";"None";"359.79";"0";"3.20";"GW759710A";"Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1";"Inhibition";"'='";"3.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.52"
"CHEMBL408564";"";"None";"347.17";"0";"3.33";"SB-739452";"O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1";"Inhibition";"'='";"-1.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.51"
"CHEMBL183993";"GW811761X";"None";"400.36";"0";"4.35";"GW811761X";"CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.0"
"CHEMBL271594";"GW300653X";"None";"358.42";"0";"2.23";"GW300653X";"CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"0.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.63"
"CHEMBL3758502";"";"None";"347.38";"0";"3.25";"1";"CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21";"Inhibition";"'='";"4.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3761275";"Inhibition of TYK2 (unknown origin) at 100 nM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3758169";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"4.9"
"CHEMBL458415";"GSK-2186269A";"None";"483.58";"0";"3.86";"GSK2186269A";"COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2";"Inhibition";"'='";"-2.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.82"
"CHEMBL4517719";"";"None";"421.29";"1";"6.27";"22m";"O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4304960";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system at 1 uM by Kinomescan method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304739";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL4789639";"BMS-986202";"1.0";"439.47";"0";"3.14";"7; BMS-986202";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"18.15";"0.34";"4.78";"6.71";"0";"CHEMBL4775563";"Inhibition of TYK2 in IL-23 stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL1794071";"";"None";"409.92";"0";"3.73";"SB-614067-R";"Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21";"Inhibition";"'='";"-1.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.08"
"CHEMBL3675968";"";"None";"368.42";"0";"2.74";"BDBM127720";"CC(C)NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12";"IC50";"'>'";"1000.0";"nM";"";"";"258561";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4799559";"";"None";"480.54";"0";"2.62";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"14.98";"0.28";"4.53";"4.73";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"70.0"
"CHEMBL1650954";"";"None";"399.37";"0";"3.82";"8";"CN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"10000.0"
"CHEMBL1650956";"";"None";"441.41";"0";"3.59";"10";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCOCC2)ccc1C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"10000.0"
"CHEMBL522709";"GSK-317315A";"None";"461.47";"1";"5.35";"GSK317315A";"COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1";"Inhibition";"'='";"-1.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.84"
"CHEMBL1651523";"";"None";"332.40";"0";"3.58";"3";"COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1656381";"Inhibition of TYK2 by TR-FRET based LanthaScreen assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649097";"1";"Scientific Literature";"ACS Med Chem Lett";"2011";"None";"";"";"";"10000.0"
"CHEMBL4475216";"";"None";"521.58";"1";"3.32";"6f";"COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4340001";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339212";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"10000.0"
"CHEMBL4065693";"";"None";"387.44";"0";"3.66";"9a";"C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"5000.0"
"CHEMBL4084598";"";"None";"371.42";"0";"1.93";"13c";"C=CS(=O)(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"2000.0"
"CHEMBL3593765";"";"None";"349.44";"0";"2.74";"17a";"NC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1";"IC50";"'='";"110.5";"nM";"6.96";"";"";"UO_0000065";"19.91";"0.37";"4.22";"7.99";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"110.5"
"CHEMBL4761631";"";"None";"377.49";"0";"3.39";"30a";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccccc2)CC1";"IC50";"'='";"276.0";"nM";"6.56";"";"";"UO_0000065";"17.38";"0.32";"3.17";"8.98";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"276.0"
"CHEMBL4747270";"";"None";"363.47";"0";"3.00";"17c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1";"IC50";"'='";"586.0";"nM";"6.23";"";"";"UO_0000065";"17.15";"0.32";"3.23";"8.53";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"586.0"
"CHEMBL4742822";"";"None";"383.88";"0";"3.26";"19c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccc(Cl)cc2)C1";"IC50";"'='";"657.7";"nM";"6.18";"";"";"UO_0000065";"16.10";"0.31";"2.92";"8.46";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"657.7"
"CHEMBL4761365";"";"None";"411.94";"0";"4.04";"31g";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1";"IC50";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"19.59";"0.38";"4.03";"11.05";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"8.5"
"CHEMBL4542289";"";"None";"390.47";"0";"2.33";"41";"CCCC(=O)Nc1cc(Nc2ccccc2S(C)(=O)=O)c(C(=O)NC)cn1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"14.35";"0.28";"3.27";"4.78";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.5"
"CHEMBL4288086";"";"None";"322.37";"0";"2.94";"7";"C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"Tandutinib";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4293778";"";"None";"289.34";"0";"2.86";"22";"CC1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"239.0";"nM";"6.62";"";"";"UO_0000065";"22.89";"0.41";"3.76";"8.56";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"239.0"
"CHEMBL4285555";"";"None";"455.50";"0";"3.03";"31";"N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'>'";"9817.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"9817.0"
"CHEMBL3039513";"DECERNOTINIB";"2.0";"392.39";"0";"3.28";"Decernotinib";"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4160840";"";"None";"391.43";"0";"2.84";"24";"O=C(NO)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"IC50";"'='";"419.0";"nM";"6.38";"";"";"UO_0000065";"16.29";"0.30";"3.54";"6.40";"0";"CHEMBL4150583";"Inhibition of TYK2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145634";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"419.0"
"CHEMBL4290597";"";"None";"445.48";"0";"3.13";"18";"COc1cc2c(=O)n([C@@H]3CCCN(C(=O)CC#N)C3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"4.35";"nM";"8.36";"";"";"UO_0000065";"18.77";"0.35";"5.23";"7.38";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"4.35"
"CHEMBL4247704";"";"None";"410.48";"0";"4.63";"7g";"CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12";"Activity";"'='";"73.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4232951";"Inhibition of human TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229410";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"73.0"
"CHEMBL4287893";"";"None";"378.43";"0";"2.97";"17h";"COc1cc2c(=O)n([C@@H]3CCCNC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"45.1";"nM";"7.35";"";"";"UO_0000065";"19.41";"0.36";"4.38";"9.05";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"45.1"
"CHEMBL3545137";"PF-00477736";"1.0";"419.49";"0";"1.99";"PF-477736";"Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"Imatinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4632766";"";"None";"351.35";"0";"2.78";"29";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](OC(=O)[C@@H]4CC4(F)F)CC3)c12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL1946170";"REGORAFENIB";"4.0";"482.82";"1";"5.69";"Regorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4644138";"";"None";"412.43";"0";"0.40";"13";"N#C[C@@H]1C[C@H]1C(=O)N[C@@]12C[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"18.28";"0.34";"7.14";"5.71";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"29.0"
"CHEMBL3715238";"";"None";"419.45";"0";"3.00";"24";"Nc1ncc(-c2cc([C@H]3[C@@H]4CN(C5COC5)C[C@@H]43)n(CC3CC3)n2)cc1C(F)(F)F";"Inhibition";"'='";"9.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4120129";"Inhibition of recombinant N-terminal GST-tagged human TYK2 (833 to 1187 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118097";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"9.3"
"CHEMBL1982465";"";"None";"497.62";"1";"5.18";"SID103904307";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1984586";"";"None";"359.39";"0";"4.42";"SID103904368";"Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1682341";"";"None";"275.31";"0";"2.73";"SID103904526";"c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004311";"";"None";"385.47";"1";"5.17";"SID103904278";"Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982874";"";"None";"403.49";"1";"5.21";"SID103905064";"Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3645542";"";"None";"370.41";"0";"4.95";"BDBM107126";"COc1ccc(NC(=O)Nc2cccc(-c3cnc4ccccc4n3)c2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"226435";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL4474729";"";"None";"515.55";"1";"4.10";"29";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NCc2ccccn2)c1OC";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.08";"0.24";"2.64";"5.18";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"180.0"
"CHEMBL4435079";"";"None";"462.49";"0";"3.58";"36";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2nncn2C)c1OC";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.75";"0.27";"3.24";"5.74";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"150.0"
"CHEMBL1288063";"";"None";"419.36";"0";"3.49";"24";"CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccc(C(F)(F)F)cc3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL4579439";"";"None";"434.44";"0";"2.09";"6h";"CNc1cc(Nc2cccn(-c3cccc(F)n3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"22.23";"0.41";"7.57";"8.17";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.22"
"CHEMBL4547009";"";"None";"379.42";"0";"1.90";"6b";"CNc1cc(Nc2cccn(C3CC3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"131.0";"nM";"6.88";"";"";"UO_0000065";"18.14";"0.34";"4.98";"6.53";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"131.0"
"CHEMBL4434711";"";"None";"473.54";"0";"2.79";"6d";"CNc1cc(Nc2cccn(-c3ccc(C(C)(C)O)cc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"811.0";"nM";"6.09";"";"";"UO_0000065";"12.86";"0.24";"3.30";"4.85";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"811.0"
"CHEMBL4571920";"";"None";"452.43";"0";"2.04";"6r";"CNc1cc(Nc2cccn(-c3cccc(F)n3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"136.0";"nM";"6.87";"";"";"UO_0000065";"15.18";"0.28";"4.83";"5.81";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"136.0"
"CHEMBL4537678";"";"None";"380.38";"0";"2.56";"5";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"23.36";"0.43";"6.33";"7.28";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0013"
"CHEMBL3309998";"";"None";"378.39";"0";"1.58";"12b";"Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375006";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352169";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"10.0"
"CHEMBL4855730";"";"None";"452.51";"0";"3.33";"I-51";"Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804690";"Inhibition of TYK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 10.0 microM";"";"";"0.0"
"CHEMBL603469";"LESTAURTINIB";"3.0";"439.47";"0";"3.47";"CEP-701";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.80";"0.32";"4.35";"8.83";"0";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"15.0"
"CHEMBL4870912";"";"None";"505.56";"1";"2.73";"1a";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-n3c(-c4ccc(CO)o4)cc4cnc5[nH]ccc5c43)cn2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";""
"CHEMBL1650952";"";"None";"374.29";"0";"3.89";"5";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(F)ccc1C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"10000.0"
"CHEMBL4443010";"";"None";"431.46";"0";"1.66";"6l";"CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"147.0";"nM";"6.83";"";"";"UO_0000065";"15.84";"0.29";"5.17";"5.21";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"147.0"
"CHEMBL4543066";"";"None";"462.51";"0";"1.81";"6p";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NCC(C)(C)CO)cnc12";"Ki";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"15.30";"0.28";"5.27";"5.11";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"84.0"
"CHEMBL4437714";"";"None";"435.42";"0";"1.49";"6k";"CNc1cc(Nc2cccn(-c3ncc(F)cn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"464.0";"nM";"6.33";"";"";"UO_0000065";"14.55";"0.27";"4.84";"4.83";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"464.0"
"CHEMBL1089813";"";"None";"485.58";"1";"5.13";"18";"COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4C)c3n2)cc(OC)c1OC";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"11.07";"0.20";"0.25";"8.15";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"4200.0"
"CHEMBL3746293";"";"None";"529.60";"1";"4.74";"23";"Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1";"Inhibition";"'='";"4.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3751264";"Inhibition of TYK2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"4.3"
"CHEMBL3658859";"";"None";"374.47";"0";"1.35";"BDBM159778";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CC[C@H](C#N)C2)C1";"IC50";"'='";"1100.0";"nM";"5.96";"";"302672";"UO_0000065";"15.91";"0.31";"4.61";"5.62";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1100.0"
"CHEMBL4851606";"";"None";"514.53";"1";"4.70";"13b";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C)c1";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"13.27";"0.26";"2.13";"7.34";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"148.0"
"CHEMBL4872338";"";"None";"361.38";"0";"3.63";"14k";"Cn1ccc2cc(Nc3ncc(F)c(-c4cnn(CCC#N)c4)n3)ccc21";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"21.43";"0.39";"4.11";"9.18";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"18.0"
"CHEMBL4852080";"";"None";"529.63";"1";"4.22";"11f";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc3c(c2)CC(=O)N3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"12.32";"nM";"7.91";"";"";"UO_0000065";"14.93";"0.28";"3.69";"6.48";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"12.32"
"CHEMBL3758602";"";"None";"381.83";"0";"3.91";"15";"CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21";"Inhibition";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3761275";"Inhibition of TYK2 (unknown origin) at 100 nM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3758169";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"2.0"
"CHEMBL2387225";"";"None";"365.22";"0";"3.57";"4";"Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"EC50";"'='";"248.0";"nM";"6.61";"";"";"UO_0000065";"18.09";"0.38";"3.04";"6.80";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"248.0"
"CHEMBL2181320";"";"None";"375.43";"0";"4.20";"16f, 85:15 trans/cis mixture";"Oc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"18.03";"0.33";"2.57";"8.85";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.17"
"CHEMBL2181322";"";"None";"443.55";"0";"3.90";"17c, 85:15 trans/cis mixture";"C1=CCOCc2cc(ccc2N2CCNCC2)Nc2nccc(n2)-c2cccc(c2)COC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.45";"0.28";"2.95";"9.58";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.14"
"CHEMBL4295039";"";"None";"398.47";"0";"2.27";"27";"CNc1cc(Nc2ccccc2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"17.37";"0.33";"4.65";"6.13";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.12"
"CHEMBL4290130";"";"None";"518.47";"1";"3.55";"35";"C[C@](O)(CO)CNc1cc(Nc2cccc(-c3ccc(C(F)(F)F)cc3F)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"15.62";"0.30";"4.55";"5.88";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.008"
"CHEMBL4279819";"";"None";"310.36";"0";"1.30";"(R)-6c";"CN(c1ncnc2[nH]ccc12)[C@H]1CN(C(=O)CC#N)CC12CC2";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"21.27";"0.39";"5.30";"7.43";"0";"CHEMBL4258468";"Inhibition of human TYK2 using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257478";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";"";"250.0"
"CHEMBL4578164";"MRL-CB1-NC";"None";"550.85";"2";"5.80";"EUB0002784a";"CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"% Control";"'='";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"94.0"
"CHEMBL4279720";"";"None";"289.34";"0";"2.86";"23";"C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"179.0";"nM";"6.75";"";"";"UO_0000065";"23.32";"0.42";"3.89";"8.72";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"179.0"
"CHEMBL4287845";"";"None";"351.41";"0";"4.35";"34";"N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL2348350";"";"None";"438.56";"0";"2.40";"15u";"CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1";"Activity";"'='";"82.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806814";"Inhibition of human TYK2 JH1 catalytic domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804286";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 2000.0 nM";"";"";"82.0"
"CHEMBL4089164";"";"None";"379.47";"0";"2.21";"24";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncnc4)cc23)CC[C@]1(C)N";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"17.71";"0.33";"4.51";"5.41";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"190.0"
"CHEMBL4080797";"";"None";"408.51";"0";"2.82";"35";"COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"18.61";"0.35";"4.78";"6.31";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"25.0"
"CHEMBL3675688";"";"None";"362.82";"0";"4.43";"BDBM120131";"O=C(Nc1nccc2nc(-c3c(F)cccc3Cl)sc12)NC1CC1";"Ki";"'='";"1.4";"nM";"8.85";"";"247337";"UO_0000065";"24.40";"0.50";"4.42";"13.23";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1.4"
"CHEMBL2403108";"CERITINIB";"4.0";"558.15";"2";"6.36";"Ceritinib";"Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1614710";"OSI-930";"1.0";"443.45";"1";"6.06";"OSI-930";"O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4789894";"";"None";"320.36";"0";"2.75";"1";"C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(C)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4642527";"";"None";"416.50";"1";"5.07";"34b";"Fc1cccc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)c1";"Activity";"'<'";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4603936";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as enzyme residual activity at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602637";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"10.0"
"CHEMBL3814195";"";"None";"301.39";"0";"0.95";"3g";"NCCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"14.96";"0.28";"3.56";"4.56";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"31.0"
"CHEMBL4444169";"";"None";"418.47";"0";"2.87";"30";"[2H]C([2H])([2H])NC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"16.36";"0.32";"3.93";"6.01";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.16"
"CHEMBL4519857";"";"None";"405.46";"0";"1.67";"8";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H]3CN4C(=O)CC#N)n2)cc1";"IC50";"'='";"774.0";"nM";"6.11";"";"";"UO_0000065";"15.07";"0.28";"4.44";"5.35";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"774.0"
"CHEMBL4471304";"";"None";"389.41";"0";"1.79";"25";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@H]3CC3(F)F)n2)cn1";"IC50";"'='";"702.0";"nM";"6.15";"";"";"UO_0000065";"15.80";"0.30";"4.36";"7.77";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"702.0"
"CHEMBL1163566";"";"None";"488.95";"0";"4.66";"5n";"FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21";"Inhibition";"'='";"72.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"72.0"
"CHEMBL574738";"AST-487";"1.0";"529.57";"2";"5.11";"AST-487";"CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1";"Kd";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.85";"0.21";"0.63";"6.07";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"1800.0"
"CHEMBL1236107";"SGX-523";"1.0";"359.42";"0";"3.22";"SGX-523";"Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4580425";"";"None";"403.48";"0";"4.18";"23";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CC2CCC2)c2cn[nH]c2c1";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"15.12";"0.30";"1.92";"6.42";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.1"
"CHEMBL3359908";"";"None";"272.35";"0";"2.42";"3b";"CC1(C)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"29.73";"0.55";"5.68";"11.18";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"8.0"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"Imatinib";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4438202";"";"None";"388.45";"0";"1.94";"40";"CNC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"22.64";"0.44";"6.86";"7.50";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0016"
"CHEMBL4517645";"";"None";"377.44";"0";"3.79";"21";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C(C)C)c2cn[nH]c2c1";"pIC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";""
"CHEMBL4544386";"";"None";"363.41";"0";"3.03";"20";"CCc1cc(O)c(F)cc1-c1cc(N(C)S(C)(=O)=O)c2cn[nH]c2c1";"pIC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";""
"CHEMBL4516561";"";"None";"335.36";"0";"2.84";"15";"CCS(=O)(=O)Nc1cc(-c2ccc(O)c(F)c2)cc2[nH]ncc12";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"19.68";"0.39";"3.76";"6.94";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.6"
"CHEMBL3939800";"";"None";"349.37";"0";"3.63";"BDBM214689";"Cc1cc(Nc2nc([C@@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1";"Kd";"'='";"1600.0";"nM";"5.80";"";"312375";"UO_0000065";"16.59";"0.30";"2.17";"6.68";"0";"CHEMBL3887154";"Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at room temperature to generate affinity resins. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific binding. Binding reactions were assembled by combining kinase, liganded affinity beads, and test compounds in 1x binding buffer (20% SeaBlock, 0.17xPBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 100x stocks in DMSO and rapidly diluted into the aqueous environment. DMSO was added to control assays lacking a test compound. Primary screen interactions were performed in polypropylene 384-well plates in a final volume of 34 uL, while Kd determinations were performed in polystyrene 96-well plates in a final volume of 135 uL. The assay plates were incubated at room temperature with shaking for 1 hr, long enough for binding reactions to reach equilibrium, and the affinity beads were washed extensively with wash buffer (1xPBS, 0.05% Tween 20) to remove unbound protein. The beads were then resuspended in elution buffer (1xPBS, 0.05% Tween 20, 2 uM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886191";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"1600.0"
"CHEMBL4087655";"";"None";"391.52";"0";"3.73";"8";"Cc1cccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1";"IC50";"'='";"7.9";"nM";"8.10";"";"";"UO_0000065";"20.69";"0.38";"4.37";"8.23";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"7.9"
"CHEMBL4079880";"";"None";"396.47";"0";"2.95";"28";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4F)cc23)CC[C@]1(C)N";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"18.51";"0.35";"4.39";"6.59";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"46.0"
"CHEMBL3354190";"";"None";"367.46";"0";"3.16";"9";"COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C)n2)CC1";"Inhibition";"'<'";"20.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3375811";"Inhibition of Tyk2 (unknown origin) at 1000 nM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"20.0"
"CHEMBL1800685";"PPTN";"None";"475.51";"1";"7.36";"EUB0000274";"O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507292";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"K00013, Pyridone 6";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"29.09";"0.53";"5.01";"14.62";"1";"CHEMBL937052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145498";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"None";"";"";"";"1.0"
"CHEMBL1651521";"";"None";"348.40";"0";"2.55";"1";"COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"15.37";"0.29";"2.81";"5.76";"0";"CHEMBL1656381";"Inhibition of TYK2 by TR-FRET based LanthaScreen assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649097";"1";"Scientific Literature";"ACS Med Chem Lett";"2011";"None";"";"";"";"4400.0"
"CHEMBL4092626";"";"None";"373.39";"0";"1.43";"29";"CN(C)c1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc(F)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.12";"0.40";"6.46";"6.46";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"13.0"
"CHEMBL3309997";"";"None";"363.38";"0";"2.47";"12a";"OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375006";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352169";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"10.0"
"CHEMBL3310151";"";"None";"435.46";"0";"2.07";"17";"CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375006";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352169";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"10.0"
"CHEMBL4073562";"";"None";"392.51";"0";"3.12";"27";"Cc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"21.00";"0.39";"5.12";"7.41";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"5.7"
"CHEMBL2386629";"";"None";"381.40";"0";"3.60";"26";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](NCC(F)(F)F)CC1";"Ki";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"22.20";"0.43";"4.87";"10.75";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"3.4"
"CHEMBL3911320";"";"None";"340.81";"0";"3.78";"13";"Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12";"Inhibition";"'='";"70.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"70.0"
"CHEMBL3939280";"";"None";"385.26";"0";"3.88";"14";"Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12";"Inhibition";"'='";"76.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"76.0"
"CHEMBL607196";"";"None";"380.45";"0";"4.53";"6";"O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1066108";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152632";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"0.0"
"CHEMBL2387129";"";"None";"368.19";"0";"3.94";"25, enantiomer 1";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@@H]2F)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"11.4";"nM";"7.94";"";"";"UO_0000065";"21.57";"0.45";"4.00";"11.17";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"11.4"
"CHEMBL2387119";"";"None";"393.27";"0";"3.71";"14";"CNCc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"EC50";"'='";"273.0";"nM";"6.56";"";"";"UO_0000065";"16.69";"0.34";"2.85";"7.90";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"273.0"
"CHEMBL2387126";"";"None";"416.27";"0";"4.38";"21";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(-c2cn[nH]c2)cc1Cl";"Ki";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"20.34";"0.41";"4.09";"8.49";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"3.4"
"CHEMBL377383";"";"None";"383.86";"0";"2.05";"SID103905002";"CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1981782";"";"None";"335.19";"0";"4.19";"SID103904659";"O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002649";"";"None";"241.25";"0";"1.91";"SID103905117";"COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2";"Ki";"'='";"1995.26";"nM";"5.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1968070";"";"None";"289.68";"0";"1.54";"SID103905636";"NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979855";"";"None";"466.55";"1";"5.22";"SID103904847";"CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005936";"";"None";"436.52";"1";"5.28";"SID103904513";"CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1978099";"";"None";"460.49";"0";"2.18";"SID103904603";"CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1";"Ki";"'='";"63.1";"nM";"7.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.2"
"CHEMBL1972158";"";"None";"366.43";"0";"4.12";"SID103904464";"Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL411903";"";"None";"459.41";"0";"4.80";"SID103905219";"Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1725279";"SP-600125";"None";"220.23";"0";"4.43";"SID103905675";"Oc1c2ccccc2c2c3c(cccc13)N=N2";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL2006933";"";"None";"242.30";"0";"3.21";"SID103905576";"CSc1cnc2c(ccc3cnccc32)c1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965660";"";"None";"348.19";"0";"3.13";"SID103904985";"NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl";"Ki";"'='";"794.33";"nM";"6.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.1"
"CHEMBL1983963";"";"None";"359.39";"0";"4.42";"SID103904275";"Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1981410";"";"None";"455.44";"1";"5.12";"SID103904744";"CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1834657";"INFIGRATINIB PHOSPHATE";"4.0";"658.48";"2";"5.35";"1h, NVP-BGJ398";"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O";"IC50";"'='";"3303.0";"nM";"5.48";"";"";"UO_0000065";"9.78";"0.20";"0.13";"5.76";"0";"CHEMBL1839970";"Inhibition of TYK2-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833940";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"3303.0"
"CHEMBL1081290";"";"None";"376.41";"1";"5.26";"3";"COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"14.53";"0.27";"0.21";"8.32";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"3.4"
"CHEMBL1081975";"";"None";"427.46";"1";"5.81";"6";"COc1cc(Nc2nc3cccc(-c4ccc5ncccc5c4)c3o2)cc(OC)c1OC";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"13.69";"0.25";"0.04";"7.44";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"1.4"
"CHEMBL3114762";"";"None";"483.50";"0";"3.84";"11f";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(O[C@@H]2CCN(c3ccnc(F)c3)C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL1078665";"";"None";"477.35";"0";"4.89";"19";"Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1101783";"Inhibition of TYK2 at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154277";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";"";"50.0"
"CHEMBL1287812";"";"None";"387.35";"0";"2.75";"12";"CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1";"IC50";"'='";"1720.0";"nM";"5.76";"";"";"UO_0000065";"14.88";"0.28";"3.01";"5.14";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"1720.0"
"CHEMBL1287883";"";"None";"394.36";"0";"1.22";"11";"Nc1nc(Nc2cccc(S(N)(=O)=O)c2)nn1C(=O)c1c(F)cccc1F";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"18.14";"0.36";"5.93";"4.90";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"70.0"
"CHEMBL4562491";"";"None";"421.93";"0";"3.52";"8h";"O=C(CCCCCCn1cc(Nc2ncc(Cl)c(N3CCCCC3)n2)cn1)NO";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"17.12";"0.34";"3.70";"6.67";"0";"CHEMBL4347603";"Inhibition of recombinant human TYK2 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.06"
"CHEMBL3703085";"";"None";"386.89";"0";"3.17";"2";"CN(C)[C@H]1CC[C@H](n2cc(C(N)=O)c(Nc3ccc(Cl)cc3)n2)[C@@H](C#N)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"20.38";"0.40";"4.72";"7.89";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"13.0"
"CHEMBL4098999";"";"None";"376.42";"0";"2.58";"25";"N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1C1CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"19.65";"0.36";"4.82";"5.70";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"40.0"
"CHEMBL4079092";"";"None";"377.41";"0";"2.08";"33";"Cc1ncnc2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"20.81";"0.38";"5.77";"5.96";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"14.0"
"CHEMBL2425645";"";"None";"309.37";"0";"2.53";"11";"O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2427783";"Competitive binding affinity to TYK2 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424622";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"50.0"
"CHEMBL4439957";"";"None";"452.43";"0";"2.04";"6q";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"0.035";"nM";"10.46";"";"";"UO_0000065";"23.11";"0.43";"8.42";"8.84";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.035"
"CHEMBL4571920";"";"None";"452.43";"0";"2.04";"6r";"CNc1cc(Nc2cccn(-c3cccc(F)n3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"0.024";"nM";"10.62";"";"";"UO_0000065";"23.47";"0.44";"8.58";"8.98";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.024"
"CHEMBL4454109";"";"None";"433.48";"0";"1.60";"6m";"CNc1cc(Nc2cccn(-c3cc(C)n(C)n3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"135.0";"nM";"6.87";"";"";"UO_0000065";"15.85";"0.29";"5.27";"5.58";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"135.0"
"CHEMBL4754005";"";"None";"383.42";"0";"2.54";"28, trans isomer";"Cn1ccc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)n1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"18.71";"0.34";"4.63";"6.33";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"67.0"
"CHEMBL4758753";"";"None";"388.44";"0";"2.41";"18, trans isomer";"CO[C@H]1C[C@](CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"19.71";"0.36";"5.25";"7.75";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"22.0"
"CHEMBL399410";"";"None";"453.57";"1";"5.72";"SB-437013";"COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1";"Inhibition";"'='";"-4.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.84"
"CHEMBL1909402";"GW568326X";"None";"373.31";"0";"4.20";"GW568326X";"Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1";"Inhibition";"'='";"-4.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.56"
"CHEMBL1991078";"";"None";"454.49";"0";"4.14";"SID103904505";"COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC";"Ki";"'='";"19.95";"nM";"7.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.7"
"CHEMBL2000393";"";"None";"420.38";"0";"3.11";"SID103905603";"O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21";"Ki";"'='";"63.1";"nM";"7.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.2"
"CHEMBL1974935";"";"None";"370.46";"0";"4.08";"SID103904749";"NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL526133";"";"None";"288.31";"0";"2.98";"SID103904527";"O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987007";"";"None";"340.45";"0";"3.12";"SID103904998";"CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1967878";"CENISERTIB";"2.0";"451.55";"0";"2.51";"SID103904402";"Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1";"Ki";"'='";"6.31";"nM";"8.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"8.2"
"CHEMBL1998121";"";"None";"363.25";"0";"3.94";"SID103904657";"NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996817";"";"None";"267.33";"0";"3.80";"SID103904502";"CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982466";"";"None";"454.56";"1";"5.90";"SID103904290";"Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975787";"";"None";"290.29";"0";"3.34";"SID103905044";"NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2420859";"";"None";"303.17";"0";"3.19";"22";"O=S(=O)(Nc1ccncc1)c1c(Cl)cccc1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL4224807";"";"None";"284.32";"0";"0.91";"6";"CN(c1ncnc2[nH]ccc12)[C@@H]1CCN(C(=O)CC#N)C1";"Inhibition";"'>'";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4220897";"Inhibition of recombinant human TYK2 (875-end residues) at 10 uM in presence of ATP relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219073";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"90.0"
"CHEMBL408019";"";"None";"294.31";"0";"2.68";"13";"O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL1909367";"GW680908A";"None";"587.94";"2";"5.38";"GW680908A";"COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl";"Inhibition";"'='";"-1.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.55"
"CHEMBL1909411";"";"None";"393.87";"0";"4.96";"GI261520A";"COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl";"Inhibition";"'='";"-2.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.4"
"CHEMBL1984162";"";"None";"527.63";"2";"5.72";"SID103904784";"COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1";"Ki";"'='";"630.96";"nM";"6.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.2"
"CHEMBL3545154";"POZIOTINIB";"3.0";"491.35";"1";"5.38";"Poziotinib";"C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1822792";"MK-2461";"2.0";"495.56";"0";"2.15";"MK-2461";"CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1287971";"";"None";"315.28";"0";"2.57";"18";"Nc1nc(Nc2ccccc2)nn1C(=O)c1c(F)cccc1F";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"20.44";"0.38";"3.87";"7.51";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"360.0"
"CHEMBL4785812";"";"None";"455.34";"0";"2.77";"29";"CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21";"Inhibition";"'='";"5.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4667278";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (833 to 1187 residues) expressed in baculovirus expression system using Tyr 03 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665648";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"Dose = 10.0 microM | TIME = 1.0 hr";"";"";"5.5"
"CHEMBL1980391";"RG-1530";"1.0";"356.79";"0";"4.75";"SID103905607";"COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2";"Ki";"'='";"50.12";"nM";"7.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.3"
"CHEMBL2007044";"";"None";"367.46";"0";"3.61";"SID103904810";"CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL375284";"";"None";"342.40";"1";"5.18";"SID103904328";"Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL1995172";"";"None";"235.08";"0";"2.74";"SID103905581";"Brc1ccc2c(c1)-c1[nH]ncc1C2";"Ki";"'>'";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.0"
"CHEMBL1964307";"";"None";"356.43";"0";"4.30";"SID103905033";"Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL553";"ERLOTINIB";"4.0";"393.44";"0";"3.41";"SID103905339";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972221";"";"None";"386.48";"0";"3.73";"SID103905136";"CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1";"Ki";"'='";"79.43";"nM";"7.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.1"
"CHEMBL1977619";"";"None";"245.26";"0";"2.16";"SID103905074";"O=C(O)c1cc(-c2cccs2)n2nccc2n1";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL4465866";"";"None";"901.82";"None";"None";"8a";"CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"8.98";"None";"None";"None";"0";"CHEMBL4322752";"Binding affinity to recombinant N-terminal His-FLAG-GST-tagged TYK2 (unknown origin) (871 to 1187 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321812";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308860";"";"";"";"8.0"
"CHEMBL4530719";"";"None";"401.42";"0";"2.61";"29";"CS(=O)(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"23.65";"0.46";"6.88";"7.47";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00032"
"CHEMBL4544320";"";"None";"397.46";"0";"2.73";"38";"CNC(=O)c1cnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"0.95";"nM";"9.02";"";"";"UO_0000065";"22.70";"0.44";"6.29";"7.98";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00095"
"CHEMBL4559521";"";"None";"394.41";"0";"2.95";"6";"CCNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.0"
"CHEMBL4476830";"";"None";"403.36";"0";"3.75";"22";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccc(F)c(F)c1OC";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"21.88";"0.42";"5.07";"10.01";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0015"
"CHEMBL4460194";"";"None";"367.38";"0";"3.47";"21";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1OC";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"14.92";"0.28";"2.01";"6.22";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"3.3"
"CHEMBL4537678";"";"None";"380.38";"0";"2.56";"5";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.0"
"CHEMBL4438202";"";"None";"388.45";"0";"1.94";"40";"CNC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"16.76";"0.33";"4.57";"5.55";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.31"
"CHEMBL1834657";"INFIGRATINIB PHOSPHATE";"4.0";"658.48";"2";"5.35";"1h, NVP-BGJ398";"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1839927";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"10.0"
"CHEMBL4288673";"";"None";"320.40";"0";"2.98";"7a";"CN(C)CCCn1c(=O)c2ccccc2c2cnc3[nH]ccc3c21";"IC50";"'='";"708.65";"nM";"6.15";"";"";"UO_0000065";"19.19";"0.35";"3.17";"11.40";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"708.65"
"CHEMBL4279819";"";"None";"310.36";"0";"1.30";"(R)-6c";"CN(c1ncnc2[nH]ccc12)[C@H]1CN(C(=O)CC#N)CC12CC2";"Inhibition";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4258489";"Inhibition of human TYK2 at 10 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257478";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";"";"90.0"
"CHEMBL4247298";"";"None";"586.70";"2";"5.44";"15i";"Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4230996";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229344";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"100.0"
"CHEMBL4100288";"";"None";"311.35";"0";"1.83";"7; 13";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccccc2)n1";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"27.42";"0.51";"6.71";"8.06";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"2.9"
"CHEMBL4555459";"";"None";"481.60";"1";"5.59";"43";"O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1";"Inhibition";"'='";"0.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4389524";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"0.6"
"CHEMBL4785957";"";"None";"436.49";"0";"2.70";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C)cn2)c1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.19";"0.34";"5.19";"6.02";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL4799031";"";"None";"422.46";"0";"2.39";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncccn2)c1OC";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"17.35";"0.32";"4.89";"5.55";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"53.0"
"CHEMBL4799019";"";"None";"452.49";"0";"2.40";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(OC)cn2)c1OC";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"15.65";"0.29";"4.64";"5.02";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"92.0"
"CHEMBL4785512";"";"None";"492.55";"0";"2.70";"27";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"15.07";"0.28";"4.68";"5.33";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"42.0"
"CHEMBL4460368";"";"None";"451.47";"0";"1.55";"6s";"CNc1cc(Nc2cccn(-c3cc(C)n(C)n3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"16.96";"0.32";"6.11";"6.22";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"22.0"
"CHEMBL4547009";"";"None";"379.42";"0";"1.90";"6b";"CNc1cc(Nc2cccn(C3CC3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"817.0";"nM";"6.09";"";"";"UO_0000065";"16.04";"0.30";"4.19";"5.78";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"817.0"
"CHEMBL4585272";"";"None";"416.45";"0";"1.95";"6g";"CNc1cc(Nc2cccn(-c3ccncc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"346.0";"nM";"6.46";"";"";"UO_0000065";"15.51";"0.28";"4.51";"5.46";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"346.0"
"CHEMBL185569";"";"None";"357.41";"0";"4.55";"SID103904337";"Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997846";"";"None";"327.82";"0";"4.42";"SID103904204";"Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1";"Ki";"'='";"1584.89";"nM";"5.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL1985566";"";"None";"560.65";"2";"6.20";"SID103904723";"COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1983534";"";"None";"317.42";"0";"4.97";"SID103904564";"c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996780";"";"None";"400.43";"0";"4.24";"SID103905358";"CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL377408";"";"None";"375.41";"0";"0.51";"SID103905185";"CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004716";"";"None";"542.71";"2";"5.97";"SID103904320";"CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12";"Ki";"'='";"794.33";"nM";"6.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.1"
"CHEMBL1976090";"";"None";"218.25";"0";"0.80";"SID103905284";"Nc1ncnc2c1sc1ncnc(N)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1964399";"";"None";"425.49";"0";"3.42";"SID103904938";"COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996234";"";"None";"421.50";"0";"4.82";"SID103905463";"CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1967544";"";"None";"497.62";"0";"4.67";"SID103905145";"CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4846921";"";"None";"508.67";"1";"4.62";"26";"CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1";"Inhibition";"'='";"95.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4839041";"Inhibition of TYK2 (unknown origin) at 0.1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4837239";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 0.1 microM";"INHIBITOR";"";"95.9"
"CHEMBL4568120";"";"None";"388.83";"0";"3.29";"G28_14";"C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl";"Activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4335333";"Inhibition of human TYK2 (875 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334438";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"94.0"
"CHEMBL4238926";"";"None";"326.40";"0";"2.01";"2";"NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.49";"0.47";"6.31";"8.00";"0";"CHEMBL4341336";"Inhibition of human TYK2 kinase domain using biotin-IRS1-substrate as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340527";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"4.8"
"CHEMBL4472924";"";"None";"320.40";"0";"3.45";"15";"NC(=O)c1cnn2cc(-c3ccccc3)cc2c1NC1CCCC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"24.03";"0.44";"4.25";"10.63";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"20.0"
"CHEMBL4450347";"";"None";"340.38";"0";"1.25";"24";"C[C@H](O)[C@@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"19.62";"0.36";"5.43";"5.92";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"210.0"
"CHEMBL4526351";"BAY-309";"None";"519.50";"2";"7.41";"EUB0000703";"Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1";"% Control";"'='";"51.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507270";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"51.0"
"CHEMBL1986869";"";"None";"367.46";"0";"3.96";"SID103905569";"Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001547";"";"None";"424.46";"0";"3.88";"SID103904774";"CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965131";"";"None";"379.27";"0";"4.87";"SID103904746";"Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4453545";"";"None";"412.48";"0";"2.43";"37";"CNC(=O)c1cnc(Nc2ccc(C)nn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"15.03";"0.29";"3.77";"4.92";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.63"
"CHEMBL4587406";"";"None";"420.52";"0";"2.56";"14";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cc1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.82";"0.33";"4.93";"8.29";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"32.0"
"CHEMBL1967302";"";"None";"398.47";"0";"3.67";"SID103904477";"NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969537";"";"None";"320.43";"0";"2.80";"SID103905585";"S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991356";"";"None";"290.32";"0";"3.46";"SID103904914";"COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1965836";"";"None";"442.44";"0";"4.78";"SID103904463";"Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4802045";"BAY-091";"None";"440.48";"1";"5.56";"EUB0001564";"CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O";"Inhibition";"'='";"1.22";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4888101";"TYK2(h) Millipore kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4800729";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"1.22"
"CHEMBL2001920";"";"None";"341.21";"0";"2.26";"SID103905481";"O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1077575";"";"None";"414.47";"0";"3.58";"31";"N#CCC(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4744519";"";"None";"377.41";"0";"2.58";"37";"COCCn1cc(Nc2nccc(-c3ccc(NC(=O)CC#N)cc3)n2)cn1";"IC50";"'='";"2496.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"2496.0"
"CHEMBL1078166";"";"None";"414.47";"0";"3.58";"39";"N#CCC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4749141";"";"None";"367.48";"0";"3.23";"44";"Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1";"Activity";"'='";"47.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4674073";"Inhibition of human TYK2 assessed as residual activity using KKSRGDYMTMQIG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673210";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 1.0 microM";"INHIBITOR";"";"47.04"
"CHEMBL4796925";"";"None";"378.40";"0";"2.19";"14l; YD57";"C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1";"Activity";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4686935";"Inhibition of human recombinant TYK2 (875 to end residues) assessed as residual activity using GGMEDIYFEFMGG as substrate at 1 uM incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680251";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"Dose = 1.0 microM | TIME = 0.6667 hr";"INHIBITOR";"";"15.0"
"CHEMBL2420823";"";"None";"358.23";"1";"5.38";"33";"O=C(Nc1ccnc(Nc2ccccc2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"19.13";"0.39";"1.47";"12.69";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.14"
"CHEMBL4466720";"";"None";"406.42";"0";"3.09";"7";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(=O)NC1CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"18.41";"0.34";"4.39";"6.13";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.033"
"CHEMBL1978014";"";"None";"415.50";"0";"2.91";"SID103904547";"CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1682346";"";"None";"290.33";"0";"2.45";"SID103904471";"Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988838";"";"None";"428.47";"0";"1.78";"SID103904596";"Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1";"Ki";"'='";"25.12";"nM";"7.60";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.6"
"CHEMBL2387218";"";"None";"394.21";"0";"3.30";"32";"O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@@H]2C(=O)O)c1)c1c(Cl)cccc1Cl";"EC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5.0"
"CHEMBL1976455";"";"None";"333.27";"0";"3.69";"SID103904884";"O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4101734";"";"None";"357.24";"1";"5.56";"4";"O=C(Nc1nccc2cc(-c3c(Cl)cccc3Cl)ccc12)C1CC1";"Ki";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"21.75";"0.44";"2.21";"18.50";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.017"
"CHEMBL4086518";"";"None";"347.21";"0";"4.28";"5";"O=C(Nc1cc2nc(-c3c(Cl)cccc3Cl)[nH]c2cn1)C1CC1";"Ki";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"15.71";"0.32";"1.18";"7.72";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"3.5"
"CHEMBL4068427";"";"None";"348.19";"0";"4.55";"9";"O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)oc12)C1CC1";"Ki";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"23.14";"0.48";"3.51";"11.84";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0088"
"CHEMBL4850588";"";"None";"435.84";"0";"4.86";"11b";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3ccccc3Cl)n2)cc1";"IC50";"'='";"39.07";"nM";"7.41";"";"";"UO_0000065";"17.00";"0.34";"2.55";"9.38";"0";"CHEMBL4824349";"Inhibition of TYK2 (unknown origin) measured after 40 mins by HTRF";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4823267";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"39.07"
"CHEMBL2420834";"";"None";"366.25";"0";"4.63";"44";"CC(C)(C)C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL4789693";"";"None";"411.94";"0";"4.04";"31b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)[C@@H](C)C1";"GI50";"'='";"4752.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"4.752"
"CHEMBL4288300";"";"None";"352.39";"0";"3.99";"Yfq07";"COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4267277";"Inhibition of human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265907";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"0.0"
"CHEMBL4282460";"";"None";"334.76";"0";"3.07";"Yfq71";"O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1";"Inhibition";"'='";"-0.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4267277";"Inhibition of human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265907";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"-0.6"
"CHEMBL4537782";"";"None";"445.57";"0";"3.93";"13e";"CCC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL4237340";"";"None";"337.39";"0";"1.00";"10g";"Cn1cc(-c2nn(CC3CCN(C#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4245422";"";"None";"382.43";"0";"0.88";"11b";"C=CC(=O)N1CCC(n2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"1722.2";"nM";"5.76";"";"";"UO_0000065";"15.07";"0.28";"4.88";"4.93";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"1722.2"
"CHEMBL450519";"";"None";"309.37";"0";"2.31";"17";"Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1";"Activity";"'='";"13.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"13.4"
"CHEMBL4247506";"";"None";"472.47";"1";"5.62";"2a";"CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21";"Inhibition";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4230251";"Inhibition of TYK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229333";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"2.0"
"CHEMBL3736320";"";"None";"464.45";"0";"4.66";"1";"CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21";"Inhibition";"'='";"31.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4230251";"Inhibition of TYK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229333";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"31.0"
"CHEMBL4065613";"";"None";"339.42";"0";"0.49";"33";"COCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4285755";"";"None";"336.40";"0";"2.76";"11";"Cc1cc(C)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"22.76";"0.42";"4.90";"7.87";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.022"
"CHEMBL4283351";"";"None";"338.42";"0";"2.91";"31";"CNc1cc(Nc2cccc(C(C)(C)C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"23.30";"0.43";"4.98";"8.10";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.013"
"CHEMBL4647506";"";"None";"247.30";"0";"1.58";"33";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](O)CC3)c12";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"21.74";"0.41";"3.80";"6.58";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"4.2"
"CHEMBL4648820";"";"None";"282.35";"0";"2.60";"42";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4C[C@@H]3C[C@H]4CC#N)c12";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"22.96";"0.42";"3.88";"7.60";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.33"
"CHEMBL4125861";"";"None";"483.58";"0";"4.36";"28";"CN1CCN(C(=O)C(C#N)=Cc2ccc(-c3nc4cnc5[nH]ccc5c4n3C3CCCCC3)o2)CC1";"IC50";"'='";"791.0";"nM";"6.10";"";"";"UO_0000065";"12.62";"0.23";"1.74";"5.70";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"791.0"
"CHEMBL5203504";"";"None";"324.34";"0";"2.88";"7";"CC(C)c1nc(Nc2ccc(C(=O)O)cc2)c2c(=O)[nH]ccc2n1";"Ki";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"26.15";"0.48";"5.60";"7.86";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"3.3"
"CHEMBL5170973";"";"None";"451.43";"0";"2.88";"19; 28";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCOCC4)cn3)c21";"Ki";"'='";"0.83";"nM";"9.08";"";"";"UO_0000065";"20.12";"0.38";"6.20";"9.42";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.83"
"CHEMBL5181976";"";"None";"437.41";"0";"2.77";"22";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCOCC4=O)cn3)c21";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"16.12";"0.30";"4.28";"7.31";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.08900000000000001"
"CHEMBL5182688";"";"None";"450.45";"0";"3.49";"29";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCOCC4)cc3)c21";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"15.65";"0.29";"3.56";"8.44";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.08900000000000001"
"CHEMBL4787974";"";"None";"423.95";"0";"4.18";"20c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(Cl)cc1";"IC50";"'='";"134.0";"nM";"6.87";"";"";"UO_0000065";"16.21";"0.31";"2.69";"9.41";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"134.0"
"CHEMBL4741376";"";"None";"407.52";"0";"3.40";"30e";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccc(OC)cc2)CC1";"IC50";"'='";"51.2";"nM";"7.29";"";"";"UO_0000065";"17.89";"0.33";"3.89";"8.86";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"51.2"
"CHEMBL5403283";"";"None";"480.57";"1";"5.03";"A2";"Cc1cnc(Nc2ccc(CNC(=O)/C=C/C(=O)c3ccccc3)cc2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"15.33";"0.28";"2.34";"7.24";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"43.0"
"CHEMBL4747742";"";"None";"411.48";"0";"2.96";"32c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@@H]1F";"GI50";"'='";"9654.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"9.654"
"CHEMBL4445892";"";"None";"453.52";"0";"2.40";"18";"CCNC(=O)c1ncc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cc1C";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"16.14";"0.30";"4.92";"7.08";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"48.0"
"CHEMBL2420855";"";"None";"300.67";"0";"4.01";"18";"O=C(Nc1ccncc1)c1ccc(C(F)(F)F)cc1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"641.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445113";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-6 induced pSTAT3 (CD3+ cells), JAK1/JAK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"641.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"EUB0001543a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5444446";"Affinity Phenotypic Cellular interaction: (Human whole blood assay (phosphorylation of STAT5, IFN+- as stimulant to assess TYK2 potency in CD3+ T-cells)) EUB0001543a TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"Mode of action: Allosteric inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00444";"";"";"13.0"
"CHEMBL4779060";"";"None";"411.94";"0";"4.04";"31f";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)[C@H](C)C1";"IC50";"'='";"48.6";"nM";"7.31";"";"";"UO_0000065";"17.75";"0.34";"3.27";"10.01";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"48.6"
"CHEMBL5401385";"";"None";"495.49";"1";"2.51";"4e";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(OCC)nn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"18.73";"0.35";"6.71";"5.70";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.6"
"CHEMBL3991933";"";"None";"308.35";"0";"3.11";"Sapanisertib";"Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL496102";"AMG-208";"2.0";"383.41";"0";"3.93";"AMG-208";"COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2387112";"";"None";"366.20";"0";"3.69";"7";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(O)cc1Cl";"Ki";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"23.23";"0.48";"4.82";"9.32";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"3.1"
"CHEMBL2387110";"";"None";"407.26";"0";"3.95";"5";"CC(=O)Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"20.93";"0.43";"4.57";"8.51";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"3.0"
"CHEMBL462018";"TRICIRIBINE PHOSPHATE";"2.0";"400.29";"1";"-1.77";"Triciribine";"CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL377300";"BRIVANIB";"3.0";"370.38";"0";"3.52";"Brivanib";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3039517";"RABUSERTIB";"2.0";"436.31";"0";"2.87";"Rabusertib";"Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2387133";"";"None";"380.23";"0";"3.21";"29";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2CO)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"14.6";"nM";"7.84";"";"";"UO_0000065";"20.61";"0.43";"4.63";"8.58";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"14.6"
"CHEMBL2387124";"";"None";"375.21";"0";"3.86";"19";"N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"23.31";"0.48";"4.88";"9.22";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.8"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3545308";"ROCILETINIB";"3.0";"555.56";"1";"4.78";"Rociletinib";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3991934";"";"None";"591.54";"1";"4.90";"ACTB-1003";"COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4870304";"";"None";"499.53";"0";"3.51";"IV";"COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F";"Activity";"'='";"79.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4805798";"Inhibition of human TYK2 JH2 pseudokinase domain assessed as percent of control at 1000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804283";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 1000.0 nM";"";"";"79.0"
"CHEMBL5407458";"";"None";"357.44";"0";"2.96";"Example 256";"CC(=O)Nc1cc2c(cn1)c(C)nn2-c1nc(C2CCOC2)c(C)s1";"IC50";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5346250";"Inhibition of human TYK2 JH2 domain (575 to 876 residues) incubated for 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5344452";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME = 1.0 hr";"INHIBITOR";"";"10.0"
"CHEMBL4756648";"";"None";"421.46";"0";"1.97";"24";"C=CC(=O)NCC(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4743357";"";"None";"415.50";"0";"4.24";"30";"C/C=C/C(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1";"IC50";"'='";"2653.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"2653.0"
"CHEMBL273611";"";"None";"459.48";"0";"4.59";"SB-250715";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1";"Inhibition";"'='";"-3.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.97"
"CHEMBL1909342";"";"None";"395.44";"0";"1.77";"SB-657836-AAA";"N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O";"Inhibition";"'='";"-0.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.83"
"CHEMBL212250";"GW615311X";"None";"644.12";"2";"8.00";"GW615311X";"O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1";"Inhibition";"'='";"-3.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.63"
"CHEMBL3924291";"";"None";"375.43";"0";"3.73";"BDBM198195";"O=C(OCc1ccccc1)N1CCCC(c2ncn3cnc4[nH]ccc4c23)C1";"IC50";"'>'";"1000.0";"nM";"";"";"351827";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL1909341";"GW641155A";"None";"364.83";"1";"5.88";"GW641155A";"Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1";"Inhibition";"'='";"-0.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.96"
"CHEMBL1909354";"GW459057A";"None";"390.88";"0";"4.11";"GW459057A";"Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl";"Inhibition";"'='";"-2.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.42"
"CHEMBL194062";"GW572399X";"None";"315.35";"0";"2.73";"GW572399X";"NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1";"Inhibition";"'='";"2.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.33"
"CHEMBL1909361";"GW830365A";"None";"576.12";"1";"2.99";"GW830365A";"CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl";"Inhibition";"'='";"-0.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.59"
"CHEMBL1794056";"GW301789X";"None";"303.32";"0";"2.67";"GW301789X";"O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1";"Inhibition";"'='";"12.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"12.32"
"CHEMBL2152302";"";"None";"331.42";"0";"3.75";"9";"c1ccc(CN2CCC[C@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1";"Ki";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"21.57";"0.39";"3.40";"14.37";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"71.0"
"CHEMBL4526274";"";"None";"450.33";"0";"4.53";"8m";"O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"16.23";"0.33";"2.78";"6.25";"0";"CHEMBL4347603";"Inhibition of recombinant human TYK2 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.049"
"CHEMBL2387221";"";"None";"393.20";"0";"3.81";"35";"N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"Ki";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"22.52";"0.47";"5.04";"9.33";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.4"
"CHEMBL2387134";"";"None";"375.21";"0";"3.74";"30";"N#C[C@@H]1C[C@@H]1C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"21.43";"0.44";"4.30";"8.47";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"9.1"
"CHEMBL4777648";"";"None";"422.46";"0";"2.39";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccncn2)c1OC";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"18.35";"0.34";"5.31";"5.88";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"20.0"
"CHEMBL3359929";"";"None";"276.32";"0";"2.13";"5i";"C[C@@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"25.18";"0.48";"4.83";"9.61";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"110.0"
"CHEMBL4467881";"";"None";"383.45";"0";"2.32";"16";"COc1ccc(-c2cc3c(N[C@H](CO)CC(C)C)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"17.59";"0.33";"4.42";"5.88";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"180.0"
"CHEMBL4568896";"";"None";"357.37";"0";"0.27";"20";"COc1ccc(-c2cc3c(NC(CO)CO)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"18.14";"0.34";"6.21";"4.80";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"330.0"
"CHEMBL4634634";"";"None";"365.44";"0";"1.44";"29";"C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4603642";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain (833 to 1187 residues) expressed in baculovirus expression system using tyrosine-3 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"100.0"
"CHEMBL4647115";"";"None";"282.35";"0";"2.60";"39";"Cc1[nH]nc2[nH]c(=O)cc([C@@H]3C[C@@H]4C[C@H]3C[C@H]4CC#N)c12";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"23.89";"0.44";"4.14";"7.90";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.18"
"CHEMBL2425646";"";"None";"308.38";"0";"3.14";"12";"O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2427783";"Competitive binding affinity to TYK2 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424622";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"50.0"
"CHEMBL3310332";"";"None";"428.50";"0";"3.46";"9a";"Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1";"Activity";"'='";"2.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3366589";"Inhibition of TYK2 JH1 domain catalytic (unknown origin) assessed as residual activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352819";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"2.6"
"CHEMBL3359917";"";"None";"302.38";"0";"1.78";"4f";"CC1(C)C[C@](C)(O)C[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"23.30";"0.44";"5.27";"7.60";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"90.0"
"CHEMBL3359927";"";"None";"276.32";"0";"2.13";"5g";"C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"31.48";"0.59";"6.57";"12.01";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"2.0"
"CHEMBL2420821";"";"None";"324.17";"0";"3.60";"31";"CC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"21.65";"0.46";"3.42";"9.87";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.096"
"CHEMBL4291611";"";"None";"358.41";"0";"3.28";"32";"CNc1cc(Nc2cccc(-c3ccccc3)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"23.43";"0.42";"5.12";"8.63";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.004"
"CHEMBL4283351";"";"None";"338.42";"0";"2.91";"31";"CNc1cc(Nc2cccc(C(C)(C)C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"18.59";"0.34";"3.38";"6.46";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.51"
"CHEMBL4293510";"";"None";"488.42";"0";"4.92";"34";"NC(=O)c1cnc2c(N[C@H]3C[C@H]3F)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"13.08";"0.25";"1.47";"6.56";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.41"
"CHEMBL4290130";"";"None";"518.47";"1";"3.55";"35";"C[C@](O)(CO)CNc1cc(Nc2cccc(-c3ccc(C(F)(F)F)cc3F)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"11.78";"0.23";"2.56";"4.43";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.78"
"CHEMBL5406364";"";"None";"452.47";"0";"2.66";"2h";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cc2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"19.93";"0.37";"6.30";"6.80";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"1.1"
"CHEMBL5439728";"";"None";"449.49";"1";"2.23";"2j";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cccc(C)n2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.09";"nM";"10.05";"";"";"UO_0000065";"22.50";"0.42";"7.82";"6.94";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.09"
"CHEMBL5433636";"";"None";"456.48";"1";"1.10";"3d";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2noc(CNC)n2)c1OC";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"18.47";"0.35";"7.28";"4.95";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"4.2"
"CHEMBL5408060";"";"None";"427.44";"0";"1.69";"3c";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2noc(C)n2)c1OC";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.48";"0.33";"5.73";"4.72";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"38.0"
"CHEMBL5399546";"";"None";"416.42";"1";"0.96";"2g";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)OC)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"175.0";"nM";"6.76";"";"";"UO_0000065";"16.34";"0.31";"5.80";"4.27";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"175.0"
"CHEMBL5420187";"";"None";"535.56";"2";"2.55";"4f";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(N3CCOCC3)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"13.68";"0.26";"4.73";"4.79";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"52.0"
"CHEMBL3137308";"PEFICITINIB";"4.0";"326.40";"0";"2.01";"4";"NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.49";"0.47";"6.31";"8.00";"1";"CHEMBL5346998";"Inhibition of human TYK2 using Biotin-IRS1-Substrate as substrate assessed as reduction in rate of substrate phosphorylation incubated for 1 hr in presence of ATP by ELISA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"4.8"
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"21";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5347014";"Inhibition of TYK2 (unknown origin) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"";"";"10.0"
"CHEMBL5082928";"";"None";"342.37";"0";"2.69";"46b";"CCc1cc(O)c(F)cc1-c1cc(NCCO)c2nc(N)ncc2c1";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"20.15";"0.38";"4.21";"6.62";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.9"
"CHEMBL5075223";"";"None";"409.51";"0";"4.04";"51c";"CCc1cc(O)c(F)cc1-c1cc(NCC2CCN(C)CC2)c2nc(N)ncc2c1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"15.87";"0.30";"2.46";"7.45";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.5"
"CHEMBL4777645";"";"None";"377.41";"0";"1.95";"5";"C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CC(=O)NC)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL2322136";"";"None";"254.34";"0";"3.50";"6";"Cn1nc(C2CCCCC2)c2c3cc[nH]c3ncc21";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"25.65";"0.47";"3.02";"14.03";"0";"CHEMBL2327342";"Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321825";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"0.3"
"CHEMBL4526283";"";"None";"415.45";"0";"2.87";"38";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"21.75";"0.43";"6.17";"7.99";"1";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.92"
"CHEMBL1909404";"GW581744X";"None";"406.42";"0";"2.49";"GW581744X";"NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1";"Inhibition";"'='";"-5.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.12"
"CHEMBL1882194";"GW780056X";"None";"373.46";"0";"3.77";"GW780056X";"CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1";"Inhibition";"'='";"-7.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.84"
"CHEMBL4096821";"";"None";"378.40";"0";"1.41";"19";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(-n3ccnn3)cc2)n1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"24.58";"0.45";"7.89";"6.81";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.5"
"CHEMBL160876";"";"None";"377.18";"0";"3.17";"SB-360741";"O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1";"Inhibition";"'='";"0.43";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.43"
"CHEMBL473629";"GSK-204925A";"None";"423.49";"0";"3.82";"GSK204925A";"COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-3.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.55"
"CHEMBL1794062";"GW577921A";"None";"302.76";"0";"4.09";"GW577921A";"COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl";"Inhibition";"'='";"-0.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.92"
"CHEMBL3589177";"";"None";"456.55";"0";"3.87";"14";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CC[C@H](N(C)C)C5)ccc4c3c2)c1";"IC50";"'='";"243.0";"nM";"6.61";"";"";"UO_0000065";"14.49";"0.27";"2.74";"7.22";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"243.0"
"CHEMBL3589179";"";"None";"371.44";"0";"3.92";"16";"NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1cc(N3CCOCC3)ccc12";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"18.31";"0.33";"2.88";"9.53";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"158.0"
"CHEMBL1996791";"";"None";"359.17";"0";"1.49";"SID103904789";"Nc1ncnc2c1c(I)nn2C1CCC(O)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL111612";"ABT-546";"None";"532.72";"2";"5.54";"EUB0000348";"CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507258";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4747591";"";"None";"389.41";"0";"1.79";"Brepocitinib";"Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"21.27";"0.40";"6.49";"10.46";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"5.2"
"CHEMBL5268371";"";"None";"560.63";"1";"3.71";"6";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"Tm";"'='";"60.58";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"60.58"
"CHEMBL5281991";"";"None";"574.66";"1";"4.10";"7";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCCC3=O)cc2)c1OC";"Tm";"'='";"59.57";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"59.57"
"CHEMBL5279644";"";"None";"570.63";"1";"3.78";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(C4CC4)n3)cc2)c1OC";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"14.66";"0.27";"4.54";"5.04";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"4.8"
"CHEMBL495771";"GW708336X";"None";"337.39";"0";"1.60";"GW708336X";"c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1";"Inhibition";"'='";"-8.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.45"
"CHEMBL1909400";"";"None";"557.55";"1";"5.48";"SB-284847-BT";"Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F";"Inhibition";"'='";"-2.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.76"
"CHEMBL65884";"GW817396X";"None";"362.37";"0";"3.41";"GW817396X";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1";"Inhibition";"'='";"-1.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.74"
"CHEMBL1794050";"GW429374A";"None";"508.60";"1";"5.47";"GW429374A";"Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1";"Inhibition";"'='";"6.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"6.13"
"CHEMBL1909355";"GW461104A";"None";"528.46";"0";"4.42";"GW461104A";"CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl";"Inhibition";"'='";"-3.18";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.18"
"CHEMBL306865";"GW784752X";"None";"345.37";"0";"2.67";"GW784752X";"COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1";"Inhibition";"'='";"-2.74";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.74"
"CHEMBL160937";"";"None";"314.73";"0";"2.53";"SB-390527";"O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1";"Inhibition";"'='";"-2.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.87"
"CHEMBL595143";"";"None";"541.68";"2";"5.72";"24";"COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1";"Residual activity";"'='";"72.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1073365";"Residual activity of TYK2 at 10 uM by microplate scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152560";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";"";"72.0"
"CHEMBL361894";"GW806290X";"None";"346.35";"0";"2.70";"GW806290X";"c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1";"Inhibition";"'='";"12.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"12.75"
"CHEMBL189148";"GW829055X";"None";"398.86";"1";"5.25";"GW829055X";"Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1";"Inhibition";"'='";"-0.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.64"
"CHEMBL374453";"GSK-299115A";"None";"415.28";"0";"4.39";"GSK299115A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1";"Inhibition";"'='";"3.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.29"
"CHEMBL514938";"GSK-969786A";"None";"451.91";"1";"7.07";"GSK969786A";"Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1";"Inhibition";"'='";"-2.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.62"
"CHEMBL1785003";"";"None";"486.55";"0";"4.28";"SB-264866";"NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"-0.18";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.18"
"CHEMBL1164265";"";"None";"470.96";"0";"4.26";"5h";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168301";"Inhibition of TYK2 JH2 pseudokinase domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL249097";"";"None";"335.37";"0";"3.08";"9";"Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1";"Activity";"'='";"6.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"6.05"
"CHEMBL1163566";"";"None";"488.95";"0";"4.66";"5n";"FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168301";"Inhibition of TYK2 JH2 pseudokinase domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL156263";"";"None";"294.31";"0";"2.17";"SB-376719";"COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O";"Inhibition";"'='";"-1.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.53"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"AC220";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL2322140";"";"None";"255.36";"0";"3.65";"33";"c1cc2c3c(cnc2[nH]1)CCCN3C1CCCCC1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"24.58";"0.45";"2.63";"19.66";"0";"CHEMBL2327342";"Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321825";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"0.53"
"CHEMBL5415406";"";"None";"366.42";"0";"2.86";"12";"CO[C@@]1(c2cccc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"20.53";"0.38";"4.66";"9.61";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.03"
"CHEMBL3651966";"LGH-447";"1.0";"440.47";"1";"5.04";"EUB0001581a";"C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1";"% of control";"'='";"88.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5480289";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001581a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, using TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01275";"";"";"88.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"GI50";"'='";"7191.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"7.191"
"CHEMBL1972250";"";"None";"312.33";"0";"2.90";"SID103904815";"C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL379835";"";"None";"325.76";"0";"3.54";"SID103905221";"Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1968850";"";"None";"246.66";"0";"2.44";"SID103905413";"O=C1Nc2ccccc2Nc2nnc(Cl)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL484390";"";"None";"457.58";"1";"5.50";"SID103905078";"CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL52387";"(RS)-ROSCOVITINE";"None";"354.46";"0";"3.20";"SID103905125";"CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4759320";"";"None";"423.95";"0";"4.18";"20b";"CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1cccc(Cl)c1";"IC50";"'='";"292.0";"nM";"6.54";"";"";"UO_0000065";"15.41";"0.30";"2.35";"8.95";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"292.0"
"CHEMBL1242373";"";"None";"401.50";"0";"4.99";"SID103904348";"Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3694592";"";"None";"445.75";"1";"5.57";"BDBM125913";"Clc1cnc2nc1NCc1cc(Br)cc(c1)OCCCc1cccc(c1)N2";"IC50";"'='";"149.0";"nM";"6.83";"";"255724";"UO_0000065";"15.32";"0.35";"1.26";"11.56";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"149.0"
"CHEMBL3694594";"";"None";"456.94";"1";"5.23";"BDBM125915";"O=C(Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"255726";"UO_0000065";"";"";"";"";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL477069";"GSK-1173862A";"None";"517.61";"2";"5.28";"GSK1173862A";"CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1";"Inhibition";"'='";"-3.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.62"
"CHEMBL512076";"GSK-192082A";"None";"566.06";"2";"5.63";"GSK192082A";"CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1";"Inhibition";"'='";"-3.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.3"
"CHEMBL495696";"GW778894X";"None";"313.32";"0";"2.80";"GW778894X";"N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1";"Inhibition";"'='";"11.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"11.0"
"CHEMBL266707";"";"None";"297.36";"0";"3.86";"SKF-86055";"Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1";"Inhibition";"'='";"-0.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.68"
"CHEMBL4756422";"";"None";"459.60";"0";"3.98";"13am";"Cc1cnc(Nc2ccc3c(c2)CN(C(=O)/C=C/CN(C)C)CC3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"15.99";"0.30";"3.37";"9.28";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"45.0"
"CHEMBL4789273";"";"None";"520.64";"2";"5.61";"13al";"Cc1ccc(C(=O)/C=C/C(=O)N2CCc3ccc(Nc4ncc(C)c(-c5cnn(C(C)C)c5)n4)cc3C2)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"14.45";"0.26";"1.91";"8.09";"0";"CHEMBL4723822";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715869";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"30.0"
"CHEMBL4591192";"";"None";"472.47";"0";"4.17";"16d";"O=C(Nc1cccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL248757";"";"None";"471.93";"0";"4.27";"25";"N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"1936.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL941818";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140564";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";"";"1.936"
"CHEMBL5413110";"";"None";"448.55";"0";"4.07";"17";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)[C@@H](C)c1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5394230";"";"None";"436.53";"0";"3.51";"12";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)C([2H])([2H])c1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5423715";"";"None";"437.52";"0";"2.91";"13";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)C([2H])([2H])c1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5091163";"";"None";"448.57";"0";"3.00";"55";"Cc1cnc(Nc2ccc(N3C4CCC3COC4)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.94";"0.33";"5.05";"9.74";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"9.0"
"CHEMBL4585920";"TP-020n";"None";"520.95";"1";"3.61";"EUB0001079";"Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507302";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5190599";"";"None";"531.01";"1";"2.04";"12l";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1CCC(N(C)C)C1";"IC50";"'='";"186.0";"nM";"6.73";"";"";"UO_0000065";"12.67";"0.25";"4.69";"5.55";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"186.0"
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL5225295";"Induction of TYK2 degradation in human Jurkat cells assessed as reduction in TYK2 mRNA expression level up to 10 uM incubated for 6 to 24 hrs by quantitative-PCR analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE <= 10.0 microM | TIME_Lower = 6.0 hrs | TIME_Upper = 24.0 hrs";"";"";""
"CHEMBL5198580";"";"None";"420.52";"0";"3.26";"28";"N#CCC(=O)N1CCC2(CCC(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"18.04";"0.33";"4.33";"7.34";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"26.0"
"CHEMBL4168613";"";"None";"399.52";"0";"3.56";"23";"CCC(CC)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4145191";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138312";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"30.0"
"CHEMBL4072848";"";"None";"366.38";"0";"1.71";"24";"COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)ccc1C#N";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"21.96";"0.41";"6.34";"5.79";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"9.0"
"CHEMBL4070687";"";"None";"402.50";"0";"3.29";"20";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(C#N)c4)cc23)CC[C@]1(C)N";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"18.04";"0.33";"3.97";"5.94";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"55.0"
"CHEMBL409892";"GW305178X";"None";"367.39";"0";"1.65";"GW305178X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1";"Inhibition";"'='";"33.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"33.52"
"CHEMBL30432";"GW282974X";"None";"395.47";"0";"4.23";"GW282974X";"CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1";"Inhibition";"'='";"-5.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.95"
"CHEMBL506414";"GW684626B";"None";"467.98";"1";"7.53";"GW684626B";"Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1";"Inhibition";"'='";"1.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.15"
"CHEMBL4785910";"";"None";"414.51";"0";"3.40";"20f";"CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(C#N)cc1";"IC50";"'='";"96.1";"nM";"7.02";"";"";"UO_0000065";"16.93";"0.31";"3.62";"7.25";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"96.1"
"CHEMBL67241";"GW794607X";"None";"372.44";"0";"3.48";"GW794607X";"CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1";"Inhibition";"'='";"-0.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.85"
"CHEMBL204934";"GW813360X";"None";"345.37";"0";"2.67";"GW813360X";"COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1";"Inhibition";"'='";"3.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.07"
"CHEMBL531804";"GW301888X";"None";"395.47";"0";"4.30";"GW301888X";"CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1";"Inhibition";"'='";"-8.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.04"
"CHEMBL185962";"";"None";"242.24";"0";"1.40";"SB-736302";"Nc1nonc1-c1nc2cnccc2n1C1CC1";"Inhibition";"'='";"-1.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.56"
"CHEMBL233002";"";"None";"350.42";"1";"5.04";"SB-814597";"N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2";"Inhibition";"'='";"-0.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.97"
"CHEMBL524901";"GW683109X";"None";"339.40";"0";"1.32";"GW683109X";"c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1";"Inhibition";"'='";"-3.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.09"
"CHEMBL502835";"NINTEDANIB";"4.0";"539.64";"1";"3.62";"BIBF-1120";"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1";"Kd";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.68";"0.22";"2.68";"6.69";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"500.0"
"CHEMBL274863";"";"None";"382.44";"0";"2.45";"SB-216385";"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1";"Inhibition";"'='";"-3.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.95"
"CHEMBL269985";"GW701032X";"None";"413.48";"0";"4.96";"GW701032X";"COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1";"Inhibition";"'='";"1.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.88"
"CHEMBL1096626";"GSK-938890A";"None";"447.50";"0";"2.28";"GSK938890A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21";"Inhibition";"'='";"2.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.72"
"CHEMBL1909405";"GW618013A";"None";"554.57";"0";"4.98";"GW618013A";"CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O";"Inhibition";"'='";"-7.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.47"
"CHEMBL5273814";"";"None";"569.64";"1";"4.50";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"Tm";"'='";"66.54";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"66.54"
"CHEMBL5267449";"";"None";"596.68";"1";"3.12";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCS3(=O)=O)cc2)c1OC";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"14.69";"0.28";"5.60";"5.08";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"1.9"
"CHEMBL2420832";"";"None";"338.19";"0";"3.99";"42";"CCC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"21.27";"0.45";"3.20";"10.12";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.064"
"CHEMBL2420812";"";"None";"353.21";"0";"3.78";"54";"CCNC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"21.93";"0.46";"3.96";"9.32";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.018"
"CHEMBL1909365";"GW607049C";"None";"617.56";"2";"6.69";"GW607049C";"COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O";"Inhibition";"'='";"0.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.01"
"CHEMBL2392493";"";"None";"334.41";"0";"1.08";"11";"CC1(n2nnc3cnc4[nH]ccc4c32)CCN(S(C)(=O)=O)CC1";"Ki";"'='";"234.0";"nM";"6.63";"";"";"UO_0000065";"19.83";"0.39";"5.55";"6.85";"0";"CHEMBL2394362";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390952";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"234.0"
"CHEMBL2392480";"";"None";"309.38";"0";"2.29";"18";"N#CCCN[C@H]1CC[C@H](n2nnc3cnc4[nH]ccc4c32)CC1";"Ki";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"22.94";"0.42";"4.81";"7.45";"0";"CHEMBL2394362";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390952";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"80.0"
"CHEMBL2322137";"";"None";"241.29";"0";"3.75";"8";"c1cc2c(ncc3onc(C4CCCCC4)c32)[nH]1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"29.93";"0.55";"3.47";"13.20";"0";"CHEMBL2327342";"Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321825";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"0.06"
"CHEMBL5416323";"";"None";"468.44";"0";"2.86";"4b";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(F)ccn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"21.49";"0.40";"7.14";"7.16";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.1"
"CHEMBL5415132";"";"None";"440.48";"0";"1.52";"2e";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CCC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"16.30";"0.30";"5.61";"4.79";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"74.0"
"CHEMBL2420853";"";"None";"262.70";"0";"3.00";"16";"COc1ccc(Cl)c(C(=O)Nc2ccncc2)c1";"Ki";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"21.14";"0.42";"2.55";"10.84";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"2.8"
"CHEMBL3417525";"BI 665915";"None";"458.53";"0";"2.78";"EUB0000749";"CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1";"% Ctrl";"'='";"97.5";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4882173";"TYK2 Invitrogen selectivity data (BI)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Method: Inhibition of TYK2 | Target type: Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 3.0 uM";"";"";"97.5"
"CHEMBL4594275";"GUSACITINIB";"2.0";"460.54";"0";"2.55";"24";"N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.58";"0.33";"5.55";"6.04";"0";"CHEMBL5347048";"Inhibition of TYK2 (unknown origin) by flow cytometry analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"8.0"
"CHEMBL4761132";"";"None";"401.43";"0";"1.46";"14";"CC(=O)N1CC(CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1";"IC50";"'='";"678.0";"nM";"6.17";"";"";"UO_0000065";"15.37";"0.28";"4.71";"5.61";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"678.0"
"CHEMBL1165499";"";"None";"436.51";"0";"3.61";"5d";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL185939";"GW828525X";"None";"490.45";"1";"5.39";"GW828525X";"FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1";"Inhibition";"'='";"5.73";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.73"
"CHEMBL4475494";"";"None";"482.52";"0";"1.88";"EUB0001558";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O";"Inhibition";"'='";"53.5";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4886107";"TYK2 Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4879554";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"53.5"
"CHEMBL3622820";"ITACITINIB";"3.0";"553.52";"1";"3.60";"28";"N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1";"IC50";"'='";"795.0";"nM";"6.10";"";"";"UO_0000065";"11.02";"0.21";"2.50";"5.10";"0";"CHEMBL5245517";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"795.0"
"CHEMBL5422793";"";"None";"349.44";"0";"3.30";"12b";"O[C@]12C[C@@H]3C[C@H](C1)[C@H](Nc1c(-c4cn[nH]c4)cnc4[nH]ccc14)[C@@H](C3)C2";"IC50";"'='";"1120.0";"nM";"5.95";"";"";"UO_0000065";"17.03";"0.31";"2.65";"6.64";"0";"CHEMBL5342212";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338778";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1.12"
"CHEMBL475251";"R-406";"2.0";"470.46";"0";"3.63";"R406";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL103115";"GW831091X";"None";"348.36";"0";"2.31";"GW831091X";"NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1";"Inhibition";"'='";"0.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.21"
"CHEMBL1909378";"";"None";"420.86";"0";"3.63";"SB-431542-A";"Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1";"Inhibition";"'='";"-4.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.13"
"CHEMBL4753620";"";"None";"333.36";"0";"2.47";"14";"Cn1cc(Nc2cc(-c3cccc(NC(=O)CC#N)c3)ncn2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL405042";"GW335962X";"None";"329.38";"0";"2.13";"GW335962X";"C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21";"Inhibition";"'='";"1.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.41"
"CHEMBL427058";"GSK-466317A";"None";"448.83";"0";"4.75";"GSK466317A";"CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1";"Inhibition";"'='";"-1.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.59"
"CHEMBL512076";"GSK-192082A";"None";"566.06";"2";"5.63";"GSK192082A";"CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1";"Inhibition";"'='";"-3.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.06"
"CHEMBL477182";"GW769076X";"None";"454.57";"1";"5.05";"GW769076X";"Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-2.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.58"
"CHEMBL261440";"";"None";"313.31";"0";"3.86";"SB-735465";"O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1";"Inhibition";"'='";"-2.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.35"
"CHEMBL102936";"";"None";"370.43";"0";"2.95";"SB-742865";"CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1";"Inhibition";"'='";"-0.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.89"
"CHEMBL518968";"GSK-1030061A";"None";"491.49";"1";"5.06";"GSK1030061A";"CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F";"Inhibition";"'='";"-2.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.35"
"CHEMBL3645541";"";"None";"346.43";"0";"3.72";"BDBM107125";"O=C(CN1CCCCC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226434";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL1964804";"";"None";"343.41";"0";"2.22";"SID103904475";"CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL192417";"GW632046X";"None";"250.30";"0";"4.39";"GW632046X";"Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1";"Inhibition";"'='";"-4.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.11"
"CHEMBL1190711";"";"None";"390.40";"0";"2.65";"SID103905231";"COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002323";"";"None";"242.26";"0";"2.43";"SID103905202";"Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982866";"";"None";"314.78";"0";"3.31";"SID103905540";"COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL185962";"";"None";"242.24";"0";"1.40";"SB-736302";"Nc1nonc1-c1nc2cnccc2n1C1CC1";"Inhibition";"'='";"0.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.09"
"CHEMBL1909349";"GSK-1007102B";"None";"561.52";"0";"2.28";"GSK1007102B";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F";"Inhibition";"'='";"1.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.49"
"CHEMBL494089";"GSK-690693";"1.0";"425.49";"0";"1.58";"GSK-690693";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL259084";"MLN-8054";"1.0";"476.87";"1";"5.87";"MLN-8054";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL176553";"GW631581B";"None";"296.33";"0";"4.10";"GW631581B";"COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1";"Inhibition";"'='";"-1.72";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.72"
"CHEMBL477978";"GW782907X";"None";"390.53";"0";"4.86";"GW782907X";"Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.37"
"CHEMBL14112";"SB-210313";"None";"366.44";"0";"3.47";"SB-210313";"Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1";"Inhibition";"'='";"-0.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.81"
"CHEMBL270164";"GW607117X";"None";"394.43";"1";"5.14";"GW607117X";"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1";"Inhibition";"'='";"-1.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.12"
"CHEMBL522892";"DOVITINIB";"3.0";"392.44";"0";"2.54";"CHIR-258/TKI-258";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL205158";"GW695874X";"None";"427.51";"0";"3.91";"GW695874X";"c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1";"Inhibition";"'='";"1.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.87"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445874";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-7, JAK1/3, pSTAT5 in CD3+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"38.0"
"CHEMBL1909361";"GW830365A";"None";"576.12";"1";"2.99";"GW830365A";"CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl";"Inhibition";"'='";"-6.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.06"
"CHEMBL194062";"GW572399X";"None";"315.35";"0";"2.73";"GW572399X";"NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1";"Inhibition";"'='";"-1.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.15"
"CHEMBL1956068";"GW296115X";"None";"385.38";"0";"3.86";"GW296115X";"COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O";"Inhibition";"'='";"-0.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.6"
"CHEMBL456252";"GSK-2110236A";"None";"520.62";"1";"3.45";"GSK2110236A";"COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2";"Inhibition";"'='";"-1.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.13"
"CHEMBL1909379";"";"None";"387.87";"0";"4.84";"GR-269666A";"Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1";"Inhibition";"'='";"-0.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.14"
"CHEMBL458865";"GSK-1220512A";"None";"518.60";"1";"4.22";"GSK1220512A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1";"Inhibition";"'='";"-1.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.63"
"CHEMBL518953";"GSK-1023156A";"None";"428.31";"0";"4.53";"GSK1023156A";"NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br";"Inhibition";"'='";"-4.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.77"
"CHEMBL1909343";"";"None";"394.31";"0";"1.76";"SB-675259-M";"O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F";"Inhibition";"'='";"1.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.8"
"CHEMBL14014";"";"None";"433.46";"1";"5.00";"SB-251505";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1";"Inhibition";"'='";"-5.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.29"
"CHEMBL407113";"";"None";"356.41";"0";"2.23";"SB-741905";"NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1";"Inhibition";"'='";"1.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.94"
"CHEMBL495902";"GW820759X";"None";"291.35";"0";"3.43";"GW820759X";"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1";"Inhibition";"'='";"0.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.52"
"CHEMBL359963";"GW805758X";"None";"330.40";"0";"4.05";"GW805758X";"CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1";"Inhibition";"'='";"-0.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.82"
"CHEMBL1794057";"GW284408X";"None";"292.30";"0";"2.26";"GW284408X";"O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1";"Inhibition";"'='";"-6.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.64"
"CHEMBL2402081";"";"None";"432.46";"0";"3.10";"37";"CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2405483";"Inhibition of TYK2 (unknown origin) at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401733";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"0.0"
"CHEMBL2443139";"";"None";"466.54";"0";"4.19";"31";"CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2443724";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439976";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL3763697";"";"None";"286.34";"0";"1.36";"11";"CC(C)Cn1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"24.94";"0.46";"5.78";"7.56";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"72.0"
"CHEMBL3765517";"";"None";"433.54";"0";"1.16";"19";"CC(C)[C@H](C)n1cc(-c2cc(N3CCS(=O)(=O)CC3)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.31";"0.30";"5.48";"5.03";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"230.0"
"CHEMBL3763697";"";"None";"286.34";"0";"1.36";"11";"CC(C)Cn1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"20.81";"0.39";"4.60";"6.30";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"1100.0"
"CHEMBL3764637";"";"None";"300.37";"0";"1.92";"9";"CC(C)C(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"21.67";"0.40";"4.59";"6.89";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"310.0"
"CHEMBL1909409";"GSK-238583A";"None";"653.68";"1";"4.58";"GSK238583A";"O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"-3.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.27"
"CHEMBL3114784";"";"None";"497.53";"0";"4.23";"11b";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCCN(c3ccnc(F)c3)C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL513909";"BI-2536";"2.0";"521.67";"1";"3.56";"BI-2536";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3545241";"AC-430";"1.0";"349.37";"0";"3.63";"BDBM214688";"Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1";"Kd";"'='";"1800.0";"nM";"5.75";"";"312371";"UO_0000065";"16.44";"0.30";"2.11";"6.62";"0";"CHEMBL3887154";"Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at room temperature to generate affinity resins. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific binding. Binding reactions were assembled by combining kinase, liganded affinity beads, and test compounds in 1x binding buffer (20% SeaBlock, 0.17xPBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 100x stocks in DMSO and rapidly diluted into the aqueous environment. DMSO was added to control assays lacking a test compound. Primary screen interactions were performed in polypropylene 384-well plates in a final volume of 34 uL, while Kd determinations were performed in polystyrene 96-well plates in a final volume of 135 uL. The assay plates were incubated at room temperature with shaking for 1 hr, long enough for binding reactions to reach equilibrium, and the affinity beads were washed extensively with wash buffer (1xPBS, 0.05% Tween 20) to remove unbound protein. The beads were then resuspended in elution buffer (1xPBS, 0.05% Tween 20, 2 uM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886191";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"1800.0"
"CHEMBL5193039";"";"None";"555.12";"1";"3.24";"23";"Nc1ncc(-c2ccc(CN3CCC(N4CCOCC4)CC3)cc2Cl)nc1C(=O)NC12CCC(O)(CC1)CC2";"Activity";"'='";"24.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5122013";"Binding affinity to wild type TYK2 JH2 domain (unknown origin) assessed as percent of control at 1 uM by Kinomescan method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120784";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"24.0"
"CHEMBL5428288";"";"None";"450.46";"1";"1.56";"36";"CNc1cc(Nc2cccn(-c3ncco3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"18.19";"0.34";"6.63";"5.83";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"6.4"
"CHEMBL5420172";"";"None";"350.43";"0";"3.02";"7";"CNc1cc(Nc2cc(C)cc(C)c2)nc2c(C(=O)NC3CC3)cnn12";"Kd";"'='";"0.078";"nM";"10.11";"";"";"UO_0000065";"28.84";"0.53";"7.09";"12.13";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.078"
"CHEMBL5422880";"";"None";"452.43";"0";"2.04";"12";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3C[C@H]3F)cnn12";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"15.84";"0.30";"5.13";"6.06";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"68.0"
"CHEMBL5411775";"";"None";"467.53";"0";"1.93";"41";"CNc1cc(Nc2cccn([C@H]3CCCOC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.006";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.006"
"CHEMBL5430689";"";"None";"474.53";"0";"2.28";"34";"CNc1cc(Nc2cccn(-c3ccc(C)nc3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"18.24";"0.34";"6.38";"6.79";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"2.2"
"CHEMBL5396767";"";"None";"492.52";"0";"2.50";"24";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@]3(C)OC)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL3290631";"";"None";"582.15";"2";"5.59";"17a";"CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl";"Activity";"'='";"87.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3294391";"Inhibition of human TYK2 assessed as residual activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286226";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"87.0"
"CHEMBL4744772";"";"None";"402.50";"0";"3.26";"31j";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C#N)cc2)[C@H](C)C1";"IC50";"'='";"6.73";"nM";"8.17";"";"";"UO_0000065";"20.30";"0.37";"4.91";"8.44";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"6.73"
"CHEMBL5411862";"";"None";"349.16";"0";"3.19";"Fig 2, Cpd 1";"Cc1ccn2ncc(C(=O)Nc3cc(Br)ccc3F)c2n1";"Kd";"'='";"246.0";"nM";"6.61";"";"";"UO_0000065";"18.93";"0.43";"3.42";"11.15";"0";"CHEMBL5328003";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as dissociation constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"246.0"
"CHEMBL3544944";"BMS-863233";"2.0";"289.72";"0";"2.75";"XL-413";"O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3188267";"CAPMATINIB";"4.0";"412.43";"0";"3.43";"Capmatinib";"CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL482968";"ENMD-2076";"2.0";"375.48";"0";"3.17";"ENMD-2076";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1";"Kd";"'='";"1196.0";"nM";"5.92";"";"Active";"UO_0000065";"15.77";"0.29";"2.75";"8.12";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.72 None";"";"";"1196.0"
"CHEMBL3545328";"XL-019";"1.0";"444.54";"0";"3.41";"XL-019";"O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2103839";"RIDAFOROLIMUS";"3.0";"990.22";"3";"7.74";"Deforolimus";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3182444";"MK-5108";"1.0";"461.95";"1";"5.71";"MK-5108";"O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3187723";"BINIMETINIB";"4.0";"441.23";"0";"3.01";"Binimetinib";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1909409";"GSK-238583A";"None";"653.68";"1";"4.58";"GSK238583A";"O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"-1.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.59"
"CHEMBL529066";"GW574783B";"None";"599.54";"2";"6.00";"GW574783B";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl";"Inhibition";"'='";"1.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.7"
"CHEMBL306865";"GW784752X";"None";"345.37";"0";"2.67";"GW784752X";"COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1";"Inhibition";"'='";"0.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.71"
"CHEMBL230911";"GSK-625137A";"None";"289.34";"0";"3.10";"GSK625137A";"NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N";"Inhibition";"'='";"-3.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.77"
"CHEMBL518968";"GSK-1030061A";"None";"491.49";"1";"5.06";"GSK1030061A";"CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F";"Inhibition";"'='";"-3.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.45"
"CHEMBL381604";"GW799251X";"None";"446.87";"0";"4.36";"GW799251X";"Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1";"Inhibition";"'='";"-3.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.29"
"CHEMBL1908395";"";"None";"497.04";"0";"3.76";"JNJ-28312141";"CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl";"Kd";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"13.74";"0.25";"2.57";"6.02";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"470.0"
"CHEMBL230011";"TG100-115";"2.0";"346.35";"0";"2.33";"TG-100-115";"Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1";"Kd";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"17.65";"0.32";"3.78";"4.24";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"770.0"
"CHEMBL1794062";"GW577921A";"None";"302.76";"0";"4.09";"GW577921A";"COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl";"Inhibition";"'='";"-6.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.02"
"CHEMBL305477";"GW829874X";"None";"374.40";"0";"3.28";"GW829874X";"COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1";"Inhibition";"'='";"-3.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.27"
"CHEMBL103098";"";"None";"356.41";"0";"2.23";"SB-738482";"NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1";"Inhibition";"'='";"-4.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.76"
"CHEMBL517507";"GW782912X";"None";"362.47";"0";"4.08";"GW782912X";"Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-0.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.8"
"CHEMBL202891";"GW679410X";"None";"328.38";"0";"4.21";"GW679410X";"COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1";"Inhibition";"'='";"-4.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.16"
"CHEMBL1794066";"GSK-619487A";"None";"525.49";"0";"1.34";"GSK619487A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"0.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.42"
"CHEMBL506153";"GW876790X";"None";"330.35";"0";"0.03";"GW876790X";"CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21";"Inhibition";"'='";"-3.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.99"
"CHEMBL275168";"";"None";"449.92";"1";"5.52";"SB-278539";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1";"Inhibition";"'='";"-2.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.89"
"CHEMBL1909360";"GW830263A";"None";"665.22";"1";"4.56";"GW830263A";"CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl";"Inhibition";"'='";"21.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"21.59"
"CHEMBL270054";"GW280670X";"None";"350.79";"0";"1.76";"GW280670X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1";"Inhibition";"'='";"-4.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.4"
"CHEMBL514261";"GSK-1819799A";"None";"519.58";"1";"4.82";"GSK1819799A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1";"Inhibition";"'='";"-2.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.8"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"TG-101348";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"Kd";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"12.10";"0.23";"1.53";"5.85";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"450.0"
"CHEMBL24828";"VANDETANIB";"4.0";"475.36";"0";"4.43";"Vandetanib";"COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4645113";"";"None";"217.27";"0";"2.30";"14";"O=c1cc(C2CCCCC2)c2c[nH]nc2[nH]1";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"21.26";"0.39";"2.32";"7.51";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"24.0"
"CHEMBL4647966";"";"None";"245.33";"0";"2.86";"15";"CCc1[nH]nc2[nH]c(=O)cc(C3CCCCC3)c12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL1909408";"GSK-200398A";"None";"616.15";"1";"4.38";"GSK200398A";"Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"1.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.26"
"CHEMBL402108";"GW708893X";"None";"417.90";"1";"5.60";"GW708893X";"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1";"Inhibition";"'='";"-3.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.78"
"CHEMBL517123";"GSK-182497A";"None";"566.06";"2";"5.59";"GSK182497A";"CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1";"Inhibition";"'='";"-2.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.89"
"CHEMBL1909381";"GW575808A";"None";"371.83";"0";"3.08";"GW575808A";"Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl";"Inhibition";"'='";"-1.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.77"
"CHEMBL505915";"GSK-1751853A";"None";"601.69";"1";"3.61";"GSK1751853A";"COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2";"Inhibition";"'='";"-1.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.21"
"CHEMBL486124";"GW874091X";"None";"352.44";"0";"2.23";"GW874091X";"Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12";"Inhibition";"'='";"0.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.82"
"CHEMBL519881";"GW861893X";"None";"483.53";"1";"5.66";"GW861893X";"COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC";"Inhibition";"'='";"-3.18";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.18"
"CHEMBL485598";"GSK-317354A";"None";"494.45";"1";"5.12";"GSK317354A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1";"Inhibition";"'='";"-2.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.96"
"CHEMBL1909415";"GW693881A";"None";"487.39";"1";"6.80";"GW693881A";"Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1";"Inhibition";"'='";"0.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.5"
"CHEMBL365297";"GW827099X";"None";"440.44";"0";"4.51";"GW827099X";"Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1";"Inhibition";"'='";"-8.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.76"
"CHEMBL1794052";"GW405841X";"None";"453.09";"0";"4.20";"GW405841X";"COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2";"Inhibition";"'='";"51.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"51.52"
"CHEMBL5077096";"";"None";"377.40";"0";"2.23";"48";"Cc1cnc(Nc2cnn(C(F)F)c2)nc1N1CCC2(CCNC2=O)CC1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL5041940";"Inhibition of human recombinant TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 min in presence of ATP measured by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";""
"CHEMBL5091036";"";"None";"344.44";"0";"2.09";"45";"Cc1cnc(Nc2nccs2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"455.0";"nM";"6.34";"";"";"UO_0000065";"18.41";"0.36";"4.25";"7.64";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"455.0"
"CHEMBL1938645";"";"None";"430.53";"0";"4.63";"10";"Nc1ncc(C(=O)Nc2ccccc2)c2sc(-c3ccc(N4CCOCC4)cc3)cc12";"IC50";"'='";"1990.0";"nM";"5.70";"";"";"UO_0000065";"13.24";"0.25";"1.07";"7.08";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"1.99"
"CHEMBL1938649";"";"None";"283.36";"0";"2.91";"14";"CNC(=O)c1cnc(N)c2cc(-c3ccccc3)sc12";"IC50";"'='";"937.0";"nM";"6.03";"";"";"UO_0000065";"21.27";"0.41";"3.12";"8.86";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.937"
"CHEMBL1938651";"";"None";"339.46";"0";"4.20";"16";"CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C)cc3)sc12";"IC50";"'='";"202.0";"nM";"6.70";"";"";"UO_0000065";"19.72";"0.38";"2.49";"9.84";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.202"
"CHEMBL1993661";"";"None";"479.95";"0";"3.55";"SID103904591";"CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl";"Ki";"'='";"6.31";"nM";"8.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"8.2"
"CHEMBL408732";"";"None";"308.34";"0";"2.98";"SB-711237";"COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1";"Inhibition";"'='";"-0.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.42"
"CHEMBL1909370";"GW694234A";"None";"532.78";"1";"5.94";"GW694234A";"COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl";"Inhibition";"'='";"0.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.6"
"CHEMBL95207";"";"None";"352.42";"0";"3.00";"SB-220455";"CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1";"Inhibition";"'='";"-2.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.21"
"CHEMBL495902";"GW820759X";"None";"291.35";"0";"3.43";"GW820759X";"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1";"Inhibition";"'='";"2.43";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.43"
"CHEMBL1956068";"GW296115X";"None";"385.38";"0";"3.86";"GW296115X";"COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O";"Inhibition";"'='";"-2.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.11"
"CHEMBL267228";"";"None";"371.40";"0";"4.03";"SB-431533";"OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1";"Inhibition";"'='";"-1.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.9"
"CHEMBL3622835";"";"None";"312.33";"0";"1.17";"5l";"NCCn1c(-c2ccc(O)cc2O)nc2cc(C(N)=O)ccc21";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"17.39";"0.32";"4.26";"4.26";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.7"
"CHEMBL318728";"GW549390X";"None";"236.27";"0";"4.09";"GW549390X";"c1ccc(Nc2ncc(-c3ccccc3)o2)cc1";"Inhibition";"'='";"-2.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.68"
"CHEMBL485598";"GSK-317354A";"None";"494.45";"1";"5.12";"GSK317354A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1";"Inhibition";"'='";"-0.65";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.65"
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL396107";"GW795486X";"None";"481.36";"1";"6.15";"GW795486X";"Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12";"Inhibition";"'='";"-5.22";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.22"
"CHEMBL524057";"GW683768X";"None";"280.34";"0";"2.32";"GW683768X";"CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1";"Inhibition";"'='";"-2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.0"
"CHEMBL1888586";"";"None";"353.40";"0";"3.20";"SB-223133";"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1";"Inhibition";"'='";"-2.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.03"
"CHEMBL1909343";"";"None";"394.31";"0";"1.76";"SB-675259-M";"O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F";"Inhibition";"'='";"2.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.04"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1738758";"ONVANSERTIB";"2.0";"532.53";"1";"1.92";"7g";"CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1775243";"Inhibition of TYK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1773059";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";"";"10.0"
"CHEMBL445813";"AT-7519";"2.0";"382.25";"0";"2.45";"AT-7519";"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL91829";"RUBOXISTAURIN";"3.0";"468.56";"0";"3.51";"LY-333531";"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1938648";"";"None";"382.49";"0";"3.08";"13";"CN(C)C(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'='";"5150.0";"nM";"5.29";"";"";"UO_0000065";"13.83";"0.27";"2.21";"7.38";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"5.15"
"CHEMBL1939491";"";"None";"595.08";"1";"4.91";"R-16";"CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl";"Inhibition";"'='";"93.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1944387";"Inhibition of TYK2 (kin.Domain.2) at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938300";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"None";"";"";"";"93.0"
"CHEMBL1938651";"";"None";"339.46";"0";"4.20";"16";"CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL3426891";"";"None";"402.93";"0";"3.22";"(R)-9b";"CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"20.60";"0.40";"5.08";"12.66";"0";"CHEMBL3429145";"Inhibition of human TYK2 using KKSRGDYMTMQIG peptide substrate by 33P Hotspot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425491";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"5.0"
"CHEMBL5437261";"";"None";"294.32";"0";"1.73";"2";"Cn1cc(Nc2nccc(-c3cnn(CCC#N)c3)n2)cn1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"24.84";"0.45";"5.58";"7.52";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"49.0"
"CHEMBL5440510";"";"None";"304.36";"0";"3.31";"8";"Cc1cnc(Nc2ccccc2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"26.15";"0.47";"4.65";"10.02";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"11.0"
"CHEMBL5402073";"";"None";"389.46";"0";"3.14";"11";"Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"22.34";"0.41";"5.56";"9.47";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"2.0"
"CHEMBL31965";"CANERTINIB";"3.0";"485.95";"0";"4.39";"CI-1033";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1908394";"GSK-461364";"1.0";"543.62";"2";"5.09";"GSK-461364A";"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL185238";"GW786460X";"None";"287.33";"0";"3.39";"GW786460X";"Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1";"Inhibition";"'='";"0.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.67"
"CHEMBL206544";"GW682841X";"None";"340.43";"1";"5.32";"GW682841X";"CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1";"Inhibition";"'='";"-0.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.96"
"CHEMBL1909376";"";"None";"378.82";"0";"0.13";"SB-759335-B";"CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl";"Inhibition";"'='";"-2.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.3"
"CHEMBL230597";"GSK-586581A";"None";"381.46";"0";"3.07";"GSK586581A";"CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1";"Inhibition";"'='";"-2.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.96"
"CHEMBL5183381";"";"None";"365.44";"0";"2.54";"9";"O=C(Nc1nc2cccc(C3=CCC(NC(=O)C4CC4)CC3)n2n1)C1CC1";"IC50";"'='";"497.0";"nM";"6.30";"";"";"UO_0000065";"17.25";"0.32";"3.76";"7.13";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"497.0"
"CHEMBL5202814";"";"None";"415.44";"0";"2.83";"16";"O=C(Nc1nc2cccc([C@@H]3CCC4(C3)CN(C(=O)[C@@H]3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"404.0";"nM";"6.39";"";"";"UO_0000065";"15.39";"0.29";"3.56";"8.03";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"404.0"
"CHEMBL608533";"MIDOSTAURIN";"4.0";"570.65";"2";"5.91";"PKC-412";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL261849";"GW632580X";"None";"366.42";"0";"2.83";"GW632580X";"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1";"Inhibition";"'='";"3.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.75"
"CHEMBL2387113";"";"None";"380.23";"0";"4.00";"8";"COc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"21.32";"0.44";"4.11";"10.09";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"7.8"
"CHEMBL1909354";"GW459057A";"None";"390.88";"0";"4.11";"GW459057A";"Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl";"Inhibition";"'='";"-2.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.23"
"CHEMBL1909353";"GW458344A";"None";"379.85";"0";"4.31";"GW458344A";"Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl";"Inhibition";"'='";"2.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.63"
"CHEMBL220244";"GW427984X";"None";"296.37";"0";"3.28";"GW427984X";"Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1";"Inhibition";"'='";"-1.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.5"
"CHEMBL4095629";"";"None";"285.35";"0";"1.94";"9";"C/C=C/C(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL4083094";"";"None";"299.38";"0";"1.82";"3";"C=CC(=O)N1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL1938656";"";"None";"462.60";"0";"3.00";"22";"COCCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12";"IC50";"'='";"1480.0";"nM";"5.83";"";"";"UO_0000065";"12.60";"0.26";"2.83";"4.72";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"1.48"
"CHEMBL63728";"GW644007X";"None";"326.36";"0";"2.57";"GW644007X";"COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O";"Inhibition";"'='";"0.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.13"
"CHEMBL1909394";"GW621823A";"None";"659.61";"2";"7.26";"GW621823A";"CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl";"Inhibition";"'='";"-0.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.78"
"CHEMBL305477";"GW829874X";"None";"374.40";"0";"3.28";"GW829874X";"COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1";"Inhibition";"'='";"-1.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.11"
"CHEMBL1789961";"GW513184X";"None";"360.38";"0";"2.98";"GW513184X";"COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O";"Inhibition";"'='";"-0.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.09"
"CHEMBL1909387";"GW567808A";"None";"633.09";"2";"6.37";"GW567808A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl";"Inhibition";"'='";"-4.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.13"
"CHEMBL514499";"GW843682X";"None";"477.46";"0";"4.80";"GW843682X";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-1.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.61"
"CHEMBL1082023";"";"None";"511.63";"1";"4.77";"16";"Cc1cc(-c2cccc3nc(Nc4ccc(N5CCN(C)CC5)cc4)oc23)ccc1C(=O)N1CCOCC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"12.75";"0.23";"1.75";"8.81";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.3"
"CHEMBL185939";"GW828525X";"None";"490.45";"1";"5.39";"GW828525X";"FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1";"Inhibition";"'='";"3.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.04"
"CHEMBL1909398";"GW282536X";"None";"330.37";"0";"1.41";"GW282536X";"Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"-2.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.96"
"CHEMBL189415";"GW819077X";"None";"432.41";"1";"5.62";"GW819077X";"FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1";"Inhibition";"'='";"-2.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.57"
"CHEMBL1909358";"GW654652C";"None";"489.00";"0";"3.98";"GW654652C";"CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl";"Inhibition";"'='";"-6.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.13"
"CHEMBL4092191";"";"None";"381.23";"0";"4.94";"19";"N#Cc1ccnc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)c1";"EC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"19.56";"0.39";"2.52";"8.26";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.035"
"CHEMBL5282623";"";"None";"587.63";"1";"4.64";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"Tm";"'='";"66.0";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"66.0"
"CHEMBL5270456";"";"None";"345.40";"0";"4.41";"10a, CG13250";"Cc1noc(C)c1-c1ccc2[nH]c(=O)cc(NCc3ccccc3)c2c1";"Inhibition";"'>'";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5255661";"Inhibition of TYK2 (unknown origin) at 10 uM by DiscoverX KINOMEscan relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252613";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"65.0"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"14.0";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471852";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 0.2 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"14.0"
"CHEMBL1909377";"";"None";"341.80";"0";"3.29";"SB-400868-A";"Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1";"Inhibition";"'='";"-1.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.07"
"CHEMBL218932";"GW432441X";"None";"339.40";"0";"2.95";"GW432441X";"CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1";"Inhibition";"'='";"-0.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.46"
"CHEMBL1909384";"";"None";"378.82";"0";"0.26";"SB-772077-B";"CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl";"Inhibition";"'='";"-0.69";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.69"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445110";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IFN+- induced pSTAT3 (lymphocytes), TYK2/JAK1 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"30.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445119";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-27 induced pSTAT3 (lymphocytes), JAK1/JAK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"86.0"
"CHEMBL1794073";"GW770220A";"None";"459.96";"0";"2.83";"GW770220A";"Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl";"Inhibition";"'='";"2.39";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.39"
"CHEMBL479038";"GW806776X";"None";"334.42";"0";"3.39";"GW806776X";"O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1";"Inhibition";"'='";"-5.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.6"
"CHEMBL1909372";"GW700494A";"None";"622.07";"2";"6.21";"GW700494A";"CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl";"Inhibition";"'='";"0.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.88"
"CHEMBL2387120";"";"None";"407.30";"0";"4.05";"15";"CN(C)Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"60.8";"nM";"7.22";"";"";"UO_0000065";"17.72";"0.37";"3.17";"9.71";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"60.8"
"CHEMBL477979";"GW785974X";"None";"350.46";"0";"3.94";"GW785974X";"Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"2.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.94"
"CHEMBL185962";"";"None";"242.24";"0";"1.40";"SB-736302";"Nc1nonc1-c1nc2cnccc2n1C1CC1";"Inhibition";"'='";"-4.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.88"
"CHEMBL218970";"GW445017X";"None";"272.74";"0";"3.27";"GW445017X";"CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1";"Inhibition";"'='";"2.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.63"
"CHEMBL1909400";"";"None";"557.55";"1";"5.48";"SB-284847-BT";"Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F";"Inhibition";"'='";"-3.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.24"
"CHEMBL330422";"";"None";"396.47";"0";"2.82";"SB-226879";"CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1";"Inhibition";"'='";"-4.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.71"
"CHEMBL182283";"GW819230X";"None";"293.33";"0";"3.55";"GW819230X";"Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1";"Inhibition";"'='";"-1.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.91"
"CHEMBL2387121";"";"None";"449.34";"0";"3.82";"16";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(CN2CCOCC2)cc1Cl";"Ki";"'='";"35.1";"nM";"7.46";"";"";"UO_0000065";"16.59";"0.34";"3.63";"8.92";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"35.1"
"CHEMBL2387115";"";"None";"394.26";"0";"4.04";"10";"CC(O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"20.59";"0.43";"4.08";"8.89";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"7.6"
"CHEMBL1909388";"GW568377A";"None";"565.10";"2";"5.35";"GW568377A";"CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl";"Inhibition";"'='";"1.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.14"
"CHEMBL275798";"";"None";"415.47";"0";"4.86";"SB-239272";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1";"Inhibition";"'='";"-4.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.41"
"CHEMBL179465";"GW621970X";"None";"376.41";"0";"4.03";"GW621970X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1";"Inhibition";"'='";"-2.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.12"
"CHEMBL4554938";"";"None";"416.49";"0";"2.29";"EUB0000178b";"CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21";"Kd";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"14.92";"0.30";"3.92";"5.11";"0";"CHEMBL5213020";"Selectivity interaction (KinomeScan (DiscoverX, competition-binding assay)) EUB0000178b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity Comments: XMU-MP-1 treatment inhibited hydrogen peroxide (H2O2)-Âstimulated MOB1 phosphorylation and MST1/2 autophosphorylation in a variety of cell lines, including mouse macrophage-like cells (RAW264.7), human osteosarcoma (U2OS), human colorectal adenocarcinoma (SW480), immortalized human retinal pigment epithelial cells (RPE1), human pleomorphic hepatocellular carcinoma (SNU-423): EC50 <3 ÂµM, PMID: 27535619; | Selectivity number of off-targets = 20.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: In-vitro potency, TYK2(JH1 catalytic domain) | Selectivity Source Knowledge: https://doi.org/10.1126/scitranslmed.aaf2304";"";"";"610.0"
"CHEMBL5420972";"";"None";"421.46";"0";"2.76";"16";"CO[C@@]1(c2cc(OCC#N)cc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"15.32";"0.28";"3.70";"5.80";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.35"
"CHEMBL67241";"GW794607X";"None";"372.44";"0";"3.48";"GW794607X";"CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1";"Inhibition";"'='";"4.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.3"
"CHEMBL519881";"GW861893X";"None";"483.53";"1";"5.66";"GW861893X";"COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC";"Inhibition";"'='";"-0.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.63"
"CHEMBL187081";"PYRAZOLOPYRIDAZINE 1";"None";"318.34";"0";"2.94";"GW810576X";"COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1";"Inhibition";"'='";"30.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"30.29"
"CHEMBL514938";"GSK-969786A";"None";"451.91";"1";"7.07";"GSK969786A";"Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1";"Inhibition";"'='";"-1.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.9"
"CHEMBL91829";"RUBOXISTAURIN";"3.0";"468.56";"0";"3.51";"LY-333531";"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1997617";"";"None";"482.63";"1";"5.20";"SID103904991";"CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991285";"";"None";"429.86";"0";"3.83";"SID103905154";"Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1997872";"";"None";"307.35";"0";"2.70";"SID103905009";"O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1909375";"GSK-614526A";"None";"525.49";"0";"1.34";"GSK614526A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"-1.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.89"
"CHEMBL243907";"GW673715X";"None";"445.48";"1";"5.74";"GW673715X";"CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1";"Inhibition";"'='";"-5.85";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.85"
"CHEMBL188784";"GW828529X";"None";"468.39";"1";"5.89";"GW828529X";"Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F";"Inhibition";"'='";"-3.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.95"
"CHEMBL3359926";"";"None";"283.34";"0";"1.93";"5e";"C[C@]1(C#N)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"29.02";"0.53";"6.29";"8.55";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"6.0"
"CHEMBL3352892";"";"None";"283.34";"0";"1.93";"5f";"C[C@@]1(C#N)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"26.55";"0.49";"5.59";"7.82";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"30.0"
"CHEMBL1909370";"GW694234A";"None";"532.78";"1";"5.94";"GW694234A";"COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl";"Inhibition";"'='";"0.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.49"
"CHEMBL1938642";"";"None";"354.44";"0";"2.48";"3";"NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"Inhibition";"'>'";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1941376";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate at 1 uM after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"90.0"
"CHEMBL521851";"PICTILISIB";"2.0";"513.65";"1";"2.15";"GDC-0941";"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1";"Kd";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.18";"0.22";"3.59";"5.34";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"1800.0"
"CHEMBL3114775";"";"None";"471.49";"0";"3.68";"8e";"Cn1cc(C2=C(Nc3cccc(OCCNc4ccnc(F)c4)c3)C(=O)NC2=O)c2ccccc21";"IC50";"'='";"5104.0";"nM";"5.29";"";"";"UO_0000065";"11.22";"0.21";"1.61";"5.44";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"5104.0"
"CHEMBL3114771";"";"None";"471.49";"0";"4.06";"8a";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCCNc2ccnc(F)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL69757";"GW817394X";"None";"362.37";"0";"3.41";"GW817394X";"COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1";"Inhibition";"'='";"-0.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.2"
"CHEMBL374060";"GW439255X";"None";"325.41";"0";"4.53";"GW439255X";"Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1";"Inhibition";"'='";"-0.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.75"
"CHEMBL365248";"GW810372X";"None";"402.34";"0";"3.84";"GW810372X";"COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1";"Inhibition";"'='";"-3.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.37"
"CHEMBL1909363";"GSK-269962B";"None";"607.07";"2";"3.84";"GSK269962B";"CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl";"Inhibition";"'='";"-1.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.28"
"CHEMBL3114770";"";"None";"413.44";"0";"2.92";"7e";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccccc1OCCn1ccnc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL3114767";"";"None";"413.44";"0";"2.92";"7b";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCn2ccnc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL477069";"GSK-1173862A";"None";"517.61";"2";"5.28";"GSK1173862A";"CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1";"Inhibition";"'='";"-2.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.19"
"CHEMBL384407";"GW616030X";"None";"620.11";"2";"6.38";"GW616030X";"CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Inhibition";"'='";"-4.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.41"
"CHEMBL384073";"GSK-180736A";"None";"365.37";"0";"2.97";"GSK180736A";"CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1";"Inhibition";"'='";"26.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"26.3"
"CHEMBL458865";"GSK-1220512A";"None";"518.60";"1";"4.22";"GSK1220512A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1";"Inhibition";"'='";"-2.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.61"
"CHEMBL2385096";"";"None";"367.38";"0";"3.21";"29";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@@H](NCC(F)(F)F)C1";"Ki";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.96";"0.40";"4.49";"9.78";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"20.0"
"CHEMBL1966069";"";"None";"316.33";"0";"1.94";"SID103905296";"c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974416";"";"None";"349.34";"0";"4.76";"SID103904194";"O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1909414";"";"None";"508.02";"0";"4.87";"SB-590885-AAD";"CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O";"Inhibition";"'='";"-2.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.09"
"CHEMBL1964290";"";"None";"307.36";"0";"2.44";"SID103905598";"Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005886";"";"None";"479.97";"0";"3.86";"SID103905488";"Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12";"Ki";"'='";"50.12";"nM";"7.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.3"
"CHEMBL1992645";"";"None";"567.62";"2";"5.43";"SID103905028";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991180";"";"None";"388.34";"1";"-0.06";"SID103905665";"COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O";"Ki";"'='";"1584.89";"nM";"5.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL246970";"";"None";"404.90";"0";"3.83";"SID103905472";"NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001998";"";"None";"457.54";"0";"2.64";"SID103904816";"CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4438748";"";"None";"457.49";"0";"4.13";"12j";"CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379480";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376834";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10.0"
"CHEMBL1965589";"";"None";"408.41";"0";"3.38";"SID103904761";"Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994074";"";"None";"273.13";"0";"3.99";"SID103904963";"Brc1ccc2[nH]nc(-c3ccccc3)c2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1980297";"ILORASERTIB";"2.0";"488.55";"1";"5.18";"SID103904272";"Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12";"Ki";"'='";"794.33";"nM";"6.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.1"
"CHEMBL101804";"";"None";"268.28";"0";"2.57";"SB-743899";"O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1";"Inhibition";"'='";"-1.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.75"
"CHEMBL4292010";"";"None";"275.31";"0";"2.68";"11";"N#CNC1CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"2890.0";"nM";"5.54";"";"";"UO_0000065";"20.12";"0.36";"2.86";"7.16";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2890.0"
"CHEMBL4281048";"";"None";"505.09";"1";"4.55";"40; JSH-150";"COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4264586";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"100.0"
"CHEMBL1909359";"GW771127A";"None";"459.96";"0";"2.83";"GW771127A";"Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl";"Inhibition";"'='";"-3.19";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.19"
"CHEMBL205158";"GW695874X";"None";"427.51";"0";"3.91";"GW695874X";"c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1";"Inhibition";"'='";"4.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.24"
"CHEMBL4248256";"";"None";"410.48";"0";"1.34";"10b";"C=CC(=O)N1CCC(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4244148";"";"None";"352.40";"0";"1.16";"12a";"C=CC(=O)N1CCCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"1175.5";"nM";"5.93";"";"";"UO_0000065";"16.83";"0.31";"4.77";"5.50";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"1175.5"
"CHEMBL4238190";"";"None";"409.45";"0";"1.00";"12d";"COCCn1cc(-c2nn(C3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1";"IC50";"'='";"3219.4";"nM";"5.49";"";"";"UO_0000065";"13.41";"0.25";"4.49";"3.90";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"3219.4"
"CHEMBL4239767";"";"None";"383.46";"0";"0.53";"12e";"CN(C)CC(=O)N1CCCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4245633";"";"None";"365.40";"0";"0.89";"13c";"Cn1cc(-c2nn(C3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4286006";"";"None";"372.43";"0";"3.93";"22";"Cc1cc(C)cc(Nc2cc(Nc3ccccc3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"14.58";"0.26";"1.50";"5.58";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"3.7"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"TG-101348";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"Kd";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"14.63";"0.28";"2.86";"7.08";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"21.0"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"Crizotinib";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.65";"0.26";"0.66";"7.31";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"2000.0"
"CHEMBL1908391";"MASITINIB";"4.0";"498.66";"1";"5.26";"AB-1010";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL385426";"GW450241X";"None";"294.40";"0";"3.74";"GW450241X";"CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1";"Inhibition";"'='";"-3.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.91"
"CHEMBL1909369";"GW693917A";"None";"556.93";"2";"7.07";"GW693917A";"COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl";"Inhibition";"'='";"1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.02"
"CHEMBL428877";"";"None";"443.53";"1";"5.43";"SB-242719";"CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"1.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.68"
"CHEMBL182283";"GW819230X";"None";"293.33";"0";"3.55";"GW819230X";"Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1";"Inhibition";"'='";"-1.62";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.62"
"CHEMBL3352835";"";"None";"473.36";"0";"4.79";"3";"COC1CCN(c2nccc(Nc3cc(NC(=O)c4c(Cl)cccc4Cl)ccn3)n2)CC1";"Ki";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.47";"0.33";"3.01";"8.45";"0";"CHEMBL3375810";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"16.0"
"CHEMBL3354191";"";"None";"382.47";"0";"2.74";"10";"COC1CCN(c2nccc(Nc3cc4c(cn3)c(N)nn4C(C)C)n2)CC1";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375810";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"1000.0"
"CHEMBL1986263";"";"None";"342.42";"0";"3.45";"SID103904649";"CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O";"Ki";"'='";"501.19";"nM";"6.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.3"
"CHEMBL1971694";"";"None";"282.34";"0";"3.30";"SID103904461";"CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL127898";"";"None";"519.48";"1";"4.73";"SID103905591";"Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1993781";"";"None";"361.45";"0";"3.57";"SID103904968";"NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969372";"";"None";"364.38";"0";"3.05";"SID103904758";"COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3114764";"";"None";"481.53";"0";"4.57";"11h";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(C2CCN(c3ccnc(F)c3)CC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"26.63";"0.49";"6.78";"9.36";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"4.8"
"CHEMBL521851";"PICTILISIB";"2.0";"513.65";"1";"2.15";"GDC-0941";"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL296468";"BMS-387032";"1.0";"380.54";"0";"3.66";"BMS-387032/SNS-032";"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4637190";"";"None";"426.46";"0";"0.65";"16";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(CCO)c4)ncc3F)C[C@]12NC(=O)[C@H]1C[C@@H]1C#N";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.57";"0.33";"6.84";"5.68";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"32.0"
"CHEMBL428690";"ALVOCIDIB";"3.0";"401.85";"0";"3.30";"Flavopiridol";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL515466";"";"None";"440.59";"1";"6.35";"18";"Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL427159";"GW827396X";"None";"430.42";"0";"4.88";"GW827396X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1";"Inhibition";"'='";"-1.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.25"
"CHEMBL3297762";"";"None";"512.10";"1";"3.80";"15a";"CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3300852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297733";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL1096634";"GSK-943949A";"None";"447.50";"0";"2.28";"GSK943949A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21";"Inhibition";"'='";"-3.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.88"
"CHEMBL1785004";"";"None";"451.45";"1";"5.14";"SB-253228";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1";"Inhibition";"'='";"-3.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.58"
"CHEMBL517907";"GW680191X";"None";"438.55";"0";"3.15";"GW680191X";"C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1";"Inhibition";"'='";"-6.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.6"
"CHEMBL185710";"";"None";"230.23";"0";"1.08";"SB-738561";"CCn1c(-c2nonc2N)nc2ccncc21";"Inhibition";"'='";"0.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.97"
"CHEMBL275168";"";"None";"449.92";"1";"5.52";"SB-278539";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1";"Inhibition";"'='";"-0.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.81"
"CHEMBL1794064";"GSK-561866B";"None";"470.41";"0";"0.12";"GSK561866B";"CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"5.33";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.33"
"CHEMBL156524";"";"None";"324.77";"0";"2.77";"SB-333612";"O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1";"Inhibition";"'='";"-4.08";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.08"
"CHEMBL4795299";"";"None";"441.42";"0";"2.48";"9";"Cn1cc(-c2cc(-c3cnn(C4(CC#N)CN(CC(F)(F)F)C4)c3)n3ncnc3c2)cn1";"IC50";"'='";"476.0";"nM";"6.32";"";"";"UO_0000065";"14.32";"0.27";"3.84";"6.81";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"476.0"
"CHEMBL4778704";"";"None";"441.42";"0";"2.48";"11";"Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CC(F)(F)F)C4)c3)n2)cn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.12";"0.34";"5.52";"8.62";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL1909407";"";"None";"374.85";"0";"2.65";"SB-220025-A";"Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"-0.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.21"
"CHEMBL1909373";"GW701427A";"None";"497.90";"0";"4.88";"GW701427A";"COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl";"Inhibition";"'='";"-0.42";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.42"
"CHEMBL4645039";"";"None";"406.49";"0";"2.17";"9";"CCNC(=O)c1ccc(Nc2nccc(N3CC4CC(C3)N4C(=O)C3CC3)n2)cc1";"IC50";"'='";"209.0";"nM";"6.68";"";"";"UO_0000065";"16.43";"0.30";"4.51";"7.38";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"209.0"
"CHEMBL13972";"";"None";"440.48";"0";"4.73";"SB-242721";"N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1";"Inhibition";"'='";"-3.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.12"
"CHEMBL3798256";"";"None";"446.44";"0";"2.65";"6a";"CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3802477";"Inhibition of partial length wild type human TYK2 (catalytic JH1 domain) expressed in mammalian system assessed as enzyme activity at 1 uM relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797029";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";"";"100.0"
"CHEMBL511765";"GSK-2213727A";"None";"506.54";"1";"3.50";"GSK2213727A";"COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1";"Inhibition";"'='";"-1.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.61"
"CHEMBL2386635";"";"None";"323.40";"0";"3.61";"33";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1";"EC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"21.65";"0.40";"3.39";"7.73";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"100.0"
"CHEMBL2386653";"";"None";"286.33";"0";"2.32";"21";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CCCOC1";"EC50";"'>'";"5800.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5800.0"
"CHEMBL427058";"GSK-466317A";"None";"448.83";"0";"4.75";"GSK466317A";"CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1";"Inhibition";"'='";"-1.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.04"
"CHEMBL189353";"GW809897X";"None";"571.49";"2";"6.48";"GW809897X";"CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1";"Inhibition";"'='";"-2.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.98"
"CHEMBL1173655";"AFATINIB";"4.0";"485.95";"0";"4.39";"BIBW-2992";"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL494089";"GSK-690693";"1.0";"425.49";"0";"1.58";"GSK-690693";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL259084";"MLN-8054";"1.0";"476.87";"1";"5.87";"MLN-8054";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL428690";"ALVOCIDIB";"3.0";"401.85";"0";"3.30";"Flavopiridol";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1";"Kd";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"18.55";"0.36";"4.16";"7.92";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"35.0"
"CHEMBL558752";"RAF-265";"2.0";"518.42";"2";"6.93";"CHIR-265/RAF-265";"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL189459";"GW833373X";"None";"396.43";"1";"5.04";"GW833373X";"Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1";"Inhibition";"'='";"-4.65";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.65"
"CHEMBL4640981";"";"None";"387.42";"0";"0.65";"10";"O=C(N[C@@]12C[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2)C1CC1";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"17.70";"0.33";"6.21";"6.34";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"139.0"
"CHEMBL4634433";"";"None";"396.43";"0";"1.19";"17";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1C[C@H]1C#N";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"18.91";"0.35";"6.30";"6.71";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"32.0"
"CHEMBL1909386";"GW566221A";"None";"565.10";"2";"5.35";"GW566221A";"CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl";"Inhibition";"'='";"1.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.95"
"CHEMBL493326";"GSK-317314A";"None";"427.91";"0";"4.99";"GSK317314A";"COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1";"Inhibition";"'='";"-5.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.78"
"CHEMBL359963";"GW805758X";"None";"330.40";"0";"4.05";"GW805758X";"CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1";"Inhibition";"'='";"-0.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.13"
"CHEMBL220243";"GW406731X";"None";"283.33";"0";"3.36";"GW406731X";"COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1";"Inhibition";"'='";"-4.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.1"
"CHEMBL218970";"GW445017X";"None";"272.74";"0";"3.27";"GW445017X";"CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1";"Inhibition";"'='";"2.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.16"
"CHEMBL1909371";"GW694590A";"None";"453.89";"1";"5.18";"GW694590A";"COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl";"Inhibition";"'='";"-2.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.96"
"CHEMBL1794061";"GW627834A";"None";"297.74";"0";"3.96";"GW627834A";"Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1";"Inhibition";"'='";"-5.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.06"
"CHEMBL257113";"GW734508X";"None";"333.39";"0";"3.85";"GW734508X";"Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1";"Inhibition";"'='";"-4.07";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.07"
"CHEMBL1909404";"GW581744X";"None";"406.42";"0";"2.49";"GW581744X";"NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1";"Inhibition";"'='";"-3.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.98"
"CHEMBL205966";"GW659893X";"None";"444.90";"1";"5.57";"GW659893X";"Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1";"Inhibition";"'='";"0.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.67"
"CHEMBL347580";"";"None";"320.35";"0";"2.13";"SB-361058";"COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1";"Inhibition";"'='";"-3.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.26"
"CHEMBL230592";"GSK-635416A";"None";"453.54";"0";"3.89";"GSK635416A";"CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N";"Inhibition";"'='";"-1.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.28"
"CHEMBL463931";"GSK-2163632A";"None";"548.67";"1";"4.19";"GSK2163632A";"COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C";"Inhibition";"'='";"-1.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.34"
"CHEMBL372474";"GW678313X";"None";"452.51";"1";"5.69";"GW678313X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1";"Inhibition";"'='";"1.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.51"
"CHEMBL483748";"GSK-953913A";"None";"390.46";"0";"4.13";"GSK953913A";"NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1";"Inhibition";"'='";"-0.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.94"
"CHEMBL493326";"GSK-317314A";"None";"427.91";"0";"4.99";"GSK317314A";"COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1";"Inhibition";"'='";"-5.25";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.25"
"CHEMBL1909375";"GSK-614526A";"None";"525.49";"0";"1.34";"GSK614526A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"-0.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.97"
"CHEMBL241517";"GW856804X";"None";"433.92";"0";"4.65";"GW856804X";"Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12";"Inhibition";"'='";"-2.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.5"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"2, INCB018424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"30.36";"0.55";"5.83";"11.18";"0";"CHEMBL2160363";"Inhibition of TYK2 kinase domain using N-terminal 5-carboxyfluorescein-tagged Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157937";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.5"
"CHEMBL529066";"GW574783B";"None";"599.54";"2";"6.00";"GW574783B";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl";"Inhibition";"'='";"1.67";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.67"
"CHEMBL4638696";"";"None";"261.32";"0";"2.10";"17";"Cc1[nH]nc2[nH]c(=O)c(CO)c(C3CCCCC3)c12";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"23.68";"0.44";"4.09";"7.57";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.65"
"CHEMBL1785004";"";"None";"451.45";"1";"5.14";"SB-253228";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1";"Inhibition";"'='";"-5.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.44"
"CHEMBL4648246";"";"None";"257.34";"0";"3.18";"16";"O=c1cc(C2CCCCC2)c2c(C3CC3)[nH]nc2[nH]1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"22.52";"0.42";"2.62";"9.42";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"1.6"
"CHEMBL4761545";"";"None";"401.47";"0";"3.85";"3";"C=CC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4750831";"";"None";"377.45";"0";"2.77";"4";"C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CCN(C)C)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL3694584";"";"None";"352.83";"0";"4.42";"BDBM125905";"Clc1cnc2nc1NCCc1cccc(c1)OCc1cccc(c1)N2";"IC50";"'='";"438.0";"nM";"6.36";"";"255716";"UO_0000065";"18.02";"0.35";"1.94";"10.76";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"438.0"
"CHEMBL4444169";"";"None";"418.47";"0";"2.87";"30";"[2H]C([2H])([2H])NC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"22.41";"0.44";"6.44";"8.23";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00049"
"CHEMBL4548200";"";"None";"411.49";"0";"3.04";"35";"CNC(=O)c1cnc(Nc2cc(C)ccn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"16.33";"0.32";"3.68";"5.94";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.19"
"CHEMBL271595";"GW297361X";"None";"372.43";"0";"2.35";"GW297361X";"NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1";"Inhibition";"'='";"40.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"40.98"
"CHEMBL272414";"GW416469X";"None";"358.42";"0";"1.81";"GW416469X";"CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.02"
"CHEMBL4571470";"";"None";"363.43";"0";"3.08";"12a'";"C/C=C/C(=O)Nc1ccc(CNc2cc(Nc3cnn(C)c3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL223360";"LINIFANIB";"3.0";"375.41";"0";"4.90";"ABT-869";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3354190";"";"None";"367.46";"0";"3.16";"9";"COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C)n2)CC1";"Inhibition";"'>'";"80.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3375819";"Inhibition of Tyk2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"80.0"
"CHEMBL3354185";"";"None";"391.44";"0";"2.50";"4";"COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)nc4cn3)n2)CC1";"Ki";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"14.07";"0.26";"3.01";"4.57";"0";"CHEMBL3375810";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"3100.0"
"CHEMBL3335686";"";"None";"394.50";"0";"1.92";"13";"CC(C)(C)CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL3377099";"Binding affinity to TYK2 JH2 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351377";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";""
"CHEMBL2181314";"";"None";"490.58";"1";"5.10";"22g, 85:15 trans/cis mixture";"Fc1ccc2cc1COCC=CCOCc1cc(ccc1OCCN1CCCC1)Nc1nccc-2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";""
"CHEMBL4545456";"";"None";"462.58";"0";"4.05";"24";"CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2";"Inhibition";"'='";"32.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4387373";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain (833 to 1187 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"32.5"
"CHEMBL4582205";"";"None";"410.41";"0";"2.57";"17";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(N)=O)c1OC";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"16.86";"0.32";"4.35";"5.27";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"120.0"
"CHEMBL4578980";"";"None";"537.60";"1";"2.84";"28";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NCCN2CCOCC2)c1OC";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"12.64";"0.24";"3.96";"5.24";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"160.0"
"CHEMBL4443834";"";"None";"463.47";"0";"4.14";"31";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2nnc(C)o2)c1OC";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.10";"0.28";"2.86";"5.51";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"100.0"
"CHEMBL4572855";"";"None";"448.46";"0";"3.56";"34";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2nc[nH]n2)c1OC";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"17.03";"0.32";"4.08";"5.89";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"23.0"
"CHEMBL2181085";"";"None";"374.44";"0";"4.07";"21k, 85:15 trans/cis mixture";"Nc1cc2cc(c1)Nc1nccc(n1)-c1cccc(c1)COCC=CCOC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";""
"CHEMBL1979970";"";"None";"317.30";"0";"3.04";"SID103905386";"CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1958401";"";"None";"270.34";"0";"2.58";"SID103904798";"O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL326282";"";"None";"392.67";"1";"5.81";"SID103905352";"O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992732";"";"None";"411.43";"1";"1.00";"SID103905628";"CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1976872";"";"None";"175.19";"0";"1.29";"SID103905485";"CC(=O)Nc1cc2ccccn2n1";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL1973211";"";"None";"481.63";"1";"5.95";"SID103904281";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2387222";"";"None";"351.74";"0";"3.42";"36";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2F)c1)c1c(F)cccc1Cl";"EC50";"'='";"211.0";"nM";"6.68";"";"";"UO_0000065";"18.98";"0.38";"3.26";"9.39";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"211.0"
"CHEMBL2181328";"";"None";"437.93";"1";"5.11";"21a, 85:15 trans/cis mixture";"ClCCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"14.45";"0.28";"1.22";"9.66";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.47"
"CHEMBL3618146";"";"None";"346.42";"0";"1.28";"14";"O=S(=O)(C1CC1)N1CCC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1";"INH";"'='";"2.6";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"2.6"
"CHEMBL4077123";"";"None";"647.78";"2";"6.25";"9; CHMFL-BTK-01";"C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1";"Activity";"'='";"74.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4025427";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024706";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"74.0"
"CHEMBL4104931";"";"None";"368.44";"1";"5.43";"8";"CCCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1";"IC50";"'='";"437.5";"nM";"6.36";"";"";"UO_0000065";"17.26";"0.31";"0.93";"8.20";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"437.5"
"CHEMBL1615025";"TAK-733";"1.0";"504.23";"1";"1.07";"TAK-733";"Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3797887";"(S)-9s";"None";"300.75";"0";"2.20";"EUB0000341";"C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N";"% Control";"'='";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507301";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"94.0"
"CHEMBL3622130";"";"None";"352.44";"0";"2.75";"8";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC)nc21";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"20.30";"0.38";"4.40";"10.53";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"70.0"
"CHEMBL4242999";"";"None";"407.31";"0";"2.01";"18, trans-isomer";"Br.NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.49";"0.47";"6.31";"8.00";"0";"CHEMBL4236470";"Inhibition of recombinant human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229549";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"4.8"
"CHEMBL2181083";"";"None";"472.59";"0";"4.96";"21h, 85:15 trans/cis mixture";"C1=CCOCc2cccc(c2)-c2ccnc(n2)Nc2cc(cc(OCCN3CCCC3)c2)COC1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"15.02";"0.28";"2.14";"10.32";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.08"
"CHEMBL2181331";"";"None";"486.62";"1";"5.35";"21d, 85:15 trans/cis mixture";"C1=CCOCc2cc(ccc2OCCN2CCCCC2)Nc2nccc(n2)-c2cccc(c2)COC1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"14.54";"0.27";"1.73";"10.29";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.084"
"CHEMBL2152304";"";"None";"303.37";"0";"2.97";"11";"c1ccc(CN2CC(n3cnc4cnc5[nH]ccc5c43)C2)cc1";"Ki";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"20.66";"0.37";"3.30";"12.60";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"540.0"
"CHEMBL2181084";"";"None";"488.59";"0";"4.20";"21i, 85:15 trans/cis mixture";"C1=CCOCc2cccc(c2)-c2ccnc(n2)Nc2cc(cc(OCCN3CCOCC3)c2)COC1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"14.51";"0.27";"2.89";"9.10";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.081"
"CHEMBL2035183";"";"None";"478.62";"1";"5.03";"14j, 95:5 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(s2)COC/1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"15.66";"0.30";"2.46";"10.90";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.032"
"CHEMBL218969";"GW445015X";"None";"252.32";"0";"2.92";"GW445015X";"CNC(=O)c1cncc(/C=C/c2ccccc2C)c1";"Inhibition";"'='";"-2.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.79"
"CHEMBL188794";"GW829115X";"None";"496.88";"1";"6.28";"GW829115X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1";"Inhibition";"'='";"1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.02"
"CHEMBL521806";"GSK-237700A";"None";"457.94";"0";"5.00";"GSK237700A";"COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-4.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.63"
"CHEMBL1909394";"GW621823A";"None";"659.61";"2";"7.26";"GW621823A";"CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl";"Inhibition";"'='";"-3.81";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.81"
"CHEMBL185710";"";"None";"230.23";"0";"1.08";"SB-738561";"CCn1c(-c2nonc2N)nc2ccncc21";"Inhibition";"'='";"-0.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.83"
"CHEMBL3261514";"";"None";"366.23";"0";"3.26";"74";"NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl";"Inhibition";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3266945";"Inhibition of JH1 catalytic domain of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259739";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";"";"";"100.0"
"CHEMBL303687";"GW829877X";"None";"358.41";"0";"3.58";"GW829877X";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1";"Inhibition";"'='";"-1.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.47"
"CHEMBL1794059";"GW275616X";"None";"315.35";"0";"1.74";"GW275616X";"NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1";"Inhibition";"'='";"-1.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.95"
"CHEMBL1909406";"";"None";"333.82";"0";"3.86";"SKF-86002-A2";"Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1";"Inhibition";"'='";"-3.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.88"
"CHEMBL270054";"GW280670X";"None";"350.79";"0";"1.76";"GW280670X";"NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1";"Inhibition";"'='";"0.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.36"
"CHEMBL175321";"";"None";"263.30";"0";"3.20";"GR-105659X";"O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21";"Inhibition";"'='";"6.88";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"6.88"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"19.59";"0.38";"6.18";"6.03";"0";"CHEMBL3625892";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"53.0"
"CHEMBL3667517";"";"None";"454.45";"1";"1.90";"BDBM153665";"COc1ccc(C#N)cc1-c1nn(Cc2nncn2C)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"65.0";"nM";"7.19";"";"295020";"UO_0000065";"15.81";"0.29";"5.29";"5.10";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"65.0"
"CHEMBL1682345";"";"None";"275.31";"0";"2.87";"SID103904508";"c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3787112";"";"None";"349.44";"0";"3.04";"2";"Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"16.67";"0.31";"2.78";"7.26";"0";"CHEMBL3790310";"Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"1.5"
"CHEMBL1938643";"";"None";"368.46";"0";"2.74";"8";"CNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'='";"1330.0";"nM";"5.88";"";"";"UO_0000065";"15.95";"0.31";"3.14";"7.30";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"1.33"
"CHEMBL1938655";"";"None";"448.57";"0";"2.34";"21";"CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCO)c3s2)cc1";"IC50";"'='";"932.0";"nM";"6.03";"";"";"UO_0000065";"13.44";"0.27";"3.69";"4.49";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.932"
"CHEMBL2181329";"";"None";"474.61";"1";"5.21";"21b, 85:15 trans/cis mixture";"CCN(CC)CCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"14.96";"0.28";"1.89";"10.33";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.079"
"CHEMBL4740088";"";"None";"387.45";"0";"1.94";"12";"CCN1CC(CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"18.94";"0.35";"5.40";"7.90";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"46.0"
"CHEMBL69757";"GW817394X";"None";"362.37";"0";"3.41";"GW817394X";"COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1";"Inhibition";"'='";"-0.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.15"
"CHEMBL208437";"GW711782X";"None";"408.47";"0";"4.48";"GW711782X";"c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1";"Inhibition";"'='";"-0.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.27"
"CHEMBL207247";"GW807930X";"None";"500.96";"2";"5.63";"GW807930X";"CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1";"Inhibition";"'='";"0.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.84"
"CHEMBL3114776";"";"None";"471.49";"0";"3.70";"8f";"CN(CCOc1cccc(NC2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1)c1ccnc(F)c1";"IC50";"'='";"995.0";"nM";"6.00";"";"";"UO_0000065";"12.73";"0.23";"2.30";"6.04";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"995.0"
"CHEMBL3613596";"";"None";"382.26";"0";"4.70";"11";"CC(C)c1nn(-c2ccccc2)cc1-c1nc2cc(Br)cnc2[nH]1";"Inhibition";"'='";"38.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615451";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"38.0"
"CHEMBL4586794";"ABT-100";"None";"504.47";"2";"5.04";"EUB0000289";"Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1";"% Control";"'='";"56.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507257";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"56.0"
"CHEMBL3622836";"";"None";"281.32";"0";"1.16";"5m";"NCCn1c(-c2ccncc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"5800.0";"nM";"5.24";"";"";"UO_0000065";"18.61";"0.34";"4.08";"5.25";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"5.8"
"CHEMBL3629013";"";"None";"392.51";"0";"3.59";"11";"N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1";"Inhibition";"'='";"25.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631700";"Inhibition of TYK2 (unknown origin) at 1 uM by FRET method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627690";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"25.6"
"CHEMBL3622137";"";"None";"449.58";"0";"4.53";"18";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C)s3)nc21";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"15.48";"0.30";"2.43";"8.60";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"110.0"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"Crizotinib";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"14.83";"0.30";"1.64";"8.56";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"210.0"
"CHEMBL4750665";"";"None";"389.50";"0";"3.53";"17i";"O=C(NC1CC1)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1";"IC50";"'='";"1346.0";"nM";"5.87";"";"";"UO_0000065";"15.07";"0.28";"2.34";"8.04";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"1346.0"
"CHEMBL4747285";"";"None";"402.50";"0";"3.26";"30f";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccc(C#N)cc2)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"17.19";"0.32";"3.66";"7.15";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"120.0"
"CHEMBL4746186";"";"None";"407.52";"0";"3.40";"31e";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(OC)cc2)[C@@H](C)C1";"IC50";"'='";"504.0";"nM";"6.30";"";"";"UO_0000065";"15.45";"0.29";"2.90";"7.65";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"504.0"
"CHEMBL4779340";"";"None";"407.52";"0";"3.40";"31i";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(OC)cc2)[C@H](C)C1";"IC50";"'='";"161.0";"nM";"6.79";"";"";"UO_0000065";"16.67";"0.31";"3.39";"8.26";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"161.0"
"CHEMBL3359924";"";"None";"288.35";"0";"1.40";"5c";"C[C@]1(CO)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"25.90";"0.49";"6.07";"8.06";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"34.0"
"CHEMBL3929398";"";"None";"439.57";"0";"4.44";"BDBM198513";"N#CC1(c2ccccc2)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353491";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"18.9";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471856";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 0.01 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"18.9"
"CHEMBL3956550";"";"None";"389.44";"0";"4.00";"BDBM198455";"N#Cc1cc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)ccc1F";"IC50";"'>'";"1000.0";"nM";"";"";"353433";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4566849";"";"None";"430.51";"0";"3.79";"11d'";"C=CC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"3000.0"
"CHEMBL5207105";"";"None";"423.42";"0";"3.09";"17";"CCNC(=O)Cc1ccc(Nc2cc(-c3c(F)cccc3F)nc3c2C(=O)NC3)nc1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"15.93";"0.30";"3.65";"7.03";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.18"
"CHEMBL205765";"GW794726X";"None";"487.92";"1";"5.34";"GW794726X";"CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1";"Inhibition";"'='";"4.58";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.58"
"CHEMBL5196418";"";"None";"257.25";"0";"0.73";"6";"NC(=O)c1ccc(NC(=O)c2ccc[nH]c2=O)cc1";"Ki";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"23.32";"0.43";"5.27";"5.71";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"1000.0"
"CHEMBL5170799";"";"None";"384.34";"0";"2.89";"8";"NC(=O)c1cnc(-c2c(F)cccc2F)nc1Nc1ccc(CC(=O)O)cc1";"Ki";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"21.20";"0.40";"5.26";"6.89";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"7.1"
"CHEMBL5200655";"";"None";"430.44";"0";"2.98";"27";"N#Cc1cccc(F)c1-c1cc(Nc2ccc(N3CCOCC3)cn2)c2c(n1)CNC2=O";"Ki";"'='";"0.051";"nM";"10.29";"";"";"UO_0000065";"23.91";"0.44";"7.31";"9.98";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.051"
"CHEMBL4846921";"";"None";"508.67";"1";"4.62";"26";"CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"16.45";"0.33";"3.75";"9.25";"0";"CHEMBL4839026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4837239";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"4.3"
"CHEMBL3670397";"";"None";"347.38";"0";"2.37";"BDBM116319";"Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2ccccc2C)n1";"Ki";"'='";"97.6";"nM";"7.01";"";"241653";"UO_0000065";"20.18";"0.37";"4.64";"6.80";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"97.6"
"CHEMBL3655094";"";"None";"371.41";"0";"1.64";"BDBM159761";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CC(F)(F)C2)C1";"IC50";"'='";"323.0";"nM";"6.49";"";"302655";"UO_0000065";"17.48";"0.35";"4.85";"7.13";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"323.0"
"CHEMBL4791733";"";"None";"369.39";"0";"2.53";"25, cis isomer";"N#CC[C@]1(n2cc(-c3nc(-c4cc[nH]n4)cn4nccc34)cn2)C[C@@H](C#N)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"21.78";"0.39";"5.52";"6.47";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"9.0"
"CHEMBL1794066";"GSK-619487A";"None";"525.49";"0";"1.34";"GSK619487A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F";"Inhibition";"'='";"-1.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.36"
"CHEMBL4787411";"";"None";"440.43";"0";"3.09";"8";"Cn1cc(-c2cc(-c3cnn(C4(CC#N)CN(CC(F)(F)F)C4)c3)n3ccnc3c2)cn1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.84";"0.28";"3.45";"8.18";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"290.0"
"CHEMBL3622132";"";"None";"440.50";"0";"2.90";"13";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC(=O)OCCOC)nc21";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"13.10";"0.25";"2.87";"5.57";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"1700.0"
"CHEMBL4781679";"";"None";"388.48";"0";"2.87";"17h";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(C#N)c2)CC1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"15.83";"0.29";"3.28";"6.35";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"710.0"
"CHEMBL4746952";"";"None";"411.94";"0";"3.90";"18c";"CNC(=O)c1cnc2[nH]ccc2c1NCC1CCN(Cc2ccc(Cl)cc2)CC1";"IC50";"'='";"48.9";"nM";"7.31";"";"";"UO_0000065";"17.75";"0.34";"3.41";"10.01";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"48.9"
"CHEMBL4749677";"";"None";"407.52";"0";"3.26";"18e";"CNC(=O)c1cnc2[nH]ccc2c1NCC1CCN(Cc2ccc(OC)cc2)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.44";"0.30";"3.44";"8.14";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"200.0"
"CHEMBL4786466";"";"None";"419.53";"0";"3.54";"20e";"CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(OC)cc1";"IC50";"'='";"79.1";"nM";"7.10";"";"";"UO_0000065";"16.93";"0.31";"3.56";"8.63";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"79.1"
"CHEMBL4777577";"";"None";"411.94";"0";"4.04";"31c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@@H](C)C1";"IC50";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"16.54";"0.32";"2.78";"9.33";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"153.0"
"CHEMBL4849617";"";"None";"509.59";"2";"5.64";"14h";"CC(C)(C)c1ccc(C(=O)N2CCc3cc(Nc4ncc(F)c(-c5cnn(CCC#N)c5)n4)ccc32)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.52";"0.27";"1.76";"7.42";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"40.0"
"CHEMBL4873455";"";"None";"431.54";"0";"3.61";"11q";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)[C@H]2CCCN2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.24";"0.35";"4.69";"9.44";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"5.0"
"CHEMBL4868074";"";"None";"422.49";"0";"2.22";"11s";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)[C@@H](O)CO)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"10.84";"nM";"7.96";"";"";"UO_0000065";"18.85";"0.35";"5.74";"6.84";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"10.84"
"CHEMBL4447631";"";"None";"467.59";"0";"4.01";"9";"Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.60";"0.35";"4.69";"10.56";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2.0"
"CHEMBL4864674";"";"None";"438.48";"0";"4.52";"11j";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)C2CC2(F)F)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"5.72";"nM";"8.24";"";"";"UO_0000065";"18.80";"0.35";"3.72";"10.85";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"5.72"
"CHEMBL3658855";"";"None";"375.46";"0";"0.60";"BDBM159774";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@H](NS(=O)(=O)N2CCC(C#N)C2)C1";"IC50";"'='";"7870.0";"nM";"5.10";"";"302668";"UO_0000065";"13.59";"0.27";"4.50";"4.33";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"7870.0"
"CHEMBL3963532";"";"None";"254.34";"0";"3.57";"BDBM198193";"Cc1nc(C2CCCCC2)c2c3cc[nH]c3ncn12";"IC50";"'='";"590.0";"nM";"6.23";"";"351825";"UO_0000065";"24.49";"0.45";"2.66";"13.55";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"590.0"
"CHEMBL1970709";"";"None";"345.20";"0";"3.65";"SID103904666";"O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969126";"";"None";"379.37";"0";"4.87";"SID103905066";"CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999714";"";"None";"224.26";"0";"3.30";"SID103904727";"Cc1ccc2c(c1)NC(=O)c1ccccc1N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1975256";"";"None";"386.42";"1";"1.79";"SID103905141";"Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1964692";"";"None";"426.40";"0";"4.88";"SID103904366";"Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3622148";"";"None";"446.56";"0";"3.98";"12";"CCn1nc(Nc2nc3c(cc(C(=O)N(C4CC4)C4CC4)n3CC)c3c2ncn3C)cc1C";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"14.91";"0.28";"2.68";"7.76";"0";"CHEMBL3625648";"Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621135";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"220.0"
"CHEMBL4643392";"";"None";"433.51";"0";"3.43";"26";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCCCCOCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"15.40";"0.29";"3.25";"6.65";"0";"CHEMBL4627624";"Inhibition of TYK2 in human Jurkat cells by luciferase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307526";"";"";"";"210.0"
"CHEMBL2003657";"";"None";"455.54";"0";"4.39";"SID103905061";"CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000335";"";"None";"389.48";"1";"5.20";"SID103904296";"Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2000071";"";"None";"268.32";"0";"2.42";"SID103904212";"OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1979883";"";"None";"455.59";"1";"5.41";"SID103904280";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1";"Ki";"'>'";"1584.89";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL1967531";"";"None";"361.43";"0";"4.58";"SID103904284";"Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3613597";"";"None";"495.43";"0";"3.96";"12";"CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3615458";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of basal level STAT3 phosphorylation at 10 uM after 30 mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL4793380";"";"None";"423.48";"0";"4.34";"17d";"CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1";"Activity";"'='";"104.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4766969";"Inhibition of recombinant human TYK2 (875 to end residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765237";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"Dose = 10.0 microM | TIME = 0.6667 hr";"";"";"104.0"
"CHEMBL4794578";"";"None";"397.44";"0";"2.58";"7";"CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12";"Activity";"'='";"96.48";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4721566";"Inhibition of wild-type human partial length TYK2 expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 1.0 microM";"";"";"96.48"
"CHEMBL4780057";"";"None";"436.49";"0";"2.70";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(C)n2)c1OC";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"19.26";"0.36";"5.65";"6.37";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"4.5"
"CHEMBL4793760";"";"None";"439.47";"0";"3.14";"33";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncccn2)c1OC";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"17.80";"0.33";"4.63";"6.58";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"17.0"
"CHEMBL4780057";"";"None";"436.49";"0";"2.70";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(C)n2)c1OC";"IC50";"'='";"226.0";"nM";"6.65";"";"";"UO_0000065";"15.33";"0.28";"3.95";"5.07";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"226.0"
"CHEMBL3960901";"";"None";"391.48";"0";"2.86";"BDBM116318";"O=C(NC1CCC(O)CC1)c1cnn2ccc(NC3CCc4ccccc43)nc12";"Ki";"'='";"50.9";"nM";"7.29";"";"241652";"UO_0000065";"18.63";"0.34";"4.43";"7.97";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"50.9"
"CHEMBL3648433";"";"None";"357.39";"0";"2.21";"BDBM107142";"CS(=O)(=O)OCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226452";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL4092508";"";"None";"658.56";"2";"5.74";"2t";"COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl";"Activity";"'='";"83.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4044238";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043093";"1";"Scientific Literature";"Eur J Med Chem";"2017";"CHEMBL3307715";"";"";"";"83.0"
"CHEMBL4218175";"";"None";"405.55";"0";"3.48";"13a";"CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4188996";"Inhibition of wild-type human partial length TYK2 expressed in mammalian expression system at 1 uM using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184298";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";""
"CHEMBL4777200";"";"None";"415.90";"0";"3.60";"32a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)C[C@H]1F";"IC50";"'='";"308.0";"nM";"6.51";"";"";"UO_0000065";"15.66";"0.31";"2.91";"8.91";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"308.0"
"CHEMBL4080797";"";"None";"408.51";"0";"2.82";"35";"COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4055272";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"100.0"
"CHEMBL2420842";"";"None";"212.25";"0";"2.64";"4";"Cc1ccccc1C(=O)Nc1ccncc1";"Ki";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"26.48";"0.48";"2.98";"13.38";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"2.4"
"CHEMBL2420858";"";"None";"267.12";"0";"3.64";"21";"O=C(Nc1c(Cl)cccc1Cl)c1ccncc1";"Ki";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"22.31";"0.48";"2.32";"14.19";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.1"
"CHEMBL1702157";"";"None";"232.67";"0";"2.99";"3";"O=C(Nc1ccncc1)c1ccccc1Cl";"Ki";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"25.61";"0.51";"2.97";"14.19";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.1"
"CHEMBL2420839";"";"None";"340.17";"0";"2.57";"50";"O=C(CO)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"19.41";"0.41";"4.03";"7.23";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.25"
"CHEMBL2420836";"";"None";"364.23";"0";"4.38";"47";"O=C(Nc1ccnc(NC(=O)C2CCC2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"19.58";"0.41";"2.75";"10.03";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.074"
"CHEMBL2420831";"";"None";"283.11";"0";"3.35";"41";"O=C(Nc1ccnc(O)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"23.38";"0.50";"3.27";"10.64";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.24"
"CHEMBL4761365";"";"None";"411.94";"0";"4.04";"31g";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1";"Activity";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4713291";"Inhibition of recombinant human TYK2 (875 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 microM | TIME = 0.6667 hr";"INHIBITOR";"";"8.0"
"CHEMBL3622133";"";"None";"439.52";"0";"2.48";"14";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC(=O)NCCOC)nc21";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.87";"0.28";"4.06";"6.15";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"290.0"
"CHEMBL939";"GEFITINIB";"4.0";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL535";"SUNITINIB";"4.0";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"16.17";"0.30";"3.11";"8.34";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"360.0"
"CHEMBL3593290";"";"None";"533.66";"1";"4.99";"7h";"CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1";"Inhibition";"'='";"21.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3595421";"Inhibition of human TYK2 at 0.1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3593229";"1";"Scientific Literature";"Eur J Med Chem";"2015";"None";"";"";"";"21.0"
"CHEMBL4096145";"";"None";"377.49";"0";"3.42";"2";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4055272";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"100.0"
"CHEMBL1287883";"";"None";"394.36";"0";"1.22";"11";"Nc1nc(Nc2cccc(S(N)(=O)=O)c2)nn1C(=O)c1c(F)cccc1F";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1292869";"Inhibition of TYK2-mediated INFgamma production in IL-12-stimulated human PBMC at 10 uM treated for 15 mins before IL12 challenge measured after 48 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL1287970";"";"None";"387.35";"0";"2.75";"16";"CCOC(=O)c1cccc(Nc2nc(N)nn2C(=O)c2c(F)cccc2F)c1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1292869";"Inhibition of TYK2-mediated INFgamma production in IL-12-stimulated human PBMC at 10 uM treated for 15 mins before IL12 challenge measured after 48 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL1163565";"";"None";"530.98";"1";"4.92";"5o";"CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168301";"Inhibition of TYK2 JH2 pseudokinase domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL1163567";"";"None";"545.01";"2";"6.10";"5l";"COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL3961632";"";"None";"248.29";"0";"2.99";"22";"Cc1cccc(-c2cc(N)nc3[nH]cc(C#N)c23)c1";"Inhibition";"'>'";"95.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4031837";"Inhibition of recombinant human TYK2 JH1 catalytic domain (887 to 1187 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028875";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"95.0"
"CHEMBL218859";"GW445012X";"None";"266.34";"0";"3.23";"GW445012X";"CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1";"Inhibition";"'='";"0.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.52"
"CHEMBL220465";"GSK-248233A";"None";"484.52";"0";"4.19";"GSK248233A";"CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21";"Inhibition";"'='";"-5.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.17"
"CHEMBL1880739";"GW305074X";"None";"520.95";"2";"5.01";"GW305074X";"O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1";"Inhibition";"'='";"-1.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.21"
"CHEMBL4457060";"";"None";"462.49";"0";"3.87";"35";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2n[nH]c(C)n2)c1OC";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"16.00";"0.30";"3.53";"5.70";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"40.0"
"CHEMBL4565054";"";"None";"462.49";"0";"3.58";"37";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2ncnn2C)c1OC";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"15.27";"0.28";"3.48";"5.94";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"87.0"
"CHEMBL303687";"GW829877X";"None";"358.41";"0";"3.58";"GW829877X";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1";"Inhibition";"'='";"-1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.37"
"CHEMBL471789";"GSK-1030059A";"None";"476.48";"1";"5.90";"GSK1030059A";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC";"Inhibition";"'='";"-1.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.78"
"CHEMBL458438";"GSK-1511931A";"None";"508.63";"2";"5.53";"GSK1511931A";"COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1";"Inhibition";"'='";"-4.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.59"
"CHEMBL1081292";"";"None";"406.44";"1";"5.27";"5";"COc1ccc(-c2cccc3nc(Nc4cc(OC)c(OC)c(OC)c4)oc23)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10.0"
"CHEMBL3359916";"";"None";"302.38";"0";"1.78";"4e";"CC1(C)C[C@@](C)(O)C[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"21.67";"0.41";"4.77";"7.07";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"280.0"
"CHEMBL5076728";"";"None";"451.51";"0";"4.01";"15d";"O=C(CCCCCCn1cc(Nc2ncc3ccn(Cc4ccccc4F)c3n2)cn1)NO";"Inhibition";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5038985";"Inhibition of human recombinant TYK2 assessed as reduction in substrate phosphorylation at 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 500.0 nM | TIME = 1.0 hr";"INHIBITOR";"";"90.0"
"CHEMBL1909405";"GW618013A";"None";"554.57";"0";"4.98";"GW618013A";"CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O";"Inhibition";"'='";"-0.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.14"
"CHEMBL1794067";"GSK-978744A";"None";"487.97";"0";"3.71";"GSK978744A";"C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl";"Inhibition";"'='";"2.03";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.03"
"CHEMBL2012519";"";"None";"364.39";"0";"1.52";"L-783277";"COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"14.78";"0.28";"3.87";"4.76";"0";"CHEMBL1656381";"Inhibition of TYK2 by TR-FRET based LanthaScreen assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649097";"1";"Scientific Literature";"ACS Med Chem Lett";"2011";"None";"";"";"";"4100.0"
"CHEMBL5088804";"";"None";"267.29";"0";"2.59";"20";"COc1cc(-c2ccc(O)cc2)cc2cnc(N)nc12";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"22.82";"0.42";"3.51";"7.51";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.1"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"24.55";"0.45";"4.05";"9.04";"1";"CHEMBL4351044";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350951";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"30.0"
"CHEMBL273564";"GW795493X";"None";"413.36";"1";"5.13";"GW795493X";"Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12";"Inhibition";"'='";"-3.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.79"
"CHEMBL1230165";"SILMITASERTIB";"2.0";"349.78";"0";"4.88";"Silmitasertib";"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12";"Kd";"'='";"2382.0";"nM";"5.62";"";"Active";"UO_0000065";"16.08";"0.31";"0.74";"7.49";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.96 None";"";"";"2382.0"
"CHEMBL1952329";"SGI-1776";"1.0";"405.42";"0";"4.05";"SGI-1776";"CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1289601";"LENVATINIB";"4.0";"426.86";"0";"4.07";"Lenvatinib";"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3545307";"MERESTINIB";"2.0";"552.54";"2";"5.75";"LY-2801653";"Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL505915";"GSK-1751853A";"None";"601.69";"1";"3.61";"GSK1751853A";"COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2";"Inhibition";"'='";"0.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.12"
"CHEMBL176553";"GW631581B";"None";"296.33";"0";"4.10";"GW631581B";"COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1";"Inhibition";"'='";"-5.97";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.97"
"CHEMBL4062062";"";"None";"411.94";"0";"4.07";"18";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(Cl)cc4)cc23)CC[C@]1(C)N";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.42";"0.38";"3.93";"8.13";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"10.0"
"CHEMBL3671805";"";"None";"392.51";"0";"3.12";"31";"Cc1ccncc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"17.18";"0.32";"3.62";"6.06";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"180.0"
"CHEMBL1909406";"";"None";"333.82";"0";"3.86";"SKF-86002-A2";"Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1";"Inhibition";"'='";"-8.34";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-8.34"
"CHEMBL4062932";"";"None";"349.39";"0";"2.56";"13b";"C/C=C/C(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"2000.0"
"CHEMBL4066730";"";"None";"348.37";"0";"1.90";"13d";"N#CCC(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"16.36";"0.30";"3.80";"4.55";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"2000.0"
"CHEMBL4105148";"";"None";"371.23";"0";"4.77";"27";"Cc1nccc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)n1";"EC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"13.54";"0.27";"0.26";"6.33";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"9.4"
"CHEMBL3936356";"";"None";"255.32";"0";"2.90";"BDBM198199";"CC1CCCCC1c1nnn2cnc3[nH]ccc3c12";"IC50";"'='";"56.0";"nM";"7.25";"";"351831";"UO_0000065";"28.40";"0.52";"4.35";"12.32";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"56.0"
"CHEMBL1082022";"";"None";"492.53";"1";"5.02";"15";"CNC(=O)c1ccc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)cc1C";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"14.05";"0.26";"1.90";"8.69";"0";"CHEMBL1102773";"Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154949";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"0.12"
"CHEMBL4645613";"";"None";"243.31";"0";"2.46";"11";"Cc1[nH]nc2[nH]c(=O)cc([C@@H]3C[C@H]4CC[C@@H]3C4)c12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"28.05";"0.52";"4.36";"11.09";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.15"
"CHEMBL1088856";"";"None";"499.57";"0";"4.77";"16";"COc1cc(-c2cnc3cccc(-c4ccc(C(=O)N5CCOCC5)c(C)c4)c3n2)cc(OC)c1OC";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.72";"0.22";"1.08";"7.05";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"1400.0"
"CHEMBL1088857";"";"None";"489.55";"0";"4.96";"17";"COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(F)c4)c3n2)cc(OC)c1OC";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"11.56";"0.21";"0.70";"8.58";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"2200.0"
"CHEMBL1090090";"VX-702";"2.0";"404.32";"0";"3.62";"VX-702";"NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4084193";"";"None";"None";"None";"None";"RDEA-436";"";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3359920";"";"None";"301.39";"0";"1.75";"4i";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@@]1(C)N";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"24.17";"0.45";"5.53";"7.40";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"52.0"
"CHEMBL3359922";"";"None";"274.32";"0";"1.15";"5a";"C[C@]1(O)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"24.88";"0.47";"5.67";"7.37";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"150.0"
"CHEMBL3359925";"";"None";"288.35";"0";"1.40";"5d";"C[C@@]1(CO)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"22.23";"0.42";"5.01";"6.92";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"390.0"
"CHEMBL4787974";"";"None";"423.95";"0";"4.18";"20c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(Cl)cc1";"GI50";"'='";"1714.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"1.714"
"CHEMBL4759666";"";"None";"411.94";"0";"4.04";"30b";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2cccc(Cl)c2)CC1";"IC50";"'='";"59.8";"nM";"7.22";"";"";"UO_0000065";"17.53";"0.34";"3.18";"9.89";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"59.8"
"CHEMBL4069942";"";"None";"400.27";"0";"4.53";"21";"CN(C)c1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"23.04";"0.47";"4.69";"11.16";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0006"
"CHEMBL4075453";"";"None";"426.31";"1";"5.07";"22";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3cc(N4CCCC4)ncn3)c2[nH]1";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.82";"0.44";"4.23";"11.26";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0005"
"CHEMBL4076947";"";"None";"396.24";"0";"4.65";"30";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"23.10";"0.46";"4.50";"8.87";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0007"
"CHEMBL1288032";"";"None";"316.27";"0";"1.97";"21";"Nc1nc(Nc2cccnc2)nn1C(=O)c1c(F)cccc1F";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"20.62";"0.39";"4.55";"6.61";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"300.0"
"CHEMBL1240703";"CGP-52421";"None";"586.65";"2";"5.40";"CGP-52421";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL4635625";"";"None";"407.40";"0";"1.69";"19";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"18.50";"0.35";"5.85";"8.57";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"29.0"
"CHEMBL4638206";"";"None";"420.52";"0";"2.56";"7";"CCNC(=O)c1ccc(Nc2nccc(N3CC4CCC(C3)N4C(=O)C3CC3)n2)cc1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.82";"0.33";"4.93";"8.29";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"32.0"
"CHEMBL4635334";"";"None";"387.42";"0";"0.65";"11";"O=C(N[C@]12C[C@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2)C1CC1";"IC50";"'='";"5303.0";"nM";"5.28";"";"";"UO_0000065";"13.62";"0.26";"4.63";"4.88";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"5303.0"
"CHEMBL4516471";"BI 1675";"None";"554.64";"1";"2.95";"EUB0000319";"O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1";"% Control";"'='";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507284";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"98.0"
"CHEMBL5205855";"";"None";"518.55";"1";"2.43";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)C(=O)NC3)c1OC";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"14.37";"0.27";"4.98";"4.53";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"39.0"
"CHEMBL4641006";"";"None";"446.51";"0";"2.18";"23";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCCCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"18.50";"0.34";"6.08";"6.87";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"5.5"
"CHEMBL4643392";"";"None";"433.51";"0";"3.43";"26";"N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCCCCOCc1cccc(n1)Nc1cc2ccn1";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"19.17";"0.35";"4.88";"8.28";"0";"CHEMBL4627617";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"4.9"
"CHEMBL3589175";"";"None";"429.48";"0";"3.57";"12";"COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCOCC5)ccc4c3c2)c1";"IC50";"'='";"171.0";"nM";"6.77";"";"";"UO_0000065";"15.76";"0.29";"3.20";"6.93";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"171.0"
"CHEMBL3589176";"";"None";"447.47";"0";"3.71";"13";"COc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCOCC5)ccc4c3c2)cc1F";"IC50";"'='";"201.0";"nM";"6.70";"";"";"UO_0000065";"14.97";"0.28";"2.99";"6.86";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"201.0"
"CHEMBL572881";"MOTESANIB";"3.0";"373.46";"0";"4.04";"Motesanib";"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2216870";"IDELALISIB";"4.0";"415.43";"0";"3.75";"Idelalisib";"CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4093872";"";"None";"442.31";"0";"4.30";"23";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3cc(N4CCOCC4)ncn3)c2[nH]1";"EC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"15.15";"0.30";"2.40";"7.29";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.2"
"CHEMBL3694585";"";"None";"366.85";"0";"4.46";"BDBM125906";"Clc1cnc2nc1NCCc1cccc(c1)OCCc1cccc(c1)N2";"IC50";"'='";"53.0";"nM";"7.28";"";"255717";"UO_0000065";"19.83";"0.38";"2.82";"12.32";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"53.0"
"CHEMBL3675686";"";"None";"354.22";"0";"4.84";"BDBM120129";"COC(=O)Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12";"Ki";"'='";"1.4";"nM";"8.85";"";"247335";"UO_0000065";"25.00";"0.55";"4.01";"13.81";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1.4"
"CHEMBL4849458";"";"None";"438.56";"0";"3.83";"11c";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)C2CC2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"2.69";"nM";"8.57";"";"";"UO_0000065";"19.54";"0.38";"4.74";"9.21";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2.69"
"CHEMBL4876729";"";"None";"504.62";"1";"4.73";"11d";"COc1ccc(S(=O)(=O)N2CCc3cc(Nc4ncc(C)c(-c5cnn(C(C)C)c5)n4)ccc32)cc1";"IC50";"'='";"7.82";"nM";"8.11";"";"";"UO_0000065";"16.07";"0.31";"3.38";"7.93";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"7.82"
"CHEMBL4869302";"";"None";"376.46";"0";"3.88";"11h";"CC(=O)N1CCc2cc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)ccc21";"IC50";"'='";"1.81";"nM";"8.74";"";"";"UO_0000065";"23.22";"0.43";"4.86";"11.51";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1.81"
"CHEMBL4854704";"";"None";"402.50";"0";"4.27";"11i";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)C2CC2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"3.76";"nM";"8.43";"";"";"UO_0000065";"20.93";"0.38";"4.15";"11.09";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"3.76"
"CHEMBL4845662";"";"None";"359.39";"0";"2.55";"14d";"Cc1cnc(Nc2ccc3c(c2)CNC3=O)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"0.67";"nM";"9.17";"";"";"UO_0000065";"25.53";"0.46";"6.62";"8.45";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"0.67"
"CHEMBL4853438";"";"None";"557.53";"1";"4.91";"14f";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)c3ccc(C(F)(F)F)cc3)ncc2F)cn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.43";"0.28";"3.14";"6.89";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"9.0"
"CHEMBL4872557";"";"None";"415.43";"0";"4.14";"14n";"N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4C(=O)C4CC4)c3)ncc2F)cn1";"IC50";"'='";"151.0";"nM";"6.82";"";"";"UO_0000065";"16.42";"0.30";"2.68";"6.73";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"151.0"
"CHEMBL4535276";"";"None";"401.45";"0";"1.14";"16";"O=C(C1CC1)N1[C@@H]2CC[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"18.08";"0.34";"6.12";"7.30";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"55.0"
"CHEMBL3114781";"";"None";"418.43";"0";"3.19";"10a";"O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(OCCNc2ccnc(F)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL176857";"GW442130X";"None";"502.16";"2";"5.48";"GW442130X";"COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O";"Inhibition";"'='";"-5.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.9"
"CHEMBL218720";"GSK-466314A";"None";"428.41";"0";"4.41";"GSK466314A";"CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1";"Inhibition";"'='";"37.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"37.47"
"CHEMBL2035042";"";"None";"395.51";"1";"5.23";"13b, 95:5 trans/Cis mixture";"CN1C/C=C/CCn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)C1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.73";"0.27";"0.59";"12.67";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"1.5"
"CHEMBL2035047";"";"None";"362.43";"0";"4.00";"13g, 95:5 trans/Cis mixture";"CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)C1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"16.07";"0.29";"1.82";"9.18";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"1.5"
"CHEMBL446024";"GW683003X";"None";"294.24";"0";"2.16";"GW683003X";"FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1";"Inhibition";"'='";"-4.86";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.86"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"208.0";"nM";"6.68";"";"";"UO_0000065";"21.39";"0.40";"5.14";"7.52";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"208.0"
"CHEMBL5435482";"";"None";"402.51";"0";"3.06";"12";"Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1-c1cnn(CCC#N)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.61";"0.40";"5.64";"10.13";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"2.0"
"CHEMBL5427850";"";"None";"464.49";"1";"1.87";"37";"CNc1cc(Nc2cccn(-c3nc(C)co3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.73";"0.35";"6.83";"6.19";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"2.0"
"CHEMBL5422880";"";"None";"452.43";"0";"2.04";"12";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3C[C@H]3F)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5405569";"";"None";"452.43";"0";"2.04";"11";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3C[C@@H]3F)cnn12";"Kd";"'='";"0.068";"nM";"10.17";"";"";"UO_0000065";"22.47";"0.42";"8.13";"8.60";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.068"
"CHEMBL5402351";"";"None";"484.44";"0";"2.73";"15";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CCC3(F)F)cnn12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.61";"0.31";"5.32";"6.80";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"9.0"
"CHEMBL5193226";"";"None";"587.63";"1";"4.35";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"65.36";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"65.36"
"CHEMBL5194842";"";"None";"578.67";"1";"3.34";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCSC3)cc2)c1OC";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.01";"0.29";"5.30";"5.59";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"2.3"
"CHEMBL5191508";"";"None";"578.64";"1";"3.02";"30";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"15.15";"0.28";"5.70";"5.29";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.9"
"CHEMBL5197776";"";"None";"415.44";"0";"2.83";"15";"O=C(Nc1nc2cccc([C@H]3CCC4(C3)CN(C(=O)[C@@H]3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"14.64";"0.28";"3.25";"7.64";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"830.0"
"CHEMBL5206101";"";"None";"443.50";"0";"3.61";"26";"O=C(Nc1nc2cccc(C3CCC4(CC3)CCN(C(=O)[C@@H]3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"16.18";"0.31";"3.56";"9.01";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"67.0"
"CHEMBL5205480";"";"None";"515.95";"1";"1.88";"12h";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1C[C@@H]2C[C@H]1CO2";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"13.24";"0.26";"4.95";"5.37";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"148.0"
"CHEMBL5189220";"";"None";"534.59";"1";"2.94";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NCC)cc2)c1OC";"Tm";"'='";"60.06";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"60.06"
"CHEMBL5203217";"";"None";"597.65";"1";"3.32";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3[C@H](C#N)C[C@@H]4C[C@@H]43)cc2)c1OC";"Tm";"'='";"67.12";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"67.12"
"CHEMBL5182426";"";"None";"506.54";"1";"2.29";"5";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(N)=O)cc2)c1OC";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"14.88";"0.28";"5.20";"4.22";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"32.0"
"CHEMBL5415586";"";"None";"349.39";"0";"3.38";"1c";"COc1ccccc1Nc1cc(Nc2cccc(C)n2)ncc1C(N)=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"22.39";"0.41";"4.44";"7.66";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"15.0"
"CHEMBL3764167";"";"None";"286.34";"0";"1.68";"10";"CCC(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"26.13";"0.49";"5.80";"7.92";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"33.0"
"CHEMBL1650953";"";"None";"440.43";"0";"3.16";"7";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCNCC2)ccc1C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1657305";"Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649080";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"10000.0"
"CHEMBL4522317";"";"None";"403.36";"0";"3.90";"25";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C(F)(F)F)c2cn[nH]c2c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.88";"0.30";"2.10";"6.31";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.0"
"CHEMBL3589169";"";"None";"446.94";"0";"4.13";"6";"CN1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)cc5)cc4c3c2)CC1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"19.14";"0.37";"4.42";"10.38";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"2.8"
"CHEMBL1968705";"";"None";"535.65";"2";"6.13";"SID103905541";"CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2001257";"";"None";"483.64";"1";"6.19";"SID103904319";"CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973893";"";"None";"372.45";"0";"3.34";"SID103905137";"CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1";"Ki";"'='";"25.12";"nM";"7.60";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.6"
"CHEMBL1994241";"";"None";"370.21";"0";"4.10";"SID103904926";"COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O";"Ki";"'='";"398.11";"nM";"6.40";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.4"
"CHEMBL4572373";"";"None";"379.42";"0";"2.15";"11b";"C=CC(=O)Nc1cccc(CNc2cc(Nc3cnn(CCO)c3)ncn2)c1";"IC50";"'='";"2561.0";"nM";"5.59";"";"";"UO_0000065";"14.74";"0.27";"3.44";"4.78";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"2561.0"
"CHEMBL4555932";"";"None";"456.55";"0";"3.44";"14e'";"CN1CCN(c2ccc(Nc3cc(NCc4ccc(NC(=O)CC#N)cc4)ncn3)cc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL1993722";"";"None";"405.39";"0";"4.29";"SID103904859";"Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005475";"";"None";"339.46";"0";"4.60";"SID103904997";"O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2005899";"";"None";"315.37";"0";"2.21";"SID103905650";"CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991846";"";"None";"331.42";"0";"3.60";"SID103904967";"NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970083";"";"None";"523.52";"2";"7.41";"SID103904279";"Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1966279";"";"None";"477.55";"0";"2.47";"SID103905097";"NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991728";"";"None";"746.89";"2";"1.02";"SID103905366";"CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1";"Ki";"'='";"1995.26";"nM";"5.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3589329";"";"None";"438.54";"0";"3.73";"21";"CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc5c(cnn5C)c4)cc23)CC1";"IC50";"'='";"247.0";"nM";"6.61";"";"";"UO_0000065";"15.07";"0.27";"2.88";"7.94";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"247.0"
"CHEMBL1088752";"LOSMAPIMOD";"3.0";"383.47";"0";"3.86";"Losmapimod";"Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL259084";"MLN-8054";"1.0";"476.87";"1";"5.87";"MLN-8054";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3590106";"ULIXERTINIB";"2.0";"433.34";"0";"4.67";"Ulixertinib";"CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3301610";"ABEMACICLIB";"4.0";"506.61";"1";"4.94";"Abemaciclib";"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL426800";"GW785404X";"None";"247.23";"0";"1.83";"GW785404X";"CCn1c(-c2nonc2N)nc2ccc(F)cc21";"Inhibition";"'='";"-3.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.66"
"CHEMBL5200095";"";"None";"429.47";"0";"3.22";"34";"O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)C3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.28";"0.33";"4.20";"9.32";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"38.0"
"CHEMBL5422616";"";"None";"460.50";"0";"1.97";"30; TAK-279";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"19.04";"0.35";"6.80";"6.88";"0";"CHEMBL5327988";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human PBMC";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.7"
"CHEMBL5398548";"";"None";"464.46";"0";"1.72";"13";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3C[C@@H]3OC)cnn12";"Kd";"'='";"0.023";"nM";"10.64";"";"";"UO_0000065";"22.90";"0.43";"8.92";"8.35";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.023"
"CHEMBL3676058";"";"None";"394.45";"0";"3.20";"BDBM127817";"Cc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NC3(C)CC3)c2n1";"IC50";"'>'";"1000.0";"nM";"";"";"258568";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4785602";"";"None";"358.51";"0";"3.97";"46";"Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1";"Activity";"'='";"85.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4674073";"Inhibition of human TYK2 assessed as residual activity using KKSRGDYMTMQIG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673210";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 1.0 microM";"";"";"85.7"
"CHEMBL191105";"";"None";"287.33";"0";"1.02";"SB-751399";"CN(C)CCCn1c(-c2nonc2N)nc2cnccc21";"Inhibition";"'='";"-2.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.04"
"CHEMBL3694589";"";"None";"380.88";"0";"4.85";"BDBM125910";"Clc1cnc2nc1NCCCc1cccc(c1)OCCc1cccc(c1)N2";"IC50";"'='";"106.0";"nM";"6.97";"";"255721";"UO_0000065";"18.31";"0.35";"2.12";"11.81";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"106.0"
"CHEMBL2035045";"";"None";"373.46";"0";"3.80";"13e, 95:5 trans/Cis mixture";"CN1C/C=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)C1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"14.00";"0.26";"1.43";"8.28";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"5.9"
"CHEMBL2035182";"";"None";"452.58";"0";"4.49";"14i, 95:5 trans/Cis mixture";"COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(s1)-c1ccnc(n1)N2";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"16.53";"0.32";"2.99";"10.88";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.033"
"CHEMBL2035185";"CT-1578";"1.0";"462.55";"0";"4.56";"14l, SB1578, 67:33 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"14.35";"0.27";"2.08";"8.11";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.23"
"CHEMBL4554938";"";"None";"416.49";"0";"2.29";"EUB0000178b";"CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21";"IC50";"'='";"254.0";"nM";"6.59";"";"";"UO_0000065";"15.84";"0.32";"4.31";"5.43";"0";"CHEMBL5213019";"Selectivity interaction (Enzymatic assay) EUB0000178b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity Comments: XMU-MP-1 treatment inhibited hydrogen peroxide (H2O2)-Âstimulated MOB1 phosphorylation and MST1/2 autophosphorylation in a variety of cell lines, including mouse macrophage-like cells (RAW264.7), human osteosarcoma (U2OS), human colorectal adenocarcinoma (SW480), immortalized human retinal pigment epithelial cells (RPE1), human pleomorphic hepatocellular carcinoma (SNU-423): EC50 <3 ÂµM, PMID: 27535619; | Selectivity Remarks: In-vitro potency, TYK2(JH1 catalytic domain) | Selectivity Source Knowledge: https://doi.org/10.1126/scitranslmed.aaf2304";"";"";"254.0"
"CHEMBL3655085";"";"None";"390.47";"0";"0.77";"BDBM159752";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2(CC#N)COC2)C1";"IC50";"'='";"878.0";"nM";"6.06";"";"302646";"UO_0000065";"15.51";"0.31";"5.29";"4.88";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"878.0"
"CHEMBL608154";"";"None";"366.81";"0";"4.33";"MLN-120B";"COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5399946";"";"None";"398.38";"0";"2.68";"Example 883";"CC(=O)Nc1cc2c(cn1)c(-c1ccn(C)n1)nn2-c1ccnc(C(C)(F)F)n1";"IC50";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5346250";"Inhibition of human TYK2 JH2 domain (575 to 876 residues) incubated for 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5344452";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME = 1.0 hr";"INHIBITOR";"";"10.0"
"CHEMBL1965495";"";"None";"234.26";"0";"2.81";"SID103905398";"Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL1984191";"";"None";"291.14";"0";"3.84";"SID103905424";"Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971029";"";"None";"590.50";"1";"3.31";"SID103904602";"CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br";"Ki";"'='";"79.43";"nM";"7.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.1"
"CHEMBL1979357";"";"None";"354.46";"0";"4.23";"SID103905237";"Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991640";"";"None";"399.42";"0";"4.13";"SID103905583";"O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1977223";"";"None";"360.42";"0";"3.61";"SID103904519";"CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988594";"";"None";"404.46";"0";"4.17";"SID103904352";"Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1789961";"GW513184X";"None";"360.38";"0";"2.98";"GW513184X";"COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O";"Inhibition";"'='";"0.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.57"
"CHEMBL1096634";"GSK-943949A";"None";"447.50";"0";"2.28";"GSK943949A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21";"Inhibition";"'='";"-2.11";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.11"
"CHEMBL3184679";"AZD-4547";"2.0";"463.58";"0";"3.65";"AZD-4547";"COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1091644";"LINSITINIB";"3.0";"421.50";"0";"4.82";"Linsitinib";"C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4091582";"";"None";"402.50";"0";"3.29";"21";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)cc4)cc23)CC[C@]1(C)N";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"20.04";"0.37";"4.78";"6.60";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"8.6"
"CHEMBL207247";"GW807930X";"None";"500.96";"2";"5.63";"GW807930X";"CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1";"Inhibition";"'='";"2.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.95"
"CHEMBL102936";"";"None";"370.43";"0";"2.95";"SB-742865";"CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1";"Inhibition";"'='";"-2.13";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.13"
"CHEMBL4070136";"";"None";"436.56";"0";"3.60";"37";"CC(C)Oc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"17.23";"0.32";"3.92";"6.24";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"30.0"
"CHEMBL160333";"";"None";"349.17";"0";"3.18";"SB-409514";"O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1";"Inhibition";"'='";"3.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.26"
"CHEMBL450786";"PHA-665752";"None";"641.62";"2";"6.11";"PHA-665752";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1";"Kd";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"8.07";"0.16";"-0.93";"5.05";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"6600.0"
"CHEMBL259084";"MLN-8054";"1.0";"476.87";"1";"5.87";"MLN-8054";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5076728";"";"None";"451.51";"0";"4.01";"15d";"O=C(CCCCCCn1cc(Nc2ncc3ccn(Cc4ccccc4F)c3n2)cn1)NO";"IC50";"'='";"40.9";"nM";"7.39";"";"";"UO_0000065";"16.36";"0.31";"3.38";"6.72";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"40.9"
"CHEMBL5194482";"";"None";"495.59";"0";"3.46";"10f";"C=CC(=O)Nc1cccc(Cn2c(=O)ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1";"IC50";"'='";"8877.0";"nM";"5.05";"";"";"UO_0000065";"10.19";"0.19";"1.59";"5.30";"0";"CHEMBL5146947";"Inhibition of TYK2 (unknown origin) incubated for 1 hr in the presence of ATP by FRET based Z'-LYTE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143636";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"8877.0"
"CHEMBL175321";"";"None";"263.30";"0";"3.20";"GR-105659X";"O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21";"Inhibition";"'='";"-2.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.35"
"CHEMBL3675696";"";"None";"407.26";"1";"5.02";"BDBM120139";"N#Cc1cc(Cl)c(-c2nc3c(F)cnc(NC(=O)C4CC4)c3s2)c(Cl)c1";"Ki";"'='";"1.5";"nM";"8.82";"";"247345";"UO_0000065";"21.67";"0.46";"3.80";"11.22";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1.5"
"CHEMBL3694586";"";"None";"366.85";"0";"4.81";"BDBM125907";"Clc1cnc2nc1NCCCc1cccc(c1)OCc1cccc(c1)N2";"IC50";"'='";"237.0";"nM";"6.62";"";"255718";"UO_0000065";"18.06";"0.35";"1.82";"11.22";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"237.0"
"CHEMBL4530035";"";"None";"411.39";"0";"3.17";"16";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)O)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10000.0"
"CHEMBL3675697";"";"None";"397.83";"0";"4.14";"BDBM120140";"N#Cc1cnc(Nc2cc(N)ncn2)c2sc(-c3c(F)cccc3Cl)nc12";"Ki";"'='";"0.4";"nM";"9.40";"";"247346";"UO_0000065";"23.62";"0.48";"5.26";"8.29";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.4"
"CHEMBL3675698";"";"None";"388.39";"0";"4.04";"BDBM120141";"[C-]#[N+]c1cccc(F)c1-c1nc2c(C#N)cnc(Nc3cc(N)ncn3)c2s1";"Ki";"'='";"0.3";"nM";"9.52";"";"247347";"UO_0000065";"24.52";"0.46";"5.48";"8.09";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.3"
"CHEMBL4526018";"";"None";"349.40";"0";"2.69";"11a'";"C=CC(=O)Nc1ccc(CNc2cc(Nc3cnn(C)c3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL1998159";"";"None";"427.43";"0";"4.30";"SID103905453";"Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1968791";"";"None";"467.62";"1";"5.61";"SID103904993";"Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"30.08";"0.56";"7.86";"10.57";"0";"CHEMBL5385206";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380863";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.4"
"CHEMBL1984432";"";"None";"303.37";"0";"3.49";"SID103904530";"Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL517507";"GW782912X";"None";"362.47";"0";"4.08";"GW782912X";"Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-2.49";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.49"
"CHEMBL1909359";"GW771127A";"None";"459.96";"0";"2.83";"GW771127A";"Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl";"Inhibition";"'='";"-3.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.68"
"CHEMBL5280466";"";"None";"546.60";"1";"3.32";"5";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCC3=O)cc2)c1OC";"Tm";"'='";"61.89";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"61.89"
"CHEMBL5180664";"";"None";"562.65";"1";"3.67";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N(CC)CC)cc2)c1OC";"Tm";"'='";"60.62";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"60.62"
"CHEMBL5184093";"";"None";"586.67";"1";"3.96";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3C4CCC3CC4)cc2)c1OC";"Tm";"'='";"62.69";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"62.69"
"CHEMBL5202702";"";"None";"324.77";"0";"3.23";"21a";"Cc1c(-c2ncnc3[nH]ccc23)nnn1Cc1ccc(Cl)cc1";"Inhibition";"'='";"67.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5133089";"Inhibition of TYK2 (unknown origin) at 1 uM by biochemical assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"67.0"
"CHEMBL5196293";"";"None";"368.42";"0";"1.98";"24a";"Cc1c(-c2ncnc3[nH]ccc23)nnn1Cc1ccc(S(C)(=O)=O)cc1";"Inhibition";"'='";"2.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5133089";"Inhibition of TYK2 (unknown origin) at 1 uM by biochemical assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"";"";"2.7"
"CHEMBL5076189";"";"None";"407.49";"0";"3.98";"51f";"CCc1cc(O)c(F)cc1-c1cc(N[C@H]2C[C@H]3CC[C@@H](C2)N3)c2nc(N)ncc2c1";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"18.90";"0.35";"3.72";"8.01";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.7"
"CHEMBL4526274";"";"None";"450.33";"0";"4.53";"8m";"O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO";"Inhibition";"'='";"68.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4347802";"Inhibition of recombinant human TYK2 at 200 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"68.0"
"CHEMBL4128181";"";"None";"428.50";"0";"4.67";"23; FM-381";"CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"459.0";"nM";"6.34";"";"";"UO_0000065";"14.79";"0.27";"1.67";"6.11";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"459.0"
"CHEMBL288441";"BOSUTINIB";"4.0";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"Kd";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"10.08";"0.20";"0.16";"6.45";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"4500.0"
"CHEMBL4568087";"";"None";"421.53";"0";"2.86";"19";"Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"17.28";"0.33";"4.42";"7.06";"0";"CHEMBL4479787";"Inhibition of recombinant human N-terminal GST-tagged cytoplasmic TYK2 (833 to 1187 residues) catalytic domain expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"52.0"
"CHEMBL2420811";"";"None";"380.23";"0";"3.76";"53";"O=C(Nc1ccnc(NC(=O)C2CCCO2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"15.32";"0.32";"2.06";"7.25";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.5"
"CHEMBL2420840";"";"None";"339.18";"0";"2.54";"51";"NCC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"17.46";"0.37";"3.38";"6.10";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.2"
"CHEMBL4539949";"";"None";"349.39";"0";"3.01";"18";"CCc1cc(O)c(F)cc1-c1cc(NS(C)(=O)=O)c2cn[nH]c2c1";"pIC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";""
"CHEMBL4551312";"";"None";"331.40";"0";"3.01";"13";"CCS(=O)(=O)Nc1cc(-c2ccc(O)c(C)c2)cc2[nH]ncc12";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"18.41";"0.36";"3.09";"6.42";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.1"
"CHEMBL4531121";"";"None";"317.37";"0";"2.70";"9";"CCS(=O)(=O)Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"20.17";"0.40";"3.70";"6.73";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.4"
"CHEMBL188381";"GW806742X";"None";"573.56";"2";"5.18";"GW806742X";"CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1";"Inhibition";"'='";"-1.91";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.91"
"CHEMBL5396334";"";"None";"481.51";"0";"2.11";"19";"[2H]C([2H])([2H])O[C@@H]1CC[C@H]1NC(=O)c1cnn2c(NC)cc(Nc3cccn(-c4ncccc4F)c3=O)nc12";"Kd";"'='";"0.003";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL5425044";"";"None";"492.52";"0";"2.50";"27";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@H](OC)C3)cnn12";"Kd";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"17.40";"0.33";"6.07";"6.72";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"2.7"
"CHEMBL5422616";"";"None";"460.50";"0";"1.97";"30; TAK-279";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.004";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL5401172";"";"None";"474.53";"0";"2.28";"33";"CNc1cc(Nc2cccn(-c3cccnc3C)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.105";"nM";"9.98";"";"";"UO_0000065";"21.03";"0.39";"7.70";"7.83";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.105"
"CHEMBL4082035";"";"None";"363.45";"0";"0.65";"15";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCCCC#N)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4059667";"";"None";"321.41";"0";"1.01";"28";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3694580";"";"None";"351.80";"0";"4.05";"BDBM125901";"O=C1Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2";"IC50";"'>'";"1000.0";"nM";"";"";"255712";"UO_0000065";"";"";"";"";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4100431";"";"None";"295.37";"0";"0.47";"5";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(C)(=O)=O)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3655081";"ABROCITINIB";"4.0";"323.42";"0";"1.25";"25; PF-04965842";"CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3934426";"";"None";"337.43";"0";"2.72";"BDBM198505";"CN(CCC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"360.0";"nM";"6.44";"";"353483";"UO_0000065";"19.10";"0.35";"3.72";"7.50";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"360.0"
"CHEMBL3962138";"";"None";"490.56";"0";"4.39";"BDBM198593";"CSc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1";"IC50";"'='";"390.0";"nM";"6.41";"";"353571";"UO_0000065";"13.06";"0.26";"2.02";"7.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"390.0"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"6.4";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471854";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 0.04 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"6.4"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"1.5";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471855";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 0.01 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"1.5"
"CHEMBL3928091";"";"None";"353.43";"0";"1.31";"BDBM198463";"O=C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CCN1";"IC50";"'='";"970.0";"nM";"6.01";"";"353441";"UO_0000065";"17.01";"0.32";"4.70";"6.59";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"970.0"
"CHEMBL274863";"";"None";"382.44";"0";"2.45";"SB-216385";"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1";"Inhibition";"'='";"-1.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.83"
"CHEMBL3942424";"";"None";"364.43";"0";"3.56";"BDBM198395";"Fc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"310.0";"nM";"6.51";"";"353373";"UO_0000065";"17.86";"0.33";"2.95";"9.18";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL3904756";"";"None";"380.88";"0";"4.08";"BDBM198400";"Clc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"353378";"UO_0000065";"18.27";"0.35";"2.88";"9.81";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL3940782";"";"None";"394.91";"0";"4.12";"BDBM198401";"Clc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"65.0";"nM";"7.19";"";"353379";"UO_0000065";"18.20";"0.35";"3.07";"10.14";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"65.0"
"CHEMBL4109603";"";"None";"376.46";"0";"2.96";"BDBM198406";"O[C@H](CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'='";"330.0";"nM";"6.48";"";"353384";"UO_0000065";"17.22";"0.32";"3.52";"7.11";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"330.0"
"CHEMBL3947749";"";"None";"387.45";"0";"2.89";"BDBM198416";"N#CCOc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353394";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445873";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-4, JAK1/3, pSTAT6 in CD3+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"50.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"406.0";"nM";"6.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445879";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-6, JAK1/2, pSTAT3 in monocytes)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Monocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308025";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"406.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445883";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-6, JAK1/2, pSTAT1 in human CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"54.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"1210.0";"nM";"5.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445893";"Affinity Phenotypic Cellular interaction: (Colony forming cell assays (inhibition of mouse myeloid progenitor cell differentiation, total mouse myeloid colonies)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Myeloid progenitor cells";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL5483204";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"1210.0"
"CHEMBL2181327";"";"None";"459.59";"0";"4.49";"17h, 85:15 trans/cis mixture";"CN(C)CCN(C)c1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"15.55";"0.29";"2.66";"11.39";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.071"
"CHEMBL2181315";"";"None";"359.43";"0";"4.99";"16a, 85:15 trans/cis mixture";"C1=CCCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)OCC1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"14.70";"0.27";"0.29";"9.39";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"5.2"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445087";"Affinity Phenotypic Cellular interaction: (Human whole blood assay (phosphorylation of STAT4, IL-12 as stimulant to assess TYK2 potency in a cellular system)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00917";"";"";"65.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445115";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-12 induced pSTAT4 (lymphocytes), JAK2/TYK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"65.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"238.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445116";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-15 induced pSTAT5 (lymphocytes), JAK1/JAK3 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"238.0"
"CHEMBL3622376";"";"None";"242.24";"0";"0.62";"65";"c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1";"IC50";"'='";"5624.0";"nM";"5.25";"";"";"UO_0000065";"21.67";"0.40";"4.63";"6.19";"1";"CHEMBL4351044";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350951";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"5624.0"
"CHEMBL3694581";"";"None";"366.85";"0";"4.81";"BDBM125902";"Clc1cnc2nc1NCc1cccc(c1)OCCCc1cccc(c1)N2";"IC50";"'='";"25.0";"nM";"7.60";"";"255713";"UO_0000065";"20.72";"0.40";"2.79";"12.87";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"25.0"
"CHEMBL3694591";"";"None";"442.95";"1";"6.48";"BDBM125912";"Clc1cnc2nc1NCc1cc(ccc1-c1ccccc1)OCCCc1cccc(c1)N2";"IC50";"'='";"400.0";"nM";"6.40";"";"255723";"UO_0000065";"14.44";"0.27";"-0.08";"10.83";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"400.0"
"CHEMBL5182121";"";"None";"421.41";"0";"3.01";"14b";"O=C1NCc2nc(-c3c(F)cccc3F)nc(Nc3ccc(C4CCNC4=O)cc3)c21";"Ki";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"21.26";"0.39";"5.95";"9.33";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"1.1"
"CHEMBL5181976";"";"None";"437.41";"0";"2.77";"22";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCOCC4=O)cn3)c21";"Ki";"'='";"0.34";"nM";"9.47";"";"";"UO_0000065";"21.65";"0.40";"6.70";"9.82";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.34"
"CHEMBL5178821";"";"None";"416.42";"0";"2.89";"26";"CCNC(=O)c1ccc(Nc2cc(-c3c(F)cccc3C#N)nc3c2C(=O)NC3)nc1";"Ki";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"23.15";"0.42";"6.75";"8.05";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.23"
"CHEMBL3658866";"";"None";"391.54";"0";"2.07";"BDBM159785";"CC(C)N1CCC(S(=O)(=O)C[C@H]2C[C@@H](N(C)c3ncnc4[nH]ccc34)C2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"302679";"UO_0000065";"";"";"";"";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"10000.0"
"CHEMBL4281393";"";"None";"275.31";"0";"2.68";"12";"N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"1839.0";"nM";"5.74";"";"";"UO_0000065";"20.83";"0.37";"3.06";"7.41";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1839.0"
"CHEMBL4284799";"";"None";"333.40";"0";"2.87";"14";"COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CC4)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4283198";"";"None";"289.34";"0";"2.93";"21";"C[C@@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N";"IC50";"'='";"4619.0";"nM";"5.33";"";"";"UO_0000065";"18.44";"0.33";"2.41";"6.89";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"4619.0"
"CHEMBL4281035";"";"None";"434.49";"0";"1.89";"30";"Cn1nccc1S(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL2387127";"";"None";"368.19";"0";"3.94";"23";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2F)c1)c1c(Cl)cccc1Cl";"EC50";"'='";"193.0";"nM";"6.71";"";"";"UO_0000065";"18.24";"0.38";"2.77";"9.44";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"193.0"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"37";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"EC50";"'='";"737.0";"nM";"6.13";"";"";"UO_0000065";"16.28";"0.32";"2.84";"6.46";"0";"CHEMBL2389255";"Inhibition of TYK2 in human whole blood assessed as IL-12/IL18-stumulated IFNgamma production";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"737.0"
"CHEMBL5193702";"";"None";"533.03";"1";"2.56";"12n";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4OC)n2)ccc1N(C)CCN(C)C";"Inhibition";"'='";"36.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5141297";"Inhibition of human TYK2 at 0.5 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 0.5 microM";"";"";"36.0"
"CHEMBL513897";"GSK-994854A";"None";"481.60";"1";"5.35";"GSK994854A";"CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1";"Inhibition";"'='";"-1.46";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.46"
"CHEMBL3648434";"";"None";"321.34";"0";"2.80";"BDBM107143";"CC(=O)OCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226453";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL4858303";"";"None";"475.60";"0";"3.58";"11p";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)CCN2CCOCC2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"9.64";"nM";"8.02";"";"";"UO_0000065";"16.85";"0.31";"4.44";"9.07";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"9.64"
"CHEMBL5074436";"";"None";"364.45";"0";"2.91";"16";"CC(=O)N1CCC(Cc2cccc3cnc(Nc4cnn(C)c4)nc23)CC1";"IC50";"'='";"79.43";"nM";"7.10";"";"";"UO_0000065";"19.48";"0.36";"4.19";"9.35";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.1"
"CHEMBL386051";"";"None";"443.36";"1";"5.77";"PD-173955";"CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1";"Kd";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"14.36";"0.30";"0.60";"10.64";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"430.0"
"CHEMBL386051";"";"None";"443.36";"1";"5.77";"PD-173955";"CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4862564";"";"None";"534.54";"2";"5.93";"10";"Cc1cnc(Nc2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3)c(F)c2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.75";"0.29";"1.96";"7.75";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"13.0"
"CHEMBL4854514";"";"None";"536.56";"2";"6.00";"11n";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)Cc2ccc(OC(F)(F)F)cc2)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"51.06";"nM";"7.29";"";"";"UO_0000065";"13.59";"0.26";"1.29";"8.56";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"51.06"
"CHEMBL5267449";"";"None";"596.68";"1";"3.12";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCS3(=O)=O)cc2)c1OC";"Tm";"'='";"64.8";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"64.8"
"CHEMBL5280466";"";"None";"546.60";"1";"3.32";"5";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCC3=O)cc2)c1OC";"Tm";"'='";"56.54";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"56.54"
"CHEMBL5289104";"";"None";"556.60";"1";"3.54";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3cccc(=O)[nH]3)cc2)c1OC";"Tm";"'='";"52.55";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"52.55"
"CHEMBL5282377";"";"None";"558.62";"1";"3.47";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(CC)n3)cc2)c1OC";"Tm";"'='";"54.85";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"54.85"
"CHEMBL5282377";"";"None";"558.62";"1";"3.47";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(CC)n3)cc2)c1OC";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"13.26";"0.25";"3.90";"4.46";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"43.0"
"CHEMBL3675690";"";"None";"418.31";"0";"5.00";"BDBM120133";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(CO)cc4Cl)sc23)ncn1";"Ki";"'='";"1.0";"nM";"9.00";"";"247339";"UO_0000065";"21.52";"0.46";"4.00";"10.74";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1.0"
"CHEMBL3675691";"";"None";"365.25";"0";"4.41";"BDBM120134";"O=C(Nc1ncnc2nc(-c3c(Cl)cccc3Cl)sc12)C1CC1";"Ki";"'='";"6.2";"nM";"8.21";"";"247340";"UO_0000065";"22.47";"0.49";"3.80";"12.11";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"6.2"
"CHEMBL2181313";"";"None";"502.62";"1";"4.97";"22f, 85:15 trans/cis mixture";"COc1ccc2cc1COCC=CCOCc1cc(ccc1OCCN1CCCC1)Nc1nccc-2n1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.42";"0.25";"1.77";"8.65";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.18"
"CHEMBL2181311";"";"None";"502.62";"1";"4.97";"22d, 85:15 trans/cis mixture";"COc1ccc2cc1-c1ccnc(n1)Nc1ccc(OCCN3CCCC3)c(c1)COCC=CCOC2";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"12.35";"0.23";"1.24";"7.96";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.62"
"CHEMBL5209315";"";"None";"569.64";"1";"4.22";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"69.25";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"69.25"
"CHEMBL5171417";"";"None";"558.61";"1";"3.31";"26";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CN(C2CC2)C3=O)c1OC";"Tm";"'='";"59.96";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"59.96"
"CHEMBL5203256";"";"None";"596.63";"1";"3.16";"32";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Tm";"'='";"66.31";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"66.31"
"CHEMBL408564";"";"None";"347.17";"0";"3.33";"SB-739452";"O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1";"Inhibition";"'='";"-1.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.26"
"CHEMBL3354190";"";"None";"367.46";"0";"3.16";"9";"COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C)n2)CC1";"Ki";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3375810";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351701";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"1000.0"
"CHEMBL5179468";"";"None";"587.66";"2";"3.81";"31";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Tm";"'='";"56.94";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"56.94"
"CHEMBL5189913";"";"None";"520.56";"1";"2.55";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NC)cc2)c1OC";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.96";"0.28";"5.19";"4.74";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"18.0"
"CHEMBL5196735";"";"None";"560.63";"1";"3.43";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.07";"0.30";"5.53";"5.79";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.1"
"CHEMBL103667";"DORAMAPIMOD";"2.0";"527.67";"2";"5.99";"BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL103667";"DORAMAPIMOD";"2.0";"527.67";"2";"5.99";"BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4101725";"";"None";"323.42";"0";"1.25";"26";"CCCS(=O)(=O)N[C@H]1C[C@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4063642";"";"None";"350.45";"0";"0.85";"38";"CN(C1CC1)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL222419";"GSK-237701A";"None";"457.94";"0";"5.00";"GSK237701A";"COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-0.12";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.12"
"CHEMBL374060";"GW439255X";"None";"325.41";"0";"4.53";"GW439255X";"Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1";"Inhibition";"'='";"-2.24";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.24"
"CHEMBL4554460";"";"None";"375.43";"0";"3.54";"22";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C2CC2)c2cn[nH]c2c1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"17.31";"0.34";"2.96";"6.84";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.5"
"CHEMBL4551061";"";"None";"345.42";"0";"3.26";"11";"CCc1cc(O)ccc1-c1cc(NS(=O)(=O)CC)c2cn[nH]c2c1";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"18.24";"0.36";"3.04";"6.63";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.3"
"CHEMBL202891";"GW679410X";"None";"328.38";"0";"4.21";"GW679410X";"COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1";"Inhibition";"'='";"-6.95";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.95"
"CHEMBL3667511";"";"None";"397.24";"0";"3.24";"BDBM153659";"Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccccc2Br)n1";"Ki";"'='";"480.0";"nM";"6.32";"";"295016";"UO_0000065";"15.91";"0.35";"3.08";"8.19";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"480.0"
"CHEMBL4281492";"";"None";"409.44";"0";"3.42";"17i";"COC(=O)[C@@H](C(C)C)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"256.5";"nM";"6.59";"";"";"UO_0000065";"16.10";"0.30";"3.17";"6.91";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"256.5"
"CHEMBL362155";"GW827102X";"None";"490.45";"1";"5.39";"GW827102X";"FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1";"Inhibition";"'='";"-2.27";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.27"
"CHEMBL4483484";"";"None";"375.38";"1";"5.37";"35";"CCc1cc(O)c(F)cc1-c1cc(NP(=O)(CC)CC)c2cn[nH]c2c1";"IC50";"'='";"19952.62";"nM";"4.70";"";"";"UO_0000065";"12.52";"0.25";"-0.67";"6.02";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"4.7"
"CHEMBL4483364";"";"None";"363.41";"0";"3.40";"19";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CC)c2cn[nH]c2c1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"18.71";"0.37";"3.40";"7.15";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.8"
"CHEMBL3651966";"LGH-447";"1.0";"440.47";"1";"5.04";"8; PIM447";"C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3748465";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745712";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"10.0"
"CHEMBL4128181";"";"None";"428.50";"0";"4.67";"23; FM-381";"CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"11800.0";"nM";"4.93";"";"";"UO_0000065";"11.50";"0.21";"0.26";"4.75";"0";"CHEMBL4124188";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 200 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"11800.0"
"CHEMBL1938643";"";"None";"368.46";"0";"2.74";"8";"CNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"25.0"
"CHEMBL4090883";"";"None";"285.35";"0";"1.57";"5";"C=CC(=O)N1CCC[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL2205426";"";"None";"414.47";"0";"3.83";"49";"CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2209625";"Inhibition of recombinant TYK2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"1900.0"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"37";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"Ki";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"23.35";"0.46";"5.51";"9.27";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.6"
"CHEMBL2387220";"";"None";"417.26";"0";"3.50";"34";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2c2nnc[nH]2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"18.75";"0.38";"4.32";"6.94";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"15.0"
"CHEMBL2387131";"";"None";"384.65";"0";"4.21";"27";"O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2Cl)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"21.56";"0.47";"4.08";"11.66";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"5.1"
"CHEMBL2387128";"";"None";"368.19";"0";"3.94";"24";"O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@@H]2F)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"22.13";"0.46";"4.21";"11.46";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"7.1"
"CHEMBL2387122";"";"None";"392.24";"0";"4.19";"17";"CC(=O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"20.67";"0.43";"3.92";"9.20";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"7.8"
"CHEMBL2387119";"";"None";"393.27";"0";"3.71";"14";"CNCc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"21.57";"0.45";"4.77";"10.20";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"3.3"
"CHEMBL2387118";"";"None";"379.25";"0";"3.45";"13";"NCc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"22.03";"0.46";"4.91";"8.61";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"4.4"
"CHEMBL2387225";"";"None";"365.22";"0";"3.57";"4";"Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"24.64";"0.51";"5.43";"9.27";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"1.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"2, INCB018424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"30.36";"0.55";"5.83";"11.18";"1";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"0.5"
"CHEMBL2153264";"";"None";"211.23";"0";"1.60";"7";"Nc1nc2c(-c3ccccn3)nccc2[nH]1";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL2154877";"Binding affinity to JH domain of TYK2 assessed as ATP binding remaining at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150858";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";""
"CHEMBL4476770";"";"None";"444.85";"0";"3.45";"SAR-20347";"NC(=O)c1nc(-c2c(F)cccc2Cl)oc1Nc1ccc(C(=O)N2CCOCC2)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"20.73";"0.41";"5.77";"8.33";"0";"CHEMBL4331751";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFN-alpha stimulated TYK2 phosphorylation by caspase3/7 reagent-based Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307526";"";"";"";"0.6"
"CHEMBL2178803";"";"None";"361.41";"0";"2.58";"BDBM50399016";"Cc1ccc(C)c(-c2nn(C)cc2NC(=O)c2cnn3ccc(N)nc23)c1";"Ki";"'='";"7.3";"nM";"8.14";"";"241644";"UO_0000065";"22.51";"0.41";"5.56";"7.89";"0";"CHEMBL3707970";"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638370";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"7.3"
"CHEMBL4447360";"";"None";"340.38";"0";"1.25";"22";"C[C@@H](O)[C@@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"21.94";"0.41";"6.22";"6.62";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"34.0"
"CHEMBL4846148";"";"None";"554.60";"2";"5.89";"13i";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C2CCC2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.28";"0.28";"2.03";"8.52";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"12.0"
"CHEMBL3655093";"";"None";"385.44";"0";"1.89";"BDBM159760";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC(F)(F)C2)C1";"IC50";"'='";"770.0";"nM";"6.11";"";"302654";"UO_0000065";"15.86";"0.32";"4.22";"6.72";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"770.0"
"CHEMBL2035043";"";"None";"368.44";"0";"4.93";"13c, 95:5 trans/Cis mixture";"C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)COC/1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"18.52";"0.33";"1.89";"13.13";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.15"
"CHEMBL2035052";"";"None";"473.58";"0";"4.61";"14d, 95:5 trans/Cis mixture";"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccnc(c2)OCC/1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"15.89";"0.29";"2.91";"9.22";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.03"
"CHEMBL2035053";"";"None";"487.60";"0";"4.92";"14e, 95:5 trans/Cis mixture";"Cc1cnc2nc1-c1ccnc(c1)OCC/C=C/COCc1cc(ccc1OCCN1CCCC1)N2";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"14.65";"0.27";"2.22";"8.75";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.072"
"CHEMBL2035054";"";"None";"475.59";"0";"4.47";"14f, 95:5 trans/Cis mixture";"CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"12.93";"0.24";"1.68";"8.10";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.71"
"CHEMBL2035055";"";"None";"491.66";"0";"4.94";"14g, 95:5 trans/Cis mixture";"CN1C/C=C/COCc2ccc(s2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"15.03";"0.29";"2.45";"11.77";"0";"CHEMBL2040122";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2034857";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.041"
"CHEMBL1287910";"";"None";"359.29";"0";"2.27";"13";"Nc1nc(Nc2cccc(C(=O)O)c2)nn1C(=O)c1c(F)cccc1F";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"17.15";"0.32";"3.89";"5.00";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"690.0"
"CHEMBL1288769";"";"None";"247.26";"0";"1.31";"17";"CCOC(=O)c1cccc(Nc2n[nH]c(N)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL2420857";"";"None";"262.70";"0";"3.00";"20";"COc1ccc(C(=O)Nc2ccncc2)c(Cl)c1";"Ki";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"20.92";"0.42";"2.49";"10.73";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.2"
"CHEMBL3589165";"";"None";"399.45";"0";"3.56";"2";"NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"19.52";"0.35";"4.24";"8.82";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"16.0"
"CHEMBL3589173";"";"None";"472.37";"0";"4.20";"10";"NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c3c([nH]c12)CCC(C(=O)N1CCOCC1)C3";"IC50";"'='";"608.0";"nM";"6.22";"";"";"UO_0000065";"13.16";"0.27";"2.02";"7.03";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"608.0"
"CHEMBL3589328";"";"None";"386.46";"0";"3.63";"20";"Cc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(N5CCOCC5)ccc4c3c2)cn1";"IC50";"'='";"117.0";"nM";"6.93";"";"";"UO_0000065";"17.94";"0.33";"3.30";"8.23";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"117.0"
"CHEMBL3645535";"";"None";"306.37";"0";"2.80";"BDBM107118";"CN(C)CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226427";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"25.27";"0.47";"6.35";"8.88";"0";"CHEMBL3784141";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779778";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"12.8"
"CHEMBL2420852";"";"None";"300.67";"0";"4.01";"15";"O=C(Nc1ccncc1)c1cc(C(F)(F)F)ccc1Cl";"Ki";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"20.11";"0.41";"2.04";"14.40";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.9"
"CHEMBL5405140";"";"None";"395.48";"0";"3.53";"19c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(F)cc2)[C@H](C)C1";"IC50";"'='";"123.4";"nM";"6.91";"";"";"UO_0000065";"17.47";"0.33";"3.38";"9.46";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"123.4"
"CHEMBL3929096";"";"None";"324.31";"0";"2.35";"BDBM198217";"FC(F)(F)CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"353199";"UO_0000065";"20.95";"0.40";"4.45";"10.94";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"160.0"
"CHEMBL3974904";"";"None";"242.29";"0";"1.07";"BDBM198219";"c1cc2c(ncn3nnc(C4CCNCC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353201";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3922240";"";"None";"350.40";"0";"3.12";"BDBM198235";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"353217";"UO_0000065";"19.98";"0.37";"3.88";"11.27";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL3981443";"";"None";"339.43";"0";"2.44";"BDBM198240";"c1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)n1";"IC50";"'='";"460.0";"nM";"6.34";"";"353222";"UO_0000065";"18.67";"0.36";"3.90";"8.45";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"460.0"
"CHEMBL3983303";"";"None";"371.45";"0";"3.86";"BDBM198285";"N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353263";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3937827";"";"None";"439.45";"0";"4.88";"BDBM198298";"N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F";"IC50";"'='";"370.0";"nM";"6.43";"";"353276";"UO_0000065";"14.64";"0.27";"1.55";"6.79";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"370.0"
"CHEMBL3897849";"";"None";"385.48";"0";"3.89";"BDBM198301";"CN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(C#N)cc1";"IC50";"'='";"580.0";"nM";"6.24";"";"353279";"UO_0000065";"16.18";"0.29";"2.35";"7.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"580.0"
"CHEMBL3962689";"";"None";"464.88";"1";"5.54";"BDBM198308";"FC(F)(F)Oc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353286";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3978777";"";"None";"361.45";"0";"2.86";"BDBM198315";"c1cc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1";"IC50";"'='";"340.0";"nM";"6.47";"";"353293";"UO_0000065";"17.90";"0.33";"3.61";"7.72";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"340.0"
"CHEMBL3975250";"";"None";"375.41";"0";"3.75";"BDBM198322";"N#Cc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1";"IC50";"'='";"180.0";"nM";"6.75";"";"353300";"UO_0000065";"17.97";"0.33";"2.99";"7.12";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"180.0"
"CHEMBL3931093";"";"None";"418.32";"0";"3.20";"BDBM198352";"Brc1ncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'='";"110.0";"nM";"6.96";"";"353330";"UO_0000065";"16.63";"0.38";"3.76";"9.28";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL3940267";"";"None";"351.39";"0";"2.52";"BDBM198360";"Fc1cnccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353338";"UO_0000065";"19.51";"0.36";"4.33";"9.14";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3934664";"";"None";"363.43";"0";"2.39";"BDBM198369";"COc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"353347";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3973302";"";"None";"376.47";"0";"2.77";"BDBM198382";"Cc1cnc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cn1";"IC50";"'='";"41.0";"nM";"7.39";"";"353360";"UO_0000065";"19.62";"0.36";"4.62";"7.64";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"41.0"
"CHEMBL3978620";"";"None";"478.91";"0";"4.32";"BDBM198402";"OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccc(Cl)cc1)C(F)(F)F";"IC50";"'='";"440.0";"nM";"6.36";"";"353380";"UO_0000065";"13.27";"0.26";"2.04";"6.98";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"440.0"
"CHEMBL3898196";"";"None";"376.46";"0";"2.96";"BDBM198407";"O[C@@H](CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'='";"350.0";"nM";"6.46";"";"353385";"UO_0000065";"17.15";"0.31";"3.50";"7.08";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"350.0"
"CHEMBL3972033";"";"None";"406.46";"0";"3.38";"BDBM198411";"O=C(NCCc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"370.0";"nM";"6.43";"";"353389";"UO_0000065";"15.82";"0.29";"3.05";"7.31";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"370.0"
"CHEMBL3947711";"";"None";"430.43";"0";"3.54";"BDBM198415";"OC(CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(C(F)(F)F)cc1";"IC50";"'='";"450.0";"nM";"6.35";"";"353393";"UO_0000065";"14.75";"0.28";"2.81";"7.71";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"450.0"
"CHEMBL3896566";"";"None";"417.34";"0";"3.81";"BDBM198440";"Brc1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353418";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3967749";"";"None";"417.34";"0";"3.81";"BDBM198441";"Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'='";"110.0";"nM";"6.96";"";"353419";"UO_0000065";"16.67";"0.38";"3.15";"11.20";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL3972962";"";"None";"421.51";"1";"5.02";"BDBM198451";"N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c2ccccc12";"IC50";"'>'";"1000.0";"nM";"";"";"353429";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4279883";"";"None";"436.42";"0";"1.27";"29";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"14.74";"0.28";"5.16";"4.83";"0";"CHEMBL4251858";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha-induced IP10 production";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.37"
"CHEMBL4247801";"";"None";"397.49";"0";"0.61";"10e";"CN(C)CC(=O)N1CCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL1972584";"";"None";"591.72";"1";"4.47";"SID103904787";"CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL514499";"GW843682X";"None";"477.46";"0";"4.80";"GW843682X";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"-6.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.76"
"CHEMBL5084426";"";"None";"534.52";"1";"4.35";"EUB0001548";"COc1cnccc1Nc1nc(-c2nn(Cc3c(F)cc(OCCO)cc3F)c3ccccc23)ncc1OC";"Inhibition";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL5059979";"TYK2(JH2domain-pseudokinase) DiscoveRx kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5058649";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2022";"None";"Compound concentration = 1.0 uM";"";"";"100.0"
"CHEMBL1288093";"";"None";"394.44";"0";"2.54";"25";"CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccc(N(C)C)cc3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL1288033";"";"None";"351.37";"0";"2.47";"22";"CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccccc3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10000.0"
"CHEMBL5268371";"";"None";"560.63";"1";"3.71";"6";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"Tm";"'='";"66.58";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"66.58"
"CHEMBL5270823";"";"None";"578.62";"1";"3.85";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2F)c1OC";"Tm";"'='";"60.75";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"60.75"
"CHEMBL5266772";"";"None";"574.59";"1";"3.68";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ccc(F)c(=O)[nH]3)cc2)c1OC";"Tm";"'='";"60.07";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"60.07"
"CHEMBL2420854";"";"None";"267.12";"0";"3.64";"17";"O=C(Nc1ccncc1)c1ccc(Cl)cc1Cl";"Ki";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"22.17";"0.48";"2.28";"14.10";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"1.2"
"CHEMBL2420819";"";"None";"282.13";"0";"3.22";"29";"Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"21.38";"0.46";"2.81";"8.87";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.93"
"CHEMBL2420856";"";"None";"247.69";"0";"2.57";"19";"Nc1ccc(C(=O)Nc2ccncc2)c(Cl)c1";"Ki";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"25.92";"0.52";"3.85";"9.44";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.38"
"CHEMBL2420835";"";"None";"364.23";"0";"4.38";"45";"O=C(CC1CC1)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"19.29";"0.40";"2.65";"9.88";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.094"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"BDBM103727";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"79.07";"nM";"7.10";"";"221732";"UO_0000065";"16.69";"0.32";"5.12";"7.35";"0";"CHEMBL3707911";"Inhibition Assay: In vitro inhibition assay using various enzyme.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638964";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"79.07"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"2";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"Ki";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"23.35";"0.46";"5.51";"9.27";"1";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"1.6"
"CHEMBL3655083";"";"None";"374.47";"0";"1.54";"BDBM159750";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@H](CC#N)C2)C1";"IC50";"'='";"965.0";"nM";"6.01";"";"302644";"UO_0000065";"16.06";"0.32";"4.48";"5.24";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"965.0"
"CHEMBL3763991";"";"None";"382.47";"0";"2.42";"14";"CC(C)[C@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"23.63";"0.44";"6.62";"8.85";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"0.92"
"CHEMBL3763289";"";"None";"260.68";"0";"1.95";"3";"Nc1n[nH]c2ccn(-c3ccccc3Cl)c(=O)c12";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"24.67";"0.49";"4.48";"8.39";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"370.0"
"CHEMBL3667508";"";"None";"366.81";"0";"3.44";"BDBM153656";"Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(Cl)ccc2C)n1";"Ki";"'='";"99.6";"nM";"7.00";"";"295014";"UO_0000065";"19.09";"0.37";"3.56";"9.08";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"99.6"
"CHEMBL4780057";"";"None";"436.49";"0";"2.70";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2nccc(C)n2)c1OC";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"16.54";"0.31";"4.47";"5.47";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"68.0"
"CHEMBL4782449";"";"None";"422.46";"0";"2.39";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnccn2)c1OC";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"16.83";"0.31";"4.67";"5.39";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"87.0"
"CHEMBL4278763";"";"None";"469.57";"0";"4.20";"21";"NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1";"Inhibition";"'='";"2.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4263972";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261595";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";"";"2.0"
"CHEMBL160876";"";"None";"377.18";"0";"3.17";"SB-360741";"O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1";"Inhibition";"'='";"0.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.04"
"CHEMBL191705";"GW621431X";"None";"400.46";"0";"4.09";"GW621431X";"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1";"Inhibition";"'='";"-3.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.16"
"CHEMBL185962";"";"None";"242.24";"0";"1.40";"SB-736302";"Nc1nonc1-c1nc2cnccc2n1C1CC1";"Inhibition";"'='";"-1.02";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.02"
"CHEMBL410295";"";"None";"530.64";"1";"4.69";"25";"Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"11.16";"0.20";"1.23";"7.08";"0";"CHEMBL934199";"Inhibition of Tyk2 by HTRF assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143254";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"1.2"
"CHEMBL1614712";"";"None";"439.56";"0";"4.92";"NVP-AEW541";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3790310";"Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3785066";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL1938650";"";"None";"297.38";"0";"3.21";"15";"CNC(=O)c1cnc(N)c2cc(-c3ccc(C)cc3)sc12";"IC50";"'='";"888.0";"nM";"6.05";"";"";"UO_0000065";"20.35";"0.39";"2.84";"8.90";"0";"CHEMBL1941386";"Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3308860";"";"";"";"0.888"
"CHEMBL1987813";"";"None";"292.24";"0";"-0.74";"4";"O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2";"Activity";"'='";"57.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3813074";"Inhibition of human TYK2 JH1 catalytic domain (877 to 1187 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808372";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"57.0"
"CHEMBL4060201";"";"None";"328.38";"0";"2.28";"24";"O=C(CCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO";"IC50";"'='";"188.0";"nM";"6.73";"";"";"UO_0000065";"20.48";"0.38";"4.45";"6.19";"0";"CHEMBL4031309";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]-ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028864";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.188"
"CHEMBL1164180";"";"None";"502.97";"1";"5.00";"5e";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1";"Inhibition";"'='";"79.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"79.0"
"CHEMBL3895703";"";"None";"354.84";"0";"4.24";"19";"CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12";"Inhibition";"'='";"32.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"32.0"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"1";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Inhibition";"'>'";"80.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4674078";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673210";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"Dose = 0.5 microM";"INHIBITOR";"";"80.0"
"CHEMBL516908";"GW796920X";"None";"362.47";"0";"4.54";"GW796920X";"Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-4.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.51"
"CHEMBL2322135";"";"None";"240.31";"0";"3.49";"5";"c1cc2c(ncc3[nH]nc(C4CCCCC4)c32)[nH]1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"30.38";"0.55";"3.81";"12.73";"0";"CHEMBL2327342";"Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321825";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"0.05"
"CHEMBL4093643";"";"None";"351.48";"0";"1.89";"23";"CCCCNS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL2322141";"";"None";"241.30";"0";"2.65";"12";"c1cc2c(ncc3nnc(C4CCCCC4)n32)[nH]1";"INH";"'='";"0.53";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"0.53"
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"VX-680";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Activity";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"5.0"
"CHEMBL1370276";"";"None";"234.21";"0";"2.61";"7";"O=C(Nc1ccncc1)c1c(F)cccc1F";"Ki";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"26.76";"0.50";"3.66";"14.93";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.54"
"CHEMBL366266";"";"None";"411.47";"0";"3.41";"5, JP539654";"O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1";"IC50";"'='";"2310.0";"nM";"5.64";"";"";"UO_0000065";"13.70";"0.25";"2.23";"6.96";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"2310.0"
"CHEMBL1983945";"";"None";"383.45";"0";"3.64";"SID103904683";"NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1241473";"";"None";"440.42";"0";"3.00";"SID103904595";"COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC";"Ki";"'='";"158.49";"nM";"6.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.8"
"CHEMBL340921";"";"None";"371.40";"0";"3.17";"SID103905356";"Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971649";"";"None";"387.42";"0";"4.97";"SID103904350";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1969190";"";"None";"410.38";"1";"5.01";"SID103904443";"COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970317";"";"None";"458.52";"1";"5.73";"SID103904314";"Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL509032";"TAE-684";"None";"614.22";"2";"5.02";"SID103904598";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL2035187";"PACRITINIB";"4.0";"472.59";"0";"4.47";"21c, SB1518, 85:15 trans/cis mixture";"C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.45";"0.28";"2.83";"10.79";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.05"
"CHEMBL1967094";"";"None";"367.86";"0";"4.87";"SID103904999";"O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1976328";"";"None";"388.50";"1";"5.81";"SID103904381";"Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.30";"0.32";"4.96";"7.17";"1";"CHEMBL4258468";"Inhibition of human TYK2 using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257478";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";"";"116.0"
"CHEMBL5094597";"";"None";"341.42";"0";"1.37";"8";"Cc1cnc(Nc2cnn(C)c2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"22.49";"0.42";"6.31";"8.73";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"21.0"
"CHEMBL5075516";"";"None";"367.45";"0";"2.64";"12";"COc1ccc(Nc2ncc(C)c(N3CCC4(CCNC4=O)CC3)n2)cc1";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"19.16";"0.36";"4.40";"8.87";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"91.0"
"CHEMBL478649";"";"None";"348.45";"0";"3.69";"10";"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL13868";"";"None";"507.57";"2";"6.66";"SB-245392";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1";"Inhibition";"'='";"-3.59";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.59"
"CHEMBL361237";"GW785804X";"None";"322.37";"0";"4.14";"GW785804X";"Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1";"Inhibition";"'='";"-1.99";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.99"
"CHEMBL1909383";"GW784307A";"None";"494.99";"0";"2.56";"GW784307A";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl";"Inhibition";"'='";"5.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"5.84"
"CHEMBL191003";"JNJ-7706621";"None";"394.36";"0";"1.22";"JNJ-7706621";"Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F";"Kd";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"19.01";"0.38";"6.27";"5.13";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"32.0"
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL5076101";"";"None";"441.55";"0";"3.86";"54a";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2nc(NCCCN(C)C)ncc2c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.85";"0.30";"3.14";"7.48";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL2443044";"";"None";"454.44";"0";"3.28";"18, NMS-E973";"CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1";"IC50";"'>'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2443724";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439976";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL1288002";"";"None";"358.35";"0";"2.64";"20";"CN(C)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1292869";"Inhibition of TYK2-mediated INFgamma production in IL-12-stimulated human PBMC at 10 uM treated for 15 mins before IL12 challenge measured after 48 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL4864328";"";"None";"420.49";"0";"4.22";"11k";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)[C@@H]2C[C@@H]2F)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"6.28";"nM";"8.20";"";"";"UO_0000065";"19.51";"0.36";"3.98";"10.80";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"6.28"
"CHEMBL4865736";"";"None";"524.52";"2";"6.33";"11l";"Cc1cnc(Nc2ccc3c(c2)CCN3C(=O)c2ccc(C(F)(F)F)cc2F)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"10.62";"nM";"7.97";"";"";"UO_0000065";"15.20";"0.29";"1.64";"10.50";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"10.62"
"CHEMBL3137331";"DEFACTINIB";"2.0";"510.50";"1";"2.40";"EUB0000138";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"% Control";"'='";"87.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507299";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"87.0"
"CHEMBL4228713";"A-1211212";"None";"896.51";"3";"9.44";"EUB0000263";"CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"% Control";"'='";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"98.0"
"CHEMBL4533479";"A-1806262";"None";"558.68";"2";"5.81";"EUB0000339";"CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1";"% Control";"'='";"74.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507261";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"74.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4085414";"";"None";"348.19";"0";"4.55";"10";"O=C(Nc1nccc2oc(-c3c(Cl)cccc3Cl)nc12)C1CC1";"Ki";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"22.11";"0.46";"3.15";"11.32";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.02"
"CHEMBL4099854";"";"None";"387.23";"0";"4.47";"20";"COc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"23.64";"0.48";"4.68";"10.33";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0007"
"CHEMBL4286867";"";"None";"518.62";"1";"4.51";"69c";"O=C(CCCCCCC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)NO";"IC50";"'='";"79.4";"nM";"7.10";"";"";"UO_0000065";"13.69";"0.26";"2.59";"5.52";"0";"CHEMBL4268227";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate preincubated for 20 mins followed by [gamma33P]ATP addition measured after 120 mins by ion exchange filter paper method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265943";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"79.4"
"CHEMBL2420845";"";"None";"246.70";"0";"3.30";"8";"Cc1cccc(Cl)c1C(=O)Nc1ccncc1";"Ki";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"22.51";"0.45";"2.25";"13.22";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"2.8"
"CHEMBL3301622";"GILTERITINIB";"4.0";"552.72";"1";"2.70";"Gilteritinib";"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4520788";"BAY-294";"None";"448.59";"1";"5.58";"EUB0000743";"CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1";"% Control";"'='";"76.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507273";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"76.0"
"CHEMBL4518342";"THPP-1-NC";"None";"493.45";"1";"5.47";"EUB0000744";"CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507293";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL4466720";"";"None";"406.42";"0";"3.09";"7";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(=O)NC1CC1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.0"
"CHEMBL4516272";"";"None";"394.41";"0";"2.90";"8";"CN(C)C(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.0"
"CHEMBL4740191";"";"None";"364.41";"0";"2.59";"21";"C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CCO)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4543090";"";"None";"394.41";"0";"2.82";"19";"CNC(=O)c1cccc(Nc2cc(Nc3ccc(F)cn3)ncc2C(=O)NC)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10000.0"
"CHEMBL4277610";"";"None";"448.48";"0";"3.30";"32";"N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"7";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"15.74";"0.30";"3.28";"5.22";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"480.0"
"CHEMBL3658860";"";"None";"336.46";"0";"2.39";"19";"CCCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4089515";"";"None";"498.61";"0";"2.48";"4";"C[C@@H]1CCN(C(=O)N2CC[C@@H](S(=O)(=O)c3cccc(O)c3)C2)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"958.6";"nM";"6.02";"";"";"UO_0000065";"12.07";"0.23";"3.54";"4.90";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"958.6"
"CHEMBL4090590";"";"None";"322.43";"0";"2.00";"18";"CCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"0.234";"nM";"9.63";"";"";"UO_0000065";"20.64";"0.38";"5.28";"13.87";"0";"CHEMBL4720516";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"INHIBITOR";"";"2.34"
"CHEMBL215152";"AZD-1152-HQPA";"-1.0";"507.57";"1";"3.50";"AZD-1152 HQPA";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL359999";"GW801372X";"None";"348.37";"0";"2.95";"GW801372X";"COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1";"Inhibition";"'='";"31.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"31.78"
"CHEMBL3955720";"";"None";"309.38";"0";"1.99";"BDBM198462";"N#CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"353440";"UO_0000065";"24.02";"0.44";"5.44";"7.85";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"37.0"
"CHEMBL3941598";"";"None";"296.38";"0";"2.38";"BDBM198599";"c1cc2c(ncn3nnc([C@H]4CC[C@H](NC5CC5)CC4)c23)[nH]1";"IC50";"'='";"330.0";"nM";"6.48";"";"353577";"UO_0000065";"21.87";"0.40";"4.10";"9.14";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"330.0"
"CHEMBL3900105";"";"None";"280.34";"0";"2.79";"BDBM198643";"N#CC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"2.9";"nM";"8.54";"";"353621";"UO_0000065";"30.45";"0.56";"5.75";"10.33";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.9"
"CHEMBL5411001";"";"None";"415.40";"0";"2.12";"Example 204";"CC(=O)Nc1cc2c(cn1)c(N1CC3(COC3)C1)nn2-c1nccc(C(C)(F)F)n1";"IC50";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5346250";"Inhibition of human TYK2 JH2 domain (575 to 876 residues) incubated for 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5344452";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME = 1.0 hr";"INHIBITOR";"";"10.0"
"CHEMBL5395925";"";"None";"434.52";"0";"3.51";"20";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL101253";"VATALANIB";"3.0";"346.82";"1";"5.01";"PTK-787";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5434116";"";"None";"415.90";"0";"3.60";"17b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)C[C@@H]1F";"IC50";"'='";"593.1";"nM";"6.23";"";"";"UO_0000065";"14.97";"0.29";"2.63";"8.52";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"593.1"
"CHEMBL4071850";"";"None";"324.41";"0";"0.37";"11";"CCNS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4066876";"";"None";"349.46";"0";"1.50";"24";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)NCC2CC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL2165191";"AZD-6482";"2.0";"408.46";"0";"2.71";"EUB0000621a";"Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5468216";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000621a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 441.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20038/results";"";"";"100.0"
"CHEMBL4103980";"";"None";"372.40";"1";"5.18";"11";"CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1";"IC50";"'='";"15.3";"nM";"7.82";"";"";"UO_0000065";"20.99";"0.38";"2.64";"10.07";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"15.3"
"CHEMBL4069951";"";"None";"437.53";"0";"3.21";"20";"CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(S(C)(=O)=O)CC4)n[nH]c2c1";"IC50";"'='";"25.1";"nM";"7.60";"";"";"UO_0000065";"17.37";"0.33";"4.39";"6.61";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"25.1"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"Kd";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"19.87";"0.37";"4.67";"6.98";"0";"CHEMBL5473627";"Selectivity interaction (Competition binding assay with immobilized ligands) EUB0000286bCit TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 3.0 None | Selectivity number of targets = 317.0 None | Selectivity Remarks: In-vitro potency (TYK2, Kin.Dom.2/JH1 - catalytic) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/18183025/";"";"";"620.0"
"CHEMBL3931713";"";"None";"360.41";"0";"3.22";"BDBM198531";"FC1(F)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"900.0";"nM";"6.05";"";"353509";"UO_0000065";"16.77";"0.32";"2.83";"9.73";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"900.0"
"CHEMBL3908073";"";"None";"378.44";"0";"3.10";"BDBM198552";"Cc1ccc(CNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)o1";"IC50";"'='";"250.0";"nM";"6.60";"";"353530";"UO_0000065";"17.45";"0.32";"3.50";"6.53";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"250.0"
"CHEMBL3931435";"";"None";"399.46";"0";"3.26";"BDBM198554";"N#CC(NC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"353532";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3921442";"";"None";"337.39";"0";"1.91";"BDBM198559";"N#CCCNC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"353537";"UO_0000065";"20.14";"0.37";"4.89";"6.08";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"160.0"
"CHEMBL4113620";"";"None";"340.43";"0";"1.95";"BDBM198470";"O[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"19.0";"nM";"7.72";"";"353448";"UO_0000065";"22.68";"0.42";"5.77";"9.38";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"19.0"
"CHEMBL3904312";"";"None";"314.39";"0";"1.46";"BDBM198475";"OCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"353453";"UO_0000065";"22.35";"0.42";"5.57";"7.71";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"94.0"
"CHEMBL3909024";"";"None";"417.47";"0";"3.32";"BDBM198476";"O=C1COc2cc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)ccc2N1";"IC50";"'='";"240.0";"nM";"6.62";"";"353454";"UO_0000065";"15.86";"0.29";"3.30";"6.06";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"240.0"
"CHEMBL3902428";"";"None";"383.50";"0";"1.49";"BDBM198518";"OCCN1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"530.0";"nM";"6.28";"";"353496";"UO_0000065";"16.36";"0.31";"4.79";"7.33";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"530.0"
"CHEMBL3902570";"";"None";"271.32";"0";"1.87";"BDBM198608";"OC[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"353586";"UO_0000065";"25.15";"0.47";"4.95";"8.63";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3985119";"";"None";"374.47";"0";"1.96";"BDBM198624";"O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NC1CC1";"IC50";"'='";"420.0";"nM";"6.38";"";"353602";"UO_0000065";"17.03";"0.33";"4.42";"6.07";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"420.0"
"CHEMBL3899634";"";"None";"375.41";"0";"3.00";"BDBM198232";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"353214";"UO_0000065";"18.18";"0.33";"3.82";"7.94";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3897798";"";"None";"401.40";"0";"3.40";"BDBM198244";"FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1";"IC50";"'='";"360.0";"nM";"6.44";"";"353226";"UO_0000065";"16.05";"0.30";"3.04";"8.59";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"360.0"
"CHEMBL3903353";"";"None";"356.43";"0";"3.16";"BDBM198252";"CC(C)(C)OC(=O)N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353234";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3983127";"";"None";"277.28";"0";"2.90";"BDBM198257";"FC1(F)CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"353239";"UO_0000065";"23.47";"0.44";"3.61";"11.06";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL3905627";"";"None";"329.43";"0";"3.16";"BDBM198264";"CC(=O)SC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"353244";"UO_0000065";"22.93";"0.45";"4.39";"9.95";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"28.0"
"CHEMBL3967735";"";"None";"269.31";"0";"2.08";"BDBM198271";"O=C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"55.0";"nM";"7.26";"";"353251";"UO_0000065";"26.96";"0.50";"5.18";"9.56";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"55.0"
"CHEMBL3929124";"";"None";"291.31";"0";"3.14";"BDBM198272";"FC(F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"353252";"UO_0000065";"25.29";"0.48";"4.23";"12.51";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"43.0"
"CHEMBL3896777";"";"None";"388.50";"0";"1.61";"BDBM198281";"O=S1(=O)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"353259";"UO_0000065";"17.56";"0.35";"5.21";"7.09";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3894474";"";"None";"323.40";"0";"2.38";"BDBM198283";"N#CCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"353261";"UO_0000065";"22.75";"0.42";"4.98";"7.77";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"44.0"
"CHEMBL4082278";"";"None";"484.59";"1";"5.62";"EUB0000171b";"C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1";"% of control";"'='";"77.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5470004";"Selectivity interaction (ProQinase) EUB0000171b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Cysteine for covalent attachment conserved among all isoforms; Metabolically stable: 31% degradation after 190 min; | Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 410.0 None | Selectivity Remarks: Screened at 1 uM (in vitro) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/27977190/";"";"";"77.0"
"CHEMBL3976885";"";"None";"414.44";"1";"5.01";"BDBM198292";"FC(F)(F)c1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353270";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3909814";"";"None";"364.43";"0";"4.13";"BDBM198293";"Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"470.0";"nM";"6.33";"";"353271";"UO_0000065";"17.36";"0.32";"2.20";"8.93";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"470.0"
"CHEMBL3984960";"";"None";"378.45";"0";"3.81";"BDBM198294";"Fc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"353272";"UO_0000065";"22.83";"0.42";"4.83";"12.18";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.3"
"CHEMBL3957990";"";"None";"410.47";"0";"4.51";"BDBM198302";"CC(NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)c(F)c1";"IC50";"'='";"72.0";"nM";"7.14";"";"353280";"UO_0000065";"17.40";"0.33";"2.63";"10.07";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"72.0"
"CHEMBL3943501";"";"None";"431.54";"0";"3.83";"BDBM198311";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNc5ccc(N6CCOCC6)cc5)CC4)c23)[nH]1";"IC50";"'='";"130.0";"nM";"6.89";"";"353289";"UO_0000065";"15.96";"0.29";"3.06";"8.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL3927316";"";"None";"369.47";"0";"1.55";"BDBM198319";"c1cc2c(ncn3nnc(C4CCC(NCCN5CCOCC5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353297";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3983231";"";"None";"350.40";"0";"3.88";"BDBM198324";"Fc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"353302";"UO_0000065";"19.65";"0.36";"3.01";"9.71";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL3922392";"";"None";"357.42";"0";"3.62";"BDBM198327";"N#Cc1ccc(N[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"370.0";"nM";"6.43";"";"353305";"UO_0000065";"18.00";"0.33";"2.81";"6.79";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"370.0"
"CHEMBL3952151";"";"None";"341.42";"0";"1.47";"BDBM198337";"c1cc2c(ncn3nnc([C@H]4CC[C@@H](NN5CCOCC5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353315";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3984482";"";"None";"341.42";"0";"1.47";"BDBM198338";"c1cc2c(ncn3nnc([C@H]4CC[C@H](NN5CCOCC5)CC4)c23)[nH]1";"IC50";"'='";"500.0";"nM";"6.30";"";"353316";"UO_0000065";"18.46";"0.34";"4.83";"7.56";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"500.0"
"CHEMBL3906967";"";"None";"271.32";"0";"1.87";"BDBM198202";"OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"38.0";"nM";"7.42";"";"353318";"UO_0000065";"27.35";"0.51";"5.55";"9.38";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"38.0"
"CHEMBL3986588";"";"None";"398.47";"0";"3.17";"BDBM198424";"c1cn(-c2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"353402";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3945676";"";"None";"352.47";"0";"3.36";"BDBM198439";"Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'>'";"1000.0";"nM";"";"";"353417";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3938277";"";"None";"346.44";"0";"3.55";"BDBM198448";"CC(c1ccccc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353426";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3946824";"";"None";"405.89";"0";"4.52";"BDBM198450";"N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1Cl";"IC50";"'>'";"1000.0";"nM";"";"";"353428";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL1794072";"";"None";"490.00";"1";"5.74";"SB-682330-A";"CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl";"Inhibition";"'='";"0.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.89"
"CHEMBL4439957";"";"None";"452.43";"0";"2.04";"6q";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"15.63";"0.29";"5.03";"5.98";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"85.0"
"CHEMBL103104";"GW831090X";"None";"330.37";"0";"2.17";"GW831090X";"NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1";"Inhibition";"'='";"-3.05";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.05"
"CHEMBL4169221";"";"None";"385.49";"0";"3.17";"24; AZ-3";"CC[C@@H](C)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4145191";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138312";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"30.0"
"CHEMBL1909389";"GW574782A";"None";"633.09";"2";"6.37";"GW574782A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl";"Inhibition";"'='";"-3.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.76"
"CHEMBL2152298";"";"None";"335.46";"0";"3.30";"5";"C[C@@H]1CCN(Cc2ccccc2)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"16.26";"0.30";"2.16";"11.35";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"3500.0"
"CHEMBL2152303";"";"None";"317.40";"0";"3.36";"10";"c1ccc(CN2CC[C@@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1";"Ki";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"22.21";"0.40";"3.69";"14.17";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"89.0"
"CHEMBL4782449";"";"None";"422.46";"0";"2.39";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnccn2)c1OC";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"17.97";"0.33";"5.15";"5.75";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"29.0"
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL4777969";"";"None";"383.42";"0";"2.54";"27, cis isomer";"Cn1ccc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@H](C#N)C4)c3)n2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"20.86";"0.38";"5.46";"7.05";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL3919463";"";"None";"391.50";"0";"1.52";"BDBM254981";"CN1CN([C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"32.0";"nM";"7.50";"";"444022";"UO_0000065";"19.14";"0.38";"5.97";"7.62";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"32.0"
"CHEMBL3941925";"";"None";"436.95";"0";"4.05";"BDBM198511";"Clc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)COC2)cc1";"IC50";"'='";"790.0";"nM";"6.10";"";"353489";"UO_0000065";"13.97";"0.27";"2.05";"7.62";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"790.0"
"CHEMBL4799398";"";"None";"569.59";"1";"4.59";"BBT594";"CC(=O)Nc1cc(Oc2ccc3c(c2)CCN3C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)ncn1";"GI50";"'='";"150.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"0.15"
"CHEMBL3923030";"";"None";"395.39";"0";"1.90";"BDBM198590";"O=C(CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353568";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL5076478";"";"None";"430.39";"0";"4.27";"EUB0001049a";"COc1cc(Nc2nc(C)cc(-c3cnn4nc(OC)ccc34)n2)cc(C(F)(F)F)c1";"% of control";"'='";"61.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5475001";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001049a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673624/";"";"";"61.0"
"CHEMBL1964275";"";"None";"467.61";"1";"6.04";"11";"Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Activity";"";"";"";"";"";"Not Evaluated";"";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";""
"CHEMBL3891030";"";"None";"322.37";"0";"2.58";"BDBM198345";"c1coc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'='";"170.0";"nM";"6.77";"";"353323";"UO_0000065";"21.00";"0.39";"4.19";"9.00";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"170.0"
"CHEMBL3923513";"";"None";"448.27";"0";"3.18";"BDBM198346";"Ic1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1";"IC50";"'='";"160.0";"nM";"6.80";"";"353324";"UO_0000065";"15.16";"0.37";"3.62";"9.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"160.0"
"CHEMBL3981338";"";"None";"367.84";"0";"3.03";"BDBM198362";"Clc1cnccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"353340";"UO_0000065";"17.69";"0.34";"3.48";"8.68";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL3907770";"";"None";"368.39";"0";"3.26";"BDBM198363";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"353341";"UO_0000065";"17.75";"0.33";"3.28";"10.53";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"290.0"
"CHEMBL3902287";"";"None";"328.42";"0";"1.85";"BDBM198383";"C[C@H](O)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"87.0";"nM";"7.06";"";"353361";"UO_0000065";"21.50";"0.40";"5.21";"7.75";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"87.0"
"CHEMBL3977017";"";"None";"367.84";"0";"3.03";"BDBM198417";"Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1";"IC50";"'='";"290.0";"nM";"6.54";"";"353395";"UO_0000065";"17.77";"0.34";"3.51";"8.72";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"290.0"
"CHEMBL3905498";"";"None";"333.40";"0";"2.38";"BDBM198442";"c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1";"IC50";"'='";"650.0";"nM";"6.19";"";"353420";"UO_0000065";"18.56";"0.34";"3.81";"8.25";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"650.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445878";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IFN-g, JAK1/JAK2, pSTAT1 in monocytes)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Monocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308025";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"178.0"
"CHEMBL3909793";"";"None";"333.40";"0";"2.38";"BDBM198210";"c1cncc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353192";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3944831";"";"None";"332.41";"0";"2.99";"BDBM198224";"c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"990.0";"nM";"6.00";"";"353206";"UO_0000065";"18.06";"0.33";"3.01";"9.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"990.0"
"CHEMBL3936616";"";"None";"400.41";"0";"4.00";"BDBM198231";"FC(F)(F)c1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353213";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL1909385";"GW458787A";"None";"565.10";"2";"5.35";"GW458787A";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl";"Inhibition";"'='";"-1.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.78"
"CHEMBL4559936";"";"None";"613.73";"2";"6.20";"(+/-)-6";"O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O";"Activity";"'='";"19.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4391628";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4390652";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"19.0"
"CHEMBL4065365";"";"None";"381.39";"0";"1.56";"64; E738";"COc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\OCC(O)CO)C(=O)N2";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"24.00";"0.45";"7.59";"8.14";"0";"CHEMBL5347081";"Inhibition of recombinant TYK2 (unknown origin) incubated for 120 mins in presence of [33P]-ATP by hotspot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";"";"0.7"
"CHEMBL475761";"GW784684X";"None";"564.09";"2";"6.81";"GW784684X";"CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1";"Inhibition";"'='";"-7.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.87"
"CHEMBL507329";"GW869810X";"None";"608.10";"2";"5.36";"GW869810X";"O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1";"Inhibition";"'='";"-3.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.98"
"CHEMBL160333";"";"None";"349.17";"0";"3.18";"SB-409514";"O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1";"Inhibition";"'='";"20.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"20.04"
"CHEMBL5413544";"";"None";"426.46";"0";"1.13";"2d";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"23.84";"0.44";"8.97";"6.78";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.08"
"CHEMBL5440225";"";"None";"463.52";"1";"2.53";"2l";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(C)c(C)cn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"97.0";"nM";"7.01";"";"";"UO_0000065";"15.23";"0.28";"4.48";"4.85";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"97.0"
"CHEMBL482767";"SNS-314";"1.0";"430.95";"1";"5.10";"SID103905586";"O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL443563";"GW627512B";"None";"326.35";"0";"4.11";"GW627512B";"COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC";"Inhibition";"'='";"6.55";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"6.55"
"CHEMBL4526351";"BAY-309";"None";"519.50";"2";"7.41";"EUB0000703";"Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507270";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4586794";"ABT-100";"None";"504.47";"2";"5.04";"EUB0000289";"Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507257";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"CP-690-550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Inhibition";"'='";"5.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"5.1"
"CHEMBL5431527";"";"None";"433.51";"0";"1.60";"86-1";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ncc(C2CC2)cc1S(C)(=O)=O";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383663";"Inhibition of TYK2 in HEK-Blue IL-23 cells assessed as reduction in SEAP reporter gene expression by Quanti-blue assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5400869";"";"None";"493.56";"0";"1.14";"86-2";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)[C@H]2CC23CC3)cc1Nc1ncc(OCCOC)cc1S(C)(=O)=O";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383663";"Inhibition of TYK2 in HEK-Blue IL-23 cells assessed as reduction in SEAP reporter gene expression by Quanti-blue assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5415395";"";"None";"426.51";"0";"3.57";"87-1";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"100.0"
"CHEMBL5424894";"";"None";"382.42";"0";"2.17";"92-1";"CNc1cc2nn3c(cnc13)C(=O)N[C@H](C)COCc1ccc(OC)c(c1)N2";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"23.33";"0.44";"6.75";"8.76";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.2"
"CHEMBL5437575";"";"None";"461.52";"1";"3.63";"87-4";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383667";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5437575";"";"None";"461.52";"1";"3.63";"87-4";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383668";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IL-2 induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"100.0"
"CHEMBL5422022";"";"None";"457.51";"0";"2.67";"90-5";"COCCOc1cc(Nc2cc(NC(C)=O)ncc2-c2ccccn2)nc(S(C)(=O)=O)c1";"IC50";"'='";"0.018";"nM";"10.74";"";"";"UO_0000065";"23.49";"0.46";"8.07";"8.12";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.018"
"CHEMBL5418288";"";"None";"499.55";"0";"3.20";"90-8";"COc1cc(Nc2cc(NC(C)=O)ncc2-c2ccc3c(n2)OCC(C)(C)O3)nc(S(C)(=O)=O)c1";"IC50";"'='";"0.026";"nM";"10.59";"";"";"UO_0000065";"21.19";"0.41";"7.39";"7.47";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.026"
"CHEMBL3545110";"RIBOCICLIB";"4.0";"434.55";"0";"2.80";"Ribociclib";"CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1944698";"ZOTIRACICLIB";"2.0";"372.47";"0";"4.66";"SB-1317";"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4088216";"TP-030-1";"None";"402.45";"0";"2.35";"EUB0000719";"CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.91";"0.27";"3.65";"8.87";"0";"CHEMBL4884888";"Tyk2(TYK2LGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"6.0"
"CHEMBL4287367";"";"None";"406.44";"0";"4.70";"29";"Fc1cccc(F)c1-c1ccc2[nH]cc(-c3cncc(O[C@@H]4CCCNC4)n3)c2c1";"Kd";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"16.24";"0.30";"1.90";"10.51";"1";"CHEMBL5364823";"Binding affinity to N-terminal His6-tagged human TYK2 (556 to 871 residues) expressed in baculovirus assessed as dissociation constant incubated for 72 hrs by fluorescence polarization method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 72.0 hr";"INHIBITOR";"";"0.25"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"31";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5364830";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"50.0"
"CHEMBL1614766";"RO-4987655";"1.0";"565.29";"1";"3.16";"Ro-4987655";"O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1287940";"";"None";"373.32";"0";"2.36";"14";"COC(=O)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"16.39";"0.31";"3.76";"5.46";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"760.0"
"CHEMBL3918943";"";"None";"406.33";"0";"3.71";"BDBM198607";"FC(F)(F)C(N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F";"IC50";"'='";"840.0";"nM";"6.08";"";"353585";"UO_0000065";"14.95";"0.30";"2.37";"8.57";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"840.0"
"CHEMBL3904571";"";"None";"376.42";"0";"2.15";"BDBM198615";"N#CCC(=O)N(CC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"353593";"UO_0000065";"17.29";"0.32";"4.36";"5.13";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL4279157";"";"None";"310.36";"0";"2.23";"18";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"26.28";"0.48";"5.92";"8.38";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.007"
"CHEMBL4285755";"";"None";"336.40";"0";"2.76";"11";"Cc1cc(C)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251839";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"50.0"
"CHEMBL4287081";"";"None";"324.39";"0";"2.62";"19";"CCNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"19.18";"0.35";"3.60";"6.39";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.6"
"CHEMBL4281304";"";"None";"470.43";"0";"4.97";"33";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.67";"0.24";"0.99";"6.12";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.1"
"CHEMBL4283823";"";"None";"320.35";"0";"3.48";"Yfq26";"COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1";"Inhibition";"'='";"-7.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4267277";"Inhibition of human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265907";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"-7.9"
"CHEMBL4551344";"A-1210227";"None";"904.37";"3";"8.88";"EUB0000746";"O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1";"% Control";"'='";"84.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"84.0"
"CHEMBL1800685";"PPTN";"None";"475.51";"1";"7.36";"EUB0000274";"O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507292";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3622376";"";"None";"242.24";"0";"0.62";"77";"c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1";"IC50";"'='";"5624.0";"nM";"5.25";"";"";"UO_0000065";"21.67";"0.40";"4.63";"6.19";"1";"CHEMBL4322093";"Inhibition of human TYK2 using KKSRGDYMTMQIG] substrate preincubated for 20 mis followed by addition of ATP and measured after 120 mins in presence of 33P-gamma ATP by hotspot kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321787";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"5624.0"
"CHEMBL5399546";"";"None";"416.42";"1";"0.96";"2g";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)OC)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"22.50";"0.42";"8.34";"5.88";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.5"
"CHEMBL5411146";"";"None";"422.46";"0";"2.39";"3a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ccccn2)c1OC";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"23.84";"0.44";"7.61";"7.63";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.1"
"CHEMBL5416323";"";"None";"468.44";"0";"2.86";"4b";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(F)ccn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"2610.0";"nM";"5.58";"";"";"UO_0000065";"12.00";"0.22";"2.72";"4.00";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"2610.0"
"CHEMBL3981841";"";"None";"448.49";"0";"3.80";"BDBM255022";"N#CCCCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"200.0";"nM";"6.70";"";"444012";"UO_0000065";"14.94";"0.29";"2.90";"7.61";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"200.0"
"CHEMBL3913143";"";"None";"378.48";"0";"2.62";"BDBM255042";"N#CCN1CN([C@H]2CC[C@H](CNC3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"130.0";"nM";"6.89";"";"444048";"UO_0000065";"18.19";"0.34";"4.27";"7.82";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"130.0"
"CHEMBL4463007";"";"None";"365.40";"0";"2.20";"34";"N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"18.85";"0.35";"4.69";"5.21";"0";"CHEMBL4416492";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414617";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"130.0"
"CHEMBL603469";"LESTAURTINIB";"3.0";"439.47";"0";"3.47";"CEP-701";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"13.75";"0.25";"2.57";"6.81";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"910.0"
"CHEMBL4583948";"";"None";"337.36";"0";"3.46";"20";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"23.59";"0.43";"4.50";"10.08";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.011"
"CHEMBL4583185";"";"None";"419.46";"0";"2.26";"49";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"22.18";"0.43";"6.98";"7.33";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00058"
"CHEMBL476259";"GSK-1326255A";"None";"517.61";"2";"5.28";"GSK1326255A";"CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1";"Inhibition";"'='";"-2.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.8"
"CHEMBL573339";"PI-103";"None";"348.36";"0";"2.98";"PI-103";"Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4572426";"";"None";"461.50";"0";"4.18";"33";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2ccnn2C)c1OC";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"14.13";"0.26";"2.34";"6.15";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"300.0"
"CHEMBL4515441";"";"None";"597.12";"2";"6.05";"15a";"C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4358175";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354843";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"100.0"
"CHEMBL5094089";"";"None";"471.58";"0";"3.49";"54b";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2nc(NCCOCCN(C)C)ncc2c1";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"14.63";"0.28";"3.41";"6.71";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.9"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"INCB18424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Kd";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"29.53";"0.54";"5.58";"10.87";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"0.9"
"CHEMBL5418587";"";"None";"499.58";"0";"4.11";"92-4";"CNC(=O)c1cnc2cc1Nc1cc(cc(-c3ccn(C)n3)c1OC)CCOCc1nc(ccc1C)N2";"Kd";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5437575";"";"None";"461.52";"1";"3.63";"87-4";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"100.0"
"CHEMBL5436690";"";"None";"427.50";"0";"2.97";"87-2";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383667";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL5278635";"";"None";"556.60";"1";"3.34";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2cccc(-n3ccccc3=O)c2)c1OC";"Tm";"'='";"57.62";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"57.62"
"CHEMBL5285091";"";"None";"574.66";"1";"4.32";"4";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC(=O)C3CCCC3)cc2)c1OC";"Tm";"'='";"52.74";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"52.74"
"CHEMBL5291007";"";"None";"540.60";"1";"4.25";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3cccnc3)cc2)c1OC";"Tm";"'='";"54.13";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"54.13"
"CHEMBL5269164";"";"None";"544.59";"1";"2.98";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(C)n3)cc2)c1OC";"Tm";"'='";"53.83";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"53.83"
"CHEMBL4862667";"";"None";"540.57";"2";"5.50";"13g";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C2CC2)c1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"13.36";"0.26";"1.72";"7.76";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"60.0"
"CHEMBL3799292";"(R)-9s";"None";"300.75";"0";"2.20";"EUB0000300";"C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N";"% Control";"'='";"75.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507301";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"75.0"
"CHEMBL4846163";"";"None";"543.65";"1";"4.24";"11g";"Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc3c(c2)CC(=O)N3C)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"62.98";"nM";"7.20";"";"";"UO_0000065";"13.25";"0.25";"2.96";"6.35";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"62.98"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"6";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"29.09";"0.53";"5.01";"14.62";"0";"CHEMBL819922";"Inhibition of Tyrosine kinase 2 kinase";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135866";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";"";"0.001"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"75.1";"nM";"7.12";"";"335043";"UO_0000065";"21.11";"0.42";"5.67";"7.83";"0";"CHEMBL3887375";"Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886293";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"75.1"
"CHEMBL5203904";"";"None";"565.50";"1";"2.65";"12a";"CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(O[C@H]5CO[C@H]6[C@@H]5OC[C@H]6O)n4)cc3Cl)CC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"";"";"10000.0"
"CHEMBL3622829";"";"None";"294.36";"0";"1.68";"5f";"NCCn1c(Cc2ccccc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"17.41";"0.32";"3.44";"5.90";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"7.5"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"37.4";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471848";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 5 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"37.4"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"-8.7";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471850";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"-8.7"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445889";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-6, JAK1/2, pSTAT1 in rat CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"62.0"
"CHEMBL4877117";"";"None";"499.37";"0";"3.18";"EUB0001632a";"Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1";"% of control";"'='";"2.012";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5482666";"Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 272.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, concentration ATP = Km app) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/31668947/";"";"";"2.0124"
"CHEMBL4573218";"";"None";"430.51";"0";"3.79";"11d";"C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"3000.0"
"CHEMBL4577029";"";"None";"443.56";"0";"3.71";"11e'";"C=CC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"3000.0"
"CHEMBL3893600";"";"None";"371.46";"0";"2.67";"BDBM255031";"O=C1NCN([C@H]2CC[C@H](CN3CC[C@@H](F)C3)CC2)c2c1cnc1[nH]ccc21";"IC50";"'='";"330.0";"nM";"6.48";"";"444037";"UO_0000065";"17.45";"0.33";"3.81";"10.09";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"330.0"
"CHEMBL3903817";"";"None";"421.47";"0";"3.66";"BDBM255034";"CN1CN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"34.0";"nM";"7.47";"";"444040";"UO_0000065";"17.72";"0.34";"3.81";"11.62";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"34.0"
"CHEMBL4472294";"";"None";"390.45";"1";"5.13";"11g";"C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21";"Activity";"'='";"60.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4337157";"Inhibition of recombinant human TYK2 (875 to end residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334471";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"60.0"
"CHEMBL4438024";"";"None";"265.19";"0";"0.29";"7a; NSC30049; NSC49L";"ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]";"Activity";"'='";"98.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4328663";"Inhibition of human TYK2 assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"98.84"
"CHEMBL4446405";"";"None";"292.81";"0";"1.21";"7b; ASR352";"C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]";"Activity";"'='";"97.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4328663";"Inhibition of human TYK2 assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"97.15"
"CHEMBL1950289";"TANZISERTIB";"2.0";"448.45";"0";"3.66";"Tanzisertib";"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL210963";"";"None";"434.47";"0";"1.54";"6s";"CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL862052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148638";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1900.0"
"CHEMBL4455923";"";"None";"575.63";"2";"4.23";"48c";"CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4405607";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402587";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"50.0"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"BAY-439006";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"Baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL592445";"GEDATOLISIB";"3.0";"615.74";"1";"3.02";"Gedatolisib";"CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL403989";"TG100-801";"2.0";"580.09";"2";"7.09";"TG-100801";"Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1234354";"PF-04691502";"2.0";"425.49";"0";"2.25";"PF-04691502";"COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1645462";"AC-480";"1.0";"530.56";"1";"3.86";"AC-480";"Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2048872";"";"None";"379.49";"0";"3.61";"AZD-1208";"N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"1";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"29.09";"0.53";"5.01";"14.62";"1";"CHEMBL987117";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142524";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"1.0"
"CHEMBL373751";"GSK-319347A";"None";"469.54";"0";"3.96";"GSK319347A";"COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC";"Inhibition";"'='";"-7.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-7.35"
"CHEMBL5081471";"";"None";"419.49";"0";"3.82";"6a";"O=C(CCCCCCn1cc(Nc2ncc3ccn(-c4ccccc4)c3n2)cn1)NO";"IC50";"'='";"23.5";"nM";"7.63";"";"";"UO_0000065";"18.19";"0.34";"3.81";"6.94";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"23.5"
"CHEMBL4281304";"";"None";"470.43";"0";"4.97";"33";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"15.26";"0.29";"2.21";"7.38";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.066"
"CHEMBL5204171";"";"None";"518.55";"1";"2.43";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CNC3=O)c1OC";"Tm";"'='";"54.88";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"54.88"
"CHEMBL5184123";"";"None";"518.55";"1";"2.43";"25";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2cccc3c2C(=O)NC3)c1OC";"Tm";"'='";"54.85";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"54.85"
"CHEMBL5179489";"";"None";"512.57";"1";"2.35";"7";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2csc(C(N)=O)c2)c1OC";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"14.20";"0.27";"4.89";"4.08";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"58.0"
"CHEMBL4878072";"";"None";"449.56";"0";"4.30";"Senexin C/6148/GJ-2331/2335";"CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1";"Activity";"'='";"62.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4805209";"Inhibition of human TYK2 JH1 catalytic domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804282";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 2000.0 nM";"";"";"62.0"
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Emax";"'='";"77.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5225293";"Induction of TYK2 degradation in human Jurkat cells at 10 uM incubated for 24 hrs by Western blot analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM | TIME = 24.0 hr";"DEGRADER";"";"77.0"
"CHEMBL5436690";"";"None";"427.50";"0";"2.97";"87-2";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"Kd";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL5184447";"";"None";"453.45";"0";"2.75";"13a";"CCNC(=O)C(C)(O)c1ccc(Nc2nc(-c3c(F)cccc3F)nc3c2C(=O)NC3)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"14.60";"0.27";"3.87";"5.69";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.24"
"CHEMBL4287081";"";"None";"324.39";"0";"2.62";"19";"CCNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"23.95";"0.44";"5.15";"7.98";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.017"
"CHEMBL4293619";"";"None";"308.35";"0";"2.15";"10";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3ccccc3)nn12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"19.32";"0.35";"3.81";"6.12";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.1"
"CHEMBL4289875";"";"None";"340.36";"0";"2.59";"12";"Cc1cc(F)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"17.20";"0.32";"3.26";"6.01";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.4"
"CHEMBL4279157";"";"None";"310.36";"0";"2.23";"18";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"22.55";"0.42";"4.77";"7.19";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.1"
"CHEMBL4285841";"";"None";"380.41";"0";"2.18";"26";"CNc1cc(Nc2cccc3c2OCCO3)nn2c(C(=O)NC3CC3)cnc12";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.24";"0.38";"5.52";"7.56";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.02"
"CHEMBL4281304";"";"None";"470.43";"0";"4.97";"33";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.59";"0.24";"0.95";"6.08";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.2"
"CHEMBL4279157";"";"None";"310.36";"0";"2.23";"18";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"23.52";"0.43";"5.07";"7.50";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.05"
"CHEMBL4282627";"";"None";"350.43";"0";"3.15";"20";"Cc1cc(C)cc(Nc2cc(NC3CCC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"15.37";"0.28";"2.24";"5.53";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"4.1"
"CHEMBL3965307";"";"None";"404.52";"0";"3.37";"BDBM198471";"OCCN(Cc1ccccc1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"353449";"UO_0000065";"17.11";"0.32";"3.55";"8.41";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"120.0"
"CHEMBL3939325";"";"None";"335.42";"0";"2.33";"BDBM198484";"N#CC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"480.0";"nM";"6.32";"";"353462";"UO_0000065";"18.84";"0.35";"3.99";"7.36";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"480.0"
"CHEMBL3962117";"";"None";"338.46";"0";"3.27";"BDBM198493";"CC1(C)CC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"353471";"UO_0000065";"19.41";"0.36";"3.30";"9.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"270.0"
"CHEMBL3942459";"";"None";"363.47";"0";"3.11";"BDBM198621";"N#CCN(CC1CC1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"353599";"UO_0000065";"19.14";"0.35";"3.85";"8.10";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL5409590";"";"None";"414.44";"0";"1.13";"2b";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CC)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"22.84";"0.43";"8.27";"6.31";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.4"
"CHEMBL5438688";"";"None";"428.47";"0";"1.52";"2c";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CCC)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"22.38";"0.42";"8.00";"6.40";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.3"
"CHEMBL5415661";"";"None";"384.85";"0";"3.46";"18";"C[C@H]1C[C@@H](N)CN(c2ncnc3[nH]c(Cl)c(-c4cccc(C#N)c4F)c23)C1";"Inhibition";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5383531";"Inhibition of TYK2 (unknown origin) at 0.1 uM by FRET based Z'-LYTE assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380824";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 0.1 microM";"INHIBITOR";"";"94.0"
"CHEMBL3924902";"";"None";"327.43";"0";"2.19";"BDBM254983";"CN(C)C[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"444024";"UO_0000065";"20.46";"0.38";"4.51";"10.42";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"200.0"
"CHEMBL210032";"";"None";"252.28";"0";"2.16";"24";"CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL862052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148638";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1900.0"
"CHEMBL3645539";"";"None";"330.35";"0";"2.53";"BDBM107123";"O=C(Cn1cncn1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226432";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL4577685";"";"None";"345.42";"0";"3.31";"17";"CCS(=O)(=O)Nc1cc(-c2c(C)cc(O)cc2C)cc2[nH]ncc12";"IC50";"'='";"6309.57";"nM";"5.20";"";"";"UO_0000065";"15.05";"0.30";"1.89";"5.47";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"5.2"
"CHEMBL4516272";"";"None";"394.41";"0";"2.90";"8";"CN(C)C(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"17.90";"0.33";"4.16";"6.23";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.087"
"CHEMBL4465409";"";"None";"362.39";"0";"2.42";"17";"CNC(=O)c1cnc(Nc2ccccn2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"24.27";"0.44";"6.38";"7.21";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0016"
"CHEMBL4580693";"";"None";"380.38";"0";"2.56";"18";"CNC(=O)c1cnc(Nc2ncccc2F)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"21.63";"0.40";"5.67";"6.74";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0059"
"CHEMBL4530719";"";"None";"401.42";"0";"2.61";"29";"CS(=O)(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"18.64";"0.36";"4.87";"5.89";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.033"
"CHEMBL3622833";"";"None";"348.33";"0";"2.78";"5j";"NCCn1c(-c2ccc(C(F)(F)F)cc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"15.77";"0.30";"2.71";"6.32";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.2"
"CHEMBL3622834";"";"None";"296.33";"0";"1.47";"5k";"NCCn1c(-c2ccc(O)cc2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"18.54";"0.34";"4.02";"5.13";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.2"
"CHEMBL4535413";"";"None";"461.56";"0";"2.63";"30";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCN2CCN(C)CC2)c2cn[nH]c2c1";"IC50";"'='";"7943.28";"nM";"5.10";"";"";"UO_0000065";"11.05";"0.22";"2.47";"5.02";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"5.1"
"CHEMBL4531775";"SR-321";"None";"512.58";"2";"5.91";"EUB0000711";"O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507315";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL5440225";"";"None";"463.52";"1";"2.53";"2l";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(C)c(C)cn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.05";"nM";"10.30";"";"";"UO_0000065";"22.37";"0.41";"7.77";"7.12";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.05"
"CHEMBL5413544";"";"None";"426.46";"0";"1.13";"2d";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.80";"0.35";"6.83";"5.35";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"11.0"
"CHEMBL5406364";"";"None";"452.47";"0";"2.66";"2h";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cc2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"296.0";"nM";"6.53";"";"";"UO_0000065";"14.53";"0.27";"3.87";"4.95";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"296.0"
"CHEMBL5437122";"";"None";"449.49";"1";"2.23";"2k";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(C)ccn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"17.46";"0.32";"5.57";"5.39";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"16.0"
"CHEMBL5418485";"";"None";"465.49";"1";"1.93";"2n";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cc(OC)ccn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"131.0";"nM";"6.88";"";"";"UO_0000065";"14.88";"0.28";"4.95";"4.47";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"131.0"
"CHEMBL4632827";"";"None";"252.30";"0";"3.01";"13";"c1ccc2sc(-c3cnn4cccnc34)nc2c1";"Activity";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4603936";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as enzyme residual activity at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602637";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";"";"5.0"
"CHEMBL3898786";"";"None";"308.35";"0";"1.83";"BDBM198196";"N#CCC(=O)N1CCCC(c2ncn3cnc4[nH]ccc4c23)C1";"IC50";"'='";"230.0";"nM";"6.64";"";"351828";"UO_0000065";"21.53";"0.39";"4.81";"7.37";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"230.0"
"CHEMBL3935714";"";"None";"272.38";"0";"3.92";"BDBM198200";"S=c1[nH]c(C2CCCCC2)c2c3cc[nH]c3ncn12";"IC50";"'='";"36.0";"nM";"7.44";"";"351832";"UO_0000065";"27.33";"0.54";"3.52";"15.23";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"36.0"
"CHEMBL4093955";"";"None";"363.49";"0";"1.84";"42";"CN(CC1CC1)S(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3900631";"";"None";"324.43";"0";"2.98";"BDBM198490";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCCC5)CC4)c23)[nH]1";"IC50";"'='";"330.0";"nM";"6.48";"";"353468";"UO_0000065";"19.98";"0.37";"3.50";"10.44";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"330.0"
"CHEMBL3956966";"";"None";"533.00";"2";"5.54";"BDBM198512";"OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"353490";"UO_0000065";"12.21";"0.24";"0.97";"7.90";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL3985390";"";"None";"328.40";"0";"2.53";"BDBM198541";"FC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"590.0";"nM";"6.23";"";"353519";"UO_0000065";"18.97";"0.35";"3.70";"10.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"590.0"
"CHEMBL3963387";"";"None";"342.47";"0";"2.58";"BDBM198547";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CSC5)CC4)c23)[nH]1";"IC50";"'='";"390.0";"nM";"6.41";"";"353525";"UO_0000065";"18.71";"0.36";"3.83";"9.04";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"390.0"
"CHEMBL3906986";"";"None";"422.92";"0";"3.89";"BDBM198555";"O=C(NCCc1ccc(Cl)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353533";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3981393";"";"None";"337.39";"0";"1.91";"BDBM198575";"N#CCC(=O)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"410.0";"nM";"6.39";"";"353553";"UO_0000065";"18.93";"0.35";"4.48";"5.72";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"410.0"
"CHEMBL3911096";"";"None";"388.34";"0";"3.42";"BDBM198589";"FC(F)(F)C(F)(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"353567";"UO_0000065";"17.43";"0.34";"3.35";"9.55";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"170.0"
"CHEMBL3979623";"";"None";"416.43";"0";"2.36";"BDBM198627";"O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F";"IC50";"'='";"300.0";"nM";"6.52";"";"353605";"UO_0000065";"15.66";"0.32";"4.16";"6.21";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"300.0"
"CHEMBL5409590";"";"None";"414.44";"0";"1.13";"2b";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CC)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"17.70";"0.33";"6.15";"4.89";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"52.0"
"CHEMBL4569337";"";"None";"361.40";"0";"3.03";"16";"CNC(=O)c1cnc(Nc2ccccc2)cc1Nc1ccccc1C(N)=O";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"20.70";"0.38";"4.45";"6.85";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.033"
"CHEMBL3622831";"";"None";"294.36";"0";"2.07";"5h";"Cc1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"18.53";"0.34";"3.39";"6.28";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.5"
"CHEMBL4064018";"";"None";"297.36";"0";"1.57";"7";"C=CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL1090360";"";"None";"587.71";"2";"6.28";"26";"O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109668";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156213";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"1.0"
"CHEMBL1895450";"GSK-2220400A";"None";"529.61";"1";"3.05";"GSK2220400A";"CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12";"Inhibition";"'='";"-3.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.3"
"CHEMBL4752561";"";"None";"496.49";"0";"4.53";"EUB0000739";"COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507289";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1789963";"GW406108X";"None";"400.22";"1";"5.02";"GW406108X";"O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1";"Inhibition";"'='";"26.36";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"26.36"
"CHEMBL4585243";"BAY-7598";"None";"505.57";"1";"3.60";"EUB0000728";"O=C(O)[C@H]1[C@H](Cn2nnc3ccccc3c2=O)CC[C@@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1";"% Control";"'='";"41.0";"%";"";"";"Slightly Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507264";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"41.0"
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"EUB0000262";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"% Control";"'='";"75.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507311";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"75.0"
"CHEMBL3694579";"";"None";"387.85";"0";"3.60";"BDBM125900";"O=S1(=O)Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2";"IC50";"'='";"830.0";"nM";"6.08";"";"255711";"UO_0000065";"15.68";"0.32";"2.48";"6.33";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"830.0"
"CHEMBL4630641";"A-769";"None";"339.47";"0";"3.00";"EUB0000332";"CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1";"% Control";"'='";"84.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507260";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"84.0"
"CHEMBL521851";"PICTILISIB";"2.0";"513.65";"1";"2.15";"Pictilisib";"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL475251";"R-406";"2.0";"470.46";"0";"3.63";"R-406";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL230011";"TG100-115";"2.0";"346.35";"0";"2.33";"TG-100115";"Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"Quizartinib";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL24828";"VANDETANIB";"4.0";"475.36";"0";"4.43";"Vandetanib";"COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL581096";"GW440139A";"None";"363.85";"1";"5.05";"GW440139A";"Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl";"Inhibition";"'='";"-4.79";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.79"
"CHEMBL3264002";"AVUTOMETINIB";"2.0";"471.47";"0";"2.68";"Ro-5126766";"CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3944322";"";"None";"428.93";"0";"3.09";"BDBM239955";"Cn1cc(Nc2ncc(Cl)c(NC3CCC4(CC3)CCN(C(=O)CC#N)C4)n2)cn1";"IC50";"'='";"1.0";"nM";"9.00";"";"418601";"UO_0000065";"20.98";"0.41";"5.91";"8.05";"0";"CHEMBL3888836";"Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 Î¼L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886854";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"1.0"
"CHEMBL5181780";"";"None";"507.53";"1";"1.68";"6";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(N)=O)cn2)c1OC";"Tm";"'='";"56.49";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"56.49"
"CHEMBL5179489";"";"None";"512.57";"1";"2.35";"7";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2csc(C(N)=O)c2)c1OC";"Tm";"'='";"58.76";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"58.76"
"CHEMBL5196735";"";"None";"560.63";"1";"3.43";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"65.9";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"65.9"
"CHEMBL5204955";"";"None";"596.68";"1";"2.97";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"64.95";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"64.95"
"CHEMBL5177410";"";"None";"576.67";"1";"4.03";"28";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NCC3CCOCC3)cc2)c1OC";"Tm";"'='";"61.85";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"61.85"
"CHEMBL5188967";"";"None";"574.66";"1";"3.86";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NC3CCCC3)cc2)c1OC";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"13.69";"0.25";"3.96";"4.79";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"15.0"
"CHEMBL5204171";"";"None";"518.55";"1";"2.43";"23";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CNC3=O)c1OC";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.02";"0.28";"5.31";"4.74";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"18.0"
"CHEMBL5173760";"";"None";"518.55";"1";"2.68";"27";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CC(=O)N3)c1OC";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.23";"0.28";"5.17";"4.81";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"14.0"
"CHEMBL5203256";"";"None";"596.63";"1";"3.16";"32";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"14.92";"0.28";"5.69";"5.37";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.4"
"CHEMBL5191508";"";"None";"578.64";"1";"3.02";"30";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5131239";"Inhibition of TYK2 JH1 (unknown origin) using ULight -poly GT as substrate in presence of ATP incubated for 120 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"";"";"1000.0"
"CHEMBL3980883";"";"None";"461.61";"0";"3.04";"BDBM255029";"N#CCCN1CCN(C[C@H]2CC[C@H](N3CN(C4CC4)C(=O)c4cnc5[nH]ccc5c43)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"444019";"UO_0000065";"";"";"";"";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"1000.0"
"CHEMBL3892444";"";"None";"409.46";"0";"3.47";"BDBM254984";"CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CN(C)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"52.0";"nM";"7.28";"";"444025";"UO_0000065";"17.79";"0.34";"3.81";"13.13";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"52.0"
"CHEMBL3901392";"";"None";"420.44";"0";"3.02";"BDBM254986";"N#CCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"57.0";"nM";"7.24";"";"444027";"UO_0000065";"17.23";"0.33";"4.22";"8.23";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"57.0"
"CHEMBL4526274";"";"None";"450.33";"0";"4.53";"8m";"O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO";"Inhibition";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4347801";"Inhibition of recombinant human TYK2 at 20 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"4.0"
"CHEMBL4547761";"";"None";"371.40";"0";"0.66";"21";"COc1ccc(-c2cc3c(N[C@H](CO)[C@@H](C)O)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"20.38";"0.38";"6.91";"5.61";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"27.0"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"23";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"19.86";"0.37";"3.94";"8.35";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.11"
"CHEMBL3984494";"";"None";"338.39";"0";"3.65";"17";"Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12";"Inhibition";"'='";"17.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"17.0"
"CHEMBL3655086";"";"None";"351.43";"0";"0.49";"BDBM159753";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2COC2)C1";"IC50";"'='";"2380.0";"nM";"5.62";"";"302647";"UO_0000065";"16.00";"0.32";"5.13";"5.61";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2380.0"
"CHEMBL3645547";"";"None";"332.19";"0";"4.04";"BDBM107133";"O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)C(Cl)Cl";"IC50";"'>'";"10000.0";"nM";"";"";"226443";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL481491";"";"None";"417.41";"0";"4.78";"SID103905430";"NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5409445";"";"None";"481.47";"1";"2.12";"4d";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(OC)nn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"485.0";"nM";"6.31";"";"";"UO_0000065";"13.20";"0.25";"4.19";"3.90";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"485.0"
"CHEMBL5411149";"";"None";"507.55";"2";"2.91";"4g";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(C(C)(C)N)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"15.18";"0.28";"4.75";"4.62";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"22.0"
"CHEMBL1986603";"";"None";"451.51";"0";"3.75";"SID103905597";"Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3944237";"";"None";"435.49";"0";"3.90";"BDBM255020";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC1CC1";"IC50";"'='";"290.0";"nM";"6.54";"";"444010";"UO_0000065";"15.01";"0.29";"2.64";"10.17";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"290.0"
"CHEMBL3893247";"";"None";"473.52";"0";"2.84";"BDBM254990";"CCN1CN([C@H]2CC[C@H](CNS(=O)(=O)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"170.0";"nM";"6.77";"";"444031";"UO_0000065";"14.30";"0.29";"3.93";"6.88";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"170.0"
"CHEMBL1537091";"";"None";"294.38";"0";"3.21";"BDBM67663";"CNC(=S)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226436";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL3359909";"";"None";"260.34";"0";"2.28";"3c";"C[C@H](Nc1c(C(N)=O)cnn2cccc12)C(C)(C)C";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"23.69";"0.44";"3.89";"8.52";"0";"CHEMBL3377595";"Inhibition of TYK2 (unknown origin) by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"680.0"
"CHEMBL2420829";"";"None";"376.25";"0";"4.60";"39";"CCn1cc(Nc2cc(NC(=O)c3c(Cl)cccc3Cl)ccn2)cn1";"Ki";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"20.52";"0.42";"3.12";"10.75";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.019"
"CHEMBL2420828";"";"None";"360.20";"0";"4.17";"38";"O=C(Nc1ccnc(Nc2cccnn2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"22.21";"0.46";"3.83";"10.03";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.01"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"AC220";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3963443";"";"None";"310.41";"0";"2.63";"BDBM198483";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CC5)CC4)c23)[nH]1";"IC50";"'='";"100.0";"nM";"7.00";"";"353461";"UO_0000065";"22.55";"0.42";"4.37";"9.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL3963480";"";"None";"380.46";"0";"2.40";"BDBM198573";"CC(C)(O)c1cn(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)nn1";"IC50";"'>'";"1000.0";"nM";"";"";"353551";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3889789";"";"None";"388.48";"0";"2.88";"BDBM198581";"O[C@H]1Cc2ccccc2[C@H]1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"353559";"UO_0000065";"17.24";"0.32";"3.82";"7.35";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL3931001";"";"None";"350.40";"0";"3.88";"BDBM198584";"Fc1ccc(N[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353562";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL468963";"GW779439X";"None";"454.46";"0";"3.70";"GW779439X";"CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1";"Inhibition";"'='";"8.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"8.28"
"CHEMBL4534573";"";"None";"378.43";"0";"2.86";"34";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)N(C)C)c2cn[nH]c2c1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"17.97";"0.36";"3.94";"6.92";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.8"
"CHEMBL4528395";"";"None";"412.45";"0";"3.83";"32";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2ccccn2)c2cn[nH]c2c1";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"15.03";"0.29";"2.37";"5.74";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.2"
"CHEMBL4529314";"";"None";"446.55";"0";"3.86";"29";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCN2CCCCC2)c2cn[nH]c2c1";"IC50";"'='";"6309.57";"nM";"5.20";"";"";"UO_0000065";"11.64";"0.23";"1.34";"5.29";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"5.2"
"CHEMBL4564318";"";"None";"347.40";"0";"2.71";"16";"CCS(=O)(=O)Nc1cc(-c2ccc(O)c(OC)c2)cc2[nH]ncc12";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"16.12";"0.32";"2.89";"5.37";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"5.6"
"CHEMBL4589842";"";"None";"351.82";"0";"3.35";"12";"CCS(=O)(=O)Nc1cc(-c2ccc(O)cc2Cl)cc2[nH]ncc12";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"18.48";"0.39";"3.15";"6.84";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.5"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"20";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"22.87";"0.42";"5.60";"8.03";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.072"
"CHEMBL3934061";"";"None";"442.31";"0";"3.21";"BDBM254979";"O=C1NCN([C@H]2CC[C@H](CNCC(F)(F)Br)CC2)c2c1cnc1[nH]ccc21";"IC50";"'='";"37.0";"nM";"7.43";"";"443987";"UO_0000065";"16.80";"0.38";"4.22";"10.17";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"37.0"
"CHEMBL3986613";"";"None";"381.40";"0";"2.78";"BDBM254999";"O=C1NCN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c1cnc1[nH]ccc21";"IC50";"'='";"22.0";"nM";"7.66";"";"443989";"UO_0000065";"20.08";"0.39";"4.88";"10.48";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"22.0"
"CHEMBL3936358";"";"None";"316.38";"0";"2.94";"BDBM255009";"CN1CN([C@H]2CC[C@H](CF)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"38.0";"nM";"7.42";"";"443999";"UO_0000065";"23.45";"0.44";"4.48";"14.21";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"38.0"
"CHEMBL3966746";"";"None";"441.52";"0";"3.81";"BDBM255016";"CSCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"160.0";"nM";"6.80";"";"444006";"UO_0000065";"15.39";"0.31";"2.99";"10.58";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"160.0"
"CHEMBL3963389";"";"None";"425.46";"0";"3.10";"BDBM255018";"COCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"74.0";"nM";"7.13";"";"444008";"UO_0000065";"16.76";"0.32";"4.03";"9.70";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"74.0"
"CHEMBL3947499";"";"None";"353.47";"0";"2.72";"BDBM255019";"CN1CN([C@H]2CC[C@H](CNC3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"444009";"UO_0000065";"19.31";"0.36";"4.10";"10.62";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"150.0"
"CHEMBL3947242";"";"None";"459.49";"0";"2.45";"BDBM254980";"CN1CN([C@H]2CC[C@H](CNS(=O)(=O)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"26.0";"nM";"7.58";"";"444021";"UO_0000065";"16.51";"0.33";"5.14";"7.71";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"26.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"EUB0001543a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.96";"0.43";"7.97";"7.13";"0";"CHEMBL5479501";"Selectivity interaction (HTRF assay) EUB0001543a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Remarks: In-vitro potency (using 1 mM ATP) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00444";"";"";"0.2"
"CHEMBL3932070";"";"None";"378.48";"0";"2.62";"BDBM255033";"CN1CN([C@H]2CC[C@H](CNC3(C#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"65.0";"nM";"7.19";"";"444039";"UO_0000065";"18.99";"0.35";"4.57";"8.16";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"65.0"
"CHEMBL3934831";"";"None";"402.45";"0";"2.72";"BDBM255039";"N#CCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"54.0";"nM";"7.27";"";"444045";"UO_0000065";"18.06";"0.34";"4.55";"8.25";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"54.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"Kd";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"26.63";"0.49";"6.78";"9.36";"0";"CHEMBL5473626";"Selectivity interaction (KinomeScan (competition-binding assay, DiscoverX)) EUB0000286bCit TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 10.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: In-vitro potency (TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20188/results";"";"";"4.8"
"CHEMBL601661";"";"None";"519.61";"1";"3.47";"EUB0000607a";"CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5467011";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000607a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Highly selective over various PI3Ks, the PI3K-related kinases hSMG1 and ATR (>50000-fold); | Selectivity number of off-targets = 2.0 None | Selectivity number of targets = 450.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20079/results";"";"";"100.0"
"CHEMBL3904186";"";"None";"324.43";"0";"3.02";"BDBM198498";"CC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"330.0";"nM";"6.48";"";"353476";"UO_0000065";"19.98";"0.37";"3.46";"9.14";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"330.0"
"CHEMBL3971717";"";"None";"358.45";"0";"1.17";"BDBM198501";"OCCN(CCO)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"590.0";"nM";"6.23";"";"353479";"UO_0000065";"17.38";"0.33";"5.06";"6.07";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"590.0"
"CHEMBL3971373";"";"None";"292.35";"0";"2.96";"BDBM198649";"N#C/C=C/[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353627";"UO_0000065";"23.44";"0.43";"3.89";"8.29";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3962051";"";"None";"292.35";"0";"2.79";"BDBM198655";"N#CC1CC12CCC(c1nnn3cnc4[nH]ccc4c13)CC2";"IC50";"'='";"45.0";"nM";"7.35";"";"353633";"UO_0000065";"25.13";"0.46";"4.56";"8.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"45.0"
"CHEMBL3902431";"";"None";"309.37";"0";"2.19";"BDBM198656";"OC12CC3CC(C1)CC(c1nnn4cnc5[nH]ccc5c14)(C3)C2";"IC50";"'='";"52.0";"nM";"7.28";"";"353634";"UO_0000065";"23.54";"0.43";"5.09";"9.21";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"52.0"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"19.4";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471847";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 5 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"19.4"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"2.3";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471851";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 0.2 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"2.3"
"CHEMBL2387124";"";"None";"375.21";"0";"3.86";"19";"N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"EC50";"'='";"157.0";"nM";"6.80";"";"";"UO_0000065";"18.13";"0.37";"2.94";"7.17";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"157.0"
"CHEMBL3966840";"";"None";"326.40";"0";"1.56";"BDBM198460";"OC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"49.0";"nM";"7.31";"";"353438";"UO_0000065";"22.40";"0.42";"5.75";"8.88";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"49.0"
"CHEMBL3969516";"";"None";"396.46";"0";"3.73";"BDBM198465";"N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C#N";"IC50";"'='";"910.0";"nM";"6.04";"";"353443";"UO_0000065";"15.24";"0.28";"2.31";"5.10";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"910.0"
"CHEMBL3973072";"";"None";"392.51";"0";"2.41";"BDBM198517";"N#CCCN1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"750.0";"nM";"6.12";"";"353495";"UO_0000065";"15.60";"0.29";"3.71";"6.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"750.0"
"CHEMBL4107883";"";"None";"363.43";"0";"2.25";"BDBM198560";"N#C[C@H]1CCN(C(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"870.0";"nM";"6.06";"";"353538";"UO_0000065";"16.68";"0.31";"3.81";"5.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"870.0"
"CHEMBL3986443";"";"None";"413.49";"0";"3.11";"BDBM198565";"N#Cc1ccc(CCNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353543";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3910017";"";"None";"309.38";"0";"2.14";"BDBM198601";"N#CCCN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353579";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3930389";"";"None";"319.37";"0";"2.93";"BDBM198639";"N#CC(C#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"67.0";"nM";"7.17";"";"353617";"UO_0000065";"22.46";"0.41";"4.24";"6.74";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"67.0"
"CHEMBL1256459";"TORIN1";"None";"607.64";"2";"6.83";"EUB0000092b";"CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1";"% of control";"'='";"55.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5477366";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000092b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 24.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20064/results";"";"";"55.0"
"CHEMBL3955793";"";"None";"342.40";"0";"2.72";"BDBM198205";"CC(C)(C)OC(=O)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353187";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL1908397";"KW-2449";"1.0";"332.41";"0";"2.78";"KW-2449";"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1";"Kd";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"18.90";"0.34";"3.50";"10.30";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"520.0"
"CHEMBL1241674";"";"None";"308.35";"0";"2.84";"PP-242";"CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21";"Kd";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"21.25";"0.39";"3.71";"6.20";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"280.0"
"CHEMBL384304";"RG-547";"2.0";"441.46";"0";"1.41";"R-547";"COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3353410";"OSIMERTINIB";"4.0";"499.62";"0";"4.51";"Osimertinib";"C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4071005";"";"None";"375.82";"0";"2.49";"28";"COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)ccc1Cl";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"21.08";"0.42";"5.43";"6.88";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"12.0"
"CHEMBL4066193";"ATINVICITINIB";"2.0";"360.35";"0";"1.37";"30";"COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc(F)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.88";"0.41";"6.52";"6.16";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"13.0"
"CHEMBL4088262";"";"None";"410.41";"0";"2.52";"31";"COc1ccnc2c(F)cc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"19.73";"0.37";"5.58";"6.32";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"8.0"
"CHEMBL4099854";"";"None";"387.23";"0";"4.47";"20";"COc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"EC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"14.06";"0.29";"0.97";"6.14";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"3.6"
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"VX-680/MK-0457";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL3137331";"DEFACTINIB";"2.0";"510.50";"1";"2.40";"7";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"IC50";"'='";"129.01";"nM";"6.89";"";"";"UO_0000065";"13.50";"0.27";"4.49";"4.85";"0";"CHEMBL4824349";"Inhibition of TYK2 (unknown origin) measured after 40 mins by HTRF";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4823267";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"129.01"
"CHEMBL4554881";"";"None";"406.49";"0";"2.17";"11";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H]3CN4C(=O)C3CC3)n2)cc1";"IC50";"'='";"1738.0";"nM";"5.76";"";"";"UO_0000065";"14.17";"0.26";"3.59";"6.37";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1738.0"
"CHEMBL4093172";"";"None";"363.27";"1";"5.62";"12";"O=C(Nc1nccc2cc(-c3c(Cl)cccc3Cl)sc12)C1CC1";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"25.04";"0.54";"3.48";"21.66";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0008"
"CHEMBL4100889";"";"None";"347.21";"0";"4.08";"14";"O=C(Nc1nccc2nn(-c3c(Cl)cccc3Cl)cc12)C1CC1";"Ki";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"25.59";"0.53";"4.81";"14.86";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0013"
"CHEMBL4062758";"";"None";"371.23";"0";"4.77";"16";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"25.32";"0.51";"4.63";"11.84";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0004"
"CHEMBL4071399";"";"None";"386.25";"0";"4.51";"18";"CNc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"24.08";"0.49";"4.79";"10.18";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0005"
"CHEMBL4061128";"";"None";"336.36";"0";"1.70";"22";"N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"26.52";"0.49";"7.22";"6.88";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"1.2"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"12.6";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471849";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"12.6"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"5.135";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471857";"Selectivity interaction (Kinase panel (Invitrogen)) EUB0000639a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 277.0 None | Selectivity Remarks: Screened at 200 nM (in vitro, concentration ATP = Km) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"5.1354"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.61";"0.37";"5.85";"9.65";"0";"CHEMBL5446215";"Affinity Biochemical interaction: (Microfluidic assay (phosphorylation of synthetic peptide by recombinant human TYK2, at 1 mM ATP, Caliper Life Science)) EUB0001542aTs TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5446079";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Biochemical Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00917";"";"";"23.0"
"CHEMBL5076178";"";"None";"397.48";"0";"2.65";"13";"COc1ccc(Nc2ncc(C)c(N3CCC4(CCNC4=O)CC3)n2)cc1OC";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"17.73";"0.33";"4.40";"7.95";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"90.0"
"CHEMBL4799019";"";"None";"452.49";"0";"2.40";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(OC)cn2)c1OC";"IC50";"'='";"0.25";"nM";"9.60";"";"";"UO_0000065";"21.36";"0.40";"7.20";"6.85";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4799559";"";"None";"480.54";"0";"2.62";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"19.94";"0.37";"6.90";"6.30";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.3"
"CHEMBL4796821";"";"None";"479.56";"0";"3.23";"26";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.62";"0.31";"4.69";"5.72";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL4789015";"";"None";"421.48";"0";"3.00";"30";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncccn2)c1OC";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"19.58";"0.36";"5.19";"6.94";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"6.4"
"CHEMBL4777648";"";"None";"422.46";"0";"2.39";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccncn2)c1OC";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"16.56";"0.31";"4.56";"5.30";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"113.0"
"CHEMBL4777528";"";"None";"493.54";"0";"2.10";"25";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2cnc(C(=O)N(C)C)cn2)c1OC";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"15.53";"0.29";"5.52";"5.04";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"24.0"
"CHEMBL4793760";"";"None";"439.47";"0";"3.14";"33";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncccn2)c1OC";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"16.56";"0.31";"4.09";"6.12";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"59.0"
"CHEMBL4747591";"";"None";"389.41";"0";"1.79";"10; PF-06700841";"Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.61";"0.37";"5.85";"9.65";"0";"CHEMBL4714262";"Inhibition of recombinant human Tyk2 expressed in sf21 baculovirus expression system assessed as phosphorylation level in presence of 1 mM ATP";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";"";"23.0"
"CHEMBL1236107";"SGX-523";"1.0";"359.42";"0";"3.22";"SGX-523";"Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL188381";"GW806742X";"None";"573.56";"2";"5.18";"GW806742X";"CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1";"Inhibition";"'='";"-2.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.45"
"CHEMBL2420826";"";"None";"360.20";"0";"4.17";"36";"O=C(Nc1ccnc(Nc2cnccn2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"21.80";"0.45";"3.68";"9.84";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.014"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"Fedratinib";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4461078";"";"None";"445.93";"0";"4.39";"12j";"COc1ccc(F)c(Cl)c1C(C)Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N";"IC50";"'='";"774.0";"nM";"6.11";"";"";"UO_0000065";"13.70";"0.27";"1.72";"7.01";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"0.774"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"4";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"20.03";"0.37";"4.00";"8.42";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"96.0"
"CHEMBL4471710";"";"None";"464.36";"0";"4.92";"8a";"O=C(CCCCCCn1cc(Nc2ncc(Cl)c(Nc3cccc(Cl)c3)n2)cn1)NO";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"15.45";"0.32";"2.25";"6.13";"0";"CHEMBL4347603";"Inhibition of recombinant human TYK2 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.067"
"CHEMBL4466059";"";"None";"393.88";"0";"3.10";"8i";"O=C(CCCCCCn1cc(Nc2ncc(Cl)c(NC3CC3)n2)cn1)NO";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"20.11";"0.40";"4.82";"6.77";"0";"CHEMBL4347603";"Inhibition of recombinant human TYK2 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.012"
"CHEMBL4453646";"";"None";"321.17";"0";"3.99";"7";"Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4347603";"Inhibition of recombinant human TYK2 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL3426621";"RIPASUDIL";"3.0";"323.39";"0";"1.75";"Ripasudil";"C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3615457";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of IFNalpha5-induced STAT3 phosphorylation at 10 uM pre-incubated for 30 mins before IFNalpha5 stimulation for 30 mins mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL3613594";"";"None";"320.19";"0";"3.24";"1";"CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1";"Inhibition";"'='";"92.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615449";"Inhibition of Tyk2 (unknown origin) at 30 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"92.0"
"CHEMBL3613594";"";"None";"320.19";"0";"3.24";"1";"CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1";"Inhibition";"'='";"97.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615448";"Inhibition of Tyk2 (unknown origin) at 100 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"97.0"
"CHEMBL2420851";"";"None";"267.12";"0";"3.64";"14";"O=C(Nc1ccncc1)c1cc(Cl)ccc1Cl";"Ki";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"22.85";"0.49";"2.46";"14.53";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.79"
"CHEMBL2436945";"";"None";"283.34";"0";"1.98";"38";"CCc1nc(N[C@@H]2CCC[C@@H]2C#N)c2cc[nH]c(=O)c2n1";"Ki";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"28.09";"0.52";"5.98";"8.43";"0";"CHEMBL2438569";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434881";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"11.0"
"CHEMBL2420827";"";"None";"360.20";"0";"4.17";"37";"O=C(Nc1ccnc(Nc2ccncn2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"23.07";"0.47";"4.14";"10.41";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.0049"
"CHEMBL3137331";"DEFACTINIB";"2.0";"510.50";"1";"2.40";"EUB0000138c";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3622837";"";"None";"296.33";"0";"0.74";"5n";"NCCn1c(-c2cccnc2N)nc2cc(C(N)=O)ccc21";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"18.11";"0.33";"4.63";"4.26";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"4.3"
"CHEMBL4562564";"";"None";"353.43";"0";"1.54";"24";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cn1";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"20.14";"0.37";"5.58";"8.99";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"76.0"
"CHEMBL2152300";"";"None";"308.35";"0";"1.99";"7";"N#CCC(=O)N1CCC[C@@H](n2cnc3cnc4[nH]ccc4c32)C1";"Ki";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"27.01";"0.49";"6.34";"9.19";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"4.7"
"CHEMBL3655081";"ABROCITINIB";"4.0";"323.42";"0";"1.25";"BDBM159748";"CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"1250.0";"nM";"5.90";"";"302642";"UO_0000065";"18.25";"0.37";"4.65";"6.49";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1250.0"
"CHEMBL4578164";"MRL-CB1-NC";"None";"550.85";"2";"5.80";"EUB0002784a";"CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O";"% Control";"'='";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"89.0"
"CHEMBL377300";"BRIVANIB";"3.0";"370.38";"0";"3.52";"BMS-540215";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL105442";"CI-1040";"2.0";"478.66";"1";"5.04";"CI-1040";"O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL572881";"MOTESANIB";"3.0";"373.46";"0";"4.04";"AMG-706";"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4535474";"BAY-293";"None";"448.59";"1";"5.58";"EUB0000320";"CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1";"% Control";"'='";"99.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507273";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"99.0"
"CHEMBL4878072";"";"None";"449.56";"0";"4.30";"Senexin C/6148/GJ-2331/2335";"CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1";"Activity";"'='";"63.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4805210";"Inhibition of human TYK2 JH2 pseudokinase domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804282";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 2000.0 nM";"";"";"63.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"6; BMS-686165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.96";"0.43";"7.97";"7.13";"1";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.2"
"CHEMBL4589415";"";"None";"472.47";"0";"4.17";"16d'";"O=C(Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL251549";"GW782612X";"None";"345.37";"0";"2.94";"GW782612X";"NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1";"Inhibition";"'='";"4.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"4.66"
"CHEMBL524057";"GW683768X";"None";"280.34";"0";"2.32";"GW683768X";"CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1";"Inhibition";"'='";"2.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.1"
"CHEMBL4455582";"BAY-693";"None";"529.57";"1";"3.59";"EUB0000708";"Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1";"% Control";"'='";"88.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"88.0"
"CHEMBL485745";"GW434756X";"None";"289.31";"0";"4.20";"GW434756X";"Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1";"Inhibition";"'='";"0.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.8"
"CHEMBL4638906";"";"None";"412.43";"0";"0.40";"14";"N#C[C@H]1C[C@@H]1C(=O)N[C@@]12C[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"17.39";"0.33";"6.77";"5.44";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"67.0"
"CHEMBL4648631";"";"None";"396.43";"0";"1.19";"18";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@H]1C[C@@H]1C#N";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"18.44";"0.34";"6.12";"6.54";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"49.0"
"CHEMBL4635104";"";"None";"407.40";"0";"1.69";"20";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@H]1CC1(F)F";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"17.80";"0.34";"5.56";"8.24";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"56.0"
"CHEMBL4564973";"";"None";"544.64";"1";"4.20";"50";"O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1";"Inhibition";"'='";"71.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4390002";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4387741";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"71.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"20, CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"18.95";"0.35";"4.38";"6.66";"0";"CHEMBL1941393";"Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938231";"1";"Scientific Literature";"J Med Chem";"2011";"CHEMBL3307634";"";"";"";"1.2"
"CHEMBL371206";"";"None";"403.51";"1";"5.51";"SID103904294";"Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1974664";"";"None";"347.38";"0";"3.57";"SID103905525";"COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC";"Ki";"'='";"316.23";"nM";"6.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.5"
"CHEMBL404367";"";"None";"372.43";"0";"4.17";"SID103904339";"Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973808";"";"None";"271.71";"0";"3.47";"SID103904664";"O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988173";"";"None";"425.94";"0";"3.90";"SID103904448";"Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002322";"";"None";"390.31";"1";"5.10";"SID103905048";"NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973540";"";"None";"449.52";"0";"3.90";"SID103904953";"O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1";"Ki";"'='";"251.19";"nM";"6.60";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.6"
"CHEMBL2006439";"";"None";"327.82";"0";"4.42";"SID103904197";"Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1981725";"";"None";"612.71";"2";"6.74";"SID103904418";"CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1";"Ki";"'='";"1995.26";"nM";"5.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"4";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"28.21";"0.52";"6.87";"11.86";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.13"
"CHEMBL270164";"GW607117X";"None";"394.43";"1";"5.14";"GW607117X";"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1";"Inhibition";"'='";"-1.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.14"
"CHEMBL3917073";"";"None";"411.92";"0";"1.69";"BDBM239966";"Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(S(C)(=O)=O)CC4C3)n2)cn1";"IC50";"'='";"18.0";"nM";"7.75";"";"418603";"UO_0000065";"18.80";"0.39";"6.05";"7.37";"0";"CHEMBL3888836";"Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 Î¼L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886854";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"18.0"
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"Tozasertib";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Kd";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"13.54";"0.26";"2.79";"6.16";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"510.0"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"STI-571";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL180022";"NERATINIB";"4.0";"557.05";"2";"5.93";"HKI-272";"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL464552";"";"None";"532.58";"1";"3.40";"GSK-1838705A";"CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL2420838";"";"None";"386.24";"0";"4.89";"49";"O=C(Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1)c1ccccc1";"Ki";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.75";"0.30";"0.81";"8.02";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"2.0"
"CHEMBL2420844";"";"None";"250.66";"0";"3.13";"6";"O=C(Nc1ccncc1)c1c(F)cccc1Cl";"Ki";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"26.48";"0.53";"3.51";"15.81";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.23"
"CHEMBL2420824";"";"None";"359.22";"0";"4.78";"34";"O=C(Nc1ccnc(Nc2ccccn2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"20.98";"0.43";"2.76";"11.27";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.029"
"CHEMBL4278853";"";"None";"462.43";"0";"3.68";"20b";"CC[C@H](C(=O)NCC(F)(F)F)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"336.3";"nM";"6.47";"";"";"UO_0000065";"14.00";"0.27";"2.79";"6.59";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"336.3"
"CHEMBL4284499";"";"None";"391.47";"0";"4.63";"17b";"COc1cc2c(=O)n(CC3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"39.43";"nM";"7.40";"";"";"UO_0000065";"18.91";"0.35";"2.77";"10.71";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"39.43"
"CHEMBL4293578";"";"None";"408.49";"0";"2.12";"46";"CN(c1ncnc2[nH]ccc12)[C@H]1CN(S(=O)(=O)c2cccc(C#N)c2)CC12CC2";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"18.61";"0.36";"5.48";"7.17";"0";"CHEMBL4258468";"Inhibition of human TYK2 using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257478";"1";"Scientific Literature";"Medchemcomm";"2018";"None";"";"";"";"25.0"
"CHEMBL5075565";"";"None";"366.43";"0";"2.50";"9";"CC(=O)N1CCC(Oc2cccc3cnc(Nc4cnn(C)c4)nc23)CC1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"17.74";"0.33";"4.00";"7.63";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.5"
"CHEMBL188343";"REVERSINE";"None";"393.50";"0";"3.68";"22";"c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"18.35";"0.34";"3.54";"7.94";"0";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.06"
"CHEMBL495727";"AT-9283";"2.0";"381.44";"0";"2.07";"AT; AT-9283";"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"19.39";"0.36";"5.33";"6.67";"0";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.04"
"CHEMBL4469750";"";"None";"455.48";"0";"3.00";"40";"CNC(=O)c1cnc(Nc2ccc(C#N)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"20.91";"0.38";"6.52";"6.67";"0";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.3"
"CHEMBL188343";"REVERSINE";"None";"393.50";"0";"3.68";"22";"c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"17.59";"0.33";"3.24";"7.61";"0";"CHEMBL5364822";"Inhibition of human recombinant TYK2 JH1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.12"
"CHEMBL5314423";"ZASOCITINIB";"2.0";"460.50";"0";"1.97";"36; NDI-034858";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.003";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5364832";"Binding affinity to TYK2 JH2 (unknown origin) assessed as dissociation constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL4594444";"PECAVAPTAN";"2.0";"543.33";"1";"3.62";"EUB0003011";"C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1";"Inhibition";"'='";"8.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5464760";"Inhibition of TYK2(h) at 10.0 ÂµM in the Eurofins Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5463729";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2023";"None";"Compound concentration = 10.0 uM";"";"";"8.75"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445882";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-21, JAK1/3, pSTAT3 in human CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"25.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445891";"Affinity Phenotypic Cellular interaction: (Colony forming cell assays (inhibition of human myeloid progenitor cell differentiation, total human myeloid colonies)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Myeloid progenitor cells";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL5483204";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"870.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"1128.0";"nM";"5.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445894";"Affinity Phenotypic Cellular interaction: (Colony forming cell assays (inhibition of mouse myeloid progenitor cell differentiation,  mouse CFU-G colonies)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Myeloid progenitor cells";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL5483204";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"1128.0"
"CHEMBL4563039";"";"None";"412.45";"0";"3.83";"33";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2cccnc2)c2cn[nH]c2c1";"IC50";"'='";"2511.89";"nM";"5.60";"";"";"UO_0000065";"13.58";"0.26";"1.77";"5.19";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"5.6"
"CHEMBL4560212";"";"None";"445.90";"1";"5.09";"31";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2ccccc2Cl)c2cn[nH]c2c1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"14.58";"0.30";"1.41";"6.84";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.5"
"CHEMBL2387130";"";"None";"368.19";"0";"3.94";"26, enantiomer 2";"O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@H]2F)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"22.2";"nM";"7.65";"";"";"UO_0000065";"20.79";"0.44";"3.71";"10.77";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"22.2"
"CHEMBL483158";"ALISERTIB";"3.0";"518.93";"2";"5.75";"Alisertib";"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2425654";"";"None";"310.36";"0";"1.93";"3";"O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2427783";"Competitive binding affinity to TYK2 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424622";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"50.0"
"CHEMBL3907479";"FGFR INHIBITOR DEBIO 1347";"2.0";"356.39";"0";"3.35";"CH-5183284";"Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2387132";"";"None";"364.23";"0";"4.24";"28";"C[C@@H]1C[C@@H]1C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"8.5";"nM";"8.07";"";"";"UO_0000065";"22.16";"0.46";"3.83";"11.35";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"8.5"
"CHEMBL2387123";"";"None";"421.28";"0";"3.69";"18";"CN(C)C(=O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1";"Ki";"'='";"30.1";"nM";"7.52";"";"";"UO_0000065";"17.85";"0.37";"3.83";"8.23";"0";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"30.1"
"CHEMBL1233528";"VOLASERTIB";"3.0";"618.83";"1";"4.27";"Volasertib";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL3989868";"TUCATINIB";"4.0";"480.53";"1";"5.09";"ARRY-380";"Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2387221";"";"None";"393.20";"0";"3.81";"35";"N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"EC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"17.39";"0.36";"3.03";"7.21";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"145.0"
"CHEMBL3991932";"PEXMETINIB";"2.0";"556.64";"2";"6.07";"Pexmetinib";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4279991";"";"None";"364.41";"0";"2.58";"17g";"COc1cc2c(=O)n([C@@H]3CCNC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"176.3";"nM";"6.75";"";"";"UO_0000065";"18.53";"0.34";"4.17";"8.32";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"176.3"
"CHEMBL4281080";"";"None";"405.50";"1";"5.33";"17d";"COc1cc2c(=O)n(C3CCCCCCC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"8.38";"nM";"8.08";"";"";"UO_0000065";"19.92";"0.37";"2.75";"11.68";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"8.38"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"10.38";"nM";"7.98";"";"";"UO_0000065";"25.56";"0.47";"6.44";"8.98";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10.38"
"CHEMBL3105874";"";"None";"360.38";"0";"1.52";"1f";"NC(=O)c1cc(-c2cc(N)cc3[nH]ncc23)cc2c(C#CCCO)n[nH]c12";"Inhibition";"'='";"27.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3106999";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"27.2"
"CHEMBL5465173";"";"None";"498.29";"0";"4.18";"EUB0003013";"O=c1n(Cc2cncn2-c2cccc(Cl)c2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F";"Inhibition";"'='";"5.83";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5465138";"Inhibition of TYK2(h) at 10.0 ÂµM in the Eurofins Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5463729";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2023";"None";"Compound concentration = 10.0 uM";"";"";"5.83"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"23";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.98";"0.37";"3.98";"8.40";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.1"
"CHEMBL4116008";"CERDULATINIB";"2.0";"445.55";"0";"1.37";"23; PRT062070";"CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"20.88";"0.41";"7.93";"6.96";"1";"CHEMBL5346986";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"0.5"
"CHEMBL2420814";"";"None";"281.14";"0";"3.67";"24";"CN(C(=O)c1c(Cl)cccc1Cl)c1ccncc1";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL5432626";"";"None";"376.46";"0";"3.78";"A6";"C=CC(=O)NCc1ccc(Nc2ncc(C)c(-c3cnn(C(C)C)c3)n2)cc1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"18.90";"0.35";"3.33";"8.40";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"77.0"
"CHEMBL1986943";"";"None";"343.82";"0";"3.39";"SID103904193";"OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1";"Ki";"'='";"1000.0";"nM";"6.00";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.0"
"CHEMBL535";"SUNITINIB";"4.0";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"14.54";"0.27";"2.47";"7.50";"1";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"1600.0"
"CHEMBL491473";"CEDIRANIB";"3.0";"450.51";"1";"5.22";"SID103905340";"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3675908";"";"None";"343.34";"0";"2.45";"BDBM127657";"NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12";"IC50";"'>'";"1000.0";"nM";"";"";"258558";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3675966";"";"None";"380.43";"0";"2.89";"BDBM127718";"CC1(NC(=O)c2cnn3ccc(N4CCC[C@@H]4c4cncc(F)c4)nc23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"258565";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3935688";"";"None";"298.39";"0";"2.44";"BDBM198499";"CN(C)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"353477";"UO_0000065";"22.53";"0.42";"4.28";"10.82";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"190.0"
"CHEMBL4114175";"";"None";"439.56";"0";"3.48";"BDBM198502";"CC(C)(C)OC(=O)N[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353480";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3914847";"";"None";"382.51";"0";"3.16";"BDBM198516";"OC1(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CCCCC1";"IC50";"'='";"510.0";"nM";"6.29";"";"353494";"UO_0000065";"16.45";"0.31";"3.13";"6.90";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"510.0"
"CHEMBL3927961";"";"None";"310.41";"0";"2.63";"BDBM198613";"c1cc2c(ncn3nnc([C@H]4CC[C@@H](CNC5CC5)CC4)c23)[nH]1";"IC50";"'='";"940.0";"nM";"6.03";"";"353591";"UO_0000065";"19.42";"0.36";"3.40";"8.50";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"940.0"
"CHEMBL3947782";"";"None";"335.39";"0";"1.77";"BDBM198623";"O=S(=O)(O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"680.0";"nM";"6.17";"";"353601";"UO_0000065";"18.39";"0.37";"4.40";"5.45";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"680.0"
"CHEMBL5401054";"";"None";"489.54";"1";"1.97";"70-1";"CNc1cc(Nc2cccn(-c3cnc(C(C)(C)O)cn3)c2=O)nc2c(C(=O)NC3CCC3)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5383647";"Inhibition of TYK2 JH1 (unknown origin) at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 10.0 microM";"";"";"50.0"
"CHEMBL5433451";"";"None";"409.45";"0";"1.48";"71-1";"CNc1cc(Nc2ccccc2OC)nc2c(C(=O)N[C@@H]3CCN(C)C3=O)cnn12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"19.78";"0.37";"6.62";"7.17";"0";"CHEMBL5383650";"Inhibition of TYK2 JH2 in human TF-1 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.008"
"CHEMBL5415395";"";"None";"426.51";"0";"3.57";"87-1";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383667";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5433889";"";"None";"383.43";"0";"2.64";"90-3";"CC(=O)Nc1cc(Nc2ncccc2S(C)(=O)=O)c(-c2ccccn2)cn1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"18.51";"0.36";"4.46";"6.23";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"80.0"
"CHEMBL5427396";"";"None";"454.53";"0";"3.01";"22";"CO[C@@]1(c2cc(OCC[C@@H](C)O)cc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"15.65";"0.29";"4.10";"6.60";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.077"
"CHEMBL1230609";"FORETINIB";"2.0";"632.66";"2";"5.77";"Foretinib";"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4093318";"";"None";"342.40";"0";"3.71";"4";"NC(=O)c1cnn2cc(-c3ccccc3)cc2c1NCc1ccccc1";"IC50";"'='";"118.0";"nM";"6.93";"";"";"UO_0000065";"20.23";"0.36";"3.22";"9.57";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"118.0"
"CHEMBL4065693";"";"None";"387.44";"0";"3.66";"9a";"C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1";"Activity";"'<='";"10.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4047246";"Inhibition of TYK2 domain 1 (unknown origin) assessed as residual activity relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"10.0"
"CHEMBL5418845";"";"None";"438.48";"0";"2.90";"18";"COc1cc(-c2cn(C3COC3)c3cnc(NC(C)=O)cc23)nc([C@]2(OC)CCOC2)c1";"EC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"15.87";"0.30";"4.06";"7.19";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.11"
"CHEMBL5270581";"";"None";"358.40";"0";"3.74";"18";"O=C(Nc1cnccc1-c1ccccc1)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252872";"Inhibition of TYK2 (0 to 887 residues) (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL288441";"BOSUTINIB";"4.0";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"Kd";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"9.78";"0.20";"0.00";"6.26";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"6500.0"
"CHEMBL4561806";"BTZO-4";"None";"242.30";"0";"2.62";"EUB0001135";"O=C1NC(c2ccccn2)Sc2ccccc21";"% Control";"'='";"88.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507329";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"88.0"
"CHEMBL3745885";"";"None";"467.46";"0";"3.66";"7ao; ON1231320";"Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750197";"Inhibition of human TYK2 using [KKSRGDYMTMQIG] as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745707";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";"";"10.0"
"CHEMBL4281048";"";"None";"505.09";"1";"4.55";"40; JSH-150";"COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1";"Activity";"'='";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4264585";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261600";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"90.0"
"CHEMBL365286";"GW549034X";"None";"229.24";"0";"1.69";"GW549034X";"CCn1c(-c2nonc2N)nc2ccccc21";"Inhibition";"'='";"-1.66";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.66"
"CHEMBL2153266";"";"None";"261.29";"0";"2.76";"9";"Nc1nc2c(-c3cnc4ccccc4c3)nccc2[nH]1";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL2154877";"Binding affinity to JH domain of TYK2 assessed as ATP binding remaining at 10 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150858";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";""
"CHEMBL608533";"MIDOSTAURIN";"4.0";"570.65";"2";"5.91";"PKC-412";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL5266772";"";"None";"574.59";"1";"3.68";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ccc(F)c(=O)[nH]3)cc2)c1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"13.80";"0.26";"4.21";"4.72";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL5284232";"";"None";"529.58";"1";"3.37";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccnc3)cc2)c1OC";"Tm";"'='";"52.2";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"52.2"
"CHEMBL5279644";"";"None";"570.63";"1";"3.78";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(C4CC4)n3)cc2)c1OC";"Tm";"'='";"57.04";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"57.04"
"CHEMBL5182065";"";"None";"503.94";"1";"1.74";"12i";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1CCOCC1";"IC50";"'='";"335.0";"nM";"6.47";"";"";"UO_0000065";"12.85";"0.25";"4.73";"5.09";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"335.0"
"CHEMBL3544983";"TESEVATINIB";"3.0";"491.39";"1";"5.79";"Tesevatinib";"COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5188061";"";"None";"465.46";"0";"2.81";"10";"O=C1NCc2nc(-c3c(F)cccc3F)nc(Nc3ccc(CC(=O)N4CCOCC4)cc3)c21";"Ki";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"17.82";"0.33";"5.48";"8.60";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"5.1"
"CHEMBL522892";"DOVITINIB";"3.0";"392.44";"0";"2.54";"Dovitinib";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1233300";"HYDROXYFASUDIL";"None";"307.38";"0";"0.92";"Hydroxyfasudil";"O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3655098";"";"None";"375.46";"0";"0.60";"BDBM159765";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC[C@@H](C#N)C2)C1";"IC50";"'='";"337.0";"nM";"6.47";"";"302659";"UO_0000065";"17.24";"0.34";"5.87";"5.48";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"337.0"
"CHEMBL2333445";"";"None";"339.42";"0";"3.44";"1";"CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1";"Activity";"'='";"75.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2352137";"Inhibition of TYK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346629";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"75.0"
"CHEMBL2420833";"";"None";"352.22";"0";"4.24";"43";"CC(C)C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1";"Ki";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"17.25";"0.36";"1.84";"8.55";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.84"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"7";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.30";"0.32";"4.96";"7.17";"1";"CHEMBL5347010";"Inhibition of recombinant human TYK2 using ULight-JAK-1(Tyr1023) peptide as substrate assessed as incorporation of phosphate into the substrate preincubated with compound for 60 mins followed by substrate addition and measured after 90 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";"";"116.0"
"CHEMBL2420849";"";"None";"247.69";"0";"2.57";"12";"Nc1cccc(C(=O)Nc2ccncc2)c1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL3741589";"";"None";"366.24";"0";"4.09";"29; A-971432";"O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3743944";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739276";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"10.0"
"CHEMBL2420837";"";"None";"378.26";"0";"4.77";"48";"O=C(Nc1ccnc(NC(=O)C2CCCC2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"17.50";"0.36";"1.85";"9.31";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.24"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"Baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"21.70";"0.42";"6.96";"6.69";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"8.7"
"CHEMBL517171";"GSK-1713088A";"None";"568.05";"2";"5.60";"GSK1713088A";"CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1";"Inhibition";"'='";"0.45";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.45"
"CHEMBL2205766";"";"None";"346.42";"0";"1.45";"14, CZC24758";"CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2214464";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203257";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"5.0"
"CHEMBL5076556";"";"None";"444.50";"0";"3.90";"26";"O=C1NCCC12CCN(c1nc(Nc3ccc([N+](=O)[O-])cc3)ncc1-c1ccccc1)CC2";"Activity";"'='";"89.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"89.0"
"CHEMBL5074143";"";"None";"382.42";"0";"2.54";"34";"Cc1cnc(Nc2ccccc2[N+](=O)[O-])nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"96.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"96.0"
"CHEMBL5081149";"";"None";"338.42";"0";"2.03";"43";"Cc1cnc(Nc2cccnc2)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"106.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"106.0"
"CHEMBL4088027";"";"None";"403.45";"0";"1.95";"13e";"CN(C)/C=C(/C#N)C(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"2000.0"
"CHEMBL5396554";"";"None";"463.49";"0";"2.95";"(S)-14";"COc1ccccc1Nc1cc(Nc2ccc(CC(=O)O[C@H]3CCOC3)cn2)ncc1C(N)=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.77";"0.35";"5.75";"6.32";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"2.0"
"CHEMBL5394367";"";"None";"373.44";"0";"1.84";"9";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)n3)cn(C)c2cn1";"EC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"20.40";"0.40";"5.78";"7.84";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.024"
"CHEMBL3897850";"";"None";"430.43";"0";"4.95";"BDBM198326";"Cc1cc(OC(F)(F)F)ccc1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353304";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3909146";"";"None";"390.37";"0";"3.60";"BDBM198342";"FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1";"IC50";"'='";"120.0";"nM";"6.92";"";"353320";"UO_0000065";"17.73";"0.34";"3.32";"9.20";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"120.0"
"CHEMBL5426374";"";"None";"429.37";"0";"2.98";"6; WD-118313";"CS(=O)(=O)N1CC[C@H](C#CC(=O)N2CCC[C@@H](c3ccc(Cl)c(Cl)c3)C2)C1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.46";"0.38";"4.51";"12.99";"0";"CHEMBL5364796";"Inhibition of TYK2 signalling pathway in human PBMC cells assessed as IFN alpha induced p-STAT1 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"CHEMBL3308021";"";"INHIBITOR";"";"32.0"
"CHEMBL5429461";"";"None";"400.32";"0";"4.28";"24";"O=c1cc(-c2ccccc2)nc2c(-c3cccc([N+](=O)[O-])c3)c(C(F)(F)F)[nH]n12";"IC50";"'='";"9700.0";"nM";"5.01";"";"";"UO_0000065";"12.52";"0.24";"0.73";"5.37";"0";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"9.7"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"31";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"12.21";"0.23";"1.86";"4.04";"1";"CHEMBL5364826";"Inhibition of TYK2 JH2 in human KIT225 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation by AlphaLISA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"12.6"
"CHEMBL4640335";"";"None";"217.27";"0";"2.22";"8";"Cc1[nH]nc2[nH]c(=O)cc(C3CCCC3)c12";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"27.99";"0.52";"3.86";"9.88";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.83"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"TG101348";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"13.18";"0.26";"2.10";"6.38";"0";"CHEMBL5373207";"Inhibition of TYK2 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370605";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"121.0"
"CHEMBL4297507";"DELGOCITINIB";"3.0";"310.36";"0";"1.30";"Delgocitinib";"C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2";"IC50";"'='";"147.0";"nM";"6.83";"";"";"UO_0000065";"22.02";"0.41";"5.53";"7.68";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"147.0"
"CHEMBL5403330";"";"None";"339.79";"0";"3.72";"1d";"NC(=O)c1cnc(Nc2ccccn2)cc1Nc1ccccc1Cl";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"23.42";"0.45";"4.24";"8.56";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"11.0"
"CHEMBL4282627";"";"None";"350.43";"0";"3.15";"20";"Cc1cc(C)cc(Nc2cc(NC3CCC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"14.86";"0.27";"2.06";"5.35";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"6.2"
"CHEMBL4287761";"";"None";"434.45";"0";"2.55";"28";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"16.47";"0.32";"4.60";"6.34";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.07"
"CHEMBL4782611";"";"None";"378.44";"0";"3.24";"36";"C/C=C/C(=O)Nc1ccc(-c2ccnc(Nc3cnn(CCOC)c3)n2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";"3000.0"
"CHEMBL4780288";"";"None";"397.45";"0";"2.93";"19, cis isomer";"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@H](CC#N)C4)c3)n2)cn1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"20.37";"0.37";"5.17";"7.14";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"8.0"
"CHEMBL3929865";"";"None";"326.36";"0";"4.48";"6";"Oc1cccc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c1";"IC50";"'='";"291.2";"nM";"6.54";"";"";"UO_0000065";"20.03";"0.36";"2.06";"8.42";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"291.2"
"CHEMBL3969473";"";"None";"241.30";"0";"2.65";"BDBM198198";"c1cc2c(ncn3nnc(C4CCCCC4)c23)[nH]1";"IC50";"'='";"46.0";"nM";"7.34";"";"351830";"UO_0000065";"30.41";"0.56";"4.69";"12.46";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"46.0"
"CHEMBL4473365";"";"None";"602.16";"1";"4.93";"7c";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4382806";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4382192";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"100.0"
"CHEMBL607535";"MEISOINDIGO";"None";"276.30";"0";"2.53";"Meisoindigo";"CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21";"Activity";"'='";"88.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806249";"Inhibition of DNA-tagged human TYK2 JH2 pseudokinase domain assessed as percent of control at 50000 nM by qPCR analysis relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804284";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 50000.0 nM";"";"";"88.0"
"CHEMBL4077508";"";"None";"395.48";"0";"3.56";"15";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)cc4)cc23)CC[C@]1(C)N";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"19.86";"0.37";"4.29";"7.98";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"14.0"
"CHEMBL4066906";"";"None";"416.46";"0";"1.18";"23";"C[C@@H]1NS(=O)(=O)c2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc21";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"21.06";"0.41";"7.59";"5.76";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"1.7"
"CHEMBL3621496";"";"None";"430.48";"0";"3.61";"6";"CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1";"IC50";"'='";"753.0";"nM";"6.12";"";"";"UO_0000065";"14.22";"0.26";"2.51";"7.43";"0";"CHEMBL3627433";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"753.0"
"CHEMBL3955496";"";"None";"256.31";"0";"2.55";"BDBM198201";"O=c1[nH]c(C2CCCCC2)c2c3cc[nH]c3ncn12";"IC50";"'='";"78.0";"nM";"7.11";"";"351833";"UO_0000065";"27.73";"0.51";"4.56";"10.78";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"78.0"
"CHEMBL86755";"";"None";"210.24";"0";"2.51";"6";"O=C1Nc2ccccc2/C1=C/c1ccc[nH]1";"Activity";"'='";"7.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1025743";"Binding affinity to human TYK2 at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"7.3"
"CHEMBL4206831";"";"None";"535.61";"2";"5.49";"2; FMF-03-145-1";"CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1";"Activity";"'='";"93.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4186097";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"93.0"
"CHEMBL2420830";"";"None";"306.15";"0";"4.12";"40";"O=C(Nc1ccnc2[nH]ccc12)c1c(Cl)cccc1Cl";"Ki";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"22.86";"0.48";"2.88";"12.11";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.1"
"CHEMBL2386636";"";"None";"337.43";"0";"4.00";"34";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CCC#N)CC1";"EC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"17.81";"0.33";"2.01";"6.64";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"980.0"
"CHEMBL2386633";"";"None";"309.37";"0";"3.22";"31";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](C#N)CC1";"Ki";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"25.60";"0.47";"4.70";"8.75";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"12.0"
"CHEMBL5172670";"";"None";"403.43";"0";"2.88";"23";"O=C(Nc1nc2cccc([C@H]3CC[C@H](NC(=O)[C@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"5761.0";"nM";"5.24";"";"";"UO_0000065";"12.99";"0.25";"2.36";"5.93";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"5761.0"
"CHEMBL5187733";"";"None";"443.50";"0";"3.61";"27";"O=C(Nc1nc2cccc(C3CCC4(CC3)CCN(C(=O)[C@H]3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"692.0";"nM";"6.16";"";"";"UO_0000065";"13.89";"0.26";"2.55";"7.74";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"692.0"
"CHEMBL5172397";"";"None";"429.47";"0";"3.22";"36; TUL01101";"O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)[C@@H]3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"17.33";"0.33";"4.22";"9.35";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"36.0"
"CHEMBL5203588";"";"None";"411.48";"0";"3.07";"37";"O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)C3(F)CC3)C4)n2n1)C1CC1";"IC50";"'='";"366.0";"nM";"6.44";"";"";"UO_0000065";"15.64";"0.29";"3.37";"8.09";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"366.0"
"CHEMBL5201720";"";"None";"417.46";"0";"3.22";"39";"O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)CC(F)F)C4)n2n1)C1CC1";"IC50";"'='";"134.0";"nM";"6.87";"";"";"UO_0000065";"16.46";"0.31";"3.65";"8.63";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"134.0"
"CHEMBL5394153";"";"None";"344.83";"0";"4.02";"7";"Cc1cc(Nc2cc(-c3cnn(CCC#N)c3)c(Cl)cn2)sn1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"12.47";"0.26";"0.28";"5.42";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"50000.0"
"CHEMBL5412619";"";"None";"366.47";"0";"2.22";"23";"Cc1cnc(Nc2cnn(C)c2)nc1N1CC2CCCC(C1)N2CCC#N";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"23.11";"0.43";"6.25";"9.86";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"3.4"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"BDBM185700";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"75.1";"nM";"7.12";"";"370428";"UO_0000065";"21.11";"0.42";"5.67";"7.83";"1";"CHEMBL3888066";"JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886558";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"75.1"
"CHEMBL3985391";"";"None";"475.48";"0";"3.08";"BDBM198594";"COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cn1";"IC50";"'='";"180.0";"nM";"6.75";"";"353572";"UO_0000065";"14.19";"0.27";"3.66";"5.96";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"180.0"
"CHEMBL3977129";"";"None";"340.43";"0";"1.95";"BDBM198629";"CC1(O)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"130.0";"nM";"6.89";"";"353607";"UO_0000065";"20.23";"0.38";"4.94";"8.36";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL5270549";"";"None";"353.81";"0";"4.02";"CEE321";"Cc1cccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"20.64";"0.40";"3.28";"7.86";"1";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"50.0"
"CHEMBL5404574";"";"None";"465.51";"0";"3.19";"(R)-3";"COC[C@@H](C)OC(=O)Cc1ccc(Nc2cc(Nc3ccccc3OC)c(C(N)=O)cn2)nc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.69";"0.35";"5.51";"6.32";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"2.0"
"CHEMBL5417474";"";"None";"439.90";"0";"4.21";"7";"CCOC(=O)CCc1ccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)nc1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"16.89";"0.33";"3.22";"6.23";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"37.0"
"CHEMBL1256459";"TORIN1";"None";"607.64";"2";"6.83";"EUB0000092b";"CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1";"% of control";"'='";"70.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5477365";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000092b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 24.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20064/results";"";"";"70.0"
"CHEMBL5076478";"";"None";"430.39";"0";"4.27";"EUB0001049a";"COc1cc(Nc2nc(C)cc(-c3cnn4nc(OC)ccc34)n2)cc(C(F)(F)F)c1";"% of control";"'='";"90.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5475002";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001049a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673624/";"";"";"90.0"
"CHEMBL24828";"VANDETANIB";"4.0";"475.36";"0";"4.43";"Vandetanib";"COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1241674";"";"None";"308.35";"0";"2.84";"PP-242";"CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21";"Kd";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"17.73";"0.32";"2.63";"5.18";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"3400.0"
"CHEMBL5441087";"";"None";"406.47";"0";"2.82";"17e";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(C#N)c2)C[C@@H]1F";"IC50";"'='";"357.6";"nM";"6.45";"";"";"UO_0000065";"15.86";"0.29";"3.63";"6.66";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"357.6"
"CHEMBL223367";"";"None";"431.88";"0";"3.51";"22";"N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL915372";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142994";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";"";"10.0"
"CHEMBL5440447";"";"None";"481.51";"0";"2.11";"70-7";"[2H]C([2H])([2H])O[C@@H]1CC[C@@H]1NC(=O)c1cnn2c(NC)cc(Nc3cccn(-c4ncccc4F)c3=O)nc12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL5440264";"";"None";"427.87";"0";"3.62";"56-1";"NC(=O)c1nnc(-c2c(F)cccc2Cl)cc1Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.67";"0.44";"6.08";"10.39";"0";"CHEMBL5383631";"Inhibition of human recombinant TYK2 preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"0.2"
"CHEMBL5437575";"";"None";"461.52";"1";"3.63";"87-4";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"Kd";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL5273814";"";"None";"569.64";"1";"4.50";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"Tm";"'='";"63.98";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"63.98"
"CHEMBL5286565";"";"None";"560.63";"1";"3.18";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C3CCCNC3=O)cc2)c1OC";"Tm";"'='";"60.07";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"60.07"
"CHEMBL5286565";"";"None";"560.63";"1";"3.18";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C3CCCNC3=O)cc2)c1OC";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"15.68";"0.29";"5.56";"5.35";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"1.8"
"CHEMBL3983344";"";"None";"284.32";"0";"1.36";"BDBM198551";"NC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"290.0";"nM";"6.54";"";"353529";"UO_0000065";"22.99";"0.43";"5.18";"6.41";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"290.0"
"CHEMBL5416410";"";"None";"506.03";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL3951060";"";"None";"271.32";"0";"2.28";"BDBM198256";"CO[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"353238";"UO_0000065";"24.69";"0.46";"4.42";"9.84";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL3917030";"";"None";"340.43";"0";"2.21";"BDBM198284";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCOCC5)CC4)c23)[nH]1";"IC50";"'='";"320.0";"nM";"6.50";"";"353262";"UO_0000065";"19.08";"0.35";"4.28";"9.10";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"320.0"
"CHEMBL3965670";"";"None";"454.46";"0";"4.89";"BDBM198374";"FC(F)(F)c1nc2cc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)ccc2[nH]1";"IC50";"'='";"45.0";"nM";"7.35";"";"353352";"UO_0000065";"16.17";"0.30";"2.46";"7.38";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"45.0"
"CHEMBL3894535";"";"None";"450.57";"0";"3.35";"BDBM198388";"CS(=O)(=O)c1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"380.0";"nM";"6.42";"";"353366";"UO_0000065";"14.25";"0.27";"3.07";"6.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"380.0"
"CHEMBL1089815";"";"None";"522.65";"1";"4.89";"21";"Cc1cc(-c2cccc3ncc(-c4ccc(C(=O)N5CCOCC5)c(C)c4)nc23)ccc1CN1CCOCC1";"IC50";"'='";"439.0";"nM";"6.36";"";"";"UO_0000065";"12.16";"0.22";"1.47";"9.38";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"439.0"
"CHEMBL4855542";"";"None";"372.45";"0";"3.89";"I-13";"Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O";"Inhibition";"'='";"0.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4804690";"Inhibition of TYK2 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 10.0 microM";"";"";"0.0"
"CHEMBL4091991";"";"None";"524.60";"2";"5.01";"EUB0000045b";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5469115";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000045b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 12.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH1domain-catalytic) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20332/";"";"";"100.0"
"CHEMBL4476261";"";"None";"421.46";"0";"2.34";"42";"CNC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"18.50";"0.34";"5.46";"6.34";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"16.0"
"CHEMBL507361";"MIRDAMETINIB";"2.0";"482.20";"0";"2.47";"EUB0000666a";"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5473565";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000666a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 451.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: http://identifiers.org/lincs.data/LDS-1066";"";"";"100.0"
"CHEMBL4859660";"";"None";"378.36";"0";"3.33";"I-9";"Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O";"% inhibition";"'='";"29.9";"uM";"";"";"Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ";"UO_0000064";"";"";"";"";"0";"CHEMBL4804508";"Inhibition of TYK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"29.9"
"CHEMBL4860361";"";"None";"410.88";"0";"3.20";"B12";"CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1";"Inhibition";"'='";"-1.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4812086";"Inhibition of TYK2 (871 to 1187 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811240";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"Dose = 10.0 microM | TIME = 0.1667 hr";"";"";"-1.53"
"CHEMBL5086595";"";"None";"558.09";"2";"5.05";"EUB0000090b";"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1";"% of control";"'='";"94.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5476288";"Selectivity interaction (Ambit KINOMEscan and KiNATiv profiling in Jurkat cells) EUB0000090b TYK2";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307526";"Selectivity number of off-targets = 9.0 None | Selectivity number of targets = 456.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://www.nature.com/articles/nchembio.2166";"";"";"94.0"
"CHEMBL475251";"R-406";"2.0";"470.46";"0";"3.63";"R406";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.29";"0.27";"3.09";"5.22";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"190.0"
"CHEMBL5429085";"";"None";"502.62";"1";"4.97";"4";"COc1ccc2cc1COC/C=C/COCc1cc(ccc1OCCN1CCCC1)Nc1nccc-2n1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.42";"0.25";"1.77";"8.65";"0";"CHEMBL5380357";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5376015";"1";"Scientific Literature";"RSC Med Chem";"2024";"None";"";"INHIBITOR";"";"0.18"
"CHEMBL5434272";"";"None";"487.60";"0";"3.60";"6";"OCCN1CCN(c2ccc3cc2COC/C=C/COCc2cccc(c2)-c2ccnc(n2)N3)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"13.94";"0.26";"3.20";"8.19";"0";"CHEMBL5380357";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5376015";"1";"Scientific Literature";"RSC Med Chem";"2024";"None";"";"INHIBITOR";"";"0.16"
"CHEMBL1982992";"";"None";"277.74";"0";"3.79";"SID103905084";"Oc1cccc(Nc2ncnc3scc(Cl)c23)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1971149";"";"None";"438.44";"0";"3.96";"SID103904775";"Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL207400";"";"None";"317.65";"0";"2.80";"SID103905391";"Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"37";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"20.29";"0.38";"5.13";"5.46";"0";"CHEMBL5364826";"Inhibition of TYK2 JH2 in human KIT225 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation by AlphaLISA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"37.0"
"CHEMBL5424497";"";"None";"380.41";"0";"1.92";"43";"CNC(=O)c1nnc(NC(=O)C2CC2)c2[nH]c(-c3ccc(N)cc3OC)cc12";"Kd";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"17.15";"0.32";"4.60";"4.83";"0";"CHEMBL5364841";"Binding affinity to TYK2 JH1 domain (unknown origin) assessed as dissociation constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"300.0"
"CHEMBL4744041";"";"None";"435.53";"0";"3.25";"EUB0001868a";"Cc1cc(-c2ccnc(Nc3cnn(C)c3)n2)ccc1CNC(=O)N1CC(OC(C)C)C1";"% of control";"'='";"47.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5482961";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001868a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 395.0 None | Selectivity Remarks: Screened at 1 uM (in vitro) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/32696648/";"";"";"47.0"
"CHEMBL4638808";"";"None";"350.44";"0";"1.67";"30";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NS(=O)(=O)C4CC4)CC3)c12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL3920091";"";"None";"370.48";"0";"2.50";"BDBM198456";"O=C1SCCC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"353434";"UO_0000065";"19.86";"0.39";"4.86";"8.36";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"44.0"
"CHEMBL3935532";"";"None";"366.39";"0";"3.42";"BDBM198459";"FC(F)(F)CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"353437";"UO_0000065";"17.93";"0.35";"3.15";"9.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"270.0"
"CHEMBL3960109";"";"None";"354.41";"0";"1.78";"BDBM198482";"O=C1OCCC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"353460";"UO_0000065";"18.90";"0.35";"4.92";"6.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL3911362";"";"None";"399.50";"0";"3.58";"BDBM198485";"N#Cc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"353463";"UO_0000065";"17.76";"0.32";"3.52";"7.49";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"80.0"
"CHEMBL3923711";"";"None";"298.39";"0";"2.49";"BDBM198533";"CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353511";"UO_0000065";"22.97";"0.43";"4.36";"9.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3954792";"";"None";"439.56";"0";"3.48";"BDBM198540";"CC(C)(C)OC(=O)N1CC[C@H](NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"510.0";"nM";"6.29";"";"353518";"UO_0000065";"14.32";"0.27";"2.81";"6.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"510.0"
"CHEMBL3981130";"";"None";"346.39";"0";"2.83";"BDBM198542";"FC1(F)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"860.0";"nM";"6.07";"";"353520";"UO_0000065";"17.51";"0.33";"3.24";"9.77";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"860.0"
"CHEMBL3893196";"";"None";"431.57";"0";"1.85";"BDBM198548";"CCS(=O)(=O)N1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353526";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3921202";"";"None";"472.47";"0";"3.45";"BDBM198549";"O=C(NCC(O)(c1ccccc1)C(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353527";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3973276";"";"None";"354.41";"0";"1.47";"BDBM198561";"O=C([C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)N1CC[C@H](O)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353539";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3923184";"";"None";"270.34";"0";"1.84";"BDBM198574";"NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"180.0";"nM";"6.75";"";"353552";"UO_0000065";"24.95";"0.46";"4.90";"7.95";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"180.0"
"CHEMBL4111878";"";"None";"388.48";"0";"2.88";"BDBM198582";"O[C@@H]1Cc2ccccc2[C@@H]1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"290.0";"nM";"6.54";"";"353560";"UO_0000065";"16.83";"0.31";"3.66";"7.17";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"290.0"
"CHEMBL3965030";"";"None";"395.39";"0";"1.90";"BDBM198591";"O=C(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353569";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3953381";"";"None";"474.49";"0";"3.68";"BDBM198595";"COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1";"IC50";"'='";"210.0";"nM";"6.68";"";"353573";"UO_0000065";"14.07";"0.27";"3.00";"6.65";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"210.0"
"CHEMBL3934891";"";"None";"269.31";"0";"2.08";"BDBM198609";"O=C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"353587";"UO_0000065";"25.99";"0.48";"4.92";"9.22";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL3913565";"";"None";"431.50";"0";"3.72";"BDBM198617";"Cc1ccc(CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(=O)CC#N)o1";"IC50";"'='";"580.0";"nM";"6.24";"";"353595";"UO_0000065";"14.45";"0.27";"2.52";"5.37";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"580.0"
"CHEMBL3972067";"";"None";"392.43";"0";"3.91";"BDBM198620";"FC(F)(F)CN(CC1CC1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"620.0";"nM";"6.21";"";"353598";"UO_0000065";"15.82";"0.30";"2.30";"9.99";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"620.0"
"CHEMBL3956450";"";"None";"362.46";"0";"1.77";"BDBM198625";"CN(C)S(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"353603";"UO_0000065";"18.68";"0.37";"5.00";"7.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"170.0"
"CHEMBL3962364";"";"None";"353.47";"0";"2.13";"BDBM198630";"CN(C)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353608";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL156987";"";"None";"377.18";"0";"3.17";"SB-409513";"O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1";"Inhibition";"'='";"-1.23";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.23"
"CHEMBL1909380";"GW282449A";"None";"447.93";"0";"4.79";"GW282449A";"COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl";"Inhibition";"'='";"-3.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.38"
"CHEMBL522709";"GSK-317315A";"None";"461.47";"1";"5.35";"GSK317315A";"COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1";"Inhibition";"'='";"0.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.28"
"CHEMBL4635464";"";"None";"225.25";"0";"2.23";"6";"Cc1[nH]nc2[nH]c(=O)cc(-c3ccccc3)c12";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"24.01";"0.43";"3.18";"8.79";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"3.9"
"CHEMBL4566777";"";"None";"457.58";"0";"4.10";"12e";"C/C=C/C(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL263796";"GW445014X";"None";"307.18";"0";"3.92";"GW445014X";"CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1";"Inhibition";"'='";"-2.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.78"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"BDBM103727";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"73.75";"nM";"7.13";"";"221731";"UO_0000065";"16.76";"0.32";"5.15";"7.38";"0";"CHEMBL3707911";"Inhibition Assay: In vitro inhibition assay using various enzyme.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638964";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"73.75"
"CHEMBL3969370";"";"None";"533.59";"2";"5.26";"1; FMF-01-086-2";"C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1";"Activity";"'='";"88.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4186097";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"88.0"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"11";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"14.01";"0.27";"2.42";"6.80";"0";"CHEMBL4309411";"Inhibition of recombinant TYK2 (unknown origin) by alpha-screen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4308837";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"4700.0"
"CHEMBL3984562";"";"None";"348.43";"0";"1.43";"BDBM198634";"CS(=O)(=O)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"353612";"UO_0000065";"22.37";"0.44";"6.37";"7.42";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"16.0"
"CHEMBL5418687";"";"None";"386.43";"0";"1.77";"11";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)C4COC4)n3)cn(C)c2cn1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"19.29";"0.38";"5.69";"7.23";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.035"
"CHEMBL5434751";"";"None";"366.42";"0";"2.86";"13";"CO[C@]1(c2cccc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"19.71";"0.37";"4.36";"9.23";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.06"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"5";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"25.20";"0.46";"4.25";"9.28";"1";"CHEMBL5347002";"Inhibition of N-terminal epitope tagged recombinant human TYK2 (873 to 1187 residues) expressed in baculovirus infected Sf21 cells using EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by homogeneous time-resolved fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"19.0"
"CHEMBL2178799";"";"None";"387.23";"0";"3.69";"BDBM50399021";"Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2Cl)n1";"Ki";"'='";"459.0";"nM";"6.34";"";"295032";"UO_0000065";"16.37";"0.33";"2.65";"8.22";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"459.0"
"CHEMBL4636220";"";"None";"243.31";"0";"2.46";"12";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4CC[C@@H]3C4)c12";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"26.17";"0.48";"3.91";"10.35";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.43"
"CHEMBL4640029";"";"None";"284.36";"0";"3.14";"22";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CCC#N)CC3)c12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL3894516";"";"None";"366.35";"0";"2.56";"BDBM198557";"O=C(NCC(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"353535";"UO_0000065";"18.55";"0.36";"4.24";"7.73";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"160.0"
"CHEMBL3973429";"";"None";"406.88";"0";"3.51";"BDBM198420";"Clc1n[nH]c2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc12";"IC50";"'>'";"1000.0";"nM";"";"";"353398";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3985597";"";"None";"342.40";"0";"2.72";"BDBM198216";"CC(C)(C)OC(=O)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"5300.0";"nM";"5.28";"";"353198";"UO_0000065";"15.41";"0.29";"2.56";"5.97";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"5300.0"
"CHEMBL3912192";"";"None";"432.48";"0";"4.60";"BDBM198230";"FC(F)(F)Sc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353212";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3957421";"";"None";"414.44";"0";"4.44";"BDBM198335";"FC(F)(F)c1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"250.0";"nM";"6.60";"";"353313";"UO_0000065";"15.93";"0.30";"2.16";"9.31";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"250.0"
"CHEMBL3945740";"";"None";"265.28";"0";"1.76";"BDBM198339";"OCc1ccc(-c2nnn3cnc4[nH]ccc4c23)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"353317";"UO_0000065";"25.96";"0.47";"5.13";"8.71";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL3986377";"";"None";"384.85";"0";"3.78";"BDBM198358";"Fc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl";"IC50";"'='";"300.0";"nM";"6.52";"";"353336";"UO_0000065";"16.95";"0.33";"2.74";"10.50";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"300.0"
"CHEMBL3906687";"";"None";"448.42";"0";"4.22";"BDBM198368";"FC(F)C(F)(F)Oc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353346";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3940421";"";"None";"478.50";"0";"4.29";"BDBM198372";"O=S(=O)(c1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1)C(F)(F)F";"IC50";"'='";"460.0";"nM";"6.34";"";"353350";"UO_0000065";"13.24";"0.26";"2.05";"6.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"460.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"57";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"Ki";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"15.21";"0.30";"3.74";"6.66";"0";"CHEMBL5383634";"Inhibition of TYK2 JH2 (unknown origin) by morrison titration assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"57";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"IC50";"'>='";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383635";"Inhibition of TYK2 KD (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"2.0"
"CHEMBL5394021";"";"None";"397.44";"0";"1.42";"70-2";"CNc1cc(Nc2cccnc2OC)nc2c(C(=O)NCC3(CO)CC3)cnn12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL5420349";"";"None";"471.54";"0";"2.88";"90-7";"COc1cc(Nc2cc(NC(C)=O)ncc2-c2ccc(C(C)(C)O)cn2)nc(S(C)(=O)=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383677";"Inhibition of TYK2 signal transduction pathway in human TF-1 cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL5439751";"";"None";"464.57";"0";"3.29";"91-4";"CO[C@@]1(c2cc(C)cc(-n3cc(C4CCN(C)CC4)c4cnc(NC(N)=O)cc43)n2)CCOC1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"18.68";"0.35";"5.39";"8.07";"0";"CHEMBL5383684";"Inhibition of TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"2.1"
"CHEMBL3694595";"";"None";"518.00";"1";"4.65";"BDBM125916";"N#Cc1ccccc1S(=O)(=O)Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2";"IC50";"'>'";"1000.0";"nM";"";"";"255727";"UO_0000065";"";"";"";"";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4539805";"";"None";"294.36";"0";"2.92";"11";"CC(C)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"23.18";"0.42";"3.90";"9.42";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"150.0"
"CHEMBL4463195";"";"None";"340.38";"0";"1.25";"23";"C[C@H](O)[C@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"17.29";"0.32";"4.64";"5.21";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"1300.0"
"CHEMBL4469583";"";"None";"340.38";"0";"1.25";"25";"C[C@@H](O)[C@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"18.49";"0.34";"5.04";"5.57";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"510.0"
"CHEMBL4581296";"";"None";"410.41";"0";"2.57";"20";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccc(C(N)=O)cc1OC";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"15.62";"0.29";"3.84";"4.88";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"390.0"
"CHEMBL215152";"AZD-1152-HQPA";"-1.0";"507.57";"1";"3.50";"SID103905345";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2181319";"";"None";"389.46";"0";"4.50";"16e, 85:15 trans/cis mixture";"COc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"17.15";"0.31";"2.18";"10.20";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.21"
"CHEMBL4522773";"BAY-827";"None";"385.86";"0";"4.94";"EUB0002889";"CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1";"% Control";"'='";"73.1";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507263";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"73.1"
"CHEMBL2181312";"";"None";"490.58";"1";"5.10";"22e, 85:15 trans/cis mixture";"Fc1cc2cc(c1)-c1ccnc(n1)Nc1ccc(OCCN3CCCC3)c(c1)COCC=CCOC2";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"15.17";"0.28";"2.34";"10.83";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.036"
"CHEMBL2181088";"";"None";"486.62";"1";"5.27";"22b, 85:15 trans/cis mixture";"Cc1cnc2nc1-c1cccc(c1)COCC=CCOCc1cc(ccc1OCCN1CCCC1)N2";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"14.89";"0.27";"1.97";"10.54";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.057"
"CHEMBL2181087";"";"None";"502.62";"1";"4.97";"22a, 85:15 trans/cis mixture";"COc1cc2cc(c1OCCN1CCCC1)COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.47";"0.25";"1.80";"8.68";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.17"
"CHEMBL4241519";"";"None";"441.54";"0";"0.72";"10f";"COCCn1cc(-c2nn(CC3CCN(C(=O)CN(C)C)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4240663";"";"None";"323.36";"0";"0.93";"12g";"Cn1cc(-c2nn(C3CCCN(C#N)C3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4289875";"";"None";"340.36";"0";"2.59";"12";"Cc1cc(F)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"16.95";"0.32";"3.18";"5.93";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.7"
"CHEMBL3814293";"";"None";"303.36";"0";"1.15";"3a";"NC(=O)c1ccc2c(c1)nc([C@H]1CC[C@H](O)CC1)n2CCO";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"17.69";"0.33";"4.22";"5.29";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"4.3"
"CHEMBL3622826";"";"None";"287.37";"0";"0.56";"2";"NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"18.90";"0.35";"4.87";"5.49";"1";"CHEMBL3817423";"Inhibition of FLAG-tagged human TYK2 expressed in insect Sf9 cells using biotin-EQEDEPEGDYFEWLE-NH2 as substrate by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";"";"";"";"3.7"
"CHEMBL3815154";"";"None";"316.41";"0";"1.37";"3d";"CNCCn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"16.60";"0.31";"3.88";"5.64";"0";"CHEMBL3817415";"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"5.6"
"CHEMBL5424861";"";"None";"326.40";"0";"2.01";"Peficitinib";"NC(=O)c1cnc2[nH]ccc2c1NC1[C@@H]2CC3C[C@H]1CC(O)(C3)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.49";"0.47";"6.31";"8.00";"0";"CHEMBL5342294";"Inhibition of N-terminal GST tagged catalytic domain human TYK2 (871 to 1187 end residues) expressed in Sf21 insect cells using Biotin-IRS1-Substrate as substrate incubated for 1 hr followed by substrate addition in presence of ATP by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338778";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"4.8"
"CHEMBL507361";"MIRDAMETINIB";"2.0";"482.20";"0";"2.47";"EUB0000666a";"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5473564";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000666a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 451.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH1domain-catalytic) | Source Knowledge: http://identifiers.org/lincs.data/LDS-1066";"";"";"100.0"
"CHEMBL552462";"";"None";"385.45";"0";"3.73";"SKI-349";"COc1ccc(Nc2nc(N)c(C(=O)c3ccc(OC)c(OC)c3)s2)cc1";"Activity";"'='";"14.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4669267";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"Dose = 1.0 microM";"INHIBITOR";"";"14.0"
"CHEMBL4799031";"";"None";"422.46";"0";"2.39";"12";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncccn2)c1OC";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"22.22";"0.41";"6.93";"7.11";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.48"
"CHEMBL483158";"ALISERTIB";"3.0";"518.93";"2";"5.75";"SID103905632";"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4745474";"";"None";"420.38";"0";"4.13";"57";"O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12";"Inhibition";"'='";"95.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4666944";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (833 to 1187 residues) expressed in baculovirus expression system using Tyr 03 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"Dose = 0.1 microM | TIME = 1.0 hr";"INHIBITOR";"";"95.0"
"CHEMBL4567992";"";"None";"331.40";"0";"3.01";"10";"CCS(=O)(=O)Nc1cc(-c2ccc(O)cc2C)cc2[nH]ncc12";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"18.41";"0.36";"3.09";"6.42";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.1"
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"SID103905630";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4567359";"";"None";"303.34";"0";"2.31";"2";"CS(=O)(=O)Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12";"pIC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";""
"CHEMBL377383";"";"None";"383.86";"0";"2.05";"12";"CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866679";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138045";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1.9"
"CHEMBL4580985";"";"None";"371.42";"0";"1.68";"17";"Cn1cc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cn1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"19.59";"0.37";"5.60";"9.19";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"53.0"
"CHEMBL4517702";"";"None";"356.43";"0";"1.34";"22";"CCNC(=O)N1[C@@H]2CC[C@@H]1CN(c1ccnc(Nc3cnn(C)c3)n1)C2";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"20.06";"0.38";"5.81";"7.84";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"71.0"
"CHEMBL3937822";"";"None";"325.37";"0";"2.75";"BDBM198644";"CCOC(=O)C=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353622";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3912503";"";"None";"337.39";"0";"1.91";"BDBM198653";"N#CCNC(=O)C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"540.0";"nM";"6.27";"";"353631";"UO_0000065";"18.58";"0.34";"4.36";"5.61";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"540.0"
"CHEMBL3922303";"";"None";"404.49";"0";"4.16";"BDBM198596";"Fc1ccc([C@@H]2C[C@H]2CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"670.0";"nM";"6.17";"";"353574";"UO_0000065";"15.26";"0.28";"2.01";"8.71";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"670.0"
"CHEMBL3622135";"";"None";"435.56";"0";"4.22";"16";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)cs3)nc21";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"16.87";"0.32";"3.13";"9.08";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"45.0"
"CHEMBL3622136";"";"None";"435.56";"0";"4.22";"17";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3ncc(C)s3)nc21";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"16.85";"0.32";"3.12";"9.07";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"46.0"
"CHEMBL4453827";"";"None";"429.48";"0";"3.26";"24";"CCS(=O)(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(=O)NC";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.85";"0.37";"4.84";"7.16";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.008"
"CHEMBL3764030";"";"None";"300.37";"0";"1.92";"16";"CC(C)[C@H](C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"27.50";"0.51";"6.34";"8.74";"0";"CHEMBL3766477";"Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"5.5"
"CHEMBL3763358";"";"None";"393.41";"0";"1.89";"27g";"COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC";"Inhibition";"'>'";"95.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3768614";"Inhibition of human TYK2 JH2 domain pseudokinase";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763144";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"95.0"
"CHEMBL4455512";"";"None";"315.31";"0";"2.99";"G3_9";"N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1";"Activity";"'='";"107.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4335333";"Inhibition of human TYK2 (875 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4334438";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"107.0"
"CHEMBL443962";"";"None";"304.15";"0";"3.17";"SID103904947";"COc1ccc(-c2cnc3c(Br)cnn3c2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL592030";"";"None";"439.55";"0";"4.79";"SID103904960";"NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989957";"";"None";"264.33";"0";"3.31";"SID103905451";"OCCNc1cc2cc(-c3ccccc3)ccc2cn1";"Ki";"'='";"794.33";"nM";"6.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.1"
"CHEMBL1996837";"";"None";"210.26";"0";"0.62";"SID103905651";"Cc1nn(C)c2sc(C(N)=O)c(N)c12";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL1966343";"";"None";"256.31";"0";"3.00";"SID103904482";"CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1";"Ki";"'='";"158.49";"nM";"6.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.8"
"CHEMBL1990254";"";"None";"317.39";"0";"3.18";"SID103904555";"NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989805";"";"None";"380.39";"0";"0.01";"SID103905319";"N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1978448";"";"None";"331.40";"0";"1.70";"SID103904912";"CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970913";"";"None";"310.36";"0";"3.37";"SID103905383";"CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1996500";"";"None";"410.43";"0";"3.62";"SID103904762";"Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1994864";"";"None";"293.33";"0";"2.34";"SID103904955";"Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2002446";"";"None";"458.63";"0";"4.23";"SID103904811";"CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL373598";"";"None";"447.88";"0";"3.35";"SID103905148";"N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1973937";"";"None";"436.31";"1";"5.53";"SID103904334";"Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL475251";"R-406";"2.0";"470.46";"0";"3.63";"SID103904600";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Ki";"'='";"15.85";"nM";"7.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.8"
"CHEMBL1984842";"";"None";"464.55";"0";"4.46";"SID103904777";"CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4876711";"";"None";"542.59";"2";"5.57";"13r";"CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)c3ccc(C(F)(F)F)cc3)ncc2C)cn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"14.08";"0.27";"2.07";"8.21";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"23.0"
"CHEMBL4873109";"";"None";"481.44";"0";"3.35";"14e";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)C(F)(F)F)ncc2F)cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.44";"0.35";"5.05";"7.19";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"4.0"
"CHEMBL4566600";"PPTN-NC";"None";"489.54";"1";"7.67";"EUB0000337";"Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507292";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3765822";"";"None";"358.45";"0";"2.15";"20";"CC(C)[C@@H](C)n1cc(-c2cc(C(C)(C)O)n(C)n2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"18.75";"0.35";"4.57";"5.86";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"190.0"
"CHEMBL3764383";"";"None";"382.47";"0";"2.42";"15";"CC(C)[C@@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"16.62";"0.31";"3.94";"6.23";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"440.0"
"CHEMBL3763252";"";"None";"382.47";"0";"2.42";"13";"CC(C)C(C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"19.00";"0.35";"4.85";"7.12";"0";"CHEMBL3766659";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763089";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307526";"";"";"";"54.0"
"CHEMBL3613595";"";"None";"306.17";"0";"3.23";"10";"CC(C)c1n[nH]cc1-c1nc2cc(Br)cnc2[nH]1";"Inhibition";"'<'";"30.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615451";"Inhibition of Tyk2 (unknown origin) at 10 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"30.0"
"CHEMBL3780032";"";"None";"211.26";"0";"0.76";"5; IACS-4759";"Cc1cnc(N)nc1OCC(C)(C)CO";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3782403";"Inhibition of partial length human TYK2 JH1catalytic domain expressed in mammalian system at 1 uM";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779767";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";""
"CHEMBL259084";"MLN-8054";"1.0";"476.87";"1";"5.87";"SID103904597";"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1982660";"";"None";"362.31";"0";"4.30";"SID103904903";"COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990288";"";"None";"399.43";"1";"5.36";"SID103904425";"CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL505187";"GSK-718429A";"None";"528.62";"2";"7.34";"GSK718429A";"CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1";"Inhibition";"'='";"0.52";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.52"
"CHEMBL4645290";"";"None";"483.26";"None";"None";"14j";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4(C)C)ncc2C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL4648837";"";"None";"455.21";"None";"None";"14a; 9";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4)ncc2C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL4574614";"";"None";"393.45";"0";"2.80";"11c";"C=CC(=O)Nc1cccc(CNc2cc(Nc3cnn(CCOC)c3)ncn2)c1";"IC50";"'='";"2290.0";"nM";"5.64";"";"";"UO_0000065";"14.34";"0.27";"2.84";"5.32";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"2290.0"
"CHEMBL4593058";"";"None";"393.45";"0";"2.80";"11c'";"C=CC(=O)Nc1ccc(CNc2cc(Nc3cnn(CCOC)c3)ncn2)cc1";"IC50";"'='";"2295.0";"nM";"5.64";"";"";"UO_0000065";"14.33";"0.27";"2.84";"5.32";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"2295.0"
"CHEMBL4546009";"";"None";"456.55";"0";"3.44";"14e";"CN1CCN(c2ccc(Nc3cc(NCc4cccc(NC(=O)CC#N)c4)ncn3)cc2)CC1";"IC50";"'='";"1532.0";"nM";"5.82";"";"";"UO_0000065";"12.74";"0.23";"2.37";"5.32";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"1532.0"
"CHEMBL4518786";"";"None";"443.51";"0";"3.52";"14d";"N#CCC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"'='";"1564.0";"nM";"5.81";"";"";"UO_0000065";"13.09";"0.24";"2.29";"5.04";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"1564.0"
"CHEMBL4591082";"SR-302";"None";"622.79";"1";"3.26";"EUB0000712";"CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1";"% Control";"'='";"86.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507324";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"86.0"
"CHEMBL4642546";"";"None";"275.35";"0";"2.14";"18";"Cc1[nH]nc2[nH]c(=O)c(CCO)c(C3CCCCC3)c12";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"19.86";"0.37";"3.33";"6.69";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"3.4"
"CHEMBL223360";"LINIFANIB";"3.0";"375.41";"0";"4.90";"SID103904340";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL491473";"CEDIRANIB";"3.0";"450.51";"1";"5.22";"AZD-2171";"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL573339";"PI-103";"None";"348.36";"0";"2.98";"100; PI-103";"Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1";"Kd";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"15.01";"0.27";"2.25";"6.19";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"5900.0"
"CHEMBL601661";"";"None";"519.61";"1";"3.47";"EUB0000607a";"CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5467012";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000607a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Highly selective over various PI3Ks, the PI3K-related kinases hSMG1 and ATR (>50000-fold); | Selectivity number of off-targets = 2.0 None | Selectivity number of targets = 450.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20079/results";"";"";"100.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690,550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"EC50";"'='";"625.0";"nM";"6.20";"";"";"UO_0000065";"19.86";"0.37";"4.66";"6.98";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"625.0"
"CHEMBL5092781";"";"None";"437.48";"0";"3.62";"15g";"O=C(CCCCCn1cc(Nc2ncc3ccn(Cc4cccc(F)c4)c3n2)cn1)NO";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.48";"0.36";"4.90";"7.76";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"3.0"
"CHEMBL3808884";"";"None";"562.55";"2";"6.04";"6z";"COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1";"Inhibition";"'<'";"40.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3813182";"Inhibition of GST-tagged human recombinant TYK2 (832 to 1187 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808348";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"40.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445118";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-23 induced pSTAT3 (lymphocytes), JAK2/TYK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"120.0"
"CHEMBL14762";"SELICICLIB";"2.0";"354.46";"0";"3.20";"EUB0000650a";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5472604";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000650a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 12.0 None | Selectivity number of targets = 456.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20124/";"";"";"100.0"
"CHEMBL3622149";"";"None";"432.53";"0";"3.50";"13";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)nn3C)nc21";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"13.04";"0.24";"2.14";"6.57";"0";"CHEMBL3625648";"Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621135";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"2300.0"
"CHEMBL3629616";"";"None";"248.24";"0";"3.00";"1; Wrightiadione";"O=C1c2ccccc2-c2c1oc1ccccc1c2=O";"Activity";"'='";"44.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3631589";"Inhibition of TYK2 JH1 catalytic domain (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627674";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"44.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445880";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IFN-a, JAK1/TYK2, pSTAT1 in monocytes)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Monocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308025";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"148.0"
"CHEMBL4207014";"";"None";"405.44";"0";"2.34";"19";"CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1";"Inhibition";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4191227";"Inhibition of recombinant human TYK2 (875 to end residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190187";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"8.0"
"CHEMBL3648442";"";"None";"356.41";"0";"1.91";"BDBM107151";"NS(=O)(=O)CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226461";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL5077973";"";"None";"463.59";"0";"2.30";"52";"CC(=O)N1CCN(c2ccc(Nc3ncc(C)c(N4CCC5(CCNC5=O)CC4)n3)cc2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"17.74";"0.33";"5.92";"8.77";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"6.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL3615458";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of basal level STAT3 phosphorylation at 10 uM after 30 mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL3648432";"";"None";"359.31";"0";"3.76";"BDBM107141";"O=C(CC(=O)C(F)(F)F)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226451";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL5072757";"";"None";"385.43";"0";"0.85";"15";"COC(=O)c1cnc(Nc2cnn(C)c2)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"78.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"78.0"
"CHEMBL5091643";"";"None";"338.42";"0";"2.03";"44";"Cc1cnc(Nc2ccccn2)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"94.0"
"CHEMBL3658864";"";"None";"373.48";"0";"2.28";"BDBM159783";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)[C@H]2CC[C@H](C#N)C2)C1";"IC50";"'='";"840.0";"nM";"6.08";"";"302677";"UO_0000065";"16.27";"0.32";"3.80";"5.91";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"840.0"
"CHEMBL4068357";"";"None";"342.45";"0";"2.32";"3";"C[C@@H]1CCN(C(=O)N2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"1632.2";"nM";"5.79";"";"";"UO_0000065";"16.90";"0.32";"3.47";"8.47";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"1632.2"
"CHEMBL3651854";"";"None";"591.78";"2";"6.24";"20b";"Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4716846";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715698";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10.0"
"CHEMBL1997764";"";"None";"343.39";"0";"4.49";"SID103904211";"COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4778584";"";"None";"350.38";"0";"2.20";"6";"C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CCO)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL1968127";"";"None";"408.48";"0";"4.19";"SID103904424";"CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5193147";"";"None";"443.50";"0";"3.61";"13";"O=C(Nc1nc2cccc([C@H]3CCC4(CCN(C(=O)[C@@H]5CC5(F)F)CC4)C3)n2n1)C1CC1";"IC50";"'='";"829.0";"nM";"6.08";"";"";"UO_0000065";"13.71";"0.26";"2.47";"7.64";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"829.0"
"CHEMBL5170765";"";"None";"403.43";"0";"2.88";"24";"O=C(Nc1nc2cccc([C@H]3CC[C@H](NC(=O)[C@@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"1736.0";"nM";"5.76";"";"";"UO_0000065";"14.28";"0.27";"2.88";"6.52";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1736.0"
"CHEMBL4244570";"";"None";"423.48";"0";"1.07";"9d";"COCCn1cc(-c2nn(CC3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"3000.0"
"CHEMBL1965507";"";"None";"418.48";"0";"4.48";"SID103904355";"Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1236107";"SGX-523";"1.0";"359.42";"0";"3.22";"SGX-523";"Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1229517";"VEMURAFENIB";"4.0";"489.93";"1";"5.54";"Vemurafenib";"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2146883";"COBIMETINIB";"4.0";"531.32";"1";"3.78";"Cobimetinib";"O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1908397";"KW-2449";"1.0";"332.41";"0";"2.78";"KW-2449";"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2001019";"PF-04217903";"1.0";"372.39";"0";"1.67";"PF-04217903";"OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL477772";"PAZOPANIB";"4.0";"437.53";"0";"3.14";"Pazopanib";"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"Rapamycin";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3991927";"HMN-214";"1.0";"424.48";"0";"3.24";"HMN-214";"COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL288441";"BOSUTINIB";"4.0";"530.46";"2";"5.19";"Bosutinib";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3114765";"";"None";"453.48";"0";"3.79";"11i";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(C2CN(c3ccnc(F)c3)C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL3114761";"";"None";"483.50";"0";"3.84";"11e";"O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(O[C@H]2CCN(c3ccnc(F)c3)C2)c1";"IC50";"'='";"5827.0";"nM";"5.24";"";"";"UO_0000065";"10.83";"0.20";"1.39";"5.27";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"5827.0"
"CHEMBL4583948";"";"None";"337.36";"0";"3.46";"20";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10.0"
"CHEMBL4476830";"";"None";"403.36";"0";"3.75";"22";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccc(F)c(F)c1OC";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"13.93";"0.26";"1.87";"6.37";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.4"
"CHEMBL4453827";"";"None";"429.48";"0";"3.26";"24";"CCS(=O)(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(=O)NC";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"12.47";"0.24";"2.10";"4.74";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"4.4"
"CHEMBL4469812";"";"None";"383.45";"0";"4.18";"25";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1SC";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"14.37";"0.28";"1.33";"6.98";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"3.1"
"CHEMBL4444606";"";"None";"427.49";"0";"2.74";"39";"CNC(=O)c1cnc(Nc2ccc(OC)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"14.70";"0.29";"3.54";"5.14";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.52"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"25.76";"0.48";"6.51";"9.05";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"9.0"
"CHEMBL2181332";"";"None";"486.57";"0";"4.49";"21e, 85:15 trans/cis mixture";"O=C1CCCN1CCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.86";"0.26";"2.25";"7.86";"0";"CHEMBL2183781";"Inhibition of recombinant TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176955";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";"";"0.18"
"CHEMBL4103698";"";"None";"375.43";"0";"2.04";"9";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2ccc(F)cc2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3655086";"";"None";"351.43";"0";"0.49";"36";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2COC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4059894";"";"None";"337.45";"0";"1.50";"22";"CCCNS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4087961";"";"None";"337.45";"0";"1.64";"27";"CCCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4087044";"";"None";"353.45";"0";"0.88";"34";"COCCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3655099";"";"None";"375.46";"0";"0.60";"BDBM159766";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC[C@H](C#N)C2)C1";"IC50";"'='";"1120.0";"nM";"5.95";"";"302660";"UO_0000065";"15.85";"0.31";"5.35";"5.04";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1120.0"
"CHEMBL1909397";"GW279320X";"None";"364.81";"0";"2.06";"GW279320X";"Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1";"Inhibition";"'='";"-5.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.56"
"CHEMBL5423859";"";"None";"460.50";"0";"1.97";"32";"CNc1cc(Nc2cccn(-c3cccnc3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.12";"0.32";"5.92";"6.19";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL5438635";"";"None";"495.58";"0";"2.71";"43";"CNc1cc(Nc2cccn([C@H]3CC[C@@H](OC)CC3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"IC50";"'='";"9.6";"nM";"8.02";"";"";"UO_0000065";"16.18";"0.30";"5.31";"6.48";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"9.6"
"CHEMBL1164265";"";"None";"470.96";"0";"4.26";"5h";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168300";"Inhibition of TYK2 JH1 catalytic domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL4571117";"";"None";"424.48";"0";"2.34";"43";"[2H]C([2H])([2H])NC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.71";"0.35";"5.55";"6.41";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"13.0"
"CHEMBL4468025";"";"None";"438.46";"0";"3.14";"23";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.63";"0.29";"3.71";"5.84";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"140.0"
"CHEMBL4084436";"";"None";"372.22";"0";"4.05";"17";"Nc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"25.58";"0.52";"5.47";"9.03";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0003"
"CHEMBL4062680";"";"None";"411.26";"0";"4.38";"32";"CNc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"22.42";"0.45";"4.84";"8.01";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0006"
"CHEMBL4436748";"SR-318";"None";"459.59";"0";"4.47";"EUB0000132";"Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1";"% Control";"'='";"88.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507315";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"88.0"
"CHEMBL3622376";"";"None";"242.24";"0";"0.62";"84";"c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1";"IC50";"'='";"5624.0";"nM";"5.25";"";"";"UO_0000065";"21.67";"0.40";"4.63";"6.19";"0";"CHEMBL3626584";"Inhibition of TYK2 (unknown origin) after 20 mins by radiometric analysis in presence of [gamma33P]-ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621113";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"5624.0"
"CHEMBL4548580";"";"None";"547.73";"2";"6.37";"21e";"CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1";"Inhibition";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4377943";"Inhibition of human TYK2 (875 to end residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376814";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"4.0"
"CHEMBL3648435";"";"None";"279.30";"0";"2.23";"BDBM107144";"O=C(CO)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226454";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL1614701";"SELUMETINIB";"4.0";"457.69";"0";"3.53";"AZD-6244/ARRY-886";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3950680";"";"None";"446.45";"0";"4.83";"BDBM198305";"Fc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F";"IC50";"'='";"3.3";"nM";"8.48";"";"353283";"UO_0000065";"19.00";"0.36";"3.65";"11.96";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"3.3"
"CHEMBL3896725";"";"None";"390.49";"0";"3.20";"BDBM198479";"O[C@@H](CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'='";"32.0";"nM";"7.50";"";"353457";"UO_0000065";"19.19";"0.35";"4.29";"8.22";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"32.0"
"CHEMBL4106456";"";"None";"355.40";"0";"0.90";"BDBM198491";"O=C1NOC[C@H]1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"370.0";"nM";"6.43";"";"353469";"UO_0000065";"18.10";"0.34";"5.53";"5.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"370.0"
"CHEMBL4109199";"";"None";"328.42";"0";"1.85";"BDBM198384";"C[C@@H](O)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"353362";"UO_0000065";"20.97";"0.39";"5.04";"7.56";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL4112721";"";"None";"435.45";"0";"2.63";"BDBM198523";"O=C(N[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1)C(F)(F)F";"IC50";"'='";"860.0";"nM";"6.07";"";"353501";"UO_0000065";"13.93";"0.27";"3.44";"6.65";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"860.0"
"CHEMBL30432";"GW282974X";"None";"395.47";"0";"4.23";"GW282974X";"CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1";"Inhibition";"'='";"-2.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.71"
"CHEMBL318892";"";"None";"428.52";"1";"5.16";"SB-236687";"CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1";"Inhibition";"'='";"0.82";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.82"
"CHEMBL3898818";"";"None";"317.36";"0";"2.85";"BDBM198638";"N#CC(C#N)=C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"240.0";"nM";"6.62";"";"353616";"UO_0000065";"20.86";"0.38";"3.77";"6.22";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"240.0"
"CHEMBL3902992";"";"None";"280.34";"0";"2.79";"BDBM198642";"N#CC[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"353620";"UO_0000065";"24.15";"0.44";"3.98";"8.19";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"170.0"
"CHEMBL3941431";"";"None";"295.35";"0";"1.74";"BDBM198600";"N#CCN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"380.0";"nM";"6.42";"";"353578";"UO_0000065";"21.74";"0.40";"4.68";"6.78";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"380.0"
"CHEMBL4115208";"";"None";"404.47";"0";"2.73";"BDBM198556";"O=C(NC[C@@H](O)c1ccccc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"460.0";"nM";"6.34";"";"353534";"UO_0000065";"15.67";"0.29";"3.61";"5.86";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"460.0"
"CHEMBL3911142";"";"None";"334.37";"0";"2.73";"BDBM198458";"FC(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353436";"UO_0000065";"20.50";"0.39";"4.12";"9.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3974989";"";"None";"418.40";"0";"4.14";"BDBM198356";"Fc1cc(C(F)(F)F)ccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"353334";"UO_0000065";"15.56";"0.30";"2.37";"10.48";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL3978202";"";"None";"352.36";"0";"3.03";"BDBM198387";"FC(F)(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"63.0";"nM";"7.20";"";"353365";"UO_0000065";"20.44";"0.39";"4.17";"10.16";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"63.0"
"CHEMBL3966425";"";"None";"380.88";"0";"4.08";"BDBM198399";"Clc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"353377";"UO_0000065";"17.92";"0.35";"2.74";"9.62";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL4557538";"";"None";"372.86";"0";"3.51";"3c; SKLB0533";"Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1";"Activity";"'='";"95.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4314954";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311992";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"95.5"
"CHEMBL3622830";"";"None";"305.34";"0";"1.63";"5g";"N#Cc1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"18.35";"0.33";"3.97";"5.06";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"2.5"
"CHEMBL3622832";"";"None";"322.41";"0";"2.88";"5i";"CC(C)c1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"17.27";"0.32";"2.69";"6.41";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"2.7"
"CHEMBL5180050";"";"None";"434.45";"0";"4.25";"3";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCCC4)cc3)c21";"Ki";"'='";"0.51";"nM";"9.29";"";"";"UO_0000065";"21.39";"0.40";"5.04";"12.50";"1";"CHEMBL5327925";"Inhibition of TYK2 JH1 domain (unknown origin) in presence of 10 uM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.51"
"CHEMBL5433700";"";"None";"464.46";"0";"1.45";"22";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@H]3O)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5327937";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level at 50 nM relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 50.0 nM";"";"";"50.0"
"CHEMBL2035187";"PACRITINIB";"4.0";"472.59";"0";"4.47";"5; SB1518,VONJO";"C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.45";"0.28";"2.83";"10.79";"1";"CHEMBL5380357";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5376015";"1";"Scientific Literature";"RSC Med Chem";"2024";"None";"";"INHIBITOR";"";"0.05"
"CHEMBL5437552";"";"None";"508.53";"2";"2.95";"4h";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(C(C)(C)O)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"14.61";"0.27";"4.44";"4.62";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"41.0"
"CHEMBL5423799";"";"None";"464.46";"0";"1.45";"21";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3O)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5422000";"";"None";"409.40";"0";"3.65";"Example 886";"CC(=O)Nc1cc2c(cn1)c(-c1ccc(C)nc1)nn2-c1ccnc(C(C)(F)F)n1";"IC50";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5346250";"Inhibition of human TYK2 JH2 domain (575 to 876 residues) incubated for 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5344452";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME = 1.0 hr";"INHIBITOR";"";"10.0"
"CHEMBL3780091";"";"None";"323.40";"0";"2.60";"10";"N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"27.28";"0.50";"6.22";"8.86";"0";"CHEMBL3784141";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779778";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"1.5"
"CHEMBL5271559";"";"None";"355.79";"0";"3.42";"2";"NC(=O)c1cnc(Nc2cccc(O)n2)cc1Nc1ccccc1Cl";"IC50";"'='";"2094.0";"nM";"5.68";"";"";"UO_0000065";"15.96";"0.31";"2.26";"5.02";"1";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"2094.0"
"CHEMBL5420971";"";"None";"411.85";"0";"3.89";"5";"CCOC(=O)c1ccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)nc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"16.44";"0.32";"2.88";"5.68";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"170.0"
"CHEMBL5438956";"";"None";"355.32";"0";"4.38";"23";"O=c1cc(-c2ccccc2)nc2c(-c3ccccc3)c(C(F)(F)F)[nH]n12";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"12.65";"0.24";"0.11";"8.96";"0";"CHEMBL5364821";"Inhibition of human recombinant TYK2 JH2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"32.0"
"CHEMBL4284952";"";"None";"291.31";"0";"2.52";"17";"N#CN[C@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"2971.0";"nM";"5.53";"";"";"UO_0000065";"18.97";"0.34";"3.01";"6.38";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2971.0"
"CHEMBL2204538";"THPP-1";"None";"464.91";"0";"3.06";"EUB0000751";"COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507293";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL4526341";"A-108";"None";"504.47";"2";"5.04";"EUB0000736";"Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507257";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL2152944";"Skepinone-L";"None";"425.43";"0";"3.77";"EUB0000717";"O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21";"% Residual activity with Skepinone-L";"'='";"96.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4884127";"TYK2 ProQinase selectivity panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507316";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"96.0"
"CHEMBL4531220";"BI 3047";"None";"515.53";"1";"3.80";"EUB0000586";"CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1";"% Control";"'='";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507277";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"82.0"
"CHEMBL189963";"PALBOCICLIB";"4.0";"447.54";"0";"2.97";"Palbociclib";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL507361";"MIRDAMETINIB";"2.0";"482.20";"0";"2.47";"PD-325901";"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3694577";"";"None";"338.80";"0";"4.38";"BDBM125898";"Clc1cnc2nc1NCc1cccc(c1)OCc1cccc(c1)N2";"IC50";"'='";"400.0";"nM";"6.40";"";"255709";"UO_0000065";"18.88";"0.36";"2.02";"10.83";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"400.0"
"CHEMBL2103875";"TRAMETINIB";"4.0";"615.40";"1";"3.94";"Trametinib";"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5416410";"";"None";"506.03";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O";"Kd";"'='";"1401.0";"nM";"5.85";"";"Active";"UO_0000065";"11.99";"0.24";"2.54";"5.50";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.95 None";"";"";"1401.0"
"CHEMBL405130";"WHI-P131";"1.0";"297.31";"0";"3.10";"JANEX-1";"COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL223360";"LINIFANIB";"3.0";"375.41";"0";"4.90";"Linifanib";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"Lapatinib";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL38380";"FASUDIL";"3.0";"291.38";"0";"1.22";"Fasudil";"O=S(=O)(c1cccc2cnccc12)N1CCCNCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"Crizotinib";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4444178";"";"None";"392.46";"0";"1.33";"47";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"22.82";"0.45";"7.56";"6.83";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0013"
"CHEMBL4526283";"";"None";"415.45";"0";"2.87";"23";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"50.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"INH";"'='";"0.14";"uM";"";"";"";"UO_0000064";"";"";"";"";"0";"CHEMBL3619028";"Inhibition of TYK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3616446";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"0.14"
"CHEMBL2322141";"";"None";"241.30";"0";"2.65";"41";"c1cc2c(ncc3nnc(C4CCCCC4)n32)[nH]1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"24.54";"0.45";"3.27";"10.06";"0";"CHEMBL2327342";"Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321825";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"1.2"
"CHEMBL4286562";"";"None";"349.39";"0";"2.71";"19";"COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CCO4)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4587924";"";"None";"392.39";"0";"3.34";"15";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1cccc(C#N)c1OC";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"15.91";"0.29";"2.90";"5.58";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"570.0"
"CHEMBL4520790";"";"None";"367.42";"0";"0.84";"20";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)NCC#N)n2)cn1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"21.22";"0.39";"6.96";"6.78";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"16.0"
"CHEMBL4283458";"";"None";"392.46";"0";"3.31";"17e";"COc1cc2c(=O)n(C3CCN(C)CC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"166.85";"nM";"6.78";"";"";"UO_0000065";"17.27";"0.32";"3.47";"9.36";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"166.85"
"CHEMBL4291720";"";"None";"391.47";"0";"4.94";"17c";"COc1cc2c(=O)n(C3CCCCCC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"2.24";"nM";"8.65";"";"";"UO_0000065";"22.10";"0.41";"3.71";"12.51";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2.24"
"CHEMBL4285332";"";"None";"409.44";"0";"3.39";"13a";"COc1cc2c(=O)n(CC(=O)OC(C)(C)C)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1000.0"
"CHEMBL3582461";"MSD-CYP11B2-Negative-control";"None";"303.29";"0";"4.45";"EUB0000733";"FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507294";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4285841";"";"None";"380.41";"0";"2.18";"26";"CNc1cc(Nc2cccc3c2OCCO3)nn2c(C(=O)NC3CC3)cnc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"21.61";"0.40";"6.04";"8.08";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.006"
"CHEMBL3967370";"";"None";"459.49";"0";"2.45";"BDBM255001";"CS(=O)(=O)NC[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"443991";"UO_0000065";"15.14";"0.31";"4.51";"7.07";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"110.0"
"CHEMBL3892991";"";"None";"473.52";"0";"2.80";"BDBM255026";"CN(C[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O";"IC50";"'='";"430.0";"nM";"6.37";"";"444016";"UO_0000065";"13.45";"0.27";"3.57";"7.10";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"430.0"
"CHEMBL3975691";"";"None";"417.54";"0";"2.05";"BDBM254987";"CS(=O)(=O)NC[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"91.0";"nM";"7.04";"";"444028";"UO_0000065";"16.86";"0.33";"4.99";"7.16";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"91.0"
"CHEMBL3949572";"";"None";"405.52";"0";"1.91";"BDBM254993";"CCN1CN([C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"170.0";"nM";"6.77";"";"444034";"UO_0000065";"16.69";"0.33";"4.86";"6.88";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"170.0"
"CHEMBL4585920";"TP-020n";"None";"520.95";"1";"3.61";"EUB0001079a";"Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5477878";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001079a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/chemProbes#!downloadview/TP-020";"";"";"100.0"
"CHEMBL3941680";"";"None";"405.89";"0";"4.52";"BDBM198466";"N#Cc1cc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl";"IC50";"'>'";"1000.0";"nM";"";"";"353444";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3933671";"";"None";"367.50";"0";"2.52";"BDBM198631";"CCN(C)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353609";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3945399";"";"None";"294.36";"0";"3.04";"BDBM198648";"CC(C#N)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"353626";"UO_0000065";"25.83";"0.47";"4.56";"9.20";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"25.0"
"CHEMBL5415406";"";"None";"366.42";"0";"2.86";"12";"CO[C@@]1(c2cccc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"17.76";"0.33";"3.65";"8.32";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.31"
"CHEMBL5434751";"";"None";"366.42";"0";"2.86";"13";"CO[C@]1(c2cccc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"15.89";"0.29";"2.96";"7.44";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"1.5"
"CHEMBL5418961";"";"None";"452.51";"0";"3.04";"21; ABBV-712";"COCc1cc(-c2cn(C3COC3)c3cnc(NC(C)=O)cc23)nc([C@]2(OC)CCOC2)c1";"EC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.02";"0.28";"3.76";"7.03";"0";"CHEMBL5373746";"Inhibition of TYK2 in human whole blood assessed as decrease in STAT4 phosphorylation preincubated for 30 mins followed by human IL-23 stimulation and measured after 20 mins by flow cytometry";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.16"
"CHEMBL3906967";"";"None";"271.32";"0";"1.87";"BDBM198202";"OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"351834";"UO_0000065";"27.39";"0.51";"5.56";"9.40";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"37.0"
"CHEMBL3667522";"";"None";"493.96";"0";"3.52";"BDBM153670";"COc1ccc(Cl)cc1-c1nn(CC(=O)N2CCCC2C)cc1NC(=O)c1cnn2cccnc12";"Ki";"'='";"9.1";"nM";"8.04";"";"295022";"UO_0000065";"16.28";"0.31";"4.52";"7.54";"0";"CHEMBL3707884";"Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 25 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22ÃÂ° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638469";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"9.1"
"CHEMBL124660";"TANDUTINIB";"2.0";"562.72";"2";"5.03";"MLN-518";"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4445670";"BAY-885";"None";"515.54";"1";"3.28";"EUB0000250";"CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4536197";"A-486";"None";"536.48";"1";"3.68";"EUB0000326";"CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O";"% Control";"'='";"92.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507259";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"92.0"
"CHEMBL3910680";"";"None";"432.43";"1";"5.15";"BDBM198454";"Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353432";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4106545";"";"None";"367.50";"0";"2.52";"BDBM198543";"CN(C)[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353521";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3980246";"";"None";"377.45";"0";"2.78";"BDBM198616";"N#CCC(=O)N(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CC1";"IC50";"'='";"840.0";"nM";"6.08";"";"353594";"UO_0000065";"16.10";"0.30";"3.30";"5.90";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"840.0"
"CHEMBL3937456";"";"None";"294.36";"0";"3.04";"BDBM198647";"CC(C#N)[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353625";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3962451";"";"None";"323.36";"0";"1.97";"BDBM198422";"c1cc2c(ncn3nnc(C4CCN(Cc5cocn5)CC4)c23)[nH]1";"IC50";"'='";"970.0";"nM";"6.01";"";"353400";"UO_0000065";"18.60";"0.34";"4.04";"6.82";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"970.0"
"CHEMBL3942304";"";"None";"496.23";"0";"4.57";"BDBM198436";"Brc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)sc1Br";"IC50";"'>'";"1000.0";"nM";"";"";"353414";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3915844";"";"None";"323.36";"0";"1.47";"BDBM198204";"CC1CCN(C(=O)CC#N)CC1c1nnn2cnc3[nH]ccc3c12";"IC50";"'='";"910.0";"nM";"6.04";"";"353186";"UO_0000065";"18.68";"0.34";"4.57";"5.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"910.0"
"CHEMBL3958797";"";"None";"333.40";"0";"2.38";"BDBM198220";"c1cncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"353202";"UO_0000065";"17.47";"0.32";"3.44";"7.77";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1500.0"
"CHEMBL3943768";"";"None";"382.45";"0";"2.78";"BDBM198223";"Cc1cc(NC(=O)N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)sn1";"IC50";"'>'";"1000.0";"nM";"";"";"353205";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3971898";"";"None";"374.44";"0";"3.61";"BDBM198290";"FC1(F)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353268";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3891947";"";"None";"380.52";"0";"4.04";"BDBM198299";"Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'='";"3.6";"nM";"8.44";"";"353277";"UO_0000065";"22.19";"0.43";"4.40";"11.91";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"3.6"
"CHEMBL3949323";"";"None";"392.48";"0";"3.85";"BDBM198304";"Fc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"28.0";"nM";"7.55";"";"353282";"UO_0000065";"19.24";"0.36";"3.70";"10.65";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"28.0"
"CHEMBL3900189";"";"None";"428.46";"0";"4.48";"BDBM198318";"FC(F)(F)c1cccc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353296";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3934814";"";"None";"360.46";"0";"3.46";"BDBM198329";"c1ccc(CCN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353307";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL5424441";"";"None";"473.50";"0";"1.02";"71-3";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@@H]3CCN(C)C3=O)cnn12";"IC50";"'='";"112.0";"nM";"6.95";"";"";"UO_0000065";"14.68";"0.27";"5.93";"5.02";"0";"CHEMBL5383650";"Inhibition of TYK2 JH2 in human TF-1 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.112"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"EUB0000644a";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"19.09";"0.37";"4.35";"9.27";"0";"CHEMBL5446115";"Affinity Biochemical interaction: (HTRF assay  (0.1 mM ATP)) EUB0000644a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5446079";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Biochemical Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/30886973/";"";"";"55.0"
"CHEMBL4462395";"";"None";"392.38";"1";"5.05";"EUB0000229b";"COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC";"% binding";"'='";"89.0";"%";"";"";"% Binding";"UO_0000187";"";"";"";"";"0";"CHEMBL5478656";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000229b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01213#";"";"";"89.0"
"CHEMBL5408198";"";"None";"448.53";"0";"3.87";"25ap";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1ccc(C(=O)NO)cc1";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"15.62";"0.29";"3.13";"6.27";"0";"CHEMBL5373207";"Inhibition of TYK2 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370605";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"99.0"
"CHEMBL1993243";"";"None";"353.40";"0";"3.03";"SID103905095";"CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12";"Ki";"'='";"1584.89";"nM";"5.80";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.8"
"CHEMBL1992922";"";"None";"284.32";"0";"1.39";"SID103904209";"OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5410927";"";"None";"406.47";"0";"2.82";"16f";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C#N)cc2)C[C@H]1F";"IC50";"'='";"411.9";"nM";"6.38";"";"";"UO_0000065";"15.71";"0.29";"3.57";"6.59";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"411.9"
"CHEMBL5404261";"";"None";"411.48";"0";"2.96";"17d";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(OC)cc2)C[C@@H]1F";"IC50";"'='";"1124.9";"nM";"5.95";"";"";"UO_0000065";"14.46";"0.27";"2.99";"7.23";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1124.9"
"CHEMBL5420407";"";"None";"425.96";"0";"4.43";"33b";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(Cl)c2)C(C)(C)C1";"IC50";"'='";"395.5";"nM";"6.40";"";"";"UO_0000065";"15.03";"0.29";"1.97";"8.77";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"395.5"
"CHEMBL5430795";"";"None";"403.49";"0";"2.65";"20c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C#N)cn2)[C@H](C)C1";"IC50";"'='";"57.2";"nM";"7.24";"";"";"UO_0000065";"17.95";"0.33";"4.59";"6.60";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"57.2"
"CHEMBL4436895";"";"None";"388.20";"0";"3.79";"46";"O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1";"Activity";"'='";"3.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4366010";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364269";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"3.6"
"CHEMBL4067915";"";"None";"330.32";"0";"1.36";"20";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccnc(F)c2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"25.80";"0.48";"7.16";"7.17";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"3.0"
"CHEMBL1794059";"GW275616X";"None";"315.35";"0";"1.74";"GW275616X";"NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1";"Inhibition";"'='";"-2.94";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.94"
"CHEMBL1975490";"";"None";"414.47";"0";"4.21";"SID103904650";"NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970189";"";"None";"286.72";"0";"2.59";"SID103905102";"Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1983025";"";"None";"483.64";"1";"6.37";"SID103904302";"CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1991674";"";"None";"343.82";"0";"3.39";"SID103904216";"OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1";"Ki";"'>'";"1258.93";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL1984206";"";"None";"297.32";"0";"1.26";"SID103905186";"CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3697701";"A-079";"None";"207.25";"0";"3.47";"EUB0000308";"CCC(=N\O)/C(C)=C/c1ccc(F)cc1";"% Control";"'='";"72.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507256";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"72.0"
"CHEMBL4448899";"BAY-876";"None";"496.42";"0";"4.17";"EUB0000307";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1";"% Control";"'='";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507267";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"83.0"
"CHEMBL4782814";"";"None";"402.51";"0";"3.73";"12; TD-1473";"Cc1cc(Nc2cc3ncccc3c(N[C@H]3CC[C@@H]4C[C@H](C3)N4CCC#N)n2)n[nH]1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"18.62";"0.34";"3.76";"7.10";"0";"CHEMBL4714262";"Inhibition of recombinant human Tyk2 expressed in sf21 baculovirus expression system assessed as phosphorylation level in presence of 1 mM ATP";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";"";"32.0"
"CHEMBL4750779";"";"None";"407.52";"0";"3.40";"31d";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)[C@@H](C)C1";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"16.71";"0.31";"3.41";"8.28";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"155.0"
"CHEMBL4071399";"";"None";"386.25";"0";"4.51";"18";"CNc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"EC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"19.05";"0.39";"2.85";"8.05";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.044"
"CHEMBL4080904";"";"None";"485.38";"0";"3.58";"26";"OCCN1CCN(c2cc(Nc3nccc4nc(-c5c(Cl)cccc5Cl)[nH]c34)ncn2)CC1";"EC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.12";"0.28";"3.27";"6.46";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.14"
"CHEMBL3675685";"";"None";"364.26";"1";"5.01";"13";"O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12)C1CC1";"Ki";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"25.53";"0.55";"4.29";"16.95";"1";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0005"
"CHEMBL4074130";"";"None";"357.20";"0";"4.47";"15";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3ccncn3)c2[nH]1";"Ki";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"25.82";"0.52";"4.75";"11.62";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0006"
"CHEMBL4070262";"";"None";"456.34";"0";"4.43";"24";"OC1CCN(c2cc(Nc3nccc4nc(-c5c(Cl)cccc5Cl)[nH]c34)ncn2)CC1";"Ki";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.72";"0.40";"4.57";"8.75";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.001"
"CHEMBL4778274";"";"None";"414.47";"0";"3.58";"18";"N#CCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL3813842";"PAXALISIB";"2.0";"382.43";"0";"0.97";"16";"CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3816091";"Inhibition of recombinant human N-terminal GST-tagged cytoplasmic TYK2 catalytic domain (833 to 1187 residues) expressed in baculovirus expression system at 1 uM relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813614";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"50.0"
"CHEMBL3694578";"";"None";"352.83";"0";"4.42";"BDBM125899";"Clc1cnc2nc1NCc1cccc(c1)OCCc1cccc(c1)N2";"IC50";"'='";"35.0";"nM";"7.46";"";"255710";"UO_0000065";"21.13";"0.41";"3.04";"12.62";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"35.0"
"CHEMBL3694590";"";"None";"445.75";"1";"5.57";"BDBM125911";"Clc1cnc2nc1NCc1cc(ccc1Br)OCCCc1cccc(c1)N2";"IC50";"'='";"300.0";"nM";"6.52";"";"255722";"UO_0000065";"14.63";"0.33";"0.95";"11.04";"0";"CHEMBL3705229";"TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639093";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"300.0"
"CHEMBL3601722";"";"None";"443.56";"0";"3.71";"11e";"C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"3000.0"
"CHEMBL4524497";"";"None";"414.52";"0";"3.48";"15e'";"CN1CCN(c2ccc(Nc3cc(NCc4ccc(NC#N)cc4)ncn3)cc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL4518706";"PF-00911705";"None";"508.49";"1";"2.53";"EUB0000702";"CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O";"% Control";"'='";"27.0";"%";"";"";"Slightly Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507299";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"27.0"
"CHEMBL4448899";"BAY-876";"None";"496.42";"0";"4.17";"EUB0000307";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1";"% Control";"'='";"77.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507267";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"77.0"
"CHEMBL4285530";"";"None";"364.45";"0";"3.54";"21";"Cc1cc(C)cc(Nc2cc(NC3CCCC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"17.29";"0.32";"2.76";"6.47";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.5"
"CHEMBL4286006";"";"None";"372.43";"0";"3.93";"22";"Cc1cc(C)cc(Nc2cc(Nc3ccccc3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"19.60";"0.36";"3.37";"7.50";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.05"
"CHEMBL4446102";"";"None";"326.40";"0";"1.87";"2";"NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(C2)C3O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"25.43";"0.47";"6.43";"7.98";"0";"CHEMBL4309404";"Inhibition of human TYK2 kinase domain using biotin-IRS1-substrate as substrate incubated for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4308837";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"5.0"
"CHEMBL4248368";"";"None";"381.44";"0";"1.11";"10h";"COCCn1cc(-c2nn(CC3CCN(C#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL208637";"";"None";"220.23";"0";"0.89";"6a";"CCOc1nc(NC(C)=O)cc(N)c1C#N";"Ki";"'>'";"1900.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL862052";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148638";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";"";"1900.0"
"CHEMBL4569613";"";"None";"393.44";"0";"3.03";"27";"CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCOC)c2cn[nH]c2c1";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"16.01";"0.32";"3.27";"6.04";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.3"
"CHEMBL4241559";"";"None";"418.46";"0";"2.59";"7";"C=CC(=O)Nc1cccc(Cn2ncc3c(Nc4cnn(CCOC)c4)ncnc32)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4249872";"";"None";"410.48";"0";"1.34";"9b";"C=CC(=O)N1CCCC(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"3296.4";"nM";"5.48";"";"";"UO_0000065";"13.35";"0.25";"4.14";"4.69";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"3296.4"
"CHEMBL4287081";"";"None";"324.39";"0";"2.62";"19";"CCNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"19.18";"0.35";"3.60";"6.39";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.6"
"CHEMBL4238357";"";"None";"379.43";"0";"0.96";"9c";"Cn1cc(-c2nn(CC3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1";"IC50";"'='";"2352.1";"nM";"5.63";"";"";"UO_0000065";"14.83";"0.27";"4.67";"4.28";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"2352.1"
"CHEMBL4249492";"";"None";"396.46";"0";"1.27";"12b";"C=CC(=O)N1CCCC(n2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1";"IC50";"'='";"2117.2";"nM";"5.67";"";"";"UO_0000065";"14.31";"0.27";"4.40";"4.85";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"2117.2"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"25.36";"0.47";"6.38";"8.91";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"12.0"
"CHEMBL477772";"PAZOPANIB";"4.0";"437.53";"0";"3.14";"Pazopanib";"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O";"Kd";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.50";"0.24";"2.33";"4.59";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"3400.0"
"CHEMBL3648439";"";"None";"424.51";"0";"3.45";"BDBM107148";"O=C(CN1CCN(c2ccncc2)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226458";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL1165499";"";"None";"436.51";"0";"3.61";"5d";"CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1168301";"Inhibition of TYK2 JH2 pseudokinase domain at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165965";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";"";"50.0"
"CHEMBL3337894";"T-26c";"None";"479.51";"0";"3.34";"EUB0000729";"COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1";"% Control";"'='";"95.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507300";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"95.0"
"CHEMBL3645549";"";"None";"348.41";"0";"2.57";"BDBM107135";"O=C(CN1CCOCC1)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226445";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL4444178";"";"None";"392.46";"0";"1.33";"47";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"Ki";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"23.36";"0.46";"7.77";"6.99";"0";"CHEMBL4414854";"Inhibition of TYK2 JH2 (unknown origin) by morrison titration assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0008"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.30";"0.32";"4.96";"7.17";"0";"CHEMBL3625892";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"116.0"
"CHEMBL4645814";"";"None";"270.34";"0";"2.75";"21";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC#N)CC3)c12";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"25.47";"0.47";"4.14";"8.07";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.13"
"CHEMBL3964008";"";"None";"412.40";"0";"3.31";"BDBM198430";"FC1(F)Oc2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2O1";"IC50";"'='";"570.0";"nM";"6.24";"";"353408";"UO_0000065";"15.14";"0.28";"2.93";"7.75";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"570.0"
"CHEMBL1909407";"";"None";"374.85";"0";"2.65";"SB-220025-R";"Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"0.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.9"
"CHEMBL4754557";"";"None";"364.41";"0";"2.85";"7";"C=CC(=O)Nc1cccc(-c2ccnc(Nc3cnn(CCOC)c3)n2)c1";"IC50";"'='";"2871.0";"nM";"5.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"2871.0"
"CHEMBL4747498";"";"None";"415.50";"0";"4.24";"34";"C/C=C/C(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"";"";""
"CHEMBL4756788";"";"None";"393.49";"0";"3.01";"17d";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2OC)CC1";"IC50";"'='";"4180.0";"nM";"5.38";"";"";"UO_0000065";"13.67";"0.25";"2.37";"6.54";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"4180.0"
"CHEMBL4744048";"";"None";"377.49";"0";"3.39";"31a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccccc2)[C@@H](C)C1";"IC50";"'='";"276.0";"nM";"6.56";"";"";"UO_0000065";"17.38";"0.32";"3.17";"8.98";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"276.0"
"CHEMBL4075453";"";"None";"426.31";"1";"5.07";"22";"Clc1cccc(Cl)c1-c1nc2ccnc(Nc3cc(N4CCCC4)ncn3)c2[nH]1";"EC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"14.74";"0.30";"1.21";"7.61";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.52"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"2";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"EC50";"'='";"224.0";"nM";"6.65";"";"";"UO_0000065";"17.65";"0.35";"3.36";"7.01";"1";"CHEMBL4046593";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-12 induced STAT4 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"224.0"
"CHEMBL4065419";"";"None";"414.30";"0";"4.84";"28";"Cc1nc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)cc(N(C)C)n1";"Ki";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"20.50";"0.41";"3.65";"10.28";"0";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.0032"
"CHEMBL1091513";"MRK-560";"None";"517.93";"1";"4.67";"EUB0000750";"O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F";"% Control";"'='";"86.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507288";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"86.0"
"CHEMBL1998112";"";"None";"389.42";"0";"3.26";"SID103905233";"COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1964413";"";"None";"411.31";"0";"4.91";"SID103904546";"FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL424872";"";"None";"374.42";"0";"1.27";"SID103905191";"CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL2004447";"";"None";"312.35";"0";"3.06";"SID103905103";"CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5089877";"";"None";"313.33";"0";"3.29";"30";"CCc1c(-c2cc(OC)c3nc(N)ncc3c2)ccc(O)c1F";"IC50";"'='";"1584.89";"nM";"5.80";"";"";"UO_0000065";"18.51";"0.34";"2.51";"7.14";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"5.8"
"CHEMBL5085176";"";"None";"372.40";"0";"2.05";"46i";"CCc1cc(O)c(F)cc1-c1cc(NC(CO)CO)c2nc(N)ncc2c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.80";"0.35";"4.95";"5.62";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL5087255";"";"None";"395.48";"0";"3.79";"51d";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H]2CCCN(C)C2)c2nc(N)ncc2c1";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"15.68";"0.29";"2.41";"7.10";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.2"
"CHEMBL3589752";"IPP/CNRS-A017";"None";"403.40";"1";"5.45";"EUB0000276";"Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507312";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4065365";"";"None";"381.39";"0";"1.56";"82";"COc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\OCC(O)CO)C(=O)N2";"IC50";"'='";"10.7";"nM";"7.97";"";"";"UO_0000065";"20.90";"0.39";"6.41";"7.09";"0";"CHEMBL5151633";"Inhibition of recombinant Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149994";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";"";"10.7"
"CHEMBL1972576";"";"None";"418.48";"0";"4.48";"SID103904331";"Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1992342";"";"None";"330.41";"0";"2.96";"SID103904472";"CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1";"Ki";"'='";"31.62";"nM";"7.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.5"
"CHEMBL413779";"";"None";"433.85";"0";"2.96";"SID103905149";"N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990346";"";"None";"288.15";"0";"3.57";"SID103905032";"Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1967887";"";"None";"268.32";"0";"2.27";"SID103904469";"Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988717";"";"None";"492.47";"1";"5.04";"SID103904289";"Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1988370";"";"None";"453.59";"1";"5.31";"SID103904996";"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1985311";"";"None";"391.41";"0";"4.09";"SID103904855";"Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3928932";"";"None";"354.41";"1";"5.04";"5";"CCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"22.69";"0.41";"3.00";"10.36";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"9.1"
"CHEMBL4087076";"";"None";"368.44";"1";"5.60";"7";"CC(C)c1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1";"IC50";"'='";"392.3";"nM";"6.41";"";"";"UO_0000065";"17.39";"0.31";"0.81";"8.26";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"392.3"
"CHEMBL4086057";"";"None";"304.35";"0";"3.89";"12";"CCc1cc(O)ccc1-c1ccc2c(-c3ncc[nH]3)n[nH]c2c1";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"27.39";"0.50";"4.45";"10.75";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"4.6"
"CHEMBL4097152";"";"None";"467.55";"1";"5.59";"21";"CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CN(Cc3ccccc3)CC4)n[nH]c2c1";"IC50";"'='";"57.5";"nM";"7.24";"";"";"UO_0000065";"15.49";"0.28";"1.65";"8.96";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"57.5"
"CHEMBL5084542";"";"None";"423.49";"0";"3.71";"46a";"CCc1cc(O)c(F)cc1-c1cc(NC2CCN(C(C)=O)CC2)c2nc(N)ncc2c1";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"17.47";"0.33";"3.69";"7.09";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.4"
"CHEMBL5079248";"";"None";"356.40";"0";"3.08";"46h";"CCc1cc(O)c(F)cc1-c1cc(NC[C@@H](C)O)c2nc(N)ncc2c1";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"20.20";"0.38";"4.12";"6.90";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.2"
"CHEMBL4458435";"";"None";"389.41";"0";"1.79";"23; PF-06700841";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"Inhibition";"'='";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4411570";"Inhibition of N-terminal GST tagged human TYK2 (871 to 1187 end residues) catalytic domain expressed in baculovirus expression system at 1 uM in presence of 1 mM ATP relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"98.0"
"CHEMBL5196106";"";"None";"364.45";"0";"2.56";"41";"N#CCN1CC2(CCC(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)C1";"IC50";"'='";"581.0";"nM";"6.24";"";"";"UO_0000065";"17.11";"0.32";"3.68";"7.22";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"581.0"
"CHEMBL2348350";"";"None";"438.56";"0";"2.40";"15u";"CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1";"Activity";"'='";"95.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806814";"Inhibition of human TYK2 JH1 catalytic domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804286";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 2000.0 nM";"";"";"95.0"
"CHEMBL2348350";"";"None";"438.56";"0";"2.40";"15u";"CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1";"Activity";"'='";"73.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806815";"Inhibition of human TYK2 JH2 pseudokinase domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804286";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 2000.0 nM";"";"";"73.0"
"CHEMBL5194842";"";"None";"578.67";"1";"3.34";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCSC3)cc2)c1OC";"Tm";"'='";"59.34";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"59.34"
"CHEMBL5173760";"";"None";"518.55";"1";"2.68";"27";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CC(=O)N3)c1OC";"Tm";"'='";"54.5";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"54.5"
"CHEMBL5189220";"";"None";"534.59";"1";"2.94";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NCC)cc2)c1OC";"Tm";"'='";"55.51";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"55.51"
"CHEMBL5198448";"";"None";"561.62";"1";"2.82";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)nc2)c1OC";"Tm";"'='";"64.04";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"64.04"
"CHEMBL3983594";"";"None";"446.48";"0";"3.55";"BDBM255038";"N#CCN1CN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"45.0";"nM";"7.35";"";"444044";"UO_0000065";"16.45";"0.31";"3.80";"8.34";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"45.0"
"CHEMBL3950208";"";"None";"369.47";"0";"1.65";"BDBM255044";"CN1CN([C@H]2CC[C@H](CN3CC(O)C3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"61.0";"nM";"7.21";"";"444050";"UO_0000065";"19.53";"0.36";"5.56";"9.53";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"61.0"
"CHEMBL3957838";"";"None";"485.53";"0";"2.94";"BDBM254997";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)CN1CC(F)(F)F";"IC50";"'='";"350.0";"nM";"6.46";"";"444052";"UO_0000065";"13.30";"0.27";"3.52";"7.20";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"350.0"
"CHEMBL4128410";"";"None";"403.49";"0";"4.78";"8";"CN(C)C(=O)/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"17.62";"0.32";"2.33";"8.89";"0";"CHEMBL4124187";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of 10 uM [gamma33P]ATP by radiometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118225";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"78.0"
"CHEMBL5433426";"";"None";"336.36";"0";"2.47";"1b";"COc1ccccc1Nc1cc(Nc2cccnn2)ncc1C(N)=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"22.96";"0.42";"5.25";"6.71";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"19.0"
"CHEMBL5418288";"";"None";"499.55";"0";"3.20";"90-8";"COc1cc(Nc2cc(NC(C)=O)ncc2-c2ccc3c(n2)OCC(C)(C)O3)nc(S(C)(=O)=O)c1";"IC50";"'='";"1822.0";"nM";"5.74";"";"";"UO_0000065";"11.49";"0.22";"2.54";"4.05";"0";"CHEMBL5383677";"Inhibition of TYK2 signal transduction pathway in human TF-1 cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1822.0"
"CHEMBL4867931";"";"None";"464.55";"0";"3.20";"I-50";"COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1";"% inhibition";"'='";"28.8";"uM";"";"";"Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ";"UO_0000064";"";"";"";"";"0";"CHEMBL4804508";"Inhibition of TYK2 domain 2 in human NCI-H929 cells by mass spectroscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NCI-H929";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804281";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"";"INHIBITOR";"";"28.8"
"CHEMBL5439447";"";"None";"505.56";"2";"1.70";"82-2";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(N3CC(O)C3)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"14.09";"0.26";"5.38";"4.56";"0";"CHEMBL5383660";"Inhibition of TYK2 JH2 in human KIT225 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation by AlphaLISA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"83.0"
"CHEMBL5415395";"";"None";"426.51";"0";"3.57";"87-1";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"Kd";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL5396851";"";"None";"489.55";"0";"3.20";"92-3";"[2H]C([2H])([2H])NC(=O)c1nnc2cc1Nc1cc(cc(-c3ccn(C)n3)c1OC)CCOCc1cccc(n1)N2";"IC50";"'<='";"50.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"50.0"
"CHEMBL5396026";"";"None";"434.52";"0";"3.61";"1";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)Cc1nc(C)nn1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL4518744";"";"None";"351.82";"0";"3.35";"14";"CCS(=O)(=O)Nc1cc(-c2ccc(O)c(Cl)c2)cc2[nH]ncc12";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"18.76";"0.39";"3.25";"6.94";"0";"CHEMBL4478764";"Inhibition of human Gst-tagged TYK2 ( 871 to 1187 residues) expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477220";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"6.6"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"EUB0000644a";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"14.01";"0.27";"2.42";"6.80";"0";"CHEMBL5472023";"Selectivity interaction (HTRF activity assay) EUB0000644a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 85.0 None | Selectivity Remarks: In-vitro potency (using 0.001 mM ATP) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/30886973/";"";"";"4.7"
"CHEMBL5418986";"";"None";"923.00";"2";"3.18";"PTD14";"C[C@H]1CN(C(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL5342669";"Degradation of TYK2 in human TMD8 cells by measuring protein level at 111 nM for 6 hrs using label free proteomic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TMD8";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338787";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 111.0 nM | TIME = 6.0 hr";"";"";""
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"57";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.54";"0.29";"3.39";"6.37";"1";"CHEMBL5383633";"Inhibition of TYK2 JH2 (unknown origin) by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"27.0"
"CHEMBL4460368";"";"None";"451.47";"0";"1.55";"6s";"CNc1cc(Nc2cccn(-c3cc(C)n(C)n3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"0.015";"nM";"10.82";"";"";"UO_0000065";"23.97";"0.45";"9.27";"8.79";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.015"
"CHEMBL4474801";"";"None";"434.44";"0";"2.09";"6f";"CNc1cc(Nc2cccn(-c3ccc(F)nc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.78";"0.29";"4.76";"5.80";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"140.0"
"CHEMBL5284232";"";"None";"529.58";"1";"3.37";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccnc3)cc2)c1OC";"Tm";"'='";"53.99";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"53.99"
"CHEMBL5280466";"";"None";"546.60";"1";"3.32";"5";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCC3=O)cc2)c1OC";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"14.87";"0.28";"4.76";"5.23";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"8.3"
"CHEMBL5268371";"";"None";"560.63";"1";"3.71";"6";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"15.88";"0.29";"5.14";"5.73";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"1.4"
"CHEMBL5291007";"";"None";"540.60";"1";"4.25";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3cccnc3)cc2)c1OC";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"14.17";"0.26";"3.37";"5.18";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"24.0"
"CHEMBL5279644";"";"None";"570.63";"1";"3.78";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(C4CC4)n3)cc2)c1OC";"Tm";"'='";"62.02";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"62.02"
"CHEMBL4447181";"LONDAMOCITINIB";"2.0";"599.66";"1";"3.25";"16; AZD4604";"COC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cccc(S(C)(=O)=O)c4F)ncc3F)c[nH]c12)N1CCN(C)CC1";"IC50";"'='";"657.0";"nM";"6.18";"";"";"UO_0000065";"10.31";"0.20";"2.93";"4.66";"0";"CHEMBL5369347";"Inhibition of GST-tagged human recombinant TYK2 (833 to 1187 residues) expressed in insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365521";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"657.0"
"CHEMBL3601115";"";"None";"427.90";"0";"3.45";"45";"C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1";"IC50";"'='";"407.0";"nM";"6.39";"";"";"UO_0000065";"14.93";"0.29";"2.94";"6.03";"0";"CHEMBL3603320";"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600288";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"407.0"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"EUB0000644a";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"19.09";"0.37";"4.35";"9.27";"0";"CHEMBL5472022";"Selectivity interaction (HTRF activity assay) EUB0000644a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 85.0 None | Selectivity Remarks: In-vitro potency (using 0.1 mM ATP) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/30886973/";"";"";"0.055"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"EUB0000644a";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"14.01";"0.27";"2.42";"6.80";"0";"CHEMBL5472024";"Selectivity interaction (Biochemical assay) EUB0000644a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Remarks: In-vitro potency (using 0.1 mM ATP) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/30886973/";"";"";"4690.0"
"CHEMBL5395502";"";"None";"588.71";"2";"5.32";"30";"Cc1cnc(Nc2ccc(OCCCCCCC(=O)NO)c(F)c2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"IC50";"'='";"780.4";"nM";"6.11";"";"";"UO_0000065";"10.37";"0.20";"0.79";"3.95";"0";"CHEMBL5385206";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380863";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"780.4"
"CHEMBL160937";"";"None";"314.73";"0";"2.53";"SB-390527";"O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1";"Inhibition";"'='";"-5.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.26"
"CHEMBL3981542";"";"None";"323.36";"0";"1.52";"BDBM198558";"N#CCNC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"353536";"UO_0000065";"21.10";"0.39";"5.30";"6.11";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3983856";"";"None";"324.39";"0";"2.16";"BDBM198562";"O=C(NC1CC1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"560.0";"nM";"6.25";"";"353540";"UO_0000065";"19.27";"0.36";"4.09";"7.11";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"560.0"
"CHEMBL210618";"";"None";"356.38";"0";"2.13";"SID103905189";"CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SID103904989";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL302449";"GO-6976";"None";"378.44";"0";"4.60";"SID103905532";"Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O";"Ki";"'='";"3.162";"nM";"8.50";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"8.5"
"CHEMBL95692";"SB-242235";"None";"353.40";"0";"3.08";"SID103905256";"COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1972365";"";"None";"210.24";"0";"1.98";"SID103905283";"Nc1cc2nc(-c3ccccc3)cn2cn1";"Ki";"'>'";"19952.62";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"4.7"
"CHEMBL5419627";"";"None";"437.46";"0";"1.62";"82-1";"CNC(=O)c1nnc(NC(=O)N2CCC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Kd";"'='";"0.028";"nM";"10.55";"";"";"UO_0000065";"24.12";"0.45";"8.93";"7.58";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.028"
"CHEMBL3675997";"";"None";"394.45";"0";"3.13";"BDBM127750";"C[C@@H](NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12)C1CC1";"IC50";"'>'";"1000.0";"nM";"";"";"258566";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3952936";"";"None";"339.40";"0";"1.86";"BDBM255003";"N#CCN1CN([C@H]2CC[C@H](CO)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"52.0";"nM";"7.28";"";"443993";"UO_0000065";"21.46";"0.40";"5.42";"7.57";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"52.0"
"CHEMBL188343";"REVERSINE";"None";"393.50";"0";"3.68";"22";"c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"18.35";"0.34";"3.54";"7.94";"0";"CHEMBL5364821";"Inhibition of human recombinant TYK2 JH2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.06"
"CHEMBL3923802";"";"None";"338.46";"0";"3.41";"BDBM198487";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CCCC5)CC4)c23)[nH]1";"IC50";"'='";"320.0";"nM";"6.50";"";"353465";"UO_0000065";"19.19";"0.35";"3.08";"9.16";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"320.0"
"CHEMBL3976587";"";"None";"336.44";"0";"3.02";"BDBM198519";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC56CC(C5)C6)CC4)c23)[nH]1";"IC50";"'='";"590.0";"nM";"6.23";"";"353497";"UO_0000065";"18.51";"0.34";"3.21";"8.79";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"590.0"
"CHEMBL4112922";"";"None";"381.48";"0";"2.09";"BDBM198521";"CC(=O)N[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"610.0";"nM";"6.21";"";"353499";"UO_0000065";"16.29";"0.30";"4.12";"6.81";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"610.0"
"CHEMBL3931935";"";"None";"435.45";"0";"2.63";"BDBM198524";"O=C(N[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1)C(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353502";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL5182426";"";"None";"506.54";"1";"2.29";"5";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(N)=O)cc2)c1OC";"Tm";"'='";"52.96";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"52.96"
"CHEMBL5181780";"";"None";"507.53";"1";"1.68";"6";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(N)=O)cn2)c1OC";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"13.66";"0.25";"5.21";"3.62";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"129.0"
"CHEMBL1427221";"";"None";"297.75";"0";"3.47";"BDBM67818";"O=C(CCl)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"226426";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"20000.0"
"CHEMBL3981673";"";"None";"485.53";"0";"2.99";"BDBM255002";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)CN1CC(F)(F)F";"IC50";"'='";"420.0";"nM";"6.38";"";"443992";"UO_0000065";"13.13";"0.26";"3.39";"6.48";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"420.0"
"CHEMBL3952221";"";"None";"405.52";"0";"1.86";"BDBM255014";"CN1CN([C@H]2CC[C@H](CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"110.0";"nM";"6.96";"";"444004";"UO_0000065";"17.16";"0.34";"5.10";"7.77";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"110.0"
"CHEMBL3891913";"";"None";"463.43";"0";"4.06";"BDBM255017";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC(F)(F)F";"IC50";"'='";"230.0";"nM";"6.64";"";"444007";"UO_0000065";"14.32";"0.28";"2.58";"10.33";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"230.0"
"CHEMBL3916308";"";"None";"465.52";"0";"3.67";"BDBM255021";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC1CCCO1";"IC50";"'='";"100.0";"nM";"7.00";"";"444011";"UO_0000065";"15.04";"0.29";"3.33";"9.53";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"100.0"
"CHEMBL3949226";"";"None";"435.58";"0";"2.50";"BDBM255030";"CN1CN([C@H]2CC[C@H](CN3CCN(CCC#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"910.0";"nM";"6.04";"";"444020";"UO_0000065";"13.87";"0.26";"3.54";"7.32";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"910.0"
"CHEMBL3907106";"";"None";"391.47";"0";"3.22";"BDBM255036";"CCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"330.0";"nM";"6.48";"";"444042";"UO_0000065";"16.56";"0.32";"3.26";"10.09";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"330.0"
"CHEMBL4244213";"";"None";"337.39";"0";"1.00";"9g";"Cn1cc(-c2nn(CC3CCCN(C#N)C3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4287761";"";"None";"434.45";"0";"2.55";"28";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"18.92";"0.36";"5.67";"7.29";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.006"
"CHEMBL5439728";"";"None";"449.49";"1";"2.23";"2j";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cccc(C)n2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.52";"0.32";"5.59";"5.41";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"15.0"
"CHEMBL5433636";"";"None";"456.48";"1";"1.10";"3d";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2noc(CNC)n2)c1OC";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"15.93";"0.30";"6.12";"4.27";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"60.0"
"CHEMBL5430970";"";"None";"413.46";"0";"1.73";"1a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CC)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"124.0";"nM";"6.91";"";"";"UO_0000065";"16.83";"0.31";"5.18";"5.08";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"124.0"
"CHEMBL66292";"PYRAZOLOPYRIMIDINE 2";"None";"422.47";"0";"2.67";"GW811168X";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1";"Inhibition";"'='";"1.37";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.37"
"CHEMBL3940644";"";"None";"406.46";"0";"4.15";"BDBM198461";"FC(F)(F)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"740.0";"nM";"6.13";"";"353439";"UO_0000065";"15.08";"0.29";"1.98";"9.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"740.0"
"CHEMBL3622825";"";"None";"261.33";"0";"-0.01";"5b";"NCCCc1nc2cc(C(N)=O)ccc2n1CCN";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"21.44";"0.40";"5.61";"4.96";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"2.5"
"CHEMBL4110648";"";"None";"354.46";"0";"2.65";"BDBM198492";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC[C@H]5CCCO5)CC4)c23)[nH]1";"IC50";"'='";"160.0";"nM";"6.80";"";"353470";"UO_0000065";"19.17";"0.36";"4.15";"8.48";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"160.0"
"CHEMBL3916636";"";"None";"378.40";"0";"3.56";"BDBM198495";"FC(F)(F)C1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"353473";"UO_0000065";"17.36";"0.33";"3.01";"9.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"270.0"
"CHEMBL3909751";"";"None";"399.50";"0";"4.30";"BDBM198503";"N#CCCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"353481";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3896766";"";"None";"326.45";"0";"3.27";"BDBM198535";"CC(C)(C)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"490.0";"nM";"6.31";"";"353513";"UO_0000065";"19.33";"0.36";"3.04";"8.90";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"490.0"
"CHEMBL3965485";"";"None";"340.39";"0";"1.08";"BDBM198564";"O=C([C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)N1CC(O)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353542";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3963994";"";"None";"343.39";"0";"2.86";"BDBM198579";"N#Cc1ccc(N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353557";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3943928";"";"None";"399.24";"0";"3.21";"BDBM198587";"FC(F)(Br)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"353565";"UO_0000065";"19.75";"0.45";"4.68";"11.12";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"13.0"
"CHEMBL5420928";"";"None";"412.40";"0";"2.50";"56-3";"NC(=O)c1nnc(-c2c(F)cccc2F)cc1Nc1ccc(N2CCOCC2)cn1";"IC50";"'<'";"0.06";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383631";"Inhibition of human recombinant TYK2 preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"0.06"
"CHEMBL5394021";"";"None";"397.44";"0";"1.42";"70-2";"CNc1cc(Nc2cccnc2OC)nc2c(C(=O)NCC3(CO)CC3)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5383647";"Inhibition of TYK2 JH1 (unknown origin) at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 10.0 microM";"";"";"50.0"
"CHEMBL5409126";"";"None";"406.49";"0";"3.83";"91-3";"CO[C@@]1(c2cc(C)cc(-n3cc(C4CC4)c4cnc(NC(C)=O)cc43)n2)CCOC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383685";"Inhibition of TYK2 JH1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL365286";"GW549034X";"None";"229.24";"0";"1.69";"GW549034X";"CCn1c(-c2nonc2N)nc2ccccc21";"Inhibition";"'='";"-0.21";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.21"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"23.91";"0.44";"5.93";"8.40";"0";"CHEMBL1632944";"Inhibition of Tyk2 by solution phase kinase assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1629452";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";"";"34.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"26";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.30";"0.32";"4.96";"7.17";"1";"CHEMBL5245530";"Inhibition of recombinant TYK2 (unknown origin) in the presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"116.0"
"CHEMBL3648436";"";"None";"337.40";"0";"3.52";"BDBM107145";"CC(=O)SCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"226455";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"10000.0"
"CHEMBL1553519";"";"None";"299.36";"0";"2.67";"BDBM107130";"CS(=O)(=O)Nc1cccc(-c2cnc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"226440";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL3622131";"";"None";"410.52";"0";"3.16";"12";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NCCCOC)nc21";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"15.01";"0.28";"3.00";"7.98";"0";"CHEMBL3625477";"Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621098";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"690.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"12.4";"nM";"7.91";"";"";"UO_0000065";"25.31";"0.47";"6.37";"8.89";"1";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"12.4"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"EUB0000626a";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.30";"0.32";"4.96";"7.17";"0";"CHEMBL5212897";"Selectivity interaction (Radioactive biochemical assays (Millipore and Galapagos N.V.)) EUB0000626a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity Comments: Flow Cytometry (JAK1-JAK3 involved, STAT6 phosphorylation induced by IL-2 in NK-92 cells): IC50 = 347 nM, PMID: 24006460; Flow Cytometry (JAK1-TYK2 involved, STAT1 phosphorylation induced by IFN-aB2 in U2OS cells): IC50 =  468 nM, PMID: 24006460; | Selectivity number of off-targets = 4.0 None | Selectivity number of targets = 175.0 None | Selectivity Remarks: Screened at 1 ÂµM (in vitro) | Selectivity Source Knowledge: https://doi.org/10.4049/jimmunol.1201348";"";"";"116.0"
"CHEMBL514409";"HESPERADIN";"None";"516.67";"2";"5.37";"7";"CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2";"Kd";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"13.79";"0.26";"1.75";"7.87";"0";"CHEMBL988917";"Binding affinity to human TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151712";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";"";"75.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"4379.0";"nM";"5.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445887";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine GM-CSF, JAK2, pSTAT5 in mouse monocytes)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Monocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308582";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"4379.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"EUB0001543a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.96";"0.43";"7.97";"7.13";"0";"CHEMBL5446216";"Affinity Biochemical interaction: (HTRF assay (TYK2, JH2 domain with 1 mM ATP)) EUB0001543a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Allosteric inhibitor | Protein family: Protein Kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5446079";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Biochemical Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00444";"";"";"0.2"
"CHEMBL4453441";"";"None";"440.47";"0";"2.43";"6c";"CNc1cc(Nc2cccn(-c3ccc(C#N)cc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"14.92";"0.27";"4.14";"5.09";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"268.0"
"CHEMBL3954249";"";"None";"391.87";"0";"3.51";"BDBM198580";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]cc(Cl)c5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353558";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3948921";"";"None";"284.37";"0";"2.10";"BDBM198532";"CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"353510";"UO_0000065";"23.48";"0.43";"4.58";"9.42";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"210.0"
"CHEMBL5439075";"";"None";"486.62";"1";"5.27";"3";"Cc1cnc2nc1-c1cccc(c1)COC/C=C/COCc1cc(ccc1OCCN1CCCC1)N2";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"14.89";"0.27";"1.97";"10.54";"0";"CHEMBL5380357";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5376015";"1";"Scientific Literature";"RSC Med Chem";"2024";"None";"";"INHIBITOR";"";"0.057"
"CHEMBL5419439";"";"None";"459.59";"0";"4.49";"7";"CN(C)CCN(C)c1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"15.55";"0.29";"2.66";"11.39";"0";"CHEMBL5380357";"Inhibition of human recombinant TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5376015";"1";"Scientific Literature";"RSC Med Chem";"2024";"None";"";"INHIBITOR";"";"0.071"
"CHEMBL3904453";"";"None";"310.41";"0";"2.63";"BDBM198603";"c1cc2c(ncn3nnc([C@H]4CC[C@H](NCC5CC5)CC4)c23)[nH]1";"IC50";"'='";"710.0";"nM";"6.15";"";"353581";"UO_0000065";"19.81";"0.37";"3.52";"8.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"710.0"
"CHEMBL3931368";"";"None";"270.34";"0";"1.85";"BDBM198605";"CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"750.0";"nM";"6.12";"";"353583";"UO_0000065";"22.66";"0.42";"4.27";"8.64";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"750.0"
"CHEMBL5182121";"";"None";"421.41";"0";"3.01";"14a";"O=C1NCc2nc(-c3c(F)cccc3F)nc(Nc3ccc(C4CCNC4=O)cc3)c21";"Ki";"'='";"0.85";"nM";"9.07";"";"";"UO_0000065";"21.52";"0.40";"6.06";"9.45";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.85"
"CHEMBL3896461";"";"None";"354.46";"0";"2.34";"BDBM198474";"OC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"430.0";"nM";"6.37";"";"353452";"UO_0000065";"17.96";"0.33";"4.03";"7.73";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"430.0"
"CHEMBL3962300";"";"None";"328.38";"0";"0.99";"BDBM198563";"O=C(NCCO)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"330.0";"nM";"6.48";"";"353541";"UO_0000065";"19.74";"0.37";"5.49";"5.99";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"330.0"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"7";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"12.21";"0.23";"1.86";"4.04";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"12.6"
"CHEMBL3621515";"";"None";"483.57";"0";"3.74";"25";"CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1C";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3627433";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621099";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"2000.0"
"CHEMBL3613597";"";"None";"495.43";"0";"3.96";"12";"CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1";"Inhibition";"";"";"%";"";"";"Dose-dependent effect";"UO_0000187";"";"";"";"";"0";"CHEMBL3615459";"Inhibition of Tyk2 in human Huh7 cells assessed as reduction of IFNalpha5-induced STAT3 phosphorylation pre-incubated for 30 mins before IFNalpha5 stimulation for 30 mins mins by immunoblotting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Huh-7";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307515";"";"";"";""
"CHEMBL3613597";"";"None";"495.43";"0";"3.96";"12";"CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.15";"0.34";"4.04";"10.16";"0";"CHEMBL3615452";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"10.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"3";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.54";"0.29";"3.39";"6.37";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"27.0"
"CHEMBL5279787";"";"None";"427.85";"0";"4.25";"2";"CCOC(=O)Oc1cccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)n1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"16.90";"0.33";"2.98";"5.63";"0";"CHEMBL5252498";"Inhibition of GST-fused Tyk2 (888 to 1187 residues) (unknown origin) using FITC-AhxKKSRGDYMTMQIG-NH2 peptide as substrate incubated for 60 mins in presence of ATP by Janus kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247683";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"59.0"
"CHEMBL4518706";"PF-00911705";"None";"508.49";"1";"2.53";"EUB0000702";"CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O";"% Control";"'='";"59.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507299";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"59.0"
"CHEMBL4585920";"TP-020n";"None";"520.95";"1";"3.61";"EUB0001079";"Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507302";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"5";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"30.1";"nM";"7.52";"";"";"UO_0000065";"24.55";"0.45";"4.05";"9.04";"0";"CHEMBL3299203";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297690";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"30.1"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"8";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"13.13";"0.25";"3.61";"5.78";"0";"CHEMBL3299203";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297690";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"2600.0"
"CHEMBL223460";"";"None";"466.91";"0";"2.96";"SID103905152";"CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4530740";"BI 1950";"None";"646.51";"2";"5.16";"EUB0000310";"C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507282";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5405274";"";"None";"492.52";"0";"2.50";"26";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@H](OC)C3)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5407138";"";"None";"478.49";"0";"1.70";"28";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NCC3(CO)CC3)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5417888";"";"None";"259.31";"0";"3.54";"Fig 2, Cpd 2";"CNc1ncnc2cc(-c3ccc(F)cc3)sc12";"Kd";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"26.56";"0.52";"3.35";"18.21";"0";"CHEMBL5328003";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as dissociation constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"130.0"
"CHEMBL4560241";"BI 0153";"None";"430.47";"0";"2.14";"EUB0000740";"CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1";"% Control";"'='";"90.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"90.0"
"CHEMBL5427107";"";"None";"440.48";"0";"1.52";"2f";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CC2CC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.01";"nM";"11.00";"";"";"UO_0000065";"25.15";"0.47";"9.48";"7.39";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.01"
"CHEMBL5423859";"";"None";"460.50";"0";"1.97";"32";"CNc1cc(Nc2cccn(-c3cccnc3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.001";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.001"
"CHEMBL5403115";"";"None";"465.49";"1";"1.93";"2m";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cccc(OC)n2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"16.18";"0.30";"5.55";"4.86";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"33.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"2";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"19.59";"0.38";"6.18";"6.03";"1";"CHEMBL5346990";"Inhibition of recombinant epitope tagged TYK2 (unknown origin) (873 to 1187 residues) using peptide as substrate in presence of ATP by homogeneous time-resolved fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"53.0"
"CHEMBL4281348";"";"None";"434.85";"1";"6.50";"18i";"CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1";"Activity";"'='";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4254367";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251622";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"65.0"
"CHEMBL4560241";"BI 0153";"None";"430.47";"0";"2.14";"EUB0000740";"CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1093749";"";"None";"465.53";"0";"3.90";"1";"CNS(=O)(=O)c1ccc(-c2cccc3ncc(-c4cc(OC)c(OC)c(OC)c4)nc23)cc1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"13.30";"0.26";"2.29";"6.22";"0";"CHEMBL1116986";"Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156975";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"640.0"
"CHEMBL4088673";"";"None";"396.47";"0";"2.95";"33";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncc(F)c4)cc23)CC[C@]1(C)N";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"18.22";"0.34";"4.27";"6.49";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"60.0"
"CHEMBL4076794";"";"None";"407.52";"0";"3.43";"11";"COc1cccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"19.44";"0.36";"4.49";"7.36";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"12.0"
"CHEMBL4071806";"";"None";"395.48";"0";"3.56";"14";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(F)c4)cc23)CC[C@]1(C)N";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"19.36";"0.36";"4.10";"7.78";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"22.0"
"CHEMBL4105015";"";"None";"411.94";"0";"4.07";"16";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4Cl)cc23)CC[C@]1(C)N";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"17.79";"0.35";"3.26";"7.44";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"47.0"
"CHEMBL5398372";"";"None";"445.49";"0";"4.41";"36a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C(F)(F)F)cc2)[C@H](C)C1";"IC50";"'='";"788.6";"nM";"6.10";"";"";"UO_0000065";"13.70";"0.26";"1.69";"8.35";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"788.6"
"CHEMBL5086526";"";"None";"395.48";"0";"3.79";"51e";"CCc1cc(O)c(F)cc1-c1cc(N[C@H]2CCCN(C)C2)c2nc(N)ncc2c1";"IC50";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"18.46";"0.34";"3.51";"8.36";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.3"
"CHEMBL4530401";"MRL-SYKi-NC";"None";"505.56";"2";"6.37";"EUB0000704";"Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507285";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL223460";"";"None";"466.91";"0";"2.96";"18d";"CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL915372";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142994";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";"";"10.0"
"CHEMBL4078799";"";"None";"391.44";"0";"2.23";"18";"Cn1cc(-c2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc2)cn1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"24.78";"0.46";"7.47";"7.84";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.2"
"CHEMBL4089118";"";"None";"409.37";"0";"2.42";"21";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc([C@H](O)C(F)(F)F)cc2)n1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"22.96";"0.44";"6.98";"7.45";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.4"
"CHEMBL4076473";"";"None";"414.83";"0";"3.17";"32";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2cc(F)c3nccc(Cl)c3c2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"19.09";"0.37";"4.75";"6.66";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"12.0"
"CHEMBL1976093";"";"None";"419.51";"0";"3.99";"SID103904757";"CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1970522";"";"None";"326.38";"0";"3.29";"SID103905209";"COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL458997";"";"None";"468.95";"0";"3.82";"SID103904601";"CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5180050";"";"None";"434.45";"0";"4.25";"30";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCCC4)cc3)c21";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"16.02";"0.30";"2.71";"9.36";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.11"
"CHEMBL1985406";"";"None";"315.32";"0";"4.25";"SID103905036";"CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1990821";"";"None";"427.54";"1";"6.78";"SID103905170";"Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1989646";"";"None";"304.36";"0";"2.76";"SID103904483";"Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1";"Ki";"'='";"630.96";"nM";"6.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.2"
"CHEMBL1682357";"";"None";"275.31";"0";"3.81";"SID103904525";"c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL583144";"";"None";"271.13";"0";"3.44";"SID103905309";"O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL260135";"";"None";"287.33";"0";"3.27";"SID103905492";"Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL220241";"GSK-269962A";"None";"570.61";"2";"3.84";"SID103905674";"CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1999496";"";"None";"342.44";"0";"4.64";"SID103904958";"Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1987359";"";"None";"355.44";"0";"2.23";"SID103905554";"CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL495727";"AT-9283";"2.0";"381.44";"0";"2.07";"26; AT-9283";"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.18";"0.38";"5.63";"6.94";"0";"CHEMBL5364815";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH1 (886 to 1187 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.02"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"Fedratinib";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"IC50";"'='";"200.8";"nM";"6.70";"";"";"UO_0000065";"12.76";"0.25";"1.88";"6.17";"0";"CHEMBL5385206";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380863";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.8"
"CHEMBL5181582";"";"None";"401.42";"0";"2.79";"17";"O=C(Nc1nc2cccc(C3=CC[C@H](NC(=O)[C@@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"17.71";"0.33";"4.32";"8.04";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"78.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"2";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"26.75";"0.50";"6.82";"9.40";"1";"CHEMBL5150284";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149965";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"4.4"
"CHEMBL3137308";"PEFICITINIB";"4.0";"326.40";"0";"2.01";"11";"NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.49";"0.47";"6.31";"8.00";"1";"CHEMBL5150284";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149965";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"4.8"
"CHEMBL3960523";"";"None";"342.42";"0";"3.47";"BDBM255043";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CF)CC2)CN1C1CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"444049";"UO_0000065";"20.32";"0.38";"3.49";"13.32";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"110.0"
"CHEMBL3960910";"";"None";"356.43";"0";"3.46";"BDBM198413";"N#Cc1ccc(CN2CCC(c3ncn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"290.0";"nM";"6.54";"";"353391";"UO_0000065";"18.34";"0.33";"3.08";"8.95";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"290.0"
"CHEMBL3934943";"";"None";"398.42";"0";"3.59";"BDBM198423";"FC(F)Oc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353401";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3975255";"";"None";"414.52";"0";"3.34";"BDBM198429";"CN(CCC#N)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353407";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3900738";"";"None";"425.42";"0";"3.88";"BDBM198446";"N#Cc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1C(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353424";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3902123";"";"None";"281.32";"0";"1.31";"BDBM198449";"N#CCN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353427";"UO_0000065";"24.36";"0.45";"5.54";"7.98";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL5422938";"";"None";"412.52";"0";"3.54";"A8";"C=CS(=O)(=O)NCc1ccc(Nc2ncc(C)c(-c3cnn(C(C)C)c3)n2)cc1";"IC50";"'='";"206.0";"nM";"6.69";"";"";"UO_0000065";"16.21";"0.31";"3.15";"6.57";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"206.0"
"CHEMBL5400209";"";"None";"383.42";"0";"2.54";"49-2";"Cn1cc(-c2cn3ncnc3c(-c3ccn([C@]4(CC#N)C[C@H](C#N)C4)c3)n2)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"20.48";"0.37";"5.31";"6.93";"0";"CHEMBL5383624";"Inhibition of TYK2 (unknown origin) using ULight - JAK (Tyr1023) substrate incubated for 60 mins in presence of ATP by envision plate reader based analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.014"
"CHEMBL5396851";"";"None";"489.55";"0";"3.20";"92-3";"[2H]C([2H])([2H])NC(=O)c1nnc2cc1Nc1cc(cc(-c3ccn(C)n3)c1OC)CCOCc1cccc(n1)N2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383685";"Inhibition of TYK2 JH1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL4237788";"";"None";"423.48";"0";"1.07";"10d";"COCCn1cc(-c2nn(CC3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL5407231";"";"None";"487.51";"0";"2.68";"70-3";"CNc1cc(Nc2cccn(C3CC(F)(F)C3)c2=O)nc2c(C(=O)N[C@@H]3CCC[C@@H](O)C3)cnn12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL607535";"MEISOINDIGO";"None";"276.30";"0";"2.53";"Meisoindigo";"CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21";"Activity";"'='";"77.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4806248";"Inhibition of DNA-tagged human TYK2 JH1 catalytic domain assessed as percent of control at 50000 nM by qPCR analysis relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4804284";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 50000.0 nM";"";"";"77.0"
"CHEMBL1825138";"";"None";"450.35";"1";"5.04";"SID103905247";"CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL514499";"GW843682X";"None";"477.46";"0";"4.80";"SID103905429";"COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4585272";"";"None";"416.45";"0";"1.95";"6g";"CNc1cc(Nc2cccn(-c3ccncc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.29";"nM";"9.54";"";"";"UO_0000065";"22.90";"0.42";"7.59";"8.07";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.29"
"CHEMBL4453441";"";"None";"440.47";"0";"2.43";"6c";"CNc1cc(Nc2cccn(-c3ccc(C#N)cc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"16.00";"0.29";"4.62";"5.46";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"90.0"
"CHEMBL4441840";"";"None";"452.49";"0";"3.53";"24";"CCNC(=O)c1cccc(Nc2cc(Nc3cc(C)c(F)cn3)ncc2C(=O)NC)c1OC";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"14.48";"0.27";"3.02";"5.59";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"280.0"
"CHEMBL3918854";"";"None";"416.41";"0";"3.88";"BDBM198229";"FC(F)(F)Oc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353211";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3934580";"";"None";"333.42";"0";"1.92";"BDBM198270";"CS(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"353250";"UO_0000065";"22.06";"0.44";"5.44";"7.91";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"44.0"
"CHEMBL3913397";"";"None";"371.45";"0";"3.92";"BDBM198325";"Cc1cc(C#N)ccc1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"353303";"UO_0000065";"18.73";"0.34";"3.04";"7.35";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL3906263";"";"None";"360.46";"0";"3.46";"BDBM198330";"c1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"180.0";"nM";"6.75";"";"353308";"UO_0000065";"18.71";"0.34";"3.28";"9.51";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"180.0"
"CHEMBL3940483";"";"None";"384.45";"0";"2.93";"BDBM198421";"c1cnc2cc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)ccc2n1";"IC50";"'>'";"1000.0";"nM";"";"";"353399";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4585920";"TP-020n";"None";"520.95";"1";"3.61";"EUB0001079a";"Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5477877";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001079a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/chemProbes#!downloadview/TP-020";"";"";"100.0"
"CHEMBL4249310";"";"None";"338.38";"0";"0.77";"11a";"C=CC(=O)N1CCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"'='";"1419.7";"nM";"5.85";"";"";"UO_0000065";"17.28";"0.32";"5.08";"5.43";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"1419.7"
"CHEMBL4516843";"BAY-207";"None";"477.37";"1";"5.10";"EUB0000548";"NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507265";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3920329";"";"None";"380.37";"0";"2.95";"BDBM198576";"O=C(CC(F)(F)F)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"530.0";"nM";"6.28";"";"353554";"UO_0000065";"16.50";"0.32";"3.33";"7.13";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"530.0"
"CHEMBL3927682";"";"None";"452.87";"0";"3.71";"BDBM198577";"Cc1c(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)nn1CC(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353555";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3940316";"";"None";"371.45";"0";"2.90";"BDBM198578";"N#Cc1ccc(CCN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353556";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4114436";"";"None";"354.46";"0";"2.34";"BDBM198468";"OC[C@H]1CCCN1C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353446";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4516611";"BTZO-1";"None";"240.29";"0";"2.72";"EUB0000301";"O=c1nc(-c2ccccn2)sc2ccccc12";"% Control";"'='";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507329";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"98.0"
"CHEMBL223360";"LINIFANIB";"3.0";"375.41";"0";"4.90";"ABT-869";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL5408759";"";"None";"384.46";"0";"2.83";"7";"CN(C)S(=O)(=O)c1cccc(-c2c[nH]c3cnc(NC(=O)C4CC4)cc23)c1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"16.44";"0.32";"3.49";"6.64";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.48"
"CHEMBL5425395";"";"None";"416.43";"0";"3.79";"17";"CO[C@@]1(c2cc(C(F)F)cc(-c3cn(C)c4cnc(NC(C)=O)cc34)n2)CCOC1";"EC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"17.77";"0.34";"3.61";"9.45";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.04"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"35.5";"nM";"7.45";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4685312";"Inhibition of recombinant human N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680201";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.5833 hr";"INHIBITOR";"";"35.5"
"CHEMBL4435047";"";"None";"434.44";"0";"2.09";"6j";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"313.0";"nM";"6.50";"";"";"UO_0000065";"14.97";"0.28";"4.41";"5.50";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"313.0"
"CHEMBL4630643";"BAY-448";"None";"458.46";"0";"2.78";"EUB0000333";"Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507269";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4455357";"TP-020";"None";"654.02";"2";"5.45";"EUB0000315";"Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% Control";"'='";"90.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507302";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"90.0"
"CHEMBL3137331";"DEFACTINIB";"2.0";"510.50";"1";"2.40";"EUB0000138";"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1";"% Control";"'='";"27.0";"%";"";"";"Slightly Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507299";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"27.0"
"CHEMBL3577885";"PF-05105679";"1.0";"428.46";"1";"5.48";"EUB0000304";"C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1";"% Control";"'='";"92.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507296";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"92.0"
"CHEMBL4443010";"";"None";"431.46";"0";"1.66";"6l";"CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.091";"nM";"10.04";"";"";"UO_0000065";"23.27";"0.43";"8.38";"7.66";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.091"
"CHEMBL4434711";"";"None";"473.54";"0";"2.79";"6d";"CNc1cc(Nc2cccn(-c3ccc(C(C)(C)O)cc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"14.69";"0.27";"4.16";"5.54";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"111.0"
"CHEMBL4438107";"";"None";"418.46";"0";"2.20";"6n";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC(C)C)cnc12";"Ki";"'='";"153.0";"nM";"6.82";"";"";"UO_0000065";"16.29";"0.30";"4.62";"5.76";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"153.0"
"CHEMBL5190418";"";"None";"578.62";"1";"3.56";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)c(F)c2)c1OC";"Tm";"'='";"66.68";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"66.68"
"CHEMBL5200056";"";"None";"578.64";"1";"3.02";"29";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@@H]3COCCO3)cc2)c1OC";"Tm";"'='";"62.88";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"62.88"
"CHEMBL5198448";"";"None";"561.62";"1";"2.82";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)nc2)c1OC";"Tm";"'='";"57.86";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"57.86"
"CHEMBL5175777";"";"None";"566.68";"1";"2.85";"19";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)NC2CCC(C(=O)N3CCCC3)CC2)c1OC";"Tm";"'='";"54.11";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"54.11"
"CHEMBL5180664";"";"None";"562.65";"1";"3.67";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N(CC)CC)cc2)c1OC";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"16.10";"0.30";"5.34";"5.83";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"0.98"
"CHEMBL5209315";"";"None";"569.64";"1";"4.22";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.88";"0.29";"4.78";"5.98";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.0"
"CHEMBL5200056";"";"None";"578.64";"1";"3.02";"29";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@@H]3COCCO3)cc2)c1OC";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.42";"0.27";"5.28";"5.04";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"5.0"
"CHEMBL206834";"BAFETINIB";"2.0";"576.63";"2";"5.39";"Bafetinib";"Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL296468";"BMS-387032";"1.0";"380.54";"0";"3.66";"BMS-387032/SNS-032";"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL14762";"SELICICLIB";"2.0";"354.46";"0";"3.20";"Roscovitine/CYC-202";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL440084";"SB-431542";"None";"384.40";"0";"3.63";"SB-431542";"NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL1834184";"BI 99179";"None";"391.47";"0";"4.15";"EUB0000294";"CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1";"% Control";"'='";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507280";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"83.0"
"CHEMBL4546802";"BAY-4900";"None";"437.24";"1";"5.07";"EUB0000709";"Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21";"% Control";"'='";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507274";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"81.0"
"CHEMBL3799292";"(R)-9s";"None";"300.75";"0";"2.20";"EUB0000300";"C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507301";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL101253";"VATALANIB";"3.0";"346.82";"1";"5.01";"Vatalanib";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL939";"GEFITINIB";"4.0";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4644578";"";"None";"426.46";"0";"0.65";"15";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(CCO)c4)ncc3F)C[C@]12NC(=O)[C@@H]1C[C@H]1C#N";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"17.43";"0.33";"6.78";"5.63";"0";"CHEMBL4620435";"Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"37.0"
"CHEMBL4104658";"";"None";"525.66";"1";"4.92";"8";"C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C";"Inhibition";"'='";"14.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4053912";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052618";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";"";"";"";"14.0"
"CHEMBL3301625";"SPEBRUTINIB";"2.0";"423.45";"0";"4.25";"Spebrutinib";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";""
"CHEMBL2138625";"";"None";"507.01";"1";"4.67";"AV-412";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4472802";"";"None";"482.57";"0";"2.56";"36";"CNC(=O)c1cnc(Nc2ccc(N3CCOCC3)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"15.00";"0.29";"4.68";"5.76";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.058"
"CHEMBL483748";"GSK-953913A";"None";"390.46";"0";"4.13";"GSK953913A";"NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1";"Inhibition";"'='";"-3.96";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.96"
"CHEMBL514162";"GW852849X";"None";"443.91";"0";"4.44";"GW852849X";"COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"2.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.41"
"CHEMBL4557190";"";"None";"462.49";"0";"3.58";"38";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.13";"0.32";"4.34";"6.66";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"12.0"
"CHEMBL3685796";"MRL-SYKi";"None";"452.58";"1";"5.06";"EUB0000714";"Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507285";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL4526341";"A-108";"None";"504.47";"2";"5.04";"EUB0000736";"Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1";"% Control";"'='";"92.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507257";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"92.0"
"CHEMBL4552370";"";"None";"438.51";"0";"2.70";"15";"CCNC(=O)c1ccc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"17.61";"0.33";"5.02";"8.54";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"19.0"
"CHEMBL4435302";"";"None";"405.46";"0";"1.67";"9";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@H]4C[C@@H]3CN4C(=O)CC#N)n2)cc1";"IC50";"'='";"2690.0";"nM";"5.57";"";"";"UO_0000065";"13.74";"0.25";"3.90";"4.88";"0";"CHEMBL4411530";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using ATP at its Km level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"2690.0"
"CHEMBL4458435";"";"None";"389.41";"0";"1.79";"23; PF-06700841";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"Inhibition";"'='";"101.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4411549";"Inhibition of N-terminal GST tagged human TYK2 (871 to 1187 end residues) catalytic domain expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"101.0"
"CHEMBL101253";"VATALANIB";"3.0";"346.82";"1";"5.01";"SID103905548";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4550335";"";"None";"332.77";"0";"3.99";"12q";"CC(Oc1cc(-c2cn[nH]c2)cnc1N)c1cc(F)ccc1Cl";"IC50";"'='";"1453.0";"nM";"5.84";"";"";"UO_0000065";"17.54";"0.35";"1.85";"7.60";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"1.453"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1245016";"Binding affinity to TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL4294156";"";"None";"330.34";"0";"2.42";"Yfq75";"COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1";"Inhibition";"'='";"-4.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4267277";"Inhibition of human N-terminal GST-tagged TYK2 catalytic domain (871 to 1187 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265907";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"-4.4"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"% of inhibition";"'='";"98.0";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5479495";"Selectivity interaction (Kinase panel (Carna Biosciences)) EUB0001542aTs TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 157.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, conc. ATP = 1 mM) | Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"98.0"
"CHEMBL4546802";"BAY-4900";"None";"437.24";"1";"5.07";"EUB0000709";"Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21";"% Control";"'='";"85.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507274";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"85.0"
"CHEMBL5076598";"";"None";"323.40";"0";"2.27";"17";"Cn1cc(Nc2ncc3cccc(NC4CCNCC4)c3n2)cn1";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"22.26";"0.41";"4.93";"9.03";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.2"
"CHEMBL5084913";"";"None";"356.40";"0";"2.71";"46c";"CCc1cc(O)c(F)cc1-c1cc(N(C)CCO)c2nc(N)ncc2c1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"18.52";"0.35";"3.89";"6.91";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.6"
"CHEMBL189584";"PD-173074";"None";"523.68";"2";"5.16";"EUB0000699a";"CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5474369";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000699a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 6.0 None | Selectivity number of targets = 317.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(Kin.Dom.2)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20055/";"";"";"100.0"
"CHEMBL3943994";"";"None";"438.56";"0";"3.07";"BDBM198306";"CS(=O)(=O)c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"8.7";"nM";"8.06";"";"353284";"UO_0000065";"18.38";"0.36";"4.99";"7.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"8.7"
"CHEMBL3980241";"";"None";"340.43";"0";"1.95";"BDBM198312";"O[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"100.0";"nM";"7.00";"";"353290";"UO_0000065";"20.56";"0.38";"5.05";"8.50";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL5424640";"";"None";"464.46";"0";"1.72";"14";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3C[C@H]3OC)cnn12";"Kd";"'='";"0.088";"nM";"10.06";"";"";"UO_0000065";"21.65";"0.40";"8.34";"7.89";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.088"
"CHEMBL5419398";"";"None";"490.50";"0";"2.11";"25";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NC3CC4(COC4)C3)cnn12";"Kd";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"19.04";"0.35";"7.23";"7.33";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.46"
"CHEMBL5427850";"";"None";"464.49";"1";"1.87";"37";"CNc1cc(Nc2cccn(-c3nc(C)co3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL5396334";"";"None";"481.51";"0";"2.11";"19";"[2H]C([2H])([2H])O[C@@H]1CC[C@H]1NC(=O)c1cnn2c(NC)cc(Nc3cccn(-c4ncccc4F)c3=O)nc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"16.48";"0.31";"5.78";"6.19";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL5423799";"";"None";"464.46";"0";"1.45";"21";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3O)cnn12";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"13.98";"0.26";"5.04";"4.69";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"320.0"
"CHEMBL5422616";"";"None";"460.50";"0";"1.97";"30; TAK-279";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"17.75";"0.33";"6.20";"6.41";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"6.7"
"CHEMBL5424640";"";"None";"464.46";"0";"1.72";"14";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3C[C@H]3OC)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5327937";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level at 50 nM relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 50.0 nM";"INHIBITOR";"";"50.0"
"CHEMBL5419398";"";"None";"490.50";"0";"2.11";"25";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NC3CC4(COC4)C3)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5327937";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level at 50 nM relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 50.0 nM";"";"";"50.0"
"CHEMBL477989";"SB590885";"None";"453.55";"0";"4.87";"EUB0000655a";"CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5473112";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000655a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 13.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20023/results";"";"";"100.0"
"CHEMBL5187505";"";"None";"403.43";"0";"2.88";"21";"O=C(Nc1nc2cccc([C@H]3CC[C@@H](NC(=O)[C@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"455.0";"nM";"6.34";"";"";"UO_0000065";"15.72";"0.30";"3.46";"7.18";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"455.0"
"CHEMBL5182980";"";"None";"356.35";"0";"4.15";"4";"N#Cc1ccc(Nc2ccc3[nH]nc(-c4ccncc4)c3c2)c([N+](=O)[O-])c1";"Inhibition";"'='";"92.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5157080";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154686";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"92.0"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"pyridone-6";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"26.83";"0.49";"4.31";"13.49";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"0.005"
"CHEMBL5412034";"";"None";"453.46";"1";"2.06";"2i";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"16.77";"0.31";"5.49";"5.22";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"28.0"
"CHEMBL5403572";"";"None";"450.45";"0";"2.72";"4a";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"21.68";"0.40";"6.98";"6.94";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.2"
"CHEMBL5409445";"";"None";"481.47";"1";"2.12";"4d";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(OC)nn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.81";"0.35";"6.88";"5.56";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"1.0"
"CHEMBL5408580";"";"None";"461.53";"0";"2.61";"70-5";"CNc1cc(-c2cnc3n([C@H]4CCOC4)cccc2-3)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL1879463";"DACTOLISIB";"3.0";"469.55";"1";"5.89";"NVP-BEZ235";"Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3906857";"";"None";"357.42";"0";"3.62";"BDBM198328";"N#Cc1ccc(N[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"56.0";"nM";"7.25";"";"353306";"UO_0000065";"20.29";"0.37";"3.63";"7.66";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"56.0"
"CHEMBL3951230";"";"None";"338.44";"0";"3.05";"BDBM198347";"c1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"353325";"UO_0000065";"19.73";"0.38";"3.63";"10.75";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"210.0"
"CHEMBL3651966";"LGH-447";"1.0";"440.47";"1";"5.04";"EUB0001581a";"C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1";"% of control";"'='";"93.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5480288";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001581a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, using TYK2(JH1domain-catalytic)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01275";"";"";"93.0"
"CHEMBL5436690";"";"None";"427.50";"0";"2.97";"87-2";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383668";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IL-2 induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5416227";"";"None";"431.45";"0";"2.79";"90-6";"COc1cc(Nc2cc(NC(C)=O)ncc2-c2ccc(F)cn2)nc(S(C)(=O)=O)c1";"IC50";"'='";"0.026";"nM";"10.59";"";"";"UO_0000065";"24.53";"0.48";"7.80";"8.59";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.026"
"CHEMBL5418587";"";"None";"499.58";"0";"4.11";"92-4";"CNC(=O)c1cnc2cc1Nc1cc(cc(-c3ccn(C)n3)c1OC)CCOCc1nc(ccc1C)N2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383685";"Inhibition of TYK2 JH1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL3977718";"";"None";"400.87";"0";"2.17";"BDBM239953";"Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(C(=O)CC#N)CC4C3)n2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"418600";"UO_0000065";"20.34";"0.40";"5.98";"7.30";"0";"CHEMBL3888836";"Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 Î¼L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886854";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"7.0"
"CHEMBL5404455";"";"None";"448.55";"0";"4.07";"24";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)[C@@H](C)c1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL2204538";"THPP-1";"None";"464.91";"0";"3.06";"EUB0000751";"COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507293";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL5089987";"";"None";"454.56";"0";"2.31";"19";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(CN4CCOCC4)c3)n2)cc1";"IC50";"'='";"276.0";"nM";"6.56";"";"";"UO_0000065";"14.43";"0.28";"4.25";"5.36";"0";"CHEMBL5046599";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"276.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445875";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-6, JAK1/2, pSTAT1 in CD3+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"54.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"185.0";"nM";"6.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445886";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-6, JAK1/2, pSTAT1 in mouse CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"185.0"
"CHEMBL3916717";"SELONSERTIB";"3.0";"445.50";"0";"4.68";"EUB0000695a";"Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1";"% of control";"'='";"73.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5474047";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000695a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 321.0 None | Selectivity Remarks: Screened at 100 nM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01458";"";"";"73.0"
"CHEMBL4538174";"ERKi";"None";"311.35";"0";"2.33";"EUB0000298";"C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1";"% Control";"'='";"97.8";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"97.8"
"CHEMBL4521594";"BAY-1797";"None";"416.89";"0";"3.96";"EUB0000309";"NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1";"% Control";"'='";"67.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507265";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"67.0"
"CHEMBL3973017";"";"None";"432.43";"1";"5.15";"BDBM198310";"Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c(C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353288";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3949040";"";"None";"384.85";"0";"3.78";"BDBM198357";"Fc1cc(Cl)ccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"97.0";"nM";"7.01";"";"353335";"UO_0000065";"18.22";"0.35";"3.23";"11.29";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"97.0"
"CHEMBL3912419";"";"None";"374.49";"0";"3.71";"BDBM198373";"c1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"99.0";"nM";"7.00";"";"353351";"UO_0000065";"18.70";"0.34";"3.29";"9.88";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"99.0"
"CHEMBL3948691";"";"None";"364.45";"0";"3.57";"BDBM198381";"Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)o1";"IC50";"'='";"16.0";"nM";"7.80";"";"353359";"UO_0000065";"21.39";"0.39";"4.23";"9.28";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"16.0"
"CHEMBL3964133";"";"None";"382.43";"0";"2.73";"BDBM198445";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C#N";"IC50";"'>'";"1000.0";"nM";"";"";"353423";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4107757";"";"None";"349.44";"0";"2.72";"BDBM198386";"N#C[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"360.0";"nM";"6.44";"";"353364";"UO_0000065";"18.44";"0.34";"3.72";"7.50";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"360.0"
"CHEMBL5076068";"";"None";"355.42";"0";"2.92";"51a";"CCc1cc(O)c(F)cc1-c1cc(NCCNC)c2nc(N)ncc2c1";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"18.01";"0.34";"3.48";"6.66";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.4"
"CHEMBL4530740";"BI 1950";"None";"646.51";"2";"5.16";"EUB0000310";"C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507282";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4516611";"BTZO-1";"None";"240.29";"0";"2.72";"EUB0000301";"O=c1nc(-c2ccccn2)sc2ccccc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507329";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1682546";"";"None";"306.39";"0";"4.30";"SID103904545";"c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4080797";"";"None";"408.51";"0";"2.82";"35";"COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1";"Activity";"'='";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4054938";"Inhibition of TYK2 (unknown origin) assessed as residual activity at 50 nM by KINOMEscan assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"50.0"
"CHEMBL4541547";"";"None";"379.42";"0";"2.15";"11b'";"C=CC(=O)Nc1ccc(CNc2cc(Nc3cnn(CCO)c3)ncn2)cc1";"IC50";"'='";"2175.0";"nM";"5.66";"";"";"UO_0000065";"14.92";"0.28";"3.51";"4.84";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"2175.0"
"CHEMBL4525246";"";"None";"364.41";"0";"2.57";"15c";"COCCn1cc(Nc2cc(NCc3cccc(NC#N)c3)ncn2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL5416410";"";"None";"506.03";"0";"3.31";"Dasatinib";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3950399";"";"None";"381.48";"0";"2.08";"BDBM198464";"NC(=O)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"640.0";"nM";"6.19";"";"353442";"UO_0000065";"16.24";"0.30";"4.11";"5.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"640.0"
"CHEMBL3926516";"";"None";"420.49";"0";"3.53";"BDBM198525";"Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)COC2)cc1";"IC50";"'='";"430.0";"nM";"6.37";"";"353503";"UO_0000065";"15.14";"0.28";"2.84";"7.95";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"430.0"
"CHEMBL3959692";"";"None";"418.52";"0";"4.69";"BDBM198527";"Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)CCC2)cc1";"IC50";"'='";"750.0";"nM";"6.12";"";"353505";"UO_0000065";"14.63";"0.27";"1.43";"8.64";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"750.0"
"CHEMBL3972353";"";"None";"402.37";"0";"3.67";"BDBM198545";"FC(F)(F)C(F)(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"350.0";"nM";"6.46";"";"353523";"UO_0000065";"16.04";"0.31";"2.79";"9.11";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"350.0"
"CHEMBL3907774";"";"None";"359.46";"0";"2.46";"BDBM198569";"O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CC1";"IC50";"'='";"260.0";"nM";"6.58";"";"353547";"UO_0000065";"18.32";"0.36";"4.13";"7.08";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"260.0"
"CHEMBL3956945";"";"None";"394.40";"0";"2.49";"BDBM198632";"OC1(C(F)(F)F)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"370.0";"nM";"6.43";"";"353610";"UO_0000065";"16.31";"0.31";"3.94";"7.81";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"370.0"
"CHEMBL3985220";"";"None";"278.32";"0";"2.71";"BDBM198641";"N#CC=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"353619";"UO_0000065";"26.83";"0.49";"4.76";"9.04";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"34.0"
"CHEMBL1614705";"";"None";"415.86";"0";"3.02";"SID103905593";"O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"EUB0001487a";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"% of inhibition";"'='";"71.0";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5479456";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001487a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20107/results";"";"";"71.0"
"CHEMBL417804";"";"None";"445.50";"0";"4.87";"SB-251527";"COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"-4.38";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.38"
"CHEMBL3589164";"";"None";"468.34";"0";"4.87";"1";"NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"16.03";"0.32";"2.64";"8.49";"0";"CHEMBL3592852";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588791";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"31.0"
"CHEMBL3937326";"";"None";"400.41";"0";"4.41";"BDBM198453";"Fc1cc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc(F)c1F";"IC50";"'>'";"1000.0";"nM";"";"";"353431";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL5423715";"";"None";"437.52";"0";"2.91";"13";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)C([2H])([2H])c1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5396254";"";"None";"460.53";"0";"4.23";"87-3";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"Kd";"'<='";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL5396851";"";"None";"489.55";"0";"3.20";"92-3";"[2H]C([2H])([2H])NC(=O)c1nnc2cc1Nc1cc(cc(-c3ccn(C)n3)c1OC)CCOCc1cccc(n1)N2";"Kd";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL522892";"DOVITINIB";"3.0";"392.44";"0";"2.54";"SID103904684";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL1983111";"";"None";"474.49";"0";"4.06";"SID103904739";"CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12";"Ki";"'='";"12.59";"nM";"7.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.9"
"CHEMBL5423027";"";"None";"325.40";"0";"3.07";"5";"Cc1cc(Nc2ncc(C)c(-c3cnn(CCC#N)c3)n2)sn1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"27.12";"0.52";"5.75";"9.56";"0";"CHEMBL5334094";"Inhibition of TYK2 (unknown origin) incubated for 45 to 120 mins in presence of ATP by Kinase-Glo luminescent assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331110";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME_Lower = 45.0 min | TIME_Upper = 120.0 min";"INHIBITOR";"";"1.5"
"CHEMBL5415543";"";"None";"554.61";"1";"3.47";"XL-12";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(NC(=O)c4ccc(N(C)C)cc4)c4c3OCO4)c3c(N)ncnc32)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5330443";"Inhibition of TYK2 (unknown origin) using kinetic substrate in presence of ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5329199";"1";"Scientific Literature";"Bioorg Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL1969664";"AZD-1080";"1.0";"334.38";"0";"2.64";"SID103905163";"N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4091991";"";"None";"524.60";"2";"5.01";"EUB0000045b";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5469117";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000045b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 4.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20332/";"";"";"100.0"
"CHEMBL296586";"KENPAULLONE";"None";"327.18";"0";"4.09";"SID103905487";"O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3985603";"";"None";"435.45";"0";"2.49";"BDBM198633";"O=C(NCC(F)(F)F)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"580.0";"nM";"6.24";"";"353611";"UO_0000065";"14.32";"0.27";"3.75";"6.84";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"580.0"
"CHEMBL3902333";"";"None";"266.31";"0";"2.40";"BDBM198637";"N#C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"410.0";"nM";"6.39";"";"353615";"UO_0000065";"23.98";"0.44";"3.99";"7.73";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"410.0"
"CHEMBL2029988";"CEP-32496";"2.0";"517.46";"2";"5.91";"CEP-32496";"COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1908360";"EVEROLIMUS";"4.0";"958.24";"3";"6.20";"Certican";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1236962";"OMIPALISIB";"2.0";"505.51";"1";"4.84";"Omipalisib";"COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2079588";"TELATINIB";"2.0";"409.83";"0";"3.95";"Telatinib";"CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3924572";"";"None";"462.40";"0";"4.22";"BDBM198618";"O=C(CC(F)(F)F)N(CC(F)(F)F)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"360.0";"nM";"6.44";"";"353596";"UO_0000065";"13.94";"0.28";"2.22";"8.14";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"360.0"
"CHEMBL3952261";"";"None";"419.41";"0";"3.18";"BDBM198619";"N#CCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(=O)CC(F)(F)F";"IC50";"'='";"320.0";"nM";"6.50";"";"353597";"UO_0000065";"15.49";"0.30";"3.31";"6.31";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"320.0"
"CHEMBL3973453";"";"None";"338.46";"0";"3.37";"BDBM198242";"c1cc2c(ncn3nnc(C4CCN(CC5CCCCC5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353224";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3897131";"";"None";"414.39";"0";"3.64";"BDBM198251";"O=C(c1ccc(C(F)(F)F)cc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353233";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3301606";"SOLCITINIB";"2.0";"389.46";"0";"3.23";"29";"CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"17.07";"0.31";"3.42";"8.35";"0";"CHEMBL5245517";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"225.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3905617";"";"None";"467.62";"0";"4.12";"BDBM198538";"CC(C)(C)OC(=O)N1CCC(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"710.0";"nM";"6.15";"";"353516";"UO_0000065";"13.15";"0.25";"2.03";"6.12";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"710.0"
"CHEMBL601719";"CRIZOTINIB";"4.0";"450.35";"1";"5.04";"4";"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl";"IC50";"'='";"1269.0";"nM";"5.90";"";"";"UO_0000065";"13.09";"0.27";"0.86";"7.56";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"1.269"
"CHEMBL5077653";"";"None";"313.33";"0";"3.29";"38";"CCc1cc(O)c(F)cc1-c1cc(OC)c2nc(N)ncc2c1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"21.70";"0.40";"3.51";"8.37";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.8"
"CHEMBL5084340";"";"None";"356.40";"0";"3.08";"46d";"CCc1cc(O)c(F)cc1-c1cc(NCCCO)c2nc(N)ncc2c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.64";"0.37";"3.92";"6.71";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL5078647";"";"None";"356.40";"0";"3.08";"46e";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2nc(N)ncc2c1";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"20.76";"0.39";"4.32";"7.10";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.4"
"CHEMBL5076662";"";"None";"372.40";"0";"2.37";"47";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2[nH]c(N)nc(=O)c2c1";"IC50";"'='";"12589.25";"nM";"4.90";"";"";"UO_0000065";"13.16";"0.25";"2.53";"3.94";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"4.9"
"CHEMBL3917405";"";"None";"518.61";"2";"5.32";"51";"O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO";"Activity";"'='";"4.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3877390";"Inhibition of human TYK2 (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by KINOMEScan assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3877241";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"4.9"
"CHEMBL3917405";"";"None";"518.61";"2";"5.32";"51";"O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.43";"0.29";"2.68";"6.97";"0";"CHEMBL3877407";"Inhibition of human TYK2 (V877 to C1187 residues) expressed in mammalian expression system by KINOMEScan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3877241";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"10.0"
"CHEMBL3894490";"";"None";"407.47";"0";"2.80";"BDBM255037";"COCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"230.0";"nM";"6.64";"";"444043";"UO_0000065";"16.29";"0.31";"3.84";"9.03";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"230.0"
"CHEMBL3934192";"";"None";"396.54";"0";"3.51";"BDBM198509";"OCCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CCCCC1";"IC50";"'='";"620.0";"nM";"6.21";"";"353487";"UO_0000065";"15.65";"0.29";"2.70";"7.54";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"620.0"
"CHEMBL3951710";"";"None";"396.54";"0";"3.36";"BDBM198514";"CC(C)(O)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"940.0";"nM";"6.03";"";"353492";"UO_0000065";"15.20";"0.28";"2.67";"7.32";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"940.0"
"CHEMBL3897648";"";"None";"284.37";"0";"2.19";"BDBM198604";"CN(C)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"800.0";"nM";"6.10";"";"353582";"UO_0000065";"21.44";"0.40";"3.91";"9.82";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"800.0"
"CHEMBL3973343";"";"None";"284.32";"0";"2.34";"BDBM198636";"O/N=C/[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"520.0";"nM";"6.28";"";"353614";"UO_0000065";"22.10";"0.41";"3.94";"6.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"520.0"
"CHEMBL2140408";"AMG-900";"1.0";"503.59";"2";"6.64";"AMG-900";"Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1614707";"MUBRITINIB";"2.0";"468.48";"1";"6.06";"Mubritinib";"FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL564829";"MILCICLIB";"2.0";"460.59";"0";"2.57";"Milciclib";"CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL428690";"ALVOCIDIB";"3.0";"401.85";"0";"3.30";"Alvocidib";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1";"Kd";"'='";"3468.0";"nM";"5.46";"";"Active";"UO_0000065";"13.59";"0.27";"2.16";"5.80";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.87 None";"";"";"3468.0"
"CHEMBL2220486";"LUCITANIB";"2.0";"443.50";"0";"4.42";"Lucitanib";"CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1983268";"ENTRECTINIB";"4.0";"560.65";"2";"5.03";"84";"CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2336325";"VISTUSERTIB";"2.0";"462.55";"0";"2.50";"AZD-2014";"CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2103851";"AMUVATINIB";"2.0";"447.52";"0";"3.30";"Amuvatinib";"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3545083";"RGB-286638";"1.0";"545.64";"1";"2.42";"RGB-286638";"COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5408060";"";"None";"427.44";"0";"1.69";"3c";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2noc(C)n2)c1OC";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"22.44";"0.42";"7.83";"6.06";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.3"
"CHEMBL5403477";"";"None";"441.44";"0";"1.93";"3b";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"16.24";"0.30";"5.19";"4.95";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"76.0"
"CHEMBL5403572";"";"None";"450.45";"0";"2.72";"4a";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"339.0";"nM";"6.47";"";"";"UO_0000065";"14.46";"0.27";"3.75";"4.63";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"339.0"
"CHEMBL4444178";"";"None";"392.46";"0";"1.33";"39";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"22.82";"0.45";"7.56";"6.83";"1";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.3"
"CHEMBL5429461";"";"None";"400.32";"0";"4.28";"24";"O=c1cc(-c2ccccc2)nc2c(-c3cccc([N+](=O)[O-])c3)c(C(F)(F)F)[nH]n12";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"10.74";"0.20";"0.02";"4.61";"0";"CHEMBL5364815";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH1 (886 to 1187 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"50.0"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"37";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"21.36";"0.40";"5.52";"5.75";"1";"CHEMBL5364834";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"15.0"
"CHEMBL4524832";"";"None";"424.44";"0";"2.83";"BMS-cpd 18";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL5225297";"Induction of TYK2 degradation in human Jurkat cells at 10 uM incubated for 24 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM | TIME = 24.0 hr";"DEGRADER";"";""
"CHEMBL300138";"ENZASTAURIN";"3.0";"515.62";"1";"4.93";"LY-317615";"Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5395925";"";"None";"434.52";"0";"3.51";"20";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5439072";"";"None";"436.53";"0";"3.51";"22";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)C([2H])([2H])c1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5414851";"";"None";"464.46";"0";"1.45";"20";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3O)cnn12";"Kd";"'='";"0.007";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.007"
"CHEMBL4291298";"";"None";"378.43";"0";"2.97";"17f";"COc1cc2c(=O)n(C3CCNCC3)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"32.39";"nM";"7.49";"";"";"UO_0000065";"19.79";"0.37";"4.52";"9.23";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"32.39"
"CHEMBL5437653";"";"None";"383.42";"0";"2.54";"49-1";"Cn1cc(-c2cn3ncnc3c(-c3ccn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1";"IC50";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"18.14";"0.33";"4.41";"6.13";"0";"CHEMBL5383624";"Inhibition of TYK2 (unknown origin) using ULight - JAK (Tyr1023) substrate incubated for 60 mins in presence of ATP by envision plate reader based analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.111"
"CHEMBL5433451";"";"None";"409.45";"0";"1.48";"71-1";"CNc1cc(Nc2ccccc2OC)nc2c(C(=O)N[C@@H]3CCN(C)C3=O)cnn12";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"17.94";"0.33";"5.87";"6.51";"0";"CHEMBL5383633";"Inhibition of TYK2 JH2 (unknown origin) by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.045"
"CHEMBL5436959";"";"None";"528.61";"1";"2.03";"84-1";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-n2cc3c(n2)CN(S(C)(=N)=O)C3)c1OC";"Kd";"'='";"0.009";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.009"
"CHEMBL5419627";"";"None";"437.46";"0";"1.62";"82-1";"CNC(=O)c1nnc(NC(=O)N2CCC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"16.61";"0.31";"5.65";"5.22";"0";"CHEMBL5383660";"Inhibition of TYK2 JH2 in human KIT225 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation by AlphaLISA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"54.0"
"CHEMBL5427277";"";"None";"383.43";"0";"2.64";"90-1";"CC(=O)Nc1cc(Nc2cccc(S(C)(=O)=O)n2)c(-c2ccccn2)cn1";"IC50";"'='";"0.016";"nM";"10.80";"";"";"UO_0000065";"28.16";"0.55";"8.16";"9.48";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.016"
"CHEMBL4551587";"";"None";"406.49";"0";"2.17";"13";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@H]4C[C@@H](C3)N4C(=O)C3CC3)n2)cc1";"IC50";"'='";"201.0";"nM";"6.70";"";"";"UO_0000065";"16.47";"0.30";"4.53";"7.40";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"201.0"
"CHEMBL4526032";"";"None";"410.40";"0";"1.88";"21";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)NCC(F)(F)F)n2)cn1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"18.40";"0.36";"5.67";"8.28";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"28.0"
"CHEMBL4458435";"";"None";"389.41";"0";"1.79";"23; PF-06700841";"Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.61";"0.37";"5.85";"9.65";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"23.0"
"CHEMBL5424640";"";"None";"464.46";"0";"1.72";"14";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3C[C@H]3OC)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5427213";"";"None";"484.44";"0";"2.73";"16";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CCC3(F)F)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5418744";"";"None";"478.49";"0";"2.11";"17";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5422880";"";"None";"452.43";"0";"2.04";"12";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3C[C@H]3F)cnn12";"Kd";"'='";"0.073";"nM";"10.14";"";"";"UO_0000065";"22.40";"0.42";"8.10";"8.57";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.073"
"CHEMBL5423799";"";"None";"464.46";"0";"1.45";"21";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3O)cnn12";"Kd";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"21.29";"0.40";"8.44";"7.14";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.13"
"CHEMBL5431732";"";"None";"439.48";"0";"1.15";"47";"CNc1cc(Nc2cccn(C3COC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.006";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.006"
"CHEMBL5398548";"";"None";"464.46";"0";"1.72";"13";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3C[C@@H]3OC)cnn12";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"15.58";"0.29";"5.52";"5.68";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"58.0"
"CHEMBL5414602";"";"None";"478.49";"0";"2.11";"31";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"16.91";"0.32";"5.98";"6.35";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"8.1"
"CHEMBL4225537";"";"None";"523.66";"1";"2.53";"VH-298";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(C#N)CC2)C(C)(C)C)cc1";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL5225297";"Induction of TYK2 degradation in human Jurkat cells at 10 uM incubated for 24 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM | TIME = 24.0 hr";"DEGRADER";"";""
"CHEMBL4585243";"BAY-7598";"None";"505.57";"1";"3.60";"EUB0000728";"O=C(O)[C@H]1[C@H](Cn2nnc3ccccc3c2=O)CC[C@@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507264";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4752561";"";"None";"496.49";"0";"4.53";"EUB0000739";"COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507289";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5186817";"";"None";"437.45";"0";"3.37";"23";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCC(O)CC4)cn3)c21";"Ki";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"22.12";"0.41";"6.31";"10.71";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.21"
"CHEMBL4530401";"MRL-SYKi-NC";"None";"505.56";"2";"6.37";"EUB0000704";"Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507285";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL3617968";"BAY-678";"None";"400.36";"0";"4.11";"EUB0000735";"CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1";"% Control";"'='";"91.3";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507272";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"91.3"
"CHEMBL4458424";"BAY-899";"None";"459.46";"1";"5.12";"EUB0000240";"O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1";"% Control";"'='";"97.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507317";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"97.0"
"CHEMBL2204283";"MSD-M1PAM-NC";"None";"441.54";"0";"2.99";"EUB0000344";"N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507295";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3962269";"";"None";"349.37";"0";"3.63";"BDBM214690";"Cc1cc(Nc2nc([C@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1";"Kd";"'='";"8800.0";"nM";"5.06";"";"312379";"UO_0000065";"14.47";"0.27";"1.43";"5.83";"0";"CHEMBL3887154";"Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at room temperature to generate affinity resins. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific binding. Binding reactions were assembled by combining kinase, liganded affinity beads, and test compounds in 1x binding buffer (20% SeaBlock, 0.17xPBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 100x stocks in DMSO and rapidly diluted into the aqueous environment. DMSO was added to control assays lacking a test compound. Primary screen interactions were performed in polypropylene 384-well plates in a final volume of 34 uL, while Kd determinations were performed in polystyrene 96-well plates in a final volume of 135 uL. The assay plates were incubated at room temperature with shaking for 1 hr, long enough for binding reactions to reach equilibrium, and the affinity beads were washed extensively with wash buffer (1xPBS, 0.05% Tween 20) to remove unbound protein. The beads were then resuspended in elution buffer (1xPBS, 0.05% Tween 20, 2 uM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886191";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"8800.0"
"CHEMBL4282720";"";"None";"459.51";"0";"3.23";"19a";"COc1cc2c(=O)n([C@@H](C(=O)N3CC(C#N)C3)C(C)C)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"5730.0";"nM";"5.24";"";"";"UO_0000065";"11.41";"0.21";"2.01";"4.63";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"5730.0"
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"Tozasertib";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL101253";"VATALANIB";"3.0";"346.82";"1";"5.01";"PTK-787";"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1245017";"Binding affinity to TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240346";"1";"Scientific Literature";"Blood";"2009";"None";"";"";"";"10.0"
"CHEMBL5084861";"";"None";"347.38";"0";"3.49";"19";"COc1cc(-c2ccc(O)cc2)cc2cnc(Nc3cnn(C)c3)nc12";"IC50";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"24.47";"0.45";"5.01";"9.99";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"8.5"
"CHEMBL3114782";"";"None";"342.33";"0";"1.66";"10b";"O=C1C=C(Nc2cccc(OCCNc3ccnc(F)c3)c2)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"10000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690,550, Tofacitinib, Xeljanz";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"26.05";"0.48";"6.60";"9.15";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"7.3"
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL3968872";"";"None";"434.47";"0";"3.36";"BDBM254995";"CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CN(CC#N)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"61.0";"nM";"7.21";"";"444036";"UO_0000065";"16.61";"0.32";"3.85";"9.10";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"61.0"
"CHEMBL4289532";"";"None";"462.43";"0";"3.68";"21";"CC[C@@H](C(=O)NCC(F)(F)F)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"273.4";"nM";"6.56";"";"";"UO_0000065";"14.19";"0.27";"2.88";"6.68";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"273.4"
"CHEMBL5396026";"";"None";"434.52";"0";"3.61";"1";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)Cc1nc(C)nn1-2";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"17.43";"0.32";"3.91";"7.16";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL1965351";"";"None";"418.50";"0";"3.08";"SID103905497";"Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1";"Ki";"'='";"1258.93";"nM";"5.90";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.9"
"CHEMBL306380";"";"None";"281.36";"0";"3.14";"SID103904783";"Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4557026";"ERKi-NC";"None";"312.33";"0";"1.73";"EUB0000700";"C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3337894";"T-26c";"None";"479.51";"0";"3.34";"EUB0000729";"COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1";"% Control";"'='";"79.8";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507300";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"79.8"
"CHEMBL3182621";"AZD-8330";"1.0";"461.23";"0";"1.83";"AZD-8330";"Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1230020";"PLX-4720";"None";"413.83";"0";"3.88";"PLX-4720";"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4442827";"";"None";"449.45";"0";"1.60";"6t";"CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"0.018";"nM";"10.74";"";"";"UO_0000065";"23.91";"0.44";"9.14";"8.19";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.018"
"CHEMBL4442827";"";"None";"449.45";"0";"1.60";"6t";"CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"16.44";"0.31";"5.79";"5.63";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"41.0"
"CHEMBL5188445";"";"None";"443.50";"0";"3.61";"14";"O=C(Nc1nc2cccc([C@@H]3CCC4(CCN(C(=O)[C@@H]5CC5(F)F)CC4)C3)n2n1)C1CC1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"14.08";"0.27";"2.63";"7.84";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"570.0"
"CHEMBL4471290";"";"None";"322.41";"0";"3.56";"13";"CC(C)CCNc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"21.08";"0.39";"3.24";"9.38";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"160.0"
"CHEMBL402108";"GW708893X";"None";"417.90";"1";"5.60";"GW708893X";"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1";"Inhibition";"'='";"-6.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-6.26"
"CHEMBL5407138";"";"None";"478.49";"0";"1.70";"28";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)NCC3(CO)CC3)cnn12";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"14.15";"0.26";"5.07";"4.89";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"170.0"
"CHEMBL5440491";"";"None";"467.53";"0";"1.93";"42";"CNc1cc(Nc2cccn([C@@H]3CCCOC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"17.47";"0.33";"6.24";"6.60";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"6.8"
"CHEMBL506414";"GW684626B";"None";"467.98";"1";"7.53";"GW684626B";"Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1";"Inhibition";"'='";"-0.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.26"
"CHEMBL318892";"";"None";"428.52";"1";"5.16";"SB-236687";"CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1";"Inhibition";"'='";"1.84";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.84"
"CHEMBL1096290";"GSK-1000163A";"None";"395.47";"0";"1.80";"GSK1000163A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21";"Inhibition";"'='";"-0.89";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.89"
"CHEMBL3906070";"";"None";"270.34";"0";"2.40";"BDBM254978";"O=C1NCN(C2CCCCC2)c2c1cnc1[nH]ccc21";"IC50";"'='";"26.0";"nM";"7.58";"";"443986";"UO_0000065";"28.06";"0.52";"5.19";"12.43";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"26.0"
"CHEMBL3911589";"";"None";"443.57";"0";"2.54";"BDBM254988";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)CN1C1CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"444029";"UO_0000065";"15.10";"0.30";"4.16";"7.48";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"200.0"
"CHEMBL3922146";"";"None";"392.51";"0";"2.96";"BDBM255040";"CN(CC#N)C[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"480.0";"nM";"6.32";"";"444046";"UO_0000065";"16.10";"0.30";"3.36";"7.97";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"480.0"
"CHEMBL3906210";"";"None";"312.42";"0";"2.88";"BDBM198534";"CC(C)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"420.0";"nM";"6.38";"";"353512";"UO_0000065";"20.41";"0.38";"3.50";"8.99";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"420.0"
"CHEMBL3973102";"";"None";"399.24";"0";"3.21";"BDBM198586";"FC(F)(Br)CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"760.0";"nM";"6.12";"";"353564";"UO_0000065";"15.33";"0.35";"2.91";"8.63";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"760.0"
"CHEMBL3975399";"";"None";"419.41";"0";"3.18";"BDBM198614";"N#CCC(=O)N(CC(F)(F)F)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"353592";"UO_0000065";"16.42";"0.31";"3.71";"6.69";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"130.0"
"CHEMBL3980041";"";"None";"374.49";"0";"3.85";"BDBM198331";"c1ccc(CCCN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353309";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3896784";"";"None";"390.49";"0";"3.20";"BDBM198385";"OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'='";"44.0";"nM";"7.36";"";"353363";"UO_0000065";"18.84";"0.35";"4.16";"8.07";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"44.0"
"CHEMBL3919034";"";"None";"479.61";"0";"3.19";"BDBM198389";"CN(C)S(=O)(=O)c1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"610.0";"nM";"6.21";"";"353367";"UO_0000065";"12.96";"0.25";"3.02";"6.25";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"610.0"
"CHEMBL3980095";"";"None";"364.43";"0";"3.56";"BDBM198396";"Fc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"353374";"UO_0000065";"18.99";"0.35";"3.36";"9.76";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"120.0"
"CHEMBL3963428";"";"None";"444.46";"0";"3.67";"BDBM198398";"OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F";"IC50";"'='";"270.0";"nM";"6.57";"";"353376";"UO_0000065";"14.78";"0.28";"2.90";"7.21";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"270.0"
"CHEMBL5270781";"";"None";"414.47";"0";"3.27";"rac-47";"CC1CN(c2ccncc2NC(=O)c2ccnn3cc(-c4ccccc4)nc23)CCO1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252064";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247659";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"2.0"
"CHEMBL5401070";"";"None";"367.41";"0";"2.39";"14";"CO[C@@]1(c2cccc(-c3cn(C)c4cnc(NC(N)=O)cc34)n2)CCOC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"22.59";"0.42";"5.91";"7.96";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.005"
"CHEMBL4159366";"";"None";"623.78";"1";"4.44";"20h";"CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCC(C(=O)NCCCCCCCC(=O)NO)CC4)cc3)n2)cc1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"11.43";"0.22";"2.69";"4.30";"0";"CHEMBL4150583";"Inhibition of TYK2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145634";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"74.0"
"CHEMBL4278842";"";"None";"367.36";"0";"2.22";"13b";"COC(=O)Cn1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"18.42";"nM";"7.74";"";"";"UO_0000065";"21.05";"0.39";"5.51";"8.10";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"18.42"
"CHEMBL4174988";"";"None";"494.04";"0";"4.20";"15i";"Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4157317";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152344";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"100.0"
"CHEMBL4174988";"";"None";"494.04";"0";"4.20";"15i";"Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4157318";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4152344";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"100.0"
"CHEMBL3948605";"";"None";"240.31";"0";"3.26";"BDBM198194";"c1cc2c(ncn3cnc(C4CCCCC4)c23)[nH]1";"IC50";"'='";"59.0";"nM";"7.23";"";"351826";"UO_0000065";"30.08";"0.55";"3.97";"15.72";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"59.0"
"CHEMBL2387224";"";"None";"350.20";"0";"3.99";"46";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl";"EC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"18.33";"0.38";"2.43";"9.03";"1";"CHEMBL2421809";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced stat4 phosphorylation pretreated for 20 minutes prior to addition of cytokine by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.38"
"CHEMBL5428659";"";"None";"424.47";"0";"1.27";"71-4";"CCOc1cccc(Nc2cc(NC)n3ncc(C(=O)N[C@@H]4CCN(C)C4=O)c3n2)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.48";"0.33";"6.15";"5.90";"0";"CHEMBL5383650";"Inhibition of TYK2 JH2 in human TF-1 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.038"
"CHEMBL5403297";"";"None";"436.49";"0";"1.98";"92-2";"[2H]C([2H])([2H])n1nnc2c3cc(cc21)CO[C@@H]1CCC[C@H]1NC(=O)c1cnc2c(NC)cc(nn12)N3";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"20.23";"0.37";"6.79";"7.11";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.7"
"CHEMBL5396254";"";"None";"460.53";"0";"4.23";"87-3";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383667";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5415395";"";"None";"426.51";"0";"3.57";"87-1";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383668";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IL-2 induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5424894";"";"None";"382.42";"0";"2.17";"92-1";"CNc1cc2nn3c(cnc13)C(=O)N[C@H](C)COCc1ccc(OC)c(c1)N2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383668";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IL-2 induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL3360353";"";"None";"377.45";"0";"2.58";"BDBM103728";"O=C(Nc1nc2cccc(-c3ccc(CN4CCOCC4)cc3)n2n1)C1CC1";"IC50";"'='";"2096.0";"nM";"5.68";"";"221734";"UO_0000065";"15.04";"0.28";"3.10";"7.91";"0";"CHEMBL3707911";"Inhibition Assay: In vitro inhibition assay using various enzyme.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638964";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"2096.0"
"CHEMBL1650951";"";"None";"526.52";"1";"3.17";"3";"CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1";"IC50";"'='";"1691.0";"nM";"5.77";"";"";"UO_0000065";"10.96";"0.21";"2.60";"5.46";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"1691.0"
"CHEMBL5188094";"";"None";"373.36";"0";"1.96";"6";"O=C(Nc1nc2cccc(C3=CCN(C(=O)C4CC4(F)F)C3)n2n1)C1CC1";"IC50";"'='";"244.0";"nM";"6.61";"";"";"UO_0000065";"17.71";"0.33";"4.65";"8.31";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"244.0"
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"EUB0000262";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"% Control";"'='";"85.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507311";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"85.0"
"CHEMBL2144409";"";"None";"490.57";"0";"4.67";"16";"Cc1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cn1";"Kd";"'<'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3395907";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393060";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"1.0"
"CHEMBL5175927";"";"None";"369.23";"0";"3.34";"22a";"Cc1c(-c2ncnc3[nH]ccc23)nnn1Cc1ccc(Br)cc1";"Inhibition";"'='";"61.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5133089";"Inhibition of TYK2 (unknown origin) at 1 uM by biochemical assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"61.6"
"CHEMBL3896712";"";"None";"332.41";"0";"2.99";"BDBM198208";"c1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1";"IC50";"'='";"2600.0";"nM";"5.58";"";"353190";"UO_0000065";"16.80";"0.31";"2.60";"8.99";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2600.0"
"CHEMBL3953550";"";"None";"357.42";"0";"2.86";"BDBM198226";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"353208";"UO_0000065";"18.94";"0.34";"3.91";"7.88";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"170.0"
"CHEMBL3975158";"";"None";"285.35";"0";"2.53";"BDBM198255";"COC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"353237";"UO_0000065";"24.02";"0.45";"4.32";"10.06";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3958601";"";"None";"407.50";"0";"4.39";"BDBM198278";"O=C(OCc1ccccc1)N1CCC(c2[nH]c(=S)n3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"500.0";"nM";"6.30";"";"353257";"UO_0000065";"15.46";"0.30";"1.91";"8.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"500.0"
"CHEMBL3932581";"";"None";"431.49";"1";"5.27";"BDBM198279";"FC(F)(F)c1ccc(CN2CCC(c3[nH]c(=S)n4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353258";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3965965";"";"None";"351.39";"0";"2.52";"BDBM198344";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1";"IC50";"'='";"200.0";"nM";"6.70";"";"353322";"UO_0000065";"19.06";"0.35";"4.18";"8.93";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL3922180";"";"None";"322.38";"0";"1.71";"BDBM198350";"c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)[nH]n1";"IC50";"'>'";"1000.0";"nM";"";"";"353328";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL1643772";"CRTH2-negative-control";"None";"494.57";"0";"2.45";"EUB0000334";"CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507290";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"83.0"
"CHEMBL4439287";"";"None";"545.65";"2";"5.78";"30";"Cc1ccc(-n2ccc3c(Nc4cccc(NC(=O)c5ccc(NC(=O)/C=C/CN(C)C)cc5)c4)ncnc32)cc1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4345231";"Inhibition of human TYK2 expressed in mammalian expression system assessed as enzyme activity at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342488";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";"";"";"100.0"
"CHEMBL4293619";"";"None";"308.35";"0";"2.15";"10";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3ccccc3)nn12";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"24.31";"0.45";"5.34";"7.70";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.032"
"CHEMBL4291200";"";"None";"442.37";"0";"1.54";"30";"CNc1cc(Nc2c(F)c(F)cc(F)c2F)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"14.75";"0.29";"4.98";"5.27";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.3"
"CHEMBL4282627";"";"None";"350.43";"0";"3.15";"20";"Cc1cc(C)cc(Nc2cc(NC3CCC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"19.86";"0.37";"3.81";"7.15";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.11"
"CHEMBL4247298";"";"None";"586.70";"2";"5.44";"15i";"Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Activity";"'='";"91.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4230997";"Binding affinity to wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229344";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";"";"91.0"
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"25.20";"0.46";"4.25";"9.28";"1";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"19.0"
"CHEMBL91829";"RUBOXISTAURIN";"3.0";"468.56";"0";"3.51";"LY-333531";"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL4444169";"";"None";"418.47";"0";"2.87";"30";"[2H]C([2H])([2H])NC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"50.0"
"CHEMBL278041";"SB-202190";"None";"331.35";"0";"4.65";"SB-202190";"Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL215152";"AZD-1152-HQPA";"-1.0";"507.57";"1";"3.50";"AZD-1152 HQPA";"CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL483321";"CP-724714";"2.0";"469.55";"0";"4.95";"CP-724714";"COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL513909";"BI-2536";"2.0";"521.67";"1";"3.56";"EUB0000169b";"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3218575";"PILARALISIB";"None";"448.53";"0";"4.49";"Pilaralisib-analogue";"Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3813873";"PEXIDARTINIB";"4.0";"417.82";"1";"5.23";"Pexidartinib";"FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL565612";"SOTRASTAURIN";"2.0";"438.49";"0";"2.43";"Sotrastaurin";"CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL300138";"ENZASTAURIN";"3.0";"515.62";"1";"4.93";"EUB0000154b";"Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2364611";"GALUNISERTIB";"2.0";"369.43";"0";"3.51";"Galunisertib";"Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3914503";"";"None";"356.38";"0";"4.49";"9";"COc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1";"IC50";"'='";"102.1";"nM";"6.99";"";"";"UO_0000065";"19.62";"0.35";"2.50";"8.05";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"102.1"
"CHEMBL3907503";"";"None";"253.31";"0";"2.82";"BDBM198640";"C=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"353618";"UO_0000065";"27.32";"0.50";"4.10";"11.76";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"120.0"
"CHEMBL1969102";"";"None";"440.53";"1";"5.89";"SID103904308";"Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1";"Ki";"'='";"501.19";"nM";"6.30";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.3"
"CHEMBL3965217";"";"None";"425.42";"0";"3.88";"BDBM198447";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F";"IC50";"'='";"790.0";"nM";"6.10";"";"353425";"UO_0000065";"14.34";"0.27";"2.22";"7.10";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"790.0"
"CHEMBL3896798";"";"None";"351.41";"0";"2.59";"BDBM198228";"Cc1noc(C)c1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353210";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4112119";"";"None";"342.42";"0";"2.92";"BDBM198288";"F[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"430.0";"nM";"6.37";"";"353266";"UO_0000065";"18.59";"0.35";"3.45";"10.25";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"430.0"
"CHEMBL3972506";"";"None";"316.38";"0";"2.44";"BDBM198300";"FCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"36.0";"nM";"7.44";"";"353278";"UO_0000065";"23.53";"0.44";"5.00";"10.50";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"36.0"
"CHEMBL3956418";"";"None";"364.46";"0";"2.43";"BDBM198391";"c1nc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c[nH]1";"IC50";"'='";"100.0";"nM";"7.00";"";"353369";"UO_0000065";"19.21";"0.35";"4.57";"7.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL3890951";"";"None";"362.39";"0";"2.73";"BDBM198414";"O=C(OCc1ccccc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353392";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL5405538";"";"None";"435.49";"0";"1.80";"71-2";"CNc1cc(Nc2cccc3c2OCCC3)nc2c(C(=O)N[C@@H]3CCN(C)C3=O)cnn12";"IC50";"'<'";"254.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383633";"Inhibition of TYK2 JH2 (unknown origin) by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.254"
"CHEMBL5416592";"";"None";"587.68";"2";"1.70";"84-2";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2noc(CN3CCN(S(C)(=N)=O)CC3)n2)c1OC";"Kd";"'='";"0.008";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.008"
"CHEMBL5407231";"";"None";"487.51";"0";"2.68";"70-3";"CNc1cc(Nc2cccn(C3CC(F)(F)C3)c2=O)nc2c(C(=O)N[C@@H]3CCC[C@@H](O)C3)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5383647";"Inhibition of TYK2 JH1 (unknown origin) at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 10.0 microM";"";"";"50.0"
"CHEMBL5403297";"";"None";"436.49";"0";"1.98";"92-2";"[2H]C([2H])([2H])n1nnc2c3cc(cc21)CO[C@@H]1CCC[C@H]1NC(=O)c1cnc2c(NC)cc(nn12)N3";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL5417355";"";"None";"382.45";"0";"3.25";"90-2";"CC(=O)Nc1cc(Nc2cccc(S(C)(=O)=O)c2)c(-c2ccccn2)cn1";"IC50";"'='";"0.038";"nM";"10.42";"";"";"UO_0000065";"27.25";"0.53";"7.17";"10.31";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.038"
"CHEMBL5398472";"";"None";"382.45";"0";"3.25";"90-4";"CC(=O)Nc1cc(Nc2ccccc2S(C)(=O)=O)c(-c2ccccn2)cn1";"IC50";"'='";"117.0";"nM";"6.93";"";"";"UO_0000065";"18.12";"0.35";"3.68";"6.86";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"117.0"
"CHEMBL5420349";"";"None";"471.54";"0";"2.88";"90-7";"COc1cc(Nc2cc(NC(C)=O)ncc2-c2ccc(C(C)(C)O)cn2)nc(S(C)(=O)=O)c1";"IC50";"'='";"0.027";"nM";"10.57";"";"";"UO_0000065";"22.41";"0.44";"7.69";"7.37";"0";"CHEMBL5383674";"Inhibition of TYK2 JH2 (561 to 860 residues) (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.027"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"23.91";"0.44";"5.93";"8.40";"0";"CHEMBL5446128";"Affinity Biochemical interaction: (Peptide mobility shift assay (phosphorylation of JAKtide peptide substrate at Km(MgATP)) EUB0000286bCit TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Protein family: Protein Kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5446079";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Biochemical Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"34.0"
"CHEMBL4091991";"";"None";"524.60";"2";"5.01";"EUB0000045b";"C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C";"% of control";"'='";"80.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5469118";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000045b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 4.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2/JH1domain-catalytic) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20332/";"";"";"80.0"
"CHEMBL1885746";"GW561436X";"None";"370.39";"0";"4.04";"GW561436X";"N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1";"Inhibition";"'='";"-2.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.44"
"CHEMBL180022";"NERATINIB";"4.0";"557.05";"2";"5.93";"Neratinib";"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL483321";"CP-724714";"2.0";"469.55";"0";"4.95";"EUB0000595a";"COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1";"% of control";"'='";"24.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5466050";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000595a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 17.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH2domain-pseudokinase) | Source Knowledge: lincs.hms.harvard.edu/db/datasets/20029/";"";"";"24.0"
"CHEMBL4460194";"";"None";"367.38";"0";"3.47";"21";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1OC";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"22.55";"0.42";"4.81";"9.40";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0052"
"CHEMBL260417";"";"None";"373.21";"0";"3.44";"SB-725317";"O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1";"Inhibition";"'='";"17.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"17.63"
"CHEMBL5278465";"";"None";"392.85";"0";"4.40";"33";"O=C(Nc1cnccc1-c1ccc(Cl)cc1)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252872";"Inhibition of TYK2 (0 to 887 residues) (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"EUB0000644a";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"2715.0";"nM";"5.57";"";"";"UO_0000065";"14.63";"0.28";"2.66";"7.11";"0";"CHEMBL5445994";"Affinity On-target Cellular interaction: (SureFire pSTAT5 Assay kit (phosphorylation of STAT5 in TEL-TYK2 engineered Ba/F3 cells)) EUB0000644a TYK2";"B";"BAO_0000219";"cell-based format";"Mus musculus";"None";"None";"BaF3";"None";"Mode of action: Inhibitor | Protein family: Protein Kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5445981";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307634";"Affinity On-target Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/30886973/";"";"";"2715.0"
"CHEMBL4742766";"";"None";"411.48";"0";"2.96";"16c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@H]1F";"IC50";"'='";"493.2";"nM";"6.31";"";"";"UO_0000065";"15.33";"0.29";"3.35";"7.67";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"493.2"
"CHEMBL5396523";"";"None";"395.48";"0";"3.53";"19b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(F)c2)[C@H](C)C1";"IC50";"'='";"8.42";"nM";"8.07";"";"";"UO_0000065";"20.42";"0.38";"4.54";"11.05";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"8.42"
"CHEMBL5398372";"";"None";"445.49";"0";"4.41";"19d";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C(F)(F)F)cc2)[C@H](C)C1";"IC50";"'='";"40.3";"nM";"7.39";"";"";"UO_0000065";"16.60";"0.32";"2.98";"10.12";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"40.3"
"CHEMBL5435417";"";"None";"446.48";"0";"3.80";"21c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C(F)(F)F)nc2)[C@H](C)C1";"IC50";"'='";"36.9";"nM";"7.43";"";"";"UO_0000065";"16.65";"0.32";"3.63";"8.65";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"36.9"
"CHEMBL5396134";"";"None";"358.42";"0";"2.44";"6";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)c3)c[nH]c2cn1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"20.99";"0.41";"5.08";"7.91";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.03"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"EUB0001543a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.59";"0.38";"6.97";"6.40";"0";"CHEMBL5446057";"Affinity On-target Cellular interaction: (STAT-dependent luciferase reporter assay in PBMCs (IFNxcexb1-stimulation, measuring STAT5 phosphorylation in CD3+ T-cells as end point, TYK2/JAK1 dependent signaling)) EUB0001543a TYK2";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CD3+ T-cells";"None";"Mode of action: Allosteric inhibitor | Protein family: Protein Kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5445981";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity On-target Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/31318208/";"";"";"2.0"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"EUB0001487a";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"% of inhibition";"'='";"100.0";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5479455";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001487a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 5.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2/JH1domain-catalytic) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20107/results";"";"";"100.0"
"CHEMBL464552";"";"None";"532.58";"1";"3.40";"GSK-1838705A";"CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5284095";"";"None";"1056.31";"None";"None";"37";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"DC50";"'='";"14.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5225299";"Induction of TYK2 degradation in human Jurkat cells incubated for 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 24.0 hr";"DEGRADER";"";"14.0"
"CHEMBL4293619";"";"None";"308.35";"0";"2.15";"10";"NC(=O)c1cnc2c(NC3CC3)cc(Nc3ccccc3)nn12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251839";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"2.0"
"CHEMBL3936693";"";"None";"409.46";"0";"3.51";"BDBM255024";"CCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"260.0";"nM";"6.58";"";"444014";"UO_0000065";"16.08";"0.31";"3.08";"10.25";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"260.0"
"CHEMBL3901870";"";"None";"466.51";"0";"2.58";"BDBM255025";"CN(C)C(=O)CN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"80.0";"nM";"7.10";"";"444015";"UO_0000065";"15.21";"0.29";"4.52";"8.39";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"80.0"
"CHEMBL3896113";"";"None";"367.45";"0";"2.90";"BDBM255032";"CN1CN([C@H]2CC[C@H](COCCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"24.0";"nM";"7.62";"";"444038";"UO_0000065";"20.74";"0.39";"4.72";"8.94";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"24.0"
"CHEMBL3903941";"";"None";"381.48";"0";"2.09";"BDBM198522";"CC(=O)N[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353500";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3917056";"";"None";"490.46";"0";"3.58";"BDBM198550";"O=C(NCC(O)(c1ccc(F)cc1)C(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353528";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3932456";"";"None";"338.34";"0";"2.78";"BDBM198602";"FC(F)(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"353580";"UO_0000065";"20.17";"0.39";"4.04";"9.62";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3911332";"";"None";"464.57";"0";"3.37";"BDBM198635";"CC(C)(C)OC(=O)N1CC(CC#N)(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353613";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3935408";"";"None";"292.35";"0";"3.10";"BDBM198645";"CC(C#N)=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"450.0";"nM";"6.35";"";"353623";"UO_0000065";"21.71";"0.39";"3.25";"7.68";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"450.0"
"CHEMBL1090479";"GSK-1070916";"1.0";"507.64";"2";"5.94";"GSK-1070916";"CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1614725";"TAK-285";"1.0";"547.97";"2";"5.92";"TAK-285";"CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1922094";"APITOLISIB";"2.0";"498.61";"1";"0.90";"Apitolisib";"Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL514201";"TALMAPIMOD";"2.0";"513.01";"1";"3.98";"Talmapimod";"C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c1cc2c(C(=O)C(=O)N(C)C)cn(C)c2cc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2103840";"DINACICLIB";"3.0";"396.50";"0";"2.28";"Dinaciclib";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL536151";"IMD-0354";"1.0";"383.68";"1";"5.34";"IMD-0354";"O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4636368";"";"None";"246.31";"0";"1.54";"32";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](N)CC3)c12";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"19.47";"0.36";"3.26";"5.48";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"16.0"
"CHEMBL5177410";"";"None";"576.67";"1";"4.03";"28";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NCC3CCOCC3)cc2)c1OC";"Tm";"'='";"57.14";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"57.14"
"CHEMBL5198448";"";"None";"561.62";"1";"2.82";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)nc2)c1OC";"IC50";"'='";"2.9";"nM";"8.54";"";"";"UO_0000065";"15.28";"0.28";"5.72";"5.10";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"2.9"
"CHEMBL5171417";"";"None";"558.61";"1";"3.31";"26";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)CN(C2CC2)C3=O)c1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"14.03";"0.26";"4.49";"5.04";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"16.0"
"CHEMBL5179468";"";"None";"587.66";"2";"3.81";"31";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"14.40";"0.27";"4.61";"5.24";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"3.8"
"CHEMBL4855726";"";"None";"504.02";"2";"2.53";"B3";"Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1";"Activity";"'>'";"75.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4808037";"Inhibition of TYK2 (unknown origin) assessed as residual activity measured at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 1.0 microM";"";"";"75.0"
"CHEMBL4543984";"";"None";"449.45";"0";"3.83";"30";"CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2nnco2)c1OC";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.06";"0.28";"2.94";"5.33";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"170.0"
"CHEMBL3927827";"";"None";"390.45";"0";"3.56";"BDBM198253";"O=C(N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)OCc1ccccc1";"IC50";"'='";"4200.0";"nM";"5.38";"";"353235";"UO_0000065";"13.77";"0.25";"1.82";"5.53";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"4200.0"
"CHEMBL3911186";"";"None";"255.28";"0";"1.83";"BDBM198275";"O=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"550.0";"nM";"6.26";"";"353254";"UO_0000065";"24.52";"0.45";"4.43";"8.24";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"550.0"
"CHEMBL3937067";"";"None";"363.45";"0";"2.92";"BDBM198343";"N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'='";"62.0";"nM";"7.21";"";"353321";"UO_0000065";"19.83";"0.38";"4.29";"8.39";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"62.0"
"CHEMBL3894161";"";"None";"340.42";"0";"1.84";"BDBM198351";"c1cc2c(ncn3nnc(C4CCN(Cc5csnn5)CC4)c23)[nH]1";"IC50";"'='";"110.0";"nM";"6.96";"";"353329";"UO_0000065";"20.44";"0.40";"5.12";"7.92";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL3979988";"";"None";"356.82";"0";"3.23";"BDBM198431";"Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1";"IC50";"'='";"100.0";"nM";"7.00";"";"353409";"UO_0000065";"19.62";"0.38";"3.77";"9.30";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL4115251";"";"None";"390.50";"0";"2.79";"BDBM198435";"c1cc[n+]2cc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)sc2c1";"IC50";"'='";"740.0";"nM";"6.13";"";"353413";"UO_0000065";"15.70";"0.30";"3.34";"9.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"740.0"
"CHEMBL3979388";"";"None";"339.43";"0";"2.44";"BDBM198443";"c1cc2c(ncn3nnc(C4CCN(Cc5cscn5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353421";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3980369";"";"None";"375.44";"0";"2.08";"BDBM198444";"NC(=O)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353422";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3896215";"";"None";"369.41";"0";"1.87";"BDBM198212";"O=C(Nc1nncs1)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1";"IC50";"'='";"420.0";"nM";"6.38";"";"353194";"UO_0000065";"17.26";"0.33";"4.51";"5.45";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"420.0"
"CHEMBL3963555";"";"None";"382.45";"0";"2.78";"BDBM198213";"Cc1cc(NC(=O)N2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)sn1";"IC50";"'='";"710.0";"nM";"6.15";"";"353195";"UO_0000065";"16.08";"0.31";"3.37";"5.91";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"710.0"
"CHEMBL3902447";"";"None";"357.42";"0";"2.86";"BDBM198214";"N#Cc1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1";"IC50";"'='";"880.0";"nM";"6.06";"";"353196";"UO_0000065";"16.94";"0.31";"3.20";"7.05";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"880.0"
"CHEMBL3927649";"";"None";"411.31";"0";"3.75";"BDBM198233";"Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"353215";"UO_0000065";"16.59";"0.36";"3.07";"10.99";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3913228";"";"None";"360.47";"0";"3.42";"BDBM198237";"c1ccc(CCCN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353219";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3900724";"";"None";"468.40";"1";"5.02";"BDBM198239";"FC(F)(F)c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc(C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"353221";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3949285";"";"None";"372.89";"0";"3.70";"BDBM198241";"Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1";"IC50";"'='";"57.0";"nM";"7.24";"";"353223";"UO_0000065";"19.43";"0.40";"3.54";"11.66";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"57.0"
"CHEMBL3959789";"";"None";"429.41";"0";"4.04";"BDBM198250";"O=C(Nc1cccc(C(F)(F)F)c1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353232";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3954894";"";"None";"289.77";"0";"3.12";"BDBM198268";"ClC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"353248";"UO_0000065";"30.79";"0.61";"5.80";"15.15";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1.2"
"CHEMBL3984424";"";"None";"257.30";"0";"1.62";"BDBM198274";"O[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"353253";"UO_0000065";"26.52";"0.49";"5.20";"8.63";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"150.0"
"CHEMBL3908040";"";"None";"385.48";"0";"3.54";"BDBM198286";"N#Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"5.9";"nM";"8.23";"";"353264";"UO_0000065";"21.35";"0.39";"4.69";"8.69";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"5.9"
"CHEMBL3895546";"";"None";"342.42";"0";"2.92";"BDBM198287";"F[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"250.0";"nM";"6.60";"";"353265";"UO_0000065";"19.28";"0.36";"3.68";"10.63";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"250.0"
"CHEMBL3919766";"";"None";"389.44";"0";"4.00";"BDBM198309";"N#Cc1cc(F)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"353287";"UO_0000065";"17.26";"0.32";"2.72";"7.10";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"190.0"
"CHEMBL3934627";"";"None";"354.46";"0";"2.65";"BDBM198313";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC[C@@H]5CCCO5)CC4)c23)[nH]1";"IC50";"'='";"120.0";"nM";"6.92";"";"353291";"UO_0000065";"19.52";"0.36";"4.27";"8.64";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"120.0"
"CHEMBL3897300";"";"None";"374.49";"0";"3.85";"BDBM198332";"c1ccc(CCCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"450.0";"nM";"6.35";"";"353310";"UO_0000065";"16.95";"0.31";"2.50";"8.95";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"450.0"
"CHEMBL3903790";"";"None";"371.45";"0";"3.29";"BDBM198334";"N#Cc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"88.0";"nM";"7.06";"";"353312";"UO_0000065";"18.99";"0.34";"3.77";"7.45";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"88.0"
"CHEMBL3945964";"";"None";"350.40";"0";"3.12";"BDBM198341";"Fc1ccccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"280.0";"nM";"6.55";"";"353319";"UO_0000065";"18.70";"0.34";"3.43";"10.55";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"280.0"
"CHEMBL3969811";"";"None";"351.39";"0";"2.52";"BDBM198361";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)nc1";"IC50";"'>'";"1000.0";"nM";"";"";"353339";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3925854";"";"None";"384.85";"0";"3.78";"BDBM198364";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)c1";"IC50";"'='";"340.0";"nM";"6.47";"";"353342";"UO_0000065";"16.81";"0.33";"2.69";"10.41";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"340.0"
"CHEMBL3931226";"";"None";"418.40";"0";"4.14";"BDBM198366";"Fc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1C(F)(F)F";"IC50";"'='";"980.0";"nM";"6.01";"";"353344";"UO_0000065";"14.36";"0.27";"1.87";"9.67";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"980.0"
"CHEMBL3949195";"";"None";"385.47";"0";"2.31";"BDBM198370";"CC(C)(C)OC(=O)NCCN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353348";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3939331";"";"None";"380.88";"0";"4.64";"BDBM198375";"Clc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353353";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3921365";"";"None";"367.50";"0";"2.52";"BDBM198380";"CN(C)[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"490.0";"nM";"6.31";"";"353358";"UO_0000065";"17.17";"0.32";"3.79";"9.66";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"490.0"
"CHEMBL3975439";"";"None";"382.47";"0";"1.49";"BDBM198390";"O=C1NCCN1CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"180.0";"nM";"6.75";"";"353368";"UO_0000065";"17.63";"0.33";"5.25";"6.53";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"180.0"
"CHEMBL3985363";"";"None";"346.44";"0";"3.42";"BDBM198394";"c1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"353372";"UO_0000065";"20.09";"0.37";"3.54";"9.81";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"110.0"
"CHEMBL5441067";"";"None";"448.49";"0";"2.28";"91-1";"CO[C@@]1(c2cc(C)cc(-n3nc(-c4cnn(C)c4)c4cnc(NC(N)=O)cc43)n2)CCOC1";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.40";"0.36";"6.42";"6.44";"0";"CHEMBL5383681";"Binding affinity to His-tagged human recombinant TYK2 JH2 (556 to 871 residues) incubated for 10 hrs by microplate reader based analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 10.0 hr";"INHIBITOR";"";"2.0"
"CHEMBL5409126";"";"None";"406.49";"0";"3.83";"91-3";"CO[C@@]1(c2cc(C)cc(-n3cc(C4CC4)c4cnc(NC(C)=O)cc43)n2)CCOC1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"22.69";"0.42";"5.39";"11.78";"0";"CHEMBL5383684";"Inhibition of TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.6"
"CHEMBL4280783";"";"None";"380.45";"0";"3.00";"1";"COc1cc2c(=O)n(CCCN(C)C)c3c4cc[nH]c4ncc3c2cc1OC";"IC50";"'='";"427.45";"nM";"6.37";"";"";"UO_0000065";"16.74";"0.31";"3.37";"8.80";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"427.45"
"CHEMBL4552628";"";"None";"425.89";"0";"3.66";"27";"Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.74";"0.24";"1.34";"5.86";"0";"CHEMBL4479787";"Inhibition of recombinant human N-terminal GST-tagged cytoplasmic TYK2 (833 to 1187 residues) catalytic domain expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"10000.0"
"CHEMBL5414765";"";"None";"372.45";"0";"2.45";"8";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)c3)cn(C)c2cn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"21.48";"0.42";"5.55";"9.49";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.01"
"CHEMBL5403272";"";"None";"358.42";"0";"2.39";"10";"CCS(=O)(=O)c1cccc(-c2cn(C)c3cnc(NC(C)=O)cc23)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"22.45";"0.44";"5.66";"8.56";"0";"CHEMBL5373711";"Inhibition of recombinant human N-terminal His-tagged TYK2 JH2 domain (577 to 870 residues) expressed in Sf9 cells using N-(2-(2-(2-((3-(5-acetamido-3-(3-(N,N-dimethylsulfamoyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-1-yl)propyl)amino)-2-oxoethoxy)ethoxy)ethyl)-2',7'-difluoro-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide trifluoroacetate as substrate incubated for 60 mins by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"0.009"
"CHEMBL5396134";"";"None";"358.42";"0";"2.44";"6";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)c3)c[nH]c2cn1";"EC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"19.31";"0.38";"4.48";"7.27";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.12"
"CHEMBL5086232";"";"None";"323.40";"0";"2.33";"9";"O=C1NCCC12CCN(c1ccnc(Nc3ccccc3)n1)CC2";"Activity";"'='";"66.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"66.0"
"CHEMBL5088284";"";"None";"382.42";"0";"2.54";"35";"Cc1cnc(Nc2cccc([N+](=O)[O-])c2)nc1N1CCC2(CCNC2=O)CC1";"Activity";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"3.0"
"CHEMBL5436255";"";"None";"435.51";"0";"2.91";"11";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL3622826";"";"None";"287.37";"0";"0.56";"5c";"NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"759500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625907";"Inhibition of Tyk2 (unknown origin) using 1 mM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"759.5"
"CHEMBL5402702";"";"None";"437.54";"0";"3.51";"14";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)Cc1nn(C([2H])([2H])[2H])nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL4466139";"";"None";"416.45";"0";"1.95";"6e";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"16.87";"0.31";"5.08";"5.94";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"94.0"
"CHEMBL4439957";"";"None";"452.43";"0";"2.04";"6q";"CNc1cc(Nc2cccn(-c3ccc(F)cn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"16.77";"0.31";"5.55";"6.41";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"26.0"
"CHEMBL2348862";"";"None";"383.45";"0";"1.95";"10b, CC214-2";"CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1";"Activity";"'='";"94.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2350843";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346597";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"94.0"
"CHEMBL3675980";"";"None";"380.43";"0";"2.74";"BDBM127733";"O=C(NCC1CC1)c1cnn2ccc(N3CCCC3c3cncc(F)c3)nc12";"IC50";"'>'";"1000.0";"nM";"";"";"258562";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3675973";"";"None";"434.40";"0";"3.43";"BDBM127725";"O=C(NC1(C(F)(F)F)CC1)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12";"IC50";"'>'";"1000.0";"nM";"";"";"258569";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL4474801";"";"None";"434.44";"0";"2.09";"6f";"CNc1cc(Nc2cccn(-c3ccc(F)nc3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"14.78";"0.27";"4.33";"5.43";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"380.0"
"CHEMBL4443010";"";"None";"431.46";"0";"1.66";"6l";"CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"247.0";"nM";"6.61";"";"";"UO_0000065";"15.31";"0.28";"4.95";"5.04";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"247.0"
"CHEMBL5199420";"";"None";"392.46";"0";"2.48";"32";"N#CCC(=O)N1CC2(CCC(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)C1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"19.29";"0.36";"5.09";"7.32";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"27.0"
"CHEMBL5172426";"";"None";"418.50";"0";"2.87";"38";"N#CC1(C(=O)N2CC3(CCC(c4cccc5nc(NC(=O)C6CC6)nn45)CC3)C2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"18.51";"0.34";"4.87";"7.49";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"18.0"
"CHEMBL2420810";"";"None";"365.22";"0";"2.80";"52";"O=C(Nc1ccnc(NC(=O)C2CNC2)c1)c1c(Cl)cccc1Cl";"Ki";"'>'";"3500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"3.5"
"CHEMBL434729";"GW829906X";"None";"446.44";"1";"5.92";"GW829906X";"Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1";"Inhibition";"'='";"-1.28";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.28"
"CHEMBL205966";"GW659893X";"None";"444.90";"1";"5.57";"GW659893X";"Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1";"Inhibition";"'='";"-2.76";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.76"
"CHEMBL520037";"GW837331X";"None";"459.43";"0";"4.89";"GW837331X";"COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC";"Inhibition";"'='";"-1.61";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.61"
"CHEMBL2103842";"VARLITINIB";"2.0";"466.95";"1";"5.25";"Varlitinib";"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2017974";"BUPARLISIB";"3.0";"410.40";"0";"1.81";"Buparlisib";"Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1079175";"MK-2206";"2.0";"407.48";"0";"4.24";"MK-2206";"NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1289926";"AXITINIB";"4.0";"386.48";"0";"4.64";"Axitinib";"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL488436";"AZD-5438";"1.0";"371.47";"0";"3.38";"AZD-5438";"Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3348923";"TOVORAFENIB";"3.0";"506.30";"1";"3.98";"MLN-2480";"C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4581532";"";"None";"414.52";"0";"3.48";"15e";"CN1CCN(c2ccc(Nc3cc(NCc4cccc(NC#N)c4)ncn3)cc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL5184093";"";"None";"586.67";"1";"3.96";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3C4CCC3CC4)cc2)c1OC";"Tm";"'='";"67.34";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"67.34"
"CHEMBL5416227";"";"None";"431.45";"0";"2.79";"90-6";"COc1cc(Nc2cc(NC(C)=O)ncc2-c2ccc(F)cn2)nc(S(C)(=O)=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383677";"Inhibition of TYK2 signal transduction pathway in human TF-1 cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL4556768";"";"None";"363.40";"0";"4.10";"11f";"C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(F)cc3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL5423894";"";"None";"395.48";"0";"3.53";"19a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccccc2F)[C@H](C)C1";"IC50";"'='";"75.9";"nM";"7.12";"";"";"UO_0000065";"18.00";"0.34";"3.59";"9.75";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"75.9"
"CHEMBL4563864";"";"None";"406.45";"0";"2.53";"14c";"COCCn1cc(Nc2cc(NCc3cccc(NC(=O)CC#N)c3)ncn2)cn1";"IC50";"'='";"1740.0";"nM";"5.76";"";"";"UO_0000065";"14.17";"0.26";"3.23";"4.44";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"1740.0"
"CHEMBL3606021";"";"None";"395.43";"0";"2.92";"20by, NMS-P118";"NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3606464";"Inhibition of human TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3603755";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"10.0"
"CHEMBL5075281";"";"None";"382.47";"0";"2.23";"33";"COc1ccc(Nc2ncc(C)c(N3CCC4(CCNC4=O)CC3)n2)cc1N";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"20.71";"0.39";"5.69";"7.52";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL5087251";"";"None";"440.52";"0";"2.61";"51";"Cc1cnc(Nc2ccc(N3CCOCC3)c(F)c2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.90";"0.34";"5.28";"9.54";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL31965";"CANERTINIB";"3.0";"485.95";"0";"4.39";"CI-1033";"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445112";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-6 induced pSTAT1 (CD3+ cells), JAK1/JAK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"81.0"
"CHEMBL483321";"CP-724714";"2.0";"469.55";"0";"4.95";"CP-724714";"COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL460702";"BMS-777607";"2.0";"512.90";"2";"5.19";"BMS-777607";"CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL91829";"RUBOXISTAURIN";"3.0";"468.56";"0";"3.51";"Ruboxistaurin";"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3128043";"PF-03758309";"1.0";"490.64";"0";"4.53";"PF-3758309";"Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1908396";"";"None";"480.55";"1";"5.39";"Ki-20227";"COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3188551";"GSK-2636771";"2.0";"433.43";"0";"4.26";"GSK-2636771";"Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL553";"ERLOTINIB";"4.0";"393.44";"0";"3.41";"Erlotinib";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Kd";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"14.28";"0.26";"2.21";"7.52";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"2400.0"
"CHEMBL3545085";"XL-228";"1.0";"437.55";"0";"3.30";"XL-228";"CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4569508";"";"None";"529.59";"2";"5.28";"1";"O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"13.45";"0.26";"1.84";"9.93";"0";"CHEMBL4479787";"Inhibition of recombinant human N-terminal GST-tagged cytoplasmic TYK2 (833 to 1187 residues) catalytic domain expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"75.0"
"CHEMBL3393348";"";"None";"305.34";"0";"2.33";"EUB0001619a";"N#Cc1cccc(-c2c[nH]c3ncnc(N4CCOCC4)c23)c1";"% of control";"'='";"69.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5480971";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001619a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 7.0 None | Selectivity number of targets = 426.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/jm5014055";"";"";"69.0"
"CHEMBL3393348";"";"None";"305.34";"0";"2.33";"EUB0001619a";"N#Cc1cccc(-c2c[nH]c3ncnc(N4CCOCC4)c23)c1";"% of control";"'='";"75.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5480972";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001619a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 7.0 None | Selectivity number of targets = 426.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://pubs.acs.org/doi/10.1021/jm5014055";"";"";"75.0"
"CHEMBL1614701";"SELUMETINIB";"4.0";"457.69";"0";"3.53";"AZD-6244/ARRY-886";"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL5430831";"";"None";"433.89";"0";"3.90";"18c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccc(Cl)cc2)CC1(F)F";"IC50";"'='";"1069.5";"nM";"5.97";"";"";"UO_0000065";"13.76";"0.27";"2.07";"8.17";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1069.5"
"CHEMBL5410919";"";"None";"446.48";"0";"3.80";"20d";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C(F)(F)F)cn2)[C@H](C)C1";"IC50";"'='";"31.6";"nM";"7.50";"";"";"UO_0000065";"16.80";"0.32";"3.70";"8.73";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"31.6"
"CHEMBL5403115";"";"None";"465.49";"1";"1.93";"2m";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cccc(OC)n2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"20.97";"0.39";"7.77";"6.30";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.2"
"CHEMBL5396654";"";"None";"465.47";"1";"2.42";"4c";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cnc(C)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"21.62";"0.40";"7.58";"6.55";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.1"
"CHEMBL428690";"ALVOCIDIB";"3.0";"401.85";"0";"3.30";"Alvocidib";"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1";"Kd";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"16.78";"0.33";"3.44";"7.16";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"180.0"
"CHEMBL3967682";"";"None";"360.46";"0";"3.46";"BDBM198316";"c1ccc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"230.0";"nM";"6.64";"";"353294";"UO_0000065";"18.42";"0.34";"3.18";"9.36";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"230.0"
"CHEMBL3968423";"";"None";"371.45";"0";"3.29";"BDBM198333";"N#Cc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"310.0";"nM";"6.51";"";"353311";"UO_0000065";"17.52";"0.32";"3.22";"6.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"310.0"
"CHEMBL3983447";"";"None";"378.45";"0";"3.60";"BDBM198404";"Fc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"353382";"UO_0000065";"18.50";"0.34";"3.40";"9.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL3975123";"";"None";"424.53";"0";"2.28";"BDBM198437";"c1cc2c(ncn3nnc(C4CCN(Cc5cnc(N6CCOCC6)s5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353415";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3824068";"";"None";"432.57";"0";"3.06";"8a";"CN1CCN(c2ccc(-n3cc(-c4ccncc4OCC4CCNCC4)cn3)cc2)CC1";"Inhibition";"'='";"93.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3824976";"Inhibition of partial-length human wild type TYK2 expressed in mammalian expression system at 1 uM by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3822415";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"93.0"
"CHEMBL3963319";"";"None";"356.43";"0";"2.97";"BDBM198203";"CC1CCN(C(=O)OC(C)(C)C)CC1c1nnn2cnc3[nH]ccc3c12";"IC50";"'='";"4100.0";"nM";"5.39";"";"353185";"UO_0000065";"15.11";"0.28";"2.42";"6.09";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"4100.0"
"CHEMBL3977496";"";"None";"242.29";"0";"1.07";"BDBM198207";"c1cc2c(ncn3nnc(C4CCCNC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353189";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3970109";"";"None";"349.44";"0";"2.87";"BDBM198320";"N#CC1CCN(C2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"420.0";"nM";"6.38";"";"353298";"UO_0000065";"18.25";"0.33";"3.51";"7.42";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"420.0"
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"Tozasertib";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Kd";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"11.15";"0.21";"1.68";"5.08";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"6600.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"204.0";"nM";"6.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445117";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-21 induced pSTAT3 (lymphocytes), JAK1/JAK3 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"204.0"
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"EUB0000639a";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"% of inhibition";"'='";"4.0";"%";"";"";"% Of Inhibition";"UO_0000187";"";"";"";"";"0";"CHEMBL5471853";"Selectivity interaction (ActivX KiNativ screen (kinase selectivity in THP-1 cell lysates)) EUB0000639a TYK2";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"THP-1";"lysate";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307574";"Selectivity number of off-targets = 0.0 None | Selectivity number of targets = 283.0 None | Selectivity Remarks: Screened at 0.04 uM (in vitro, TYK2 (domain 2)) | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/28498658/";"";"";"4.0"
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Activity";"";"";"";"";"";"Tde";"";"";"";"";"";"0";"CHEMBL5225294";"Induction of TYK2 degradation in human Jurkat cells at 1 uM by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM | TIME_Lower = 3.0 hrs | TIME_Upper = 24.0 hrs";"DEGRADER";"";""
"CHEMBL4532948";"";"None";"434.44";"0";"1.90";"6";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"0.086";"nM";"10.07";"";"";"UO_0000065";"23.17";"0.43";"8.17";"8.51";"0";"CHEMBL4402444";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"0.086"
"CHEMBL4066404";"";"None";"365.50";"0";"2.23";"41";"CCCCN(C)S(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4085264";"";"None";"338.44";"0";"0.71";"37";"CCN(C)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL3655104";"";"None";"363.45";"0";"0.60";"40";"CN(CCC#N)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4291200";"";"None";"442.37";"0";"1.54";"30";"CNc1cc(Nc2c(F)c(F)cc(F)c2F)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.30";"0.36";"6.56";"6.54";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.008"
"CHEMBL4285755";"";"None";"336.40";"0";"2.76";"11";"Cc1cc(C)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"17.40";"0.32";"3.09";"6.01";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.4"
"CHEMBL4285530";"";"None";"364.45";"0";"3.54";"21";"Cc1cc(C)cc(Nc2cc(NC3CCCC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"14.59";"0.27";"1.78";"5.46";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"4.8"
"CHEMBL4278757";"";"None";"412.49";"0";"1.85";"25";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(CO)CO)cnc12";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"15.71";"0.30";"4.63";"5.24";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.33"
"CHEMBL4283724";"";"None";"314.39";"0";"2.15";"13";"NC(=O)c1cnc2c(NC3CC3)cc(NC3CCCCC3)nn12";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"17.48";"0.33";"3.34";"5.65";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"3.2"
"CHEMBL5411149";"";"None";"507.55";"2";"2.91";"4g";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(C(C)(C)N)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"19.82";"0.37";"7.09";"6.03";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.1"
"CHEMBL3907057";"BAY-826";"None";"558.54";"2";"7.59";"EUB0000713";"Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1";"% Control";"'='";"87.3";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507270";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"87.3"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"21.08";"0.39";"5.05";"7.41";"0";"CHEMBL4341347";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340527";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"260.0"
"CHEMBL1236095";"";"None";"676.74";"2";"5.82";"EUB0000612a";"CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5467315";"Selectivity interaction (Kinase panel (Enzyme activity assay)) EUB0000612a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 60.0 None | Selectivity Remarks: In-vitro potency | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/21159646/";"";"";"10.0"
"CHEMBL1950289";"TANZISERTIB";"2.0";"448.45";"0";"3.66";"EUB0000618a";"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1";"% of control";"'='";"81.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5467744";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000618a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Screened against a panel of 75 receptors, ion channels and neurotransmitter transporters at 10 uM: no target >50% inhibition; Screened against 22 diverse non-kinase enzymes at 10 uM, no inhibition >50%, https://pubmed.ncbi.nlm.nih.gov/22244937/; Inhibited LPS-induced TNF+- production (PK-PD model) by 23% and 77% at 10 and 30 mg/kg oral dose respectively, https://pubmed.ncbi.nlm.nih.gov/22244937/; | Selectivity number of off-targets = 8.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20114/results";"";"";"81.0"
"CHEMBL3889920";"";"None";"337.39";"0";"1.91";"BDBM198654";"N#CCNC(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353632";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL476259";"GSK-1326255A";"None";"517.61";"2";"5.28";"GSK1326255A";"CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1";"Inhibition";"'='";"-2.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.78"
"CHEMBL517907";"GW680191X";"None";"438.55";"0";"3.15";"GW680191X";"C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1";"Inhibition";"'='";"-1.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.47"
"CHEMBL4440718";"";"None";"401.47";"0";"2.12";"48";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O";"Ki";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"25.49";"0.50";"8.03";"8.06";"0";"CHEMBL4414854";"Inhibition of TYK2 JH2 (unknown origin) by morrison titration assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00007"
"CHEMBL381948";"GW680975X";"None";"316.34";"0";"4.34";"GW680975X";"Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1";"Inhibition";"'='";"-1.71";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.71"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"4";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"25.49";"0.47";"7.04";"6.86";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00046"
"CHEMBL5082590";"";"None";"369.47";"0";"2.41";"46";"Cc1cnc(Nc2cnn(C(C)C)c2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"22.07";"0.41";"5.74";"9.27";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"7.0"
"CHEMBL5077096";"";"None";"377.40";"0";"2.23";"48";"Cc1cnc(Nc2cnn(C(F)F)c2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"21.79";"0.42";"5.99";"9.35";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"6.0"
"CHEMBL5090010";"";"None";"344.44";"0";"1.37";"49";"[2H]C([2H])([2H])n1cc(Nc2ncc(C)c(N3CCC4(CCNC4=O)CC3)n2)cn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"23.43";"0.44";"6.63";"9.09";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL5083015";"";"None";"450.59";"0";"3.11";"54";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"15.54";"0.29";"3.89";"8.48";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"99.0"
"CHEMBL261849";"GW632580X";"None";"366.42";"0";"2.83";"GW-2580";"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL233001";"GW620972X";"None";"332.43";"0";"4.90";"GW620972X";"N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2";"Inhibition";"'='";"-3.92";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.92"
"CHEMBL5203217";"";"None";"597.65";"1";"3.32";"15";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3[C@H](C#N)C[C@@H]4C[C@@H]43)cc2)c1OC";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"14.94";"0.28";"5.57";"4.98";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"1.3"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"30.68";"0.56";"5.93";"11.30";"1";"CHEMBL5385206";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380863";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.4"
"CHEMBL1651534";"REDAFAMDASTAT";"2.0";"455.44";"1";"5.39";"EUB0000306";"O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507297";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4100408";"TP-024n";"None";"377.39";"0";"4.22";"EUB0000336";"Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507305";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5424894";"";"None";"382.42";"0";"2.17";"92-1";"CNc1cc2nn3c(cnc13)C(=O)N[C@H](C)COCc1ccc(OC)c(c1)N2";"Kd";"'='";"0.002";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383664";"Binding affinity to TYK2 JH2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.002"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"2";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"Ratio EC50";"'='";"5.0";"";"";"";"";"";"";"";"";"";"0";"CHEMBL4046588";"Ratio of EC50 for TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation to EC50 for inhibition of TYK2 (unknown origin) assessed as reduction in IL-12 induced STAT4 phosphorylation";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"5.0"
"CHEMBL553";"ERLOTINIB";"4.0";"393.44";"0";"3.41";"Erlotinib";"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL939";"GEFITINIB";"4.0";"446.91";"0";"4.28";"Gefitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL5277592";"";"None";"1018.25";"None";"None";"36";"CNC(=O)c1cccc(Nc2cc(Nc3ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)cn3)ncc2C(N)=O)c1OC";"DC50";"'='";"23.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5225299";"Induction of TYK2 degradation in human Jurkat cells incubated for 24 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 24.0 hr";"DEGRADER";"";"23.0"
"CHEMBL5277592";"";"None";"1018.25";"None";"None";"36";"CNC(=O)c1cccc(Nc2cc(Nc3ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)cn3)ncc2C(N)=O)c1OC";"Emax";"'='";"85.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5225300";"Induction of TYK2 degradation in human Jurkat cells at 1 uM incubated for 24 hrs relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM | TIME = 24.0 hr";"DEGRADER";"";"85.0"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"pyridone-6";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"18.65";"0.34";"1.78";"9.38";"0";"CHEMBL3625907";"Inhibition of Tyk2 (unknown origin) using 1 mM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"1.7"
"CHEMBL5089987";"";"None";"454.56";"0";"2.31";"19";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(CN4CCOCC4)c3)n2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046627";"Inhibition of NanoLuc-fused TYK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"";"";"10000.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"2";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"3";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4444178";"";"None";"392.46";"0";"1.33";"47";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"17.05";"0.34";"5.31";"5.10";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.23"
"CHEMBL5278635";"";"None";"556.60";"1";"3.34";"16";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2cccc(-n3ccccc3=O)c2)c1OC";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.38";"0.27";"4.62";"5.09";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"11.0"
"CHEMBL5269164";"";"None";"544.59";"1";"2.98";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(C)n3)cc2)c1OC";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"14.50";"0.27";"4.87";"4.76";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"14.0"
"CHEMBL255863";"NILOTINIB";"4.0";"529.53";"2";"6.36";"Nilotinib";"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL445813";"AT-7519";"2.0";"382.25";"0";"2.45";"AT-7519";"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1667969";"SAR-407899";"2.0";"244.29";"0";"1.66";"SAR-407899";"O=c1[nH]ccc2cc(OC3CCNCC3)ccc12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3544932";"TAK-901";"1.0";"504.66";"1";"4.62";"TAK-901";"CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2041933";"AZD-7762";"1.0";"362.43";"0";"2.53";"AZD-7762";"NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL427159";"GW827396X";"None";"430.42";"0";"4.88";"GW827396X";"COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1";"Inhibition";"'='";"-2.09";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.09"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"0.72";"nM";"9.14";"";"";"UO_0000065";"29.84";"0.54";"5.67";"10.99";"0";"CHEMBL3784141";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779778";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"0.72"
"CHEMBL3685796";"MRL-SYKi";"None";"452.58";"1";"5.06";"EUB0000714";"Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1";"% Control";"'='";"68.6";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507285";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"68.6"
"CHEMBL4632897";"";"None";"342.44";"0";"2.89";"26";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)C4CCCC4)CC3)c12";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"15.09";"0.28";"2.28";"5.70";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"6.8"
"CHEMBL4642642";"";"None";"455.21";"None";"None";"14h";"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)COB4O)ncc2C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"235.0";"nM";"6.63";"";"";"UO_0000065";"21.22";"0.39";"5.09";"7.46";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"235.0"
"CHEMBL524901";"GW683109X";"None";"339.40";"0";"1.32";"GW683109X";"c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1";"Inhibition";"'='";"-5.16";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.16"
"CHEMBL4535474";"BAY-293";"None";"448.59";"1";"5.58";"EUB0000320";"CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1";"% Control";"'='";"71.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507273";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"71.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"30";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"25.20";"0.46";"4.25";"9.28";"1";"CHEMBL5131753";"Inhibition of N-terminal epitope-tagged TYK2 (873 to 1187 residues) (unknown origin) expressed in Sf21 cells using EQEDEPEGDYFEWLE as substrate in presence of ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"19.0"
"CHEMBL4528675";"";"None";"535.55";"1";"4.76";"8d-1";"COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1";"Inhibition";"'='";"11.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4366632";"Inhibition of human TYK2 at 100 nM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364276";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"11.32"
"CHEMBL275666";"";"None";"483.47";"1";"5.88";"SB-253226";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1";"Inhibition";"'='";"-3.63";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.63"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Ki";"'='";"0.02";"nM";"10.70";"";"";"UO_0000065";"25.33";"0.47";"8.97";"7.87";"1";"CHEMBL4331751";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFN-alpha stimulated TYK2 phosphorylation by caspase3/7 reagent-based Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"CHEMBL3307526";"";"";"";"0.02"
"CHEMBL5181361";"";"None";"435.43";"0";"3.40";"15b";"O=C1NCc2nc(-c3c(F)cccc3F)nc(Nc3ccc(C4CCCNC4=O)cc3)c21";"Ki";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"19.31";"0.36";"5.01";"8.76";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"3.9"
"CHEMBL4093092";"";"None";"414.30";"0";"4.84";"29";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)nc(N(C)C)n1";"EC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";""
"CHEMBL4084341";"";"None";"392.51";"0";"3.12";"26";"Cc1cnccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"19.20";"0.35";"4.42";"6.77";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"29.0"
"CHEMBL4459585";"ROPSACITINIB";"2.0";"383.42";"0";"2.54";"22, PF-06826647";"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"20.41";"0.37";"5.28";"6.90";"0";"CHEMBL4675809";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected Sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of ATP at Km by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673239";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR";"";"15.0"
"CHEMBL4460904";"";"None";"420.52";"0";"2.56";"12";"CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4CC[C@H]3CN4C(=O)C3CC3)n2)cc1";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"16.24";"0.30";"4.27";"7.55";"0";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"148.0"
"CHEMBL5191514";"";"None";"355.37";"0";"1.81";"7";"O=C(Nc1nc2cccc(C3=CCN(C(=O)C4(F)CC4)C3)n2n1)C1CC1";"IC50";"'='";"2873.0";"nM";"5.54";"";"";"UO_0000065";"15.59";"0.29";"3.73";"6.96";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2873.0"
"CHEMBL3643413";"LENIOLISIB";"4.0";"450.47";"0";"2.88";"EUB0000877a";"CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5474482";"Selectivity interaction (Kinase panel (33PanQinase(R) Activity Assay)) EUB0000877a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Favorable pharmacokinetic profile in rodents and monkeys | Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 46.0 None | Selectivity Remarks: In-vitro potency (using 1 uM ATP) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acsmedchemlett.7b00293";"";"";"10.0"
"CHEMBL5169563";"";"None";"351.41";"0";"2.10";"10";"O=C(Nc1nc2cccc(C3=CCN(C(=O)C4CC4)CC3)n2n1)C1CC1";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"19.21";"0.35";"4.65";"8.48";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"178.0"
"CHEMBL5195430";"";"None";"463.50";"0";"4.30";"29";"O=C(Nc1nc2cccc(C3CCC4(CC3)CCN(C(=O)CC(F)(F)F)CC4)n2n1)C1CC1";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"14.69";"0.28";"2.51";"8.55";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"155.0"
"CHEMBL5269603";"";"None";"369.81";"0";"3.72";"5";"COc1cccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)n1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"19.24";"0.37";"3.39";"6.96";"0";"CHEMBL5252498";"Inhibition of GST-fused Tyk2 (888 to 1187 residues) (unknown origin) using FITC-AhxKKSRGDYMTMQIG-NH2 peptide as substrate incubated for 60 mins in presence of ATP by Janus kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247683";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"77.0"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"577.0";"nM";"6.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445120";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (EPO induced pSTAT5 (spiked CD34+ progenitor cells), JAK2/JAK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"577.0"
"CHEMBL5270581";"";"None";"358.40";"0";"3.74";"18";"O=C(Nc1cnccc1-c1ccccc1)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252893";"Inhibition of TYK2 (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL5414765";"";"None";"372.45";"0";"2.45";"8";"CC(=O)Nc1cc2c(-c3cccc(S(=O)(=O)N(C)C)c3)cn(C)c2cn1";"EC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.67";"0.40";"5.25";"9.13";"0";"CHEMBL5373712";"Inhibition of TYK2 in human T-blast cells assessed as IL-12 induced STAT4 phosphorylation at Tyr694 residue preincubated for 30 mins followed by IL-12 stimulation and measured after 20 mins by AlphaScreen assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-blast cell";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370619";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.8333 hr";"INHIBITOR";"";"0.02"
"CHEMBL5397297";"";"None";"445.49";"0";"4.41";"36b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(C(F)(F)F)cc2)[C@@H](C)C1";"Activity";"'='";"9.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5377917";"Inhibition of human TYK2 assessed as remaining activity at 1 uM in presence of ATP by Eurofins kinase profiler method relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"9.0"
"CHEMBL4526283";"";"None";"415.45";"0";"2.87";"23";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"21.75";"0.43";"6.17";"7.99";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00092"
"CHEMBL4444178";"";"None";"392.46";"0";"1.33";"47";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"11.04";"0.22";"2.97";"3.30";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"50.0"
"CHEMBL4456123";"BI 639667";"1.0";"451.48";"0";"2.78";"EUB0000352";"CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1";"% Control";"'='";"73.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507278";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"73.0"
"CHEMBL4456123";"BI 639667";"1.0";"451.48";"0";"2.78";"EUB0000352";"CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507278";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3898916";"";"None";"400.41";"0";"4.76";"BDBM198321";"FC(F)(F)c1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353299";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3907944";"";"None";"364.43";"0";"3.91";"BDBM198323";"CN(c1ccc(F)cc1)C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"180.0";"nM";"6.75";"";"353301";"UO_0000065";"18.51";"0.34";"2.83";"10.86";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"180.0"
"CHEMBL4076947";"";"None";"396.24";"0";"4.65";"30";"Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1";"EC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"18.12";"0.36";"2.53";"6.96";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.066"
"CHEMBL3980979";"";"None";"414.44";"0";"4.44";"BDBM198336";"FC(F)(F)c1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"46.0";"nM";"7.34";"";"353314";"UO_0000065";"17.70";"0.33";"2.90";"10.35";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"46.0"
"CHEMBL3967397";"";"None";"360.46";"0";"3.67";"BDBM198392";"c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"5.5";"nM";"8.26";"";"353370";"UO_0000065";"22.91";"0.42";"4.59";"11.65";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"5.5"
"CHEMBL3949257";"";"None";"436.39";"0";"4.28";"BDBM198427";"Fc1cc(C(F)(F)F)cc(F)c1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"950.0";"nM";"6.02";"";"353405";"UO_0000065";"13.80";"0.27";"1.74";"9.70";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"950.0"
"CHEMBL3934440";"";"None";"382.42";"0";"4.27";"BDBM198452";"Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1F";"IC50";"'='";"860.0";"nM";"6.07";"";"353430";"UO_0000065";"15.86";"0.30";"1.80";"8.56";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"860.0"
"CHEMBL4568735";"NVS-MALT1";"None";"574.03";"1";"4.72";"EUB0000239";"CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507320";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4584981";"NVS-MALT1-C";"None";"574.03";"1";"4.72";"EUB0000747";"CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12";"% Control";"'='";"98.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507320";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"98.0"
"CHEMBL509032";"TAE-684";"None";"614.22";"2";"5.02";"TAE-684";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"IC50";"'='";"2309.0";"nM";"5.64";"";"";"UO_0000065";"9.18";"0.18";"0.62";"5.48";"0";"CHEMBL1006341";"Inhibition of Tel-fused TYK2 kinase-mediated mouse BaF3 cell proliferation";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156430";"1";"Scientific Literature";"Proc Natl Acad Sci U S A";"2007";"CHEMBL3307634";"";"";"";"2.309"
"CHEMBL3286797";"PF-04418948";"1.0";"409.41";"0";"3.59";"EUB0000351";"COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507298";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4238926";"";"None";"326.40";"0";"2.01";"4";"NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"25.43";"0.47";"6.29";"7.98";"1";"CHEMBL4377458";"Inhibition of TYK2 JH1 domain (unknown origin) in presence of Km ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"5.0"
"CHEMBL4469750";"";"None";"455.48";"0";"3.00";"39";"CNC(=O)c1cnc(Nc2ccc(C#N)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.18";"0.31";"4.82";"5.48";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"15.0"
"CHEMBL4455357";"TP-020";"None";"654.02";"2";"5.45";"EUB0000315";"Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1";"% Control";"'='";"78.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507302";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"78.0"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"EUB0000050b";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5475822";"Selectivity interaction (KINOMEscan kinase binding assays (Eurofins)) EUB0000050b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 17.0 None | Selectivity number of targets = 403.0 None | Selectivity Remarks: In-vitro potency | Source Knowledge: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082118/";"";"";"30000.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445872";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-2, JAK1/3, pSTAT5 in CD3+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"28.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445892";"Affinity Phenotypic Cellular interaction: (Colony forming cell assays (inhibition of human myeloid progenitor cell differentiation, human CFU-G C colonies )) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Myeloid progenitor cells";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL5483204";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"930.0"
"CHEMBL4864387";"";"None";"479.42";"0";"3.79";"14l";"N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4S(=O)(=O)C(F)(F)F)c3)ncc2F)cn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.78";"0.33";"4.26";"6.79";"1";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"9.0"
"CHEMBL3955876";"";"None";"340.81";"0";"3.43";"18";"Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12";"Inhibition";"'='";"23.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3854821";"Inhibition of TYK2 (unknown origin) at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3853318";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"23.0"
"CHEMBL475761";"GW784684X";"None";"564.09";"2";"6.81";"GW784684X";"CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1";"Inhibition";"'='";"-0.75";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.75"
"CHEMBL3545215";"BMS-911543";"2.0";"432.53";"0";"3.50";"BMS-911543";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3544964";"RAVOXERTINIB";"2.0";"440.87";"0";"3.16";"GDC-0994";"Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4206831";"";"None";"535.61";"2";"5.49";"2; FMF-03-145-1";"CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1";"Activity";"'='";"58.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4186096";"Binding affinity to wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"58.0"
"CHEMBL4630644";"BAY-386";"None";"514.53";"1";"3.27";"EUB0000291b";"O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1";"% of control";"'='";"53.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5214262";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000291b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity number of off-targets = 4.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 ÂµM (in vitro) | Selectivity Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-386";"";"";"53.0"
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL5225296";"Induction of TYK2 degradation in human Jurkat cells at 1 uM incubated for 24 hrs in presence of 6-(5-fluoropyridin-2-ylamino)-4-(2-methoxy-3-(methylcarbamoyl)phenylamino)-N-methylnicotinamide by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM | TIME = 24.0 hr";"DEGRADER";"";""
"CHEMBL5184123";"";"None";"518.55";"1";"2.43";"25";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2cccc3c2C(=O)NC3)c1OC";"Tm";"'='";"59.17";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"59.17"
"CHEMBL5209315";"";"None";"569.64";"1";"4.22";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"65.87";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"65.87"
"CHEMBL5205855";"";"None";"518.55";"1";"2.43";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)C(=O)NC3)c1OC";"Tm";"'='";"52.49";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"52.49"
"CHEMBL5204955";"";"None";"596.68";"1";"2.97";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)N3CCCC3)cc2)c1OC";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"14.33";"0.28";"5.54";"4.95";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"3.1"
"CHEMBL1794070";"GSK-579289A";"None";"511.05";"2";"5.45";"GSK579289A";"C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl";"Inhibition";"'='";"-3.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.41"
"CHEMBL1909407";"";"None";"374.85";"0";"2.65";"SB-220025-R";"Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"2.68";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.68"
"CHEMBL5192374";"";"None";"457.43";"0";"4.64";"24";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCC(F)(F)CC4)cn3)c21";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"15.48";"0.29";"2.44";"10.09";"0";"CHEMBL5105740";"Inhibition of TYK2 in human PBMC assessed as inhibition of IL-12-stimulated phosphorylation of STAT4 measured by immunoblotting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"0.083"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"27.03";"0.50";"6.90";"9.50";"0";"CHEMBL3106993";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102787";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";"";"";"3.6"
"CHEMBL5181361";"";"None";"435.43";"0";"3.40";"15a";"O=C1NCc2nc(-c3c(F)cccc3F)nc(Nc3ccc(C4CCCNC4=O)cc3)c21";"Ki";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"20.20";"0.38";"5.40";"9.16";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"1.6"
"CHEMBL5198005";"";"None";"409.40";"0";"3.16";"18";"CCNC(=O)c1ccc(Nc2cc(-c3c(F)cccc3F)nc3c2C(=O)NC3)nc1";"Ki";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"24.00";"0.45";"6.66";"10.23";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.15"
"CHEMBL513330";"GW781673X";"None";"336.79";"0";"3.45";"GW781673X";"Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1";"Inhibition";"'='";"-1.15";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.15"
"CHEMBL2348862";"";"None";"383.45";"0";"1.95";"10b, CC214-2";"CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1";"Activity";"'='";"95.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2352820";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346597";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";"";"95.0"
"CHEMBL4251240";"";"None";"427.51";"0";"0.64";"13f";"COCCn1cc(-c2nn(C3CCN(C(=O)CN(C)C)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4289875";"";"None";"340.36";"0";"2.59";"12";"Cc1cc(F)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251839";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"2.0"
"CHEMBL4291200";"";"None";"442.37";"0";"1.54";"30";"CNc1cc(Nc2c(F)c(F)cc(F)c2F)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"14.35";"0.28";"4.81";"5.13";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.45"
"CHEMBL4293510";"";"None";"488.42";"0";"4.92";"34";"NC(=O)c1cnc2c(N[C@H]3C[C@H]3F)cc(Nc3cccc(-c4ccc(C(F)(F)F)cc4F)c3)nn12";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.56";"0.30";"2.68";"7.81";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.025"
"CHEMBL4285755";"";"None";"336.40";"0";"2.76";"11";"Cc1cc(C)cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)c1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"18.30";"0.34";"3.39";"6.32";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.7"
"CHEMBL4295039";"";"None";"398.47";"0";"2.27";"27";"CNc1cc(Nc2ccccc2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"17.13";"0.32";"4.55";"6.05";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.15"
"CHEMBL255863";"NILOTINIB";"4.0";"529.53";"2";"6.36";"Nilotinib";"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"4, CP-690550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Kd";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"19.87";"0.37";"4.67";"6.98";"1";"CHEMBL1292873";"Binding affinity to TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"620.0"
"CHEMBL5422022";"";"None";"457.51";"0";"2.67";"90-5";"COCCOc1cc(Nc2cc(NC(C)=O)ncc2-c2ccccn2)nc(S(C)(=O)=O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383677";"Inhibition of TYK2 signal transduction pathway in human TF-1 cells assessed as reduction in GM-CSF induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10.0"
"CHEMBL1971943";"BAY-549";"None";"402.79";"0";"4.71";"EUB0000716";"Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12";"% Control";"'='";"78.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507274";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"78.0"
"CHEMBL5433552";"";"None";"570.72";"2";"5.18";"21";"Cc1cnc(Nc2ccc(OCCCCCCC(=O)NO)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"IC50";"'='";"414.4";"nM";"6.38";"";"";"UO_0000065";"11.18";"0.22";"1.20";"4.13";"0";"CHEMBL5385206";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380863";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"414.4"
"CHEMBL5439582";"";"None";"415.90";"0";"3.60";"17c";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)C[C@@H]1F";"IC50";"'='";"458.5";"nM";"6.34";"";"";"UO_0000065";"15.24";"0.30";"2.74";"8.68";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"458.5"
"CHEMBL5402123";"";"None";"425.96";"0";"4.43";"33c";"CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccc(Cl)cc2)C(C)(C)C1";"IC50";"'='";"38.7";"nM";"7.41";"";"";"UO_0000065";"17.40";"0.34";"2.98";"10.15";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"38.7"
"CHEMBL5401575";"";"None";"463.52";"0";"1.97";"70-6";"[2H]C([2H])([2H])O[C@@H]1CC[C@H]1NC(=O)c1cnn2c(NC)cc(Nc3cccn(-c4ccccn4)c3=O)nc12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL5439447";"";"None";"505.56";"2";"1.70";"82-2";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(N3CC(O)C3)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Kd";"'='";"0.005";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.005"
"CHEMBL5409953";"";"None";"411.85";"0";"3.43";"9";"COC(=O)Cc1ccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)nc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.42";"0.38";"4.57";"6.71";"0";"CHEMBL5375114";"Inhibition of GST-fused TYK2 (888 to 1187 residues)(unknown origin) using FITC-Ahr-KKSRGDYMTMQIG-NH2 peptide as substrate incubated for 30 mins in presence of ATP by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5370660";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"10.0"
"CHEMBL5424385";"";"None";"449.53";"0";"3.39";"16";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1nn(CC)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5424385";"";"None";"449.53";"0";"3.39";"16";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1nn(CC)nc1-2";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"16.85";"0.31";"4.13";"6.38";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5439072";"";"None";"436.53";"0";"3.51";"22";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)C([2H])([2H])c1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5396254";"";"None";"460.53";"0";"4.23";"87-3";"[2H]C([2H])([2H])CC(=O)c1cnc(Nc2cccc(C#N)n2)cc1Nc1cccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"100.0"
"CHEMBL5401054";"";"None";"489.54";"1";"1.97";"70-1";"CNc1cc(Nc2cccn(-c3cnc(C(C)(C)O)cn3)c2=O)nc2c(C(=O)NC3CCC3)cnn12";"Kd";"'<'";"0.2";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"200.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"Baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"19.42";"0.38";"6.11";"5.98";"1";"CHEMBL4812339";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811248";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";"";"61.0"
"CHEMBL2219422";"AFURESERTIB";"2.0";"427.33";"0";"3.89";"GSK-2110183";"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1231124";"AZD-1480";"2.0";"348.77";"0";"3.01";"AZD-1480";"Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1727312";"";"None";"210.24";"0";"3.00";"SID103904709";"O=C1Nc2ccccc2Nc2ccccc21";"Ki";"'>'";"10000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.0"
"CHEMBL4564312";"BAY-786";"None";"672.12";"2";"5.26";"EUB0000335";"O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"46.0";"%";"";"";"Slightly Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507266";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"46.0"
"CHEMBL4577237";"BI 9446";"None";"602.48";"2";"5.77";"EUB0000549";"C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507282";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4533479";"A-1806262";"None";"558.68";"2";"5.81";"EUB0000339";"CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1";"% Control";"'='";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507261";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"81.0"
"CHEMBL346551";"";"None";"264.28";"0";"2.17";"SKF-62604";"O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1";"Inhibition";"'='";"-3.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.44"
"CHEMBL475761";"GW784684X";"None";"564.09";"2";"6.81";"GW784684X";"CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1";"Inhibition";"'='";"-3.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.9"
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1230609";"FORETINIB";"2.0";"632.66";"2";"5.77";"EXEL-2880/GSK-1363089";"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4753549";"";"None";"459.60";"0";"3.98";"13ac";"Cc1cnc(Nc2ccc3c(c2)CCN(C(=O)/C=C/CN(C)C)C3)nc1-c1cnn(C(C)C)c1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"15.50";"0.29";"3.14";"9.00";"1";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"75.0"
"CHEMBL4526283";"";"None";"415.45";"0";"2.87";"38";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"17.33";"0.34";"4.33";"6.37";"0";"CHEMBL5364826";"Inhibition of TYK2 JH2 in human KIT225 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation by AlphaLISA assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"63.0"
"CHEMBL5405178";"";"None";"400.42";"0";"0.74";"2a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(C)=O)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"131.0";"nM";"6.88";"";"";"UO_0000065";"17.32";"0.32";"6.14";"4.62";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"131.0"
"CHEMBL3985243";"";"None";"413.27";"0";"3.46";"BDBM198472";"FC(F)(Br)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"353450";"UO_0000065";"16.94";"0.38";"3.54";"9.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"100.0"
"CHEMBL3957921";"";"None";"324.43";"0";"2.88";"BDBM198488";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNCC5CC5)CC4)c23)[nH]1";"IC50";"'='";"68.0";"nM";"7.17";"";"353466";"UO_0000065";"22.09";"0.41";"4.29";"10.11";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"68.0"
"CHEMBL3907565";"";"None";"350.40";"0";"3.88";"BDBM198585";"Fc1ccc(N[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"353563";"UO_0000065";"18.89";"0.35";"2.74";"9.34";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"240.0"
"CHEMBL3944859";"";"None";"294.36";"0";"3.18";"BDBM198650";"N#CCC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"353628";"UO_0000065";"25.89";"0.47";"4.44";"9.22";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"24.0"
"CHEMBL4225537";"";"None";"523.66";"1";"2.53";"VH-298";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(C#N)CC2)C(C)(C)C)cc1";"Activity";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL5225296";"Induction of TYK2 degradation in human Jurkat cells at 1 uM incubated for 24 hrs in presence of 6-(5-fluoropyridin-2-ylamino)-4-(2-methoxy-3-(methylcarbamoyl)phenylamino)-N-methylnicotinamide by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM | TIME = 24.0 hr";"";"";""
"CHEMBL3137336";"UPROSERTIB";"2.0";"429.25";"0";"3.56";"Uprosertib";"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2107832";"PIMASERTIB";"2.0";"431.20";"0";"1.65";"Pimasertib";"O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3989914";"GLESATINIB";"2.0";"619.72";"2";"6.22";"MGCD-265";"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1908391";"MASITINIB";"4.0";"498.66";"1";"5.26";"AB-1010";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4552985";"";"None";"363.43";"0";"3.08";"12a";"C/C=C/C(=O)Nc1cccc(CNc2cc(Nc3cnn(C)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL4245728";"";"None";"409.45";"0";"1.00";"13d";"COCCn1cc(-c2nn(C3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4289426";"";"None";"396.50";"0";"2.88";"24";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(C)CO)cnc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.94";"0.41";"5.82";"8.40";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.002"
"CHEMBL4237694";"";"None";"397.49";"0";"0.61";"9e";"CN(C)CC(=O)N1CCCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";""
"CHEMBL4291611";"";"None";"358.41";"0";"3.28";"32";"CNc1cc(Nc2cccc(-c3ccccc3)c2)nn2c(C(N)=O)cnc12";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"18.69";"0.34";"3.42";"6.88";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.2"
"CHEMBL1173655";"AFATINIB";"4.0";"485.95";"0";"4.39";"Afatinib";"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4440767";"";"None";"397.44";"0";"1.05";"18";"COc1ccc(-c2cc3c(NC(CO)[C@H](O)C4CC4)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.34";"0.27";"4.65";"4.22";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"2000.0"
"CHEMBL1088751";"PH-797804";"2.0";"477.31";"0";"4.43";"PH-797804";"CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4069127";"";"None";"408.51";"0";"2.82";"30";"COc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"18.22";"0.34";"4.62";"6.17";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"36.0"
"CHEMBL2152768";"";"None";"504.61";"1";"4.13";"3";"CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1";"Inhibition";"'='";"2.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2157721";"Inhibition of TYK2 at 1 uM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2151019";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"2.7"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"11; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.96";"0.43";"7.97";"7.13";"0";"CHEMBL4377472";"Allosteric inhibition of fluorescein labeled probe binding to His-tagged recombinant human TYK2 pseudokinase JH2 domain (575-869 residues) incubated for 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.2"
"CHEMBL5193226";"";"None";"587.63";"1";"4.35";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC3)cc2)c1OC";"Tm";"'='";"68.68";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"68.68"
"CHEMBL5205855";"";"None";"518.55";"1";"2.43";"24";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc3c(c2)C(=O)NC3)c1OC";"Tm";"'='";"56.82";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"56.82"
"CHEMBL5191508";"";"None";"578.64";"1";"3.02";"30";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Tm";"'='";"63.51";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"63.51"
"CHEMBL5181780";"";"None";"507.53";"1";"1.68";"6";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(N)=O)cn2)c1OC";"Tm";"'='";"51.67";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"51.67"
"CHEMBL5189913";"";"None";"520.56";"1";"2.55";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NC)cc2)c1OC";"Tm";"'='";"54.58";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"54.58"
"CHEMBL5428659";"";"None";"424.47";"0";"1.27";"71-4";"CCOc1cccc(Nc2cc(NC)n3ncc(C(=O)N[C@@H]4CCN(C)C4=O)c3n2)n1";"IC50";"'<'";"254.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383633";"Inhibition of TYK2 JH2 (unknown origin) by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.254"
"CHEMBL4455923";"";"None";"575.63";"2";"4.23";"48c";"CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4405608";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4402587";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"50.0"
"CHEMBL263796";"GW445014X";"None";"307.18";"0";"3.92";"GW445014X";"CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1";"Inhibition";"'='";"-3.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.44"
"CHEMBL3964946";"";"None";"334.37";"0";"3.24";"BDBM255008";"CN1CN([C@H]2CC[C@H](C(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"44.0";"nM";"7.36";"";"443998";"UO_0000065";"22.00";"0.42";"4.12";"14.08";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"44.0"
"CHEMBL3956439";"";"None";"421.47";"0";"3.66";"BDBM255023";"O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1C1CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"444013";"UO_0000065";"15.95";"0.31";"3.06";"10.46";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"190.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690550, Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"25.96";"0.48";"6.57";"9.12";"0";"CHEMBL2155761";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"7.8"
"CHEMBL4069942";"";"None";"400.27";"0";"4.53";"21";"CN(C)c1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1";"EC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"17.12";"0.35";"2.32";"8.30";"0";"CHEMBL4046592";"Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"0.14"
"CHEMBL5285091";"";"None";"574.66";"1";"4.32";"4";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC(=O)C3CCCC3)cc2)c1OC";"Tm";"'='";"56.23";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"56.23"
"CHEMBL5270823";"";"None";"578.62";"1";"3.85";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2F)c1OC";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"14.32";"0.27";"4.39";"5.33";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"5.7"
"CHEMBL5075556";"";"None";"469.61";"0";"4.64";"54c";"CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2nc(NCCCCCN(C)C)ncc2c1";"IC50";"'='";"19.95";"nM";"7.70";"";"";"UO_0000065";"16.40";"0.31";"3.06";"8.23";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.7"
"CHEMBL5425044";"";"None";"492.52";"0";"2.50";"27";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@H](OC)C3)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5427213";"";"None";"484.44";"0";"2.73";"16";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CCC3(F)F)cnn12";"Kd";"'='";"0.31";"nM";"9.51";"";"";"UO_0000065";"19.63";"0.37";"6.78";"8.04";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.31"
"CHEMBL5418744";"";"None";"478.49";"0";"2.11";"17";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.003";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.003"
"CHEMBL5433700";"";"None";"464.46";"0";"1.45";"22";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@H]3O)cnn12";"Kd";"'='";"0.019";"nM";"10.72";"";"";"UO_0000065";"23.08";"0.43";"9.27";"7.74";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.019"
"CHEMBL5405274";"";"None";"492.52";"0";"2.50";"26";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@H](OC)C3)cnn12";"Kd";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"19.13";"0.36";"6.92";"7.39";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.38"
"CHEMBL5397381";"";"None";"425.49";"0";"2.16";"29";"CNc1cc(Nc2cccn(C(C)C)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.004";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL5430689";"";"None";"474.53";"0";"2.28";"34";"CNc1cc(Nc2cccn(-c3ccc(C)nc3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.034";"nM";"10.47";"";"";"UO_0000065";"22.06";"0.41";"8.19";"8.21";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.034"
"CHEMBL5414946";"";"None";"467.53";"0";"1.93";"40";"CNc1cc(Nc2cccn(C3CCOCC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.004";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL5440491";"";"None";"467.53";"0";"1.93";"42";"CNc1cc(Nc2cccn([C@@H]3CCCOC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'='";"0.004";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327932";"Binding affinity to human wild type TYK2 JH2 domain (G556/D888) expressed in mammalian expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL5420172";"";"None";"350.43";"0";"3.02";"7";"CNc1cc(Nc2cc(C)cc(C)c2)nc2c(C(=O)NC3CC3)cnn12";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"22.41";"0.41";"4.83";"9.42";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"14.0"
"CHEMBL5403825";"";"None";"512.59";"1";"2.19";"44";"CNc1cc(Nc2cccn(C3CCN(CCF)CC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"15.21";"0.29";"5.61";"6.62";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"16.0"
"CHEMBL5431732";"";"None";"439.48";"0";"1.15";"47";"CNc1cc(Nc2cccn(C3COC3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"17.57";"0.33";"6.57";"6.24";"0";"CHEMBL5327934";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"19.0"
"CHEMBL5396767";"";"None";"492.52";"0";"2.50";"24";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@@H]3CC[C@@]3(C)OC)cnn12";"Inhibition";"'<'";"50.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5327937";"Inhibition of TYK2 in human PBMC cells assessed as IL-12 induced phosphorylation of STAT4 level at 50 nM relative to control";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 50.0 nM";"";"";"50.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445881";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-15, JAK1/3, pSTAT5 in human CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"56.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"1377.0";"nM";"5.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445884";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine GM-CSF, JAK2, pSTAT5 in human monocytes)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Monocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307530";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"1377.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"877.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445890";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine GM-CSF, JAK2, pSTAT5 in rat monocytes)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Monocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3308025";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"877.0"
"CHEMBL5436255";"";"None";"435.51";"0";"2.91";"11";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5404455";"";"None";"448.55";"0";"4.07";"24";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)[C@@H](C)c1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690,550, Tofacitinib, Xeljanz";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"EC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"19.68";"0.37";"4.61";"6.92";"0";"CHEMBL2390364";"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"710.0"
"CHEMBL3942741";"";"None";"273.32";"0";"2.85";"BDBM198266";"FC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"353246";"UO_0000065";"29.12";"0.54";"5.11";"13.52";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"11.0"
"CHEMBL3918308";"";"None";"334.22";"0";"3.27";"BDBM198267";"BrC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"2.6";"nM";"8.59";"";"353247";"UO_0000065";"25.69";"0.59";"5.32";"14.58";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.6"
"CHEMBL3979340";"";"None";"401.27";"0";"3.34";"BDBM198348";"Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1";"IC50";"'='";"98.0";"nM";"7.01";"";"353326";"UO_0000065";"17.47";"0.38";"3.67";"9.31";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"98.0"
"CHEMBL3941241";"";"None";"346.44";"0";"3.42";"BDBM198393";"c1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"330.0";"nM";"6.48";"";"353371";"UO_0000065";"18.71";"0.34";"3.06";"9.14";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"330.0"
"CHEMBL3938956";"";"None";"392.44";"0";"3.33";"BDBM198410";"O=C(NCc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353388";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL491758";"";"None";"280.31";"0";"4.10";"SID103904610";"Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1";"Ki";"'='";"630.96";"nM";"6.20";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.2"
"CHEMBL3926894";"";"None";"445.45";"0";"3.07";"BDBM198657";"OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1cccnc1)C(F)(F)F";"IC50";"'='";"210.0";"nM";"6.68";"";"353570";"UO_0000065";"14.99";"0.29";"3.61";"6.42";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"210.0"
"CHEMBL3957659";"";"None";"367.84";"0";"3.03";"BDBM198359";"Clc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1";"IC50";"'='";"260.0";"nM";"6.58";"";"353337";"UO_0000065";"17.90";"0.35";"3.56";"8.78";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"260.0"
"CHEMBL3953486";"";"None";"368.39";"0";"3.26";"BDBM198365";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F";"IC50";"'='";"490.0";"nM";"6.31";"";"353343";"UO_0000065";"17.13";"0.32";"3.05";"10.16";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"490.0"
"CHEMBL3902256";"";"None";"423.57";"0";"2.68";"BDBM198537";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCC(N6CCOCC6)CC5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353515";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL256835";"";"None";"368.41";"0";"3.63";"SID103905255";"COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL482967";"CYC-116";"1.0";"368.47";"0";"3.07";"SID103904403";"Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1";"Ki";"'='";"79.43";"nM";"7.10";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"7.1"
"CHEMBL1909407";"";"None";"374.85";"0";"2.65";"SB-220025-R";"Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"1.47";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"1.47"
"CHEMBL3746463";"";"None";"419.89";"0";"3.85";"30";"COc1cc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC";"IC50";"'='";"28000.0";"nM";"4.55";"";"";"UO_0000065";"10.84";"0.21";"0.70";"5.41";"0";"CHEMBL3751021";"Inhibition of N-terminal 6His-tagged human recombinant Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745697";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";"";"28.0"
"CHEMBL4207079";"";"None";"498.44";"0";"3.70";"17";"Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1";"Activity";"'='";"98.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4187312";"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184198";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"98.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"65.3";"nM";"7.18";"";"";"UO_0000065";"16.89";"0.33";"5.21";"7.43";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"65.3"
"CHEMBL5427932";"";"None";"412.93";"0";"3.44";"21a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)nc2)[C@H](C)C1";"IC50";"'='";"13.1";"nM";"7.88";"";"";"UO_0000065";"19.09";"0.37";"4.44";"9.17";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"13.1"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"3";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"111.7";"nM";"6.95";"";"";"UO_0000065";"16.34";"0.32";"4.97";"7.19";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"111.7"
"CHEMBL5408324";"";"None";"412.93";"0";"3.44";"20a";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cn2)[C@H](C)C1";"IC50";"'='";"16.6";"nM";"7.78";"";"";"UO_0000065";"18.84";"0.37";"4.34";"9.05";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"16.6"
"CHEMBL5397297";"";"None";"445.49";"0";"4.41";"36b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(C(F)(F)F)cc2)[C@@H](C)C1";"IC50";"'='";"58.3";"nM";"7.23";"";"";"UO_0000065";"16.24";"0.31";"2.82";"9.90";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"58.3"
"CHEMBL103098";"";"None";"356.41";"0";"2.23";"SB-738482";"NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1";"Inhibition";"'='";"-5.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-5.6"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"6a";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"Ki";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"28.21";"0.52";"6.87";"11.86";"1";"CHEMBL5327931";"Inhibition of TYK2 JH2 domain (unknown origin) in presence of 10 uM of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.13"
"CHEMBL5437552";"";"None";"508.53";"2";"2.95";"4h";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(C(C)(C)O)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"19.78";"0.37";"7.05";"6.25";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.1"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690,550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"25.96";"0.48";"6.57";"9.12";"1";"CHEMBL2390026";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"7.8"
"CHEMBL4175808";"";"None";"399.52";"0";"3.41";"22";"Cc1cnc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)nc1N[C@H](C)C(C)C";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"11.56";"0.22";"1.21";"6.68";"0";"CHEMBL4145191";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138312";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"24.0"
"CHEMBL3609749";"";"None";"514.48";"1";"4.67";"EUB0000753";"COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507289";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"3, INCB-018424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"25.20";"0.46";"4.25";"9.28";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"19.0"
"CHEMBL3943509";"";"None";"366.47";"0";"2.43";"BDBM255012";"CN(CC#N)C[C@H]1CC[C@H](N2CN(C)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"240.0";"nM";"6.62";"";"444002";"UO_0000065";"18.06";"0.33";"4.19";"8.35";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"240.0"
"CHEMBL3942783";"";"None";"434.47";"0";"3.36";"BDBM254994";"CN(CC#N)C[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"440.0";"nM";"6.36";"";"444035";"UO_0000065";"14.63";"0.28";"3.00";"8.02";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"440.0"
"CHEMBL3930342";"";"None";"395.43";"0";"3.12";"BDBM254996";"CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"444051";"UO_0000065";"19.06";"0.37";"4.42";"11.73";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"29.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"BDBM103727";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"86.77";"nM";"7.06";"";"221733";"UO_0000065";"16.60";"0.32";"5.08";"7.30";"0";"CHEMBL3707911";"Inhibition Assay: In vitro inhibition assay using various enzyme.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638964";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"86.77"
"CHEMBL5086595";"";"None";"558.09";"2";"5.05";"EUB0000090b";"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1";"% of control";"'='";"99.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5476289";"Selectivity interaction (Ambit KINOMEscan and KiNATiv profiling in Jurkat cells) EUB0000090b TYK2";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307526";"Selectivity number of off-targets = 9.0 None | Selectivity number of targets = 456.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://www.nature.com/articles/nchembio.2166";"";"";"99.0"
"CHEMBL3947889";"";"None";"342.47";"0";"2.89";"BDBM198457";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCSC5)CC4)c23)[nH]1";"IC50";"'='";"160.0";"nM";"6.80";"";"353435";"UO_0000065";"19.84";"0.39";"3.91";"10.94";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"160.0"
"CHEMBL3907648";"";"None";"326.40";"0";"1.87";"BDBM198497";"c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5COC5)CC4)c23)[nH]1";"IC50";"'='";"340.0";"nM";"6.47";"";"353475";"UO_0000065";"19.82";"0.37";"4.60";"8.07";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"340.0"
"CHEMBL3934116";"";"None";"381.22";"0";"3.31";"BDBM198570";"IC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"7.3";"nM";"8.14";"";"353548";"UO_0000065";"21.34";"0.56";"4.83";"13.82";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"7.3"
"CHEMBL3946758";"";"None";"320.35";"0";"2.49";"BDBM198606";"FC(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"353584";"UO_0000065";"20.91";"0.40";"4.21";"9.45";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"200.0"
"CHEMBL3890993";"";"None";"326.40";"0";"1.56";"BDBM198610";"OC1CN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'='";"810.0";"nM";"6.09";"";"353588";"UO_0000065";"18.66";"0.35";"4.53";"7.40";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"810.0"
"CHEMBL3903493";"";"None";"340.43";"0";"1.95";"BDBM198611";"O[C@H]1CCN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353589";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3980120";"";"None";"406.46";"0";"4.15";"BDBM198622";"FC(F)(F)CN(CC1CC1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353600";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3896324";"";"None";"373.44";"0";"1.32";"BDBM198626";"N#CCNS(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"353604";"UO_0000065";"17.59";"0.35";"5.25";"5.10";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"270.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1171837";"PONATINIB";"4.0";"532.57";"1";"4.46";"Ponatinib";"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5436690";"";"None";"427.50";"0";"2.97";"87-2";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C([2H])([2H])[2H])n2)c1OC";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"100.0"
"CHEMBL5418587";"";"None";"499.58";"0";"4.11";"92-4";"CNC(=O)c1cnc2cc1Nc1cc(cc(-c3ccn(C)n3)c1OC)CCOCc1nc(ccc1C)N2";"IC50";"'<='";"50.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383666";"Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 level";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"50.0"
"CHEMBL4785957";"";"None";"436.49";"0";"2.70";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C)cn2)c1OC";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"20.58";"0.38";"6.22";"6.81";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.2"
"CHEMBL4792231";"";"None";"480.54";"0";"2.62";"18";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(C)(C)O)cn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4800399";"";"None";"521.60";"1";"2.88";"21";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(C(=O)N(CC)CC)cn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4785512";"";"None";"492.55";"0";"2.70";"27";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(=O)N(C)C)cn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4792694";"";"None";"493.54";"0";"2.10";"29";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(=O)N(C)C)nn2)c1OC";"IC50";"'<'";"0.25";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"0.25"
"CHEMBL4784838";"";"None";"498.53";"0";"2.76";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(-c2ncc(C(C)(C)O)cn2)c1OC";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.63";"0.29";"4.98";"5.12";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"18.0"
"CHEMBL4797596";"";"None";"480.54";"0";"2.62";"28";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ccc(C(C)(C)O)nn2)c1OC";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"15.08";"0.28";"4.58";"4.76";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"63.0"
"CHEMBL502835";"NINTEDANIB";"4.0";"539.64";"1";"3.62";"BIBF-1120";"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1";"Kd";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"13.77";"0.25";"3.81";"7.89";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"37.0"
"CHEMBL482967";"CYC-116";"1.0";"368.47";"0";"3.07";"Cyc-116";"Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1";"Kd";"'='";"1021.0";"nM";"5.99";"";"Active";"UO_0000065";"16.26";"0.31";"2.92";"6.72";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.88 None";"";"";"1021.0"
"CHEMBL3039513";"DECERNOTINIB";"2.0";"392.39";"0";"3.28";"48";"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F";"Ki";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"20.28";"0.39";"4.68";"8.33";"0";"CHEMBL5245567";"Inhibition of TYK2 (unknown origin) assessed as inhibition constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"11.0"
"CHEMBL1381197";"";"None";"335.80";"0";"4.06";"SID103904921";"Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL226403";"";"None";"340.39";"0";"3.58";"SID103905260";"O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4539137";"";"None";"349.40";"0";"2.69";"11a";"C=CC(=O)Nc1cccc(CNc2cc(Nc3cnn(C)c3)ncn2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4482014";"Inhibition of human TYK2 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4480445";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";""
"CHEMBL4075278";"";"None";"417.85";"0";"4.43";"EUB0000316";"O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1";"% Control";"'='";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507304";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"94.0"
"CHEMBL535";"SUNITINIB";"4.0";"398.48";"0";"3.33";"Sunitinib";"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C";"Kd";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"14.54";"0.27";"2.47";"7.50";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"1600.0"
"CHEMBL1939876";"BI 4394";"None";"446.46";"0";"3.37";"EUB0000730";"CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1";"% Control";"'='";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507281";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"91.0"
"CHEMBL4082756";"TP-024";"None";"392.36";"0";"3.73";"EUB0000317";"Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507305";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3920352";"";"None";"400.41";"0";"4.00";"BDBM198215";"FC(F)(F)c1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353197";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3916915";"";"None";"400.41";"0";"4.00";"BDBM198225";"FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"630.0";"nM";"6.20";"";"353207";"UO_0000065";"15.49";"0.29";"2.20";"9.98";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"630.0"
"CHEMBL3943946";"";"None";"310.41";"0";"2.73";"BDBM198243";"c1cc2c(ncn3nnc(C4CCN(C5CCCC5)CC4)c23)[nH]1";"IC50";"'>'";"1000.0";"nM";"";"";"353225";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3972475";"";"None";"393.40";"0";"3.14";"BDBM198245";"N#Cc1cc(F)c(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1";"IC50";"'='";"47.0";"nM";"7.33";"";"353227";"UO_0000065";"18.63";"0.35";"4.19";"8.53";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"47.0"
"CHEMBL3986618";"";"None";"366.86";"0";"3.64";"BDBM198246";"Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"210.0";"nM";"6.68";"";"353228";"UO_0000065";"18.20";"0.35";"3.04";"10.75";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"210.0"
"CHEMBL3956311";"";"None";"392.43";"0";"3.91";"BDBM198249";"FC(F)(F)C1CCC(N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353230";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3956311";"";"None";"392.43";"0";"3.91";"BDBM198249";"FC(F)(F)C1CCC(N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353231";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3945787";"";"None";"256.31";"0";"1.59";"BDBM198254";"N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"440.0";"nM";"6.36";"";"353236";"UO_0000065";"24.80";"0.46";"4.77";"7.49";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"440.0"
"CHEMBL3926766";"";"None";"253.31";"0";"2.51";"BDBM198258";"c1cc2c(ncn3nnc(C4CC5CCC4C5)c23)[nH]1";"IC50";"'='";"25.0";"nM";"7.60";"";"353240";"UO_0000065";"30.01";"0.55";"5.09";"12.91";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"25.0"
"CHEMBL3891204";"";"None";"213.24";"0";"1.87";"BDBM198260";"c1cc2c(ncn3nnc(C4CCC4)c23)[nH]1";"IC50";"'='";"410.0";"nM";"6.39";"";"353242";"UO_0000065";"29.95";"0.55";"4.52";"10.85";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"410.0"
"CHEMBL3927252";"";"None";"287.39";"0";"2.81";"BDBM198269";"SC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"9.7";"nM";"8.01";"";"353249";"UO_0000065";"27.88";"0.55";"5.20";"13.61";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"9.7"
"CHEMBL3943557";"";"None";"257.30";"0";"1.62";"BDBM198276";"O[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"96.0";"nM";"7.02";"";"353255";"UO_0000065";"27.27";"0.50";"5.40";"8.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"96.0"
"CHEMBL3973060";"";"None";"375.43";"0";"3.73";"BDBM198277";"O=C(OCc1ccccc1)N1CCC(c2ncn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"540.0";"nM";"6.27";"";"353256";"UO_0000065";"16.69";"0.31";"2.54";"8.30";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"540.0"
"CHEMBL3970198";"";"None";"338.46";"0";"3.22";"BDBM198289";"CC1(C)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353267";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3899650";"";"None";"385.48";"0";"4.17";"BDBM198296";"Cc1cc(C#N)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"470.0";"nM";"6.33";"";"353274";"UO_0000065";"16.42";"0.30";"2.16";"6.68";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"470.0"
"CHEMBL3924171";"";"None";"444.46";"1";"5.20";"BDBM198297";"Cc1cc(OC(F)(F)F)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353275";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3956611";"";"None";"357.42";"0";"3.62";"BDBM198314";"N#Cc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"140.0";"nM";"6.85";"";"353292";"UO_0000065";"19.18";"0.35";"3.23";"7.24";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"140.0"
"CHEMBL3899570";"";"None";"418.40";"0";"4.14";"BDBM198353";"Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F";"IC50";"'='";"700.0";"nM";"6.16";"";"353331";"UO_0000065";"14.71";"0.28";"2.01";"9.91";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"700.0"
"CHEMBL3936565";"";"None";"434.85";"0";"4.66";"BDBM198354";"FC(F)(F)c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl";"IC50";"'>'";"1000.0";"nM";"";"";"353332";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4095596";"";"None";"342.40";"0";"2.84";"45";"CC(CCCCCC(=O)NO)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"19.98";"0.37";"4.00";"6.29";"0";"CHEMBL4031309";"Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]-ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028864";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.144"
"CHEMBL445813";"AT-7519";"2.0";"382.25";"0";"2.45";"AT-7519";"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL3644618";"";"None";"499.52";"1";"5.36";"22";"CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(F)cc3)C4)n[nH]c2c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"18.21";"0.34";"3.74";"9.29";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"0.8"
"CHEMBL5207378";"";"None";"368.34";"0";"3.42";"16";"COc1ccc(Nc2nc(-c3c(F)cccc3F)nc3c2C(=O)NC3)cc1";"Ki";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"21.90";"0.41";"4.65";"10.59";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"8.6"
"CHEMBL5188608";"";"None";"423.42";"0";"3.25";"21";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(N4CCOCC4)cn3)c21";"Ki";"'='";"0.36";"nM";"9.44";"";"";"UO_0000065";"22.30";"0.42";"6.19";"11.90";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.36"
"CHEMBL4870513";"";"None";"509.95";"1";"3.38";"18; RDN009";"COc1cc(Nc2nc(NCc3cccc(NC(=O)CCl)c3)n3ccnc3c2C(N)=O)cc(OC)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4821574";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4819075";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"";"";"1.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"3";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"11.55";"0.23";"1.83";"5.06";"0";"CHEMBL4251842";"Inhibition of TYK2 JH2 domain in IFNalpha-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.97"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"35.5";"nM";"7.45";"";"";"UO_0000065";"23.85";"0.44";"5.91";"8.38";"0";"CHEMBL4236385";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229546";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";"";"35.5"
"CHEMBL4536197";"A-486";"None";"536.48";"1";"3.68";"EUB0000326";"CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O";"% Control";"'='";"68.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507259";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"68.0"
"CHEMBL230011";"TG100-115";"2.0";"346.35";"0";"2.33";"TG-100-115";"Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4539943";"BAY-694";"None";"505.57";"1";"3.60";"EUB0000725";"O=C(O)[C@@H]1[C@@H](Cn2nnc3ccccc3c2=O)CC[C@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1";"% Control";"'='";"58.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507264";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"58.0"
"CHEMBL5184857";"";"None";"401.42";"0";"2.79";"8";"O=C(Nc1nc2cccc(C3=CCC(NC(=O)C4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"73.0";"nM";"7.14";"";"";"UO_0000065";"17.78";"0.34";"4.35";"8.07";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"73.0"
"CHEMBL5200989";"";"None";"403.43";"0";"2.88";"11";"O=C(Nc1nc2cccc(C3CCC(NC(=O)C4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.83";"0.38";"5.12";"9.05";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"10.0"
"CHEMBL5195684";"";"None";"401.42";"0";"2.79";"18";"O=C(Nc1nc2cccc(C3=CC[C@@H](NC(=O)[C@@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"1369.0";"nM";"5.86";"";"";"UO_0000065";"14.61";"0.28";"3.07";"6.63";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"1369.0"
"CHEMBL5195551";"";"None";"401.42";"0";"2.79";"19";"O=C(Nc1nc2cccc(C3=CC[C@@H](NC(=O)[C@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"942.0";"nM";"6.03";"";"";"UO_0000065";"15.01";"0.28";"3.24";"6.82";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"942.0"
"CHEMBL5174068";"";"None";"401.42";"0";"2.79";"20";"O=C(Nc1nc2cccc(C3=CC[C@H](NC(=O)[C@H]4CC4(F)F)CC3)n2n1)C1CC1";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"17.81";"0.34";"4.36";"8.09";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"71.0"
"CHEMBL5191228";"";"None";"457.53";"0";"4.00";"25";"O=C(Nc1nc2cccc(C3CCC4(CC3)CCN(C(=O)[C@@H]3CC3(F)F)CC4)n2n1)C1CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"16.58";"0.31";"3.59";"9.53";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"26.0"
"CHEMBL5181588";"";"None";"429.47";"0";"3.22";"35";"O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)[C@H]3CC3(F)F)C4)n2n1)C1CC1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"15.00";"0.28";"3.22";"8.10";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"360.0"
"CHEMBL5081617";"";"None";"356.39";"0";"0.44";"6";"Cc1cnc(Nc2cnn(C)c2)nc1N1CCC2(CC1)NC(=O)NC2=O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"20.96";"0.39";"7.03";"6.38";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"34.0"
"CHEMBL5087106";"";"None";"385.44";"0";"2.78";"40";"COc1ccc(Nc2ncc(C)c(N3CCC4(CCNC4=O)CC3)n2)cc1F";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.16";"0.38";"4.99";"9.79";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"17.0"
"CHEMBL1241855";"RIGOSERTIB";"3.0";"451.50";"0";"2.80";"Rigosertib";"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL281948";"K-252A";"None";"467.48";"0";"3.66";"K-252a";"COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2396661";"ALPELISIB";"4.0";"441.48";"0";"3.84";"BYL-719";"Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL608533";"MIDOSTAURIN";"4.0";"570.65";"2";"5.91";"PKC-412";"CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Kd";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"11.57";"0.21";"0.69";"8.49";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"250.0"
"CHEMBL5084809";"";"None";"365.44";"0";"2.53";"18";"CC(=O)N1CCC(Nc2cccc3cnc(Nc4cnn(C)c4)nc23)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.15";"0.35";"4.47";"7.96";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL215814";"GW576484X";"None";"614.62";"2";"6.50";"GW576484X";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1";"Inhibition";"'='";"-4.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.14"
"CHEMBL373598";"";"None";"447.88";"0";"3.35";"16a";"N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2";"Ki";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL915372";"Inhibition of Tyk2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142994";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";"";"10.0"
"CHEMBL5432382";"";"None";"478.49";"0";"2.11";"18";"CNc1cc(Nc2cccn(-c3ncccc3F)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL5396334";"";"None";"481.51";"0";"2.11";"19";"[2H]C([2H])([2H])O[C@@H]1CC[C@H]1NC(=O)c1cnn2c(NC)cc(Nc3cccn(-c4ncccc4F)c3=O)nc12";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5327929";"Binding affinity to TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL417804";"";"None";"445.50";"0";"4.87";"SB-251527";"COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1";"Inhibition";"'='";"-3.01";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.01"
"CHEMBL473420";"GSK-1030058A";"None";"492.48";"1";"5.49";"GSK1030058A";"COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F";"Inhibition";"'='";"-1.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.4"
"CHEMBL514162";"GW852849X";"None";"443.91";"0";"4.44";"GW852849X";"COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC";"Inhibition";"'='";"2.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"2.29"
"CHEMBL517666";"GW796921X";"None";"336.44";"0";"4.15";"GW796921X";"CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1";"Inhibition";"'='";"-2.17";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.17"
"CHEMBL352222";"";"None";"394.17";"0";"3.09";"SB-358518";"O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1";"Inhibition";"'='";"-1.44";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.44"
"CHEMBL1230609";"FORETINIB";"2.0";"632.66";"2";"5.77";"EXEL-2880/GSK-1363089";"COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1";"Kd";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.38";"0.16";"-0.47";"4.76";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"5000.0"
"CHEMBL4098877";"MLi-2";"None";"379.46";"0";"3.56";"EUB0000715";"C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1";"% Control";"'='";"76.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"76.0"
"CHEMBL3613594";"";"None";"320.19";"0";"3.24";"1";"CC(C)c1nn(C)cc1-c1nc2cc(Br)cnc2[nH]1";"Inhibition";"'='";"60.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3615450";"Inhibition of Tyk2 (unknown origin) at 3 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3612014";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";"";"60.0"
"CHEMBL522892";"DOVITINIB";"3.0";"392.44";"0";"2.54";"CHIR-258/TKI-258";"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1";"Kd";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"17.39";"0.32";"4.28";"7.26";"0";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"150.0"
"CHEMBL66292";"PYRAZOLOPYRIMIDINE 2";"None";"422.47";"0";"2.67";"GW811168X";"COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1";"Inhibition";"'='";"-0.06";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.06"
"CHEMBL3905686";"";"None";"417.95";"0";"3.59";"BDBM239963";"CC(=O)N1CCC2(CCC(Nc3nc(Nc4cnn(C)c4)ncc3Cl)CC2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"418602";"UO_0000065";"20.09";"0.40";"4.81";"9.55";"0";"CHEMBL3888836";"Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 Î¼L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886854";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"4.0"
"CHEMBL3947742";"";"None";"444.46";"0";"3.67";"BDBM198397";"OC(CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"353375";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3907227";"";"None";"378.41";"0";"3.66";"BDBM198409";"O=C(Nc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353387";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"6";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"14.01";"0.27";"2.42";"6.80";"1";"CHEMBL5347006";"Inhibition of recombinant human N-terminal histidine-tagged/C-terminal FLAG-tagged TYK2 (880 to 1185 residues) in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"4690.0"
"CHEMBL4580220";"BAY-3827";"None";"468.54";"1";"5.45";"EUB0000311";"CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3935174";"";"None";"366.86";"0";"4.40";"BDBM198408";"Clc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"750.0";"nM";"6.12";"";"353386";"UO_0000065";"16.70";"0.32";"1.72";"8.64";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"750.0"
"CHEMBL3933458";"";"None";"356.41";"0";"2.45";"BDBM198412";"O=C([C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)N1CC[C@H](F)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353390";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"2, INCB018424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"25.20";"0.46";"4.25";"9.28";"1";"CHEMBL2155757";"Inhibition of human TYK2 kinase domain expressed in Sf21 cells using EQEDEPEGDYFEWLE as substrate after 1 hr by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"CHEMBL4106362";"";"";"";"19.0"
"CHEMBL3655080";"";"None";"363.37";"0";"1.41";"BDBM159747";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC(F)(F)F)C1";"IC50";"'='";"1020.0";"nM";"5.99";"";"302641";"UO_0000065";"16.49";"0.34";"4.58";"6.59";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1020.0"
"CHEMBL399410";"";"None";"453.57";"1";"5.72";"SB-437013";"COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1";"Inhibition";"'='";"-2.53";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.53"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"3; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.96";"0.43";"7.97";"7.13";"1";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.2"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"16";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"29.09";"0.53";"5.01";"14.62";"1";"CHEMBL5245498";"Inhibition of N-terminal flag tagged human TYK2 expressed in baculovirus infected Sf9 cells using biotin-EQEDEPEGDYFEWLE-NH2 as substrate in the presence of [gamma p33]-ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"16";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"29.09";"0.53";"5.01";"14.62";"1";"CHEMBL5245517";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL3967688";"";"None";"377.44";"0";"2.83";"BDBM255011";"CN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O";"IC50";"'='";"84.0";"nM";"7.08";"";"444001";"UO_0000065";"18.75";"0.36";"4.25";"11.01";"0";"CHEMBL3889260";"Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.ÃÂ  As the assay buffer, one having the following composition was used.ÃÂ  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3887014";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"84.0"
"CHEMBL3980992";"";"None";"342.45";"0";"2.46";"BDBM198528";"COCCN(C)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"880.0";"nM";"6.06";"";"353506";"UO_0000065";"17.68";"0.33";"3.60";"8.49";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"880.0"
"CHEMBL3907394";"";"None";"386.50";"0";"2.47";"BDBM198529";"COCCN(CCOC)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353507";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3959556";"";"None";"308.39";"0";"2.10";"BDBM198536";"C#CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"353514";"UO_0000065";"21.30";"0.39";"4.47";"9.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"270.0"
"CHEMBL3916687";"";"None";"409.42";"0";"2.15";"BDBM198544";"O=C(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F";"IC50";"'='";"320.0";"nM";"6.50";"";"353522";"UO_0000065";"15.86";"0.31";"4.34";"6.49";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"320.0"
"CHEMBL590109";"";"None";"425.52";"0";"4.40";"31a";"NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.75";"0.22";"0.60";"4.49";"0";"CHEMBL1073288";"Inhibition of TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153138";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10.0"
"CHEMBL261849";"GW632580X";"None";"366.42";"0";"2.83";"GW632580X";"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1";"Inhibition";"'='";"0.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.26"
"CHEMBL2387224";"";"None";"350.20";"0";"3.99";"46";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"23.75";"0.49";"4.33";"11.70";"1";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.0048"
"CHEMBL191003";"JNJ-7706621";"None";"394.36";"0";"1.22";"1, JNJ-7706621";"Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F";"Kd";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"19.01";"0.38";"6.27";"5.13";"1";"CHEMBL1292873";"Binding affinity to TYK2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"32.0"
"CHEMBL5424098";"";"None";"414.54";"0";"3.41";"A9";"CCS(=O)(=O)NCc1ccc(Nc2ncc(C)c(-c3cnn(C(C)C)c3)n2)cc1";"IC50";"'='";"192.0";"nM";"6.72";"";"";"UO_0000065";"16.20";"0.32";"3.31";"6.60";"0";"CHEMBL5329062";"Inhibition of TYK2 (unknown origin) in presence of Mg/ATP mixture by [gamma p33]-ATP based radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325511";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"192.0"
"CHEMBL5431366";"";"None";"374.51";"0";"2.30";"a25";"CNCCN(C)Cc1cncc(-c2ccc(NS(=O)(=O)C3CC3)cc2)c1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL5333398";"Inhibition of TYK2 (unknown origin) at 10 uM by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5331091";"1";"Scientific Literature";"Eur J Med Chem";"2023";"None";"DOSE = 10.0 microM";"";"";""
"CHEMBL5394230";"";"None";"436.53";"0";"3.51";"12";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)C([2H])([2H])c1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5278465";"";"None";"392.85";"0";"4.40";"33";"O=C(Nc1cnccc1-c1ccc(Cl)cc1)c1ccnc(NC(=O)C2CC2)c1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5252893";"Inhibition of TYK2 (unknown origin) by Ambit kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252511";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";"";"2.0"
"CHEMBL188343";"REVERSINE";"None";"393.50";"0";"3.68";"22";"c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"17.59";"0.33";"3.24";"7.61";"0";"CHEMBL5364815";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH1 (886 to 1187 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.12"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"31";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"15.74";"0.30";"3.28";"5.22";"1";"CHEMBL5364824";"Inhibition of N-terminal His-tagged human TYK2 JH2 domain incubated for 30 mins by scintillation method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.5 hr";"INHIBITOR";"";"480.0"
"CHEMBL5419652";"";"None";"410.41";"0";"4.55";"34";"N#Cc1ccc(Nc2nccc(C(=O)Nc3cnccc3-c3ccc(F)cc3)n2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5343418";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338804";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"50.0"
"CHEMBL1908396";"";"None";"480.55";"1";"5.39";"Ki-20227";"COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1950289";"TANZISERTIB";"2.0";"448.45";"0";"3.66";"EUB0000618a";"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1";"% of control";"'='";"61.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5467745";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0000618a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Screened against a panel of 75 receptors, ion channels and neurotransmitter transporters at 10 uM: no target >50% inhibition; Screened against 22 diverse non-kinase enzymes at 10 uM, no inhibition >50%, https://pubmed.ncbi.nlm.nih.gov/22244937/; Inhibited LPS-induced TNF+- production (PK-PD model) by 23% and 77% at 10 and 30 mg/kg oral dose respectively, https://pubmed.ncbi.nlm.nih.gov/22244937/; | Selectivity number of off-targets = 8.0 None | Selectivity number of targets = 442.0 None | Selectivity Remarks: Screened at 10 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20114/results";"";"";"61.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"367.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445876";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-6, JAK1/2, pSTAT3 in CD3+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"367.0"
"CHEMBL5424497";"";"None";"380.41";"0";"1.92";"43";"CNC(=O)c1nnc(NC(=O)C2CC2)c2[nH]c(-c3ccc(N)cc3OC)cc12";"Kd";"'='";"0.019";"nM";"10.72";"";"";"UO_0000065";"28.18";"0.52";"8.80";"7.94";"0";"CHEMBL5364840";"Binding affinity to human recombinant TYK2 (556 to 871 residues) incubated for 10 hrs by microplate reader based analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 10.0 hr";"INHIBITOR";"";"0.019"
"CHEMBL5420187";"";"None";"535.56";"2";"2.55";"4f";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(N3CCOCC3)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"17.32";"0.32";"6.67";"6.06";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.6"
"CHEMBL5427107";"";"None";"440.48";"0";"1.52";"2f";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CC2CC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"16.89";"0.32";"5.87";"4.96";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"41.0"
"CHEMBL5396654";"";"None";"465.47";"1";"2.42";"4c";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2cnc(C)cn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"15.19";"0.28";"4.61";"4.60";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"94.0"
"CHEMBL481510";"GW853606X";"None";"496.31";"1";"5.55";"GW853606X";"NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br";"Inhibition";"'='";"-4.87";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.87"
"CHEMBL4289375";"";"None";"409.44";"0";"3.42";"17j";"COC(=O)[C@H](C(C)C)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"1502.0";"nM";"5.82";"";"";"UO_0000065";"14.22";"0.27";"2.40";"6.10";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1502.0"
"CHEMBL4277379";"";"None";"365.39";"0";"2.89";"7b";"CN(C)CCCn1c(=O)c2cc([N+](=O)[O-])ccc2c2cnc3[nH]ccc3c21";"IC50";"'='";"4766.0";"nM";"5.32";"";"";"UO_0000065";"14.56";"0.27";"2.43";"5.48";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"4766.0"
"CHEMBL4286103";"";"None";"445.48";"0";"2.98";"20a";"CC[C@H](C(=O)N1CC(C#N)C1)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21";"IC50";"'='";"73.66";"nM";"7.13";"";"";"UO_0000065";"16.01";"0.30";"4.15";"6.30";"0";"CHEMBL4261269";"Inhibition of TYK2 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257589";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"73.66"
"CHEMBL440687";"ABT-724";"None";"293.37";"0";"2.28";"EUB0000290";"c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507260";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3358954";"BI 653048";"1.0";"515.53";"1";"3.80";"EUB0000314";"CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507277";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4282878";"";"None";"291.31";"0";"2.52";"18";"N#CN[C@@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"'='";"1816.0";"nM";"5.74";"";"";"UO_0000065";"19.71";"0.36";"3.22";"6.63";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"1816.0"
"CHEMBL4290377";"";"None";"289.34";"0";"2.86";"24";"C[C@@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";""
"CHEMBL4292320";"";"None";"368.42";"0";"1.73";"28";"CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21";"IC50";"'>'";"9443.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"9443.0"
"CHEMBL5270549";"";"None";"353.81";"0";"4.02";"CEE321; 1";"Cc1cccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"20.41";"0.39";"3.20";"7.77";"0";"CHEMBL5252498";"Inhibition of GST-fused Tyk2 (888 to 1187 residues) (unknown origin) using FITC-AhxKKSRGDYMTMQIG-NH2 peptide as substrate incubated for 60 mins in presence of ATP by Janus kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247683";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"60.0"
"CHEMBL5396848";"";"None";"438.52";"0";"2.91";"15";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1nn(C([2H])([2H])[2H])nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5403157";"";"None";"435.54";"0";"4.12";"21";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)C([2H])([2H])c1cn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"SID103905596";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL477772";"PAZOPANIB";"4.0";"437.53";"0";"3.14";"Pazopanib";"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL608154";"";"None";"366.81";"0";"4.33";"MLN-120B";"COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C";"Kd";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"17.18";"0.33";"1.97";"7.89";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"500.0"
"CHEMBL554";"LAPATINIB";"4.0";"581.07";"2";"6.14";"SID103905567";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"11";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL4085582";"";"None";"264.29";"0";"2.75";"6";"C=CC(=O)Nc1cccc(-c2ncnc3[nH]ccc23)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4005720";"Inhibition of recombinant human His-tagged TYK2 expressed in baculovirus infected sf21 cells using 5FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by microfluidic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4004825";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10000.0"
"CHEMBL270544";"GW396574X";"None";"370.43";"0";"2.53";"GW396574X";"CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2";"Inhibition";"'='";"20.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"20.7"
"CHEMBL14014";"";"None";"433.46";"1";"5.00";"SB-251505";"Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1";"Inhibition";"'='";"-2.32";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-2.32"
"CHEMBL467581";"GSK-2219385A";"None";"520.57";"1";"3.52";"GSK2219385A";"COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1";"Inhibition";"'='";"-1.64";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.64"
"CHEMBL215814";"GW576484X";"None";"614.62";"2";"6.50";"GW576484X";"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1";"Inhibition";"'='";"-3.56";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.56"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"10.1";"nM";"8.00";"";"";"UO_0000065";"25.60";"0.47";"6.46";"8.99";"1";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"10.1"
"CHEMBL4238926";"";"None";"326.40";"0";"2.01";"5";"NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"25.43";"0.47";"6.29";"7.98";"1";"CHEMBL4714269";"Inhibition of human Tyk2 using Biotin-Lyn-Substrate-2 in presence of 1 mM ATP by phosphotyrosine-specific ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";"";"5.0"
"CHEMBL2178352";"";"None";"468.61";"1";"5.18";"9e";"CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"11.04";"0.20";"-0.01";"6.98";"0";"CHEMBL2188509";"Inhibition of human recombinant TYK2 by radiometric kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177100";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"6.7"
"CHEMBL5282623";"";"None";"587.63";"1";"4.64";"9";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1OC";"Tm";"'='";"68.84";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"68.84"
"CHEMBL5269164";"";"None";"544.59";"1";"2.98";"22";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3ncn(C)n3)cc2)c1OC";"Tm";"'='";"56.97";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"56.97"
"CHEMBL5273136";"";"None";"546.65";"1";"4.18";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3)cc2)c1OC";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.57";"0.27";"3.74";"5.76";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL1789963";"GW406108X";"None";"400.22";"1";"5.02";"GW406108X";"O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1";"Inhibition";"'='";"-3.77";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-3.77"
"CHEMBL405021";"";"None";"277.33";"0";"3.58";"SB-732941";"O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1";"Inhibition";"'='";"-4.78";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.78"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"Ruxolitinib";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Ki";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"30.22";"0.55";"5.79";"11.13";"0";"CHEMBL2186171";"Inhibition of purified TYK2 incubated for 30 mins";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176876";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"0.55"
"CHEMBL1880739";"GW305074X";"None";"520.95";"2";"5.01";"GW305074X";"O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1";"Inhibition";"'='";"-0.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.2"
"CHEMBL296468";"BMS-387032";"1.0";"380.54";"0";"3.66";"BMS-387032/SNS-032";"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL261849";"GW632580X";"None";"366.42";"0";"2.83";"GW-2580";"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"37";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"EC50";"'='";"168.0";"nM";"6.78";"";"";"UO_0000065";"17.98";"0.36";"3.48";"7.14";"0";"CHEMBL2389256";"Inhibition of TYK2 in human PBMC assessed as IL-12/IL18-stumulated IFNgamma production";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"168.0"
"CHEMBL3655095";"";"None";"335.43";"0";"1.25";"BDBM159762";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC2)C1";"IC50";"'='";"1870.0";"nM";"5.73";"";"302656";"UO_0000065";"17.08";"0.34";"4.48";"6.30";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1870.0"
"CHEMBL4635625";"";"None";"407.40";"0";"1.69";"19";"C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F";"Inhibition";"'='";"90.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4620453";"Inhibition of TYK2(unknown origin) in presence of 1 mM ATP relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619733";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"90.2"
"CHEMBL2387224";"";"None";"350.20";"0";"3.99";"46";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl";"Ratio";"'='";"100.0";"";"";"";"";"";"";"";"";"";"0";"CHEMBL2421778";"Ratio of EC50 for TYK2 in human NK92 cells to Ki for TYK2 (unknown origin)";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"NK92";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"100.0"
"CHEMBL3039513";"DECERNOTINIB";"2.0";"392.39";"0";"3.28";"decernotinib";"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"20.28";"0.39";"4.68";"8.33";"0";"CHEMBL3625892";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"11.0"
"CHEMBL3622826";"";"None";"287.37";"0";"0.56";"5c";"NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"18.90";"0.35";"4.87";"5.49";"0";"CHEMBL3625900";"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621116";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";"";"3.7"
"CHEMBL4649397";"";"None";"418.22";"None";"None";"14p";"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc4c(c3)COB4O)ncc2OC)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";"1000.0"
"CHEMBL4641076";"";"None";"217.27";"0";"1.90";"9";"Cc1[nH]nc2[nH]c(=O)cc(CC3CCC3)c12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"27.42";"0.51";"4.06";"9.68";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"1.1"
"CHEMBL4640521";"";"None";"245.33";"0";"2.85";"10";"Cc1[nH]nc2[nH]c(=O)cc([C@H]3CCCC[C@H]3C)c12";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"25.09";"0.47";"3.30";"10.00";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.7"
"CHEMBL1800285";"MSD-M1PAM";"None";"388.43";"0";"2.45";"EUB0000252";"N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1";"% Control";"'='";"93.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507295";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"93.0"
"CHEMBL1738757";"REBASTINIB";"2.0";"553.60";"2";"6.05";"Rebastinib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL400402";"";"None";"475.98";"1";"5.58";"TG-100572";"Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12";"Kd";"'='";"0.7";"nM";"9.15";"";"Active";"UO_0000065";"19.23";"0.37";"3.57";"10.98";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.96 None";"";"";"0.7"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"6; BMS-686165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"18.33";"0.34";"6.01";"5.70";"0";"CHEMBL4775529";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"18.0"
"CHEMBL4068357";"";"None";"342.45";"0";"2.32";"17";"C[C@@H]1CCN(C(=O)N2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"20.13";"0.38";"4.57";"10.08";"0";"CHEMBL4668315";"Inhibition of human TYK2 using 5FAM-KKSRGDYMTMQID as substrate by caliper microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665673";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"DEGRADER";"";"128.0"
"CHEMBL4072239";"";"None";"318.38";"0";"3.54";"3";"NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1";"IC50";"'='";"774.0";"nM";"6.11";"";"";"UO_0000065";"19.19";"0.35";"2.57";"7.64";"0";"CHEMBL4047230";"Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043231";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"774.0"
"CHEMBL103667";"DORAMAPIMOD";"2.0";"527.67";"2";"5.99";"BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL5289104";"";"None";"556.60";"1";"3.54";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3cccc(=O)[nH]3)cc2)c1OC";"Tm";"'='";"56.49";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"56.49"
"CHEMBL5270922";"";"None";"595.07";"1";"4.36";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)c(Cl)c2)c1OC";"Tm";"'='";"60.41";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"60.41"
"CHEMBL5273136";"";"None";"546.65";"1";"4.18";"13";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3)cc2)c1OC";"Tm";"'='";"58.23";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"58.23"
"CHEMBL5270922";"";"None";"595.07";"1";"4.36";"11";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCC3=O)c(Cl)c2)c1OC";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"14.37";"0.28";"4.15";"5.50";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"3.1"
"CHEMBL4592872";"BAY-897";"None";"457.48";"1";"6.33";"EUB0000340";"O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1";"% Control";"'='";"95.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507317";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"95.0"
"CHEMBL5438688";"";"None";"428.47";"0";"1.52";"2c";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CCC)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"108.0";"nM";"6.97";"";"";"UO_0000065";"16.37";"0.31";"5.45";"4.68";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"108.0"
"CHEMBL5397906";"";"None";"381.44";"0";"2.77";"91-2";"CO[C@@]1(c2cc(C)cc(-c3cc(C)n4cnc(NC(N)=O)cc34)n2)CCOC1";"Ki";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"22.81";"0.42";"5.93";"8.38";"0";"CHEMBL5383681";"Binding affinity to His-tagged human recombinant TYK2 JH2 (556 to 871 residues) incubated for 10 hrs by microplate reader based analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 10.0 hr";"INHIBITOR";"";"2.0"
"CHEMBL477772";"PAZOPANIB";"4.0";"437.53";"0";"3.14";"13";"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061188";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150977";"1";"Scientific Literature";"Nat Biotechnol";"2008";"None";"";"";"";"10.0"
"CHEMBL494089";"GSK-690693";"1.0";"425.49";"0";"1.58";"GSK-690693";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1094408";"NMS-1286937";"None";"448.53";"0";"1.58";"NMS-1286937";"COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2110732";"DACOMITINIB ANHYDROUS";"4.0";"469.95";"1";"5.16";"Dacomitinib";"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4531220";"BI 3047";"None";"515.53";"1";"3.80";"EUB0000586";"CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1";"% Control";"'='";"83.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507277";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"83.0"
"CHEMBL3286797";"PF-04418948";"1.0";"409.41";"0";"3.59";"EUB0000351";"COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1";"% Control";"'='";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507298";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"89.0"
"CHEMBL4066040";"A-1596584";"None";"539.53";"2";"5.45";"EUB0000264";"COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507262";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL581096";"GW440139A";"None";"363.85";"1";"5.05";"GW440139A";"Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl";"Inhibition";"'='";"-4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.0"
"CHEMBL4552180";"BAY-588";"None";"527.52";"2";"5.59";"EUB0000251";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507267";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"PF-06651600; 6";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4265557";"Inhibition of recombinant human His-tagged TYK2 expressed in SF21/baculovirus expression system using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261650";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"10000.0"
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"8; PF-06651600";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4377463";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10000.0"
"CHEMBL5077395";"";"None";"300.37";"0";"1.63";"7";"Cc1cnc(Nc2cnn(C)c2)nc1N1C2CCC1COC2";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"23.13";"0.43";"5.32";"10.20";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"113.0"
"CHEMBL5091093";"";"None";"370.43";"0";"2.36";"41";"Cc1cnc(Nc2ccc(F)c(N)c2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"21.72";"0.41";"5.69";"8.37";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"9.0"
"CHEMBL2436978";"";"None";"421.55";"1";"5.13";"1, URMC-099";"CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1";"Inhibition";"'>'";"90.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2439123";"Inhibition of human wild type TYK2 at 1 uM by qPCR analysis relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2434948";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"90.0"
"CHEMBL2386653";"";"None";"286.33";"0";"2.32";"21";"C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CCCOC1";"Ki";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"26.22";"0.49";"5.19";"9.88";"0";"CHEMBL2390365";"Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385026";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"31.0"
"CHEMBL5405043";"";"None";"403.49";"0";"2.65";"21b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C#N)nc2)[C@H](C)C1";"IC50";"'='";"74.9";"nM";"7.13";"";"";"UO_0000065";"17.66";"0.32";"4.48";"6.49";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"74.9"
"CHEMBL5415132";"";"None";"440.48";"0";"1.52";"2e";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CCC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"20.68";"0.39";"7.53";"6.08";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.9"
"CHEMBL5430970";"";"None";"413.46";"0";"1.73";"1a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)CC)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"22.16";"0.41";"7.37";"6.69";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.8"
"CHEMBL5401385";"";"None";"495.49";"1";"2.51";"4e";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(OCC)nn2)cc1Nc1nccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"288.0";"nM";"6.54";"";"";"UO_0000065";"13.28";"0.25";"4.03";"4.04";"0";"CHEMBL5365709";"Inhibition of TYK2 JH2 domain in human whole blood assessed as reduction in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.25 hr";"INHIBITOR";"";"288.0"
"CHEMBL5185192";"";"None";"385.44";"0";"2.72";"12";"O=C(Nc1nc2cccc(C3CCC(NC(=O)C4(F)CC4)CC3)n2n1)C1CC1";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"17.89";"0.34";"4.18";"7.80";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"127.0"
"CHEMBL3918875";"";"None";"369.43";"0";"3.35";"BDBM198433";"N#C/C(=C\N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"353411";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3971389";"";"None";"352.32";"0";"2.26";"BDBM198209";"O=C(CC(F)(F)F)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1";"IC50";"'='";"570.0";"nM";"6.24";"";"353191";"UO_0000065";"17.72";"0.34";"3.98";"7.89";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"570.0"
"CHEMBL3892138";"";"None";"357.42";"0";"2.86";"BDBM198227";"N#Cc1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'='";"460.0";"nM";"6.34";"";"353209";"UO_0000065";"17.73";"0.32";"3.48";"7.38";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"460.0"
"CHEMBL3975090";"";"None";"380.43";"0";"3.13";"BDBM198238";"COc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F";"IC50";"'>'";"1000.0";"nM";"";"";"353220";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3957937";"";"None";"350.40";"0";"3.12";"BDBM198247";"Fc1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1";"IC50";"'='";"390.0";"nM";"6.41";"";"353229";"UO_0000065";"18.29";"0.34";"3.29";"10.32";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"390.0"
"CHEMBL3892296";"";"None";"313.36";"0";"2.44";"BDBM198265";"CC(=O)OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"353245";"UO_0000065";"23.92";"0.45";"5.05";"8.80";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"32.0"
"CHEMBL3915165";"";"None";"378.46";"0";"4.15";"BDBM198295";"CN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353273";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3986660";"";"None";"444.46";"0";"4.57";"BDBM198303";"FC(F)(F)Oc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"4.9";"nM";"8.31";"";"353281";"UO_0000065";"18.70";"0.35";"3.74";"10.37";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"4.9"
"CHEMBL3973486";"";"None";"430.43";"0";"4.89";"BDBM198307";"FC(F)(F)Oc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"870.0";"nM";"6.06";"";"353285";"UO_0000065";"14.08";"0.27";"1.17";"7.56";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"870.0"
"CHEMBL3962232";"";"None";"392.46";"0";"2.36";"BDBM198367";"OCCOc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353345";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3954454";"";"None";"394.91";"0";"4.32";"BDBM198376";"Clc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"2.8";"nM";"8.55";"";"353354";"UO_0000065";"21.66";"0.42";"4.23";"12.06";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"2.8"
"CHEMBL3926817";"";"None";"408.94";"0";"4.37";"BDBM198377";"Clc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'='";"53.0";"nM";"7.28";"";"353355";"UO_0000065";"17.79";"0.34";"2.91";"10.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"53.0"
"CHEMBL3951107";"";"None";"376.47";"0";"3.01";"BDBM198379";"N#CCCN(CCC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"353357";"UO_0000065";"20.34";"0.37";"4.65";"6.98";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"22.0"
"CHEMBL3946125";"";"None";"462.45";"0";"3.81";"BDBM198403";"OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccc(F)cc1)C(F)(F)F";"IC50";"'='";"240.0";"nM";"6.62";"";"353381";"UO_0000065";"14.31";"0.27";"2.81";"7.26";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"240.0"
"CHEMBL4594441";"IFIDANCITINIB";"2.0";"395.39";"0";"4.16";"33";"COc1cc(Nc2ncc(C)c(Nc3ccc4oc(=O)[nH]c4c3)n2)cc(C)c1F";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"20.03";"0.37";"3.76";"7.54";"0";"CHEMBL5120640";"Inhibition of human recombinant N-terminal GST-tagged TYK2 (833 to 1187 residues) expressed in baculovirus expression system by Z'-lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113550";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"";"INHIBITOR";"";"12.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"EUB0001543a";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5479500";"Selectivity interaction (HTRF assay) EUB0001543a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Remarks: In-vitro potency (using 1 mM ATP) | Source Knowledge: https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00444";"";"";"10.0"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"EUB0000050b";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5475821";"Selectivity interaction (Ambit KINOMEscan) EUB0000050b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 9.0 None | Selectivity number of targets = 402.0 None | Selectivity Remarks: Screened at 10 uM (in-vitro potency, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://ashpublications.org/blood/article/114/14/2984/107842/AC220-is-a-uniquely-potent-and-selective-inhibitor";"";"";"10000.0"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"37";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"25.49";"0.47";"7.04";"6.86";"1";"CHEMBL5364814";"Inhibition of human recombinant C-terminal Histidine tagged TYK2 JH2 (564 to 876 residues) expressed in Sf9 cells by chromatography method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.46"
"CHEMBL5421894";"";"None";"780.91";"2";"6.08";"SKS; yl19";"C/C(=C\C[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)[O-])[C@H]4C[C@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])C[C@]4(C)[C@H]3CC[C@]12C)C(C)(C)C(C)C.[Na+].[Na+].[Na+]";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"8.78";"0.19";"0.20";"3.29";"0";"CHEMBL5389346";"Inhibition of N-terminal GST-tagged human TYK2 (871to 1187 residues) expressed in Sf21 cells incubated for 30 mins in presence of ATP by LANCE Ultra assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5385928";"1";"Scientific Literature";"J Nat Prod";"2024";"None";"TIME = 0.5 hr";"INHIBITOR";"";"0.53"
"CHEMBL4537788";"BAY-784";"None";"672.12";"2";"5.26";"EUB0000347";"O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"79.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507266";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"79.0"
"CHEMBL4564280";"";"None";"428.50";"0";"4.67";"49; FM381";"CN(C)C(=O)/C(C#N)=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1";"IC50";"'='";"807.0";"nM";"6.09";"";"";"UO_0000065";"14.22";"0.26";"1.42";"5.87";"0";"CHEMBL5245517";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"807.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445877";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IFN-a, JAK1/TYK2, pSTAT1 in CD3+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"44.0"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445885";"Affinity Phenotypic Cellular interaction: (Whole blood STAT phosphorylation assay (cytokine IL-15, JAK1/3, pSTAT5 in mouse CD8+T cells)) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/20701804/";"";"";"42.0"
"CHEMBL5184447";"";"None";"453.45";"0";"2.75";"13b";"CCNC(=O)C(C)(O)c1ccc(Nc2nc(-c3c(F)cccc3F)nc3c2C(=O)NC3)cc1";"Ki";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"18.68";"0.35";"5.72";"7.29";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"3.4"
"CHEMBL50894";"ALSTERPAULLONE";"None";"293.28";"0";"3.24";"SID103905621";"O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL3582478";"MSD-CYP11B2";"None";"311.36";"0";"3.80";"EUB0000313";"CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507294";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3582478";"MSD-CYP11B2";"None";"311.36";"0";"3.80";"EUB0000313";"CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1";"% Control";"'='";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507294";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"94.0"
"CHEMBL4577237";"BI 9446";"None";"602.48";"2";"5.77";"EUB0000549";"C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507282";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL253969";"OSI-632";"2.0";"532.41";"1";"3.86";"CP-547632";"NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL440687";"ABT-724";"None";"293.37";"0";"2.28";"EUB0000290";"c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507260";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"6; BMS-686165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"19.59";"0.36";"6.55";"6.09";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"5.3"
"CHEMBL4784391";"";"None";"440.45";"0";"2.53";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"17.13";"0.32";"4.96";"5.72";"0";"CHEMBL4775528";"Inhibition of TYK2 in IFN-alpha stimulated human Kit225 T cells by luciferase reporter gene assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"KIT225";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"32.0"
"CHEMBL205798";"GW703087X";"None";"486.93";"1";"5.95";"GW703087X";"CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1";"Inhibition";"'='";"0.26";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.26"
"CHEMBL270995";"BRIVANIB ALANINATE";"3.0";"441.46";"0";"3.42";"Brivanib_alaninate";"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1738797";"ALECTINIB";"4.0";"482.63";"0";"4.77";"Alectinib";"CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2408045";"SAPITINIB";"2.0";"473.94";"0";"3.76";"Sapitinib";"CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1078178";"MOMELOTINIB";"4.0";"414.47";"0";"2.98";"Momelotinib";"N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"Kd";"'='";"401.0";"nM";"6.40";"";"Active";"UO_0000065";"15.43";"0.28";"3.42";"6.20";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.89 None";"";"";"401.0"
"CHEMBL3545366";"VOXTALISIB";"2.0";"270.30";"0";"1.09";"XL-765";"CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3655104";"";"None";"363.45";"0";"0.60";"BDBM159771";"CN(CCC#N)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"1190.0";"nM";"5.92";"";"302665";"UO_0000065";"16.30";"0.32";"5.32";"5.02";"0";"CHEMBL3707947";"Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 Î¼M peptide substrate. The JAK1 and TYK2 assays contained 1 Î¼M of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 Î¼M of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639016";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1190.0"
"CHEMBL5281991";"";"None";"574.66";"1";"4.10";"7";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(N3CCCCCC3=O)cc2)c1OC";"Tm";"'='";"64.85";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"64.85"
"CHEMBL5285091";"";"None";"574.66";"1";"4.32";"4";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NC(=O)C3CCCC3)cc2)c1OC";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.99";"0.26";"3.68";"4.89";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"10.0"
"CHEMBL5289104";"";"None";"556.60";"1";"3.54";"17";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-c3cccc(=O)[nH]3)cc2)c1OC";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"13.11";"0.24";"3.72";"4.34";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"55.0"
"CHEMBL5284232";"";"None";"529.58";"1";"3.37";"20";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccnc3)cc2)c1OC";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"13.85";"0.26";"3.92";"4.79";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"51.0"
"CHEMBL5396848";"";"None";"438.52";"0";"2.91";"15";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc2c1N(C)Cc1nn(C([2H])([2H])[2H])nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360385";"Inhibition of TYK2 in HEK-Blue IL-23 cells pretreated for 60 mins followed by IL-23 stimulation for 22 to 24 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IL-23";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 23.0 hrs | TIME_Upper = 25.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL5413110";"";"None";"448.55";"0";"4.07";"17";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)[C@@H](C)c1nn(C)nc1-2";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL3545215";"BMS-911543";"2.0";"432.53";"0";"3.50";"11, BMS-911543";"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"16.60";"0.31";"3.68";"8.37";"0";"CHEMBL3625648";"Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621135";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";"";"";"";"66.0"
"CHEMBL4568183";"SR-301";"None";"673.84";"1";"3.82";"EUB0001060";"CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507324";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL4780458";"";"None";"457.42";"0";"4.04";"EUB0000540";"O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1";"% Control";"'='";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507297";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"82.0"
"CHEMBL4282264";"A-485";"None";"536.48";"1";"3.68";"EUB0000328";"CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O";"% Control";"'='";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507259";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"91.0"
"CHEMBL1834199";"BI 99990";"None";"391.47";"0";"4.15";"EUB0000738";"CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507280";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1794058";"GW278681X";"None";"329.38";"0";"2.46";"GW278681X";"CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1";"Inhibition";"'='";"3.51";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"3.51"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"De";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Tm";"'='";"56.72";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"56.72"
"CHEMBL274654";"ORANTINIB";"3.0";"310.35";"0";"3.14";"Orantinib";"Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2028663";"DABRAFENIB";"4.0";"519.57";"2";"5.36";"Dabrafenib";"CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1976040";"ADAVOSERTIB";"2.0";"500.61";"1";"2.89";"MK-1775";"C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3218578";"BGT-226";"2.0";"534.54";"1";"4.38";"BGT-226";"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL607707";"PELITINIB";"2.0";"467.93";"1";"5.10";"Pelitinib";"CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5182374";"";"None";"565.50";"1";"2.65";"12b";"CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(O[C@@H]5CO[C@H]6[C@@H]5OC[C@@H]6O)n4)cc3Cl)CC2)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"11.97";"0.24";"4.12";"7.09";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"170.0"
"CHEMBL5207354";"";"None";"585.11";"1";"3.22";"12f";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1CCC2(CCN(C)CC2)CC1";"IC50";"'='";"233.0";"nM";"6.63";"";"";"UO_0000065";"11.34";"0.22";"3.41";"5.47";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"233.0"
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"7";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4714262";"Inhibition of recombinant human Tyk2 expressed in sf21 baculovirus expression system assessed as phosphorylation level in presence of 1 mM ATP";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"";"";"10000.0"
"CHEMBL4561806";"BTZO-4";"None";"242.30";"0";"2.62";"EUB0001135";"O=C1NC(c2ccccn2)Sc2ccccc21";"% Control";"'='";"86.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507329";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"86.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"6";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"19.42";"0.38";"6.11";"5.98";"0";"CHEMBL3299203";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297690";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"61.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"489.0";"nM";"6.31";"";"";"UO_0000065";"20.20";"0.37";"4.77";"7.10";"0";"CHEMBL3299203";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297690";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"489.0"
"CHEMBL3039513";"DECERNOTINIB";"2.0";"392.39";"0";"3.28";"7";"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3299203";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3297690";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"10000.0"
"CHEMBL4539555";"BI 9307";"None";"546.61";"1";"1.77";"EUB0000343";"CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507278";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL223360";"LINIFANIB";"3.0";"375.41";"0";"4.90";"ABT-869";"Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908609";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"1";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"25.98";"0.47";"4.49";"9.57";"0";"CHEMBL4341689";"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340536";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"0.011"
"CHEMBL4436748";"SR-318";"None";"459.59";"0";"4.47";"EUB0000132";"Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507315";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL3797887";"(S)-9s";"None";"300.75";"0";"2.20";"EUB0000341";"C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507301";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL260417";"";"None";"373.21";"0";"3.44";"SB-725317";"O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1";"Inhibition";"'='";"-1.54";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-1.54"
"CHEMBL3913693";"";"None";"385.48";"0";"4.06";"BDBM198467";"N#CCc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"353445";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL5400756";"";"None";"406.47";"0";"2.82";"16e";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(C#N)c2)C[C@H]1F";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"14.69";"0.27";"3.15";"6.17";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"1070.0"
"CHEMBL3917954";"";"None";"426.43";"0";"4.31";"BDBM198478";"FC1(F)Oc2ccc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)cc2O1";"IC50";"'='";"520.0";"nM";"6.28";"";"353456";"UO_0000065";"14.74";"0.28";"1.97";"7.03";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"520.0"
"CHEMBL3956911";"";"None";"349.44";"0";"2.72";"BDBM198504";"N#C[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"353482";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3892562";"";"None";"368.49";"0";"2.77";"BDBM198508";"O[C@H]1CC[C@H](NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353486";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3976356";"";"None";"467.62";"0";"4.12";"BDBM198539";"CC(C)(C)OC(=O)NCC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353517";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL598797";"CUDC-101";"1.0";"434.50";"0";"4.20";"CUDC-101";"C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5412034";"";"None";"453.46";"1";"2.06";"2i";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccc(F)cn2)cc1Nc1nccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.06";"nM";"10.22";"";"";"UO_0000065";"22.69";"0.42";"8.16";"7.07";"0";"CHEMBL5365708";"Displacement of fluorescein-labeled kinase tracer from His-TVMV-TYK2 JH2 (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365398";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"TIME = 1.5 hr";"INHIBITOR";"";"0.06"
"CHEMBL3905358";"";"None";"348.41";"0";"3.09";"BDBM198418";"C(=C/c1ccco1)\CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"353396";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3978366";"";"None";"375.41";"0";"3.00";"BDBM198426";"N#Cc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1F";"IC50";"'>'";"1000.0";"nM";"";"";"353404";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL3902770";"";"None";"403.45";"0";"2.32";"BDBM198428";"O=C1COc2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2N1";"IC50";"'>'";"1000.0";"nM";"";"";"353406";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL247228";"GW770249X";"None";"431.35";"1";"5.27";"GW770249X";"Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12";"Inhibition";"'='";"0.57";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.57"
"CHEMBL5303356";"";"None";"561.62";"0";"1.79";"EUB0001542aTs";"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1";"IC50";"'='";"305.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445114";"Affinity Phenotypic Cellular interaction: (Human Whole Blood Assay (IL-10 induced pSTAT3 (lymphocytes), TYK2/JAK2 signaling)) EUB0001542aTs TYK2";"F";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"Lymphocyte";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 1.0 uM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL4295354";"Affinity Phenotypic Cellular Source Knowledge: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00917";"";"";"305.0"
"CHEMBL1327969";"";"None";"267.12";"0";"3.64";"1";"O=C(Nc1ccncc1)c1c(Cl)cccc1Cl";"Ki";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"24.85";"0.53";"3.00";"15.81";"0";"CHEMBL2421816";"Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417497";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";"";"0.23"
"CHEMBL2103743";"TOFACITINIB CITRATE";"4.0";"504.50";"0";"1.54";"EUB0000286bCit";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5445802";"Affinity Phenotypic Cellular interaction: (IL-2 induced T cell blast proliferation assay) EUB0000286bCit TYK2";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"T-cell";"None";"Mode of action: Inhibitor | Protein family: Protein kinase | Recommended concentration = 100.0 nM";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5444388";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307588";"Affinity Phenotypic Cellular Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/14593182/";"";"";"11.0"
"CHEMBL4279883";"";"None";"436.42";"0";"1.27";"3";"CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NC[C@](C)(O)CO)cnc12";"EC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"19.29";"0.37";"7.15";"6.33";"0";"CHEMBL4414853";"Inhibition of TYK2 JH2 (unknown origin) by Scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0038"
"CHEMBL1990288";"";"None";"399.43";"1";"5.36";"SID103904425";"CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL1336";"SORAFENIB";"4.0";"464.83";"1";"5.55";"Sorafenib";"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL4440718";"";"None";"401.47";"0";"2.12";"48";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"17.28";"0.34";"4.77";"5.47";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.13"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"2, INCB018424";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"EC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"26.11";"0.48";"4.53";"9.62";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"10.0"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"23";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"23.11";"0.43";"5.08";"9.71";"0";"CHEMBL4251840";"Displacement of [3H]-(R)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide from N-terminal His-tagged TYK2 JH2 domain (unknown origin) after 30 mins by scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"0.008"
"CHEMBL4092805";"";"None";"309.40";"0";"0.86";"6";"CCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL4630642";"BAY-974";"None";"422.49";"0";"4.42";"EUB0000707";"CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1";"% Control";"'='";"88.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"88.0"
"CHEMBL5083125";"";"None";"533.45";"1";"3.07";"6";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(CN4CCOCC4)c3)ncc2Br)cc1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"13.45";"0.30";"4.10";"5.86";"0";"CHEMBL5046599";"Inhibition of human TYK2 (875 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"67.0"
"CHEMBL3655081";"ABROCITINIB";"4.0";"323.42";"0";"1.25";"Abrocitinib";"CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"21.01";"0.42";"5.55";"7.47";"0";"CHEMBL4612624";"Inhibition of N-terminal GST-tagged human TYK2 catalytic domain (871 to 1187 residues) incubated for 40 mins in presence of TK substrate-biotin by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610114";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.16"
"CHEMBL4630644";"BAY-386";"None";"514.53";"1";"3.27";"EUB0000291";"O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1";"% Control";"'='";"53.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507269";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"53.0"
"CHEMBL3719135";"";"None";"423.44";"0";"3.05";"14";"CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@H]1[C@@H]2CN(C3COC3)C[C@@H]21";"Inhibition";"'='";"10.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4120129";"Inhibition of recombinant N-terminal GST-tagged human TYK2 (833 to 1187 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118097";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"10.7"
"CHEMBL495727";"AT-9283";"2.0";"381.44";"0";"2.07";"AT-9283";"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1";"Kd";"'='";"279.0";"nM";"6.55";"";"Active";"UO_0000065";"17.18";"0.32";"4.48";"5.91";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"r = 0.91 None";"";"";"279.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"11; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Ki";"'='";"0.02";"nM";"10.70";"";"";"UO_0000065";"25.33";"0.47";"8.97";"7.87";"1";"CHEMBL4377473";"Inhibition of fluorescein labeled probe binding to His-tagged human TYK2 pseudokinase domain (575-869 residues) by Morrison titration based HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.02"
"CHEMBL4539943";"BAY-694";"None";"505.57";"1";"3.60";"EUB0000725";"O=C(O)[C@@H]1[C@@H](Cn2nnc3ccccc3c2=O)CC[C@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507264";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4784391";"";"None";"440.45";"0";"2.53";"14";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncc(F)cn2)c1OC";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"19.94";"0.37";"6.19";"6.66";"0";"CHEMBL4775527";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765480";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"1.9"
"CHEMBL1614713";"CC-401";"2.0";"388.48";"0";"3.88";"CC-401";"c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL233001";"GW620972X";"None";"332.43";"0";"4.90";"GW620972X";"N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2";"Inhibition";"'='";"-0.41";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.41"
"CHEMBL1721885";"SU-014813";"2.0";"442.49";"0";"1.69";"SU-14813";"Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL491473";"CEDIRANIB";"3.0";"450.51";"1";"5.22";"Cediranib";"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3186534";"RIVOCERANIB";"3.0";"397.48";"0";"4.68";"Apatinib";"N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3301612";"ENCORAFENIB";"4.0";"540.02";"1";"3.91";"Encorafenib";"COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL561132";"MK-7246";"1.0";"416.47";"0";"3.04";"EUB0000297";"CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507290";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4100408";"TP-024n";"None";"377.39";"0";"4.22";"EUB0000336";"Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507305";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"4";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"Ki";"'='";"0.06";"nM";"10.22";"";"";"UO_0000065";"27.90";"0.52";"7.92";"7.51";"0";"CHEMBL4414854";"Inhibition of TYK2 JH2 (unknown origin) by morrison titration assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00006"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"489.0";"nM";"6.31";"";"";"UO_0000065";"20.20";"0.37";"4.77";"7.10";"1";"CHEMBL4411593";"Inhibition of human TYK2 using fluorescence labeled peptide as substrate and using 1 mM ATP level by microfluidic based mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4411260";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"489.0"
"CHEMBL4552354";"BI 3017";"None";"407.43";"0";"1.30";"EUB0001066";"Cc1nccc(COC(=O)N2C[C@@H]3[C@@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@@H]3C2)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507275";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4066040";"A-1596584";"None";"539.53";"2";"5.45";"EUB0000264";"COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1";"% Control";"'='";"85.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507262";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"85.0"
"CHEMBL4552354";"BI 3017";"None";"407.43";"0";"1.30";"EUB0001066";"Cc1nccc(COC(=O)N2C[C@@H]3[C@@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@@H]3C2)n1";"% Control";"'='";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507275";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"82.0"
"CHEMBL4521353";"";"None";"230.31";"0";"2.99";"9";"CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4352581";"Inhibition of human TYK2 at 10 uM using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]-ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350963";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL4580220";"BAY-3827";"None";"468.54";"1";"5.45";"EUB0000311";"CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12";"% residual kinase activity";"'='";"87.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4884515";"TYK2(h) Eurofins kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"87.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"EUB0000626a";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"16.30";"0.32";"4.96";"7.17";"0";"CHEMBL5212898";"Selectivity interaction (Radiometric kinase assay) EUB0000626a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2023";"None";"Selectivity Comments: Flow Cytometry (JAK1-JAK3 involved, STAT6 phosphorylation induced by IL-2 in NK-92 cells): IC50 = 347 nM, PMID: 24006460; Flow Cytometry (JAK1-TYK2 involved, STAT1 phosphorylation induced by IFN-aB2 in U2OS cells): IC50 =  468 nM, PMID: 24006460; | Selectivity Remarks: In-vitro potency | Selectivity Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/24006460/";"";"";"116.0"
"CHEMBL3701197";"A-226";"None";"221.27";"0";"3.78";"EUB0000547";"CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507256";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4532948";"";"None";"434.44";"0";"1.90";"6";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"16.32";"0.30";"5.19";"6.00";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"81.0"
"CHEMBL4549667";"TP-030-2";"None";"481.35";"0";"3.12";"EUB0000720";"CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"12.46";"0.26";"2.88";"8.87";"0";"CHEMBL4885179";"Tyk2(TYK2LGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507326";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"6.0"
"CHEMBL4568735";"NVS-MALT1";"None";"574.03";"1";"4.72";"EUB0000239";"CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507320";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL225519";"";"None";"213.24";"0";"1.36";"SID103905167";"O=C1NCCc2[nH]c(-c3ccncc3)cc21";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL565612";"SOTRASTAURIN";"2.0";"438.49";"0";"2.43";"SID103905056";"CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL38380";"FASUDIL";"3.0";"291.38";"0";"1.22";"SID103905389";"O=S(=O)(c1cccc2cnccc12)N1CCCNCC1";"Ki";"'>'";"1995.26";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"5.7"
"CHEMBL5184019";"";"None";"531.01";"1";"2.05";"12k";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1CCN(CC)CC1";"IC50";"'='";"166.0";"nM";"6.78";"";"";"UO_0000065";"12.77";"0.25";"4.73";"5.59";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"166.0"
"CHEMBL5079734";"";"None";"322.42";"0";"2.65";"15";"Cn1cc(Nc2ncc3cccc(CC4CCNCC4)c3n2)cn1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"21.71";"0.40";"4.35";"10.35";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.0"
"CHEMBL5074310";"";"None";"356.40";"0";"3.08";"46f";"CCc1cc(O)c(F)cc1-c1cc(N[C@H](C)CO)c2nc(N)ncc2c1";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"18.80";"0.35";"3.62";"6.42";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"6.7"
"CHEMBL5078141";"";"None";"356.40";"0";"3.08";"46g";"CCc1cc(O)c(F)cc1-c1cc(NC[C@H](C)O)c2nc(N)ncc2c1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"21.04";"0.39";"4.42";"7.19";"0";"CHEMBL5047429";"Inhibition of human TYK2 (888 to 1178 residues) expressed in insect cells using ULight-JAK-1 Tyr1023 peptide as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins in presence of ATP by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046242";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";"";"7.5"
"CHEMBL576982";"QUIZARTINIB";"4.0";"560.68";"2";"5.86";"AC220";"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL105442";"CI-1040";"2.0";"478.66";"1";"5.04";"CI-1040";"O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"3";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.52";"0.23";"1.82";"5.05";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"1.0"
"CHEMBL3907057";"BAY-826";"None";"558.54";"2";"7.59";"EUB0000713";"Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1";"% Control";"'='";"76.9";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507270";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"76.9"
"CHEMBL1939880";"BI 4395";"None";"374.40";"0";"3.20";"EUB0000727";"Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1";"% Control";"'='";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507281";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"82.0"
"CHEMBL4780458";"";"None";"457.42";"0";"4.04";"EUB0000540";"O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1";"% Control";"'='";"79.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507297";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"79.0"
"CHEMBL1572928";"";"None";"315.33";"0";"4.14";"BDBM107127";"O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)c1ccco1";"IC50";"'>'";"50000.0";"nM";"";"";"226437";"UO_0000065";"";"";"";"";"0";"CHEMBL3707588";"In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638666";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"50000.0"
"CHEMBL5180664";"";"None";"562.65";"1";"3.67";"10";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)N(CC)CC)cc2)c1OC";"Tm";"'='";"66.27";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"66.27"
"CHEMBL5203256";"";"None";"596.63";"1";"3.16";"32";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cc(F)cc(C(=O)Nc2ccc(NC[C@H]3COCCO3)cc2)c1OC";"Tm";"'='";"59.95";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131232";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 1.0 microM";"INHIBITOR";"";"59.95"
"CHEMBL5177410";"";"None";"576.67";"1";"4.03";"28";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(NCC3CCOCC3)cc2)c1OC";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"14.35";"0.27";"4.20";"5.29";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"5.9"
"CHEMBL4293907";"";"None";"350.43";"0";"3.02";"4";"CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12";"Ki";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4402446";"Inhibition of TYK2 JH2 domain in human whole blood assessed as decrease in IFNalpha/IL2-induced STAT phosphorylation preincubated for 1 hr followed by IFNalpha/IL2 stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";""
"CHEMBL5189913";"";"None";"520.56";"1";"2.55";"8";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(C(=O)NC)cc2)c1OC";"Tm";"'='";"57.96";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"57.96"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"4";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"21.36";"0.40";"5.52";"5.75";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.015"
"CHEMBL204232";"NAPHTHYRIDINONE";"None";"514.80";"2";"6.39";"EUB0000296";"CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL204232";"NAPHTHYRIDINONE";"None";"514.80";"2";"6.39";"EUB0000296";"CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507287";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5191734";"";"None";"600.12";"2";"2.12";"12d";"C=CC(=O)Nc1cc(Nc2ncc(Cl)c(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4O)n2)ccc1N1CCC(N2CCN(C)CC2)CC1";"IC50";"'='";"369.0";"nM";"6.43";"";"";"UO_0000065";"10.72";"0.21";"4.31";"5.16";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"369.0"
"CHEMBL5402702";"";"None";"437.54";"0";"3.51";"14";"[2H]C([2H])([2H])CC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1cccc2c1N(C)Cc1nn(C([2H])([2H])[2H])nc1-2";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"17.43";"0.32";"4.01";"7.16";"0";"CHEMBL5360386";"Inhibition of TYK2 in HEK-Blue alpha/beta cells pretreated for 60 mins followed by IFN-alpha stimulation for 16 to 18 hrs by Quanti-Blue based SEAP assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK-Blue IFN-alpha/beta";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5357075";"1";"Scientific Literature";"ACS Med Chem Lett";"2024";"None";"TIME_Lower = 17.0 hrs | TIME_Upper = 19.0 hrs";"INHIBITOR";"";"30.0"
"CHEMBL3655095";"";"None";"335.43";"0";"1.25";"29";"CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC2)C1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4022977";"Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020822";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"200.0"
"CHEMBL491473";"CEDIRANIB";"3.0";"450.51";"1";"5.22";"AZD-2171";"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1";"Kd";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"10000.0"
"CHEMBL4539555";"BI 9307";"None";"546.61";"1";"1.77";"EUB0000343";"CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507278";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4540759";"BI 0054";"None";"382.39";"0";"2.12";"EUB0000545";"CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507279";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1909384";"";"None";"378.82";"0";"0.26";"SB-772077-B";"CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl";"Inhibition";"'='";"-0.04";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-0.04"
"CHEMBL191003";"JNJ-7706621";"None";"394.36";"0";"1.22";"1, JNJ-7706621";"Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL1292869";"Inhibition of TYK2-mediated INFgamma production in IL-12-stimulated human PBMC at 10 uM treated for 15 mins before IL12 challenge measured after 48 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"GI50";"'='";"1524.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713249";"Inhibition of TYK2 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 72.0 hr";"INHIBITOR";"";"1.524"
"CHEMBL3907076";"";"None";"354.46";"0";"2.34";"BDBM198469";"OC[C@@H]1CCCN1C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1";"IC50";"'='";"350.0";"nM";"6.46";"";"353447";"UO_0000065";"18.21";"0.34";"4.12";"7.84";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"350.0"
"CHEMBL3939232";"";"None";"340.43";"0";"1.99";"BDBM198530";"OCC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1";"IC50";"'='";"550.0";"nM";"6.26";"";"353508";"UO_0000065";"18.39";"0.34";"4.27";"6.87";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"550.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"11; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"19.05";"0.35";"6.32";"5.92";"0";"CHEMBL4377388";"Inhibition of TYK2 in human PBMC assessed as decrease in IL23-induced STAT3 phosphorylation in CD161+/CD3+ T cells preincubated for 1 hr followed by stimulation with IL-23 for 15 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"9.0"
"CHEMBL5423387";"";"None";"406.47";"0";"2.82";"17f";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C#N)cc2)C[C@@H]1F";"IC50";"'='";"239.2";"nM";"6.62";"";"";"UO_0000065";"16.29";"0.30";"3.80";"6.84";"0";"CHEMBL5377861";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr by TR-FRET Lanthascreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5375974";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"239.2"
"CHEMBL4537788";"BAY-784";"None";"672.12";"2";"5.26";"EUB0000347";"O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"92.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507266";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"92.0"
"CHEMBL2387224";"";"None";"350.20";"0";"3.99";"1";"O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl";"Ki";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"23.75";"0.49";"4.33";"11.70";"1";"CHEMBL4046589";"Inhibition of TYK2 (unknown origin) by biochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043190";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"4.8"
"CHEMBL5405538";"";"None";"435.49";"0";"1.80";"71-2";"CNc1cc(Nc2cccc3c2OCCC3)nc2c(C(=O)N[C@@H]3CCN(C)C3=O)cnn12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.73";"0.35";"6.35";"7.22";"0";"CHEMBL5383650";"Inhibition of TYK2 JH2 in human TF-1 cells assessed as reduction of IFNalpha induced STAT1 phosphorylation";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"TF-1";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.007"
"CHEMBL5421204";"";"None";"309.37";"0";"2.29";"3";"C[C@H]1CC(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"24.41";"0.45";"5.26";"8.82";"0";"CHEMBL5346994";"Inhibition of recombinant human TYK2 (871 to end residues) using biotinylated TK substrate in presence of [33P]ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"28.0"
"CHEMBL4538591";"BAY-440";"None";"574.01";"1";"4.47";"EUB0000701";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"% Control";"'='";"77.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"77.0"
"CHEMBL4592872";"BAY-897";"None";"457.48";"1";"6.33";"EUB0000340";"O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507317";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL2387223";"";"None";"376.75";"0";"3.29";"37";"N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1";"EC50";"'='";"224.0";"nM";"6.65";"";"";"UO_0000065";"17.65";"0.35";"3.36";"7.01";"0";"CHEMBL2389438";"Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2385054";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";"";"224.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"De";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"20.11";"0.37";"6.76";"6.25";"0";"CHEMBL5131233";"Inhibition of TYK2 in human Jurkat cells assessed as reduction in IFNalpha induced STAT3 phosphorylation incubated for 24 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 24.0 hr";"INHIBITOR";"";"3.2"
"CHEMBL4516982";"BI 1935";"None";"498.47";"0";"3.80";"EUB0000542";"CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O";"% Control";"'='";"77.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507283";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"77.0"
"CHEMBL4282264";"A-485";"None";"536.48";"1";"3.68";"EUB0000328";"CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O";"% Control";"'='";"86.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507259";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"86.0"
"CHEMBL4588900";"BI 1230";"None";"816.98";"3";"6.14";"EUB0001182";"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507284";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4458424";"BAY-899";"None";"459.46";"1";"5.12";"EUB0000240";"O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507317";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4630641";"A-769";"None";"339.47";"0";"3.00";"EUB0000332";"CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507260";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4551344";"A-1210227";"None";"904.37";"3";"8.88";"EUB0000746";"O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1";"% Control";"'='";"73.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"73.0"
"CHEMBL4513786";"A-545";"None";"532.72";"2";"5.54";"EUB0002783a";"CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507258";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"66.9";"nM";"7.17";"";"";"UO_0000065";"15.38";"0.28";"2.82";"10.33";"0";"CHEMBL4686942";"Inhibition of human recombinant TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680251";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"66.9"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"13.13";"0.25";"3.61";"5.78";"1";"CHEMBL4714262";"Inhibition of recombinant human Tyk2 expressed in sf21 baculovirus expression system assessed as phosphorylation level in presence of 1 mM ATP";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706695";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";"";"2600.0"
"CHEMBL4575813";"";"None";"464.36";"0";"4.92";"8b";"O=C(CCCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"15.13";"0.31";"2.11";"6.01";"0";"CHEMBL4347603";"Inhibition of recombinant human TYK2 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4346670";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.094"
"CHEMBL3644620";"";"None";"566.64";"2";"5.01";"2; PF-06263276";"CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cnc(N5CCCCC5)cn3)C4)n[nH]c2c1";"IC50";"'='";"29.7";"nM";"7.53";"";"";"UO_0000065";"13.28";"0.24";"2.52";"5.93";"0";"CHEMBL4003450";"Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002590";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"29.7"
"CHEMBL2170610";"BI 9627";"None";"356.35";"0";"2.05";"EUB0000295";"CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507279";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1651534";"REDAFAMDASTAT";"2.0";"455.44";"1";"5.39";"EUB0000306";"O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507297";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3358954";"BI 653048";"1.0";"515.53";"1";"3.80";"EUB0000314";"CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1";"% Control";"'='";"93.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507277";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"93.0"
"CHEMBL1834199";"BI 99990";"None";"391.47";"0";"4.15";"EUB0000738";"CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507280";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL1091513";"MRK-560";"None";"517.93";"1";"4.67";"EUB0000750";"O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507288";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4865102";"";"None";"524.58";"1";"1.76";"14i";"N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4C(=O)CN3CCS(=O)(=O)CC3)ncc2F)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.58";"0.32";"6.94";"6.34";"0";"CHEMBL4825784";"Inhibition of recombinant human TYK2 (875 to end residues) using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"2.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Ki";"'='";"0.02";"nM";"10.70";"";"";"UO_0000065";"25.33";"0.47";"8.97";"7.87";"0";"CHEMBL4434406";"Binding affinity to TYK2 pseudokinase domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4433255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"0.02"
"CHEMBL4524832";"";"None";"424.44";"0";"2.83";"18";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.64";"0.29";"3.81";"5.66";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"230.0"
"CHEMBL5092000";"";"None";"498.55";"0";"3.79";"27";"Cn1ncc2cc(-c3cnc(Nc4ccc([N+](=O)[O-])cc4)nc3N3CCC4(CCNC4=O)CC3)ccc21";"Activity";"'='";"99.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"99.0"
"CHEMBL5081340";"";"None";"524.59";"1";"4.30";"28";"Cn1cc(-c2ccc(-c3cnc(Nc4ccc([N+](=O)[O-])cc4)nc3N3CCC4(CCNC4=O)CC3)cc2)cn1";"Activity";"'='";"105.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"105.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"INCB";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"10.3";"nM";"7.99";"";"";"UO_0000065";"26.07";"0.47";"4.52";"9.60";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"10.3"
"CHEMBL4436895";"";"None";"388.20";"0";"3.79";"46";"O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1";"Activity";"'='";"52.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4366011";"Inhibition of wild-type human partial length TYK2 JH2 pseudokinase domain (G556 to D888 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364269";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"52.0"
"CHEMBL509032";"TAE-684";"None";"614.22";"2";"5.02";"TAE-684";"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1";"Kd";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.31";"0.19";"0.70";"5.56";"0";"CHEMBL1908610";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1908390";"1";"Scientific Literature";"Nat Biotechnol";"2011";"None";"";"";"";"1900.0"
"CHEMBL4580220";"BAY-3827";"None";"468.54";"1";"5.45";"EUB0000311";"CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5075663";"";"None";"382.42";"0";"2.54";"14";"Cc1cnc(Nc2ccc([N+](=O)[O-])cc2)nc1N1CCC2(CCNC2=O)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"20.62";"0.38";"5.35";"6.96";"0";"CHEMBL5041945";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"13.0"
"CHEMBL5080035";"";"None";"383.45";"0";"2.34";"10";"COc1ccc(Nc2nccc(N3CCC4(CCNC4=O)CC3)n2)cc1OC";"Activity";"'='";"72.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5042020";"Inhibition of TYK2 (unknown origin) assessed as remaining activity at 1 uM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038661";"1";"Scientific Literature";"J Med Chem";"2022";"None";"Dose = 1.0 microM";"";"";"72.0"
"CHEMBL402548";"DANUSERTIB";"2.0";"474.57";"0";"2.64";"Danusertib";"CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL1908394";"GSK-461364";"1.0";"543.62";"2";"5.09";"GSK-461364";"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL5180050";"";"None";"434.45";"0";"4.25";"30";"O=C1NCc2nc(-c3c(F)cccc3F)cc(Nc3ccc(C(=O)N4CCCC4)cc3)c21";"Ki";"'='";"0.51";"nM";"9.29";"";"";"UO_0000065";"21.39";"0.40";"5.04";"12.50";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.51"
"CHEMBL1852688";"INFIGRATINIB";"4.0";"560.49";"2";"5.35";"EUB0000678a";"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5473737";"Selectivity interaction (Kinase panel (Enzymatic assay, microfluidic mobility shift readout, Caliper lifesciences, conc.  ATP = Km for each kinase)) EUB0000678a TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity Comments: Strong effect toward FGFR3 mutants K650E and S249C with IC50s of ~5 nM (PMID:  21936542) | Selectivity number of off-targets = 4.0 None | Selectivity number of targets = 67.0 None | Selectivity Remarks: In-vitro potency | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/21936542/";"";"";"10.0"
"CHEMBL4564312";"BAY-786";"None";"672.12";"2";"5.26";"EUB0000335";"O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"73.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507266";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"73.0"
"CHEMBL1096626";"GSK-938890A";"None";"447.50";"0";"2.28";"GSK938890A";"CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21";"Inhibition";"'='";"0.35";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962303";"GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"0.35"
"CHEMBL5266102";"";"None";"1032.28";"None";"None";"5";"CNC(=O)c1cnc(Nc2ccc(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)cn2)cc1Nc1cccc(C(=O)NC)c1OC";"Activity";"";"";"";"";"";"Active";"";"";"";"";"";"0";"CHEMBL5225298";"Induction of TYK2 degradation in human Jurkat cells at 1 to 10 uM pretreated with MG-132 followed by compound treatment for 24 hrs by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5223147";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE_Lower = 1.0 microM | DOSE_Upper = 10.0 microM | TIME = 24.0 hr";"DEGRADER";"";""
"CHEMBL2170610";"BI 9627";"None";"356.35";"0";"2.05";"EUB0000295";"CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507279";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4459585";"ROPSACITINIB";"2.0";"383.42";"0";"2.54";"10; PF-06826647";"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.26";"0.37";"5.23";"6.85";"0";"CHEMBL4377467";"Inhibition of recombinant human TYK2 JH1 kinase domain using 5FAM-KKSRGDYMTMQID as substrate incubated for 135 mins by caliper method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"17.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"11; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4377471";"Inhibition of fluorescein labeled probe binding to human recombinant TYK2 JH1 domain incubated for 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"10000.0"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"6";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"14.01";"0.27";"2.42";"6.80";"0";"CHEMBL4377459";"Inhibition of N-terminal His-tagged and C-terminal FLAG-tagged human TYK2 JH1 domain (880 to 1185 residues) in presence of 0.1 mM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"4690.0"
"CHEMBL4761365";"";"None";"411.94";"0";"4.04";"38b";"CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"14.63";"0.28";"1.99";"8.25";"0";"CHEMBL4713242";"Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706658";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.5 hr";"INHIBITOR";"";"940.0"
"CHEMBL4526283";"";"None";"415.45";"0";"2.87";"23";"CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"16.23";"0.32";"3.87";"5.96";"0";"CHEMBL4414793";"Inhibition of TYK2 JH2 domain in human whole blood assessed as inhibition of IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by IFNalpha stimulation and measured after 15 mins by fluorescence assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.18"
"CHEMBL4440718";"";"None";"401.47";"0";"2.12";"48";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"23.28";"0.45";"7.16";"7.36";"0";"CHEMBL4414785";"Inhibition of fluorescein-labeled kinase tracer binding to His-TVMV-fused TYK2 JH2 domain (575 to 869 residues) (unknown origin) measured after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.00053"
"CHEMBL4513786";"A-545";"None";"532.72";"2";"5.54";"EUB0002783a";"CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC";"% Control";"'='";"95.8";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507258";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"95.8"
"CHEMBL4445670";"BAY-885";"None";"515.54";"1";"3.28";"EUB0000250";"CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1";"% residual kinase activity";"'='";"110.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4881275";"TYK2(h) Eurofins Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"110.0"
"CHEMBL1939880";"BI 4395";"None";"374.40";"0";"3.20";"EUB0000727";"Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1";"% Control";"'='";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507281";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"94.0"
"CHEMBL5416410";"";"None";"506.03";"0";"3.31";"A8";"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O";"Activity";"'>'";"75.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4808037";"Inhibition of TYK2 (unknown origin) assessed as residual activity measured at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4806967";"38";"SureChEMBL Patent Bioactivity Data";"";"2020";"None";"Dose = 1.0 microM";"";"";"75.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"3";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"19.59";"0.38";"6.18";"6.03";"1";"CHEMBL4341340";"Inhibition of recombinant epitope tagged Tyk2 kinase domain (873 to 1187 residues) (unknown origin) using peptide substrate by fluorescence based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340527";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"53.0"
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"VX-680";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"Ki";"'='";"199.53";"nM";"6.70";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963765";"PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";"";"6.7"
"CHEMBL3671804";"";"None";"378.48";"0";"2.81";"22";"CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccnc4)cc23)CC[C@]1(C)N";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"19.73";"0.36";"4.66";"6.71";"0";"CHEMBL4054820";"Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052645";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"34.0"
"CHEMBL4228713";"A-1211212";"None";"896.51";"3";"9.44";"EUB0000263";"CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"% Control";"'='";"67.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"67.0"
"CHEMBL1230607";"PHA-793887";"1.0";"361.49";"0";"2.31";"PHA-793887";"CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3675685";"";"None";"364.26";"1";"5.01";"BDBM120128";"O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12)C1CC1";"Ki";"'='";"0.5";"nM";"9.30";"";"247334";"UO_0000065";"25.53";"0.55";"4.29";"16.95";"0";"CHEMBL3705206";"Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase reactions containing 1.5 nM JAK1, 0.2 nM purified JAK2 or 1 nM purified TYK2 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 Î¼M peptide substrate, 25 Î¼M ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 Î¼L of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. Ki values were then determined using the Morrison tight binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638741";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"0.5"
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL3417525";"BI 665915";"None";"458.53";"0";"2.78";"EUB0000749";"CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1";"% Control";"'='";"65.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"65.0"
"CHEMBL4453646";"";"None";"321.17";"0";"3.99";"3f";"Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1";"Inhibition";"'='";"79.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4431287";"Inhibition of TYK2 (unknown origin) at 20 nM relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428138";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"79.4"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"2, TG101348";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"13.01";"0.25";"2.00";"6.29";"0";"CHEMBL1292868";"Inhibition of human recombinant TYK2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1287810";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"150.0"
"CHEMBL4063249";"TP-021n";"None";"284.71";"0";"3.12";"EUB0000742";"N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507304";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4098877";"MLi-2";"None";"379.46";"0";"3.56";"EUB0000715";"C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1";"% Control";"'='";"81.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"81.0"
"CHEMBL4557026";"ERKi-NC";"None";"312.33";"0";"1.73";"EUB0000700";"C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1";"% Control";"'='";"69.9";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"69.9"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"2";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"112.0";"nM";"6.95";"";"";"UO_0000065";"22.25";"0.41";"5.41";"7.82";"0";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";"";"112.0"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"7";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"12.67";"0.24";"2.05";"4.20";"0";"CHEMBL4251841";"Inhibition of TYK2 JH2 domain in IL23-stimulated human Kit225 T cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"8.2"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"Upadacitinib";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"19.78";"0.38";"4.61";"9.61";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"30.0"
"CHEMBL561132";"MK-7246";"1.0";"416.47";"0";"3.04";"EUB0000297";"CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507290";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL2035187";"PACRITINIB";"4.0";"472.59";"0";"4.47";"21; SB1518";"C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.45";"0.28";"2.83";"10.79";"1";"CHEMBL5150841";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149977";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";"";"50.0"
"CHEMBL4297507";"DELGOCITINIB";"3.0";"310.36";"0";"1.30";"ent-60, JTE-052";"C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"23.32";"0.43";"5.94";"8.14";"0";"CHEMBL4630017";"Inhibition of N-terminal GST-fused human TyK2 (871 to end residues) expressed in baculovirus expression system using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627398";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.058"
"CHEMBL4440718";"";"None";"401.47";"0";"2.12";"48";"[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4414786";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"50.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"11; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.59";"0.38";"6.97";"6.40";"0";"CHEMBL4377387";"Inhibition of TYK2 in human PBMC assessed as decrease in IFNalpha-induced STAT5 phosphorylation in CD3+ T cells preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"2.0"
"CHEMBL4516843";"BAY-207";"None";"477.37";"1";"5.10";"EUB0000548";"NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1";"% Control";"'='";"80.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507265";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"80.0"
"CHEMBL5091825";"";"None";"485.27";"1";"1.43";"4t";"OCCOCc1cn(CCNc2nonc2/C(=N/O)Nc2ccc(F)c(Br)c2)nn1";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL5058416";"Inhibition of TYK2 (unknown origin) at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055685";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Dose = 1.0 microM";"";"";""
"CHEMBL4540759";"BI 0054";"None";"382.39";"0";"2.12";"EUB0000545";"CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507279";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3617968";"BAY-678";"None";"400.36";"0";"4.11";"EUB0000735";"CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1";"% Control";"'='";"94.9";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507272";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"94.9"
"CHEMBL4584981";"NVS-MALT1-C";"None";"574.03";"1";"4.72";"EUB0000747";"CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507320";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1, CP-690550, Tofacitinib";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"Ki";"'='";"4.39";"nM";"8.36";"";"";"UO_0000065";"26.75";"0.50";"6.82";"9.40";"0";"CHEMBL2155752";"Inhibition of human recombinant GST-tagged TYK2 using 5-FAM-KKSRGDYMTMQIG as substrate by peptide mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150873";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"4.39"
"CHEMBL1939876";"BI 4394";"None";"446.46";"0";"3.37";"EUB0000730";"CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1";"% Control";"'='";"90.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507281";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"90.0"
"CHEMBL4538591";"BAY-440";"None";"574.01";"1";"4.47";"EUB0000701";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"% Control";"'='";"51.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"51.0"
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL5184447";"";"None";"453.45";"0";"2.75";"13b";"CCNC(=O)C(C)(O)c1ccc(Nc2nc(-c3c(F)cccc3F)nc3c2C(=O)NC3)cc1";"Ki";"'='";"0.24";"nM";"9.62";"";"";"UO_0000065";"21.21";"0.40";"6.87";"8.28";"0";"CHEMBL5105736";"Inhibition of TYK2 JH1 domain (unknown origin) measured in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5104135";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"0.24"
"CHEMBL1852688";"INFIGRATINIB";"4.0";"560.49";"2";"5.35";"EUB0000678a";"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1";"IC50";"'='";"3303.0";"nM";"5.48";"";"";"UO_0000065";"9.78";"0.20";"0.13";"5.76";"0";"CHEMBL5473738";"Selectivity interaction (Kinase panel (cellular selectivity, Bright-Glo proliferation assay in BaF3 Cell line, Promega)) EUB0000678a TYK2";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BaF3";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"CHEMBL3307634";"Selectivity Comments: Strong effect toward FGFR3 mutants K650E and S249C with IC50s of ~5 nM (PMID:  21936542) | Selectivity number of off-targets = 1.0 None | Selectivity number of targets = 37.0 None | Selectivity Remarks: Cellular potency | Source Knowledge: https://pubmed.ncbi.nlm.nih.gov/21936542/";"";"";"3303.0"
"CHEMBL3899587";"";"None";"420.56";"0";"3.41";"BDBM198507";"OC12CC3CC(C1)C(NC[C@H]1CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC1)C(C3)C2";"IC50";"'>'";"1000.0";"nM";"";"";"353485";"UO_0000065";"";"";"";"";"0";"CHEMBL3887759";"Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 Î¼M, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886441";"37";"BindingDB Patent Bioactivity Data";"";"2015";"None";"";"";"";"1000.0"
"CHEMBL4445670";"BAY-885";"None";"515.54";"1";"3.28";"EUB0000250";"CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1";"% Control";"'='";"93.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507268";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"93.0"
"CHEMBL3955007";"";"None";"438.51";"0";"2.95";"BDBM127821";"Cc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NC3CCC(O)CC3)c2n1";"IC50";"'>'";"1000.0";"nM";"";"";"258570";"UO_0000065";"";"";"";"";"0";"CHEMBL3705450";"Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 Î¼M ATP, 8 Î¼M Omnia Y12 peptide (Catalog # IVGN KPZ3121C; Invitrogen Corporation, Carlsbad, Calif.) and 1 nM Tyk2 in a total volume of 20 Î¼L. Human Tyk2 kinase domain, comprising amino acids 886 to 1187 with 10 additional histidine residues (histidine tag) on the carboxy terminus, was expressed and purified from bacculovirus in-house at Array BioPharma Inc. (Boulder, Colo.). The histidine tag was cleaved after purification using standard conditions.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638907";"37";"BindingDB Patent Bioactivity Data";"";"2014";"None";"";"";"";"1000.0"
"CHEMBL3360356";"";"None";"411.46";"0";"3.98";"BDBM103737";"O=C(Nc1nc2cccc(-c3ccc(CN4CCC(F)(F)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"125.8";"nM";"6.90";"";"221735";"UO_0000065";"16.77";"0.31";"2.92";"11.04";"0";"CHEMBL3707911";"Inhibition Assay: In vitro inhibition assay using various enzyme.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638964";"37";"BindingDB Patent Bioactivity Data";"";"2013";"None";"";"";"";"125.8"
"CHEMBL4538174";"ERKi";"None";"311.35";"0";"2.33";"EUB0000298";"C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1";"% Control";"'='";"94.7";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"94.7"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"4; BMS-98616";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"22.96";"0.43";"7.97";"7.13";"1";"CHEMBL5327930";"Inhibition of TYK2 JH2 domain (unknown origin) by HTRF based binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.2"
"CHEMBL3701197";"A-226";"None";"221.27";"0";"3.78";"EUB0000547";"CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507256";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4516982";"BI 1935";"None";"498.47";"0";"3.80";"EUB0000542";"CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507283";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1; CP-690,550";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"23.61";"0.44";"5.84";"8.30";"0";"CHEMBL4630017";"Inhibition of N-terminal GST-fused human TyK2 (871 to end residues) expressed in baculovirus expression system using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627398";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";"0.042"
"CHEMBL332794";"A-192621";"None";"558.68";"2";"5.81";"EUB0000350";"CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1";"% Control";"'='";"80.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507261";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"80.0"
"CHEMBL4630642";"BAY-974";"None";"422.49";"0";"4.42";"EUB0000707";"CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1";"% Control";"'='";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507319";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"82.0"
"CHEMBL4630644";"BAY-386";"None";"514.53";"1";"3.27";"EUB0000291";"O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1";"% Control";"'='";"94.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507269";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"94.0"
"CHEMBL1971943";"BAY-549";"None";"402.79";"0";"4.71";"EUB0000716";"Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12";"% Control";"'='";"89.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507274";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"89.0"
"CHEMBL4093612";"A-1596586";"None";"539.53";"2";"5.45";"EUB0000544";"COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1";"% Control";"'='";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507262";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"91.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"De";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Tm";"'='";"62.26";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"0";"CHEMBL5131231";"Inhibition of TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126671";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"Dose = 10.0 microM";"INHIBITOR";"";"62.26"
"CHEMBL3622821";"UPADACITINIB";"4.0";"380.37";"0";"2.91";"326";"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"14.01";"0.27";"2.42";"6.80";"1";"CHEMBL5231723";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5230126";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"4.7"
"CHEMBL415049";"BARASERTIB";"3.0";"587.55";"1";"3.62";"Barasertib";"CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"4; BMS-98616";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5327979";"Inhibition of TYK2 JH1 domain (unknown origin) by HTRF based binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"";"";"10000.0"
"CHEMBL3301607";"FILGOTINIB";"4.0";"425.51";"0";"1.98";"Filgotinib";"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"16.33";"0.32";"4.97";"7.19";"0";"CHEMBL5154507";"Inhibition of recombinant human TYK2 using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of Mg/ATP mixture by [gamma p33]-ATP based scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5150077";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR";"";"113.0"
"CHEMBL476351";"GW775608X";"None";"470.57";"0";"4.29";"GW775608X";"Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1";"Inhibition";"'='";"-4.98";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.98"
"CHEMBL4165749";"BI 2545";"None";"527.43";"1";"4.24";"EUB0000318";"O=C(NC[C@@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507275";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3577885";"PF-05105679";"1.0";"428.46";"1";"5.48";"EUB0000304";"C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507296";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL5314423";"ZASOCITINIB";"2.0";"460.50";"0";"1.97";"NDI-032858";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@@H]3CC[C@H]3OC)cnn12";"Kd";"'='";"0.004";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5383644";"Binding affinity to human wild-type partial length TYK2 JH2 (G556 to D888 residues) expressed in mammalian expression system by KINOMEscan assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5380830";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.004"
"CHEMBL1800285";"MSD-M1PAM";"None";"388.43";"0";"2.45";"EUB0000252";"N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1";"% Control";"'='";"99.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507295";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"99.0"
"CHEMBL1834184";"BI 99179";"None";"391.47";"0";"4.15";"EUB0000294";"CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1";"% Control";"'='";"95.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507280";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"95.0"
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"STS";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"Activity";"'<'";"65.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4328664";"Inhibition of human TYK2 assessed as residual activity at 100 uM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay relative to control";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";"";"65.0"
"CHEMBL1643772";"CRTH2-negative-control";"None";"494.57";"0";"2.45";"EUB0000334";"CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507290";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4116008";"CERDULATINIB";"2.0";"445.55";"0";"1.37";"15";"CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"20.88";"0.41";"7.93";"6.96";"0";"CHEMBL5245517";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"0.5"
"CHEMBL4630643";"BAY-448";"None";"458.46";"0";"2.78";"EUB0000333";"Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507269";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4552180";"BAY-588";"None";"527.52";"2";"5.59";"EUB0000251";"Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507267";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4532948";"";"None";"434.44";"0";"1.90";"6";"CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12";"Ki";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"17.50";"0.32";"5.70";"6.43";"0";"CHEMBL4402445";"Inhibition of TYK2 JH2 domain in IFNalpha/IL23-stimulated human Kit225 cells by luciferase reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4400582";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"25.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"4; BMS-98616";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"20.17";"0.38";"6.79";"6.27";"0";"CHEMBL5327988";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human PBMC";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5325475";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"3.0"
"CHEMBL4085457";"RITLECITINIB";"4.0";"285.35";"0";"1.94";"11; PF-06651600";"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5141277";"Inhibition of human TYK2 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137068";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"";"";"10000.0"
"CHEMBL3301610";"ABEMACICLIB";"4.0";"506.61";"1";"4.94";"3";"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1";"Inhibition";"'='";"3.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL4387373";"Inhibition of recombinant human GST-tagged TYK2 catalytic domain (833 to 1187 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4385643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"3.0"
"CHEMBL4440767";"";"None";"397.44";"0";"1.05";"18";"COc1ccc(-c2cc3c(NC(CO)[C@H](O)C4CC4)c(C(N)=O)cnn3c2)cn1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"17.33";"0.32";"5.84";"5.10";"0";"CHEMBL4339746";"Inhibition of Hs-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4339199";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";"";"";"130.0"
"CHEMBL98";"VORINOSTAT";"4.0";"264.32";"0";"2.47";"Vorinostat";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL5038807";"Inhibition of TYK2 (unknown origin) incubated for 40 min in presence of ATP by microplate reader analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038570";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"";"";""
"CHEMBL4165749";"BI 2545";"None";"527.43";"1";"4.24";"EUB0000318";"O=C(NC[C@@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507275";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4098877";"MLi-2";"None";"379.46";"0";"3.56";"EUB0000715";"C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1";"Inhibition";"'='";"1.173";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4882942";"TYK2 Kinase screen";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"";"";"1.1726"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"EC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.67";"0.35";"6.16";"5.80";"0";"CHEMBL4434407";"Inhibition of TYK2 in human whole blood assessed as reduction in IFN-alpha stimulated TYK2 phosphorylation";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4433255";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";"";"13.0"
"CHEMBL4518342";"THPP-1-NC";"None";"493.45";"1";"5.47";"EUB0000744";"CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507293";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL2165191";"AZD-6482";"2.0";"408.46";"0";"2.71";"AZD-6482";"Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL3545396";"BMS-690514";"2.0";"368.44";"0";"1.38";"BMS-690514";"COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL2103830";"FOSTAMATINIB";"4.0";"580.47";"2";"3.09";"Fostamatinib";"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL603469";"LESTAURTINIB";"3.0";"439.47";"0";"3.47";"Lestaurtinib";"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4521594";"BAY-1797";"None";"416.89";"0";"3.96";"EUB0000309";"NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1";"% Control";"'='";"90.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507265";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"90.0"
"CHEMBL4560589";"MLi-2-NC";"None";"393.49";"0";"3.58";"EUB0000706";"C[C@@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1";"% Control";"'='";"51.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"51.0"
"CHEMBL2204283";"MSD-M1PAM-NC";"None";"441.54";"0";"2.99";"EUB0000344";"N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1";"% Control";"'='";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507295";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"91.0"
"CHEMBL4063249";"TP-021n";"None";"284.71";"0";"3.12";"EUB0000742";"N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507304";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"11; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.67";"0.35";"6.16";"5.80";"0";"CHEMBL4377381";"Inhibition of TYK2 in human whole blood assessed as decrease in IFNalpha-induced STAT5 phosphorylation preincubated for 1 hr followed by stimulation with IFN-alpha for 15 mins by fluorescence analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376812";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"13.0"
"CHEMBL4531775";"SR-321";"None";"512.58";"2";"5.91";"EUB0000711";"O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507315";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"100.0"
"CHEMBL409450";"6BIO";"None";"356.18";"0";"3.42";"60; 6B10";"O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"21.12";"0.47";"4.10";"10.20";"0";"CHEMBL5346986";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"30.0"
"CHEMBL4520788";"BAY-294";"None";"448.59";"1";"5.58";"EUB0000743";"CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507273";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3582461";"MSD-CYP11B2-Negative-control";"None";"303.29";"0";"4.45";"EUB0000733";"FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507294";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL4075278";"";"None";"417.85";"0";"4.43";"EUB0000316";"O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507304";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL2204495";"";"None";"399.43";"1";"5.11";"1, GSK2578215A";"O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2209243";"Inhibition of TYK2 JH2 pseudokinase domain assessed as residual activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203081";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"100.0"
"CHEMBL2204495";"";"None";"399.43";"1";"5.11";"1, GSK2578215A";"O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1";"Activity";"'='";"100.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL2209245";"Inhibition of TYK2 JH1 catalytic domain assessed as residual activity at 10 uM relative to control";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203081";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";"";"100.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"De";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Tm";"'='";"56.72";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"1";"CHEMBL5255775";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 1 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 1.0 microM";"INHIBITOR";"";"56.72"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"De";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"19.74";"0.37";"6.61";"6.13";"0";"CHEMBL5255776";"Inhibition of TYK2 dependent IFNalpha-stimulated STAT3 phosphorylation in human Jurkat cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Jurkat";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"";"INHIBITOR";"";"4.6"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"3";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"19.59";"0.38";"6.18";"6.03";"1";"CHEMBL4341347";"Inhibition of Tyk2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4340527";"1";"Scientific Literature";"Bioorg Med Chem";"2019";"None";"";"";"";"53.0"
"CHEMBL2103874";"OCLACITINIB";"2.0";"337.45";"0";"1.45";"11";"CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2[nH]cnc3nccc2-3)CC1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"20.97";"0.42";"5.63";"7.78";"0";"CHEMBL5245508";"Inhibition of recombinant human TYK2 (870 to 1187 residues)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"84.0"
"CHEMBL1789941";"RUXOLITINIB";"4.0";"306.37";"0";"3.47";"2";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"30.68";"0.56";"5.93";"11.30";"0";"CHEMBL3118991";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112442";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";"";"0.4"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"Baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"19.59";"0.38";"6.18";"6.03";"1";"CHEMBL5342287";"Inhibition of recombinant epitope tagged TYK2 (unknown origin) (873 to 1187 residues) using peptide substrate in presence of ATP by time-resolved fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5338778";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"53.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"2";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"Inhibition";"'='";"99.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5364793";"Inhibition of human recombinant N-terminal His-tagged TYK2 (575 to 869 residues) expressed in baculovirus infected Sf9 cells at 1 uM incubated for 30 mins by scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"DOSE = 1.0 microM | TIME = 0.5 hr";"INHIBITOR";"";"99.0"
"CHEMBL4560589";"MLi-2-NC";"None";"393.49";"0";"3.58";"EUB0000706";"C[C@@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1";"% Control";"'='";"82.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507291";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"82.0"
"CHEMBL4588900";"BI 1230";"None";"816.98";"3";"6.14";"EUB0001182";"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C";"% Control";"'='";"74.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507284";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"74.0"
"CHEMBL189963";"PALBOCICLIB";"4.0";"447.54";"0";"2.97";"EUB0001326b";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5482092";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 6.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 0.1 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20339/results";"";"";"100.0"
"CHEMBL21156";"";"None";"309.34";"0";"3.99";"28";"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"29.09";"0.53";"5.01";"14.62";"1";"CHEMBL5150525";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"";"INHIBITOR";"";"1.0"
"CHEMBL5084426";"";"None";"534.52";"1";"4.35";"EUB0001548";"COc1cnccc1Nc1nc(-c2nn(Cc3c(F)cc(OCCO)cc3F)c3ccccc23)ncc1OC";"Inhibition";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL5059978";"TYK2(JH1domain-catalytic) DiscoveRx kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5058649";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2022";"None";"Compound concentration = 1.0 uM";"";"";"100.0"
"CHEMBL4093612";"A-1596586";"None";"539.53";"2";"5.45";"EUB0000544";"COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1";"% Control";"'='";"65.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507262";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"65.0"
"CHEMBL4089234";"";"None";"345.79";"0";"2.48";"14";"N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(Cl)cc2)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"25.16";"0.50";"6.22";"8.21";"0";"CHEMBL4033005";"Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4028908";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";"2.0"
"CHEMBL4082756";"TP-024";"None";"392.36";"0";"3.73";"EUB0000317";"Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507305";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL157258";"";"None";"383.62";"0";"3.83";"SB-390523";"O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1";"Inhibition";"'='";"-4.14";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL1962192";"GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn]";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1961873";"16";"GSK Published Kinase Inhibitor Set";"";"";"None";"";"";"";"-4.14"
"CHEMBL5271559";"";"None";"355.79";"0";"3.42";"3";"NC(=O)c1cnc(Nc2cccc(O)n2)cc1Nc1ccccc1Cl";"IC50";"'='";"2094.0";"nM";"5.68";"";"";"UO_0000065";"15.96";"0.31";"2.26";"5.02";"0";"CHEMBL5252498";"Inhibition of GST-fused Tyk2 (888 to 1187 residues) (unknown origin) using FITC-AhxKKSRGDYMTMQIG-NH2 peptide as substrate incubated for 60 mins in presence of ATP by Janus kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5247683";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 1.0 hr";"INHIBITOR";"";"2094.0"
"CHEMBL296468";"BMS-387032";"1.0";"380.54";"0";"3.66";"SID103905658";"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1";"Kd";"'>'";"30000.0";"nM";"";"";"Inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL3991920";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"B";"BAO_0000220";"subcellular format";"Homo sapiens";"None";"None";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"Direct Binder: no";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3991601";"48";"Kuster Lab Chemical Proteomics Drug Profiling";"Science";"2017";"None";"";"";"";"30000.0"
"CHEMBL4568183";"SR-301";"None";"673.84";"1";"3.82";"EUB0001060";"CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1";"% Control";"'='";"99.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507324";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 100.0 nM";"";"";"99.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"De";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Tm";"'='";"62.26";"degrees C";"";"";"";"UO_0000027";"";"";"";"";"1";"CHEMBL5255774";"Binding affinity to TYK2 JH2 domain (unknown origin) assessed as melting temperature at 10 uM by thermal shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5252617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2023";"None";"DOSE = 10.0 microM";"INHIBITOR";"";"62.26"
"CHEMBL332794";"A-192621";"None";"558.68";"2";"5.81";"EUB0000350";"CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1";"% Control";"'='";"51.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507261";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"51.0"
"CHEMBL4297507";"DELGOCITINIB";"3.0";"310.36";"0";"1.30";"17";"C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"23.32";"0.43";"5.94";"8.14";"1";"CHEMBL5245504";"Inhibition of recombinant human TYK2 (871 to end residues) in the presence of [gamma p33]-ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5244234";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";"";"58.0"
"CHEMBL3417525";"BI 665915";"None";"458.53";"0";"2.78";"EUB0000749";"CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1";"% Control";"'='";"75.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507276";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"75.0"
"CHEMBL4287367";"";"None";"406.44";"0";"4.70";"5";"Fc1cccc(F)c1-c1ccc2[nH]cc(-c3cncc(O[C@@H]4CCCNC4)n3)c2c1";"Kd";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"16.24";"0.30";"1.90";"10.51";"0";"CHEMBL4251860";"Inhibition of fluorescein-labeled kinase tracer binding to TYK2 JH2 domain (unknown origin) after 90 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"250.0"
"CHEMBL221959";"TOFACITINIB";"4.0";"312.38";"0";"1.54";"1";"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12";"IC50";"'='";"489.0";"nM";"6.31";"";"";"UO_0000065";"20.20";"0.37";"4.77";"7.10";"1";"CHEMBL5346986";"Inhibition of TYK2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5346859";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";"";"489.0"
"CHEMBL4435170";"DEUCRAVACITINIB";"4.0";"425.47";"0";"1.73";"3; BMS-986165";"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC";"Kd";"'='";"0.008";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5364832";"Binding affinity to TYK2 JH2 (unknown origin) assessed as dissociation constant";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5360651";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"0.008"
"CHEMBL189963";"PALBOCICLIB";"4.0";"447.54";"0";"2.97";"EUB0001326b";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5482091";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 6.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20339/results";"";"";"100.0"
"CHEMBL1287853";"FEDRATINIB";"4.0";"524.69";"1";"4.82";"5";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1";"Ki";"'='";"405.0";"nM";"6.39";"";"";"UO_0000065";"12.18";"0.24";"1.57";"5.89";"0";"CHEMBL4309408";"Inhibition of human TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4308837";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";"";"405.0"
"CHEMBL3609749";"";"None";"514.48";"1";"4.67";"EUB0000753";"COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1";"% Control";"'='";"100.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880000";"KinomeScan assay: inhibition of TYK2(JH1domain-catalytic)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: V877/C1187 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507289";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"100.0"
"CHEMBL3655081";"ABROCITINIB";"4.0";"323.42";"0";"1.25";"Abrocitinib";"CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1";"IC50";"'='";"549.0";"nM";"6.26";"";"";"UO_0000065";"19.36";"0.39";"5.01";"6.88";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"549.0"
"CHEMBL189963";"PALBOCICLIB";"4.0";"447.54";"0";"2.97";"EUB0001326b";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5482090";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 6.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 0.1 uM (in vitro, TYK2(JH1domain-catalytic)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20339/results";"";"";"100.0"
"CHEMBL5081774";"";"None";"370.42";"0";"3.33";"EUB0002260";"[2H]C([2H])([2H])C1(C([2H])([2H])[2H])Cn2nc(-c3ccc(F)cn3)c(-c3ccnc4[nH]ncc34)c2CO1";"Inhibition";"'='";"-5.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL5059357";"TYK2(h) Kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5058645";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2022";"None";"Compound concentration = 1.0 uM";"";"";"-5.0"
"CHEMBL4561663";"";"None";"366.36";"0";"2.30";"4";"NC(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(N)=O";"EC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"22.33";"0.41";"5.88";"6.01";"0";"CHEMBL4414853";"Inhibition of TYK2 JH2 (unknown origin) by Scintillation proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414548";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";"0.0066"
"CHEMBL189963";"PALBOCICLIB";"4.0";"447.54";"0";"2.97";"EUB0001326b";"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O";"% of control";"'='";"100.0";"%";"";"";"% Of Control";"UO_0000187";"";"";"";"";"0";"CHEMBL5482093";"Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b TYK2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5465560";"65";"EUbOPEN Chemogenomic Library Literature Data";"";"2024";"None";"Selectivity number of off-targets = 6.0 None | Selectivity number of targets = 468.0 None | Selectivity Remarks: Screened at 1 uM (in vitro, TYK2(JH2domain-pseudokinase)) | Source Knowledge: https://lincs.hms.harvard.edu/db/datasets/20339/results";"";"";"100.0"
"CHEMBL4289149";"";"None";"401.35";"0";"3.04";"7";"N#Cc1cc(Nc2cc(NC3CC3)c3ncc(C(N)=O)n3n2)cc(C(F)(F)F)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251839";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"50.0"
"CHEMBL4287153";"";"None";"520.64";"1";"4.18";"3";"CNc1nc2sc(-c3cccc([C@@H](C)NC(=O)c4ccccc4S(C)(=O)=O)c3)nc2c2c1ncn2C";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4251839";"Inhibition of TYK2 JH1 domain (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4251544";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";"";"2.0"
"CHEMBL1873475";"IBRUTINIB";"4.0";"440.51";"0";"4.22";"Ibrutinib";"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4610791";"Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610007";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";"";""
"CHEMBL4522930";"BI-605906";"None";"432.52";"0";"2.49";"EUB0001492";"CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12";"% Ctrl";"'='";"93.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4887618";"TYK2 Invitrogen Lab (UK) kinase screen (BI)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay technology: ZÂ´-LYTE | Mode of action: inhibitor | Target type: Kinase";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4800722";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1.0 uM";"INHIBITOR";"";"93.0"
"CHEMBL2105759";"BARICITINIB";"4.0";"371.43";"0";"1.10";"Baricitinib";"CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"20.56";"0.40";"6.54";"6.34";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"23.0"
"CHEMBL5270549";"";"None";"353.81";"0";"4.02";"1e; CEE321";"Cc1cccc(Nc2cc(Nc3ccccc3Cl)c(C(N)=O)cn2)n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"20.64";"0.40";"3.28";"7.86";"0";"CHEMBL5319086";"Inhibition of TYK2 (unknown origin) by caliper technology";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5316322";"1";"Scientific Literature";"J Med Chem";"2023";"None";"";"INHIBITOR";"";"50.0"
"CHEMBL3589752";"IPP/CNRS-A017";"None";"403.40";"1";"5.45";"EUB0000276";"Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F";"% Control";"'='";"91.0";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4880001";"KinomeScan assay: inhibition of TYK2(JH2domain-pseudokinase)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Amino acid Start/Stop: G556/D888 | Expression system: mammalian | Kinase construct length: Partial Length | Kinase form: Wild Type";"";"";"CHEMBL3553";"Tyrosine-protein kinase TYK2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507312";"54";"SGC Frankfurt - Donated Chemical Probes";"";"2021";"None";"Compound concentration None 1000.0 nM";"";"";"91.0"
